Citrus Sinensis ID: 002178
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 956 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | yes | no | 0.964 | 0.967 | 0.712 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.955 | 0.952 | 0.529 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.937 | 0.956 | 0.534 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.876 | 0.885 | 0.349 | 1e-122 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.850 | 0.697 | 0.299 | 7e-85 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.861 | 0.807 | 0.287 | 4e-79 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.323 | 0.363 | 0.461 | 2e-70 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.292 | 0.327 | 0.474 | 3e-68 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.304 | 0.353 | 0.447 | 7e-68 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.290 | 0.316 | 0.493 | 1e-67 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1351 bits (3497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/930 (71%), Positives = 783/930 (84%), Gaps = 8/930 (0%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
DLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 388
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 389 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 447
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 448 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 507
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 508 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 567
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 568 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 627
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S + S +D M S P EC+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMSSVPDECL 866
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTSKEETPPS 926
EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T + S
Sbjct: 867 EKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETMTHPSSSS 923
Query: 927 SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 924 NSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 962 bits (2488), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/954 (52%), Positives = 666/954 (69%), Gaps = 41/954 (4%)
Query: 27 DDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRE 86
D IT P +VSAL+ + + L D + L +W + DPC SNWTGV+C DG+LH++E
Sbjct: 23 DAQEITHPTDVSALQYVHRKLKDPLNHLQDWKKTDPCASNWTGVICIPDP-SDGFLHVKE 81
Query: 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L+LLN+NL+G L+PE+G LS LTIL+FMWN ++G IP E+GN+ L LLL+GN+LTGSL
Sbjct: 82 LRLLNMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTHLIFLLLSGNQLTGSL 141
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ELG L L +QID N ISG LP S ANL K +HFHMNNNSI+GQIPPE S L +++H
Sbjct: 142 PQELGSLSNLLILQIDYNEISGKLPTSLANLKKLKHFHMNNNSITGQIPPEYSTLTNVLH 201
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
L+DNN LTG LPPEL+++P L ILQLD +NF+GT IP+SY ++ L+KLSLRNC+L+GP
Sbjct: 202 FLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPNLVKLSLRNCNLEGP 261
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
+PDLS+ L YLD+SSN+L G IP + S NITTI L NN L+G+IPSNFSGLPRLQRL
Sbjct: 262 IPDLSKSLVLYYLDISSNKLTGEIPKNKFSANITTINLYNNLLSGSIPSNFSGLPRLQRL 321
Query: 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-FNIPPNVTVRLRGNPFC 385
+ NN+LSG IP IW++R L A E ILD +NN +N+S N P NVTV+L GNP C
Sbjct: 322 QVQNNNLSGEIP-VIWENRILKAEEKLILDLRNNMFSNVSSVLLNPPSNVTVKLYGNPVC 380
Query: 386 LNTNAEQ---FCG--SHSDDDNEIDRSTNSTLDCRAQSCPT--DYEYSPTSPIRCFCAAP 438
N NA + CG + + T ST DC+ QSCP +Y+Y SP+ CFCAAP
Sbjct: 381 ANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQSCPVSENYDYVIGSPVACFCAAP 440
Query: 439 LLVGYRLKSPGLSYFPAYK--NLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFP 496
L + RL+SP S F YK + + L +N YQ+ ID+F W+ GPRL M +K+FP
Sbjct: 441 LGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAWQSGPRLFMNMKIFP 500
Query: 497 VYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV---FPPSR 553
Y S NS FN++EV RI F + + D GPYE+I+ G Y+DV FP +
Sbjct: 501 EY--SELNSK-FNSTEVQRIVDFFATFTLNTDDSLGPYEIISIN-TGAYKDVTIIFP--K 554
Query: 554 NSGISKAALAGIILGAIAGAVTISAIVSLLIV----------RAHMKNYHAISRRRHSSK 603
SG+S GII+GAIA + +S++ + + M+ H + K
Sbjct: 555 KSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQEHPL------PK 608
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
+ ++ V+ + + E+ AT++F+ +QIG+GGYGKVYKG LP G VVAVKRA++GSLQG
Sbjct: 609 PPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQG 668
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
+KEF TEI+ LSRLHHRNLVSL+GYCD++GEQMLVYE+M NG+L+D LSA+ ++PL A+
Sbjct: 669 QKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQPLSLAL 728
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL IALGS+RGILYLHTEADPP+ HRDIK SNILLD K KVADFG+S+L + D G+
Sbjct: 729 RLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIAL-DGGGV 787
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
HV+T+VKGTPGY+DPEY+L+H+LT+KSDVYSLG+VFLE+LTGM+PISHG+NIVREVN
Sbjct: 788 QRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVN 847
Query: 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
A + MM SVID +MG Y ECV++F++LA++CCQD +ARP M E++RELE+I+ ++P
Sbjct: 848 EACDAGMMMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWMLEIVRELENIYGLIP 907
Query: 904 ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS-SDVSGSNLVSGVIPTITPR 956
+ + P S +S + + + Y + S+ + + LVSGVIP+I PR
Sbjct: 908 KEE--KPYSSPSVQSSASGMSGFAVASPRSSYTTFSEFTANQLVSGVIPSIAPR 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/928 (53%), Positives = 624/928 (67%), Gaps = 32/928 (3%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+ H+RELQL+ LNLSG
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
L+PE+G+L YL ILD MWN ++G IP EIG I SL+LLLLNGN+ TGSLP ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LP EL++LP L ILQLDNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
YLDLS N L G+IP +LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA------ 390
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 391 -EQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPG 449
E CG STNS C SCP +E SP C C APL + YRLKSP
Sbjct: 393 FEYICGEKKQT------STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPS 444
Query: 450 LSYFPAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVF 508
+F Y + F EY+TS L+L +QL ID E R +MYLKL P F
Sbjct: 445 FFFFTPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP------KGRITF 498
Query: 509 NASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILG 568
N SEV RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI I+ G
Sbjct: 499 NKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAG 556
Query: 569 AIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNS 628
++ A +S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+S
Sbjct: 557 SVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDS 616
Query: 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
ST IG+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY
Sbjct: 617 STLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGY 676
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV H
Sbjct: 677 SSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIH 736
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RDIK SNILLD + AKVADFGLSRLAP PAHVSTVV+GTPGYLDPEYF+T +
Sbjct: 737 RDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQ 796
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 868
LT +SDVYS GVV LELLTGM P G +I+REV A + + SV D MG + V+
Sbjct: 797 LTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVK 856
Query: 869 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 928
K +LAL CC+D + RP MS+V++ELE I + E PE + T+K +S
Sbjct: 857 KLAELALWCCEDRPETRPPMSKVVKELEGICQSVRE-----PEMFS--ETTKLLCSKTSP 909
Query: 929 SMLKHPYVSSDVSGSNLVSGVIPTITPR 956
S P S + GSNL SG + PR
Sbjct: 910 SSSSVPSPLSLLPGSNLDSGFFHAVKPR 937
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 330/943 (34%), Positives = 498/943 (52%), Gaps = 105/943 (11%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ TD + +AL+++K D SK +W DPC + W G+ C N + + L
Sbjct: 25 AFTDGSDFTALQALKNEW-DTLSK--SWKSSDPCGTEWVGITCNNDN------RVVSISL 75
Query: 90 LNLNLSGNLSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
N NL G L EI LS L LD N ++SG +P IGN++ L L L G G +P+
Sbjct: 76 TNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPD 135
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNK----------------------------- 179
+G L +L R+ ++ N SG++P S L+K
Sbjct: 136 SIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDML 195
Query: 180 --TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
T HFH NN +SG+IP +L S +L+H+L D N TG +P L + L +L+LD N
Sbjct: 196 LQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRN 255
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
G IP+S +N++ L +L L + G +P+L+ + +L LD+S+N L S P +
Sbjct: 256 RLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIP 314
Query: 297 L--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+++T++L + +L G +P++ +LQ + + +N ++ ++ S+ L+
Sbjct: 315 FLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLD-----F 369
Query: 355 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLD 413
+D ++N +T N P V V L N C + A Q G N + ST STL
Sbjct: 370 VDLRDNFITGYKSPANNP--VNVMLADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLT 422
Query: 414 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLN 471
C E + C C PL + L+SP S F N F E + + K
Sbjct: 423 KCGNHCGKGKEPNQG----CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG 478
Query: 472 LYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPD 527
Y +D + R + P L + L +FP SG FN +E+ I S FT +
Sbjct: 479 KYPVDSVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKP 532
Query: 528 SDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRA 587
FGPY + Y+ F +S + ++ + + + A+ + +R
Sbjct: 533 PPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQ 587
Query: 588 HMKNYHAISRRRHSSK--------TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGK 639
+ A + +K + ++ G ++FT+ E++ TNNF+ + +G GGYG+
Sbjct: 588 KKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQ 647
Query: 640 VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699
VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVY
Sbjct: 648 VYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVY 707
Query: 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 759
E++ NG+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD
Sbjct: 708 EYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLD 767
Query: 760 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 819
TAKVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY G
Sbjct: 768 EHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFG 822
Query: 820 VVFLELLTGMQPISHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPSECVEKFI 871
VV LELLTG PI G +V+EV N+ ++ + I N G+ + EK++
Sbjct: 823 VVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNL--KGFEKYV 880
Query: 872 KLALKCCQDETDARPSMSEVMRELESIWNMM---PESDTKTPE 911
+AL+C + E RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 881 DVALQCVEPEGVNRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 279/932 (29%), Positives = 431/932 (46%), Gaps = 119/932 (12%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRL-SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ +L++L L + LSG + PE+ L L ILD N SG +P + L+ L L
Sbjct: 276 FQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGN 335
Query: 140 NELTGS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L+G L + + + + + N ISGS+P S N + R +++N +G +P
Sbjct: 336 NYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGF 395
Query: 199 SRL---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
L P L +L+ NN L+G +P EL + L + L N G IP + L
Sbjct: 396 CSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGP-IPKEIWMLPNLSD 454
Query: 256 LSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPG-RLSLNITTIKLSNNKLTGT 312
L + +L G +P+ + NL L L++N L GSIP N+ I LS+N+LTG
Sbjct: 455 LVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGK 514
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNI 371
IPS L +L L + NNSLSG++P + ++L LD +NNLT ++ G
Sbjct: 515 IPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL-----IWLDLNSNNLTGDLPGELAS 569
Query: 372 PPNV----TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSP 427
+ +V + F N G+ + E R+ SCP YS
Sbjct: 570 QAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSG 629
Query: 428 TSPIRCFCAAPLLVGYRLKSPGLSYF--PAYKNLFEEYMTSGLKLNLYQLDI-----DSF 480
+ + F A ++ + + +S F P Y N+ Y+ LNL I DSF
Sbjct: 630 MT-MYTFSANGSMIYFDISYNAVSGFIPPGYGNM--GYLQV---LNLGHNRITGTIPDSF 683
Query: 481 RWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFT 540
LK V D S N + +G + S + ++ ++++ GP
Sbjct: 684 GG---------LKAIGVLDLSHNNLQGYLPGSLGSL-SFLSDLDVSNNNLTGPIPF---- 729
Query: 541 LQGPYRDVFPPSR---NSGI----------------------SKAALAGIILGAIAGAVT 575
G FP SR NSG+ K +A ++ IA +
Sbjct: 730 --GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFM 787
Query: 576 ISAIVSLLIVRAHMKNYHAISRRRH------SSKTSIKIDGV---------------RSF 614
++ + + R R ++ S S K+ V R
Sbjct: 788 CFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKL 847
Query: 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 674
T+ + ATN F++ T +G GG+G+VYK L DG+VVA+K+ + QG++EF+ E++ +
Sbjct: 848 TFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETI 907
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP----LGFAMRLSIALG 730
++ HRNLV L+GYC E++LVYE+M G+L L KS + L +A R IA+G
Sbjct: 908 GKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIG 967
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS- 789
++RG+ +LH P + HRD+K+SN+LLD F A+V+DFG++RL D H+S
Sbjct: 968 AARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALD------THLSV 1021
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK-----NIVREVNI 844
+ + GTPGY+ PEY+ + + T K DVYS GV+ LELL+G +PI G+ N+V
Sbjct: 1022 STLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQ 1081
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKF--IKLALKCCQDETDARPSMSEVMRELESIWNMM 902
Y+ ++D + + S VE F +K+A +C D RP+M ++M M
Sbjct: 1082 LYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMA-------MF 1134
Query: 903 PESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934
E T E + + S +ETP S K P
Sbjct: 1135 KEMKADTEEDESLDEFSLKETPLVEESRDKEP 1166
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 273/949 (28%), Positives = 427/949 (44%), Gaps = 125/949 (13%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWNRG-DPC----------------------TSNWTGVLC 72
EV AL+S+ +L K SNWN DPC T N + V+C
Sbjct: 33 EVDALQSVATAL-----KKSNWNFSVDPCDETLSEGGWRNPNAAKGFEDAVTCNCSSVIC 87
Query: 73 FNTTMD--------------DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI 118
T + G L+EL L L+G++ PE G S L I + N+I
Sbjct: 88 HVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTRNYLNGSIPPEWGASSLLNI-SLLGNRI 146
Query: 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178
SGSIPKE+GN+ +L L+L N+L+G +P ELG LP L R+ + N +SG +P +FA L
Sbjct: 147 SGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFAKLT 206
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+++N +G IP + L +++ + L G +P + L L L++ + +
Sbjct: 207 TLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDLSG 266
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMP------------DLS-------------RI 273
+ P NM+ + L LRNC+L G +P DLS +
Sbjct: 267 PESPFPP-LRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGL 325
Query: 274 PNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
++ ++ +SN LNG +P + +++IT S +K + + L +A
Sbjct: 326 SDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSKDKTEECQQKSVNTFSSTSPL-VA 384
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 389
NNS + S S +T ++ N +T+ ++ T G N
Sbjct: 385 NNSSNVSCLSKYTCPKTFYGLH---INCGGNEITSNETKYDAD---TWDTPGYYDSKNGW 438
Query: 390 AEQFCGSHSDDDNEID-----------RSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAP 438
G+ DDD + + TNS++D R + S T C
Sbjct: 439 VSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGN 498
Query: 439 LLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVY 498
V + Y NL Y ++ D + KG K +K FPV
Sbjct: 499 YTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVG-KAVVKKFPVM 557
Query: 499 DNSSGNSYVFNASEVGRIRSMFTGWN-IPDSDIFGPYELINFTLQGPYRDVFPPSRNSGI 557
V N R++ G IP ++GP LI+ P D PP
Sbjct: 558 --------VTNGKLEIRLQWAGKGTQAIPVRGVYGP--LISAVSVDP--DFIPPKE---- 601
Query: 558 SKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIK-ID-GVRSFT 615
G I++ V L+++ + + R + + K +D + SF+
Sbjct: 602 PGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFS 661
Query: 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLS 675
++ +AT+NF+ + +IG+GG+G V+KGI+ DGTV+AVK+ S QG +EFL EI +S
Sbjct: 662 LRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMIS 721
Query: 676 RLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSR 733
L H +LV L G C E + +LVYE++ N +L L +++ PL + MR I +G +R
Sbjct: 722 ALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIAR 781
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ YLH E+ + HRDIKA+N+LLD + K++DFGL++L + H+ST V
Sbjct: 782 GLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEEN------THISTRVA 835
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQS 848
GT GY+ PEY + LTDK+DVYS GVV LE++ G S ++ V++ +
Sbjct: 836 GTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQ 895
Query: 849 SMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ + V+D +G+ Y + I++ + C RPSMS V+ LE
Sbjct: 896 NTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLE 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 149/323 (46%), Positives = 200/323 (61%), Gaps = 14/323 (4%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 671
R FT E+ AT NF+ IG GG+GKVY+G L DGT++A+KRA S QG EF TEI
Sbjct: 506 RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEI 565
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 731
LSRL HR+LVSL+G+CDE E +LVYE+M+NGTLR L + PL + RL +GS
Sbjct: 566 VMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGS 625
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+RG+ YLHT ++ + HRD+K +NILLD F AK++DFGLS+ P D HVST
Sbjct: 626 ARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMD-----HTHVSTA 680
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS----HGKNIVREVNIAYQ 847
VKG+ GYLDPEYF +LT+KSDVYS GVV E + I+ + + E +++Q
Sbjct: 681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 740
Query: 848 SSM-MFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905
+ S+ID N+ G+Y E +EK+ ++A KC DE RP M EV+ LE + + E+
Sbjct: 741 KQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIH-EA 799
Query: 906 DTKTPEFINSEHTSK--EETPPS 926
+ NS +S+ EE P S
Sbjct: 800 WLRKQNGENSFSSSQAVEEAPES 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 138/291 (47%), Positives = 184/291 (63%), Gaps = 11/291 (3%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 671
R F + E+ ATN F+ S+ +G GG+G+VYKG L DGT VAVKR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 731
+ LS+L HR+LVSL+GYCDE E +LVYE+M+NG LR L PL + RL I +G+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+RG+ YLHT A + HRD+K +NILLD AKVADFGLS+ P D HVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLD-----QTHVSTA 670
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT---GMQPISHGKNI-VREVNIAYQ 847
VKG+ GYLDPEYF +LT+KSDVYS GVV +E+L + P+ + + + E +A+Q
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQ 730
Query: 848 SS-MMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
++ ++D N+ G ++KF + A KC + RPSM +V+ LE
Sbjct: 731 KKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLE 781
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 186/304 (61%), Gaps = 13/304 (4%)
Query: 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 674
++ E+ TNNF+ S IG GG+G V++G L D T VAVKR GS QG EFL+EI L
Sbjct: 478 SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITIL 537
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
S++ HR+LVSLVGYC+E+ E +LVYE+M G L+ L + PL + RL + +G++RG
Sbjct: 538 SKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARG 597
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLHT + + HRDIK++NILLD+ + AKVADFGLSR P D HVST VKG
Sbjct: 598 LHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCID-----ETHVSTGVKG 652
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQS 848
+ GYLDPEYF +LTDKSDVYS GVV E+L +P + +VN+A +
Sbjct: 653 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPAVDPLLVREQVNLAEWAIEWQRK 711
Query: 849 SMMFSVIDGNMGSYPSEC-VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 907
M+ ++D N+ C ++KF + A KCC D RP++ +V+ LE + +
Sbjct: 712 GMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPL 771
Query: 908 KTPE 911
PE
Sbjct: 772 NIPE 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 144/292 (49%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 671
R F+ E+ AT NF +S IG GG+G VY G L DGT VAVKR S QG EF TEI
Sbjct: 512 RYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEI 571
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 731
Q LS+L HR+LVSL+GYCDE E +LVYEFMSNG RD L K+ PL + RL I +GS
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+RG+ YLHT + HRD+K++NILLD AKVADFGLS+ D+ HVST
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-----DV-AFGQNHVSTA 685
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------ 845
VKG+ GYLDPEYF +LTDKSDVYS GVV LE L +P + + +VN+A
Sbjct: 686 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCA-RPAINPQLPREQVNLAEWAMQW 744
Query: 846 YQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ ++ +ID ++ G+ E ++KF + A KC +D RP+M +V+ LE
Sbjct: 745 KRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 956 | ||||||
| 225434309 | 959 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.978 | 0.757 | 0.0 | |
| 297745743 | 960 | unnamed protein product [Vitis vinifera] | 0.982 | 0.978 | 0.746 | 0.0 | |
| 357460549 | 955 | hypothetical protein MTR_3g062590 [Medic | 0.986 | 0.987 | 0.694 | 0.0 | |
| 334182352 | 953 | putative leucine-rich repeat transmembra | 0.964 | 0.967 | 0.712 | 0.0 | |
| 224124832 | 926 | predicted protein [Populus trichocarpa] | 0.959 | 0.990 | 0.715 | 0.0 | |
| 297848960 | 941 | predicted protein [Arabidopsis lyrata su | 0.971 | 0.987 | 0.709 | 0.0 | |
| 356569432 | 953 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.986 | 0.683 | 0.0 | |
| 356537716 | 954 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.985 | 0.681 | 0.0 | |
| 449439195 | 952 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.973 | 0.692 | 0.0 | |
| 224146594 | 865 | predicted protein [Populus trichocarpa] | 0.903 | 0.998 | 0.687 | 0.0 |
| >gi|225434309|ref|XP_002276020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1452 bits (3759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 717/947 (75%), Positives = 811/947 (85%), Gaps = 9/947 (0%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F G+ IPASYSNM
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGS-IPASYSNM 256
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
SKLLKLSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN LT
Sbjct: 257 SKLLKLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 316
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 317 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 376
Query: 371 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 430
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 377 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 436
Query: 431 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 490
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 437 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 496
Query: 491 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 550
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 497 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 553
Query: 551 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 610
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 554 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 613
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 670
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 614 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 673
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIAL 729
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS AKSKEPL FAMRLSIAL
Sbjct: 674 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 733
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 734 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 793
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 794 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQSG 853
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 909
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTKT
Sbjct: 854 MIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTKT 913
Query: 910 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 914 TESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 959
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745743|emb|CBI15799.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1432 bits (3708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 707/947 (74%), Positives = 802/947 (84%), Gaps = 8/947 (0%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F GT +
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGTFFLPKLQSR 257
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
S L+ LSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN LT
Sbjct: 258 SMLMNLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 317
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 318 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 377
Query: 371 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 430
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 378 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 437
Query: 431 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 490
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 438 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 497
Query: 491 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 550
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 498 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 554
Query: 551 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 610
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 555 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 614
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 670
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 615 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 674
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIAL 729
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS AKSKEPL FAMRLSIAL
Sbjct: 675 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 734
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 735 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 794
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 795 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQSG 854
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 909
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTKT
Sbjct: 855 MIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTKT 914
Query: 910 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 915 TESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460549|ref|XP_003600556.1| hypothetical protein MTR_3g062590 [Medicago truncatula] gi|355489604|gb|AES70807.1| hypothetical protein MTR_3g062590 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1363 bits (3528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/963 (69%), Positives = 795/963 (82%), Gaps = 20/963 (2%)
Query: 1 MFSSRG---AVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNW 57
MF S+G V+F+ C+ +++ A ++IT+P EV AL++IKK L+D LSNW
Sbjct: 6 MFFSKGYKHEVVFILWFCCY----VLLVAAQENITNPTEVEALKAIKKRLIDPNRNLSNW 61
Query: 58 NRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK 117
NRGDPCTS+WTGVLCFN T+ DGYLH++ELQL+NL+LSGNL+PEIG L Y+ L+FMWNK
Sbjct: 62 NRGDPCTSHWTGVLCFNETLVDGYLHVQELQLMNLSLSGNLAPEIGSLVYMERLNFMWNK 121
Query: 118 ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177
I+GSIPKEIGNIKSL LLLLNGN+LTGSLPEELG+LPKLDRIQIDQN ISG LPKSFANL
Sbjct: 122 ITGSIPKEIGNIKSLFLLLLNGNQLTGSLPEELGFLPKLDRIQIDQNNISGPLPKSFANL 181
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
NKT+HFHMNNNSISGQIPPEL+RLPSLVH LLDNNNL+GYLPP+LS+LP LLILQLDNNN
Sbjct: 182 NKTKHFHMNNNSISGQIPPELARLPSLVHFLLDNNNLSGYLPPQLSQLPNLLILQLDNNN 241
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
FEG +IP +YS+MSKLLKLSL+NC+LQGP+PDLSRIP+L YLDLSSNQLN S+P +L+
Sbjct: 242 FEGNSIPDTYSDMSKLLKLSLKNCNLQGPIPDLSRIPHLLYLDLSSNQLNESLP-SKLAE 300
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
NITTI LSNN+LTG IPS+FS L +LQRL +ANNSL+GS+PS+IWQ + LN +E FIL+
Sbjct: 301 NITTIDLSNNQLTGNIPSSFSSLSKLQRLSLANNSLNGSVPSTIWQDKKLNGSERFILEL 360
Query: 358 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQ 417
+NN T +SGS ++P VTV LRGNP C N Q C S ++ ++ TN+ C Q
Sbjct: 361 ENNQFTTVSGSTDLPSKVTVLLRGNPLCSNNTLSQLCSSEGVNNTDVLVPTNNNGSCLVQ 420
Query: 418 SCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDI 477
SCP YE+S + CFCAAPLLVGYRLKSPG S F +KN FEEY+T+GL +N+ QL+
Sbjct: 421 SCPPPYEFS----LDCFCAAPLLVGYRLKSPGFSDFLPFKNEFEEYLTTGLSINISQLNF 476
Query: 478 DSFRWEKGPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYEL 536
+FRW GPRL+M LK FP+Y D++S S+ FN +EV RIRSMFTGWNIPDSD+FGPYEL
Sbjct: 477 -TFRWVAGPRLRMDLKFFPLYVDHNS--SHTFNETEVQRIRSMFTGWNIPDSDLFGPYEL 533
Query: 537 INFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAIS 596
INF + G Y++ S SGIS A+ GI+LGAIA AVT+SAIV+LLI+R +K+YHA+S
Sbjct: 534 INFNM-GLYQNATSTSSKSGISTGAIVGIVLGAIACAVTLSAIVTLLILRTKLKDYHAVS 592
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRA 656
+RRH SK IK+DGVRSFTY E++ ATNNF+SS Q+GQGGYGKVYKG++ GT VA+KRA
Sbjct: 593 KRRHVSKIKIKMDGVRSFTYEELSSATNNFSSSAQVGQGGYGKVYKGVISGGTAVAIKRA 652
Query: 657 QEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
QEGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYE+M NGTLRD LS +K
Sbjct: 653 QEGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEYMPNGTLRDHLSVSAK 712
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
EPL F MRL IALGS++G++YLH EADPP+FHRD+KASNILLD K +AKVADFGLSRLAP
Sbjct: 713 EPLTFIMRLKIALGSAKGLMYLHNEADPPIFHRDVKASNILLDSKLSAKVADFGLSRLAP 772
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
VPD+EGIVP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE+LTGM PISHGK
Sbjct: 773 VPDMEGIVPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEILTGMHPISHGK 832
Query: 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
NIVREVN++YQS ++FS+ID MGSYPSE VEKF+ LALKC DE D RP+M+EV+RELE
Sbjct: 833 NIVREVNLSYQSGVIFSIIDERMGSYPSEHVEKFLTLALKCVNDEPDNRPTMAEVVRELE 892
Query: 897 SIWNMMPESDTKTPEFINS---EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTI 953
+IWN+MPESDT+ E I S +SK + PSSSS ++ +VS DVSGS+LVSGVIP+I
Sbjct: 893 NIWNVMPESDTRRAESITSGSVSDSSKAMSTPSSSSAIRTAFVSGDVSGSDLVSGVIPSI 952
Query: 954 TPR 956
PR
Sbjct: 953 KPR 955
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182352|ref|NP_172169.2| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|264664524|sp|C0LGD7.2|Y1684_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g06840; Flags: Precursor gi|332189923|gb|AEE28044.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1351 bits (3497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/930 (71%), Positives = 783/930 (84%), Gaps = 8/930 (0%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
DLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 388
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 389 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 447
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 448 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 507
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 508 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 567
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 568 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 627
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S + S +D M S P EC+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMSSVPDECL 866
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTSKEETPPS 926
EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T + S
Sbjct: 867 EKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETMTHPSSSS 923
Query: 927 SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 924 NSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124832|ref|XP_002319433.1| predicted protein [Populus trichocarpa] gi|222857809|gb|EEE95356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1343 bits (3477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 659/921 (71%), Positives = 766/921 (83%), Gaps = 4/921 (0%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V AL+ I+ SL+D LSNW RGDPCTSNWTGVLCFNTT +D YLH+RELQLLN+NLSG
Sbjct: 9 VKALQDIRNSLIDINKNLSNWRRGDPCTSNWTGVLCFNTTKEDAYLHVRELQLLNMNLSG 68
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
LSP +G LSY+ ILDFMWN I+GSIP EIGNIKSLELLLLNGN+LTG LPEELG LPKL
Sbjct: 69 TLSPSLGLLSYMEILDFMWNSITGSIPPEIGNIKSLELLLLNGNQLTGPLPEELGNLPKL 128
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
DRIQIDQN+ISG +PKSFA LN T+HFHMNNNSISGQIP ELSRLP+LVH LLDNNNL+G
Sbjct: 129 DRIQIDQNHISGPIPKSFAYLNSTKHFHMNNNSISGQIPAELSRLPNLVHFLLDNNNLSG 188
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LPP+L +LPKLLILQLDNN F+G+TIP SY NM++LLKLSLRNCSL+G MPDLS IPNL
Sbjct: 189 TLPPDLYKLPKLLILQLDNNQFDGSTIPPSYGNMTQLLKLSLRNCSLRGLMPDLSGIPNL 248
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
GYLDLS NQL G IPP +L NITTI LSNN L GTIP+ FS LPRLQ L IANNSLSGS
Sbjct: 249 GYLDLSFNQLAGPIPPNKLFENITTINLSNNTLNGTIPAYFSDLPRLQLLSIANNSLSGS 308
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 396
+PS+IWQ+RT N E L F+NN L+NISGS ++P NVT+ L+GNP C N+N +FCGS
Sbjct: 309 VPSTIWQTRT-NGNEGLDLHFENNRLSNISGSTSLPQNVTLWLQGNPACSNSNIVKFCGS 367
Query: 397 HSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY 456
+ D N+ + ++ C QSCP YEY T I C CAAPL+ YRLKSPG S F Y
Sbjct: 368 QNGDMNDQSTTESNVTTCSVQSCPPPYEYFQTPTISCVCAAPLIFEYRLKSPGFSKFIPY 427
Query: 457 KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRI 516
+ F++Y+TSGL+L+LYQLD+ S WEKGPRLKM LKLFPVY N + +S+ FN SEV RI
Sbjct: 428 RVAFQDYLTSGLELHLYQLDLSSAIWEKGPRLKMQLKLFPVYVNEN-SSHKFNDSEVRRI 486
Query: 517 RSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPS-RNSGISKAALAGIILGAIAGAVT 575
SMFTGWNIPDS +FGPYEL+ L GPY +V + + S +S AL GI+LGAIAGAV
Sbjct: 487 ISMFTGWNIPDSQLFGPYELLYINLLGPYINVLSVTPQKSKLSTGALVGIVLGAIAGAVA 546
Query: 576 ISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQG 635
+SA+VSLLI+R +N+ AIS+RR SK S+KI+GV+ F+Y EMALATNNFNSS+Q+GQG
Sbjct: 547 LSAVVSLLILRKRSRNHGAISKRRRVSKASLKIEGVKYFSYAEMALATNNFNSSSQVGQG 606
Query: 636 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695
GYGKVYKG L DG VA+KRA+E S QGE+EFLTEI+ LSR+HHRNLVSL+G+CDE GEQ
Sbjct: 607 GYGKVYKGYLADGRTVAIKRAEEASFQGEREFLTEIELLSRVHHRNLVSLIGFCDEGGEQ 666
Query: 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
MLVYEFMSNGTLRD LSAK+KEPL FA RL IAL S++GILYLHTEADPP+FHRD+KASN
Sbjct: 667 MLVYEFMSNGTLRDHLSAKAKEPLSFATRLGIALASAKGILYLHTEADPPIFHRDVKASN 726
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
ILLD ++ AKVADFGLS+LAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDV
Sbjct: 727 ILLDSRYNAKVADFGLSKLAPVPDIEGDVPGHISTVVKGTPGYLDPEYFLTHKLTDKSDV 786
Query: 816 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLAL 875
YSLGVVFLELLTGMQPISHGKNIVREVNIAYQ+ M+FS++DG MGSYPS+CV+KF+ LA+
Sbjct: 787 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQTGMIFSIVDGRMGSYPSDCVDKFLTLAM 846
Query: 876 KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935
KCC DETD RPSM +V+RELE++W+MMPESDTKT + +N++ T E T PSS S+LK+PY
Sbjct: 847 KCCNDETDERPSMIDVVRELENMWHMMPESDTKTTDTMNTD-TGMEMTSPSSCSLLKNPY 905
Query: 936 VSSDVSGSNLVSGVIPTITPR 956
VSS+VS S+LVSGV PTITPR
Sbjct: 906 VSSEVSSSDLVSGVAPTITPR 926
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848960|ref|XP_002892361.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297338203|gb|EFH68620.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1337 bits (3461), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/937 (70%), Positives = 785/937 (83%), Gaps = 8/937 (0%)
Query: 23 VVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL 82
V+AA + + ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYL
Sbjct: 10 VMAAAKRKLLLTFLLRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYL 69
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
H+ ELQL ++NLSGNLSP++GRL+ LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L
Sbjct: 70 HVSELQLFSMNLSGNLSPDLGRLTRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLL 129
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
G+LPEELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPE+ LP
Sbjct: 130 IGNLPEELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPEIGSLP 189
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
S+VH+LLDNNNL+GYLPPELS +P LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCS
Sbjct: 190 SIVHILLDNNNLSGYLPPELSNMPHLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCS 249
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
LQGP+PDLS IPNLGYLDLS NQLNGSIP G+LS NITTI LS+N LTGTIP+NFSGLPR
Sbjct: 250 LQGPVPDLSSIPNLGYLDLSQNQLNGSIPTGKLSDNITTIDLSSNSLTGTIPTNFSGLPR 309
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GN
Sbjct: 310 LQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNRFSNISGRSDLRPNVTVWLQGN 369
Query: 383 PFCLNTNAEQFCGSHSDDD-NEIDRSTNS-TLDCRAQSCPTDYEYSPTSPIRCFCAAPLL 440
P C + N + CG +++D N+ STNS T C CP YE+SP RCFCAAPLL
Sbjct: 370 PLCSDGNLLRLCGPITEEDINQGQGSTNSYTTTC--SDCPPPYEFSPEPLRRCFCAAPLL 427
Query: 441 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 500
VGYRLKSPG S F Y++ FEEY+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +
Sbjct: 428 VGYRLKSPGFSDFVPYRSEFEEYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGS 487
Query: 501 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKA 560
++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+SK
Sbjct: 488 NANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSKG 547
Query: 561 ALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMA 620
A+AGI+LG++A AVT++AI++L+I+R M+ Y+A++RR+ SSK S+KI+GV+SFTY E+A
Sbjct: 548 AVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYNAVARRKRSSKASLKIEGVKSFTYAELA 607
Query: 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 680
LAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHR
Sbjct: 608 LATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHR 667
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
NLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHT
Sbjct: 668 NLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHT 727
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
EA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLD
Sbjct: 728 EANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPHHVSTVVKGTPGYLD 787
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PEYFLTH+LTDKSDVYSLGVVFLELLTGMQPI+HGKNIVRE+NIAY+S + S +D M
Sbjct: 788 PEYFLTHQLTDKSDVYSLGVVFLELLTGMQPITHGKNIVREINIAYESGSILSAVDKRMS 847
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTS 919
S P EC+EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T
Sbjct: 848 SVPDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETM 904
Query: 920 KEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
+ S+SS++KHPY S DVSGS+LVSG+ P++ PR
Sbjct: 905 THPSSSSNSSIMKHPYTSMDVSGSDLVSGIAPSVAPR 941
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569432|ref|XP_003552905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1324 bits (3426), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 655/958 (68%), Positives = 789/958 (82%), Gaps = 18/958 (1%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
+ V+F+ C+ ++ AA ++ITDP+EV ALR+IK L+D LSNWN GDPCT
Sbjct: 8 KHEVVFILWFCCY----LLHAAGQNNITDPVEVDALRAIKSRLIDPNGNLSNWNDGDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DG+LH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIP
Sbjct: 64 SRWKGVLCFNETKEDGHLHVEELQLLRLNLLGTLAPDLGKLTYMKRLNFMWNNISGSIPN 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN+LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNKLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP+LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPNLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
+Y+NMSKLLK+SLRNCSLQGP+PDLSRIP+L YLDLS NQLN SIPP +LS +ITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCSLQGPIPDLSRIPHLLYLDLSLNQLNESIPPNKLSEHITTIDL 303
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
S+N+LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++T N T+TF+L+ +NNNLT
Sbjct: 304 SSNRLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTSNGTKTFLLELENNNLTT 363
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 424
ISGS ++PPNVTV L GNP C N QFCGS + + +TNS+ C Q+CP YE
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNVTLTQFCGSEGANVTDGSFTTNSS-SCPPQACPPPYE 422
Query: 425 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 484
YS + CFC PL+V YRLKSPG S F Y N FE YM SG+K++ QL D F W+
Sbjct: 423 YS----VNCFCGLPLIVDYRLKSPGFSNFLPYLNDFEVYMASGVKISTNQLQYD-FYWQV 477
Query: 485 GPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQG 543
GPRL+M LK FP Y DNSS S+ FN SE+ R+ SMFTGW IPDSD+FGPYEL+ F L G
Sbjct: 478 GPRLRMNLKFFPAYVDNSS--SHTFNRSELLRLTSMFTGWLIPDSDLFGPYELMGFNLLG 535
Query: 544 PYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 603
PY+D S SGIS AL GI++GAIA AVT+SAIV++LI+R +++YHA+SRRRH+SK
Sbjct: 536 PYQDEIGRSSKSGISTGALVGIVIGAIAFAVTLSAIVTILILRIRLRDYHAVSRRRHASK 595
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
SIKIDGVR+F+YGE++ ATNNF++S Q+GQGGYGKVYKG+L DGT+VA+KRAQEGSLQG
Sbjct: 596 ISIKIDGVRAFSYGELSSATNNFSTSAQVGQGGYGKVYKGVLSDGTIVAIKRAQEGSLQG 655
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 656 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 715
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL +ALG+++G+LYLH+EADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 716 RLKMALGAAKGLLYLHSEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 775
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
VP HVSTVVKGTPGYLDPEYFLT KLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN
Sbjct: 776 VPGHVSTVVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVN 835
Query: 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARP M+EV+RELE+IW+ MP
Sbjct: 836 VAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPRMAEVVRELENIWSTMP 895
Query: 904 ESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
ESDTK EF++S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 896 ESDTKRAEFMSSDSGKADSHSTPSSSSASASIMKTPFVSGDVSGSDLVSGVIPSIKPR 953
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537716|ref|XP_003537371.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1312 bits (3395), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/958 (68%), Positives = 782/958 (81%), Gaps = 18/958 (1%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
G V L+ C C+ ++ AA ++ITDP+EV ALR+IK+ L+D LSNW DPCT
Sbjct: 9 HGVVFLLWFC-CY----LLHAAGQNNITDPVEVDALRAIKRRLIDPNGNLSNWEDRDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DGYLH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIPK
Sbjct: 64 SRWKGVLCFNETKEDGYLHVEELQLLRLNLFGTLAPDLGKLTYMKRLNFMWNNISGSIPK 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNNLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPKLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
+Y+NMSKLLK+SLRNC+L+GP+PDL RIP+L YLDLS NQLNGSIPP +LS NITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCNLRGPLPDLRRIPHLLYLDLSFNQLNGSIPPNKLSENITTIDL 303
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
SNN LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++TLN TE F L+ +NNNLT
Sbjct: 304 SNNLLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTLNGTEKFFLELENNNLTT 363
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 424
ISGS ++PPNVTV L GNP C N QFCGS + +TN + C Q CP +E
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNITLIQFCGSEAATVTNGSLTTNFS-SCPPQGCPPPFE 422
Query: 425 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 484
Y+ + CFCA PL+V YRLKSPG + F Y N F++YMT GL+++ QL+ D F W+
Sbjct: 423 YT----VDCFCALPLIVFYRLKSPGFTNFLPYLNGFKDYMTHGLEISFDQLEYD-FYWQV 477
Query: 485 GPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGP 544
GPRLKM LK FP Y N++ N + FN SE+ RI+S FTGW IPD+D FGPYELI F L G
Sbjct: 478 GPRLKMDLKFFPPYLNNTSN-HTFNESELLRIKSKFTGWLIPDNDTFGPYELIGFNLLGS 536
Query: 545 YRDVFPP-SRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 603
Y+DV P S + I L GI++GAIA AVT+SAIV++LI+R +++YHA+S++RH+SK
Sbjct: 537 YQDVIPTRSESQNIRTGVLVGIVIGAIACAVTLSAIVTILILRIKLRDYHAVSKQRHASK 596
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
SIKIDGVR+FTYGE++ ATNNF+ S Q+GQGGYGKVYKG+L DGTVVA+KRAQEGSLQG
Sbjct: 597 ISIKIDGVRAFTYGELSFATNNFSISAQVGQGGYGKVYKGVLSDGTVVAIKRAQEGSLQG 656
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 657 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 716
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL IALG+++G++YLHTEADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 717 RLKIALGAAKGLMYLHTEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 776
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
VP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN
Sbjct: 777 VPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVN 836
Query: 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARPSM+EV+RELE+IW+ MP
Sbjct: 837 VAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPSMTEVVRELENIWSTMP 896
Query: 904 ESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
ESDTK EFI+S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 897 ESDTKRAEFISSDSGKADSHSTPSSSSASASVMKTPFVSGDVSGSDLVSGVIPSIKPR 954
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439195|ref|XP_004137372.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/937 (69%), Positives = 754/937 (80%), Gaps = 10/937 (1%)
Query: 22 IVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGY 81
+VVAA+ T P EV AL IK SL D LSNWN+GDPC SNWTGVLC+NTT DD Y
Sbjct: 24 VVVAAEMG--THPSEVDALLLIKSSLFDPNGNLSNWNKGDPCNSNWTGVLCYNTTFDDNY 81
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
LH+ ELQLLN++LSG LSP +GRLSYL +LDFMWNKISG IP+EIGN+ SLELLLLNGN+
Sbjct: 82 LHVAELQLLNMSLSGKLSPALGRLSYLRVLDFMWNKISGEIPREIGNLTSLELLLLNGNQ 141
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L+GSLPE+LG L LDRIQIDQN+ISG +PKSFANL T+HFHMNNNSISG+IP ELS L
Sbjct: 142 LSGSLPEDLGNLLHLDRIQIDQNHISGLIPKSFANLKATKHFHMNNNSISGEIPSELSGL 201
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
P+LVH LLDNNNL+G LPPEL +LP L ILQLDNNNF G TIP SY M+KLLKLSLRNC
Sbjct: 202 PNLVHFLLDNNNLSGKLPPELFQLPNLEILQLDNNNFSGATIPDSYGKMTKLLKLSLRNC 261
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321
+LQG +PDLSRI NLGYLDLSSNQL+G IP G+LS NITTI LS+N+LTGTIPS+ GLP
Sbjct: 262 TLQGSIPDLSRIKNLGYLDLSSNQLSGLIPRGKLSENITTIILSDNRLTGTIPSSLLGLP 321
Query: 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 381
LQ+L +ANNSL+GS+PS+IWQSR LN+ ++ ++ QNNN ++I GS ++P NV+VRL+G
Sbjct: 322 HLQKLSVANNSLNGSVPSTIWQSRMLNSLDSLTVELQNNNFSDILGSIHLPLNVSVRLQG 381
Query: 382 NPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE-YSPTSPIRCFCAAPLL 440
NP C N + FCGS S+D ID TN+ L C CP YE YS P C C+APLL
Sbjct: 382 NPACANNSLLDFCGSESEDI--IDIPTNNPLGCSGPICPPSYECYSAKCPSSCLCSAPLL 439
Query: 441 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 500
+GYRLKSPG S F Y+++FEEY+TSGLK++L QLDI S WEKGPRL+M LK+FP+Y
Sbjct: 440 IGYRLKSPGFSRFSPYQHMFEEYLTSGLKVHLEQLDIGSAVWEKGPRLRMSLKVFPLYVA 499
Query: 501 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV-FPPSRNSGISK 559
S +S++FN SEV RI FT W I DSDIFGPYEL++ T+ Y+ V F PS +S +SK
Sbjct: 500 DSNSSHMFNDSEVLRIVYKFTNWKIQDSDIFGPYELLSLTISDVYKKVFFTPSSDSTMSK 559
Query: 560 AALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEM 619
ALAGIILGAIAG +SAIV + I+R+ ++ +H ISRRRH SKTSIKI GV+ F Y EM
Sbjct: 560 GALAGIILGAIAGGAMLSAIVFIFIIRSRVRGHH-ISRRRHLSKTSIKIKGVKEFGYREM 618
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 679
ALATNNF+ S +GQGGYGKVYKGIL D VA+KRAQEGSLQGEKEFLTEIQ LSRLHH
Sbjct: 619 ALATNNFHCSMVVGQGGYGKVYKGILADSMAVAIKRAQEGSLQGEKEFLTEIQLLSRLHH 678
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
RNLV+L+GYCDEEGEQML YEFMSNGTLRD LS S EPL FA RL ALG+++GILYLH
Sbjct: 679 RNLVALIGYCDEEGEQMLAYEFMSNGTLRDHLSVNSAEPLSFATRLKAALGAAKGILYLH 738
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
TEADPP+FHRDIK+SNILLD K+ AKVADFGLSRLAP+P+ EG VPAHVSTVVKGTPGYL
Sbjct: 739 TEADPPIFHRDIKSSNILLDSKYVAKVADFGLSRLAPLPNAEGDVPAHVSTVVKGTPGYL 798
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
DPEYFLTHKLTDKSDVYSLGVVFLELLTG PISHGKNIVREVN AYQS +FS+IDG +
Sbjct: 799 DPEYFLTHKLTDKSDVYSLGVVFLELLTGRHPISHGKNIVREVNSAYQSGKIFSIIDGRL 858
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
GSYP+ECVEKF+ LALKCCQD+TDARPSM EV+R LE+IW M+PESD+K E + ++
Sbjct: 859 GSYPAECVEKFVTLALKCCQDDTDARPSMVEVVRTLENIWLMLPESDSKISEPLINDVIK 918
Query: 920 KEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 956
P SSS+M Y S+VSGS+LVSGV PTI PR
Sbjct: 919 VTSPPSSSSNM---NYYISEVSGSDLVSGVTPTIMPR 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146594|ref|XP_002326064.1| predicted protein [Populus trichocarpa] gi|222862939|gb|EEF00446.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1255 bits (3247), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/919 (68%), Positives = 725/919 (78%), Gaps = 55/919 (5%)
Query: 39 ALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNL 98
ALR IK SL+D + LSNW RGDPCTSNWTGVLCFN T +DGY H+REL
Sbjct: 1 ALRDIKNSLIDINNNLSNWRRGDPCTSNWTGVLCFNKTEEDGYQHVREL----------- 49
Query: 99 SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158
LLNGN+LTG LP+ELGYLP L+R
Sbjct: 50 -------------------------------------LLNGNQLTGPLPDELGYLPNLER 72
Query: 159 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218
IQIDQN ISG +PKSFANLNKT+HFHMNNNSISG IP ELSRLPSL+H LLDNNNL+G L
Sbjct: 73 IQIDQNNISGPIPKSFANLNKTQHFHMNNNSISGNIPAELSRLPSLLHFLLDNNNLSGTL 132
Query: 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGY 278
PPELS P LLILQLDNNNF+G+TIPASY NM+KLLKLSLRNCSLQGPMPDLS IPNLGY
Sbjct: 133 PPELSNFPNLLILQLDNNNFDGSTIPASYGNMTKLLKLSLRNCSLQGPMPDLSGIPNLGY 192
Query: 279 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338
LDLS NQL G IP +LS NITTI LS N L GTIP+NFS LP LQ+L IANNSLSGS+P
Sbjct: 193 LDLSFNQLAGPIPTNKLSKNITTIDLSYNNLNGTIPANFSELPLLQQLSIANNSLSGSVP 252
Query: 339 SSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398
+ WQ+R N TE LDF+NN L+NISGS ++P NVT+RL+GNP C N++ QFC S +
Sbjct: 253 FTTWQTRA-NGTEGLDLDFENNTLSNISGSISLPQNVTLRLKGNPVCSNSSIFQFCESQN 311
Query: 399 DDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKN 458
+D N ST S C QSCP+ YEYSPTSP CFCAAPL+ GYRLKSPG S F Y+
Sbjct: 312 NDMNN-QSSTESNATCFTQSCPSPYEYSPTSPTSCFCAAPLIFGYRLKSPGFSKFVPYRI 370
Query: 459 LFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRS 518
FE Y+TSGLKL+L+QLD+ S WE GPRLKM+LKLFPVY N + FN SE RI S
Sbjct: 371 RFENYLTSGLKLSLFQLDLASVVWESGPRLKMHLKLFPVYVNGTN---TFNTSEARRIIS 427
Query: 519 MFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSG-ISKAALAGIILGAIAGAVTIS 577
MFTGW IPDS+IFGPYEL+ TL PYRDV S+ S IS AL GI+LGAIAGAVT+S
Sbjct: 428 MFTGWKIPDSEIFGPYELLYITLLDPYRDVIVTSQKSNKISTGALVGIVLGAIAGAVTLS 487
Query: 578 AIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGY 637
A+VSLLI+R +++Y AIS+RR SK S+KI+GV+ F+Y EMA+ATNNFNSS+Q+GQGGY
Sbjct: 488 AVVSLLILRRRLRDYTAISKRRRQSKASLKIEGVKDFSYAEMAMATNNFNSSSQVGQGGY 547
Query: 638 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697
GKVYKGIL DG VA+KR +EGSLQGEKEFLTEI+ LSRLHHRNLVSL+GYCDE+GEQML
Sbjct: 548 GKVYKGILADGRTVAIKRTEEGSLQGEKEFLTEIELLSRLHHRNLVSLLGYCDEQGEQML 607
Query: 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757
VYEFM NGTLRD LS K KEPL FA RL IA+ S++GILYLHTEA+PP+FHRDIKASNIL
Sbjct: 608 VYEFMPNGTLRDHLSVKGKEPLSFATRLKIAMTSAKGILYLHTEANPPIFHRDIKASNIL 667
Query: 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYS 817
+D ++ AKVADFGLSRLAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDVYS
Sbjct: 668 VDSRYDAKVADFGLSRLAPVPDIEGSVPDHISTVVKGTPGYLDPEYFLTHKLTDKSDVYS 727
Query: 818 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 877
LGVVFLELLTG QPISHGKNIVREV IAYQS M+FS+ID MGSYPS+C++KF+ LA+KC
Sbjct: 728 LGVVFLELLTGKQPISHGKNIVREVKIAYQSGMIFSIIDERMGSYPSDCIDKFLTLAMKC 787
Query: 878 CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937
C +ETDARPSM++V+RELE IW+MM ESDT T + I++++ KE TPPSSSSM+ +P VS
Sbjct: 788 CNEETDARPSMADVVRELEGIWHMMSESDTATTDTISTDN-RKEMTPPSSSSMMMNPCVS 846
Query: 938 SDVSGSNLVSGVIPTITPR 956
S+VSGS+LVSG +PTITPR
Sbjct: 847 SEVSGSDLVSGAVPTITPR 865
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 956 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.969 | 0.974 | 0.555 | 3.2e-271 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.940 | 0.959 | 0.490 | 8.5e-223 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.868 | 0.854 | 0.361 | 4.4e-123 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.881 | 0.884 | 0.351 | 2e-120 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.881 | 0.891 | 0.344 | 1.5e-115 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.297 | 0.331 | 0.520 | 3.1e-108 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.310 | 0.255 | 0.386 | 1.1e-79 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.325 | 0.326 | 0.404 | 4.8e-77 | |
| TAIR|locus:2148151 | 866 | AT5G16900 [Arabidopsis thalian | 0.324 | 0.357 | 0.446 | 1.2e-75 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.316 | 0.254 | 0.391 | 5.4e-75 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2608 (923.1 bits), Expect = 3.2e-271, P = 3.2e-271
Identities = 522/940 (55%), Positives = 635/940 (67%)
Query: 23 VVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYX 82
V+ D T P EV+ALRS+K+SL+D L NWNRGDPC SNWTGV+CFN D Y
Sbjct: 19 VLLLADAQRTHPSEVTALRSVKRSLLDPKDYLRNWNRGDPCRSNWTGVICFNEIGTDDYL 78
Query: 83 XXXXXXXXXXXXXXXXSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXX 142
SPE+ +L++L ILDFMWN ISGSIP EIG I
Sbjct: 79 HVRELLLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIPNEIGQISSLVLLLLNGNKL 138
Query: 143 XXXXPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
P ELGYL L+R QID+N I+G +PKSF+NL K +H H NNNS++GQIP ELS L
Sbjct: 139 SGTLPSELGYLSNLNRFQIDENNITGPIPKSFSNLKKVKHLHFNNNSLTGQIPVELSNLT 198
Query: 203 SLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
++ H+LLDNN L+G DNNNF G+ IPASY N S +LKLSLRNCS
Sbjct: 199 NIFHVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIPASYGNFSNILKLSLRNCS 258
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
L+G +PD S+I +L YLDLS N+L G IP S ++TTI LSNN L G+IP +FS LP
Sbjct: 259 LKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFSKDVTTINLSNNILNGSIPQSFSDLPL 318
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQ L + NN LSGS+P S+W++ + +LD +NN+L+ + G P NVT+RL GN
Sbjct: 319 LQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSLSRVQGDLTPPQNVTLRLDGN 378
Query: 383 PFCLN---TNAEQFCGSHSDDDNEI-DRSTNSTLDCRAQSCPTD--YEYSPTSPIRCFCA 436
C N +NA FC S + + + STNS LDC +CPT YEYSP SP+RCFCA
Sbjct: 379 LICTNGSISNANLFCESKGKEWISLPNNSTNSALDCPPLACPTPDFYEYSPASPLRCFCA 438
Query: 437 APLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFP 496
APL +GYRLKSP SYFP Y + F EY+T L++ YQL IDS++WEKGPRL+MYLKLFP
Sbjct: 439 APLRIGYRLKSPSFSYFPPYIDQFGEYVTDFLQMEPYQLWIDSYQWEKGPRLRMYLKLFP 498
Query: 497 VYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSG 556
+ + + FN SEV RIR +F W P SD+FGPYEL+NFTLQGPY V S G
Sbjct: 499 KVNETYTRT--FNESEVLRIRGIFASWRFPGSDLFGPYELLNFTLQGPYSYVNFNSERKG 556
Query: 557 ISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTY 616
+S V ISA+V+ L++R + K+ ISRRR SSK S+ G+R F++
Sbjct: 557 VSWRRLAAITAGAVVTAVAISAVVAALLLRRYSKHEREISRRRSSSKASLLNSGIRGFSF 616
Query: 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR 676
E+A AT++F+SST +G+GGYGKVY+G+L D TV A+KRA EGSLQGEKEFL EI+ LSR
Sbjct: 617 KELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEIELLSR 676
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
LHHRNLVSL+GYCDEE EQMLVYEFMSNGTLRD LSAK KE L F MR+ +ALG+++GIL
Sbjct: 677 LHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMRIRVALGAAKGIL 736
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YLHTEA+PPVFHRDIKASNILLD F AKVADFGLSRLAPV + E VP HVSTVV+GTP
Sbjct: 737 YLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHVSTVVRGTP 796
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856
GYLDPEYFLTHKLTDKSDVYS+GVVFLELLTGM ISHGKNIVREV A Q MM S+ID
Sbjct: 797 GYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREVKTAEQRDMMVSLID 856
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINXX 916
M + E VEKF LAL+C D + RP M+EV++ELES+ P+ +T+ E +
Sbjct: 857 KRMEPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELESLLQASPDRETRV-ELASSS 915
Query: 917 XXXXXXXXXXXXXMLKHPYVSSDVSGSNLVSGVIPTITPR 956
+ Y SS + GS+L SG +P+I PR
Sbjct: 916 SVLSTSSSNVTRDL----YESSSLLGSDLSSGFVPSIAPR 951
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2151 (762.2 bits), Expect = 8.5e-223, P = 8.5e-223
Identities = 454/925 (49%), Positives = 576/925 (62%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYXXXXXXXXXXXXXXX 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 XXSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKL 156
+PE+G+L YL ILD MWN ++G IP EIG I P ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
DNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
YLDLS N L G+IP +LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN---AEQF 393
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+ QF
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 394 CGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYF 453
+ + STNS C SCP +E SP C C APL + YRLKSP +F
Sbjct: 393 FEYICGEKKQT--STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPSFFFF 448
Query: 454 PAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASE 512
Y + F EY+TS L+L +QL ID E R +MYLKL P G FN SE
Sbjct: 449 TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP-----KGR-ITFNKSE 502
Query: 513 VGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXX 572
V RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI
Sbjct: 503 VIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVA 560
Query: 573 XVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQI 632
+S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+SST I
Sbjct: 561 ATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLI 620
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692
G+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY +
Sbjct: 621 GRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDI 680
Query: 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752
GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV HRDIK
Sbjct: 681 GEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIK 740
Query: 753 ASNILLDHKFTAKVADFGLSRLAPV-PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
SNILLD + AKVADFGLSRLAP + +G PAHVSTVV+GTPGYLDPEYF+T +LT
Sbjct: 741 TSNILLDCQLHAKVADFGLSRLAPAFGEGDG-EPAHVSTVVRGTPGYLDPEYFMTQQLTV 799
Query: 812 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 871
+SDVYS GVV LELLTGM P G +I+REV A + + SV D MG + V+K
Sbjct: 800 RSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLA 859
Query: 872 KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINXXXXXXXXXXXXXXXML 931
+LAL CC+D + RP MS+V++ELE I + E PE + +
Sbjct: 860 ELALWCCEDRPETRPPMSKVVKELEGICQSVRE-----PEMFSETTKLLCSKTSPSSSSV 914
Query: 932 KHPYVSSDVSGSNLVSGVIPTITPR 956
P S + GSNL SG + PR
Sbjct: 915 PSPL--SLLPGSNLDSGFFHAVKPR 937
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1210 (431.0 bits), Expect = 4.4e-123, P = 4.4e-123
Identities = 333/921 (36%), Positives = 476/921 (51%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLS-NWNRGD-PCTSNWTGVLCFNT--------TM-- 77
S+TDP + +ALRS L+D + +W D PC + W GV C N+ TM
Sbjct: 30 SVTDPRDAAALRS----LMDQWDNTPPSWGGSDDPCGTPWEGVSCNNSRITALGLSTMGL 85
Query: 78 ------DDGYXXXXXXXXXXXXXXXXXS--PEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
D G S +G L L IL +G+IP E+G +
Sbjct: 86 KGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAGCGFTGTIPNELGYL 145
Query: 130 KXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN------LNKTRHF 183
K P LG L K+ + + N ++G +P S + L K +HF
Sbjct: 146 KDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSPGLDLLLKAKHF 205
Query: 184 HMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTT 242
H N N +SG IPP+L S L+H+L D N TG D N G
Sbjct: 206 HFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVLRLDRNTLTGK- 264
Query: 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NIT 300
+P + SN++ +++L+L + L G +PDLS + ++ Y+DLS+N + S P S ++T
Sbjct: 265 VPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWFSTLPSLT 324
Query: 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
T+ + L G +P+ G P+LQ++ + N+ +G++ S+ T+ E ++D Q+N
Sbjct: 325 TLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTL--SLGD--TVGP-ELQLVDLQDN 379
Query: 361 NLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRSTNSTLDCRAQSC 419
++++++ S N T+ L GNP C + +C I ST S +C +SC
Sbjct: 380 DISSVTLSSGYT-N-TLILEGNPVCTTALSNTNYCQIQQQQVKRI-YST-SLANCGGKSC 435
Query: 420 PTDYEYSPTSPIRCFCAAPLLVGYRLKSP---GLSYFPAYKNLFEEYMTSGLKLNLYQLD 476
P D + SP S C CA P + P LS Y +L E + L L +
Sbjct: 436 PLDQKVSPQS---CECAYPYEGTLYFRGPMFRDLSNVNTYHSL-EMSLWVKLGLTPGSVS 491
Query: 477 IDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYEL 536
+ + + L++ L LFP Y FN +EV RI + +FGPY
Sbjct: 492 LQNPFFNNDDYLQIQLALFPPM-----GKY-FNRTEVQRIGFDLSNQTYKPPPLFGPY-- 543
Query: 537 INFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNY--HA 594
+ + PY FP N G S + + +V+L I K A
Sbjct: 544 --YFIASPY--TFPADGN-GHSLSSRMVTGIITGCSALVL-CLVALGIYAMWQKRRAEQA 597
Query: 595 ISRRR------HSSKTS---IKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
I R S K S ++ G R F+Y E+ TNNF+ S+++G GGYGKVYKG+L
Sbjct: 598 IGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGML 657
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
DG +VA+KRAQ+GS QG EF TEI+ LSR+HH+NLV LVG+C E+GEQ+LVYE+MSNG
Sbjct: 658 QDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNG 717
Query: 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765
+L+D L+ +S L + RL +ALGS+RG+ YLH ADPP+ HRD+K++NILLD TAK
Sbjct: 718 SLKDSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAK 777
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VADFGLS+L V D HVST VKGT GYLDPEY+ T KLT+KSDVYS GVV +EL
Sbjct: 778 VADFGLSKL--VSDC---TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMEL 832
Query: 826 LTGMQPISHGKNIVREVNIAYQSSM--MFSVIDG------NMGSYPSECVEKFIKLALKC 877
+T QPI GK IVRE+ + S + + D ++G+ P + ++++LALKC
Sbjct: 833 ITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPE--LGRYMELALKC 890
Query: 878 CQDETDARPSMSEVMRELESI 898
+ D RP+MSEV++E+E I
Sbjct: 891 VDETADERPTMSEVVKEIEII 911
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 2.0e-120, P = 2.0e-120
Identities = 328/933 (35%), Positives = 469/933 (50%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNT--------TMD-DG 80
++T+ ++ SAL ++K + W DPC +NW G+ C N +D +G
Sbjct: 23 ALTNGLDASALNALKSEWT---TPPDGWEGSDPCGTNWVGITCQNDRVVSISLGNLDLEG 79
Query: 81 YXXXXXXXXXXXXXXXXX---------SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKX 131
P IG L L L + SG IP+ IG +K
Sbjct: 80 KLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFSGQIPESIGTLKE 139
Query: 132 XXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN-------LNKTRHFH 184
P +G L KL I N I G LP S L +T+HFH
Sbjct: 140 LIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAPGLDMLLQTKHFH 199
Query: 185 MNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTI 243
N +SG IP EL S SL+H+L D N TG D N G I
Sbjct: 200 FGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVLRLDRNKLIGD-I 258
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITT 301
P+ +N++ L +L L N G +P+L+ + +L LD+S+N L+ S IP SL +++T
Sbjct: 259 PSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIPSWISSLPSLST 318
Query: 302 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+++ +L G IP +F P+LQ + + NS+ S+ S L F+ D Q N
Sbjct: 319 LRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLE----FV-DLQYNE 373
Query: 362 LTNISGSFNIPPNVTVRLRGNPFCLNT-NAEQFCGSHSDDDNEIDRSTN-STLDCRAQSC 419
+T+ S N + V L NP CL N +C + I +T+ STL C
Sbjct: 374 ITDYKPSAN--KVLQVILANNPVCLEAGNGPSYCSA-------IQHNTSFSTLPTNCSPC 424
Query: 420 PTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLS-YFPAYK-NLFEEYMTSGLKLNLYQLDI 477
E SPT C CA P + +SP S F + ++ ++ + K Y +D
Sbjct: 425 EPGMEASPT----CRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKKFNYPVDS 480
Query: 478 DSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 533
R + P +L + L +FP+ S FN + + + F+ IFGP
Sbjct: 481 VGVRNIRENPTDHQLLIDLLVFPLGRES------FNQTGMSLVGFAFSNQTYKPPPIFGP 534
Query: 534 YELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYH 593
Y + L + DV S++S S +TI+ I +L R +
Sbjct: 535 Y-IFKADLYKQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYAL---RQKKRAER 590
Query: 594 AISRRR-----HSSKTSI---KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
A + +SK+SI ++ G ++FT+ E+ T+NF+ + +G GGYGKVY+GIL
Sbjct: 591 ATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGIL 650
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
P+G ++A+KRAQ+GSLQG EF TEI+ LSR+HH+N+V L+G+C + EQMLVYE++SNG
Sbjct: 651 PNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNG 710
Query: 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765
+L+D LS KS L + RL IALGS +G+ YLH ADPP+ HRDIK++NILLD TAK
Sbjct: 711 SLKDSLSGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAK 770
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VADFGLS+L P+ HV+T VKGT GYLDPEY++T++LT+KSDVY GVV LEL
Sbjct: 771 VADFGLSKLVGDPE-----KTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLEL 825
Query: 826 LTGMQPISHGKNIVREVNIAYQSSMMF----SVIDGNM--GSYPSECVEKFIKLALKCCQ 879
LTG PI GK +VREV S ++D + S + EK++ LAL+C +
Sbjct: 826 LTGRSPIERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVE 885
Query: 880 DETDARPSMSEVMRELESIWNMM---PESDTKT 909
+E RPSM EV++E+E+I + P SD+ T
Sbjct: 886 EEGVNRPSMGEVVKEIENIMQLAGLNPNSDSAT 918
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 1.5e-115, P = 1.5e-115
Identities = 323/938 (34%), Positives = 471/938 (50%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLC-----------FNTTMD 78
+ TD + +AL+++K D SK +W DPC + W G+ C N +
Sbjct: 25 AFTDGSDFTALQALKNEW-DTLSK--SWKSSDPCGTEWVGITCNNDNRVVSISLTNRNLK 81
Query: 79 DGYXXXXXXXXXXXXXXXXXSPE--------IGRLSYLTILDFMWNKISGSIPKEIGNIK 130
+PE IG L LT L M +G IP IGN++
Sbjct: 82 GKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSIGNLE 141
Query: 131 XXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLP----KSFANLN---KTRHF 183
P +G L KL I N + G LP S L+ +T HF
Sbjct: 142 QLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQTGHF 201
Query: 184 HMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTT 242
H NN +SG+IP +L S +L+H+L D N TG D N G
Sbjct: 202 HFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRLSGD- 260
Query: 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LN-IT 300
IP+S +N++ L +L L + G +P+L+ + +L LD+S+N L S P + LN ++
Sbjct: 261 IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSLS 320
Query: 301 TIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
T++L + +L G +P++ FS L +LQ + + +N ++ ++ S+ L+ F+ D ++
Sbjct: 321 TLRLEDIQLDGPVPTSLFSPL-QLQTVSLKHNLINTTLDLGTNYSKQLD----FV-DLRD 374
Query: 360 NNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLDCRAQS 418
N +T N P NV L N C + A Q G N + ST STL
Sbjct: 375 NFITGYKSPANNPVNVM--LADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLTKCGNH 427
Query: 419 CPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLNLYQLD 476
C E P C C PL + L+SP S F N F E + + K Y +D
Sbjct: 428 CGKGKE--PNQG--CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPVD 483
Query: 477 IDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 532
+ R + P L + L +FP SG FN +E+ I S FT + FG
Sbjct: 484 SVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKPPPRFG 537
Query: 533 PYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNY 592
PY + Y+ F +S + + A+ + +R +
Sbjct: 538 PYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQ 592
Query: 593 HAISRRRHSSKTSI---KID-----GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI 644
A + +K ++D G ++FT+ E++ TNNF+ + +G GGYG+VYKG
Sbjct: 593 RATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGT 652
Query: 645 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704
LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVYE++ N
Sbjct: 653 LPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPN 712
Query: 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764
G+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD TA
Sbjct: 713 GSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTA 772
Query: 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824
KVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY GVV LE
Sbjct: 773 KVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLE 827
Query: 825 LLTGMQPISHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK 876
LLTG PI G +V+EV N+ ++ + I N G+ EK++ +AL+
Sbjct: 828 LLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNLKG--FEKYVDVALQ 885
Query: 877 CCQDETDARPSMSEVMRELESIWNMM---PESDTKTPE 911
C + E RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 886 CVEPEGVNRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 154/296 (52%), Positives = 212/296 (71%)
Query: 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT 669
G ++FT+ EM NNF+ + +G GGYG+VYKGILP G ++A+KRAQ GSLQG EF T
Sbjct: 518 GTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKT 577
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
EI+ LSR+HH+N+V L+G+C + GEQMLVYE++ NG+LRD LS KS L + RL IAL
Sbjct: 578 EIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIAL 637
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GS +G+ YLH ADPP+ HRD+K+SN+LLD TAKVADFGLS+L V D E A+V+
Sbjct: 638 GSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANVT 692
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
VKGT GYLDPEY++T++LT+KSDVY GV+ LELLTG PI +GK +V+E+ + S
Sbjct: 693 AQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNKS 752
Query: 850 M-MFSV---IDGNMGSYPSECV---EKFIKLALKCCQDETDARPSMSEVMRELESI 898
++ + +D + + + + EK++ +AL+C E RPSM+EV++E+E+I
Sbjct: 753 KNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENI 808
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 1.1e-79, Sum P(3) = 1.1e-79
Identities = 121/313 (38%), Positives = 190/313 (60%)
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 670
+R T+ + ATN F++ + IG GG+G VYK L DG+VVA+K+ + + QG++EF+ E
Sbjct: 843 LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAE 902
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP---LGFAMRLSI 727
++ + ++ HRNLV L+GYC E++LVYE+M G+L L K+K+ L ++ R I
Sbjct: 903 METIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKI 962
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A+G++RG+ +LH P + HRD+K+SN+LLD F A+V+DFG++RL D
Sbjct: 963 AIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTH----LS 1018
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS---HGK--NIVREV 842
VST+ GTPGY+ PEY+ + + T K DVYS GV+ LELL+G +PI G+ N+V
Sbjct: 1019 VSTLA-GTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWA 1077
Query: 843 NIAYQSSMMFSVIDGNMGSYPSECVE--KFIKLALKCCQDETDARPSMSEVMRELESIWN 900
Y+ ++D + + S VE ++K+A +C D RP+M +VM + +
Sbjct: 1078 KQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQ 1137
Query: 901 MMPESDTKTPEFI 913
+ E+D+ EF+
Sbjct: 1138 VDTENDS-LDEFL 1149
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 4.8e-77, Sum P(2) = 4.8e-77
Identities = 132/326 (40%), Positives = 192/326 (58%)
Query: 579 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYG 638
IV L+ K Y + S+++ + SF+ ++ +ATNNF+S+ +IG+GG+G
Sbjct: 578 IVFLVFGTLWKKGYLRSKSQMEKDFKSLELM-IASFSLRQIKIATNNFDSANRIGEGGFG 636
Query: 639 KVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698
VYKG L DGT++AVK+ GS QG +EFL EI +S LHH NLV L G C E G+ +LV
Sbjct: 637 PVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLV 696
Query: 699 YEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756
YEF+ N +L L + L + R I +G +RG+ YLH E+ + HRDIKA+N+
Sbjct: 697 YEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNV 756
Query: 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 816
LLD + K++DFGL++L D E H+ST + GT GY+ PEY + LTDK+DVY
Sbjct: 757 LLDKQLNPKISDFGLAKL----DEED--STHISTRIAGTFGYMAPEYAMRGHLTDKADVY 810
Query: 817 SLGVVFLELLTGMQ-PISHGKN----IVREVNIAYQSSMMFSVIDGNMGS-YPSECVEKF 870
S G+V LE++ G I KN ++ V + + + + ++D +GS Y E
Sbjct: 811 SFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTM 870
Query: 871 IKLALKCCQDETDARPSMSEVMRELE 896
I++A+ C E RPSMSEV++ LE
Sbjct: 871 IQIAIMCTSSEPCERPSMSEVVKMLE 896
|
|
| TAIR|locus:2148151 AT5G16900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 579 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGV-RSFTYGEMALATNNFNSSTQIGQGGY 637
I L+++ +K + R H S+ ++ ++ R TY E+ L TNNF IG+GG+
Sbjct: 527 IAVLVLIIVFIKKRPSSIRALHPSRANLSLENKKRRITYSEILLMTNNFERV--IGEGGF 584
Query: 638 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697
G VY G L D VAVK S QG KEF E++ L R+HH NLVSLVGYCDE+ L
Sbjct: 585 GVVYHGYLNDSEQVAVKVLSPSSSQGYKEFKAEVELLLRVHHINLVSLVGYCDEQAHLAL 644
Query: 698 VYEFMSNGTLRDQLSAKSKE-PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756
+YE+M+NG L+ LS K + L + RLSIA+ ++ G+ YLH+ P + HRD+K+ NI
Sbjct: 645 IYEYMANGDLKSHLSGKHGDCVLKWENRLSIAVETALGLEYLHSGCKPLMVHRDVKSMNI 704
Query: 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 816
LLD F AK+ADFGLSR V + +HVST V GTPGYLDPEY+ T++LT+KSDVY
Sbjct: 705 LLDEHFQAKLADFGLSRSFSVGE-----ESHVSTGVVGTPGYLDPEYYRTYRLTEKSDVY 759
Query: 817 SLGVVFLELLTGMQPI----SHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFI 871
S G+V LE++T QP+ + ++I V S + +++D N+ G Y S V K +
Sbjct: 760 SFGIVLLEIITN-QPVLEQANENRHIAERVRTMLTRSDISTIVDPNLIGEYDSGSVRKAL 818
Query: 872 KLALKCCQDETDARPSMSEVMRELE 896
KLA+ C ARP MS V++EL+
Sbjct: 819 KLAMSCVDPSPVARPDMSHVVQELK 843
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 5.4e-75, Sum P(2) = 5.4e-75
Identities = 126/322 (39%), Positives = 183/322 (56%)
Query: 590 KNYHAISRRRHSSKTSIKI----DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
+N + +S R SI I + G++ AT++F+ IG GG+G VYK L
Sbjct: 877 QNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACL 936
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
P VAVK+ E QG +EF+ E++ L ++ H NLVSL+GYC E++LVYE+M NG
Sbjct: 937 PGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNG 996
Query: 706 TLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
+L L ++ E L ++ RL IA+G++RG+ +LH P + HRDIKASNILLD F
Sbjct: 997 SLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFE 1056
Query: 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 823
KVADFGL+RL + +HVSTV+ GT GY+ PEY + + T K DVYS GV+ L
Sbjct: 1057 PKVADFGLARLISACE------SHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILL 1110
Query: 824 ELLTGMQPI------SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE-KFIKLALK 876
EL+TG +P S G N+V VID + S + + + +++A+
Sbjct: 1111 ELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAML 1170
Query: 877 CCQDETDARPSMSEVMRELESI 898
C + RP+M +V++ L+ I
Sbjct: 1171 CLAETPAKRPNMLDVLKALKEI 1192
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGD7 | Y1684_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7129 | 0.9644 | 0.9674 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023921001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (903 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 956 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 90/275 (32%), Positives = 133/275 (48%), Gaps = 33/275 (12%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L G VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C EE +V E+M G L L K++ L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG---YLDP 801
HRD+ A N L+ K++DFGLSR + +G ++ P
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRD---------LYDDDYYRKRGGKLPIRWMAP 172
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
E K T KSDV+S GV+ E+ T G QP N EV + Y + +G
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EV-LEY-------LKNGYRL 222
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P C + L L+C ++ + RP+ SE++ L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 91/276 (32%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C EE M+V E+M G L D L + L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----EGIVPAHVSTVVKGTPGYLD 800
HRD+ A N L+ K++DFGLSR D G +P ++ ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IR----WMA 172
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE K T KSDV+S GV+ E+ T G +P + EV + Y + G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV-LEY-------LKKGYR 222
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P C + KL L+C ++ + RP+ SE++ L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 1e-51
Identities = 91/287 (31%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G +G+VYKG L T VAVK +E S + K+FL E + + +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYL 738
+G C EE LV E+M G L D L K L LS A+ ++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVK 793
HRD+ A N L+ K++DFGLSR D G +P ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP------IR 172
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSS 849
PE T KSDV+S GV+ E+ T G P +S EV + Y
Sbjct: 173 WMA----PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV-LEY--- 219
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ G P C ++ +L L C Q + + RP+ SE++ LE
Sbjct: 220 ----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 74/268 (27%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
++G+G +GKVY G +VA+K ++ ++ ++E L EI+ L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
++E + LV E+ G L D L + + A + YLH + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLH---SKGIVH 120
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K NILLD K+ADFGL+R + ++T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFV-GTPEYMAPEVLLGKG 172
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI---DGNMGSYPSE 865
D++SLGV+ ELLTG P + +F I +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQL----------LELFKKIGKPKPPFPPPEWD 222
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMR 893
+ L K + + R + E ++
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 88/277 (31%), Positives = 130/277 (46%), Gaps = 36/277 (12%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L T VAVK +EG+ + E+ EFL E + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C + +V E+M G L D L E L L +AL ++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVKGTPGYL 799
HRD+ A N L+ K++DFGLSR D G +P +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMA--- 172
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
PE K T KSDV+S GV+ E+ T G QP N ++ + DG
Sbjct: 173 -PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----------EEVLELLEDGY 221
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P C ++ +L L+C + + RP+ SE++ +L
Sbjct: 222 RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 78/268 (29%), Positives = 111/268 (41%), Gaps = 57/268 (21%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
+G+GG+G VY G VA+K ++ E L EI+ L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++E LV E+ G+L+D L L L I L G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 750 DIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 807
D+K NILLD K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
++KSD++SLGV+ EL
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187
Query: 868 EKFIKLALKCCQDETDARPSMSEVMREL 895
+ L K Q + + RPS E++ L
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 3e-45
Identities = 120/354 (33%), Positives = 172/354 (48%), Gaps = 40/354 (11%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWN-RGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K S+ D LSNWN D C W G+ C N++ + + L N+
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNSS------RVVSIDLSGKNI 81
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-----------------------GNIKS 131
SG +S I RL Y+ ++ N++SG IP +I G+I +
Sbjct: 82 SGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN 141
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
LE L L+ N L+G +P ++G L + + N + G +P S NL + +N +
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV 201
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
GQIP EL ++ SL + L NNL+G +P E+ L L L L NN G IP+S N+
Sbjct: 202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG-PIPSSLGNLK 260
Query: 252 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKL 309
L L L L GP+P + + L LDLS N L+G IP + L N+ + L +N
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
TG IP + LPRLQ L + +N SG IP ++ + L +LD NNLT
Sbjct: 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-----VLDLSTNNLT 369
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
++G G +G VYK G +VAVK + + + ++ EI+ L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+++ LV E+ G L D LS PL IAL RG+ YLH+ +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K NILLD K+ADFGL++ + + T GTP Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 808 KL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG-NMGSYPSE 865
K DV+SLGV+ ELLTG +P G+NI+ Q ++ ++ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG-KPPFSGENILD------QLQLIRRILGPPLEFDEPKW 226
Query: 866 C--VEKFIKLALKCCQDETDARPSMSEVM 892
E+ L KC + RP+ E++
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 33/270 (12%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY + D G ++AVK + E + EI+ LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 688 -YCDEEGEQMLVY-EFMSNGTLRDQLSAKSK--EPLGFAMRL---SIALGSSRGILYLHT 740
DEE + ++ E++S G+L L K EP+ +R I G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLHS 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK +NIL+D K+ADFG ++ + I + V+GTP ++
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKR-----LGDIETGEGTGSVRGTPYWMA 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE + +D++SLG +E+ TG P S N + +++ G
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------AALYKIGSSGEPP 223
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSE 890
P E+ KC + + RP+ E
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 8e-39
Identities = 106/318 (33%), Positives = 154/318 (48%), Gaps = 33/318 (10%)
Query: 73 FNTTMDDGYLHLRE-LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131
F ++ G + E L L N LSG + +IG S L +LD N + G IP + N+ S
Sbjct: 130 FTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS 189
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
LE L L N+L G +P ELG + L I + N +SG +P L H + N+++
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL----------------LILQLDN 235
G IP L L +L ++ L N L+G +PP + L KL L++QL N
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
Query: 236 --------NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQL 286
NNF G IP + +++ +L L L + G +P +L + NL LDLS+N L
Sbjct: 310 LEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 287 NGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
G IP G S N+ + L +N L G IP + L+R+ + +NS SG +PS +
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
Query: 346 TLNATETFILDFQNNNLT 363
+ LD NNNL
Sbjct: 429 LVY-----FLDISNNNLQ 441
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-38
Identities = 106/320 (33%), Positives = 154/320 (48%), Gaps = 39/320 (12%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L+ LQ L L LSG + P I L L LD N +SG IP+ + +++LE+L L N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-------- 192
TG +P L LP+L +Q+ N SG +PK+ N ++ N+++G
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 193 ----------------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
+IP L SL + L +N+ +G LP E ++LP + L + NN
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
N +G I + +M L LSL G +PD L LDLS NQ +G++P S
Sbjct: 439 NLQG-RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS 497
Query: 297 LN-ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
L+ + +KLS NKL+G IP S +L L +++N LSG IP+S + L+ L
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ-----L 552
Query: 356 DFQNNNLTNISGSFNIPPNV 375
D N L S IP N+
Sbjct: 553 DLSQNQL-----SGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-33
Identities = 90/265 (33%), Positives = 144/265 (54%), Gaps = 7/265 (2%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ L+ L++L+L N +G + + L L +L NK SG IPK +G +L +L L+
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N LTG +PE L L ++ + N + G +PKS R + +NS SG++P E
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++LP + + + NNNL G + ++P L +L L N F G +P S+ + +L L L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG-LPDSFGS-KRLENLDL 482
Query: 259 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSN 316
G +P L + L L LS N+L+G IP S + ++ LS+N+L+G IP++
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSI 341
FS +P L +L ++ N LSG IP ++
Sbjct: 543 FSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+GG+G+VYK G VA+K + S + +++ + EIQ L + H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ E +V EF S G+L+D L + + L + + +G+ YLH+ + HR
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122
Query: 750 DIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIKA+NILL K+ DFGLS +L+ +V GTP ++ PE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---------GTPYWMAPEVINGKP 173
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG----SYPS 864
K+D++SLG+ +EL G P S + ++ +G G S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS---------ELPPMKALFKIATNGPPGLRNPEKWS 224
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + F+K KC Q + RP+ ++++
Sbjct: 225 DEFKDFLK---KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 679
A+ + IG+G +G V G G VAVK ++ S + FL E ++ L H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
NLV L+G + +V E+M+ G+L D L ++ + + A +L AL G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HRD+ A N+L+ AKV+DFGL++ A G +P VK T
Sbjct: 120 EKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA--- 167
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG--KNIVREVNIAYQSSMMFSVID 856
PE K + KSDV+S G++ E+ + G P K++V V Y+
Sbjct: 168 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------- 217
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
M + P C + K+ C + + RP+ ++ +L I
Sbjct: 218 --MEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 23/283 (8%)
Query: 631 QIGQGGYGKVYKG---ILPDGT--VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVS 684
Q+G+G +GKV L D T VAVK G Q +F EI+ L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C++ G + L+ E++ +G+LRD L + ++ + L + +G+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-YLDP 801
HRD+ A NIL++ + K++DFGL+++ P + +P + P
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-----DYYYVKEPGESPIFWYAP 181
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-KNIVREVNIAYQSSMMFSVI----D 856
E T K + SDV+S GV EL T P +R + IA ++ ++ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
G P C ++ L C + E RPS ++++ ++ +
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 85/281 (30%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEADPPVF 747
E +V E+MS G+L D L K G +RL +A + G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTV--VKGTPGYLDPEYF 804
HRD+ A NIL+ K+ADFGL+RL IE A +K T PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTA----PEAA 176
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-------GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
+ T KSDV+S G++ E++T GM + ++ +V Y+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVERGYRMPR------- 225
Query: 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C E+ L L+C + + RP+ + LE
Sbjct: 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V++G+ + T VAVK + G++ K+FL E Q + +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E +V E M G+L + L + L + +A + G+ YL + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEYFLTHK 808
+ A N+L+ KVADFGL+R+ E I A +K T PE L ++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTA----PEAALYNR 180
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 864
+ KSDV+S G++ E++T +G+ + Y V+ Y P
Sbjct: 181 FSIKSDVWSFGILLTEIVT------YGR-------MPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
C ++ + L C +++ D RP+ + +LE
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 87/281 (30%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK L+ ++FL E + H N++SL+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHT 740
G C EG ++V +M +G LR+ + +++ P +GF ++++ +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA------KGMEYL-- 114
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
A HRD+ A N +LD FT KVADFGL+R + D E H T K ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E T K T KSDV+S GV+ EL+T G P V +I ++ G
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITVY------LLQGRR 220
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900
P C + ++ L C + + RP+ SE++ +E I++
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V+ G VA+K +EG++ E +F+ E + + +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V E+M+NG L + L + K LG L + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N L+ KV+DFGL+R V D + VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
KSDV+S GV+ E+ + G P N +V V+ Y+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR------------PKLAP 227
Query: 868 EKFIKLALKCCQDETDARPSMSEVMREL 895
+ + C ++ + RP+ +++ +L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ VAVK +E +++ E EFL E + + H NLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECV 867
+ KSDV++ GV+ E+ T GM P S ++ +++ G P C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP-----------GIDLSQVYELLEKGYRMERPEGCP 231
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELESI 898
K +L C Q RPS +E+ + E++
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 86/310 (27%), Positives = 138/310 (44%), Gaps = 60/310 (19%)
Query: 625 NFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL 677
N +G+G +GKV K T VAVK +E + E ++ L+E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 716
+H +++ L G C ++G +L+ E+ G+LR L K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 717 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-- 773
L +S A SRG+ YL A+ + HRD+ A N+L+ K++DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 774 ---LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
+ V +G +P VK ++ E H T +SDV+S GV+ E++T G
Sbjct: 178 YEEDSYVKRSKGRIP------VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 830 QPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSM 888
P IA + +F+++ G P C E+ L L C + E D RP+
Sbjct: 228 NPYP---------GIAPER--LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 889 SEVMRELESI 898
+++ +ELE +
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRN 681
N+ IG+G +G VYKG+ L G VA+K+ ++ E K + EI L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
+V +G + ++ E+ NG+LR + E L A+ + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLH 116
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ V HRDIKA+NIL K+ADFG++ +L V + V GTP +
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--------SKDDASVVGTPYW 165
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE + SD++SLG +ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 83/272 (30%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
IG G +GKVY + L G ++AVK R Q+ + KE E++ L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 689 CDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ E++ ++ E+ S GTL + L ++ L G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRDIK +NI LDH K+ DFG + +L G ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA----GTPAYMAPEVITG 177
Query: 807 HKLTDK---SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
K +D++SLG V LE+ TG +P S N + +MF V G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVGAGHKPPIP 228
Query: 864 -----SECVEKFIKLALKCCQDETDARPSMSE 890
S + F+ C + + RP+ SE
Sbjct: 229 DSLQLSPEGKDFLDR---CLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V++G+ + VA+K + L +++F E+Q L RL H++L+SL C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ E M G+L L + + L A + +A + G+ YL + HRD
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYFLTHKL 809
+ A NIL+ KVADFGL+RL E + + + K T PE
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTA----PEAASHGTF 181
Query: 810 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSE 865
+ KSDV+S G++ E+ T +G+ + Y V D Y P++
Sbjct: 182 STKSDVWSFGILLYEMFT------YGQ-------VPYPGMNNHEVYDQITAGYRMPCPAK 228
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C ++ K+ L+C E + RPS + EL++I
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 630 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+GQG G VYK P G + A+K+ + K+ L E++ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+EGE +V E+M G+L D L K P ++ + +G+ YLHT+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH--II 122
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIK SN+L++ K K+ADFG+S+ +E + + V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--GTVTYMSPERIQGE 175
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+ +D++SLG+ LE G P +M ++ DG S P+E
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELMQAICDGPPPSLPAEEF 228
Query: 868 -EKFIKLALKCCQDETDARPSMSEVMR 893
+F C Q + RPS +E+++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G V+ G + VA+K +EG++ E++F+ E Q + +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADP 744
C E LV+EFM +G L D L A+ S+E L L + L G+ YL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN-- 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+ A N L+ KV+DFG++R V D + ST K + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQ----YTSSTGTKFPVKWSSPEVF 173
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGS 861
K + KSDV+S GV+ E+ + G P + N +V +N ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------- 222
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P + +L C ++ + RPS S ++ +L
Sbjct: 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G VYKG+L T VAVK + K FL E + L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ +V E + G+L L K K L L ++L ++ G+ YL ++ HR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHK 808
D+ A N L+ K++DFG+SR + EG + VS +K P + PE +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171
Query: 809 LTDKSDVYSLGVVFLELLT-GMQPISHGKNI-VREVNIAYQSSMMFSVIDGNMGSYPSEC 866
T +SDV+S G++ E + G P N RE + G P C
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----------RIESGYRMPAPQLC 220
Query: 867 VEKFIKLALKCCQDETDARPSMSEVMRELES 897
E+ +L L+C + + RPS SE+ EL+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 88/310 (28%), Positives = 135/310 (43%), Gaps = 64/310 (20%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSR 676
NN IGQG +G+V++ G+LP T+VAVK +E S + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------------K 716
H N+V L+G C L++E+M+ G L + L +S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
PL +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 777 VPDIEGIVPAHVSTVVKGTPG------YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
+I + + K + ++ PE ++ T +SDV++ GVV E+ + GM
Sbjct: 179 --NI------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 830 QP---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 886
QP ++H E I Y V DGN+ S P C + L C RP
Sbjct: 231 QPYYGMAH------EEVIYY-------VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 887 SMSEVMRELE 896
S + + R L+
Sbjct: 278 SFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 631 QIGQGGYGKVYKG----ILPDG--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLV 683
++G+G +GKV+ G + P+ +VAVK +E + K+F E + L+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + L + L IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHV 788
+ G++YL A HRD+ N L+ + K+ DFG+SR D + G H
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG----HT 184
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP-ISHGKNIVREVNIAY 846
++ P PE + K T +SDV+S GVV E+ T G QP V E
Sbjct: 185 MLPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ G + P C + + L C + + R ++ ++ L+
Sbjct: 237 -------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (284), Expect = 5e-27
Identities = 95/336 (28%), Positives = 146/336 (43%), Gaps = 21/336 (6%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHR 680
++ ++G+G +G+VY D +VA+K E + + FL EIQ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLH 739
N+V L + +EG LV E++ G+L D L K PL + L I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 740 TEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
++ + HRDIK NILLD K+ DFGL++L P P +PA ST V GTPGY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 799 LDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQP---ISHGKNIVREVNIAYQSSMMF 852
+ PE L + SD++SLG+ ELLTG+ P + + + I +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIWNMMPESDTKTPE 911
+ S P + L K + R S S + +L + + ESD
Sbjct: 235 LASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK-LKESDLSDLL 292
Query: 912 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 947
+ + PPS +++ + +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 87/267 (32%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V E+MS G+L D L + + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPES 231
Query: 870 FIKLALKCCQDETDARPSMSEVMRELE 896
L +C + E + RP+ + LE
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 35/273 (12%)
Query: 631 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEF-LTEIQFLSRLHHRNLVSLVG 687
QIG+G +GKVY DG + +K + E+E L E++ L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 688 YCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHT 740
Y + E+G+ +V E+ G L ++ + KE F + + L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--ALKYLHS 121
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK NI L K+ DFG+S++ + V TVV GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD-LAKTVV-GTPYYLS 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE KSD++SLG V EL T P G+N + ++ G
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGEN---------LLELALKILKGQYP 221
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
PS+ + L Q + + RPS++++++
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 62/298 (20%)
Query: 630 TQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNL 682
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRG 734
V L+G ++V E M+ G L+ L ++ E P + +A + G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIV 784
+ YL A HRD+ A N ++ T K+ DFG++R DI +G++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843
P ++ PE T KSDV+S GVV E+ T QP
Sbjct: 184 PVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------ 221
Query: 844 IAYQ----SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
YQ ++ VIDG P C +K ++L C Q RP+ E++ L+
Sbjct: 222 --YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VA+K +EGS+ E EF+ E + + +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V E+MSNG L + L K + L + G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLDPEYFL 805
+ A N L+D + KV+DFGLSR V D E + S+V V+ +P PE L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDE-----YTSSVGSKFPVRWSP----PEVLL 174
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K + KSDV++ GV+ E+ + G P N S + V G P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------SETVEKVSQGLRLYRPH 224
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
EK + C ++ + RP+ +++ +E
Sbjct: 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G+V+KG L D T VAVK +E Q K +FL+E + L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+ +V E + G L K K+ L + AL ++ G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHKL 809
+ A N L+ K++DFG+SR + +GI + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGI---YSSSGLKQIPIKWTAPEALNYGRY 171
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+ +SDV+S G++ E + G+ P N RE V G S P +C
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----------QVEKGYRMSCPQKCP 220
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELES 897
+ K+ +C + + RP SE+ +EL +
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+ + +IG+G G+VYK G VA+K+ + Q ++ + EI + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEP-LGFAMRLSIALGSSRGILY 737
+V E +V E+M G+L D Q + EP + + R + +G+ Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEY 131
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFG----LSRLAPVPDIEGIVPAHVSTVVK 793
LH++ V HRDIK+ NILL + K+ADFG L++ ++VV
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV- 177
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE K D++SLG++ +E+ G P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-----EIQFLSRLHHRNLVSL 685
+G+G YG VYK G +VA+K+ + L E+E + EI L L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEAD 743
+ E + LV+E+ L+ L K P + L SI RG+ Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K NIL++ K+ADFGL+R +P + + VV T Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTYTHEVV--TLWYRAPEI 169
Query: 804 FLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
L K + D++S+G +F E++TG +P+ G +
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
QIG+G YG+VYK G +VA+K+ ++ EKE + EI+ L +L H N+V
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 685 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS---------- 732
L + G +V+E+M + D L+ G + S
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----D-LT-------GLLDSPEVKFTESQIKCYMKQLL 110
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTV 791
G+ YLH+ + HRDIK SNIL+++ K+ADFGL+R + + V
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRV 162
Query: 792 VKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ T Y PE L + + D++S+G + EL G +PI G
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY 688
IG G VY I LP+ VA+KR Q E E+Q +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPP 745
E LV ++S G+L D + KS P G IA +G+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRDIKA NILL + K+ADFG+S A + D G V GTP ++ PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVS--ASLAD-GGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 806 THK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K+D++S G+ +EL TG P S + + M+ + + S +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML--TLQNDPPSLET 229
Query: 865 ECVEK-----FIKLALKCCQDETDARPSMSEVMR 893
K F K+ C Q + RP+ E+++
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 90/294 (30%), Positives = 128/294 (43%), Gaps = 57/294 (19%)
Query: 632 IGQGGYGKVYKG----ILPDGT---VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G IL G+ VAVK ++G+ EK EFL E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGT----LRDQLSAKSKEP-LGFAMRLSIALGSSRGILYL 738
L+G C Q ++ E M G LRD + P L L I L ++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 739 HTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDI----------EGI 783
HRD+ A N L+ K K+ DFGL+R DI EG+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEGL 174
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842
+P ++ PE L K T +SDV+S GV+ E+LT G QP N EV
Sbjct: 175 LPVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV 222
Query: 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ + V G P C +K +L C + RP+ + L+
Sbjct: 223 -LQH-------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 631 QIGQGGYGKVYKGI--LPDGTV--VAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG+ + G VAVK QE G+KEFL E +++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L + + P+ + +A + G+ YL E+
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL--ESKHF 116
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG------YL 799
V HRD+ A N+LL ++ AK++DFG+SR A S + T +
Sbjct: 117 V-HRDLAARNVLLVNRHQAKISDFGMSR-ALGAG---------SDYYRATTAGRWPLKWY 165
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
PE K + KSDV+S GV E + G +P K + + ++++
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAMLESG 214
Query: 859 --MGSYPSECVEKFIKLALKCCQDETDARPSMSEV 891
+ P EC ++ + L C + + RP+ SE+
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 83/282 (29%), Positives = 120/282 (42%), Gaps = 55/282 (19%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 685
+G G +G VY+G+ L DG AVK A +G E K+ EI LS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+G EE + E + G+L L EP+ I LG + YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGY 798
HRDIK +NIL+D K+ADFG+++ V KG+P +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-------------QVVEFSFAKSFKGSPYW 167
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
+ PE +D++SLG LE+ TG P S + +F + G
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ----------LEGVAAVFKI--G 215
Query: 858 NMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMR 893
P S+ + FI LKC Q + RP+ +E++
Sbjct: 216 RSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 76/261 (29%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G YG VYK I G VVA+K E LQ E + EI L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+ + +V E+ G++ D + +K L +I + +G+ YLH HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIKA NILL+ + AK+ADFG+S A +TV+ GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 810 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
+K+D++SLG+ +E+ G P S + I + S P + +
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPE 228
Query: 870 FIKLALKCCQDETDARPSMSE 890
F KC + + RPS +
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 632 IGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V +G L P VA+K + GS ++ +FLTE + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ E+M NG+L D+ ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLDP 801
HRD+ A NIL++ KV+DFGLSR + G +P + P
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------WTAP 177
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
E K T SDV+S G+V E+++ G +P N ++V + +V DG
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDV--------IKAVEDGYRL 227
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
P +C +L L C Q + + RP+ S+++ L+
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 85/267 (31%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V EFM G+L D L + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
KSDV+S G++ EL+T G P N REV + V G P C E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REV--------LEQVERGYRMPCPQGCPES 231
Query: 870 FIKLALKCCQDETDARPSMSEVMRELE 896
+L C + + D RP+ + LE
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V+ G VA+K EG++ E++F+ E + + +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V EFM NG L + L + + L M LS+ G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N L+ KV+DFG++R V D E + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
KSDV+S GV+ E+ T G P N Y+ M S G P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS--RGFRLYRPKLASMT 229
Query: 870 FIKLALKCCQDETDARPSMSEVMREL 895
++ C ++ + RP+ +E++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-24
Identities = 85/294 (28%), Positives = 132/294 (44%), Gaps = 56/294 (19%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG----------------------- 120
L+ LQL + SG + +G+ + LT+LD N ++G
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 121 -SIPKEIGNIKSLELLLLNGNELTGSLPEELGYL------------------------PK 155
IPK +G +SL + L N +G LP E L P
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + +N G LP SF + + + ++ N SG +P +L L L+ + L N L+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIP 274
G +P ELS KL+ L L +N G IPAS+S M L +L L L G +P +L +
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQ-IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 275 NLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
+L +++S N L+GS+P L++N + + N L G + SGLP +R+
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVA-GNIDLCGGDTT--SGLPPCKRV 622
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V E+MS G+L D L L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++++NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
KSDV+S G++ EL+T G P N REV + V G P +C
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REV--------LEQVERGYRMPCPQDCPIS 231
Query: 870 FIKLALKCCQDETDARPSMSEVMRELE 896
+L L+C + + + RP+ + LE
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V++GIL VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ E+M NG L L E + + + + G + G+ YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNY 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRD+ A NIL++ KV+DFGLSR+ D EG + ++ K + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEG---TYTTSGGKIPIRWTAPEAIAY 184
Query: 807 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865
K T SDV+S G+V E+++ G +P N EV M ++ DG P +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV--------MKAINDGFRLPAPMD 234
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C +L L+C Q + RP +++ L+ +
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + P D +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSA--------------KSKEPLGFAMRLSIALG 730
G C + ++V+E+M +G L L A ++K LG + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+ G++YL A HRD+ N L+ K+ DFG+SR D V H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTML 187
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849
++ P PE + K T +SDV+S GV+ E+ T G QP N +
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------TE 233
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
++ + G + P C ++ + L C Q E R ++ E+ + L ++ P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 46/292 (15%)
Query: 631 QIGQGGYGKVYKGIL--PDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 683
++G+G +GKVYKG L P+ T VA+K +E + ++EF E + +S L H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----------------SAKSKEPLGFAMRLS 726
L+G C +E +++E++++G L + L S + F L
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LH 128
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
IA+ + G+ YL + HRD+ A N L+ T K++DFGLSR D +
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845
+ V ++ PE L K T +SD++S GVV E+ + G+QP N +EV
Sbjct: 186 SLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEV--- 235
Query: 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
+ + + P +C + L ++C + RP ++ L S
Sbjct: 236 -----IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 632 IGQGGYGKVYKGIL------PDGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNL 682
+G+G +GKV L DGT +VAVK + Q + EI L L+H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 683 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V G C E+G + L+ E++ G+LRD L K L A L A G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+LLD+ K+ DFGL++ P EG V +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVID--- 856
E +K + SDV+S GV ELLT S K + + +I+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 857 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900
G P C ++ L C + E RP+ ++ L+ + +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + P D +VAVK ++ S K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA-----------MRLSIALGSSR 733
G C E ++V+E+M +G L L A + + A L IA +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G++YL A HRD+ N L+ K+ DFG+SR D V H ++
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIR 187
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 852
P PE + K T +SDV+SLGVV E+ T G QP N + ++
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NEVIE 233
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
+ G + P C ++ L L C Q E R ++ E+ L+++ P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 82/268 (30%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG+G +G V +G G VAVK + + + Q FL E +++LHH+NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
G +V E MS G L + L + + + L +L + G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A NIL+ AKV+DFGL+R+ + +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 868
+ KSDV+S GV+ E+ + G P + K ++EV + G P C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEK--------GYRMEPPEGCPA 224
Query: 869 KFIKLALKCCQDETDARPSMSEVMRELE 896
L C + E RPS ++ +LE
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ +LP D +VAVK +E S ++F E + L+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-------------PLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + + L L+IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+ G++YL A HRD+ N L+ K+ DFG+SR DI V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 850
++ PE L K T +SD++S GVV E+ T G QP N +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----------TEA 233
Query: 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
+ + G P C + + C Q E R + ++ L++
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFLT-EIQFLSRLHHRNLVSLVGY 688
IG+G +G V K DG ++ K G++ + EK+ L E+ L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 689 CDEE--GEQMLVY---EFMSNGTLRDQLSAKSKEP---------LGFAMRLSIALGSSRG 734
D +Y E+ G L QL K K+ +L +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALY---- 119
Query: 735 ILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
H +DP V HRD+K +NI LD K+ DFGL+++ A T V
Sbjct: 120 --ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAK--TYV 171
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE +KSD++SLG + EL P +N
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-----KEFLTEIQFLSRL 677
N+ +GQG +G+VY D G +AVK+ E EIQ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 678 HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 733
H +V G C + E + ++ E+M G+++DQL A A+ ++ +R
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114
Query: 734 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPV-PDIEGIVPAHVST 790
G+ YLH+ + HRDIK +NIL D K+ DFG S RL + G+
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850
V GTP ++ PE K+DV+S+G +E+LT P + + + IA Q +
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT- 224
Query: 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + S+ S F++ + RPS E++R
Sbjct: 225 -----NPQLPSHVSPDARNFLRRTFV---ENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 631 QIGQGGYGKVYK---GILPDGT--VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V L D T VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 686 VGYCDEEG--EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G LV E++ G+LRD L K +E L L A +G+ YL ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----Y 798
HRD+ NIL++ + K+ DFGL+++ P D E V+ PG +
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKE-------YYKVR-EPGESPIFW 177
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTG-----------MQPISHGKNIVREVNIAYQ 847
PE K + SDV+S GVV EL T M+ + + K
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ-------- 229
Query: 848 SSMMFSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
+++ +I+ + P C + + +C ++ RPS SE+ ++E+I
Sbjct: 230 -MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 631 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
++G G G V K P G ++AVK + E + +K+ L E+ L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGSSRGILYLHTEADP 744
G+ + E+M G+L L LG IA+ +G+ YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE--KH 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDP 801
+ HRD+K SNIL++ + K+ DFG+S V+++ K GT Y+ P
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------VNSLAKTFVGTSSYMAP 168
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
E + + KSD++SLG+ +EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 36/256 (14%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-V 686
IG+G +GKV D + A+K + + + L E + L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIA-LGSSRGILYLHTEA 742
+ DEE ++V + + G LR LS K K F+ ++ I + + YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVL--ALEYLHSKG 120
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRDIK NILLD + + DF ++ P ++T GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT--------PDTLTTSTSGTPGYMAPE 169
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSMMFSVIDGNMG 860
+ D +SLGV E L G +P +R+ + +++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW---- 225
Query: 861 SYPSECVEKFIKLALK 876
+E ++ I L+
Sbjct: 226 --STEAID-AINKLLE 238
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 54/291 (18%)
Query: 632 IGQGGYGKVYKGI---LPDGTV---VAVK-RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+G G +G+VY+G+ V VAVK + S Q E +FL E +S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLS---AKSKEPLGFAMR--LSIALGSSRGILYLH 739
L+G E + ++ E M+ G L+ L + + P M+ L A ++G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG----------IVPA 786
HRDI A N LL K AK+ADFG++R DI ++P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP- 184
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845
+K P PE FL T K+DV+S GV+ E+ + G P N +EV
Sbjct: 185 -----IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV--- 230
Query: 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
M F G + P C ++ C Q + RP+ + ++ ++
Sbjct: 231 ----MEFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VA+K ++GS+ E FL E + +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M NG+L D L L + +A + G+ ++ + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ K+ADFGL+RL + D E +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 811 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 866
KSDV+S G++ E++T +G+ I Y VI Y P C
Sbjct: 182 IKSDVWSFGILLTEIVT------YGR-------IPYPGMTNPEVIQNLERGYRMPRPDNC 228
Query: 867 VEKFIKLALKCCQDETDARPSMSEVMREL 895
E+ +L C +++ + RP+ E +R +
Sbjct: 229 PEELYELMRLCWKEKPEERPTF-EYLRSV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-CD 690
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E+G +V E+M+ G+L D L ++ + LG L +L + YL EA+ V HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV-HRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N+L+ AKV+DFGL++ A G +P VK T PE K +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFS 177
Query: 811 DKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
KSDV+S G++ E+ + G P K++V V Y+ M + P C
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------MDA-PDGCP 225
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ +C + RPS ++ +LE I
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 632 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ +P+G VA+K +E + + KE L E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 686 VGYCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+G C Q L+ + M G L D + K+ +G L+ + ++G+ YL +
Sbjct: 75 LGIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYL 799
+ HRD+ A N+L+ K+ DFGL++L V + E G VP +K ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------IK----WM 178
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
E L T KSDV+S GV EL+T G +P G E+ + + G
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEI-----PDL---LEKGE 228
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P C + +KC + ++RP+ E++ E
Sbjct: 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 632 IGQGGYGK--VYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+ +Y+ D ++V K L + ++ L EI LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ ++ E+ + GTL D++ + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIK NI L K+ DFG+S+ I G + TVV GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK------ILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
K KSD+++LG V ELLT + R + +++ ++ GN S
Sbjct: 177 KYNFKSDIWALGCVLYELLT----------LKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 868 EKFIKLALKCCQDETDARPSMSEVM 892
+ I L Q + + RP+ EV+
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRN 681
+F +IG+G +G V+K + D V A+K+ + + + +E + E + L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ ++G+ +V E+ NG L L + PL + G+ +LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK+ N+ LD K+ D G+++L +T+V GTP YL P
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
E +KSDV++LGVV E TG P + Q +++ +I G
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPF----------DANNQGALILKIIRGVFPP 220
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
++ +L +C + RP +++R
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 70/274 (25%), Positives = 110/274 (40%), Gaps = 29/274 (10%)
Query: 631 QIGQGGYGKVYKG--ILPDGTV--VAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G G V VAVK + L +FL E + L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G M+V E G+L D+L + + A+ + G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYF 804
HRD+ A NILL K+ DFGL R P + +V P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPFAWCAPESL 172
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGS 861
T + SDV+ GV E+ T G +P + G I+++++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------E 221
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P C + + L+C RP+ + + L
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G YG VYK G +VA+K+ + K L EI+ L L+H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+G+ LV+EFM +L + L ++ S +G+ + H+ +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+L++ + K+ADFGL+R P V + VV T Y PE L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSP-----VRPYTHYVV--TRWYRAPELLLGD 173
Query: 808 KLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 843
K D++S+G +F ELL+ +P+ GK+ + ++
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 86/281 (30%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 678
N+ +GQG +G+VY D G +A K+ Q S + KE EIQ L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 679 HRNLVSLVGYCDEEGEQMLV--YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
H +V G + E+ L E+M G+++DQL A A+ S+ +R IL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQIL 116
Query: 737 ----YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
GTP ++ PE K+DV+SLG +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--- 226
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + S+ SE F L C E RPS E++R
Sbjct: 227 ---NPQLPSHISEHARDF----LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 32/275 (11%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F +IG G +G VY + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRDIKA NILL T K+ADFG + L PA+ S V GTP ++ P
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASLVS--------PAN-SFV--GTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
E L + K DV+SLG+ +EL P+ + + +IA S S D
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW- 239
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
S+ F+ C Q RPS E+++
Sbjct: 240 -----SDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLS 675
++ ++G+G +G+VYK + G VVA+K+ + EK+ L EI+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 676 RLHHRNLVSL----VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMR 724
+L H N+V L V D+ + +V +M +G L + S K E
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYM 121
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL----APVPDI 780
L + GI YLH + + HRDIKA+NIL+D++ K+ADFGL+R P P
Sbjct: 122 LQLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 836
G T + T Y PE L + T D++ +G VF E+ T +PI GK
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 21/258 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G + T VAVK + G++ + FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M+ G+L D L + + + + + G+ Y+ + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+N+L+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
KSDV+S G++ E++T G P N S +M ++ G C ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSN----------SDVMSALQRGYRMPRMENCPDE 232
Query: 870 FIKLALKCCQDETDARPS 887
+ C +++ + RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG VYK G +VA+K+ + L+ E E + EI L L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+ E + LV+EF+ + L+ + + L + S +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+K N+L+D + K+ADFGL+R VP V + VV T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTYTHEVV--TLWYRAPEIL 171
Query: 805 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835
L + + + D++S+G +F E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQ---EGSLQGEKEFLT---EIQFLSRLHHRNLVSL 685
+G+G YG VY G+ G ++AVK+ + L EKE+ E+ L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C ++ + EF+ G++ L+ P + + + G+ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNC 122
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRDIK +N++L K+ DFG +R + G +++ + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVIN 181
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYP 863
KSD++S+G E+ TG P++ + + MF + M P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYIGAHRGLMPRLP 231
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMR 893
I C + RPS +++R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG VYKG G +VA+K+ + L+ E+E + EI L L H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L +E L++EF+S + S + + + S +GIL+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+K N+L+D+K K+ADFGL+R +P V + VV T Y PE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-----VRVYTHEVV--TLWYRAPEVL 173
Query: 805 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835
L + + + D++S+G +F E+ T +P+ HG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
IG+G +G+VYK I VVA+K + E E + EIQFLS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 690 DEEGEQM-LVYEFMSNGTLRDQL-SAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPV 746
+G ++ ++ E+ G+ D L K E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----GTPGYLD 800
HRDIKA+NILL + K+ADFG V ++ T+ K GTP ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG-------------VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
PE +K+D++SLG+ +EL G P+S
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 632 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKGI +PDG VA+K +E S + KE L E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + M G L D + ++K+ +G L+ + ++G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL+RL + + E G VP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E L + T +SDV+S GV EL+T G +P RE+ + G
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK--------GER 229
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C + +KC +++ RP E++ E +
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M+V E+M NG+L D K + + G + G+ YL +D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A NIL++ KV+DFGLSR L P+ A+ + K + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIA 182
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K T SDV+S G+V E+++ G +P N ++ ++ +G P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----------QDVIKAIEEGYRLPAPM 232
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+C +L L C Q + + RP +++ L+ +
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 53/270 (19%)
Query: 649 TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707
+VAVK + + + +FL E++ LSRL N+ L+G C + ++ E+M NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 708 ---------RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758
A + + L F+ L +A + G+ YL HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 759 DHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
+T K+ADFG+SR D ++G P + ++ E L K T KSDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDV 215
Query: 816 YSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG------------S 861
++ GV E+LT QP H + VI+ N G
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTD--------------QQVIE-NAGHFFRDDGRQIYLP 260
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEV 891
P C + +L L+C + + + RP+ E+
Sbjct: 261 RPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVSL 685
+G+G Y VYK G +VA+K+ + G + K+ L EI+ L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ + LV+EFM L + KS L A S L + RG+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+K +N+L+ K+ADFGL+R P+ + VV T Y PE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVV--TRWYRAPELLF 175
Query: 806 THKL-TDKSDVYSLGVVFLELL 826
+ D++S+G +F ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 632 IGQGGYGKVYKGIL--PDGTV--VAVKRAQ-EGSLQGE-KEFLTEIQFLSRLHHRNLVSL 685
+G+G +G V +G L DG+ VAVK + + E +EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 686 VGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 735
+G C E M++ FM +G L L E L L + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVSTV-V 792
YL HRD+ A N +L T VADFGLS+ D +G ++ + V
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPV 179
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 851
K ++ E T KSDV++ GV E+ T G P +N +
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----------HEIY 225
Query: 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ GN P +C+++ L C + + RP+ +++ LE+I
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 632 IGQGGYGKVYKGIL-PDG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V +G L G VA+K + G + + ++FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ EFM NG L D ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFL 805
HRD+ A NIL++ KV+DFGLSR + + P + S++ P + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY-- 862
K T SDV+S G+V E+++ G +P Y VI+ Y
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMSNQDVINAIEQDYRL 230
Query: 863 --PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P +C +L L C Q + +ARP +++ L+ +
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 87/313 (27%), Positives = 135/313 (43%), Gaps = 54/313 (17%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKG-ILPDGTVV--AVKRAQE-GSLQGEKEFLTEIQFLS 675
L N+ IG+G +G+V K I DG + A+KR +E S ++F E++ L
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 676 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLG 720
+L HH N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 721 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780
L A +RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--- 176
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISH 834
VK T G L + L T SDV+S GV+ E+++ G P
Sbjct: 177 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC- 225
Query: 835 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894
G + + + G P C ++ L +C +++ RPS +++
Sbjct: 226 GMTC---------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI--- 273
Query: 895 LESIWNMMPESDT 907
L S+ M+ E T
Sbjct: 274 LVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-19
Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 37/266 (13%)
Query: 648 GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV--GYCDEEGEQMLVYEFM 702
G VA+K + + + E + F E +RL+H N+V+L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 703 SNGTLRDQLSAKSKEPLGFAMRL------SIALGSSRGILYLHTEADPPVFHRDIKASNI 756
TLR+ L+A P G RL ++A ++GI+ HRD+K NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIV-----------HRDLKPQNI 110
Query: 757 LL---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVS--TVVKGTPGYLDPEYFLTHKLTD 811
++ + AKV DFG+ L +P + A ++ T V GTP Y PE +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 812 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 871
SD+Y+ G++FLE LTG Q + G + V E+ S + S + + +P + + +
Sbjct: 169 NSDLYAWGLIFLECLTG-QRVVQGAS-VAEILYQQLSPVDVS-LPPWIAGHP---LGQVL 222
Query: 872 KLAL-KCCQDETDARPSMSEVMRELE 896
+ AL K + + P+++E R LE
Sbjct: 223 RKALNKDPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 44/297 (14%)
Query: 621 LATNNFNSSTQIGQGGYGKVY----KGILPDG--TVVAVKRAQEGSLQGEK-EFLTEIQF 673
+A S ++GQG +G VY KG++ D T VA+K E + E+ EFL E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 674 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRL 725
+ + ++V L+G + +++ E M+ G L+ L + + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----- 780
+A + G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 839
+G++P ++ PE T SDV+S GVV E+ T QP N
Sbjct: 180 KGLLPVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-- 227
Query: 840 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
++ V++G + P C + +L C Q RPS E++ ++
Sbjct: 228 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G +G+V+ G L D T VAVK +E +L + +FL E + L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
C ++ +V E + G L + L + + ++ G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLT 806
HRD+ A N L+ K K++DFG+SR + +G+ + + +K P + PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAS--TGGMKQIPVKWTAPEALNY 170
Query: 807 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865
+ + +SDV+S G++ E + G P + N++ Q + + G P
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYA---------NLSNQQTREA-IEQGVRLPCPEL 220
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELES 897
C + +L +C + + RPS S V +EL+S
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 678
N+ +GQG +G+VY D G +AVK+ Q S + KE EIQ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 733
H +V G + E+ L E M G+++DQL + A+ ++ +R
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQIL 116
Query: 734 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
GTP ++ PE K+D++S+G +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 226
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + + S+ F+K E RPS E++R
Sbjct: 227 ---NPVLPPHVSDHCRDFLKRIFV----EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-- 687
IG+G YGKVYK G +VA+K + E+E E L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 688 ----YCDEEGEQMLVYEFMSNGT-------LRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+ + LV E G+ LR + +E + + +R ++ RG+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL-----RGLA 127
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVK-- 793
YLH + V HRDIK NILL K+ DFG+S A + ST+ +
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------------AQLDSTLGRRN 171
Query: 794 ---GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 631 QIGQGGYGKVYKG--ILP---DGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+ +GK+YKG LP +VA+K ++ + Q EF E ++ LHH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIAL 729
L+G +E +++E+++ G L + L +S K L L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+ G+ YL + H+D+ A NIL+ + K++D GLSR D + P +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848
+ ++ PE + K + SD++S GVV E+ + G+QP N
Sbjct: 189 PI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----------Q 233
Query: 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
++ V + +C + L +C Q+ RP ++ L S
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG V+K +VA+KR + L + E L EI L L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 685 LVGYCDEEGEQMLVYEFMS----------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
L + + LV+E+ NG + D KS F +L +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKS-----FMFQLL------KG 111
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H+ V HRD+K N+L++ K+ADFGL+R +P V + + VV
Sbjct: 112 LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VRCYSAEVV-- 161
Query: 795 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI 838
T Y P+ KL S D++S G +F EL +P+ G ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 53/296 (17%)
Query: 632 IGQGGYGKVYKGIL-----PDGTV-VAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +G+V K P+ T VAVK ++ + + + + ++E++ + + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIAL 729
+L+G C +EG +V E+ ++G LRD L A+ +E L +S A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+RG+ +L A HRD+ A N+L+ K+ADFGL+R DI H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH-----HID 186
Query: 790 TVVKGTPGYLD-----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843
K T G L PE T +SDV+S GV+ E+ T G P
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------G 237
Query: 844 IAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
I + +F ++ +G P C ++ L C + RP+ +++ +L+ +
Sbjct: 238 IPVEE--LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 49/267 (18%)
Query: 626 FNSSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGEKEFLT--------EIQFL 674
+ IG+G YG+VYK DG A+K+ +G+KE T EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALL 56
Query: 675 SRLHHRNLVSLVGYC--DEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIAL 729
L H N+VSLV + L++++ + ++ AK + +M S+
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-SIPPSMVKSLLW 115
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL---APVPDIEG 782
G+ YLH+ V HRD+K +NIL+ + K+ D GL+RL P
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---- 168
Query: 783 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
A + VV T Y PE L T D++++G +F ELLT ++PI G+ +
Sbjct: 169 --LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIK 224
Query: 842 VNIAYQSSMM---FSVIDGNMGSYPSE 865
+ +Q + F V +G P+E
Sbjct: 225 KSNPFQRDQLERIFEV----LG-TPTE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV G + A+K ++ + KE LTE LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEAD 743
E + LV E+ G L LS + + +A + +AL YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLHSLG- 113
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ +RD+K NILLD K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC-GTPEYLAPEV 164
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L D +SLGV+ E+LTG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
NF +IG+G YG VYK G VVA+K+ + L E E + EI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H N+V L+ E + LV+EF+ + L+ + A + + S +G+ +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H+ V HRD+K N+L++ + K+ADFGL+R VP V + VV T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVV--TLWY 166
Query: 799 LDPEYFLTHKL-TDKSDVYSLGVVFLELLT 827
PE L K + D++SLG +F E++T
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 83/314 (26%), Positives = 145/314 (46%), Gaps = 61/314 (19%)
Query: 632 IGQGGYGKVYK----GI---LPDGTV-VAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 681
+G+G +G+V + GI PD TV VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
+++L+G C +EG ++ E+ + G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------ 781
A +RG+ YL + HRD+ A N+L+ K+ADFGL+R V DI+
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 782 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 839
G +P VK ++ PE T +SDV+S G++ E+ T G P
Sbjct: 195 NGRLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP------ 238
Query: 840 REVNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
I + +F ++ +G+ PS C + L +C RP+ +++ L+ +
Sbjct: 239 ---GIPVEE--LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 899 WNMMPES--DTKTP 910
+ E D P
Sbjct: 294 LAAVSEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 683
++GQG +G VY+G D T VAVK E SL+ EFL E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSA---KSKEPLG-----FAMRLSIALGSSRGI 735
L+G + ++V E M++G L+ L + +++ G + +A + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVST 790
YL+ + HRD+ A N ++ H FT K+ DFG++R D +G++P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849
++ PE T SD++S GVV E+ + QP N +
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQV 230
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+ F V+DG P C E+ L C Q RP+ E++ L+
Sbjct: 231 LKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 46/284 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRA--------QEGSLQGE--KEFLTEIQFLSRLHHR 680
IG+G YG+VY + + G ++AVK+ + S Q + K +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYL 738
N+V +G+ E + E++ G++ L + +E + G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ----LVRFFTEQVLEGLAYL 124
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H++ + HRD+KA N+L+D K++DFG+S+ + + I + ++G+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKS-----DDIYDNDQNMSMQGSVFW 176
Query: 799 LDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856
+ PE ++ + K D++SLG V LE+ G +P S + I + MF +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKL-- 224
Query: 857 GNMGS---YPSECVEKFIKLALK----CCQDETDARPSMSEVMR 893
GN S P + +AL C D RP+ E+++
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 34 PIEVSALRSIKK----------SLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLH 83
P + A RS+++ L +++KL D +N G ++
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG------RINSRKWD 450
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ LQ+L+L G L P+ L LD N+ SG++P+++G++ L L L+ N
Sbjct: 451 MPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+L+G +P+EL KL + + N +SG +P SF+ + ++ N +SG+IP L
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 201 LPSLVHMLLDNNNLTGYLPP 220
+ SLV + + +N+L G LP
Sbjct: 570 VESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + G A K Q S + ++F+ EI LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 690 DEEGEQMLVYEFMSNGTLR---DQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPP 745
E + ++ EF G L +L EP + + R + + +LH+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRD+KA NILL K+ADFG+S T + GTP ++ PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFI-GTPYWMAPEVVA 176
Query: 806 THKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
D K+D++SLG+ +E L M+P H N +R V + S +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE-LAQMEPPHHELNPMR-VLLKILKS------EPPTL 228
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
PS+ F C + D RP+ +E+++
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 33/225 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---F----LTEIQFLSRLHHRNLV 683
I +G YG VY+ G +VA+K+ L+ EKE F L EI L +L H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKK-----LKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 684 SL----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ VG + +V E++ + L+ + K+P + + L G+ +LH
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
D + HRD+K SN+LL+++ K+ DFGL+R P + + VV T Y
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-----LKPYTQLVV--TLWYR 173
Query: 800 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
PE L + + D++S+G +F ELLT +P+ GK+ + ++N
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 632 IGQGGYGKVYK----GILPD----GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 681
+G+G +G+V GI D VAVK ++ + + + + ++E++ + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ E + F +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 846
+T + ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----------GI 243
Query: 847 QSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901
+F ++ +G+ P+ C + + C RP+ +++ +L+ I +
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGY 688
+G G G V K +P GTV+A K G+ K+ L E+Q + +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + EFM G+L D++ K P+ + IA+ G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RDIK SNIL++ + K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 809 LTDKSDVYSLGVVFLELLTGMQPIS 833
T KSDV+SLG+ +EL G P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+G+G YG V K G +VA+K + E +K L E++ L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYLHTEADPP 745
+G LV+E++ TL + L A P G A+R I + I Y H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS---PGGLPPDAVRSYI-WQLLQAIAYCHSHN--- 120
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRDIK NIL+ K+ DFG +R PA T T Y PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR------PASPLTDYVATRWYRAPELLV 174
Query: 806 THKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
K DV+++G + ELL G +P+ G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-H 678
++F IG+G + V A+K + L EK E + L+RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H ++ L +E V E+ NG L + L A + YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP------------- 785
H++ + HRD+K NILLD K+ DFG +++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 786 -AHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKN 837
++ V GT Y+ PE L K K SD+++LG + ++LTG P G N
Sbjct: 176 RRRFASFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGY 688
IG+G +G V+K G VA+K+ L+G + L EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+LV E+M L + L + PL A S +G+ Y+H + H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 807
RD+K +N+L+ K+ADFGL+RL E + V T Y PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQV--ATRWYRAPELLYGAR 176
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
K D++++G +F ELL G P+ G+N
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKE-------FLTEIQFLSRLHHRN 681
IG G +G VY G+ G ++AVK+ + S + EI L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V +G + + E++ G L + A +E L I +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL----KGLNYL 122
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + HRDIK +NIL+D+K K++DFG+S+ + + ++G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
+ PE T K+D++SLG + +E+LTG P Q +F + +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD----------CTQLQAIFKIGENA 228
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
PS + I K + + + RP+ +E+++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKGI +P+G V + A + + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + M +G L D + + K+ +G + L+ + ++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+ A N+L+ K+ DFGL+RL +EG + + K ++ E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-----LEGDEKEYNADGGKMPIKWMALECIH 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K T +SDV+S GV EL+T G +P + RE+ + G P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLLEK--------GERLPQPP 234
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C + +KC + D+RP E+ E +
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-18
Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLV 686
+IG G +G VY VVAVK+ + G EK + + E++FL +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G +E LV E+ G+ D L K+PL +I G+ +G+ YLH+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRDIKA NILL K+ADFG + + PA+ S V GTP ++ PE L
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS--------PAN-SFV--GTPYWMAPEVILA 191
Query: 807 H---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ K DV+SLG+ +EL P+ + + +IA S
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ---------S 242
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903
+E + F C Q RP+ +E++R + + P
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH-DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 39/232 (16%)
Query: 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE-----FLT 669
+G+ + + F+ QIG+G YG+VYK D G +VA+K+ + L EKE +
Sbjct: 1 WGKRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR 55
Query: 670 EIQFLSRLHHRNLVSL----------VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSK 716
EI+ L +L+HRN+V+L + + ++G LV+E+M + G L L S+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ + M+ + G+ Y H HRDIK SNILL++K K+ADFGL+RL
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLT 827
+ + + V+ T Y PE L + DV+S G + EL T
Sbjct: 168 SEESR----PYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ T VAVK + GS+ E FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+E ++ EFM+ G+L D L + SK+PL + S + + G+ ++ H
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN---YIH 125
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD++A+NIL+ K+ADFGL+R+ + D E +K T PE
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGS 179
Query: 809 LTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSE 865
T KSDV+S G++ +E++T G P N ++R + Y+ +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN------------ 227
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELE 896
C E+ + ++C ++ + RP+ + L+
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 61/306 (19%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQ 672
A +N T +G+G +G+V+ T+V VK Q+ + + EF E+
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKE------PLGFAMRL 725
+L H+N+V L+G C E ++ E+ G L+ L A KSK+ PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR------------ 773
++ + G+ +L HRD+ A N L+ + KV+ LS+
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 774 -LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
L P+ +L PE + KSDV+S GV+ E+ T G P
Sbjct: 178 ALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 832 ISHGKNIVREVNIAYQS-SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 890
EV Q+ + V P C + KL +C RPS SE
Sbjct: 219 --FYGLSDEEVLNRLQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
Query: 891 VMRELE 896
++ L
Sbjct: 269 LVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY+G+ + VAVK + + +E FL E + + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E +V E G LR L +K L A + + S + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----YLDP 801
HRDI A N+L+ K+ DFGLSR + K + G ++ P
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDESYYKASKGKLPIKWMAP 177
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
E + T SDV+ GV E+L G++P KN + ++ + +G
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----------NDVIGRIENGERL 227
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901
P C L KC + RP +E+ +L I
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 80/328 (24%), Positives = 150/328 (45%), Gaps = 53/328 (16%)
Query: 632 IGQGGYGKVYK----GILPD----GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 681
+G+G +G+V GI D VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
+T + ++ PE T +SDV+S GV+ E+ T + + V E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEE------ 244
Query: 848 SSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
+F ++ +G+ P+ C + + +C RP+ +++ +L+ + +
Sbjct: 245 ---LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV----- 296
Query: 907 TKTPEFINSEHTSKEETP-----PSSSS 929
T T E+++ ++ +P PSS S
Sbjct: 297 TSTDEYLDLSVPFEQYSPGCPDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 53/243 (21%)
Query: 625 NFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
F +IG+G YG VY+ G +VA+K+ + + E++ L EI L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 679 HRNLVSL---------------VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
H N+V L + YC EQ L +L D + P +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPT----PFSESQ 109
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ L RG+ YLH + HRD+K SN+LL K K+ADFGL+R G+
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY------GL 160
Query: 784 VPAHVS-TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 841
++ VV T Y PE L + D++++G + ELL +P+ GK+ + +
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217
Query: 842 VNI 844
+++
Sbjct: 218 LDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 54/146 (36%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 32 TDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSN---WTGVLC-FNTTMDDGYLHLREL 87
T EVSAL+++K SL + WN GDPC W+G C F++T G + L
Sbjct: 369 TLLEEVSALQTLKSSL-GLPLRFG-WN-GDPCVPQQHPWSGADCQFDSTK--GKWFIDGL 423
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L N L G + +I +L +L ++ N I G+IP +G+I SLE+L L+ N GS+P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKS 173
E LG L L + ++ N +SG +P +
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 625 NFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRN 681
+F ++G+G YG VYK L D A+K GS+ Q E+E + EI+ L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 682 LVSLVGYCDE--EGEQM-LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGIL 736
++S Y + +G ++ +V E+ G L +S K ++ + I + RG+
Sbjct: 61 IIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
LH + + HRD+K++NILL K+ D G+S++ +++ GTP
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---------KNMAKTQIGTP 165
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856
Y+ PE + + KSD++SLG + E+ T P +++ + + V
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSM---------QDLRYKVQR 215
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
G P + Q + RP+ +++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 632 IGQGGYGKVYK----GILPDG----TVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 681
+G+G +G+V G+ + T VAVK + + + + + ++E++ + + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R DI H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH-----H 192
Query: 788 VSTVVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 841
+ K T G ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------- 244
Query: 842 VNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900
+F ++ +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 245 ---GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
Query: 901 M 901
+
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+ +G+G YG VY V +A+K E + + EI S L HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-----SKEP-LGFAMRLSIALGSSRGI 735
+V +G E G + E + G+L L +K E + F + + G+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGL 121
Query: 736 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK 793
YLH D + HRDIK N+L++ + K++DFG S RLA GI P +
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFT 170
Query: 794 GTPGYLDPEYFLTHKLTDK--------SDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845
GT Y+ PE + DK +D++SLG +E+ TG P + +
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---------IELG 215
Query: 846 YQSSMMFSVIDGNMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMRE 894
+ MF V G +P S + FI L+C + + D R S +++++
Sbjct: 216 EPQAAMFKV--GMFKIHPEIPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 676
NN + +G G +GKV + G+ V VAVK + + E+E L +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L +H N+V+L+G C G +++ E+ G L + L K + L LS + ++G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKG 794
+L A HRD+ A N+LL H K+ DFGL+R DI + S VVKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DI-----MNDSNYVVKG 201
Query: 795 TP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ PE T +SDV+S G++ E+ + G P
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 631 QIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +G V KG+ D + +K E S++ E + E + + +L + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVR 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
++G C+ E MLV E S G L LS K K+ + + + + S G+ YL +
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+ A N+LL ++ AK++DFGLS+ D + K + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECI 170
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
K + +SDV+S G+ E + G +P K +M + G P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------PEVMSFIEQGKRLDCP 220
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEV 891
+EC + L C + + RP+ ++V
Sbjct: 221 AECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 632 IGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
+G+G +G V+ + V+ + E + E+ E Q L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEA 742
E+ M+V E+ GTL + + + L F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 743 DPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K NILLD HK K+ DFG+S++ + TVV GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
E KSD+++LG V EL + + R A +++ ++ G
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAP 220
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVM 892
+L L + RP +S++M
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY- 688
IG+G YG VY+G +P G VVA+K + + + E+ LS+L ++ Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 689 -CDEEGEQM-LVYEFMSNGTLRDQLSA-KSKEP-LGFAMR-LSIALGSSRGILYLHTEAD 743
+G ++ ++ E+ G++R + A E + +R + +AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YIHKV-- 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIKA+NIL+ + K+ DFG++ L + ST V GTP ++ PE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFV-GTPYWMAPEV 172
Query: 804 FLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 833
K D K+D++SLG+ E+ TG P S
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 632 IGQGGYGKVYKGILP--DGTV--VAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G +G V + L DG+ VAVK +A S +EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 686 VGYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMR--LSIALGSSRGI 735
+G + M++ FM +G L L S +EP ++ + + + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
YL ++ HRD+ A N +L+ T VADFGLS+ D K
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----YRQGCASKLP 178
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 854
+L E + T SDV++ GV E++T G P + +N S + +
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----------SEIYNYL 228
Query: 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
I GN P +C+E +L +C E RPS + +LE IW
Sbjct: 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 632 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 686
IG+G +G+V + ++ DG + A+K +E S ++F E++ L +L HH N+++L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLS---------AKSKE-----PLGFAMRLSIALGSS 732
G C+ G + E+ G L D L A +KE L L A +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YL ++ HRD+ A N+L+ +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------------YV 173
Query: 793 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 846
K T G L + L T KSDV+S GV+ E+++ G P G
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLP 232
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
Q M P C ++ +L +C +D RP +++ +L
Sbjct: 233 QGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLH 678
NF +IG+G + VYK I L DG VVA+K+ Q + K + L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPL------GFAMRLSIALG 730
H N++ + E E +V E G L + K K + + ++L AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
++H++ + HRDIK +N+ + K+ D GL R AH S
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AH-SL 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
V GTP Y+ PE + KSD++SLG + E+
Sbjct: 167 V--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF--------LTEIQFLSRL-HHR 680
Q+G G +G VY G +VA+K+ + K+F L E++ L +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V L E E V+E+M G L + + +P ++ SI +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGY 798
FHRD+K N+L+ K+ADFGL+R +I P +VS T Y
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS-----TRWY 164
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
PE L D+++LG + EL T ++P+ G +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 9e-17
Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 626 FNSSTQIGQGGYGKVY-KGILPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F +IG G +G VY + VVA+K+ + G EK + + E++FL R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIKA NILL K+ADFG + +A PA+ GTP ++ P
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFV---GTPYWMAP 190
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----- 245
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
+E + F C Q RP+ E+++ +
Sbjct: 246 ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
+G+G YG V K + G +VA+K+ E K + EI+ L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ LV+EF+ + T+ D L K L + RGI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 749 RDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
RDIK NIL+ K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELLVGD 175
Query: 808 -KLTDKSDVYSLGVVFLELLTG 828
K D++++G + E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 39/266 (14%)
Query: 650 VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK +E + + + +FL EI+ +SRL N++ L+ C ++ E+M NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 709 DQLSA-KSKEPLGFAMRLSIALGS--------SRGILYLHTEADPPVFHRDIKASNILLD 759
LS + +E A ++I+ + + G+ YL + HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 760 HKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 814
+T K+ADFG+SR D I+G ++P ++ E L K T SD
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMSWESILLGKFTTASD 214
Query: 815 VYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY---PSECVEK 869
V++ GV E+LT QP S + + + + F D Y P+ C +
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQ----LSDEQVIENTGEFFR--DQGRQVYLPKPALCPDS 268
Query: 870 FIKLALKCCQDETDARPSMSEVMREL 895
KL L C + RPS E+ L
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRA--QEGSLQGEKE---FLTEIQFLSRLH 678
N+ +G+G +G+VY D G +AVK+ S + KE EIQ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 679 HRNLVSLVGYC--DEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
H +V G C D E +++ ++ E+M G+++DQL A R + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+ GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GT 172
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
P ++ PE K+DV+S+ +E+LT P + + + IA Q +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 632 IGQGGYGKV----YKGILPDG----TVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNL 682
+G+G +GKV Y P+G VAVK + S L EI+ L L+H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 683 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V G C E+G L+ EF+ +G+L++ L ++K + +L A+ +G+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
HRD+ A N+L++ + K+ DFGL++ V + + V +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT----GMQPIS---------HGK-NIVREVNIAY 846
PE + K SDV+S GV ELLT P++ HG+ + R V +
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ +G P C E+ +L KC + + R + ++ E+I
Sbjct: 239 -------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 632 IGQGGYGKVY---KGILPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSL 685
I +G YG+V+ K G + A+K ++ + + + LTE LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 686 VGYCDEEGEQML--VYEFMSNGTLR---------DQLSAK--SKEPLGFAMRLSIALGSS 732
Y +G++ L V E++ G L D+ A+ E I L
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE---------IVLA-- 105
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVST 790
+ YLH+ + HRD+K NIL+D K+ DFGLS++ V
Sbjct: 106 --LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+V GTP Y+ PE L + D +SLG + E L G+ P
Sbjct: 161 IV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+G G G VYK L ++AVK + +++ +K+ ++E++ L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + EFM G+L D + LG IA+ +G+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K SN+L++ + K+ DFG+S +V + T V GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISH-GKNIVREVNIAYQSSMM-----FSVIDGNMGSY 862
SDV+SLG+ F+EL G P KN Q S+M ++D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVL 220
Query: 863 P-SECVEKFIKLALKCCQDETDARPSMSEVM 892
P + EKF+ +C + + RP+ +M
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 83/334 (24%), Positives = 144/334 (43%), Gaps = 90/334 (26%)
Query: 631 QIGQGGYGKVYK------GILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +GKVYK G L V+ K +E ++++ EI+ L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
L+G +G+ ++ EF G + +L EP +++ I + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSM 129
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTP 796
+ HRD+KA N+LL K+ADFG+S +V T+ + GTP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDSFIGTP 174
Query: 797 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851
++ PE + + D K+D++SLG+ +E + ++P H N +R
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMR----------- 222
Query: 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 911
+ LK + E P++S+ S W+M + +
Sbjct: 223 ---------------------VLLKIAKSEP---PTLSQ-----PSKWSM------EFRD 247
Query: 912 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 945
F+ + ET PS++ +L+HP+VSS S L
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 626 FNSSTQIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRN 681
F +IG+G +G+V+KGI D VVA+K + E E + EI LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G + + ++ E++ G+ D L A + A L L +G+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRDIKA+N+LL + K+ADFG++ I+ +T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFV-GTPFWMAP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
E K+D++SLG+ +EL G P S + ++F + N +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD----------MHPMRVLFLIPKNNPPT 220
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
E + F + C + RP+ E+++
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR----AQEGSLQGEKEFLTEIQFLSRLHH 679
NF ++G+G Y VYKG G +VA+K A+EG+ + EI + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKH 57
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N+V L E + MLV+E+M + + + L S +GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ V HRD+K N+L++ + K+ADFGL+R +P V + VV T Y
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VNTFSNEVV--TLWYR 167
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
P+ L + S D++S+G + E++TG +P+ G N
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLV- 686
IG G YG V + G VA+K+ L K L EI+ L L H N++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 687 ----GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT 740
++ + +V E M D L KS +PL RG+ YLH+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKGTPGYL 799
A+ V HRD+K SNIL++ K+ DFGL+R D + ++ VV T Y
Sbjct: 122 -AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLTEYVV--TRWYR 173
Query: 800 DPEYFLT-HKLTDKSDVYSLGVVFLELLTG 828
PE L+ + T D++S+G +F ELLT
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G G V K L + G + A+K LQ K+ L E++ +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 688 YCDEEGEQML--VYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGILY 737
+E + E+ G+L D + K K+ LG IA +G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
LH+ + HRDIK SNILL K K+ DFG+S V + T GT
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT-GTSF 168
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
Y+ PE + SDV+SLG+ LE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
+F TQ+GQGGYG+V+ D G +VA+KR ++ L E LTE L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGI 735
LV L+ Y ++ E + L E++ G R L+ S++ F M +
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
LH HRD+K N L+D K+ DFGLS+ + A+ S V G+
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYAN-SVV--GS 161
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
P Y+ PE D +SLG + E L G P S
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G YG+V ++ DG +K+ + S + K E Q LS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 686 V-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ E+G +V F G L +L + + L + + + + YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K N+ L KV D G++R L D+ ST++ GTP Y+ PE
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-------ASTLI-GTPYYMSPEL 173
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
F KSDV++LG E+ T + H N +++N S+++ +I+G + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT----LKHAFN-AKDMN-----SLVYRIIEGKLPPMP 223
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRE 894
+ + +L + RPS+ ++R+
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 59/282 (20%)
Query: 650 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK + + + +FL E++ LSRL N++ L+G C +E ++ E+M NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 709 DQLSAKSKE-----------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
LS+ + + ++ L +AL + G+ YL + HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLT 806
N L+ T K+ADFG+SR D I+G ++P ++ E L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----------WMAWECILM 214
Query: 807 HKLTDKSDVYSLGVVFLEL-----------LTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
K T SDV++ GV E+ LT Q I + R+ Q ++
Sbjct: 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYL-- 267
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
P C + +L L+C + RPS S++ L
Sbjct: 268 -----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + V+A + + + E E ++ EI L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EF + G + D + + + PL + + + YLH + + HR
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTPGYLDPEYF 804
D+KA NIL K+ADFG+S + T+ + GTP ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 805 LTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
+ D K+DV+SLG+ +E + ++P H N +R + + + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMRVL-------LKIAKSEPPT 227
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ PS +F KC + DAR + +++++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G V+KGI +P+G VA+K Q+ S Q +E + + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + G+L D + + ++ L L+ + ++G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HR++ A NILL ++ADFG++ L PD + + T +K ++ E L
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK----WMALESIL 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID----GNMG 860
+ T +SDV+S GV E+++ G +P Y V D G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEP--------------YAGMRPHEVPDLLEKGERL 230
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
+ P C + +KC + + RP+ E+ E
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 632 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 686
IG+G +G+V K + DG + A+KR +E S ++F E++ L +L HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSS 732
G C+ G L E+ +G L D L + L L A +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------YV 166
Query: 793 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 846
K T G L + L T SDV+S GV+ E+++ G P G
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTC-------- 217
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
+ + + G P C ++ L +C +++ RPS ++++ L
Sbjct: 218 -AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFL 674
L F +G G +G VYKG+ +P+G VA+K +E S + KE L E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ + + ++ L+G C Q L+ + M G L D + + K+ +G L+ + ++G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG 121
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVS 789
+ YL + + HRD+ A N+L+ K+ DFGL++L + E G VP
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848
++ E L T +SDV+S GV EL+T G +P +
Sbjct: 177 --------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----------GIPA 217
Query: 849 SMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
S + S+++ G P C + +KC + D+RP E++ E
Sbjct: 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 54/284 (19%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLV 686
++G+G YG V K +P GT++AVKR A S Q +K L ++ R + V+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP--------LGFAMRLSIALGSSRGILYL 738
G EG+ + E M T D+ K + LG IA+ + + YL
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVKGTPG 797
H++ V HRD+K SN+L++ K+ DFG+S G +V + T+ G
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKP 168
Query: 798 YLDPEYF---LTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853
Y+ PE L K D KSDV+SLG+ +EL TG P K +++
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---------Q 219
Query: 854 VIDGN-----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
V++ + E + F+ KC + RP+ E++
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD-FVN---KCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHH-R 680
N+ + +IG G G+VYK G V+AVK+ + G+ + K L ++ + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
+V GY + + + E MS T D+L + + P+ + + + + + YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ V HRD+K SNILLD K+ DFG+S RL V + T G Y+
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---------VDSKAKTRSAGCAAYM 181
Query: 800 DPEYFLTHKLTDK----SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
PE K +DV+SLG+ +EL TG P + K + Q +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--PSL 239
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
N G P F C + RP E++
Sbjct: 240 PPNEGFSP-----DFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 625 NFNSSTQIGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRN 681
+ +IG+G +GK+Y K V + EKE E+ L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V+ E G +V E+ G L +++ + LS + S G+ ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118
Query: 742 ADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
D + HRDIK+ NI L AK+ DFG++R + D ++ GTP YL
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LND-----SMELAYTCVGTPYYLS 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE +K+D++SLG V EL T P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 26/279 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA---QEGSLQGEK---EFLTEIQFLSRL 677
+ Q+G G + Y+ + GT++AVK+ + S + E+ EI+ ++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
+H +++ ++G E+ L E+M+ G++ LS A+ ++ RG+ Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSY 118
Query: 738 LHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGT 795
LH + + HRD+K +N+L+D ++ADFG + RLA G + GT
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTG--AGEFQGQLLGT 171
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
++ PE + DV+S+G V +E+ T P + + +++F +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------AEKHSNHLALIFKIA 224
Query: 856 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
S P + L+C + + + RP E+++
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 40/267 (14%)
Query: 650 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK + + + +FL EI+ +SRL + N++ L+G C + ++ E+M NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDH 760
LS + E F +I S +LY+ + A HRD+ N L+ +
Sbjct: 106 QFLSQREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 761 KFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
+T K+ADFG+SR D I+G ++P ++ E L K T SDV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMAWESILLGKFTTASDV 214
Query: 816 YSLGVVFLEL--LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-----SYPSECVE 868
++ GV E+ L QP S ++ + + + F N G S C
Sbjct: 215 WAFGVTLWEMFTLCKEQPYS----LLSDEQVIENTGEFFR----NQGRQIYLSQTPLCPS 266
Query: 869 KFIKLALKCCQDETDARPSMSEVMREL 895
KL ++C + RP+ +++ L
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 668 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 727
+EI + +L H N+V L+G C E L++E++ L + L S E R I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE-----RRRKI 785
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A+G ++ + +LH P V ++ I++D K + RL+ P
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSL--------PGL 831
Query: 788 VSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN--IVRE 841
+ T K + Y+ PE T +T+KSD+Y G++ +ELLTG P G + IV
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 842 VNIAYQSSMMFSVID----GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
Y + ID G++ +E VE + LAL C + ARP ++V++ LES
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F+ +IG G +G VY + + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL ++ G+ +G+ YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+KA NILL K+ DFG + + + PA+ GTP ++ P
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANXFV---GTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 832
E L + K DV+SLG+ +EL P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 83/320 (25%), Positives = 132/320 (41%), Gaps = 41/320 (12%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
TN + +G G +G V G VA+K+ + + K E++ L L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
N++SL E + V E + L L+++ E L L RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---RGLKYV 124
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H+ V HRD+K SNIL++ K+ DFGL+R+ P + G V T Y
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYV---------STRYY 171
Query: 799 LDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
PE LT K + D++S G +F E+L G +P+ GK+ V + FS+I
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ----------FSIITD 220
Query: 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917
+G+ P + + C + T R S RE +D + +
Sbjct: 221 LLGTPPDDVINTI-------CSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 918 TSKEETPPSSSSMLKHPYVS 937
+ S++ L HPY++
Sbjct: 273 VFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 83/274 (30%), Positives = 121/274 (44%), Gaps = 38/274 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G G VYK I P G + A+K E +++ ++ EI+ L ++H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCH 138
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-LSIALGSSRGILYLHTEADPP 745
D GE ++ EFM G+L A + A + LS GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLHRRH--- 188
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRDIK SN+L++ K+ADFG+SR LA D P + S GT Y+ PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSV---GTIAYMSPERI 240
Query: 805 ---LTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
L H D D++SLGV LE G P G+ +S+M ++
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMSQP 293
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
P+ +F C Q E R S ++++
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-15
Identities = 79/225 (35%), Positives = 111/225 (49%), Gaps = 10/225 (4%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS-LELLLLNGNELTGSLP 147
LNLN + E+ L+ LT LD N I+ IP IG +KS L+ L L+ N++ SLP
Sbjct: 99 DLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207
L LP L + + N +S LPK +NL+ + ++ N IS +PPE+ L +L +
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267
L NN++ L LS L L L+L NN + +P S N+S L L L N +
Sbjct: 215 DLSNNSIIE-LLSSLSNLKNLSGLELSNN--KLEDLPESIGNLSNLETLDLSNNQISSIS 271
Query: 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 312
L + NL LDLS N L+ + P L + L N LT
Sbjct: 272 S-LGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNL 682
+IG+G YG VYK D +A+K+ + L+ E E + EI L + H N+
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLH 739
V L E LV+E++ + L+ + + +K P L L RGI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ V HRD+K N+L+D + A K+ADFGL+R +P V VV T Y
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----VRTFTHEVV--TLWY 169
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLT 827
PE L + + D++S+G +F E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHR 680
NF +IG+G + +VY+ L DG VA+K+ Q L K + + EI L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 736
N++ E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H+ V HRDIK +N+ + K+ D GL R AH + GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHS---LVGTP 170
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 626 FNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 683
F +IG+G +G+VYKGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G + + ++ E++ G+ D L E A L L +G+ YLH+E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRDIKA+N+LL + K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L +GE+ L E + L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y E + + LV M+ G L+ + + A + A G+ +LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
+RD+K N+LLD +++D GL+ +++G GTPGY+ PE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQG 168
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQPI-SHGKNIVRE 841
D ++LG E++ G P + + +E
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEG----SLQGEKEFLTEIQFLSRLHHRNLV 683
+IG G YG VYK + G +VA+K + + G +Q E I L H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE------ISMLKECRHPNIV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHT 740
+ G + +V E+ G+L+D ++ PL L IA + +G+ YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----G 794
HRDIK +NILL K+ADFG+S A ++ T+ K G
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVS-------------AQLTATIAKRKSFIG 163
Query: 795 TPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPIS 833
TP ++ PE + K D+++LG+ +EL P+
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 683
F +IG+G +G+V+KGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G ++ + ++ E++ G+ D L + A L L +G+ YLH+E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRDIKA+N+LL K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN----M 859
K+D++SLG+ +EL G P S + ++F + N
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSE----------LHPMKVLFLIPKNNPPTLE 222
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
G+Y S+ +++F++ C E RP+ E+++
Sbjct: 223 GNY-SKPLKEFVE---ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEF------------LTEIQFLSR 676
+G+G YGKV K G +VA+K+ + E S K+ L E++ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALG 730
+ H N++ LV E LV + M+ L+ + K +RL+ I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH--- 787
G+ LH HRD+ +NI ++ K K+ADFGL+R P +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 788 ------VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
S VV T Y PE + K D++S+G +F ELLTG +P+ G+N +
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEID 241
Query: 841 E 841
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 690 DEEG-----EQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
++ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 182
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 832
+ D KSD++SLG+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKR---------AQEGSLQGEKEFLTEI--QFLSRLHH 679
+G GG+G+V + A+K Q+ + EKE L E F+ +L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF---AMRLSIALGSSR 733
+ D++ ML+ E+ G L L + + F + L+ +R
Sbjct: 61 T-------FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI+Y RD+K N+LLD K+ DFG ++ ++ T
Sbjct: 113 GIIY-----------RDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW--TFC- 153
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
GTP Y+ PE L D +SLG++ ELLTG P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSL--- 685
IG+G YG V P G VA+K+ E ++ L EI+ L R H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 686 --VGYCDEEGEQMLVYEFMSNG---TLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+ + +V E M ++ Q LS + + + RG+ Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------RGLKYIH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGY 798
+ A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----TRWY 175
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 836
PE L K K+ D++S+G + E+L+ +P+ GK
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 632 IGQGGYGKVYKGIL-PDGTV--VAVKRAQEG-SLQGEKE-FLTEIQFLSRLHHRNLVSLV 686
+G+G +G V +G L D ++ VAVK + + E E FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 687 GYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGS--SRGIL 736
G C + E +++ FM +G L L S P ++ + + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL +++ HRD+ A N +L+ VADFGLS+ D + K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPV 178
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855
++ E T KSDV+S GV E+ T G P +N S + +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----------SEIYDYLR 228
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
GN P +C++ L C RPS + ELE
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 634 QGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVG 687
+G +G+++ GIL D V VK ++ + + + L E L L H+N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 688 YCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGILYLHT 740
C E+GE ++Y +M+ G L+ L LS +A+ + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAP-----VPDIEGIVPAHVSTVVKG 794
V H+DI A N ++D + K+ D LSR L P + D E + VK
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-------NRPVK- 184
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ E + + + SDV+S GV+ EL+T G P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 630 TQIGQGGYGKVYKGILPD-GTVVAVKR--AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
++IG+G YG V+K + G +VA+K+ E +K L EI+ L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 742
+ + LV+E+ + T+ ++L K P G + + I++ +A
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELE---KNPRG------VPEHLIKKIIWQTLQAVNFC 116
Query: 743 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K NIL+ + K+ DFG +R+ P + T T Y P
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAP 169
Query: 802 EYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836
E + + DV+++G VF ELLTG QP+ GK
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHR 680
NF +IG+G + +VY+ L D VA+K+ Q + + ++ + EI L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 736
N++ + E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H+ V HRDIK +N+ + K+ D GL R AH S V GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAH-SLV--GTP 170
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856
Y+ PE + KSD++SLG + E+ P K +N+ S+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLF---SLCQKIEQ 222
Query: 857 GNMGSYPSE-CVEKFIKLALKCCQDETDARPSMSEVMR 893
+ P+E EK +L C + D RP + V +
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 629 STQIGQGGYGKV-YKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH- 678
S +G G G V + DG AVK A + Q E L F S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 679 HRNLVSLVGYCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIAL 729
H + D + LV ++ + G LR ++ +++K F A L I +
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL--APVPDIEGIVPAH 787
+L +H + HRDIK++NILL K+ DFG S++ A V D
Sbjct: 153 -----LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-------D 200
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
V GTP Y+ PE + + K+D++SLGV+ ELLT +P G+N+ EV
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEV----- 253
Query: 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
M + G P + ++ + RPS S+++
Sbjct: 254 ---MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 36/271 (13%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G G +G++ +G L VA+ + G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G M+V E+MSNG L D K + L + + G + G+ YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYF 804
H+ + A +L++ K++ F RL E I T + G L PE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIY-----TTMSGKSPVLWAAPEAI 180
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
H + SDV+S G+V E+++ G +P +S ++ +V DG
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------------QDVIKAVEDGFRL 227
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEV 891
P C +L L C Q E RP S++
Sbjct: 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY- 688
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 689 -----CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ + LV EF G++ D + L I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 192
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 832
+ D +SD++SLG+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
E L+++ H N+V+ + +G +V E+ G L ++ + + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G+ ++H + V HRDIK+ NI L K+ DFG +RL P A+
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------GAYAC 158
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREV 842
T V GTP Y+ PE + +KSD++SLG + EL T P KN++ +V
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGIL-------PDGTVV--AVKRAQEGSLQGEKEFL 668
E+ L+T F ++G+ +GKVYKG L V +K EG L+ +EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 669 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------- 715
E SRL H N+V L+G +E +++ + S+ L + L +S
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 716 -KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774
K L A + I + G+ +L + V H+D+ N+L+ K K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833
D ++ + + ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
N ++V ++ + P +C L L+C + RP ++
Sbjct: 229 GYSN--QDVIEMIRNRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278
Query: 894 ELES 897
L +
Sbjct: 279 RLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV L G + AVK ++ + + + +TE + LS + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 688 YCDEEGEQML-VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALGSSRGILYLHTEA 742
C + +++ V EF++ G L Q S + E +A ++ AL ++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLH--- 113
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
D + +RD+K N+LLDH+ K+ADFG+ + EGI ++ GTP Y+ PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D +++GV+ E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 632 IGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSL 685
+GQG +GKV+ K PD G + A+K ++ +L+ T E L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM-RLSIALGS--SRGILYLH 739
EG+ L+ +F+ G L +LS + ++E + F + L++AL S GI+Y
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY-- 121
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
RD+K NILLD + K+ DFGLS+ E I + GT Y+
Sbjct: 122 ---------RDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYM 165
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE T +D +S GV+ E+LTG P GK+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVA---VKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV G G A VK + + E+ FL E+Q L+H N++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIALGSSRGILYLHTEAD 743
G C E +LV EF G L++ L + A + +A + G+L+LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP-- 801
H D+ N L + K+ D+GL+ D H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833
+ L T KS+++SLGV EL T QP
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 64/208 (30%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---HRNLVS 684
+IG G YG VYK P G VA+K R Q + E+ L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 685 LVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L+ C D E + LV+E + LR L L + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGY 798
+ HRD+K NIL+ K+ADFGL+R I ++ T V T Y
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVTLWY 173
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELL 826
PE L D++S+G +F E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
++ +IG+G G V I D G VAVK+ Q + E+ + H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGI 735
+V + E +V EF+ G L D ++ R++ + L + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKAL 128
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+LH + V HRDIK+ +ILL K++DFG + VP S V GT
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GT 178
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
P ++ PE + D++SLG++ +E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 71/224 (31%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV G + G V VK + S+Q + +FL E Q L H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFA-MRLSIALGSSRGILYLH 739
G C E +LV EF G L+ L + K +P M IAL G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GY 798
H D+ N LL T K+ D+GLS D +V+ P +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------YVTPDQLWVPLRW 168
Query: 799 LDPEY-------FLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834
+ PE L T +S+V+SLGV EL G QP H
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G G V G VAVK+ Q + E+ + HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V EF+ G L D ++ A ++ L R + YLH + V HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VIHR 142
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ +ILL K++DFG + VP S V GTP ++ PE
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF-----CAQVSKEVPKRKSLV--GTPYWMAPEVISRLPY 195
Query: 810 TDKSDVYSLGVVFLELLTGMQP 831
+ D++SLG++ +E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 629 STQIGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRL---HH 679
+IG+G YG VYK L G VA+K+ ++EG L EI L +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 680 RNLVSLVGYC-----DEEGEQMLVYEFMSN--GTLRDQLSAK--SKEPLGFAMRLSIALG 730
N+V L+ C D E + LV+E + T + E + MR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
RG+ +LH+ + HRD+K NIL+ K+ADFGL+R I A S
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSV 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VV T Y PE L D++S+G +F EL
Sbjct: 167 VV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 621 LATNNFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 678
L ++F +++G G G V K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V G +GE + E M G+L L + P ++SIA+ RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ PE + +SD++S+G+ +EL G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 624 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSR 676
+ + +IGQG +G+V+K +VA+K+ ++ EKE F L EI+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 677 LHHRNLVSLVGYCDEEGEQ--------MLVYEF--------MSNGTLRDQLSAKSKEPLG 720
L H N+V+L+ C + LV+EF +SN ++ LS K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 721 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780
M L+ G+ Y+H + HRD+KA+NIL+ K+ADFGL+R A
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR-AFSLSK 173
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ + VV T Y PE L + D++ G + E+ T PI G
Sbjct: 174 NSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 625 NFNSSTQIGQGGYGKVY----KG--------------ILPDGTVVAV---KRAQEGSLQG 663
+FN +G+G +GKV KG I+ D V KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL--ALPG 58
Query: 664 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL--RDQLSAKSKE 717
+ FLT++ Q + RL+ V E+++ G L Q K KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYHIQQVGKFKE 100
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---- 149
Query: 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK- 836
E I + GTP Y+ PE D ++ GV+ E+L G QP G+
Sbjct: 150 ---ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED 205
Query: 837 -----NIVREVNIAYQSSM---MFSVIDGNMGSYPSE 865
+ E N++Y S+ S+ G + +P++
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 631 QIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVS 684
+IG+G +GK IL DG +K + ++ E E+ LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYL 738
+E G +V ++ G L +++A+ + L + +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H D + HRDIK+ NI L T K+ DFG++R+ + V ++ GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTV--ELARTCIGTPYY 167
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIV 839
L PE +KSD+++LG V E+ T G KN+V
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-13
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 28/283 (9%)
Query: 669 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
+E+ L+ H +V + + +L+ E+ S G L Q+ + KE L F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
L + +L L + HRD+K++NI L K+ DFG S+ V V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848
++ GTP YL PE + + + K+D++SLGV+ ELLT +P Q
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------QR 277
Query: 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPE-- 904
+M V+ G +P L RP+ +++ L+ + N+ +
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
Query: 905 --SDTKTP----EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941
S+T +P E + S E PP SS +++ V+SDV+
Sbjct: 338 RHSETISPHDREEILRQLQESGERAPPPSS--IRYGVVTSDVT 378
|
Length = 478 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNLVSLVGY 688
+IGQG G VY I + G VA+K+ Q +KE + EI + H N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 689 CDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRGILYL 738
E +V E+++ G+L D Q++A +E L + + +L
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------------QALEFL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPG 797
H+ V HRDIK+ NILL + K+ DFG +++ P + ST+V GTP
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPY 180
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
++ PE K D++SLG++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 678
L ++F +++G G G V+K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V G +GE + E M G+L L + P ++SIA+ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ PE + +SD++S+G+ +E+ G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRN--- 681
+IG+G YGKVYK G +VA+K+ + L+ ++E L EI L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 682 -LVSLVGYCDEEGEQM--LVYEFMSNGTLR--DQLSAKSKEPLGFAMRLSIALGSSRGIL 736
L+ + ++ G+ LV+E++ + + D PL S +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 737 YLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H V HRD+K N+L+D K K+AD GL R +P V ++ +V T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-----VKSYTHEIV--T 174
Query: 796 PGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPI 832
Y PE L TH T D++S+G +F E+ QP+
Sbjct: 175 LWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 631 QIGQGGYGKV-YKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G G V + G +VAVK+ Q + E+ + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V EF+ G L D ++ A ++ L + + LH + V HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQG---VIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ +ILL H K++DFG + VP S V GTP ++ PE
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GTPYWMAPELISRLPY 193
Query: 810 TDKSDVYSLGVVFLELLTGMQP 831
+ D++SLG++ +E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG AVK Q+ ++ +KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTE 741
Y + +++ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHSL 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD + + DFGL + EGI + ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E D + LG V E+L G+ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 626 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 681
F +G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+VSL + + LV M+ G L+ + + + A G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGY 798
+ +RD+K NILLD +++D GL+ VP+ I+G V GT GY
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---------GTVGY 167
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-GKNIVRE 841
+ PE + T D ++LG + E++ G P K I RE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 34/280 (12%)
Query: 630 TQIGQGGYGKVYKGIL---PDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +G V KG+ VAVK + + E L E + +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHT 740
++G C+ E MLV E G L L K ++S+ G+ YL
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE- 112
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+LL + AK++DFGLS+ + H VK +
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYA 166
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE +K + KSDV+S GV+ E + G +P K EV +S G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES--------GER 216
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
P C + L C D RP + V L + +
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 56/246 (22%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKEFLTEIQFLSRLH 678
+G+G +GKV KG + AVK ++ EK L L+
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAG-K 54
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALG-- 730
H L L + + + L V E+++ G L Q S + EP +A + + L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
RGI+Y RD+K N+LLD + K+ADFG+ + EGI+ ++
Sbjct: 113 HERGIIY-----------RDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTS 154
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNI 844
GTP Y+ PE D ++LGV+ E+L G P G + + E +
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEV 213
Query: 845 AYQSSM 850
Y +
Sbjct: 214 RYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG+ AVK Q+ ++ +KE + E L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTE 741
Y + E++ V ++++ G L L + EP +A ++ A+G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD + + DFGL + EG+ P ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E D + LG V E+L G+ P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 37/98 (37%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ LH + HRDIK N+L+D K+ DFGLSR G+
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP YL PE L SD +SLG V E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 70/289 (24%), Positives = 113/289 (39%), Gaps = 63/289 (21%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHH-RNLVSLVGY 688
IG+G +G V K + GT++AVKR + + E K L ++ + R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 689 CDEEGEQMLVYEFMS--------------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
EG+ + E M + +++ K IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVATVKA 119
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVK 793
+ YL E + HRD+K SNILLD K+ DFG+S G +V + T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDA 168
Query: 794 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850
G Y+ PE +SDV+SLG+ E+ TG P ++ ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT------- 221
Query: 851 MFSVIDGN---MGSYP----SECVEKFIKLALKCCQDETDARPSMSEVM 892
V+ G+ + + S FI L C + RP E++
Sbjct: 222 --QVVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 84/338 (24%), Positives = 128/338 (37%), Gaps = 96/338 (28%)
Query: 632 IGQGGYGKVYK----GI--LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +GKV + GI VAVK +EG+ E K +TE++ L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 684 SLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRL- 725
+L+G C + G M++ E+ G L + L +K K+ G RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 726 ------------------------------------------SIALGSSRGILYLHTEAD 743
S + +RG+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTP----GY 798
HRD+ A NILL K+ DFGL+R + PD V KG +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------VRKGDARLPLKW 241
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
+ PE T +SDV+S GV+ E+ + G P G I E + +G
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLK--------EG 292
Query: 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
P + + L C + + RP+ SE++ L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-12
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHRNLV 683
++G+G YG V+K I D VVA+K+ A + ++ F EI FL L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 684 SLVGYCDEEGEQ--MLVYEFMSN--------GTLRD--------QLSAKSKEPLGFAMRL 725
L+ E ++ LV+E+M L D QL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785
+ + Y+H+ V HRD+K SNILL+ K+ADFGL+R + ++E
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPE 165
Query: 786 AHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG 828
V T T Y PE L + + T D++S+G + E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 31/265 (11%)
Query: 640 VYKGILPDGTVV--AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY----CDEEG 693
+YKGI + V+ K+ +G EI+ L R+ N++ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753
L+ E+ + G LR+ L K K+ L F +L +A+ +G+ L+ + P ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTD 811
+ L+ + K+ GL ++ P + +V+ +V Y + + T
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 812 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 871
K D+YSLGVV E+ TG P N+ + + N P +C +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFE---------NLTTKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 872 KLALKCCQDETDARPSMSEVMRELE 896
+ C ++ RP++ E++ L
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS---- 684
IG+G YG V I G VA+K+ + + L EI+ L L H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 685 -LVGYCDEEGEQMLVYEFMSNG-----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
L E + +V+E M + D L+ + + + + R + Y+
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------RALKYI 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
HT VFHRD+K NIL + K+ DFGL+R+A A T T Y
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDYVATRWY 172
Query: 799 LDPEY---FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844
PE F + K T D++S+G +F E+LTG +P+ GKN+V ++++
Sbjct: 173 RAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 219
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G V+ I + G VA+K+ ++ + EI + L + N+V+ +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH V HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHANQ---VIHR 139
Query: 750 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIK+ N+LL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 81/322 (25%), Positives = 124/322 (38%), Gaps = 57/322 (17%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH---HR 680
+IG+G YGKV+K + G VA+KR + +Q +E + E+ L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 681 NLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
N+V L C D E + LV+E + L L + + + RG+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+LH+ V HRD+K NIL+ K+ADFGL+R+ T V T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVT 172
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
Y PE L D++S+G +F E+ +P+ G + V Q + VI
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD------QLGKILDVI 225
Query: 856 DGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFI 913
P E +D A P + + + I + + D + +
Sbjct: 226 -----GLPGE-------------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267
Query: 914 NSEHTSKEETPPSSSSMLKHPY 935
T S+ S L HPY
Sbjct: 268 LKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSR 676
++F +G G +G+V +K G A+K A+ L+ + L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS--IALGSSRG 734
+ H LV+L G ++ LV E++ G L L + P A + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLH+ + +RD+K N+LLD K+ DFG ++ V T+ G
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC-G 160
Query: 795 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
TP YL PE L K K+ D ++LG++ E+L G P
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILPDGT--VVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSL 685
+G+G +GKV L GT V A+K ++ + + + +TE + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLG--FAMRLSIALGSSRGILYLHTE 741
+ V E+++ G L Q+ S K EP +A +++AL ++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRH 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V +RD+K NILLD + K+ADFG+ + EGI+ +T GTP Y+ P
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + D ++LGV+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 51/246 (20%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRA---------QEGSLQGEKEFLTE 670
++F IG+G +G+V+ L G V A+K Q ++ E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+V L +E LV E+M G L + L K P A R IA
Sbjct: 58 A------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-- 108
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS--------------RLAP 776
+L L + HRDIK NIL+D K+ADFGL
Sbjct: 109 --ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 777 VPDIEGIVPA---------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+ + ++ ++ V GTP Y+ PE + D +SLGV+ E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 828 GMQPIS 833
G P
Sbjct: 226 GFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 626 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 681
F +G+GG+G+V + G + A KR ++ ++ GE L E Q L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V+L + + LV M+ G L+ + L A G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLD 800
+RD+K NILLD +++D GL+ P + I G V GT GY+
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMA 169
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
PE + T D + LG + E++ G P K V+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG AVK Q+ + KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
Y + E++ V +F++ G L L + P A + + S+ G YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSIN--- 116
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ +RD+K NILLD + + DFGL + EGI + +T GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+ D + LG V E+L G+ P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L+ K + + E + L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEADPP 745
+ + LV M+ G LR + +E GF + + G+ +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ +RD+K N+LLD+ +++D GL+ +E + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+ D ++LGV E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
E V E+++ G L + + K P A S + S + YLH +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLHERG---I 117
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
+RD+K N+LLD + K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
D ++LGV+ E++ G P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY I + G VA+K+ ++ + EI + + N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSNQ---VIHR 139
Query: 750 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIK+ NILL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSR 676
T+ + IG+G YGKVYK DG++ AVK + ++ E L Q L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL---QSLP- 76
Query: 677 LHHRNLVSLVG--YCDEE---GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIAL 729
+H N+V G Y ++ G+ LV E + G++ + + + L AM I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G+ G+ +LH + HRD+K +NILL + K+ DFG+S + +
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------N 186
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPISHGKNIVREVNI 844
T V GTP ++ PE + D S DV+SLG+ +EL G P+ + I
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
+P + F +C + +ARPS++ ++
Sbjct: 246 PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRN---LVSL 685
++G+G YG VYK + P G +A+K E L+ E +F I L LH +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK---EIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEAD 743
G EG + E+M G+L D+L A G + I +G+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K +N+L++ K+ DFG+S G + A ++ G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPER 172
Query: 804 FLTHKLTD------KSDVYSLGVVFLELLTGMQPISHGKNIVREV--NIAYQSSMMFSVI 855
+ +SDV+SLG+ LE+ G P E NI Q S +++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP------PETYANIFAQLS---AIV 223
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892
DG+ + PS + KC + RP+ ++++
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVG 687
IG+GG G+VY P VA+K+ +E + K FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 688 YCDEEGEQMLVY---EFMSNGTLR---------DQLSAKSKEPLGFAMRLSIALGSSRGI 735
C + G+ VY ++ TL+ + LS + E LSI I
Sbjct: 70 ICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL------------APVPDI--- 780
Y+H++ V HRD+K NILL + D+G + +I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+P + GTP Y+ PE L ++ +D+Y+LGV+ ++LT
Sbjct: 184 SMTIPGKIV----GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEG-SLQGEKEFLT-------------EIQFLSR 676
++G+G +G VY +V K+A L+ KE E Q LS+
Sbjct: 7 RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALG 730
L H +V E ++ E+ L +L E + + LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+ Y+H + HRD+KA NI L + K+ DFG+SRL + ++T
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-------MGSCDLAT 163
Query: 791 VVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
GTP Y+ PE L H+ D KSD++SLG + E+ + G+N + S
Sbjct: 164 TFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFL---------S 212
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMR 893
++ +++G S P E + + ++ ++ + RPS +E++R
Sbjct: 213 VVLRIVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G Y VYKGI +G +VA+K + +EG + E L L H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLL 68
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG---FAMRLSIALGSSRGILYLHTEA 742
+ V+E+M D + P G + +RL RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH 123
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L+ + K+ADFGL+R +P + S VV T Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVV--TLWYRPPD 173
Query: 803 YFLTHKLTDKS---DVYSLGVVFLELLTGMQPISHGKNIVRE 841
L TD S D++ G +F+E+L G QP G + V E
Sbjct: 174 VLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 625 NFNSSTQIGQGGYGKVY----KG--------ILPDGTVV---------AVKRAQEGSLQG 663
+FN +G+G +GKV KG IL V+ KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL--ALSG 58
Query: 664 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKE 717
+ FLT++ Q + RL+ V E+++ G L Q+ + KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYQIQQVGRFKE 100
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
E + + GTP Y+ PE D ++ GV+ E+L G P G++
Sbjct: 150 ---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
Query: 838 ------IVREVNIAYQSSM---MFSVIDGNMGSYPSE 865
+ E N+AY SM ++ G M +P +
Sbjct: 206 EDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 671 IQFLSRLHHRNLVSLVGYCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 727
I+ L LH N +VG+ +GE + E M G+L L + P ++SI
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A+ RG+ YL + + HRD+K SNIL++ + K+ DFG+S G +
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDS 153
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
++ GT Y+ PE T +SD++SLG+ +E+ G PI
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 626 FNSSTQIGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKE-FLTEI 671
F +G+G +GKV YK G + A+K ++G SL EK F T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFET-- 55
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLS 726
+ H LV+L E V E+ + G L D S EP
Sbjct: 56 --ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAAC 109
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ LG + YLH + + +RD+K N+LLD + K+ADFGL + EG+
Sbjct: 110 VVLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFG 155
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
++ GTP +L PE T D + LGV+ E+L G P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ ++ ++ GE L E + L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--GILYLHTEADP 744
Y E + + LV M+ G L+ + GF + +I + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLDPEY 803
+ +RD+K NILLD + +++D GL+ P + + G V GT GY+ PE
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
K T D + LG + E++ G P K V+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 36/205 (17%)
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTL--RDQLSAKSKEPLGFAMRLSIAL 729
FL++LH C + +++ V E+++ G L Q K KEP I++
Sbjct: 62 FLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G + +LH + +RD+K N++LD + K+ADFG+ + E +V +
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTT 158
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVN 843
GTP Y+ PE D ++ GV+ E+L G QP G++ + E N
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQSIMEHN 217
Query: 844 IAYQSSM---MFSVIDGNMGSYPSE 865
++Y S+ S+ G M +PS+
Sbjct: 218 VSYPKSLSKEAVSICKGLMTKHPSK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVS 684
+GQG YG V + VA+K+ K L E++ L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 685 LVG----YCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 738
L + E L E M L +S +PL A S G+ Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPG 797
H+ A+ V HRD+K N+L++ K+ DFGL+R + P G ++ V T
Sbjct: 122 HS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP---GENAGFMTEYV-ATRW 174
Query: 798 YLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 843
Y PE L+ + K+ DV+S+G + ELL G +P+ GK+ V ++N
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL- 685
+IG+G + +V K G A+K SL+ + L EIQ L RL H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLI 64
Query: 686 -VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
V + + G LV+E M + L + L K PL S + + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+FHRDIK NIL+ K+ADFG R GI T T Y PE
Sbjct: 121 -IFHRDIKPENILIK-DDILKLADFGSCR--------GIYSKPPYTEYISTRWYRAPECL 170
Query: 805 LTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
LT K D++++G VF E+L+ + P+ G N + ++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ---VIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHK 808
DIK+ NILL + K+ DFG I P + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 687
++G+G Y VYKG L D +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
E LV+E++ + L+ L ++L + RG+ Y H V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-T 806
HRD+K N+L++ + K+ADFGL+R +P + + VV T Y P+ L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYSNEVV--TLWYRPPDILLGS 179
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
+ + D++ +G +F E+ TG +P+ G + +++ ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 632 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
IG+G +GKV + D + A+K ++ + E L E L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ LV F++ G L L + + L A + L + L V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL-----LCALENLHKFNVI 115
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
+RD+K NILLD++ + DFGL +L + + GTP YL PE L H
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 808 KLTDKSDVYSLGVVFLELLTGMQP 831
T D ++LGV+ E+LTG+ P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT---EIQFLSRLHHR 680
+F +IG G YG VYK + G + A+K + L+ ++F EI + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V+ G + + EF G+L+D PL + ++ + +G+ YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK +NILL K+ADFG+S I + S + GTP ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFI--GTPYWMA 174
Query: 801 PEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
PE + D++++G+ +E L +QP + +R + + +S+ +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE-LAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 858 NMGSYPSECVEKFIKLAL 875
M S F+K+AL
Sbjct: 234 KMKW--SNSFHHFVKMAL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK----EFLTEIQFLSRLHHRNLVSLV 686
+G+G Y VYKG G +VA+K E L+ E+ + E L L H N+V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK---EIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGILYLHTE 741
+ LV+E++ D G +M L L RG+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCH-- 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V HRD+K N+L+ + K+ADFGL+R VP + + VV T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-----SKTYSNEVV--TLWYRPP 172
Query: 802 EYFLTHKLTDKS---DVYSLGVVFLELLTGM 829
+ L T+ S D++ +G +F E+ TG
Sbjct: 173 DVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F + +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALG--SSRGILYLHT 740
E V EF+S G L + + K P ++ +S+AL RGI+Y
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY--- 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
RD+K N+LLD + K+ D+G+ + EGI P ++ GTP Y+
Sbjct: 120 --------RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA 164
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE D ++LGV+ E++ G P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
IG G YG V I G VA+K+ K L E++ L H N++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 689 CDEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGILYL 738
G +V + M + S +PL F +L RG+ Y+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHH---IIHSDQPLTEEHIRYFLYQLL------RGLKYI 123
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTP 796
H+ A+ V HRD+K SN+L++ ++ DFG++R E + +V+T
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR----- 175
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
Y PE L+ + T D++S+G +F E+L G + + GKN V +Q ++ SV
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV------HQLKLILSV- 227
Query: 856 DGNMGSYPSE 865
+GS E
Sbjct: 228 ---LGSPSEE 234
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI--ALGSSRGILYLHTEADP 744
Y E + + LV M+ G L+ + + GF ++ A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD +++D GL+ +P+ I G V GT GY+ P
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV---------GTVGYMAP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
E + T D + LG + E++ G P K V+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEA 742
LV E+++ G L + + K P +A + IAL +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K N+LLD K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D ++LGV+ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 687
++G+G Y V+KG L + +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEAD 743
+ LV+E++ D+ + + G M + RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRD+K N+L++ + K+ADFGL+R VP + + VV T Y P+
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYRPPDV 175
Query: 804 FL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
L + + + + D++ +G +F E+ +G +P+ G + E+++ ++
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ +LH++ + +RD+K NILLD K+ADFG+ + E ++ +
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFC 157
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE L K D +S GV+ E+L G P HG +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLT---EIQFLSRLH 678
+G+G +GKV L G AVK ++ + EK L E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
YC + ++ L V EF++ G L + K + L A + + G+
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+LH++ + +RD+K N++LD K+ADFG+ + E + + ++ GTP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTP 160
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y+ PE K T D +S GV+ E+L G P HG +
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L+ GEK L E + L +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ + LV M+ G L+ + + L + + + GIL+LH+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
+RD+K N+LLD + +++D GL+ + D + I T GT GY+ PE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI------TQRAGTNGYMAPEILKEE 169
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
+ D +++G E++ G P K V
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-10
Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG------SLQGEKE-----FLTEIQ 672
N + +IG G +G+V+ +V KR QE S +G KE + E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+ L H+N+V + + Q L + EF G L + K + G +I +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI-VD 122
Query: 731 SSRGIL----YLHTEADPP----VFHRDIKASNILLDH------KFTA-----------K 765
+R +L Y H D P V HRD+K NI L K TA K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFL 823
+ DFGLS+ + + AH GTP Y PE L T DKSD+++LG +
Sbjct: 183 IGDFGLSKNIGIESM-----AHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 824 ELLTGMQPISHGKN 837
EL +G P N
Sbjct: 235 ELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF-AMRLSIALGSSRGILYLHT 740
L V E+ + G L LS + S++ F + ALG YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D + LGVV E++ G P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-- 685
++G+G YG VYK DG A+K+ + + EI L L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 686 VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGILYLH 739
V + + L++++ + + S +K+P+ M S+ GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 740 TEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTVVK 793
V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----- 177
Query: 794 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 834
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLT-----EIQFLSRLHHRNLVS 684
++G+G YG VYK DG K +E +L Q E ++ EI L L H N+++
Sbjct: 8 KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 685 L--VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGIL 736
L V + + L++++ + + S +K+P+ +M S+ GI
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 737 YLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVST 790
YLH V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 791 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 834
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+++ ++G G YG VYK L G + AVK + L+ +F EI + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N+V+ G + + E+ G+L+D PL + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
++ HRDIK +NILL K+ADFG++ I + S + GTP ++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFI--GTPYWM 173
Query: 800 DPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
PE K D++++G+ +E L +QP
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 648 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707
G VAVK Q + E+ + H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767
D +S A L + + YLH++ V HRDIK+ +ILL K++
Sbjct: 106 TDIVSQTRLNEEQIATVCESVL---QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
DFG I VP S V GTP ++ PE + D++SLG++ +E++
Sbjct: 160 DFGF-----CAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 828 GMQP 831
G P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRN 681
+++ ++G+G Y VYKG +G +VA+K + +G + E L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYL 738
+V L + LV+E++ D K P G ++L + RG+ Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYI 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + HRD+K N+L+ K+ADFGL+R VP+H + T Y
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYSNEVVTLWY 169
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
P+ L + + + D++ +G +F+E++ G+ K+I
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTV--VAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+FN +G G +G+V + VA+KR ++ + +K+ +E + L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
V+L G +E LV EF+ G L + P +++ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K N+LLD K+ DFG ++ +V T+ GTP Y+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYTLC-GTPEYI 195
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE L +D ++LG+ E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 632 IGQGGYGKVYKGILPDGT----VVAVKRAQEGSL-QGEKEFL---TEIQFLSRLHHRNLV 683
+G+GGYGKV++ G + A+K ++ ++ + +K+ E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR---------LSIALGSSRG 734
L+ G+ L+ E++S G L L E G M +S+AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE---- 114
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+LH + + +RD+K NILLD + K+ DFGL + E I V+ G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCG 162
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
T Y+ PE + D +SLG + ++LTG P +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGY 688
++G+G Y V+KG +VA+K + +G + E+ L L H N+V+L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 689 CDEEGEQMLVYEFMSN---------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
E LV+E++ + G L + K F +L RG+ Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQL------LRGLSYCH 120
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HRD+K N+L++ K K+ADFGL+R VP + + VV T Y
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYR 170
Query: 800 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
P+ L + + + D++ +G + E+ TG +P+ G + E+++ ++
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG+G YG V + VA+K+ A + + K L EI+ L L H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 688 YCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGIL 736
+ +VYE M T Q+ +S + L F +L RG+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD--TDLHQI-IRSSQTLSDDHCQYFLYQLL------RGLK 122
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y+H+ A+ V HRD+K SN+LL+ K+ DFGL+R + + +V T
Sbjct: 123 YIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844
Y PE L + T DV+S+G +F ELL G +P+ GK+ V ++ +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 626 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 682
+ + + +G G YG+V G VA+K+ S K E++ L + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 683 VSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
+ L V E LV M N ++ Q LS + L + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL-------- 128
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ Y+H+ A + HRD+K SNI ++ K+ DFGL+R ++ G V
Sbjct: 129 RGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYV-------- 176
Query: 793 KGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTG 828
T Y PE L H D++S+G + ELLTG
Sbjct: 177 -ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ +LH + + +RD+K N+LLD K+ADFG+ + E + ++
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFC 157
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE K + D +S GV+ E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV + AVK Q+ ++ + EK ++E L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTEA 742
+ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG------YLHSLN 116
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K NILLD + + DFGL + E I ++ GTP YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D + LG V E+L G+ P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 77/339 (22%), Positives = 127/339 (37%), Gaps = 80/339 (23%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G G V+ + D VAVK+ Q K L EI+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSS-------- 732
VYE + S +E + + + G
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 733 -----RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 786
RG+ Y+H+ V HRD+K +N+ ++ K+ DFGL+R IV
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---------IVDP 167
Query: 787 HVSTVVKG-------TPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
H S KG T Y P L+ + T D+++ G +F E+LTG +P+ G +
Sbjct: 168 HYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE 224
Query: 839 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ ++ + +S + D N E + + R E R L
Sbjct: 225 LEQMQLILESVPVVREEDRN------ELL----------NVIPSFVRNDGGEPRRPLR-- 266
Query: 899 WNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937
+++P + + +F+ T ++ L HPY+S
Sbjct: 267 -DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
+G G +G+V +KG G A+K + +E ++ + E L L H +V+
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 685 LV-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL---YLHT 740
++ + DE + EF+ G L L + P A L +L YLH+
Sbjct: 83 MMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-----VLAFEYLHS 136
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ + +RD+K N+LLD+K KV DFG ++ VP T+ GTP YL
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---------VPDRTFTLC-GTPEYLA 183
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D +++GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 8e-09
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEA 742
L + V E+++ G L LS + F+ + G+ + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGK 115
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K N++LD K+ DFGL + EGI A GTP YL PE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFCGTPEYLAPE 165
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D + LGVV E++ G P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 625 NFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGS-LQGEK---EFLTEIQFLSR 676
NF +G G YGKV+ G G + A+K ++ + +Q K TE Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 677 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGS 731
+ LV+L + + L+ ++++ G L L + E + + +AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 732 --SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR--LAPVPD-------- 779
GI+Y RDIK NILLD + + DFGLS+ LA +
Sbjct: 121 LHQLGIIY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN 837
IE + P + G+ G+ D +SLGV+ ELLTG P + +N
Sbjct: 170 IEYMAPEVIRG---GSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
Query: 838 IVREVN--IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 877
E++ I + + + +EK K L
Sbjct: 216 SQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 73/300 (24%), Positives = 112/300 (37%), Gaps = 57/300 (19%)
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCD 690
+ K P T+VAVK+ S E K EI +L H N++ V
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPPVF 747
+ E +V M+ G+ D L K+ P G L+IA + Y+H++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIHSKG---FI 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLS--------RLAPVPDIEGIVPAHVSTVVKGTPGYL 799
HR +KAS+ILL ++ S R V D P + +L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLP----WL 175
Query: 800 DPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISH---GKNIVREVN---------- 843
PE L L +KSD+YS+G+ EL G P + ++ +V
Sbjct: 176 SPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 844 --IAYQSSMMFSVIDGNMGSYPSECV---------EKFIKLALKCCQDETDARPSMSEVM 892
Y+ SM S N + V E F + C Q + ++RPS S+++
Sbjct: 235 TYPLYEDSMSQSR-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL 677
+F+ + +G+G +G+V ++ + G + A+K ++ L ++ F E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 678 HHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAM-RLSIALGSSRGI 735
+ + L Y ++ + + LV E+ G L L+ + ++ M + +A +
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLA----ELV 112
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKG 794
L +H+ HRDIK N+L+D K+ADFG + RL +V S + G
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMV---NSKLPVG 165
Query: 795 TPGYLDPEYFLTHKLTDKS------DVYSLGVVFLELLTGMQPISHGKNIVREVNI-AYQ 847
TP Y+ PE T K D +SLGV+ E++ G P G + NI +Q
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 848 SSMMF 852
+ F
Sbjct: 226 RFLKF 230
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVG-Y 688
IG+G YGKV+K + +G+ AVK + ++E E L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 689 CDEE---GEQM-LVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYL 738
++ G+Q+ LV E + G++ D + + +EP+ A L AL G+ +L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEAL---MGLQHL 140
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H HRD+K +NILL + K+ DFG+S A + GTP +
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTR-----LRRNTSVGTPFW 190
Query: 799 LDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPIS 833
+ PE + D + DV+SLG+ +EL G P++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L V E+ + G L R+++ ++ + + + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLH 112
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+E + V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYL 163
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D + LGVV E++ G P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 29/116 (25%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDN L G++P ++S+L L + L N+ G IP S +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-IPPSLGS------------------- 464
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPP--GRL-SLNITTIKLSNNKLTGTIPSNFSGLP 321
I +L LDLS N NGSIP G+L SL I + L+ N L+G +P+ G
Sbjct: 465 ----ITSLEVLDLSYNSFNGSIPESLGQLTSLRI--LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV- 686
IG G +G V+ P DG VA+K+ +L K E++ L H N++S +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 687 ----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
+ D E +V E M + + +S + + L L RG+ YLH+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSAG 123
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRDIK N+L++ K+ DFGL+R+ PD + V T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY-----YRAPE 174
Query: 803 YFL-THKLTDKSDVYSLGVVFLELLTG 828
+ + T D++S+G +F ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 68/257 (26%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 673
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 674 LSRLHHRNLVSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSI- 727
+ +V L Y + E L+ E++ G + L K ++E F + +I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS---RLAPVPDIEGIV 784
A+ S + Y+H RDIK N+LLD K K++DFGL + + + I+
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 785 PAHV------------------------------STVVKGTPGYLDPEYFLTHKLTDKSD 814
+ STV GTP Y+ PE FL + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECD 221
Query: 815 VYSLGVVFLELLTGMQP 831
+SLGV+ E+L G P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 685
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHT 740
+ Y +++ + + M+ G L LS KE +A + + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V +RD+K +NILLD +++D GL+ D P H S GT GY+
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMA 163
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 836
PE D S D +SLG + +LL G P K
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YLH+ V +RDIK N++LD K+ DFGL + EGI GTP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTP 159
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D + LGVV E++ G P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLV 686
Q+G G YG V + G VA+K+ Q E K E++ L + H N++ L+
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 687 GY------CDEEGEQMLVYEFMSN--GTL--RDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
D + LV FM G L ++LS + L + M +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLK 132
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y+H + HRD+K N+ ++ K+ DFGL+R ++ G V T
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVV---------TR 179
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y PE L T D++S+G + E+LTG +P+ G +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV + T VA +E S + + EFL + L H N++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLS-IALGSSRGILYLHTEADP 744
G C E +LV+E+ G L+ LS + + L +A + G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGL--SRLAP---VPDIEGIVPAHVSTVVKGTPGYL 799
H D+ N L T KV D+G+ SR + + VP +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 800 DPEY-------FLTHKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREV 842
PE +T + T S+V++LGV EL QP SH + REV
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 9/125 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F+ + L EL L L+ LSG + E+ L LD N++SG IP +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L L+ N+L+G +P+ LG + L ++ I N++ GSLP + A L +N ++
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA------INASA 600
Query: 190 ISGQI 194
++G I
Sbjct: 601 VAGNI 605
|
Length = 968 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 635 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693
G G+V+ P V +K Q+G+ L E L ++H +++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRM-------- 122
Query: 694 EQMLVYEFMS-------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ LV ++ + L L+ +S+ PL L I G+ YLH + +
Sbjct: 123 KDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---I 178
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPV--PDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K NI ++ + D G ++ PV P G + GT PE
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG---------LAGTVETNAPEVL 228
Query: 805 LTHKLTDKSDVYSLGVVFLELL 826
K K+D++S G+V E+L
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQFL 674
+F S IG+G +G+V D G V A+K + Q G ++ E++ L E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGS 731
+V + ++ L+ EF+ G + L K ++E F +
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI-------- 107
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-------RLAPVPDIEGIV 784
+ +L + + HRDIK N+LLD K K++DFGL R ++ +
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 785 PAH-----------------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
P+ STV GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 822 FLELLTGMQP 831
E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHR 680
N F +G+G YG V K + +VA+K+ + E + + ++ L E++ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V L G+ LV+E++ ++ L + P G + + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHW 115
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK N+L+ H K+ DFG +R EG + V T Y
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS----EGSNANYTEYV--ATRWYRS 169
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE L D++S+G + EL G QP+ G++ + + +F+ I +G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQ---------LFT-IQKVLG 218
Query: 861 SYPSECVEKF 870
P+E ++ F
Sbjct: 219 PLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 631 QIGQGGYGKVYKGILPDG--TVVAVKRA-----QEGSLQGEKE-----FLTEIQFL-SRL 677
+G G +G VYK + ++A+K G + E++ ++E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSK-----EPLGFAMRLSIALGS 731
H N+V E +V + + L + ++ K K E + + + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+ YLH E + HRD+ +NI+L + DFGL++ P T
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--------PESKLTS 172
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851
V GT Y PE +K+DV++ G + ++ T +QP + N++ S+
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML---------SLA 222
Query: 852 FSVIDGNMGSYPSECVEKFIKLALK-CCQDETDARPSMSEV 891
+++ P + + + C + +ARP + +V
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRD+K N+LLD K+ADFG ++ D G+V T V GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM----DANGMV--RCDTAV-GTPDYISPEVLKS 217
Query: 807 HKLTD----KSDVYSLGVVFLELLTGMQP 831
+ D +S+GV E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+D + +D + G +P + L + +++ NSI G IPP L + SL + L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
G +P L +L L IL L+ N+ G +PA+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSG-RVPAA 509
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 625 NFNSSTQIGQGGYGKVYKG------------ILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 672
+ +G G +G+V+ ++ V+ +K QE + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVS 59
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
H ++ L + E ++ L + E++ G L L + F+ +
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYA 107
Query: 731 SS--RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
S + YLH++ + +RD+K NILLD + K+ DFG ++ + D
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD--------R 154
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ + GTP YL PE + K +K+ D ++LG++ E+L G P
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 653 VKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710
+KRA+ + E+ L + Q+++ LH+ +E LV ++ G L
Sbjct: 40 LKRAETACFREERNVLVNGDCQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTL 91
Query: 711 LSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769
LS + + P A R IA +L +H+ HRDIK N+LLD ++ADF
Sbjct: 92 LSKFEDRLPEDMA-RFYIA----EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLE 824
G S L D G V S+V GTP Y+ PE K + D +SLGV E
Sbjct: 147 G-SCLKMNQD--GTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 825 LLTGMQP 831
+L G P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758
Y+ ++ +++ LS E L LS +RG+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV-KGTP----GYLDPEYFLTHKLTDKS 813
K+ DFGL+R DI H S V KG+ ++ PE + T S
Sbjct: 271 AQGKIVKICDFGLAR-----DI-----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 814 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKL 873
DV+S G++ E+ + + + IV S+ + G + P ++ +
Sbjct: 321 DVWSYGILLWEIFS-LGGTPYPGMIV-------DSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 874 ALKCCQDETDARPSMSEVMRELESI 898
+KC E + RPS + +ES+
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
IG+G +G+VY+ D + A+K + + +KE + E L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 688 Y---CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ + LV ++MS G L L + + A + IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA----ELVLALEHLHKY 115
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ +RD+K NILLD + DFGLS+ ++ + GT YL PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK----ANLTD---NKTTNTFCGTTEYLAPEVL 168
Query: 805 LTHK-LTDKSDVYSLGVVFLELLTGMQP 831
L K T D +SLGV+ E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 685
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ Y +++ + + M+ G L LS G + ++ IL L +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V +RD+K +NILLD +++D GL+ D P H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVL 167
Query: 805 LTHKLTDKS-DVYSLGVVFLELLTGMQP 831
D S D +SLG + +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 681
+ S Q+G G YG V I G VA+K+ Q E K E+ L + H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 682 LVSLVGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
++ L+ DE + LV +M + S++ + + + + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CGL 130
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H+ + HRD+K N+ ++ K+ DFGL+R A ++ G V T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVV---------T 177
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
Y PE L +++ D++S+G + E+LTG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L+LS N L + L L LD +N +S +PK + N+ +L L L+GN+++
Sbjct: 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
LP L+ ++NNSI ++ LS L +
Sbjct: 200 -------------------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L NN L LP + L L L L NN + +S +++ L +L L SL
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ---ISSISSLGSLTNLRELDLSGNSL 289
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+P ++ + L L L+ ++ S+ + LSN + + P S L L
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET--SSPEALSILESL 347
Query: 324 QRL 326
L
Sbjct: 348 NNL 350
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 16/216 (7%)
Query: 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
S +L+ +++ S E + L N N EL EL L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGS-----ENLLNLLPLPSLDLNLNRLRSNISELLELTNL 118
Query: 229 LILQLDNNNFEGTTIPASYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287
L LDNNN T IP + LK L L + ++ L +PNL LDLS N L+
Sbjct: 119 TSLDLDNNNI--TDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS 176
Query: 288 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
N+ + LS NK++ +P L L+ L ++NNS+ + SS+
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-----S 229
Query: 348 NATETFILDFQNNNLTNISGSFNIPPNV-TVRLRGN 382
N L+ NN L ++ S N+ T+ L N
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 774
K PL + + +RG+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 775 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
PD V KG+ ++ PE T +SDV+S GV+ E+ + G
Sbjct: 225 YKDPDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 830 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 889
P G I E + DG P + ++ L C Q + RP+ S
Sbjct: 275 SPYP-GVQINEEFCQRLK--------DGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325
Query: 890 EVMREL 895
++ L
Sbjct: 326 ALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 35/89 (39%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-- 805
HRDIK N+LLD ++ADFG S L + D G V S V GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD--GTV---QSNVAVGTPDYISPEILQAM 178
Query: 806 ---THKLTDKSDVYSLGVVFLELLTGMQP 831
+ + D +SLGV E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 67/266 (25%), Positives = 96/266 (36%), Gaps = 89/266 (33%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQ- 672
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 673 ------FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM 723
F S RNL L+ EF+ G + L K S+E F +
Sbjct: 61 AWVVKMFYSFQDKRNL-------------YLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ +L + HRDIK N+LLD K K++DFGL G+
Sbjct: 108 --------AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC--------TGL 151
Query: 784 VPAH--------------------------------------VSTVVKGTPGYLDPEYFL 805
AH STV GTP Y+ PE F+
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFM 209
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
D +SLGV+ E+L G P
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 179
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
T Y PE L + D++S+G + E++ G
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 19/40 (47%), Positives = 23/40 (57%), Gaps = 5/40 (12%)
Query: 36 EVSALRSIKKSLVDDYS-KLSNWNR--GDPCTSNWTGVLC 72
+ AL + K SL D S LS+WN DPC +WTGV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 632 IGQGGYGKV---YKGILPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
IG G G V + +L G VAVK R + ++ + E+ L ++H+N++SL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 686 VGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+ +E + LV E M + E + + + + GI +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ + HRD+K SNI++ T K+ DFGL+R A + + P V T Y
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV------TRYYR 189
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
PE L + D++S+G + EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--- 793
YLH + HRD+K N+L+ K+ DFGLS++ + + H+ +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 794 -----GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP Y+ PE L D +++G++ E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 28/186 (15%)
Query: 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 774
K+ L + + ++G+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 775 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
PD V KG ++ PE T +SDV+S GV+ E+ + G
Sbjct: 230 YKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279
Query: 830 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 889
P G I E + +G P + + L C E RP+ S
Sbjct: 280 SPYP-GVKIDEE--------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330
Query: 890 EVMREL 895
E++ L
Sbjct: 331 ELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 632 IGQGGYGKVYKGILPDGTVV----------AVKRAQEGSLQGEKEFLT--EIQFLSRLHH 679
IG+G +G+V L + V +KRA+ + E++ L + Q+++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLG--FAMRLSIALGSSRG 734
+E LV ++ G TL + + E + + + IA+ S
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ Y+H RDIK NIL+D ++ADFG S L + D G V S+V G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMED--GTVQ---SSVAVG 165
Query: 795 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQP 831
TP Y+ PE K + D +SLGV E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 625 NFNSSTQIGQGGYGKVY---------------KGILPDGTVVAVKRAQEGSLQGEKEFLT 669
NF +G G YGKV+ +L T+V + E + + E++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 670 EIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
I+ FL LH+ + + L+ ++++ G L LS + + F +
Sbjct: 60 HIRQSPFLVTLHYA--------FQTDTKLHLILDYINGGELFTHLSQRER----FKEQ-E 106
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ + S +L L + +RDIK NILLD + DFGLS+ ++E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---- 162
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLT-DKS-DVYSLGVVFLELLTGMQPIS 833
+ GT Y+ P+ DK+ D +S+GV+ ELLTG P +
Sbjct: 163 --AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 54/202 (26%)
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
PL L + ++G+ +L A HRD+ A N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260
Query: 778 PDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
DI + VVKG ++ PE T +SDV+S G++ E+ S
Sbjct: 261 -DIMN----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------S 309
Query: 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE-KFIKLALKCCQ-DETD-ARPSMSE 890
GK+ YP V KF K+ + Q D A P +
Sbjct: 310 LGKS-----------------------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346
Query: 891 VMRELESIWNMMPESDTKTPEF 912
+M+ WN+ P T+ P F
Sbjct: 347 IMK---MCWNLEP---TERPTF 362
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 625 NFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSL-QGEK---EFLTEIQFLSR 676
NF +G G YGKV+ K D G + A+K Q+ +L Q K TE L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 677 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTL------RDQLSAKSKEPLGFAMRLSIAL 729
+ LV+L E + L+ +++S G + RD S + L++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GI+Y RDIK NILLD + + DFGLS+ + E +
Sbjct: 121 LHKLGIVY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER------T 163
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPIS 833
GT Y+ PE K+ D +SLG++ ELLTG P +
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 682
+ + + +G G YG V G VAVK+ S+ K E++ L + H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 683 VSLVGY------CDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
+ L+ +E + LV M N ++ Q L+ + L + +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL-------- 130
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ Y+H+ AD + HRD+K SN+ ++ K+ DFGL+R H +
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEM 174
Query: 793 KG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
G T Y PE L +++ D++S+G + ELLTG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+Q + E + D+L+ +++ L F+ +++ +G+ +L A H
Sbjct: 191 SGSYIDQDVTSEILEE----DELALDTEDLLSFSYQVA------KGMSFL---ASKNCIH 237
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP----GYLDPEYF 804
RD+ A NILL H K+ DFGL+R DI + VVKG ++ PE
Sbjct: 238 RDLAARNILLTHGRITKICDFGLAR-----DIRN----DSNYVVKGNARLPVKWMAPESI 288
Query: 805 LTHKLTDKSDVYSLGVVFLELLT 827
T +SDV+S G++ E+ +
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 40/124 (32%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-------------RL-------APVPDIEGIVPAH 787
HRDIK NIL+D K++DFGLS +L + + +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 788 VSTVVK--------------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
++ + GTP Y+ PE FL + D +SLG + E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 828 GMQP 831
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 676
+N +G G +GKV + G+ + V VAVK + + E+E L +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L H+N+V+L+G C G +++ E+ G L + L K++ L F M L +S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 736 LYLHTE 741
+ E
Sbjct: 158 KNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 38/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 279 LDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
L L + L G IP L ++ +I LS N + G IP + + L+ L ++ NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR-LRGNPFCLNTNAEQFCG 395
P S+ Q +L IL+ N+L S +P + R L F NA CG
Sbjct: 483 PESLGQLTSLR-----ILNLNGNSL-----SGRVPAALGGRLLHRASFNFTDNA-GLCG 530
|
Length = 623 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 630 TQIGQGGYGKVYKGILPDGTV---VAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS 684
T +G G YG V D + VAVK+ SL + E++ L + H N++
Sbjct: 21 TPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 685 LVGY------CDEEGEQMLVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L+ + E LV M N ++ Q S E + F + + RG+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL-----RGL 131
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H+ + HRD+K SN+ ++ ++ DFGL+R A ++ G V T
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYV---------AT 178
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
Y PE L +++ D++S+G + ELL G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 688 YCDEEGEQML--VYEFMSNGTLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
+C + ++ L V E+M G L + +S K + + +AL + +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+LLD K+ADFG D G+V T V GTP Y+ PE
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMV--RCDTAV-GTPDYISPE 213
Query: 803 YFLTHK----LTDKSDVYSLGVVFLELLTGMQP 831
+ + D +S+GV E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
N+ ++ LSNN+LT F GLP L+ L ++ N+L+ P + +L LD
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL-----RSLDL 55
Query: 358 QNNNL 362
NNL
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 71/284 (25%), Positives = 111/284 (39%), Gaps = 48/284 (16%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRN 681
+GQG + +YKG+L + V QE S+ F +S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
LV L G C + M V E++ G L D + K + +L +A + + YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGT 795
D + H ++ NIL VA +GL VP I+ I V+
Sbjct: 119 -DKKLVHGNVCGKNIL--------VARYGL-NEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 796 PGYLDPEYF--LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS-MM 851
P ++ PE LT +D +S G LE+ + G +P+S SS
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-----------TLSSSEKE 216
Query: 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
D + P +C E L +C + RPS ++R+L
Sbjct: 217 RFYQDQHRLPMP-DCAELA-NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 275 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 330
NL LDLS+N+L IP G L N+ + LS N LT +I FSGLP L+ L ++
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLP-NLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSG 57
Query: 331 NSL 333
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 36/120 (30%)
Query: 748 HRDIKASNILLDHKFTAKVADFGL---------SR------------LAPVPDIEGIVPA 786
HRDIK NIL+D K+ DFGL S+ + P + I
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 787 HVSTVVK---------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ + + GTP Y+ PE L T D +S+GV+ E+L G P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 632 IGQGGYGKV---YKGILPDGTVVA-VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G G V Y +L + + R + ++ + E+ + ++H+N++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 688 Y------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+E + LV E M + E + + + + GI +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA 138
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVTRYYRAP 187
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELL 826
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 632 IGQGGYGKVYKGI---LPDG-----TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+GQG + K++KGI + D T V +K + + F +S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C E ++V E++ G+L D K+K + + +L +A + + +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 744 PPVFHRDIKASNILL 758
+ H ++ A N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 46/312 (14%)
Query: 646 PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703
P GT+V V+ + E K E+ H N+++ ++ FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
G+ L E + A+ +I G+ RG+ YLH HR+IKAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL------ 133
Query: 764 AKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGY-------LDPEYFLT--HKLTDKS 813
++ GL L+ + + +V + VV P + L PE + KS
Sbjct: 134 --ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 814 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG------NMGSYP-SEC 866
D+YS+G+ EL TG P ++ M+ + G ++ ++P E
Sbjct: 192 DIYSVGITACELATGRVPFQD----------MLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 867 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-- 924
K + + E+ M++ M E + P S T +P F N ++ P
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTS-ERLRT--PSSKTFSPAFQNLVELCLQQDPEK 298
Query: 925 -PSSSSMLKHPY 935
PS+SS+L H +
Sbjct: 299 RPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 632 IGQGGYGKVYK----GILPDGT--VVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +G+V + GI T VAVK +EG+ E + ++E++ L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 684 SLVGYCDEE-GEQMLVYEFMSNGTLRDQLSAKSKE 717
+L+G C + G M++ EF G L + L +K E
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 34/191 (17%)
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ L PSL + L N E +P+ L L +
Sbjct: 42 ALASALRPQPSLKELCLSLN--------ETGRIPRGLQSLLQG-----------LTKGCG 82
Query: 253 LLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPP------GRLSLNITTI 302
L +L L + +L G + L R +L L L++N L L + +
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 303 KLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 358
L N+L G + L+ L +ANN + + ++ + N +LD
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN-CNLEVLDLN 201
Query: 359 NNNLTNISGSF 369
NN LT+ S
Sbjct: 202 NNGLTDEGASA 212
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 187
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
T Y PE L + D++S+G + E++ G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 25/154 (16%)
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGIL 736
N+V L Y E LV + G L +S P +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFG-LSRLAPVPDIEGIVPAHVSTVVKGT 795
LH E + RD+ +NILLD + ++ F S + D E +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----------E 145
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 829
Y PE + T+ D +SLG + ELLTG
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 15/60 (25%), Positives = 27/60 (45%)
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214
L + + N ++ +F L + ++ N+++ P S LPSL + L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 632 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 688
IG G +G VY+ I D + VA+K+ LQ + E+ + L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 689 --CDEEGEQML----VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS---SRGILYLH 739
C ++ E+ + V EF+ T+ + ++ + L + L S R + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 740 TEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
++ + HRD+K N+L+D + T K+ DFG ++ ++ S + Y
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFY 236
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
PE L T D++SLG + E++ G PI G++ V ++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 626 FNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLH 678
F +G+G G+V+ KG G + A+K + + + LTE + L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSS 732
H L +L E LV ++ G L L + + L +A + +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE-- 117
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD--IEGIVPAHVS- 789
YLH + +RD+K NILL ++DF LS+ + V + +
Sbjct: 118 ----YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 790 ---------TVVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830
T + GT Y+ PE D ++LG++ E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 831 PISHGKNI 838
P G N
Sbjct: 231 PFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD K+ADFG + EG+V + GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAV---GTPDYISPEVLKSQ 218
Query: 808 K----LTDKSDVYSLGVVFLELLTGMQP 831
+ D +S+GV E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 651 VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710
V +K Q G TE L ++H +++ L G L+ L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCY 172
Query: 711 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770
L+AK + L+I R I YLH + HRDIKA NI ++H + DFG
Sbjct: 173 LAAKRNIAI--CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227
Query: 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
+ PV DI A+ GT PE D++S G+V E+ T
Sbjct: 228 -AACFPV-DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-04
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
S + +I LS ++G I S LP +Q + ++NN LSG IP I+ + ++ L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRYL 123
Query: 356 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
+ NNN T +IP T+ L N
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 131 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
+L+ L L+ N LT +P+ LP L + + N ++ P++F+ L R ++ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 190 I 190
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 47/186 (25%), Positives = 71/186 (38%), Gaps = 32/186 (17%)
Query: 131 SLELLLLNGNELTGS----LPEELGYL-PKLDRIQIDQNYISG----SLPKSFANLNKTR 181
SL+ L LN N L L + L L P L+++ + +N + G +L K+ +
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 182 HFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQL 233
++ NN I + L +L + L+NN LT L L+ L L +L L
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNL 228
Query: 234 DNNNFEGTTI----PASYSNMSKLLKLSLRNC--------SLQGPMPDLSRIPNLGYLDL 281
+NN A S LL LSL L + + +L LDL
Sbjct: 229 GDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK---ESLLELDL 285
Query: 282 SSNQLN 287
N+
Sbjct: 286 RGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
E + L RL H +++L+ G LV ++ S+ L L A+ + PLG A ++A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL------SRLAPVP-DIE 781
I Y+H E + HRDIK N+L++ + DFG S P I
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824
G V + V+ G P T D++S G+V E
Sbjct: 324 GTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 646 PDGTVVAVKRAQEGSLQGEK-EFL-TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703
P G V V+R + E FL E+ +H N+V + E +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
G+ +D + + + I G + + Y+H HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SVD 137
Query: 764 AKVADFGL----------SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT--- 810
KV GL RL V D P + V+ +L PE L L
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDF----PKYSVKVLP----WLSPE-VLQQNLQGYD 188
Query: 811 DKSDVYSLGVVFLELLTGMQP 831
KSD+YS+G+ EL G P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.003
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 12/85 (14%)
Query: 748 HRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
H DIK N+L D K + D+GL + + GT Y PE
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK-----------IIGTPSCYDGTLDYFSPEKIKG 180
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
H D +++GV+ ELLTG P
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 21/59 (35%), Positives = 26/59 (44%), Gaps = 4/59 (6%)
Query: 230 ILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL 286
L L NN T IP + L L L +L P+ S +P+L LDLS N L
Sbjct: 4 SLDLSNNRL--TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 956 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.61 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.59 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-75 Score=743.30 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
...|...+.||+|+||.||+|.. .+++.||||++...... ..+|++.+++++||||++++|+|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677889999999999999996 47899999998753322 23468899999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.++++. ++|..+.+|+.||++||+|||..+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999999953 7899999999999999999997766669999999999999999988876 665543211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC----chhHHHHHHHhhcccchhhccC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG----KNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.....++..|+|||++.+..++.++|||||||++|||+||+.||... ....++....+........+++
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 11235789999999999999999999999999999999999998542 2234444433333333333443
Q ss_pred CCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 858 NMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 858 ~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
... ..+.+...++.+++.+||+.+|++||+|.++++.|+++....
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 332 234567778899999999999999999999999999886543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=442.80 Aligned_cols=284 Identities=52% Similarity=0.884 Sum_probs=247.7
Q ss_pred CcccccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 610 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
..+.|++.++..||++|...+.||+|+||.||+|..++|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred ccCC-cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 690 DEEG-EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 690 ~~~~-~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
.+.+ +.+||||||++|+|.++++.....+++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999876543799999999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC-----chhHHHHH
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-----KNIVREVN 843 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~-----~~~~~~~~ 843 (956)
||+|+..+... ........||.+|+|||++..+..+.|+||||||++++|++||+.+.+.. ....+|..
T Consensus 221 FGLa~~~~~~~------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEGD------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCccc------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99997653210 11111117999999999999999999999999999999999999888743 23577777
Q ss_pred HHhhcccchhhccCCCC--CCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 844 IAYQSSMMFSVIDGNMG--SYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.......+.+++|+.+. .++. +...++..++.+|++.+|..||+|.+|+++|+.+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 77777788899999874 5554 68888999999999999999999999999996553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=398.64 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=209.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh-------hHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++..... ....+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999995 47999999998753221 1234579999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC---CcEEEEeec
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFG 770 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DfG 770 (956)
..|+|||||+||+|.+.+-.+. .+.+...+.+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999987654 4777888899999999999999999 9999999999999766 789999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCC---CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
+|+.... ...+...+||+.|.|||++.+..+ ..++|+||+||+||-+++|..||.......
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 9998642 345677899999999999987543 347899999999999999999997542211
Q ss_pred cccch-hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 848 SSMMF-SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 848 ~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
.+. .+..+.....|. .+ .+.+.++.+||++||+.||++|+|
T Consensus 389 --sl~eQI~~G~y~f~p~-~w-----------------------------------~~Iseea~dlI~~mL~VdP~~R~s 430 (475)
T KOG0615|consen 389 --SLKEQILKGRYAFGPL-QW-----------------------------------DRISEEALDLINWMLVVDPENRPS 430 (475)
T ss_pred --cHHHHHhcCcccccCh-hh-----------------------------------hhhhHHHHHHHHHhhEeCcccCcC
Confidence 011 111122211111 11 111334558999999999999999
Q ss_pred CccCCCCCccccCCCC
Q 002178 927 SSSMLKHPYVSSDVSG 942 (956)
Q Consensus 927 a~e~L~HP~f~~~~~~ 942 (956)
++|||+||||....-+
T Consensus 431 ~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 431 ADEALNHPWFKDAPCL 446 (475)
T ss_pred HHHHhcChhhhccccc
Confidence 9999999999865544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=401.09 Aligned_cols=259 Identities=38% Similarity=0.587 Sum_probs=220.8
Q ss_pred CCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh--HHHHHHHHHHHHhcCCCceeeeecccccCC-cEEEEEecCCC
Q 002178 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFMSN 704 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~LV~e~~~~ 704 (956)
..+.||+|+||+||+|.++....||||++....... .++|.+|+.+|++++|||||+|+|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999765559999998654332 468999999999999999999999998887 79999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCCCCCCCc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 783 (956)
|+|.++++......+++..+++++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 999999988656679999999999999999999999874 99999999999999998 99999999998754321
Q ss_pred cccceecccccCCCcccccccc--cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...... ....+.++.
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~--------v~~~~~Rp~ 266 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA--------VVVGGLRPP 266 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH--------HHhcCCCCC
Confidence 2233467999999999999 56999999999999999999999999987655 221111 123445667
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
+|..++..+..++.+||+.+|..||++.+++..|+.+......
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 7888999999999999999999999999999999988775543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=384.63 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=194.7
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCC-cEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~LV~e~~ 702 (956)
.+..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||++||.|..++ +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 334678999999999999976 6899999999643 3344678999999999999999999999999988 599999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++|||++++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|+|||+|||.+..+...
T Consensus 161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999765 458899999999999999999996 66 999999999999999999999999999876422
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch-hHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ...+.. .+..++++..+
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~------Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE------LLCAIVDEPPP 300 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH------HHHHHhcCCCC
Confidence 34566799999999999999999999999999999999999999976411 111111 12234444444
Q ss_pred CCChH-HHHHHHHHHHHhcccCCCCCCCHH
Q 002178 861 SYPSE-CVEKFIKLALKCCQDETDARPSMS 889 (956)
Q Consensus 861 ~~~~~-~~~~l~~l~~~c~~~~p~~RPs~~ 889 (956)
..|++ +++++..++..|+++||.+||++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 55553 555555555555544444444333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=369.05 Aligned_cols=283 Identities=26% Similarity=0.446 Sum_probs=223.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhh--HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|...+++|+|.||.||+|++ .+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 579999999998654332 3577899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||+ -+|+..++.+ ...++..+++.++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+..++
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 996 5999999765 457899999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
...+...-|..|+|||.+.| ..|+..+||||.||++.||+-| .||..+++..++....+. .+
T Consensus 156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~----------~L 218 (318)
T KOG0659|consen 156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFR----------AL 218 (318)
T ss_pred ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHH----------Hc
Confidence 22333367889999999987 5699999999999999999987 466666665555554432 22
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH-hHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES-IWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~-~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+...++.++++..+ |++.++.+.-.. ....++.....+.||+.+|+++||.+|+||+|+|+||||++
T Consensus 219 GTP~~~~WP~~~~l------------pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSL------------PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred CCCCcccCcccccc------------ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 33333333333222 122111100000 01145666677799999999999999999999999999987
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
...
T Consensus 287 ~P~ 289 (318)
T KOG0659|consen 287 LPL 289 (318)
T ss_pred CCC
Confidence 544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=404.78 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=212.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.+|...+.||+|||++||.++. ..|+.||+|++..... ...+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 7899999999876432 23567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|+|++++|..++++ +.++++.+++.+..||+.||.|||+++ |||||||..|++++++.+|||+|||+|..+..++
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999974 457999999999999999999999999 9999999999999999999999999999876442
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......+|||.|+|||++....++..+||||+||++|-|+.|++||+...- .+
T Consensus 173 -------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-ke------------------- 225 (592)
T KOG0575|consen 173 -------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KE------------------- 225 (592)
T ss_pred -------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HH-------------------
Confidence 345677899999999999999999999999999999999999999974321 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
.++ |+..+--.+|+ .....+.++|++||+.||.+|||++++|.|+||
T Consensus 226 ----------ty~----~Ik~~~Y~~P~----------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 226 ----------TYN----KIKLNEYSMPS----------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ----------HHH----HHHhcCccccc----------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 000 11111111221 123455689999999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=397.85 Aligned_cols=288 Identities=22% Similarity=0.338 Sum_probs=232.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhH-HHHHHHHHHHHhcC-CCceeeeecccccCC-cEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLH-HRNLVSLVGYCDEEG-EQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~L 697 (956)
..++|.+.++||.|+||.||+|+. .+|..||||+++..-...+ -.-++|++.|+++. ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999994 5799999999886443332 23478999999998 999999999998887 9999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||| ..+|+++++++ ...+++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99999 56999999887 678999999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
....+....|..|+|||++.. +-|+.+.||||+|||++|+.+-++.|.+.. ..++..... +
T Consensus 163 --------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~KIc------~--- 224 (538)
T KOG0661|consen 163 --------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYKIC------E--- 224 (538)
T ss_pred --------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHHHH------H---
Confidence 234566778999999999865 679999999999999999999877775444 444433322 1
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
.+|....+.+.+-.+++..+--.-|..-|+- +...+|....++.+++..|+.|||++||||+|+|+||||
T Consensus 225 -VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~---------l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 225 -VLGTPDKDSWPEGYNLASAMNFRFPQVKPSP---------LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred -HhCCCccccchhHHHHHHHhccCCCcCCCCC---------hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 2344444444444666666555555554432 223456677778899999999999999999999999999
Q ss_pred ccCCCC
Q 002178 937 SSDVSG 942 (956)
Q Consensus 937 ~~~~~~ 942 (956)
+...+.
T Consensus 295 q~~~~~ 300 (538)
T KOG0661|consen 295 QVGRAS 300 (538)
T ss_pred cccccc
Confidence 776653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=399.10 Aligned_cols=259 Identities=31% Similarity=0.511 Sum_probs=220.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..+.+...+.||+|.||.||.|.++....||+|.++..... .+.|.+|+++|++++|+|||+++|+|..++.++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 33344456789999999999999987789999999876443 45899999999999999999999999998899999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
|+.|+|.++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+......+.
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999999866778999999999999999999999999 999999999999999999999999999954433221
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
......-+..|.|||.+..+.++.|||||||||+||||+| |+.||....+. + .+..+-.+.+.
T Consensus 360 ------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-e---------v~~~le~GyRl 423 (468)
T KOG0197|consen 360 ------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-E---------VLELLERGYRL 423 (468)
T ss_pred ------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-H---------HHHHHhccCcC
Confidence 1222234568999999999999999999999999999999 88888654331 1 11233445566
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.|+.|++.+.++|..||+.+|++|||++.+...++++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 7799999999999999999999999999999988887754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=367.94 Aligned_cols=282 Identities=24% Similarity=0.354 Sum_probs=217.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+.|+.+.++|+|+||+|||++.+ +|+.||||++.+... .-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 599999999986433 234667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||+. ++.+-+.+.. ..++...+.+++.|+++|+.|+|+++ +|||||||+|||++.+|.+||||||.|+.+..+
T Consensus 82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9976 5555554433 34888999999999999999999999 999999999999999999999999999988632
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
....+....|..|+|||.+.+ .+|..++||||.||++.||++|.+.|....+..+...+.. .+
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k-----------tL 218 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK-----------TL 218 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH-----------HH
Confidence 234566778999999999998 7899999999999999999999877766555444332211 11
Q ss_pred CCCChHHHHHHHH--HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 860 GSYPSECVEKFIK--LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 860 ~~~~~~~~~~l~~--l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
+...+.-..-+.. ....-.-+.|+. ++.....+|.......||+..+|..||++|++.+|+|.||||.
T Consensus 219 G~L~prhq~iF~~N~~F~Gv~lP~~~~----------~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 219 GNLIPRHQSIFSSNPFFHGVRLPEPEH----------PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred cccCHHHHHHhccCCceeeeecCCCCC----------ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 2221111110000 000001112221 2233345566666778999999999999999999999999994
Q ss_pred c
Q 002178 938 S 938 (956)
Q Consensus 938 ~ 938 (956)
+
T Consensus 289 ~ 289 (396)
T KOG0593|consen 289 G 289 (396)
T ss_pred H
Confidence 4
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=374.70 Aligned_cols=269 Identities=25% Similarity=0.406 Sum_probs=211.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||.+++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999975 6899999998766 4445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC------CcEEEEeecccc
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK------FTAKVADFGLSR 773 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~DfGla~ 773 (956)
|||.||+|.+|++.++ .+++..++.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998765 5899999999999999999999999 9999999999999765 569999999999
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
.+.. .......+|++.|||||+++.++|+.|+|+||.|+++|+|++|+.||...... +... .++..
T Consensus 164 ~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL~~-~~~k~---- 229 (429)
T KOG0595|consen 164 FLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-ELLL-YIKKG---- 229 (429)
T ss_pred hCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-HHHH-HHhcc----
Confidence 8863 23445678999999999999999999999999999999999999999754321 1111 11100
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
....+..+........++...-++.++.+|-.+.+ .|...++..+|.+|..+.++=.
T Consensus 230 --~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~--------------------~~~~~~l~~~p~~~~~~~~~~~ 286 (429)
T KOG0595|consen 230 --NEIVPVLPAELSNPLRELLISLLQRNPKDRISFED--------------------FFDHPFLAANPQDRADAFELES 286 (429)
T ss_pred --ccccCchhhhccCchhhhhhHHHhcCccccCchHH--------------------hhhhhhcccCcccccCcccccc
Confidence 01122334445555556666666666666655442 2444555666666655544433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=385.14 Aligned_cols=287 Identities=25% Similarity=0.370 Sum_probs=221.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~L 697 (956)
.+.|+.+++||+|+||.||+|+. .+|+.||+|++..+..+ ......+||.+|+++.||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35677788999999999999994 57999999998765432 345668999999999999999999998665 78999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|+|||++ +|.-++.. ..-.|++.+++.+++|++.||+|+|.++ |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999975 88888754 3446999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ....+...-|..|+|||++.+ ..|+.++|+||.|||+.||++|++.|.. ....++....+.
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-~tEveQl~kIfk--------- 334 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-RTEVEQLHKIFK--------- 334 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-ccHHHHHHHHHH---------
Confidence 43 223566778999999999998 4699999999999999999999877754 444555544332
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+...++++. ..++- .+....|. .+... .+.+. +...+..+++|+..||.+||++|.||+++|+|+||
T Consensus 335 -lcGSP~e~~W~-~~kLP-~~~~~kp~--~~y~r---~l~E~---~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 335 -LCGSPTEDYWP-VSKLP-HATIFKPQ--QPYKR---RLRET---FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred -HhCCCChhccc-cccCC-cccccCCC--Ccccc---hHHHH---hccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 23444444444 22221 11111111 11111 11222 23335567899999999999999999999999999
Q ss_pred ccCCC
Q 002178 937 SSDVS 941 (956)
Q Consensus 937 ~~~~~ 941 (956)
..+..
T Consensus 404 ~t~p~ 408 (560)
T KOG0600|consen 404 TTEPL 408 (560)
T ss_pred ccCCC
Confidence 66554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=370.77 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=210.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
..++|++.++||+|+||+||.++.+ +++.+|+|++++.... ..+...+|..+|.+++||.||+++-.|++.+..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567999999999999999999965 5899999999865432 24567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|+||+.||.|..+|++++ .+++..++-++..|+.||.|||+++ ||||||||+|||+|.+|.++|+|||+++..-.
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999997655 4899999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. .......+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+. .+..+. +..+
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~~---------I~~~ 240 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYDK---------ILKG 240 (357)
T ss_pred C-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHHH---------HhcC
Confidence 2 2234457899999999999999999999999999999999999999975432 111111 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCccccccccCCCCCCCC----CCccCCC
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPP----SSSSMLK 932 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~----sa~e~L~ 932 (956)
.. ...|. .+..+.++++++|+.||++|. .++++-+
T Consensus 241 k~----------------------------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 241 KL----------------------------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cC----------------------------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 00 11122 344556788888888888885 6778888
Q ss_pred CCccccCC
Q 002178 933 HPYVSSDV 940 (956)
Q Consensus 933 HP~f~~~~ 940 (956)
||||..-.
T Consensus 281 HpfF~~in 288 (357)
T KOG0598|consen 281 HPFFKGIN 288 (357)
T ss_pred CcccccCC
Confidence 99986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=356.22 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=214.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeec-ccccCCc-EEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG-YCDEEGE-QMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~LV 698 (956)
.+|++.++||+|.||+|||+. ..+|..||.|.++-+.. ...++...|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357778899999999999998 56899999999885443 34567899999999999999999999 4555554 8999
Q ss_pred EecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcC-CCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEA-DPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
||||..|+|..+++. +.+..+++..+++++.|++.||.++|..- ...|+||||||.||+++.+|.|||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999975 34567999999999999999999999832 123899999999999999999999999999988
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........|||.||+||.+.+.+|+.+|||||+||++|||+.-+.||... +...... ++.
T Consensus 179 ~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~---------KI~ 241 (375)
T KOG0591|consen 179 SSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCK---------KIE 241 (375)
T ss_pred cch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHH---------HHH
Confidence 643 23445678999999999999999999999999999999999999999765 3333222 334
Q ss_pred cCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 856 DGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 856 ~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
.+..++.| +.++..+..++..|+..||+.||+.-.+++.+..
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 45566667 7889999999999999999999986555555543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=364.65 Aligned_cols=286 Identities=24% Similarity=0.373 Sum_probs=226.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecC--CChhhHHHHHHHHHHHHhcCCCceeeeeccccc-----CC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EG 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~ 693 (956)
....|...+.||+|+||.|++|... +|+.||||++.. ......++..+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666789999999999999964 799999999873 445556788999999999999999999998854 35
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..|+|+|+| +-+|...++.+ ..++...+..+..|+++||.|+|+.+ |+|||+||+|++++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 789999999 67999999654 34899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... ......+....|..|+|||++.. ..|+.+.||||.|||+.||++|+..|.+ .+...+.+..
T Consensus 174 ~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG-~d~v~Ql~lI------- 240 (359)
T KOG0660|consen 174 YLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG-KDYVHQLQLI------- 240 (359)
T ss_pred ecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC-CchHHHHHHH-------
Confidence 87543 12334566778999999999865 6899999999999999999999877754 4444444332
Q ss_pred hhccCCCCCCChHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
-...+..+++....+. +-+...++..|...+. .+...+|..++.+.|++.+||++||.+|+||+|||
T Consensus 241 ---~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~---------~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 241 ---LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ---------PFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred ---HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCC---------CHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 2233445555444443 2222233333433221 12345688899999999999999999999999999
Q ss_pred CCCcccc
Q 002178 932 KHPYVSS 938 (956)
Q Consensus 932 ~HP~f~~ 938 (956)
+||||+.
T Consensus 309 ~hPYl~~ 315 (359)
T KOG0660|consen 309 AHPYLAP 315 (359)
T ss_pred cChhhhh
Confidence 9999964
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=356.35 Aligned_cols=286 Identities=24% Similarity=0.333 Sum_probs=217.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh--HHHHHHHHHHHHhcCCCceeeeecccc--cCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~LV 698 (956)
++|+..++|++|+||.||+|+++ +++.||+|+++...... .-..++|+.+|.+.+|||||.+-.+.. +-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46778899999999999999965 68999999998543221 235589999999999999999988764 34579999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||||+. +|..+++.-. +++...+++.+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999965 9999997654 67999999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. ...+...-|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.. ....+++...+..
T Consensus 231 ~-------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-~sE~dQl~~If~l--------- 293 (419)
T KOG0663|consen 231 L-------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-KSEIDQLDKIFKL--------- 293 (419)
T ss_pred c-------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-CchHHHHHHHHHH---------
Confidence 2 33466678999999999987 5699999999999999999999777654 4444555444322
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC--CCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~--~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
++...+..++.+..+-.. + -..+|... ...|+ ..++.. .....+|++.+|++||++|+||+|+|+|+|
T Consensus 294 -lGtPte~iwpg~~~lp~~--k--~~~f~~~p--yn~lr---~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 294 -LGTPSEAIWPGYSELPAV--K--KMTFSEHP--YNNLR---KKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred -hCCCccccCCCccccchh--h--ccccCCCC--chhhh---hhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 122222222222221100 0 00111100 11222 223333 366789999999999999999999999999
Q ss_pred cccCCC
Q 002178 936 VSSDVS 941 (956)
Q Consensus 936 f~~~~~ 941 (956)
|.....
T Consensus 364 F~e~P~ 369 (419)
T KOG0663|consen 364 FRETPL 369 (419)
T ss_pred cccCCC
Confidence 988544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=398.01 Aligned_cols=262 Identities=31% Similarity=0.507 Sum_probs=223.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
..+....+.||+|+||+||+|+.. +...||||.+++.... ..++|++|++++..++|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445555788999999999999843 3578999999987665 678999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 696 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++|+|||..|||.++|.... ..+++..+.+.||.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999996431 223889999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
|||+|||+++..-..|++.. ...-.-..+|||||.|..++++.+||||||||+|||+++ |+.||..-.+. +
T Consensus 642 VKIsDfGLsRdiYssDYYk~-----~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--E- 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKV-----RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--E- 713 (774)
T ss_pred EEecccccchhhhhhhhhcc-----cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--H-
Confidence 99999999997765554432 112234579999999999999999999999999999999 99999765431 1
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.+..+-.+...+.|+.|+.+++++|..||+..|.+||+++||-..|+++....
T Consensus 714 -------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 -------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 11223344556779999999999999999999999999999999999886543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=369.12 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=212.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhc-CCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|...+.||.|+|++|++|+.. .++.||||++.+.-... .+.+..|-.+|.+| .||.|++|+..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 456778889999999999999954 69999999987643322 34667888899999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|+||+++|+|.++|++.+ .+++...+.++.+|+.||+|||++| ||||||||+|||+|++|++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998764 5999999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCC-----Cc-cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 778 PDIE-----GI-VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 778 ~~~~-----~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.... .. .........+||..|.+||++.....+..+|+|+|||++|+|+.|.+||.......
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------------ 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------------ 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------------
Confidence 4322 00 01111245789999999999999999999999999999999999999997544311
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
-+.+++. |-- ...+.-.+.+.|+++++|..||.+|++++|+-
T Consensus 295 -----------------iFqkI~~-l~y--------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 295 -----------------IFQKIQA-LDY--------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred -----------------HHHHHHH-hcc--------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 1111111 000 01111123345788888999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
+||||.+--.
T Consensus 337 ~HpFF~~Vdw 346 (604)
T KOG0592|consen 337 AHPFFEGVDW 346 (604)
T ss_pred hCcccccCCh
Confidence 9999976544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=373.36 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=217.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
..|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...++.|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456677899999999999998 4578999999998766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+||+|.|.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--- 423 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc---
Confidence 999999998653 3899999999999999999999999 9999999999999999999999999998765322
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......||+.|||||+.....|+.++||||||++++||+-|.+||..+..+...+.+ .....+..
T Consensus 424 ----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI----------a~ng~P~l 489 (550)
T KOG0578|consen 424 ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------ATNGTPKL 489 (550)
T ss_pred ----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH----------hhcCCCCc
Confidence 2456678999999999999999999999999999999999999999865443221111 11111100
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
..+ +.....+.|||++||+.|+++|++|.|+|+||||.....-
T Consensus 490 --------------------k~~-----------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 490 --------------------KNP-----------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE 532 (550)
T ss_pred --------------------CCc-----------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence 011 1112334479999999999999999999999999766665
Q ss_pred Ccccc
Q 002178 943 SNLVS 947 (956)
Q Consensus 943 ~~~~~ 947 (956)
+.+++
T Consensus 533 ssL~p 537 (550)
T KOG0578|consen 533 SSLNP 537 (550)
T ss_pred HHhHH
Confidence 55443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.43 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=180.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.....-. .+...+|-++|+.+.||.++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 68999999998754433 345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||++||.|..++++.+ .+++..++.+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 9999999999997654 4999999999999999999999999 9999999999999999999999999998763
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
......+||+.|+|||++....+..++|.|||||++|||+.|..||.....
T Consensus 196 -------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 196 -------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred -------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 235678899999999999999999999999999999999999999976543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.64 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=212.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... ...+.+.+|++++++++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999965 689999999875332 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+.| +|..++...+ .++++.+..|+.+++.||.|||+.+ |+|||+||.|||++..|.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9965 9999997654 4899999999999999999999999 99999999999999999999999999997653
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.....+.+.||+-|||||+..++.|+..+|.||+||++||+++|++||...
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------------- 203 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------------- 203 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------------------
Confidence 245667889999999999999999999999999999999999999999532
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
.+.++++.-. .+|-.-|+ +....+..|++.+|..||..|+|=.+++.|||+.+..
T Consensus 204 --------si~~Lv~~I~-~d~v~~p~----------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 204 --------SITQLVKSIL-KDPVKPPS----------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --------HHHHHHHHHh-cCCCCCcc----------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1222222211 23322232 1122334678888889999999999999999987666
Q ss_pred CC
Q 002178 941 SG 942 (956)
Q Consensus 941 ~~ 942 (956)
.+
T Consensus 259 ~~ 260 (808)
T KOG0597|consen 259 NI 260 (808)
T ss_pred hh
Confidence 54
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=375.60 Aligned_cols=291 Identities=23% Similarity=0.344 Sum_probs=219.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-C-----CceeeeecccccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-----RNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~L 697 (956)
+|++.+.||+|+||.|-+|.+. +++.||||+++.... -..+...|+++|..++ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999964 699999999986433 3345677999999997 4 389999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC--CcEEEEeecccccc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLA 775 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DfGla~~~ 775 (956)
|+|.+ ..+|+++++.+....++...++.|+.||+.||.+||+.+ |||+||||+|||+.+- ..+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 679999999988888999999999999999999999999 9999999999999653 47999999999875
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.. .. .....+..|+|||++.+.+|+.+.||||||||+.||++|. |+..+++..+++....+
T Consensus 342 ~q---------~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e-------- 402 (586)
T KOG0667|consen 342 SQ---------RV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIE-------- 402 (586)
T ss_pred CC---------cc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHH--------
Confidence 42 11 2556788999999999999999999999999999999994 55566666666554332
Q ss_pred cCCCCCCChHHHHHHHH---H-------HHHhcccCCCCCCCHHHHHHHHHHhHh-------------hCC-CCCCCCcc
Q 002178 856 DGNMGSYPSECVEKFIK---L-------ALKCCQDETDARPSMSEVMRELESIWN-------------MMP-ESDTKTPE 911 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~---l-------~~~c~~~~p~~RPs~~~v~~~L~~~~~-------------~~~-~~~~~~~~ 911 (956)
.++.+|..+.+...+ . ...|...+-.+-+...++...+..... ..+ ..+..+.|
T Consensus 403 --~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 403 --VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred --HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 122222222221111 1 111222221111111122222211111 111 23344578
Q ss_pred ccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 912 FINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 912 ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
|+.+||.|||.+|+|+.|||+||||+....
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 999999999999999999999999985443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=365.75 Aligned_cols=268 Identities=25% Similarity=0.466 Sum_probs=220.4
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
+.+++.+..+.+.+...||+|.||+||+|.|.. .||||+++.... ...+.|.+|+..+++-+|.||+-|+|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 336667777778888999999999999999864 699999986543 3457899999999999999999999999988
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
.. .+|+.+|+|.+|+.++|... ..++..+.+.||+|||+|+.|||.++ |||||||..||++.+++.|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 77 99999999999999998754 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
..-..- ..........|...|||||+++. .+|++.+|||||||++|||+||..||. ..+.. .
T Consensus 536 tvk~~w-----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d---------q 600 (678)
T KOG0193|consen 536 TVKTRW-----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD---------Q 600 (678)
T ss_pred eeeeee-----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh---------h
Confidence 753321 11222334457889999999974 478999999999999999999999997 33321 1
Q ss_pred cchhhccCC----CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 850 MMFSVIDGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 850 ~~~~~~~~~----~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
.++.+-.+. +-.....++.++.+++..||..++++||.+.+++..|+.+....|.
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 222222221 1223467888999999999999999999999999988887665444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.01 Aligned_cols=274 Identities=25% Similarity=0.330 Sum_probs=212.3
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..+.|++.+.||.|..++||+|+ .+.+..||||++.-+.... .+.+.+|+..|+.++||||++++..|..+.+.|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34678899999999999999999 4578999999998654443 478899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
.||.+||+.+.++..-...+++..+..|.+++++||.|||++| .||||||+.|||++++|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999998877777999999999999999999999999 9999999999999999999999999976654322
Q ss_pred CCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
... ........||+.|||||+++. ..|+.|+||||||++..|+.+|+.||..-..+.-... .+.+
T Consensus 181 --~R~-~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~----------tLqn 247 (516)
T KOG0582|consen 181 --DRQ-VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL----------TLQN 247 (516)
T ss_pred --cee-eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH----------HhcC
Confidence 111 111156789999999999654 5799999999999999999999999975433211111 1111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
..+.. . ......++. . .-...+..++..+|+.||++||||+++|+|+||.
T Consensus 248 ~pp~~-~------------------t~~~~~d~~----k-------~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 248 DPPTL-L------------------TSGLDKDED----K-------KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred CCCCc-c------------------cccCChHHh----h-------hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 11100 0 000000000 0 0011334677778888888888888888888887
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
....
T Consensus 298 ~~k~ 301 (516)
T KOG0582|consen 298 KAKS 301 (516)
T ss_pred hccc
Confidence 6655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=377.98 Aligned_cols=270 Identities=28% Similarity=0.478 Sum_probs=227.3
Q ss_pred cccHHHHHHHhcCC---------CCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcC
Q 002178 613 SFTYGEMALATNNF---------NSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH 678 (956)
Q Consensus 613 ~~~~~~~~~~~~~y---------~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~ 678 (956)
.++|+|...+-..| .+.++||.|.||.||+|.++ ....||||.++....+ ...+|+.|+.+|.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46777766655444 45789999999999999975 2467999999976544 4578999999999999
Q ss_pred CCceeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 679 h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
||||++|.|+.......++|+|||+||+|+.+|+.+.. .+.+.+...+.++||.|+.||-+++ +|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 99999999999999999999999999999999987764 4999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~ 837 (956)
+.+..+||+|||+++.+..+. .. ......-.-..+|.|||.+...+++.+|||||||++|||.++ |.+||.+-.+
T Consensus 765 NsnLvCKVsDFGLSRvledd~-~~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDP-EA---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ccceEEEeccccceeecccCC-Cc---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 999999999999999875432 11 111112223468999999999999999999999999999887 9999976443
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
. +.+..+.++.+.+.|.+|+..+.++|..||++|-.+||.+.+++..|.++..
T Consensus 841 Q----------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 841 Q----------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred H----------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1 1222344555677899999999999999999999999999999999988754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.91 Aligned_cols=294 Identities=24% Similarity=0.368 Sum_probs=223.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCc-eeeeecccccCC-----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEG----- 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~----- 693 (956)
...|+..++||+|+||+||+|+.+ +|+.||+|++...... ......+|+.++++++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999954 7899999998764432 2356789999999999999 999999997766
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCC--CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 694 -EQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 694 -~~~LV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
..++||||+ .-+|.+++..... ..++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999999 5699999987553 35677889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
+|+....+ ....+...+|..|+|||++.+. .|+...||||+||+++||++++..|....+ .++....+..
T Consensus 166 lAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~- 236 (323)
T KOG0594|consen 166 LARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRL- 236 (323)
T ss_pred hHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHH-
Confidence 99965432 3345667899999999999986 799999999999999999998777765544 4433333321
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
++...++.++.+..+... +.....++....+ ....+..+....+++.+||+++|++|+||+.
T Consensus 237 ---------lGtP~e~~Wp~v~~~~~~--k~~f~~~~~~~~l-------~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 237 ---------LGTPNEKDWPGVSSLPDY--KAPFPKWPGPKDL-------SSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred ---------cCCCCccCCCCccccccc--cccCcCCCCccch-------HHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 122222222222222111 0011112222222 2334555677889999999999999999999
Q ss_pred CCCCCccccCCCCCcccc
Q 002178 930 MLKHPYVSSDVSGSNLVS 947 (956)
Q Consensus 930 ~L~HP~f~~~~~~~~~~~ 947 (956)
+|.||||.........+.
T Consensus 299 al~h~yf~~~~~~~~~~~ 316 (323)
T KOG0594|consen 299 ALTHPYFSELPEKSSQLL 316 (323)
T ss_pred HhcChhhcccccchhhhh
Confidence 999999988766544433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=368.23 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=207.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC----Ch-hhHHHHHHHHHHHHhcC-CCceeeeecccccCC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG----SL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 693 (956)
...++|.+.+.||+|+||+|+.|.. .+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999985 47899999977653 11 23456678999999999 999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeeccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 772 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla 772 (956)
..++||||+.+|+|.+++.. ..++.+.+...++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999987 345888999999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCC-CC-CcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.....- ...
T Consensus 169 ~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~k------ 234 (370)
T KOG0583|consen 169 AISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRK------ 234 (370)
T ss_pred cccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHH------
Confidence 87631 123456678999999999999977 86 679999999999999999999976322110 000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC--CCCCccccccccCCCCCCCCCCc
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~--~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
+....- .+|.. ...+.+++++||..||.+|+|++
T Consensus 235 ----i~~~~~----------------------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~ 270 (370)
T KOG0583|consen 235 ----IRKGEF----------------------------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLL 270 (370)
T ss_pred ----HhcCCc----------------------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence 000000 11211 34445788888999999999999
Q ss_pred cCCCCCcccc
Q 002178 929 SMLKHPYVSS 938 (956)
Q Consensus 929 e~L~HP~f~~ 938 (956)
|+++||||..
T Consensus 271 ~i~~h~w~~~ 280 (370)
T KOG0583|consen 271 EILEHPWFQK 280 (370)
T ss_pred HHhhChhhcc
Confidence 9999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=356.09 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=210.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
...++|+++..||+|+||.||+|+-+ +|.++|+|++++..... .+.+..|-.+|....+|+||+++-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34588999999999999999999965 69999999998765443 345678889999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
|||||++||++..+|... ..+++..++.++.+++.|++-+|+.| +|||||||+|+|||..|++||+|||++.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999764 46899999999999999999999999 9999999999999999999999999985432
Q ss_pred CCCCCC------------------ccc-----cc-----------------eecccccCCCcccccccccCCCCCcccch
Q 002178 777 VPDIEG------------------IVP-----AH-----------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVY 816 (956)
Q Consensus 777 ~~~~~~------------------~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVw 816 (956)
...... ..+ .. ......|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 210000 000 00 01124699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 817 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 817 S~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
|+|||+|||+.|.+||........+.+.. .- ..||..-++.+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~--------------------------nw-r~~l~fP~~~~~---------- 415 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIV--------------------------NW-RETLKFPEEVDL---------- 415 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------------HH-hhhccCCCcCcc----------
Confidence 99999999999999998655432222211 00 112222222221
Q ss_pred HhHhhCCCCCCCCccccccccCCCCCCCCC---CccCCCCCccccCCC
Q 002178 897 SIWNMMPESDTKTPEFINSEHTSKEETPPS---SSSMLKHPYVSSDVS 941 (956)
Q Consensus 897 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s---a~e~L~HP~f~~~~~ 941 (956)
.+++.|||.++|. ||++|+- ++|+-+||||..-.-
T Consensus 416 ---------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 416 ---------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred ---------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 2345578888888 8888864 788999999976544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=349.24 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=172.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC--cEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV~e 700 (956)
.++...+.||+|+||+||++... +|+..|||..........+.+.+|+++|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35666789999999999999965 49999999887653333567889999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 779 (956)
|+++|+|.+++.+.+. .+++..++.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988766 7999999999999999999999999 999999999999999 7999999999998765310
Q ss_pred CCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 012233457799999999999963 334599999999999999999999964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.58 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=209.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.+++|++.+.||+|.|+.||++.. .+|+.+|+|++.... ..+.+++.+|+++-+.++||||+++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999985 479999999876432 22456889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~~~ 775 (956)
+|+|+|++|..-+-.+ ..+++..+-..++||+++|.|+|.++ |||||+||+|+++.+ ..-+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997766443 45788889999999999999999999 999999999999954 346999999999877
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.. ........||++|||||++...+|+.++|||+.||+||-++.|+.||.+.+.. +..+
T Consensus 164 ~~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye------------ 222 (355)
T KOG0033|consen 164 ND--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYE------------ 222 (355)
T ss_pred CC--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHH------------
Confidence 52 12234567999999999999999999999999999999999999999764321 1110
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
+++..-...++. .++...+++.+++++||+.||.+|+||.|+|+|||
T Consensus 223 ----------------~I~~g~yd~~~~-----------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 223 ----------------QIKAGAYDYPSP-----------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ----------------HHhccccCCCCc-----------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 111111111111 22344556678999999999999999999999999
Q ss_pred cccC
Q 002178 936 VSSD 939 (956)
Q Consensus 936 f~~~ 939 (956)
+...
T Consensus 270 i~~r 273 (355)
T KOG0033|consen 270 ICNR 273 (355)
T ss_pred hcch
Confidence 8653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=348.11 Aligned_cols=275 Identities=22% Similarity=0.328 Sum_probs=203.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC-----cEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~LV 698 (956)
.|...+++|.|+||.||+|+.. +++.||||+.-.+... -.+|+++|+++.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999965 5799999987653322 235999999999999999998874322 44689
Q ss_pred EecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla~~~ 775 (956)
||||+ -+|++.++. ..+..++...++-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 599999874 23456788888899999999999999988 9999999999999976 99999999999987
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... .......|..|+|||.+.+ ..|+.+.||||.||++.||+-|+..|... +..++......
T Consensus 177 ~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik------- 240 (364)
T KOG0658|consen 177 VKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIK------- 240 (364)
T ss_pred ccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHH-------
Confidence 5432 2345668899999999987 56999999999999999999998777654 33333332211
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~--p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
.++....+.... ++.+ -.+-|.+.... ..+ -.....++++.+|+.++|+++|.+|.++.|+|.
T Consensus 241 ---~lG~Pt~e~I~~--------mn~~y~~~~~p~ik~~~--~~~--~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 241 ---VLGTPTREDIKS--------MNPNYTEFKFPQIKAHP--WHK--VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ---HhCCCCHHHHhh--------cCcccccccCccccccc--cee--ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 122222222111 1111 11111111110 000 122345677789999999999999999999999
Q ss_pred CCcccc
Q 002178 933 HPYVSS 938 (956)
Q Consensus 933 HP~f~~ 938 (956)
||||..
T Consensus 306 h~fFde 311 (364)
T KOG0658|consen 306 HPFFDE 311 (364)
T ss_pred chhhHH
Confidence 999954
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=371.30 Aligned_cols=282 Identities=20% Similarity=0.249 Sum_probs=214.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 689999996542 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+......
T Consensus 165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 9 57999988654 34788999999999999999999998 9999999999999999999999999997532211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh------HHHHHHHhhcccchhhc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI------VREVNIAYQSSMMFSVI 855 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 855 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~------~~~ 306 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII------RRS 306 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH------HHh
Confidence 11223456999999999999999999999999999999999999888643221 11111111 111
Q ss_pred cCCCCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 856 DGNMGSYPS---ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 856 ~~~~~~~~~---~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
......++. ........-...+....|..||....+... .....+++.+||.+||++||||+|+|+
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-----------PIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhh-----------hhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 100111121 111222222234455667778776544321 123457999999999999999999999
Q ss_pred CCccccC
Q 002178 933 HPYVSSD 939 (956)
Q Consensus 933 HP~f~~~ 939 (956)
||||..-
T Consensus 376 hp~f~~~ 382 (391)
T PHA03212 376 FAAFQDI 382 (391)
T ss_pred ChhhccC
Confidence 9999763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=357.98 Aligned_cols=281 Identities=23% Similarity=0.345 Sum_probs=208.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.++||+|+||+||+|..+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999965 689999999875332 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ |+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 96 59999886543 35788899999999999999999999 9999999999999999999999999997643221
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... +....... ..+
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~----------~~~ 221 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFR----------LLG 221 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH----------HhC
Confidence 11223457899999999875 56899999999999999999999999754322 21111110 011
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+.+.+..+.......-...|..|+.. .....+..+....+|+++||++||.+|+|++|+|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQP---------LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCc---------hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1122222111110000000111112111 011223445567799999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=362.27 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=210.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
-|+..+.||+|+.|.|..|+. .+|+.+|||++...... ....+.+|+-+|+-+.||||+++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466778899999999999995 57999999999865221 23467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|-|.+++-.++ ++.+.+..+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|.....
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 999999999997754 5889999999999999999999999 99999999999999999999999999987542
Q ss_pred CCccccceecccccCCCcccccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......+|++.|.|||++++.+|. .++||||.|||||.|+||+.||+++ +....+... + .|.
T Consensus 165 -----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV-~--------~G~- 228 (786)
T KOG0588|consen 165 -----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKV-Q--------RGV- 228 (786)
T ss_pred -----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHH-H--------cCc-
Confidence 3345567899999999999999885 5799999999999999999999743 222211111 0 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
+.+......++-++|++||.+||++|+|.+|+++|||+..-
T Consensus 229 ---------------------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 229 ---------------------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ---------------------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 11111223444589999999999999999999999999776
Q ss_pred CCC
Q 002178 940 VSG 942 (956)
Q Consensus 940 ~~~ 942 (956)
...
T Consensus 270 ~~~ 272 (786)
T KOG0588|consen 270 TSL 272 (786)
T ss_pred CCC
Confidence 654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=353.14 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=174.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.|+..+.||+|+||+||+|.. .+|+.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 4799999998865332 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999999887655556899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 122346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=361.94 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=209.8
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
...++|++.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4567899999999999999999974 2357899999875432 3346789999999999 899999999988654
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 002178 693 -GEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 715 (956)
Q Consensus 693 -~~~~LV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 715 (956)
+..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999987532
Q ss_pred ----CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecc
Q 002178 716 ----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791 (956)
Q Consensus 716 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 791 (956)
..++++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhcccC
Confidence 134778889999999999999999998 99999999999999999999999999986532210 011123
Q ss_pred cccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHH
Q 002178 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 870 (956)
Q Consensus 792 ~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 870 (956)
..++..|+|||++.+..++.++|||||||++|||++ |..||........... .+..+.....+..++..+
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l 306 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTRMRAPENATPEI 306 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---------HHhcCCCCCCCCCCCHHH
Confidence 346678999999999999999999999999999997 9999975432211111 111222333455667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 871 IKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 871 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+++.+||+.+|.+||++.++++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.59 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=213.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.... -+.++.+|+++-+.++||||+++++||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999954 6889999998754332 256889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
+||.++|++...|.......+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999999777778999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||.....
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------------------- 227 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------------------- 227 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------------
Confidence 3345677899999999999999999999999999999999999999964321
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
.+..+.+.+..-.+|. ....+.|+|.++|..+|.+|.+-.|+++|||+.
T Consensus 228 ------------------------------~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 228 ------------------------------SETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ------------------------------HHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 1111111111112221 234456788888999999999999999999986
Q ss_pred cC
Q 002178 938 SD 939 (956)
Q Consensus 938 ~~ 939 (956)
..
T Consensus 278 a~ 279 (281)
T KOG0580|consen 278 AN 279 (281)
T ss_pred hc
Confidence 54
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.88 Aligned_cols=298 Identities=25% Similarity=0.361 Sum_probs=216.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC---C--CcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeeccccc-CC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP---D--GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 693 (956)
....|+....||+|.||.||+|.-. + .+.+|+|+++..... -.....+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457889999999999999999643 2 237999999865322 13567899999999999999999999866 77
Q ss_pred cEEEEEecCCCCCHHHHHhhc---CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC----CcEEE
Q 002178 694 EQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKV 766 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl 766 (956)
..++++||.+. +|.+.++-+ ....++...++.|..||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999975 999988643 2246888999999999999999999999 9999999999999877 89999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+|||+|+.+..+-. +-.....+..|..|+|||.+.+ ..||.+.||||.||++.||+|-.+.|...+...+. ...
T Consensus 178 aDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~-~~P 252 (438)
T KOG0666|consen 178 ADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT-KNP 252 (438)
T ss_pred ecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc-CCC
Confidence 99999998865431 1223345678899999999998 46999999999999999999987777543211000 001
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH----------HHHhHhhCCCCCCCCcccccc
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE----------LESIWNMMPESDTKTPEFINS 915 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~----------L~~~~~~~~~~~~~~~~ll~~ 915 (956)
++...+..++. .++...++.++.+.+. |.....+.. |-.+.......++.+.+++.+
T Consensus 253 fq~dQl~rIf~-vLG~Pt~~~Wp~lkk~------------Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k 319 (438)
T KOG0666|consen 253 FQHDQLDRIFE-VLGTPTDKDWPDLKKM------------PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK 319 (438)
T ss_pred chHHHHHHHHH-HcCCCccccchhhhhC------------cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence 11111111110 1122222222222111 222222222 223333344456778999999
Q ss_pred ccCCCCCCCCCCccCCCCCccccCCC
Q 002178 916 EHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 916 ~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
||++||.+|+||++||+|+||+++.-
T Consensus 320 lL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 320 LLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred HhccCchhhccHHHHhcccccccCCC
Confidence 99999999999999999999998843
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.12 Aligned_cols=239 Identities=29% Similarity=0.515 Sum_probs=205.2
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHH
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 708 (956)
++-||.|+-|.||+|+++ ++.||||+++.- -..+++-|++|+|+||+.|.|+|.....+|||||||..|-|+
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 567999999999999985 578999987642 134788999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccce
Q 002178 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (956)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 788 (956)
..|+.. .++.......+.++||.|+.|||.+. |||||||+-||||+.+..|||+|||-++.... ...
T Consensus 201 ~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--------~ST 267 (904)
T KOG4721|consen 201 EVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD--------KST 267 (904)
T ss_pred HHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh--------hhh
Confidence 999764 45778888999999999999999999 99999999999999999999999999987642 223
Q ss_pred ecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC-CCCChHHH
Q 002178 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSECV 867 (956)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 867 (956)
....+||..|||||++...++++|+|||||||+||||+||..||.+.+. ...++.+-...+ .+.|..|+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------sAIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------SAIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------heeEEeccCCcccccCcccCc
Confidence 4567899999999999999999999999999999999999999975432 122333322222 35689999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 868 EKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 868 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+.+.-+++.||+..|..||++.+++..|+-.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999999999988743
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=382.75 Aligned_cols=261 Identities=32% Similarity=0.537 Sum_probs=218.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC--Cc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD--GT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
..+.+..+.||+|+||.||.|...+ |. .||||.++... .+...+|.+|..+|++++|||||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4455667889999999999999643 43 48999988754 45568999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhc-----CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 696 MLVYEFMSNGTLRDQLSAK-----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
++++|||++|+|..+|++. ....++..+.+.++.|||+|+.||++++ +|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999864 1345888999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 849 (956)
+|+.....+++... ....-...|||||.+..+.++.|+|||||||++||++| |..||....+..
T Consensus 848 lArDiy~~~yyr~~-----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKH-----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------- 912 (1025)
T ss_pred hhHhhhhchheecc-----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------
Confidence 99955443332111 11123468999999999999999999999999999999 889997655421
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+..+..+.+...|..|++.++++|..||+.+|++||++..+++.+..+.+.
T Consensus 913 v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 913 VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1122334446678999999999999999999999999999999988887654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=352.09 Aligned_cols=278 Identities=24% Similarity=0.351 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC--CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhc---CCCceeeeecccc-----c
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCD-----E 691 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~ 691 (956)
++|++.+.||+|+||+||+|... +++.||+|.++.... .....+.+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 478899998864322 1234566777777665 6999999999874 3
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
....++||||++ ++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 69999998765566899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.... ...
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i------ 221 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKI------ 221 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHH------
Confidence 9765322 1223456899999999999889999999999999999999999999765442221 111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
++......+.+++... .+...++...+.. ... +..+..+....+++.+||+.||++|||+.|+|
T Consensus 222 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 222 ---LDVIGLPGEEDWPRDV-ALPRQAFHSKSAQ--PIE----------KFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred ---HHHhCCCChhhchhhh-cccchhccCCCCC--CHH----------HHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 1100011112221111 1222222222111 111 12234455567899999999999999999999
Q ss_pred CCCcc
Q 002178 932 KHPYV 936 (956)
Q Consensus 932 ~HP~f 936 (956)
+||||
T Consensus 286 ~hp~f 290 (290)
T cd07862 286 SHPYF 290 (290)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=351.64 Aligned_cols=284 Identities=21% Similarity=0.277 Sum_probs=209.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||+||+|+.+ +++.||+|++..... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 688999999875322 234577899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9988777655432 245888899999999999999999998 9999999999999999999999999998754221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
........|+..|+|||++.+..++.++|||||||++|||++|+.||............ ....+
T Consensus 155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~-----------~~~~~ 218 (287)
T cd07848 155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI-----------QKVLG 218 (287)
T ss_pred -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------HHhhC
Confidence 11122346899999999999989999999999999999999999999764432221111 01112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+.+....+..- ........|........-.. .....+..+.+|+.+||+.||++|+|++|+|+||||
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 219 PLPAEQMKLFYSN----PRFHGLRFPAVNHPQSLERR---YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCHHHHHhhhcc----chhcccccCcccCcccHHHh---hhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 2233222211110 00000011111000000000 111234456789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=354.17 Aligned_cols=197 Identities=24% Similarity=0.362 Sum_probs=173.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999975 68999999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997643 5888999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=357.39 Aligned_cols=269 Identities=30% Similarity=0.480 Sum_probs=221.8
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCC--C--cE-EEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeee
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD--G--TV-VAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSL 685 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l 685 (956)
+..+.++...++-...++||+|+||.||+|.+.. + .. ||||..+.. .....++|.+|+++|+.++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3344555566666677999999999999999643 2 23 899998852 34556799999999999999999999
Q ss_pred ecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 686 ~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
||++.....+++|||+|+||+|.++|+.... .++..++.+++.++|+||+|||+++ +|||||.++|+|++.++.+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999987654 6899999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~ 844 (956)
|+|||+++....-. .......-...|+|||.+....|+.++|||||||++||+++ |..||.......-..
T Consensus 303 ISDFGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-- 373 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-- 373 (474)
T ss_pred eCccccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH--
Confidence 99999987543110 00111234578999999999999999999999999999999 888997654432111
Q ss_pred Hhhcccchhh-ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 845 AYQSSMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 845 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
.+ ..+.+...|...+..+..++..||..+|++||+|.++.+.++.+.....
T Consensus 374 --------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 --------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 12 2334456677888999999999999999999999999999999877544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=353.83 Aligned_cols=286 Identities=22% Similarity=0.329 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 6899999998754322 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 994 7888888654 345788889999999999999999999 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+........... .
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~---- 221 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV------L---- 221 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH------h----
Confidence 11233457899999999875 457889999999999999999999997654433332221110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETD--ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~--~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
+............. -...|+ .+.+...+.+... . ......+.+|+++||+.||++|+|++|+|+||||.
T Consensus 222 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 222 GTPNEDTWPGVHSL----PHFKPERFTLYSPKNLRQAWN----K-LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred CCCChhhccchhhc----cccccccccccCCccHHHHhh----c-cCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 00000000000000 000000 0001111111111 0 01224456899999999999999999999999997
Q ss_pred cC
Q 002178 938 SD 939 (956)
Q Consensus 938 ~~ 939 (956)
.-
T Consensus 293 ~~ 294 (303)
T cd07869 293 DL 294 (303)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.65 Aligned_cols=279 Identities=23% Similarity=0.318 Sum_probs=224.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+.|+..+.||+|.-|+||++.+++ +..+|+|++.+..... ..+...|-++|+.+.||.++.+|+.|+.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667889999999999999764 6899999998765443 346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|||+||+|..+.+++....+++..++.++..++-||+|||..| ||.|||||+|||+-++|.+.|+||.++.......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999975442200
Q ss_pred -C-----------------------------C-C------------------ccccceecccccCCCcccccccccCCCC
Q 002178 780 -I-----------------------------E-G------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLT 810 (956)
Q Consensus 780 -~-----------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 810 (956)
. . . ......+....||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 0001223456799999999999999999
Q ss_pred CcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002178 811 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 890 (956)
Q Consensus 811 ~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~ 890 (956)
.++|+|+|||++|||+.|..||-...+..... +++...+ .+|.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~----------NIv~~~l-~Fp~-------------------------- 356 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR----------NIVGQPL-KFPE-------------------------- 356 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHH----------HHhcCCC-cCCC--------------------------
Confidence 99999999999999999999997655432222 2221111 1110
Q ss_pred HHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC----CccCCCCCccccCCCCCccccccccccCC
Q 002178 891 VMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS----SSSMLKHPYVSSDVSGSNLVSGVIPTITP 955 (956)
Q Consensus 891 v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s----a~e~L~HP~f~~~~~~~~~~~~~~~~~~~ 955 (956)
.++....+.|+|+++|..||.+|+- |+|+-+||||.+-.-. ++...+|+.-|
T Consensus 357 -----------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa--Lir~~~PP~iP 412 (459)
T KOG0610|consen 357 -----------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA--LIRCARPPEIP 412 (459)
T ss_pred -----------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh--heeccCCCcCC
Confidence 0111234568999999999999999 9999999999887774 77777776654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.61 Aligned_cols=198 Identities=25% Similarity=0.424 Sum_probs=174.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 689999999875321 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997643 4788888999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 123468999999999999999999999999999999999999997543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.70 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=173.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC--CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||.||+|..++ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998543 4689999886432 2234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997643 4888999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123468999999999999889999999999999999999999997543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.08 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=216.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
......+.++||+|-||.|..+....+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345566789999999999999999888999999999765544 5899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||++|+|.+++.++............|+.||+.||+||.+.. +|||||.++|||+|.++++||+|||+++.+-..++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999998875554566677889999999999999998 99999999999999999999999999997655543
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh--CCCCCCCCchhHHHHHHHhhcccchhhcc-C
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVID-G 857 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 857 (956)
. +......-..+|||+|.+.-++++.++|||+||+++||+++ ...||....+.. +... ..++++ +
T Consensus 693 y-----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven-----~~~~~~~~ 760 (807)
T KOG1094|consen 693 Y-----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVEN-----AGEFFRDQ 760 (807)
T ss_pred e-----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHh-----hhhhcCCC
Confidence 3 22233345679999999999999999999999999999987 778887543321 1110 001111 1
Q ss_pred C---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 858 N---MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 858 ~---~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
. ....|.-|+..+++++.+||..+..+||+++++...|++
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1 234578899999999999999999999999999988775
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.04 Aligned_cols=296 Identities=22% Similarity=0.369 Sum_probs=222.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..++|++.++||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++|+||++++++|.+.++.++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999975 68899999887542 233467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||++++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999997643 478888999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..+.
T Consensus 158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-----~~~~ 221 (333)
T cd06650 158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCP-----VEGD 221 (333)
T ss_pred ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCc-----ccCC
Confidence 112345889999999999988999999999999999999999999754321 111111000 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC-C-----CCCCCccccccccCCCCCCCCCCccCCC
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP-E-----SDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~-~-----~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
.. ..............|....|..||++.. .+..+.+....+ . .+.+..+|+.+||+.||++|||++|+++
T Consensus 222 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 222 PA--ESETSPRPRPPGRPLSSYGPDSRPPMAI-FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cc--ccccCcccCCccchhhhhcccccccccH-HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00 0000111112223455567888887642 222222222111 1 1233468999999999999999999999
Q ss_pred CCccccCCC
Q 002178 933 HPYVSSDVS 941 (956)
Q Consensus 933 HP~f~~~~~ 941 (956)
||||+....
T Consensus 299 h~~~~~~~~ 307 (333)
T cd06650 299 HAFIKRSEA 307 (333)
T ss_pred CHHHhcCcc
Confidence 999976643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.07 Aligned_cols=267 Identities=27% Similarity=0.385 Sum_probs=206.3
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--------------hHHHHHHHHHHHHhcCCCceee
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------GEKEFLTEIQFLSRLHHRNLVS 684 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~ 684 (956)
...-++|++...||+|.||.|-+|... +++.||||++.+.... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999954 7999999998753211 1247889999999999999999
Q ss_pred eeccccc--CCcEEEEEecCCCCCHHHHHhhcCCCC-chhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC
Q 002178 685 LVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 685 l~~~~~~--~~~~~LV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
++.+..+ .+..|||+|||..|.+...= ...+ +++.++++++.++..||+|||.++ ||||||||+|+|++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9999865 46899999999888774432 2334 899999999999999999999999 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
|+|||+|||.+.........+ .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~--~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEG--SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CcEEeeccceeeecccCCccc--cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 999999999998764432221 112223367999999999998733 34578999999999999999999975432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccc
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L 917 (956)
..-.. .++. +|-.=|... +..+...|+|.+||
T Consensus 325 ~~l~~----------KIvn------------------------~pL~fP~~p--------------e~~e~~kDli~~lL 356 (576)
T KOG0585|consen 325 LELFD----------KIVN------------------------DPLEFPENP--------------EINEDLKDLIKRLL 356 (576)
T ss_pred HHHHH----------HHhc------------------------CcccCCCcc--------------cccHHHHHHHHHHh
Confidence 21110 1111 122222222 22333447888999
Q ss_pred CCCCCCCCCCccCCCCCccccCCCC
Q 002178 918 TSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 918 ~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
..||+.|++..++-.|||...+.++
T Consensus 357 ~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 357 EKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred hcChhheeehhhheecceeccCCCC
Confidence 9999999999999999999877653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.90 Aligned_cols=242 Identities=24% Similarity=0.391 Sum_probs=193.4
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhc-CCCceeeeecccccCCc
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 694 (956)
....++|....+||+|+||+|+++..+ +++.+|||++++...- ..+..+.|.+++... +||.++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578889999999999999999976 6889999999876543 235667788888777 59999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.|+||||+.||++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||+|.+|.+||+|||+++.
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999944433 3356999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
... ........+||+.|||||++.+..|+.++|.|||||+||||+.|..||..++. .+.. +.
T Consensus 518 ~m~-------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~F----------ds 579 (694)
T KOG0694|consen 518 GMG-------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVF----------DS 579 (694)
T ss_pred cCC-------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHH----------HH
Confidence 432 23456778999999999999999999999999999999999999999975432 2211 11
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDAR 885 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 885 (956)
|-..-..+|..++.+...++.+.+..+|++|
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccc
Confidence 1122234555555555555555555555444
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.16 Aligned_cols=298 Identities=23% Similarity=0.374 Sum_probs=214.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999975 68899999987543 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997643 4788899999999999999999853 2999999999999999999999999998755321
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... + ......... .+....
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~-~~~~~~~~~----~~~~~~ 224 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-E-LEAIFGRPV----VDGEEG 224 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHhcccc----cccccC
Confidence 122346899999999999999999999999999999999999999654321 1 111111000 000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC-CC-----CCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-PE-----SDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~-~~-----~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
. +.............+.......+|.+. +.+.++.+.... +. ..+...+|+++||.+||++|||++|+++||
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 E-PHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred C-ccccCcccccccccccccccccccchh-HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000000000001111222333332 111222221111 11 123346899999999999999999999999
Q ss_pred ccccCCC
Q 002178 935 YVSSDVS 941 (956)
Q Consensus 935 ~f~~~~~ 941 (956)
||.....
T Consensus 303 ~~~~~~~ 309 (331)
T cd06649 303 FIKRSEV 309 (331)
T ss_pred HHhhccc
Confidence 9976544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=352.07 Aligned_cols=194 Identities=26% Similarity=0.335 Sum_probs=168.7
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 68999999987532 222356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 999999754 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 11123456999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.51 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=205.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--------hHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
-+.|...+.||+|..++|.++..+ +|..+|+|++...... -.+.-.+|+.+|+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777889999999999998865 6889999987642211 123456799999998 699999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
...++|+|.|+.|.|.|++... -.+++...++|++|+..|++|||.+. ||||||||+|||+|++.++||+|||.|
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999653 45899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~ 846 (956)
+.+.. .......+||++|+|||.+.. ..|+..+|+||.||++|.++.|..||.+...+.-
T Consensus 171 ~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------ 236 (411)
T KOG0599|consen 171 CQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------ 236 (411)
T ss_pred eccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------
Confidence 98753 345567899999999999863 4688899999999999999999999975432110
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
+..+..+.. .+.. |. +.+......|++.++|+.||.+|+|
T Consensus 237 ----LR~ImeGky-qF~s---------------------pe--------------Wadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 237 ----LRMIMEGKY-QFRS---------------------PE--------------WADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred ----HHHHHhccc-ccCC---------------------cc--------------hhhccccHHHHHHHHHeeCchhccc
Confidence 001111111 1100 11 1112334568999999999999999
Q ss_pred CccCCCCCccc
Q 002178 927 SSSMLKHPYVS 937 (956)
Q Consensus 927 a~e~L~HP~f~ 937 (956)
++|+|+||||.
T Consensus 277 ake~LaHpff~ 287 (411)
T KOG0599|consen 277 AKEALAHPFFI 287 (411)
T ss_pred HHHHhcChHHH
Confidence 99999999993
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.57 Aligned_cols=261 Identities=20% Similarity=0.334 Sum_probs=209.4
Q ss_pred CcccccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeee
Q 002178 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLV 686 (956)
Q Consensus 610 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~ 686 (956)
+.+.++.+++. ......||+|++|.||+|.+ +|+.||||+++...... .+.+.+|++++++++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34455555552 22246799999999999998 68999999987543322 35778999999999999999999
Q ss_pred ccccc----CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCC
Q 002178 687 GYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 687 ~~~~~----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~ 761 (956)
|++.+ ....++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 99866 34789999999999999999764 3588899999999999999999985 6 8899999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhH
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~ 839 (956)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~ 228 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-K 228 (283)
T ss_pred CcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-H
Confidence 999999999998653221 12357889999999976 6899999999999999999999999975432 1
Q ss_pred HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 840 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+....... .+.....|..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 229 ~~~~~i~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLIIN--------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHh--------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111100 111223455678899999999999999999999999999987753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=356.36 Aligned_cols=285 Identities=24% Similarity=0.372 Sum_probs=215.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCC-----cEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 696 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 696 (956)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 7899999988643 2234467889999999999999999999997766 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888888543 35889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........++..|+|||++.+. .++.++||||+||++|||++|+.||...... +......
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~--------- 218 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLIT--------- 218 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHH---------
Confidence 221 1112334578899999999874 5789999999999999999999999755432 2222111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
...+..+.+.......-....+...+...|....+. ...+..++.+.+|+.+||..||++|+|++|+|+|||
T Consensus 219 -~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 219 -DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY-------TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred -HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc-------ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 111222222222222223333344455555433221 122334556678999999999999999999999999
Q ss_pred cccC
Q 002178 936 VSSD 939 (956)
Q Consensus 936 f~~~ 939 (956)
|...
T Consensus 291 ~~~~ 294 (372)
T cd07853 291 LDEG 294 (372)
T ss_pred hCCC
Confidence 9763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.15 Aligned_cols=192 Identities=29% Similarity=0.405 Sum_probs=167.6
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 9999764 35888999999999999999999999 9999999999999999999999999987542211 1
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=369.97 Aligned_cols=294 Identities=22% Similarity=0.306 Sum_probs=207.8
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC------Cceeeeecccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH------RNLVSLVGYCD 690 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~ 690 (956)
++...+++|++.++||+|+||+||+|... .++.||||+++... ....++..|+++++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44456789999999999999999999964 58899999986432 223455667777777654 45889999886
Q ss_pred cC-CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCC------
Q 002178 691 EE-GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 762 (956)
Q Consensus 691 ~~-~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~------ 762 (956)
.+ ++.++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 54 5789999988 78999988654 3588999999999999999999974 7 99999999999998765
Q ss_pred ----------cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCC
Q 002178 763 ----------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832 (956)
Q Consensus 763 ----------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf 832 (956)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999876422 1123457899999999999999999999999999999999999999
Q ss_pred CCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHH-----HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002178 833 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 907 (956)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 907 (956)
........ ... +....+.+|.++... ..++....-...|...|. .+.+............++
T Consensus 346 ~~~~~~~~-~~~----------i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 412 (467)
T PTZ00284 346 DTHDNLEH-LHL----------MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK--HLARIARARPVREVIRDD 412 (467)
T ss_pred CCCChHHH-HHH----------HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHH--HHHhhhcccchhhhhchH
Confidence 76543221 111 111223334333221 111111111111111111 111111000000001234
Q ss_pred CCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 908 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 908 ~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+.|||.+||++||++|+|++|+|+||||...-.
T Consensus 413 ~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 413 LLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 5679999999999999999999999999987433
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=352.11 Aligned_cols=287 Identities=24% Similarity=0.369 Sum_probs=208.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC-----CcEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQM 696 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 696 (956)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 6899999998742 223345788999999999999999999987432 3579
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+ +++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 579999986543 4889999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...... ..
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~------~~- 222 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLI------TD- 222 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHH------HH-
Confidence 22110 111234568999999999876 67899999999999999999999999654332 111111 01
Q ss_pred ccCCCCCCChHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
..+..+.+....+... ....+.......|.. ....++..++...+++.+||..||++|||++|+|+|
T Consensus 223 ---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 ---LLGTPSPETISRVRNEKARRYLSSMRKKQPVP---------FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred ---HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc---------hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1122222222222110 000000000111110 011234445556789999999999999999999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||.+...
T Consensus 291 p~f~~~~~ 298 (338)
T cd07859 291 PYFKGLAK 298 (338)
T ss_pred chhhhcCc
Confidence 99976554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=352.49 Aligned_cols=197 Identities=30% Similarity=0.441 Sum_probs=174.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 58999999987532 223456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999654 35788899999999999999999999 99999999999999999999999999976432
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 123456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.52 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=174.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+|++.+.||+|+||+||++... +++.||+|.+...... ....+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 6899999998753322 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999987655556899999999999999999999998 9999999999999999999999999987653211
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 112345889999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.43 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=180.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHH---HHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++.....++ .+.+|+++|+.++||||+.++.+|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35677888999999999999985 57999999999876665554 467899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||..+|.|+||+.+.+ .+++.+.+.+++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999987753
Q ss_pred CCCCccccceecccccCCCcccccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
....+..+|++-|.+||++.+.+|. +.+|-||+|++||.++.|..||+..
T Consensus 206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 3456778899999999999998885 5799999999999999999999753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=348.09 Aligned_cols=289 Identities=25% Similarity=0.350 Sum_probs=197.1
Q ss_pred CCeeeeeCCeEEEEEEeC---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcEEEEEecCC
Q 002178 629 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 703 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV~e~~~ 703 (956)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 468999999999999864 468899999875432 3457789999999999999999998843 45689999999
Q ss_pred CCCHHHHHhhc-------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----cCCCcEEEEeeccc
Q 002178 704 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 772 (956)
Q Consensus 704 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DfGla 772 (956)
+++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 46898887532 1235888999999999999999999999 9999999999999 46679999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........... .+....+
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~ 234 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN-PYHHDQL 234 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc-cccHHHH
Confidence 87543211 1112234568999999999987 4588999999999999999999999964322100000 0000000
Q ss_pred hhhccCCCCCCChHHHHHHHHH------HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKL------ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l------~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
..++ ...+..+...++.+... +.. +........ .+...++ ......+..+.+++.+||++||++|+
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~---~~~~~~~~~~~dli~~mL~~dP~~R~ 306 (317)
T cd07868 235 DRIF-NVMGFPADKDWEDIKKMPEHSTLMKD-FRRNTYTNC---SLIKYME---KHKVKPDSKAFHLLQKLLTMDPIKRI 306 (317)
T ss_pred HHHH-HhcCCCChHHhHHHhhccchhhhhhh-hhccccCcc---cccchHH---hcCCCCChHHHHHHHHHhccCcccCC
Confidence 0000 01111111122211111 000 000000000 1111111 11122344567899999999999999
Q ss_pred CCccCCCCCcc
Q 002178 926 SSSSMLKHPYV 936 (956)
Q Consensus 926 sa~e~L~HP~f 936 (956)
|++|+|+||||
T Consensus 307 t~~e~l~hp~f 317 (317)
T cd07868 307 TSEQAMQDPYF 317 (317)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.16 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=167.4
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||+||++... +++.||+|.+...... ..+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 6899999998753322 224677899999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 002178 708 RDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 708 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9887542 3346899999999999999999999998 9999999999999999999999999997654221
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=348.10 Aligned_cols=234 Identities=23% Similarity=0.283 Sum_probs=187.6
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.||+|+||.||++... +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999964 68999999987532 223346778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------
Confidence 9999886543 5889999999999999999999999 9999999999999999999999999987532111
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChH
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 865 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... . .....+|..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~---------~-~~~~~~p~~ 217 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELI---------L-MEEIRFPRT 217 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH---------h-cCCCCCCCC
Confidence 112335689999999999999999999999999999999999999975432211 1110 0 011123444
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 002178 866 CVEKFIKLALKCCQDETDARP 886 (956)
Q Consensus 866 ~~~~l~~l~~~c~~~~p~~RP 886 (956)
.+..+.+++.+|++.+|.+|+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhC
Confidence 556667777777777777776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.84 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=216.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhcC-CCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 696 (956)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+....... ...+.+|+++|+++. ||||+.+++.|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999976 49999999998655433 358899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC----CcEEEEeeccc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLS 772 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DfGla 772 (956)
+|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||+|
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999776 2899999999999999999999999 9999999999999643 57999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... .......+||+.|+|||++....|+..+||||.|+++|.|++|..||..........
T Consensus 187 ~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------- 248 (382)
T KOG0032|consen 187 KFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------- 248 (382)
T ss_pred eEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence 87653 234567789999999999999999999999999999999999999997654322211
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
.+..+.+ ...++ .++.....+.+|++.||..||.+|+|++++|+
T Consensus 249 ~i~~~~~----------------------~f~~~--------------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 AILRGDF----------------------DFTSE--------------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHcCCC----------------------CCCCC--------------CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111 00111 12233445568999999999999999999999
Q ss_pred CCccccCCCCC
Q 002178 933 HPYVSSDVSGS 943 (956)
Q Consensus 933 HP~f~~~~~~~ 943 (956)
|||+++....+
T Consensus 293 HpWi~~~~~~~ 303 (382)
T KOG0032|consen 293 HPWIKSIGEAT 303 (382)
T ss_pred CccccCCcccc
Confidence 99998875543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.15 Aligned_cols=240 Identities=24% Similarity=0.302 Sum_probs=191.4
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 68999999987532 223457788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 999988654 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChH
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 865 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +......+|..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~----------~~~~~~~~p~~ 217 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFEL----------ILMEDIKFPRT 217 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHH----------hccCCccCCCC
Confidence 11123356899999999999999999999999999999999999999754321 11111 11111233445
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 002178 866 CVEKFIKLALKCCQDETDARP-----SMSEVM 892 (956)
Q Consensus 866 ~~~~l~~l~~~c~~~~p~~RP-----s~~~v~ 892 (956)
.+..+.+++.+|++.+|.+|+ ++.+++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 556677777777777777775 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=359.39 Aligned_cols=286 Identities=22% Similarity=0.257 Sum_probs=206.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
...+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3567999999999999999999975 588999996432 245689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
++ .++|.+++.... ..+++..++.|+.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99 579999886543 36899999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch------hHHHHHHHhhcccchhh
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNIAYQSSMMFSV 854 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~------~~~~~~~~~~~~~~~~~ 854 (956)
........||..|+|||++.+..++.++|||||||++|||++|..|+..... ...+......... .
T Consensus 316 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~---~ 387 (461)
T PHA03211 316 -----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ---V 387 (461)
T ss_pred -----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc---c
Confidence 1112345699999999999999999999999999999999998877653221 0111111110000 0
Q ss_pred ccCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 855 IDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 855 ~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
........ .......+.... ......+..|+.... +...+....+|+.+||++||++|||++|+|+|
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRA-ARNRRPAYTRPAWTR-----------YYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccCCCCcchHHHHHHHhhh-hcccCCccCCcchhh-----------hccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00001111 111111111110 001111111111111 11223456689999999999999999999999
Q ss_pred Ccccc
Q 002178 934 PYVSS 938 (956)
Q Consensus 934 P~f~~ 938 (956)
|||.+
T Consensus 456 p~f~~ 460 (461)
T PHA03211 456 PLFQS 460 (461)
T ss_pred cccCC
Confidence 99975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.14 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=219.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCc-EEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-QMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~LV~ 699 (956)
++|...+.+|+|+||.++..+.+ +++.+|+|.+..... .......+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998865 678999998875433 234577899999999999999999999999988 99999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
+|++||++.+.+.++....+++..+.+++.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.....+
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999887778999999999999999999999888 9999999999999999999999999999876543
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.....+.||+.|+.||.+.+.+|..|+||||+||++|||++-+++|...+ ....+. ++.....
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li~---------ki~~~~~ 223 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELIL---------KINRGLY 223 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-hHHHHH---------HHhhccC
Confidence 23456789999999999999999999999999999999999999996443 333222 2233334
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.+.|..+..++..++..|++.+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 56788999999999999999999999999999976
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.59 Aligned_cols=287 Identities=22% Similarity=0.345 Sum_probs=211.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|.+.+.||+|+||+||+|..+ +++.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999965 688999999875432 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 96 58988886543 34788889999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...... .. .+
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~------~~----~~ 222 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIF------RL----LG 222 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH------HH----hC
Confidence 11223457889999999865 56889999999999999999999999754332 1111110 00 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
..+.+.+..+.......-...|..+|.. .....+..+....+++.+||..||++|+|++|+|+||||+.-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQP---------LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCc---------hhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 1112222111111000001112111111 1122233455667899999999999999999999999998755
Q ss_pred CC
Q 002178 941 SG 942 (956)
Q Consensus 941 ~~ 942 (956)
..
T Consensus 294 ~~ 295 (309)
T cd07872 294 TR 295 (309)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.36 Aligned_cols=290 Identities=22% Similarity=0.313 Sum_probs=212.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCC-----
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 693 (956)
..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 6899999998643 2233467889999999999999999999885433
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 694 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 694 -~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
..++||||++ ++|.+.++. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 5799999995 567776643 3778888999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+....+... .
T Consensus 171 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~------ 235 (359)
T cd07876 171 RTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV-I------ 235 (359)
T ss_pred cccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H------
Confidence 754321 1123346889999999999999999999999999999999999999765433222111 0
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHH--HhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELE--SIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~--~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
...+..+.+....+...........|..+. +..+...... .........+....+|+.+||..||++|+|++|
T Consensus 236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 236 ----EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred ----HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 112233344444444433333333333221 2222111000 000000112344578999999999999999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
+|+||||..
T Consensus 312 ~l~hp~~~~ 320 (359)
T cd07876 312 ALRHPYITV 320 (359)
T ss_pred HhcCchhhh
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=339.35 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC-----------------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 684 (956)
.++|.+.++||+|+||.||+|.+++ +..||+|.+.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578889999999999999998532 3479999987643 334567999999999999999999
Q ss_pred eecccccCCcEEEEEecCCCCCHHHHHhhcC-----------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEe
Q 002178 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (956)
Q Consensus 685 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 747 (956)
+++++.+.+..++||||+++|+|.+++.... ...+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986432 124678889999999999999999999 99
Q ss_pred ccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh
Q 002178 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (956)
Q Consensus 748 H~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt 827 (956)
||||||+|||++.++.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999976533221 111223345788999999998899999999999999999997
Q ss_pred --CCCCCCCCchhH--HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 828 --GMQPISHGKNIV--REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 828 --g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+..||....... ......+. ..........+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFR-----DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhh-----hccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 556675432211 11111100 00001112234456778999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=355.39 Aligned_cols=208 Identities=26% Similarity=0.377 Sum_probs=175.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999965 68999999987532 222356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997643 5899999999999999999999999 9999999999999999999999999987643211
Q ss_pred CCCccc-------------------------------cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhC
Q 002178 780 IEGIVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828 (956)
Q Consensus 780 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg 828 (956)
...... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000000 0011124699999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 002178 829 MQPISHGK 836 (956)
Q Consensus 829 ~~pf~~~~ 836 (956)
+.||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=349.73 Aligned_cols=205 Identities=22% Similarity=0.317 Sum_probs=174.9
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
....++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344678999999999999999999975 58899999986421 22334678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999653 3788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 193 ~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 193 DETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 3221 11123456999999999997643 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.30 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=213.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccC-----Cc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 694 (956)
+..++|.+.+.+|+|||+-||.++ ..+++.+|+|++.....+..+..++|++..++++||||++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 346789999999999999999999 568899999999887878888999999999999999999999997433 35
Q ss_pred EEEEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
.||+++|+..|||.+.+... .+..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999763 3446999999999999999999999986 68999999999999999999999999999
Q ss_pred cccCCCCCCCc--cccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 773 RLAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 773 ~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
+...-.-.... ..-+.-.....|..|+|||.+.- ...++++|||||||++|+|+.|..||+.... ..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------~G 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------QG 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------cC
Confidence 76542211100 00011134468899999999964 5678899999999999999999999963211 00
Q ss_pred cccchhhccCCCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 848 SSMMFSVIDGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 848 ~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
......+..+... +-...+++.+.++++.|++.||.+||+..+++..+++.
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111122222211 11122789999999999999999999999999887653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=349.52 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=206.4
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
...++|++.+.||+|+||+||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456788899999999999999973 236689999987533 33346788999999999 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 715 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 715 (956)
+..++||||+++|+|.++++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986532
Q ss_pred ----------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 716 ----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 716 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 124778889999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. ........++..|+|||++.+..++.++|||||||++|||++ |..||............ . ..+.
T Consensus 269 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-~--------~~~~ 334 (375)
T cd05104 269 N-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-I--------KEGY 334 (375)
T ss_pred c-----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-H--------HhCc
Confidence 1 011122335678999999999999999999999999999998 88888653322111111 1 1111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
....+...+.++.+++.+||+.+|++||++.++++.|++
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 112233445789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.46 Aligned_cols=195 Identities=27% Similarity=0.414 Sum_probs=167.5
Q ss_pred CeeeeeCCeEEEEEEe----CCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999999875321 2234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999997643 4778888899999999999999999 9999999999999999999999999987532211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 11233568999999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.94 Aligned_cols=199 Identities=27% Similarity=0.346 Sum_probs=169.5
Q ss_pred CCCCCCeeeeeCCeEEEEEEe----CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
+|++.+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+++++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 258899999986422 12234678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999654 34888999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 156 LSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 1112345689999999999875 478899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.55 Aligned_cols=250 Identities=37% Similarity=0.594 Sum_probs=200.6
Q ss_pred CCCeeeeeCCeEEEEEEeC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 628 SSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999976 25789999997643 33467899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.++++......+++..+..|+.||++||+|||+++ ++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 99999999998876677999999999999999999999998 9999999999999999999999999998763221
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.........+...|+|||.+....++.++||||||+++|||++ |+.||..... .+.... +.++...
T Consensus 158 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~---------~~~~~~~ 224 (259)
T PF07714_consen 158 ---KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEK---------LKQGQRL 224 (259)
T ss_dssp ---SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHH---------HHTTEET
T ss_pred ---cccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc---------ccccccc
Confidence 1122233456778999999999999999999999999999999 6788865432 221111 1222233
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
..+..++..+.+++..||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 45666788899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.57 Aligned_cols=194 Identities=27% Similarity=0.420 Sum_probs=166.5
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|..+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 68999999987532 12234667788888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----- 150 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----- 150 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-----
Confidence 99999987643 4888999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 1123456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.44 Aligned_cols=204 Identities=23% Similarity=0.318 Sum_probs=173.2
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
...++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999965 68999999986422 222345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998653 3677888889999999999999999 9999999999999999999999999997653
Q ss_pred CCCCCCccccceecccccCCCcccccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 194 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 221 1112345699999999998753 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=339.33 Aligned_cols=264 Identities=30% Similarity=0.505 Sum_probs=225.1
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
+++++....+....++||.|.||.||.|.|+. .-.||||.++.+.+. ..+|+.|+.+|+.++|||+|+++|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35666666777788999999999999999874 678999999986655 4589999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
+|||+|||..|+|.+||++..+..++....+.+|.||+.|++||..++ +|||||.++|+|+.++..|||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999988888888889999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
+..+.+.. + ....-.+-|.|||-+....++.|+|||+|||+|||+.| |..||...+ ..+ .+.
T Consensus 415 MtgDTYTA----H--AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSq----------VY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTA----H--AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ----------VYG 477 (1157)
T ss_pred hcCCceec----c--cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHH----------HHH
Confidence 86443221 1 11223467999999999999999999999999999999 778886432 211 122
Q ss_pred hcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 854 VID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 854 ~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+++ +.+..-|+.|++.++++|..||++.|.+||+++++-+.+|.++.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 222 33456689999999999999999999999999999999987654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=351.48 Aligned_cols=208 Identities=25% Similarity=0.338 Sum_probs=173.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 68999999886432 222356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999654 35788889999999999999999999 9999999999999999999999999996432110
Q ss_pred CC----------Cccc------------------------------cceecccccCCCcccccccccCCCCCcccchhHH
Q 002178 780 IE----------GIVP------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 819 (956)
Q Consensus 780 ~~----------~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G 819 (956)
.. .... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 0000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCc
Q 002178 820 VVFLELLTGMQPISHGK 836 (956)
Q Consensus 820 ~ll~elltg~~pf~~~~ 836 (956)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (377)
T cd05629 236 AIMFECLIGWPPFCSEN 252 (377)
T ss_pred hhhhhhhcCCCCCCCCC
Confidence 99999999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.99 Aligned_cols=208 Identities=26% Similarity=0.369 Sum_probs=175.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 689999999875322 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999764 35889999999999999999999999 9999999999999999999999999997643211
Q ss_pred CCCc----------------------------cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 002178 780 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (956)
Q Consensus 780 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~p 831 (956)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000011235799999999999999999999999999999999999999
Q ss_pred CCCCc
Q 002178 832 ISHGK 836 (956)
Q Consensus 832 f~~~~ 836 (956)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=332.70 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999853 367899999886433 334578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 46889999999999999999999998 99999999999999999999999998765321
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ........++..|+|||++.+..++.++|||||||++||+++ |+.||....... ... .+.+
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~---------~~~~ 223 (266)
T cd05064 160 EA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIK---------AVED 223 (266)
T ss_pred cc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH---------HHHC
Confidence 11 011112335678999999999999999999999999999775 999997543221 111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+...+.+..++..+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 222344666788899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=348.68 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=208.6
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccc
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 690 (956)
+....++|++.+.||+|+||.||+|.+. ++..||+|+++... ......+.+|+++++.+ +|+||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3445568999999999999999998842 24579999997543 33345788999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC-------------------------------------------------------
Q 002178 691 EEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 715 (956)
Q Consensus 691 ~~~~~~LV~e~~~~gsL~~~l~~~~------------------------------------------------------- 715 (956)
..+..++||||+++|+|.++++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999986421
Q ss_pred -------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 716 -------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 716 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
..++++..+++++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--
Confidence 124778889999999999999999998 99999999999999999999999999976532210
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
........++..|+|||++.+..++.++|||||||++|||++ |+.||............. ..+....
T Consensus 268 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---------~~~~~~~ 335 (374)
T cd05106 268 ---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---------KRGYQMS 335 (374)
T ss_pred ---eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---------HcccCcc
Confidence 111122335678999999999999999999999999999997 999996533211111110 0111112
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.+...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23344678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.62 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=177.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +++.||+|+++.... .....+.+|+++++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999975 689999999875321 23457888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 45889999999999999999999998 9999999999999999999999999997654322
Q ss_pred CC----------------------CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IE----------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000112234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=351.95 Aligned_cols=207 Identities=22% Similarity=0.317 Sum_probs=173.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.|+..+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999864 689999999875322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997643 4788889999999999999999999 99999999999999999999999999864321100
Q ss_pred CCc----------------------------------------cccceecccccCCCcccccccccCCCCCcccchhHHH
Q 002178 781 EGI----------------------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 820 (956)
Q Consensus 781 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ 820 (956)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 002178 821 VFLELLTGMQPISHGK 836 (956)
Q Consensus 821 ll~elltg~~pf~~~~ 836 (956)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.40 Aligned_cols=234 Identities=24% Similarity=0.286 Sum_probs=183.4
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 68999999987532 223356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 999988654 358899999999999999999997 67 9999999999999999999999999987532111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +......+|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~----------i~~~~~~~p~ 217 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFEL----------ILMEEIRFPR 217 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHH----------HhcCCCCCCC
Confidence 1123346899999999999999999999999999999999999999754321 11111 1111112333
Q ss_pred HHHHHHHHHHHHhcccCCCCCC
Q 002178 865 ECVEKFIKLALKCCQDETDARP 886 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RP 886 (956)
..+..+.+++.+|++.+|++|+
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhC
Confidence 3444555566666666666664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=348.84 Aligned_cols=290 Identities=20% Similarity=0.293 Sum_probs=212.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC------
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 692 (956)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999965 68899999987532 23346788999999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 578887743 3778889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+...
T Consensus 174 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~-------- 237 (364)
T cd07875 174 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV-------- 237 (364)
T ss_pred cccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 765321 1123346899999999999999999999999999999999999999765443222111
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHH-HHhH-hhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMREL-ESIW-NMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L-~~~~-~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
+. ..+....+....+...+.......|... ..+.++.... .... .........+.+||.+||+.||++|+|++|
T Consensus 238 --~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 238 --IE-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred --HH-hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 11 1222233444444444333333322221 1222111110 0000 000112334578999999999999999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
+|+||||..
T Consensus 315 ~L~hp~~~~ 323 (364)
T cd07875 315 ALQHPYINV 323 (364)
T ss_pred HhcCccccc
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.70 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=213.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
...|...++||+|.||.||+|.+. .++.||+|++.-.... ...++.+|+.++...+++||.++||.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 456777899999999999999964 6899999999865433 34688899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||.||++.+.++.. ..+.+..+..|.+++..||.|||.++ .+|||||+.|||+..+|.+|++|||.+.......
T Consensus 92 y~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999999653 33577888889999999999999999 9999999999999999999999999997765332
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..... ...++.+.....+
T Consensus 166 ------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 ------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------MRVLFLIPKSAPP 229 (467)
T ss_pred ------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------ceEEEeccCCCCC
Confidence 223567899999999999999999999999999999999999999975443 2233333344445
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.....++..+.+++..|++++|+.||++.++++.
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 5556788899999999999999999999998853
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=330.66 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3467889999999999999999988888999998875433 356889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.++++......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999998765567889999999999999999999998 99999999999999999999999999986542211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||........ ... .. .....
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-~~~-~~--------~~~~~ 223 (261)
T cd05072 159 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-MSA-LQ--------RGYRM 223 (261)
T ss_pred -----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-HHH-HH--------cCCCC
Confidence 11122345678999999998889999999999999999998 9999865432211 111 11 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
+.+..++..+.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.11 Aligned_cols=192 Identities=26% Similarity=0.389 Sum_probs=166.1
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 22335677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----- 150 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----- 150 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----
Confidence 9999988654 35889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~ 833 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 11234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.24 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=166.8
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 689999999875322 2234678899999988 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999988654 35899999999999999999999999 999999999999999999999999998742211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~ 833 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 112234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=352.65 Aligned_cols=207 Identities=22% Similarity=0.301 Sum_probs=173.3
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+|+..++||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 68999999987532 2234578889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999764 34788888999999999999999999 99999999999999999999999999854321100
Q ss_pred CC----------------------------------------ccccceecccccCCCcccccccccCCCCCcccchhHHH
Q 002178 781 EG----------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 820 (956)
Q Consensus 781 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ 820 (956)
.. ...........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 002178 821 VFLELLTGMQPISHGK 836 (956)
Q Consensus 821 ll~elltg~~pf~~~~ 836 (956)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=291.78 Aligned_cols=284 Identities=25% Similarity=0.404 Sum_probs=219.4
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|...++||+|.||+||||+. .+++.||+|++.... ........+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999994 568999999887433 22346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
| ..+|..+...-+ ..++.+.++.++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+|+-+..+
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9 579998886543 35888899999999999999999999 999999999999999999999999999976532
Q ss_pred CccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.........|..|++|.++.+.+ |+.+.|+||-||++.|+.....|.+.+.+..++....+.. ++
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~----------lg 220 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL----------LG 220 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH----------hC
Confidence 34455667889999999998854 8899999999999999999777777777777776655432 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
...++.++.+.++ +|..--|.+... ..+.+..|.......|+++++|.-+|..|++|+++|+||||+...
T Consensus 221 ~p~ed~wps~t~l------pdyk~yp~ypat----tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 221 TPTEDQWPSMTKL------PDYKPYPIYPAT----TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCccccCCccccC------CCCcccCCcccc----chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 1222222222221 111111211111 112223344445566899999999999999999999999997643
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=342.21 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=170.5
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCC-CceeeeecccccCCcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~ 699 (956)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.++++.+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 57899999987532 2234567889999999976 56888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999996543 4788899999999999999999998 9999999999999999999999999987432111
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 156 -------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred -------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.45 Aligned_cols=289 Identities=20% Similarity=0.291 Sum_probs=202.8
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
....+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999975 5789999975432 2346899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+ .++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred Ecc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 999 57999988654 346899999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhH-HHHHHHhhcccchhhcc--
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQSSMMFSVID-- 856 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-- 856 (956)
.......||..|+|||++.+..++.++|||||||++|||+++..++....... ...... ....+..++.
T Consensus 211 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~-~~~~l~~~~~~~ 282 (357)
T PHA03209 211 -------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS-CHSHLLKIISTL 282 (357)
T ss_pred -------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHH-HHHHHHHHHHHh
Confidence 11233568999999999999999999999999999999999766654322111 000000 0000011110
Q ss_pred -CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 857 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 857 -~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.....++.+.... +....+......|..... ...++. ........++|.+||+.||++||||+|+|+|||
T Consensus 283 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 283 KVHPEEFPRDPGSR---LVRGFIEYASLERQPYTR-YPCFQR-----VNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred ccChhhcCCCCccH---HHHHHHhhcccCCCcccc-cHHHhc-----cCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 0000111000000 011111111111111100 000110 122334457999999999999999999999999
Q ss_pred ccc
Q 002178 936 VSS 938 (956)
Q Consensus 936 f~~ 938 (956)
|+.
T Consensus 354 f~~ 356 (357)
T PHA03209 354 FAQ 356 (357)
T ss_pred hcc
Confidence 975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=354.83 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=217.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCC-cEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecc-cc----c--C
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY-CD----E--E 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~----~--~ 692 (956)
...++++.+.|.+|||+.||.|.+..+ ..||+|++...+....+.+.+|+++|+.|+ |+|||.+++. .. . .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667788999999999999997765 999999988777777889999999999997 9999999993 21 1 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
-+.+|.||||+||.|-|++..+-...|++.++++|+.|+++|+++||.. ++||||||||-+|||++.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3789999999999999999876555699999999999999999999987 588999999999999999999999999998
Q ss_pred cccCCCCC--CCccccceecccccCCCccccccc---ccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 773 RLAPVPDI--EGIVPAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 773 ~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
.-...... .+..--...-...-|+.|+|||.+ .+...++|+||||+||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 64322110 000000111233578999999987 467899999999999999999999999986532
Q ss_pred cccchhhccCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 848 SSMMFSVIDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
..++.+..... .+.++..+..+|..|++.+|.+||++-+|+..+.++.+.
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 24555554433 368999999999999999999999999999999887664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.76 Aligned_cols=256 Identities=30% Similarity=0.531 Sum_probs=209.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++|++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799999875432 33467899999999999999999999999889999
Q ss_pred EEEecCCCCCHHHHHhhcCC--------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC
Q 002178 697 LVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 762 (956)
++|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975421 45788899999999999999999999 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHH
Q 002178 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 841 (956)
Q Consensus 763 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~ 841 (956)
.+||+|||+++.....+. ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976532221 111223346788999999998899999999999999999998 9999875432 111
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 842 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
.. .+..+.....+..++.++.+++.+||+.+|.+||++.++.+.|+.
T Consensus 236 ~~---------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IE---------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH---------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 112223334567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.61 Aligned_cols=203 Identities=26% Similarity=0.349 Sum_probs=174.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 689999999875322 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999764 235889999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCccccceecccccCCCcccccccc------cCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11223346899999999987 4567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=347.18 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=195.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999965 689999999865432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 999986532 2456778889999999999999999 9999999999999999999999999998653221
Q ss_pred ccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... .++.
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~--------------- 282 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWA--------------- 282 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHH---------------
Confidence 11233468999999998743 2345689999999999999999999963211 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
..... .+....+. .| ........+|+.+||..||++|++++|+++||||.
T Consensus 283 ----------~~~~~---~~~~~~~~-~~----------------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 283 ----------SLMCA---ICMSQPPE-AP----------------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred ----------HHHHH---HhccCCCC-CC----------------CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 00000 00011111 00 01122234678888999999999999999999998
Q ss_pred cCCCC
Q 002178 938 SDVSG 942 (956)
Q Consensus 938 ~~~~~ 942 (956)
.....
T Consensus 333 ~~~~~ 337 (353)
T PLN00034 333 RAQPG 337 (353)
T ss_pred cCCcc
Confidence 87654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.50 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=205.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 46788899999999999999988888999998875432 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 999999997543 35889999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +.... +..+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~---------i~~~~~~~~ 222 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEM---------ISRGFRLYR 222 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH---------HHCCCCCCC
Confidence 11122235568999999998889999999999999999999 88898654432 11111 111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 444567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.46 Aligned_cols=239 Identities=24% Similarity=0.384 Sum_probs=188.5
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHH---HhcCCCceeeeecccccCCcEEEE
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFL---SRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999965 68999999987532 12234566666554 567899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|..+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +.... +.. .
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~---------i~~-~ 216 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDS---------IVN-D 216 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-C
Confidence 11223456899999999999999999999999999999999999999754321 11111 111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSM 888 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 888 (956)
...+|...+..+.+++.+|++.+|.+||++
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 122344455667777777777777777743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.89 Aligned_cols=277 Identities=25% Similarity=0.380 Sum_probs=201.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhc---CCCceeeeeccccc-----CC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE-----EG 693 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 693 (956)
+|++.+.||+|+||+||+|... +++.||+|.++..... ....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 6899999988753221 223556677776665 69999999998754 34
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 59999997765556899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~------ 221 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFD------ 221 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHH------
Confidence 654221 12234578899999999998999999999999999999999999865433221 111110
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
.... ......+.. ........ .+..... +....++.+....+++.+||..||++|+|++|++.|
T Consensus 222 ~~~~---~~~~~~~~~-~~~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 222 LIGL---PPEDDWPRD-VTLPRGAF--SPRGPRP----------VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HhCC---CChhhCccc-cccccccc--CCCCCCc----------hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000 00000000 0100001 112223344455689999999999999999999999
Q ss_pred Ccc
Q 002178 934 PYV 936 (956)
Q Consensus 934 P~f 936 (956)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=355.32 Aligned_cols=279 Identities=22% Similarity=0.337 Sum_probs=200.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccC--------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~ 693 (956)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999964 68999999886432 2345799999999999999998876321 2
Q ss_pred cEEEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeec
Q 002178 694 EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFG 770 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfG 770 (956)
..++||||++ ++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999996 588887753 23456889999999999999999999999 99999999999999665 79999999
Q ss_pred cccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 217 la~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~---- 284 (440)
T PTZ00036 217 SAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII---- 284 (440)
T ss_pred cchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----
Confidence 998654221 1223468999999999876 468999999999999999999999997554322211110
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCccccccccCCCCCCCCCCc
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
.. .+..+.+....+..-.. -. .-|...+ . .+...+|. ....+.+|+.+||++||++|+|+.
T Consensus 285 ---~~----~~~p~~~~~~~~~~~~~-~~-~~~~~~~--~-------~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 285 ---QV----LGTPTEDQLKEMNPNYA-DI-KFPDVKP--K-------DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred ---HH----hCCCCHHHHHHhchhhh-cc-cCCccCc--h-------hHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 11111111111000000 00 0011010 0 11112232 344567999999999999999999
Q ss_pred cCCCCCccccC
Q 002178 929 SMLKHPYVSSD 939 (956)
Q Consensus 929 e~L~HP~f~~~ 939 (956)
|+|+||||..-
T Consensus 347 e~l~hp~f~~~ 357 (440)
T PTZ00036 347 EALADPFFDDL 357 (440)
T ss_pred HHhCChhHHhh
Confidence 99999999654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=330.51 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=215.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
...+|++.+.||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999888999999999876665567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 99999999998766667899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .... +..+...
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~---------~~~~~~~ 223 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQ---------ITAGYRM 223 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHH---------HHhCCcC
Confidence 11123345678999999998899999999999999999998 888986543211 1111 1112223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..+..+++.+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 3456677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=351.04 Aligned_cols=287 Identities=20% Similarity=0.234 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..+|++.+.||+|+||.||+|... .++.||+|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3678999987643 24567999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|++ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999 4789998843 346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh--HHHHHHHhhcccchhhccC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 857 (956)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ..+..
T Consensus 240 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~------~~~~~ 308 (392)
T PHA03207 240 D-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII------RCMQV 308 (392)
T ss_pred c-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH------HHhcc
Confidence 1 11223456999999999999999999999999999999999999999754321 11111100 00000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
....++......+.+-. -+.....||...- -..+.. ...+....++|.+||++||++|+|++|+|.||||.
T Consensus 309 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHF---KQYAIVLRPPYTI-PPVIRK-----YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred CccccCCccchhHHHHH---HhhcccccCCccc-cchhhc-----cCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 01111211111111111 1112222332110 000000 01123445789999999999999999999999997
Q ss_pred cCC
Q 002178 938 SDV 940 (956)
Q Consensus 938 ~~~ 940 (956)
...
T Consensus 380 ~~~ 382 (392)
T PHA03207 380 KEP 382 (392)
T ss_pred ccc
Confidence 643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.65 Aligned_cols=195 Identities=26% Similarity=0.400 Sum_probs=167.0
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 58899999987532 22234567888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 99999986543 4788899999999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.53 Aligned_cols=209 Identities=22% Similarity=0.301 Sum_probs=177.4
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
..+.....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455566789999999999999999999975 68899999986422 2223467889999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998653 3778888899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 189 a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 189 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 98654221 1112345699999999998754 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.29 Aligned_cols=208 Identities=23% Similarity=0.317 Sum_probs=173.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.+|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 689999999864321 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997643 4788888899999999999999999 9999999999999999999999999985332100
Q ss_pred CCC------------------------------------ccccceecccccCCCcccccccccCCCCCcccchhHHHHHH
Q 002178 780 IEG------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 823 (956)
Q Consensus 780 ~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ 823 (956)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCc
Q 002178 824 ELLTGMQPISHGK 836 (956)
Q Consensus 824 elltg~~pf~~~~ 836 (956)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=342.85 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=209.1
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcC-CCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 692 (956)
...++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34568889999999999999999853 134799999975433 33467899999999996 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 715 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 715 (956)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999886531
Q ss_pred -------------------------------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 716 -------------------------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 716 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
...+++..+..++.|+++||+|||+.+ |+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124778888999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~ 837 (956)
+.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred eCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999986532211 111122346788999999999999999999999999999997 8899865322
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
...... .+..+.....+..++..+.+++.+||+.+|++||++.++.+.|++..
T Consensus 346 ~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 346 DSTFYN---------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hHHHHH---------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111 11111222345567788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=345.10 Aligned_cols=292 Identities=20% Similarity=0.272 Sum_probs=210.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC-----
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 692 (956)
...++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 68999999987532 23346778899999999999999999987543
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 693 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
...++||||++ ++|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999995 577777743 3778889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+....
T Consensus 166 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------ 231 (355)
T cd07874 166 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI------ 231 (355)
T ss_pred cccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence 9764321 11233468999999999999999999999999999999999999997654332221111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHH-HHHHHhHh-hCCCCCCCCccccccccCCCCCCCCCCc
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVM-RELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~-~~L~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
. ..+....+....+......+....|... ..+.... +.+..... ..........+++.+||..||++|||++
T Consensus 232 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 232 ----E-QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred ----H-HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 0 1122223333333333333332222110 0100000 00000000 0011123446899999999999999999
Q ss_pred cCCCCCccccC
Q 002178 929 SMLKHPYVSSD 939 (956)
Q Consensus 929 e~L~HP~f~~~ 939 (956)
|+|+||||..-
T Consensus 307 ell~hp~~~~~ 317 (355)
T cd07874 307 EALQHPYINVW 317 (355)
T ss_pred HHhcCcchhcc
Confidence 99999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.61 Aligned_cols=268 Identities=26% Similarity=0.390 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeeecccccCC----cEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG----EQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~L 697 (956)
...+..+.||+|.||.||||.+. ++.||||++.. +..+.|.+|-++++. ++|+||++|+++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455778999999999999985 49999999974 344578888887776 57999999999876555 8999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc------CCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------ADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
|+||.+.|+|.+||..+ .++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999764 489999999999999999999975 367899999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCC-CC-----CcccchhHHHHHHHHHhCCCCCCCC--ch----hH
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-----DKSDVYSLGVVFLELLTGMQPISHG--KN----IV 839 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDVwS~G~ll~elltg~~pf~~~--~~----~~ 839 (956)
|..+..... ........||.+|||||++.+.. +. .+.||||+|.++|||+++...+..+ .+ ..
T Consensus 363 Al~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 363 ALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 988864432 22233478999999999997643 22 3689999999999999976655321 00 00
Q ss_pred HHHHHHhhcccchhh--ccCCCCCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 840 REVNIAYQSSMMFSV--IDGNMGSYPSE-----CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 840 ~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
..+...-..+.+.+. -+..++.+|+. ....+.+.+..||..|++.|-|+.=+.+++..+....+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 000000000111111 12334445543 35678899999999999999999988888877654443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.90 Aligned_cols=280 Identities=20% Similarity=0.295 Sum_probs=209.2
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHh-cCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58899999987532 1223445667776665 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999997643 4888899999999999999999998 9999999999999999999999999997543211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +....+.+|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~----------i~~~~~~~~~ 217 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDS----------ILNDRPHFPR 217 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHH----------HHcCCCCCCC
Confidence 122345689999999999999999999999999999999999999975433 111111 1112234455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~-~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
..+..+.+++.+|++.+|.+||++. ++.+. . + +...+ .+.+.+ -...|.-++.......+++|.....
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h-~-~---~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQH-P-F---FRGID---WERLEK-REIPPPFKPKVKSPSDASNFDREFT 286 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcC-c-c---cCCCC---HHHHHh-CCCCCCcCCCCCCcchhhhcCcccc
Confidence 5667788999999999999999875 33221 0 0 00000 001111 1234555666777777888754443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.08 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=210.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4567889999999999999999987788999999875433 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997655556899999999999999999999998 99999999999999999999999999987642211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
........+..|+|||++.+..++.++||||||+++|||++ |+.||........ ... +......
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~---------~~~~~~~ 223 (261)
T cd05068 159 -----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQ---------VDQGYRM 223 (261)
T ss_pred -----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHH---------HHcCCCC
Confidence 01111223457999999999999999999999999999999 9988865432111 111 1111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..+..++..+.+++.+|++.+|.+||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3345567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.55 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998633 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 696 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++||||+++++|.+++...+ ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 235788999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VI 234 (280)
T ss_pred EEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HH
Confidence 99999999975432211 011123345678999999999999999999999999999998 999987543321 11
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
. .+..+.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 235 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 E---------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11122233345567788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=333.66 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=222.9
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeCC---C--cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILPD---G--TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
.....+.....++||.|-||.||+|.+.+ | -.||||..+.+ .....+.|..|..+|+.++||||++++|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 33444555567899999999999999532 2 36899998874 344567899999999999999999999999864
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
..++|||.++-|.|+.|++.+ +..++......++.||+.||+|||+.. +|||||..+|||+.+...||++|||++
T Consensus 464 -P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred -ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 789999999999999999765 456888999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+......++.. +...-..-|||||.+.-.+++.++|||.|||++||++. |..||+...+ .+.+
T Consensus 539 R~~ed~~yYka------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI 602 (974)
T KOG4257|consen 539 RYLEDDAYYKA------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVI 602 (974)
T ss_pred hhccccchhhc------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceE
Confidence 99876554321 22234567999999999999999999999999999998 9999986543 2345
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+-.+.+.+.|+.|++.++.++.+||..+|.+||.+.++...|.++..
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 5566678889999999999999999999999999999999999988865
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.88 Aligned_cols=260 Identities=29% Similarity=0.510 Sum_probs=213.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 356799999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 234789999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
+||+|||++........ ........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999976532211 111223446788999999999999999999999999999999 999986544321 11
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.. +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 236 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 EC---------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HH---------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 112222233445667899999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=354.50 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=207.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-C-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 4 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 703 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 703 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
++|+|.++++.. ...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999988642 3446889999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... .+..+...
T Consensus 224 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~---------~~~~~~~~ 289 (478)
T PTZ00267 224 ----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQ---------QVLYGKYD 289 (478)
T ss_pred ----ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHHhCCCC
Confidence 111233456999999999999999999999999999999999999999754321 1111 12222333
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
..+..++..+.+++..|+..+|++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 445566778999999999999999999998864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.48 Aligned_cols=279 Identities=23% Similarity=0.335 Sum_probs=208.7
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHh-cCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +++.||+|+++... ....+.+..|..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999987532 1223456677787776 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 9999999754 34788889999999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... +.... +......+|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~----------i~~~~~~~~~ 217 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQS----------IRMDNPCYPR 217 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHH----------HHhCCCCCCc
Confidence 1123456899999999999999999999999999999999999999754321 11111 0111122344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~-~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
.....+.+++.+|++.+|.+||++. ++.+. ..+.+.+ ...+. ...++|.-++...+...+.||....
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h-----~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQH-----PFFREID---WSALE-EREIEPPFKPKVKSANDCSNFDKEF 285 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcC-----cccCCCC---HHHHH-hCCCCCCcCCCCCCccchhhcChhh
Confidence 4566778888888888888888886 33211 0111110 01111 1245566777888888888875544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.05 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=210.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.+|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999965 58899999987543 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997766667899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..... .......
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~---------~~~~~~~ 225 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL---------EKGYRME 225 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH---------HCCCCCC
Confidence 11112234568999999999999999999999999999998 8888865332 2221111 1111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+..++..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4556678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.09 Aligned_cols=261 Identities=30% Similarity=0.493 Sum_probs=212.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|.+.+.||+|+||+||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45788899999999999999984 235679999988766566678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 697 LVYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 234899999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~ 844 (956)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...... +....
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIEC 234 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 999999976532211 111122335678999999999899999999999999999998 88888654321 11111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
+..+.....+..++..+.+++.+||+.+|.+||++.++.+.|+++.+.
T Consensus 235 ---------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ---------ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111122223344567799999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.51 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=202.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999965 689999998865322 223467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999997655566899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------------- 210 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------------- 210 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------------
Confidence 112346899999999999999999999999999999999999999643221000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC-----CccCCCCCc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHPY 935 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~e~L~HP~ 935 (956)
+.... +... .+. .......+...+++++||+.||++|+| ++|+++|||
T Consensus 211 ----~~~~~---~~~~----~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 211 ----EEVER---LVKE----VQE----------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----HHHHh---hhhh----hhh----------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 00000 0000 000 000111223347888899999999999 899999999
Q ss_pred ccc
Q 002178 936 VSS 938 (956)
Q Consensus 936 f~~ 938 (956)
|..
T Consensus 264 ~~~ 266 (285)
T cd05630 264 FKQ 266 (285)
T ss_pred hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.92 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeeecccccC----CcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEE----GEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~ 696 (956)
..+....+.||+|.||.||+|.| .|+.||||++.. ..++.+.+|.++++. ++|+||+.|++.-..+ .+.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45677789999999999999999 478999999974 335577888888876 4999999999886433 3789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-----cCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-----EADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
||++|.+.|||+|||.+ ..++....++++..+|.||+|||. +|+|.|.|||||+.|||+.+++...|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999965 458899999999999999999994 5889999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCC----C--CCcccchhHHHHHHHHHhC----------CCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----L--TDKSDVYSLGVVFLELLTG----------MQPISHG 835 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDVwS~G~ll~elltg----------~~pf~~~ 835 (956)
|........ . -.-......||.+|||||++...- + -..+||||||.++||+..+ +.||.+-
T Consensus 363 Av~h~~~t~--~-idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 363 AVRHDSDTD--T-IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eEEecccCC--c-ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 987654321 1 122234567999999999996531 1 2358999999999999863 3466432
Q ss_pred ---chhHHHHHHHhhcccchhhccCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 836 ---KNIVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 836 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+...++....+- ++..++.+ ..+....+.++|+.||..+|..|-++-.+.+.|.++.+
T Consensus 440 Vp~DPs~eeMrkVVC-------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC-------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhccee-------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222222111 11222333 35677899999999999999999999988888877654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=340.31 Aligned_cols=194 Identities=28% Similarity=0.422 Sum_probs=164.6
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHH-HHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +|+.||+|++..... ...+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 689999999874322 12234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 9999999754 35888899999999999999999999 999999999999999999999999998753211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.18 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=165.5
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|... +|+.||+|.++.... ...+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 689999999875321 2234566787877754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 9999998764 34788899999999999999999999 999999999999999999999999998743211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.90 Aligned_cols=283 Identities=19% Similarity=0.318 Sum_probs=216.4
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeeccccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 691 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 691 (956)
-+++|+...|+ +.||+|+|++|--++ +.+|..+|||++.+.....++++.+|++++..-+ |+||+.++++|++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45778887774 579999999999988 6789999999998876667789999999999885 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEEe
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVAD 768 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~D 768 (956)
++..|||||.|.||+|..+|+++. .+++.++.+++++|+.||.|||.+| |.|||+||+|||..+-. -+||+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999997653 4899999999999999999999999 99999999999997654 489999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhH-HHH
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REV 842 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~-~~~ 842 (956)
|.++.-......-............|+..|||||+.. ...|+.+.|.||+|+++|-|++|+.||...-... .|.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9887654322211122233345567999999999874 2458889999999999999999999996421100 000
Q ss_pred ----HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccC
Q 002178 843 ----NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 918 (956)
Q Consensus 843 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~ 918 (956)
-...+ ..+++-|......+|++.|..+. ..+.|+++.+|.
T Consensus 303 rGe~Cr~CQ-~~LFesIQEGkYeFPdkdWahIS-----------------------------------~eakdlisnLlv 346 (463)
T KOG0607|consen 303 RGEVCRVCQ-NKLFESIQEGKYEFPDKDWAHIS-----------------------------------SEAKDLISNLLV 346 (463)
T ss_pred CCCccHHHH-HHHHHHHhccCCcCChhhhHHhh-----------------------------------HHHHHHHHHHHh
Confidence 00000 01112222222333443333332 233478888999
Q ss_pred CCCCCCCCCccCCCCCccccCCCC
Q 002178 919 SKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 919 ~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
.|+..|.+|.+.++|||++.....
T Consensus 347 rda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 347 RDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccHHhhhhhhhccCCccccccchh
Confidence 999999999999999999776553
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.94 Aligned_cols=281 Identities=24% Similarity=0.365 Sum_probs=206.2
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccC-----
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 692 (956)
...++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999964 688999999875322 2345678899999999999999999987533
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 693 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999998 8899988753 34889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 165 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~---- 229 (343)
T cd07878 165 ARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIM---- 229 (343)
T ss_pred ceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH----
Confidence 9865321 123458899999999977 568899999999999999999999996543321 111110
Q ss_pred chhhccCCCCCCChHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 851 MFSVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
.. .+..+.+....+.. ........-|. .|. .+ + ...+...++...+++.+||..||++|+|++|
T Consensus 230 --~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~----~---~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 230 --EV----VGTPSPEVLKKISSEHARKYIQSLPH-MPQ-QD----L---KKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred --HH----hCCCCHHHHHhcchhhHHHHhhcccc-ccc-hh----H---HHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00 01111111111100 00111111111 110 00 1 1112233445678999999999999999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
+|+||||..
T Consensus 295 ll~hp~~~~ 303 (343)
T cd07878 295 ALAHPYFSQ 303 (343)
T ss_pred HhcCcchhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.18 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=207.4
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
+.+++|++.+.||+|+||.||+|.+. .+..||+|++.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45778999999999999999998753 25679999886433 334567889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999997532 124577888999999999999999998 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~ 844 (956)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~ 233 (277)
T cd05062 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRF 233 (277)
T ss_pred ECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH
Confidence 999999876532221 011112345678999999999899999999999999999999 6788864332 111111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+........+..++..+.+++.+|++.+|++||++.++++.++
T Consensus 234 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 ---------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1122223345566778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.32 Aligned_cols=241 Identities=20% Similarity=0.332 Sum_probs=194.3
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+|++.+.||+|+||+||+|... +++.||+|++..... .....+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999965 578999999875322 2234566788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999986543 4888999999999999999999998 9999999999999999999999999987542211
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +.. ..
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~---------i~~-~~ 217 (323)
T cd05616 156 -------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQS---------IME-HN 217 (323)
T ss_pred -------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-CC
Confidence 1123456899999999999999999999999999999999999999754432 11111 111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSM 888 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 888 (956)
..+|...+.++.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 23455566778888888888888888874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.46 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=174.0
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
|+..+.||+|+||+||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999964 6899999998654322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987655557999999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.96 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=208.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457889999999999999999988888899999875433 3457899999999999999999999885 45689999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.++++......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 9999999998755556899999999999999999999998 99999999999999999999999999976543211
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.... +......+
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~---------~~~~~~~~ 223 (260)
T cd05070 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQ---------VERGYRMP 223 (260)
T ss_pred ----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH---------HHcCCCCC
Confidence 11112235668999999988899999999999999999999 88888654321 11111 11112223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
.+...+..+.+++.+|+..+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 455667889999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=336.05 Aligned_cols=262 Identities=27% Similarity=0.456 Sum_probs=207.3
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeeccccc-
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 691 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 691 (956)
...++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+++++++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999642 257899999875432 2345678899999999 79999999998854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 715 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 715 (956)
+...++||||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457889999999999999986422
Q ss_pred ---CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceeccc
Q 002178 716 ---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792 (956)
Q Consensus 716 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~ 792 (956)
..++++..+.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..... .......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccCC
Confidence 126789999999999999999999998 99999999999999999999999999987532211 1112233
Q ss_pred ccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHH
Q 002178 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 871 (956)
Q Consensus 793 ~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 871 (956)
.++..|+|||++.+..++.++|||||||++|||++ |..||........ ..... ..+.....+......+.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRL--------KEGTRMRAPEYATPEIY 306 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHH--------hccCCCCCCccCCHHHH
Confidence 45678999999999999999999999999999998 9999864322111 11111 11112233455667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 872 KLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 872 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
+++.+||+.+|++||++.++++.|+++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=323.13 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||+||+|.+.. ...||||.++..... ...++.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999999742 458999998754333 34678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997643 36889999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... ........++..|+|||.+.+..++.++||||||+++|||++ |..||........ .. .+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~--------~~~~ 223 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IK--------AVED 223 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HH--------HHHc
Confidence 211 111122335678999999999999999999999999999998 9999865432211 11 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
......+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112233455678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=323.26 Aligned_cols=256 Identities=31% Similarity=0.475 Sum_probs=208.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.++||+|+||.||+|.+.+...||+|.+..... ..+.+.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999987767899999875332 34578999999999999999999998754 5689999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999997654556789999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||....... .... +.......
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~---------~~~~~~~~ 223 (262)
T cd05071 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ---------VERGYRMP 223 (262)
T ss_pred ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHH---------HhcCCCCC
Confidence 11122346678999999998899999999999999999999 787886443211 1111 11111123
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.+.+.+..+.+++.+|++.+|++||++.++.+.|+.++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 34567788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=340.69 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=190.9
Q ss_pred CeeeeeCCeEEEEEEe----CCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 630 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
+.||+|+||.||++.. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3589999999875332 223467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999654 35889999999999999999999999 9999999999999999999999999987643221
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ... +.. .....|
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~---------i~~-~~~~~p 218 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MTM---------ILK-AKLGMP 218 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HHH---------HHc-CCCCCC
Confidence 112345689999999999998899999999999999999999999975432211 111 111 112234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSE 890 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~ 890 (956)
...+..+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 445566777777777777777777665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=335.18 Aligned_cols=197 Identities=29% Similarity=0.413 Sum_probs=160.4
Q ss_pred CCeeeeeCCeEEEEEEeC---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccc--cCCcEEEEEecCC
Q 002178 629 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLVYEFMS 703 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~LV~e~~~ 703 (956)
..+||+|+||+||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 357899998875432 346788999999999999999999884 3557899999995
Q ss_pred CCCHHHHHhhc-------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----cCCCcEEEEeeccc
Q 002178 704 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 772 (956)
Q Consensus 704 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DfGla 772 (956)
++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877532 1235788999999999999999999999 9999999999999 56779999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87643221 1112234568899999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.44 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|.+.+.||+|+||+||+|.+.++..||+|.+..... ...++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45778899999999999999987777899998875433 34678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc----
Confidence 9999999976433 6899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ... .+..+.....
T Consensus 155 --~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~---------~~~~~~~~~~ 222 (256)
T cd05113 155 --YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TVE---------KVSQGLRLYR 222 (256)
T ss_pred --eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH---------HHhcCCCCCC
Confidence 111122335678999999998889999999999999999999 999986543211 111 1111222223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+...+..+.+++.+||+.+|.+||++.++++.++
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 4445688999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.91 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=166.9
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 688999999975432 2234678899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----- 150 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----- 150 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-----
Confidence 9999988654 35899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 112345689999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=345.26 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=174.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 68999999987432 222456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999754 35888999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 002178 780 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (956)
Q Consensus 780 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~p 831 (956)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011234699999999999999999999999999999999999999
Q ss_pred CCCCc
Q 002178 832 ISHGK 836 (956)
Q Consensus 832 f~~~~ 836 (956)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=327.35 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|++.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 246789999987533 3334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC
Q 002178 698 VYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 762 (956)
||||+++++|.+++.... ...+++.....++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985332 234788889999999999999999998 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHH
Q 002178 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 841 (956)
Q Consensus 763 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~ 841 (956)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976543221 111223345678999999998889999999999999999998 8888865332 111
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 842 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
.... ........+..++..+.+++.+|++.+|++||++.++.+.+..
T Consensus 236 ~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMV---------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1111223455667889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.04 Aligned_cols=202 Identities=28% Similarity=0.344 Sum_probs=172.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 68999999986421 223356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 235888899999999999999999999 9999999999999999999999999987653221
Q ss_pred CCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 111223458999999999863 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=336.16 Aligned_cols=195 Identities=25% Similarity=0.391 Sum_probs=167.0
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +++.||+|+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999987532 12234567888888887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 99999986543 5889999999999999999999998 9999999999999999999999999986532111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.29 Aligned_cols=284 Identities=22% Similarity=0.348 Sum_probs=208.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||.||++... ++..||+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 68899999887542 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999764 457888999999999999999997 46 999999999999999999999999998754221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+... .........
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~-~~~~~~~~~- 222 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRP-VSEGEAKES- 222 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCc-cccccccCC-
Confidence 12234688999999999888899999999999999999999999965432 11 11111100 000000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC----CC--CCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM----PE--SDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~----~~--~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
. ......+...+....+.+.++.+.... |. .+....+|+.+|+..||++||+++|+++||
T Consensus 223 --~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 223 --H------------RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred --c------------ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 000001111111111111111111110 11 122345899999999999999999999999
Q ss_pred ccccC
Q 002178 935 YVSSD 939 (956)
Q Consensus 935 ~f~~~ 939 (956)
||...
T Consensus 289 ~~~~~ 293 (308)
T cd06615 289 FIKRA 293 (308)
T ss_pred hhhhc
Confidence 99653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.14 Aligned_cols=285 Identities=23% Similarity=0.367 Sum_probs=207.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 688999999864332 2344677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 96 69999886543 35788999999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .++..... .. .+
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~------~~----~~ 222 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIF------RI----LG 222 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH------HH----cC
Confidence 11123356889999999875 4578899999999999999999999975432 22221111 00 01
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
......+..+......+....|..++.. +. ...+..++...+++.+||+.||++|+|++|+|+||||..-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADC------LH---NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CCChhhchhhhccccccccccCcccccc------HH---hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 1111111111110000000111111100 00 11123344556899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.53 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=164.8
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHH-HHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999964 68999999986432 122345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999988654 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.60 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=209.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4567889999999999999999988899999999875443 3457899999999999999999999874 4578999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999999997766667899999999999999999999998 99999999999999999999999999976542211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +..... ......
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~---------~~~~~~ 222 (260)
T cd05067 158 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNL---------ERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHH---------HcCCCC
Confidence 11122345678999999998889999999999999999999 99999654322 111110 111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..+...+.++.+++.+|+..+|++||+++++...|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2344556789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.67 Aligned_cols=206 Identities=21% Similarity=0.233 Sum_probs=168.1
Q ss_pred CCCeeeee--CCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 628 SSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 628 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999864 78999999987543 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++.......+++..+++++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997654556899999999999999999999999 9999999999999999999999998754432111000
Q ss_pred ccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 000011122346778999999976 468899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=331.06 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
..+|++.+.||+|+||+||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 343 48999987543 34456889999999999999999999998764 577
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 34788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +... ...
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~-~~~-------- 225 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISS-ILE-------- 225 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH-HHh--------
Confidence 3221 111122234678999999999999999999999999999998 99998654321 1111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..+...+.+++.+||+.+|.+||++.+++..+..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111223344566788999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.99 Aligned_cols=291 Identities=20% Similarity=0.262 Sum_probs=219.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CC-----ceeeeecccccCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~ 694 (956)
.+++|.+...+|+|+||.|-++.++ .+..||||+++.-. ...+...-|+++++++. +. -++.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4889999999999999999999865 47899999988533 23445677999999994 22 47888999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--------------
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 760 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------- 760 (956)
.|+|+|.+ |.|+++++..++..+++...++.|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 779999999988889999999999999999999999999 999999999999932
Q ss_pred ------CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 761 ------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 761 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
+..+||+|||.|+.... .......|..|+|||++.+-.+++++||||+||||+|+.||...|+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e----------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE----------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeccCCCcceEEEecCCcceecc----------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 34699999999986432 22556789999999999999999999999999999999999999986
Q ss_pred CchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHH---HHHHHhcccC--CCCCCCHHHHHHHH---HHhHhhCCCCC
Q 002178 835 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI---KLALKCCQDE--TDARPSMSEVMREL---ESIWNMMPESD 906 (956)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~l~~~c~~~~--p~~RPs~~~v~~~L---~~~~~~~~~~~ 906 (956)
.++.... .+....++++|..+..+.. ..-..+++.+ ...| .+..+.+.. ..+......+.
T Consensus 312 Hen~EHL-----------aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~-~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 312 HENLEHL-----------AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKG-KSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred CCcHHHH-----------HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccc-cchhhhcCCccHHHHhccCcHHH
Confidence 5543321 1111223455554443331 1111133321 1111 122222222 22222222233
Q ss_pred CCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 907 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 907 ~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
.+..|++++||.+||.+|+|+.|||.||||..-
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 445789999999999999999999999999753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.38 Aligned_cols=280 Identities=24% Similarity=0.398 Sum_probs=207.4
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999975 6899999998643222 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ ++|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 68888876532 35899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++.+. .++.++|||||||++|||++|..|+....+.......... . .+
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~------~----~~ 218 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------L----LG 218 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH------H----hC
Confidence 112234578899999998764 4788999999999999999999998665544333222111 0 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+......+.++... ...+...... .+....+.......+++.+||..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 219 TPTEESWPGVSKLPDY------KPYPMYPATT----SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCChHHhHHhhhcccc------cccCCCCCcc----hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1112222221111110 0001111000 0111223344556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=334.02 Aligned_cols=241 Identities=21% Similarity=0.327 Sum_probs=188.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999965 68999999987532 122346778888888885 577888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998654 34889999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +.. ..
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~---------i~~-~~ 217 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQS---------IME-HN 217 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-CC
Confidence 1123346899999999999999999999999999999999999999754321 11111 111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSM 888 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 888 (956)
..+|...+..+.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12334445566666677777777777664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.16 Aligned_cols=263 Identities=26% Similarity=0.492 Sum_probs=211.8
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccc
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 690 (956)
+....++|++.+.||+|+||.||+|... ....+|+|.+.... .....++.+|+++++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4455678999999999999999999864 23689999887532 23345788999999999 7999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhc--------------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 691 EEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 691 ~~~~~~LV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
.++..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999999652 2346889999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 002178 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~ 835 (956)
+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++||+++ |..||...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEcCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999999875432211 11122235678999999998899999999999999999998 88888654
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
... +.... +..+.....+..+...+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 239 ~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVE-ELFKL---------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHH-HHHHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 321 11111 1112222345566778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=348.54 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=208.5
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCC----
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 693 (956)
...++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999985 479999999986543 333457889999999999999999988764332
Q ss_pred ----cEEEEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 694 ----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 694 ----~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
..++||||+++|+|.++++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999753 2346889999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...
T Consensus 186 DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~---- 255 (496)
T PTZ00283 186 DFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMH---- 255 (496)
T ss_pred ecccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHH----
Confidence 9999986543211 1122345699999999999999999999999999999999999999975432 22211
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
....+.....+...+..+.+++..||+.+|.+||++.++++.
T Consensus 256 -----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 122233334566677889999999999999999999998763
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.86 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=202.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999965 6899999988643 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.++++......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765567899999999999999999999998 9999999999999999999999999988654321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||...... .... ....+....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~ 220 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALIL---------KIIRGVFPP 220 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHHcCCCCC
Confidence 1122345788999999999999999999999999999999999999754421 1111 112222333
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 44455667777777887777777777776654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.57 Aligned_cols=251 Identities=28% Similarity=0.460 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987778899999865332 34578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 9999999976433 6889999999999999999999999 99999999999999999999999999876532110
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ... +........
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~---------~~~~~~~~~ 222 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-VES---------VSAGYRLYR 222 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-HHH---------HHcCCcCCC
Confidence 11111223457999999999999999999999999999999 7888865433211 111 111111233
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
+..++.++.+++.+||..+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=327.01 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=206.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+|++.+.||+|+||+||+|... +++.||+|+++..... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999853 2578999998754432 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhc--------------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 698 VYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++||+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998532 1234788889999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVI 236 (283)
T ss_pred eEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 99999999876532221 111223345778999999998889999999999999999998 8778865332 1211
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
. .+..+.....+..++..+.+++..||+.+|++||++.++++.|+.
T Consensus 237 ~---------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 E---------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 122233344567788889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.52 Aligned_cols=282 Identities=23% Similarity=0.358 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 6899999998653322 234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ ++|.+++..... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 599998876433 6889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+.....+. . +.
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------~----~~ 222 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR------V----LG 222 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH------h----cC
Confidence 11122346788999999876 45788999999999999999999999755433333222111 0 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCC--CCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD--TKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~--~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
...++................+..++ ..+ ....+... ....+++.+||..+|++|||++|+++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPP--RPL-------INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCChhhhhhhhhccccccccccccCC--hhH-------HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11112221111111000000111111 111 11112222 455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.56 Aligned_cols=279 Identities=27% Similarity=0.403 Sum_probs=207.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|+..+.||+|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999965 689999998875332 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 68999997766667899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.||............ .. ..+
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~~----------~~~ 218 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI-FR----------TLG 218 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HH----------HhC
Confidence 1112334678999999987644 588899999999999999999999755432221111 10 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+......+..+...+. ..+.. +....++ .+..+....+++.+|+..||++||+++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKP-SFPKWARQDFSKV----------VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHh-hcccccccCHHHH----------cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111122222222211111 11111 1111111 12223344689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=326.80 Aligned_cols=282 Identities=24% Similarity=0.381 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788899999999999999965 689999999876442 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+ +++|.+++.... .++++.+++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987543 56899999999999999999999998 99999999999999999999999999986643221
Q ss_pred CccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......|+..|+|||.+.+. .++.++||||+||+++||++|+.||....+.. ....... ...
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~----------~~~ 218 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFR----------TLG 218 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHH----------HcC
Confidence 112234588899999998754 46889999999999999999977775443322 1111110 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
......+..+.++....-...+..++.. +....++.+....+++.+||..||++||+++++|+||||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIP---------LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcch---------HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111111111111110000011111111 1122344456667899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.97 Aligned_cols=203 Identities=28% Similarity=0.329 Sum_probs=172.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.++||+|+||+||++..+ +++.||+|++..... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999975 578999999864221 22345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997632 35888899999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 11223356999999999986 3467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.30 Aligned_cols=253 Identities=30% Similarity=0.458 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|++.+.||+|++|.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999876533 23457889999999999999999999875 456889999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.++++......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999997755556889999999999999999999998 99999999999999999999999999976542211
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||...+..++.++||||||+++|||++ |+.||....+.... .. +........
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~---------~~~~~~~~~ 224 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQ---------VERGYRMPC 224 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---------HHcCCCCCC
Confidence 11112335678999999998899999999999999999999 88898654332111 11 111112234
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
+...+..+.+++.+|+..+|.+||+++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 55667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=334.21 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=187.2
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHH-HHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 689999999875322 22334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----- 150 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----
Confidence 9999988653 34788888899999999999999998 9999999999999999999999999987532111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +. ......+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~---------i~-~~~~~~~~ 217 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDN---------IL-HKPLQLPG 217 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHH---------Hh-cCCCCCCC
Confidence 122345689999999999999999999999999999999999999975432 111111 11 11123344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMS 889 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~ 889 (956)
.....+.+++.+|++.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4556777788888888888888764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.81 Aligned_cols=280 Identities=24% Similarity=0.440 Sum_probs=219.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
..++|.+.+.||+|+||.||+|... ....||+|.++... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4467889999999999999999742 24579999887543 23346788999999999 69999999999998
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 899999999999999999997532 235888999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~ 836 (956)
+++++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999865422111 11112234567999999999899999999999999999999 888886432
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 916 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~ 916 (956)
. .+..... ..+.....+..++.++.+++.+|++.+|++||++.++++.|+++.....+ ...++...+
T Consensus 242 ~-~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~---~~~~~~~~~ 308 (314)
T cd05099 242 V-EELFKLL---------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE---EYLDLSMPF 308 (314)
T ss_pred H-HHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC---CceeeEEeh
Confidence 2 1111111 11112234556677889999999999999999999999999988765422 334566667
Q ss_pred cCCCCC
Q 002178 917 HTSKEE 922 (956)
Q Consensus 917 L~~dP~ 922 (956)
.+++|+
T Consensus 309 ~~~~~~ 314 (314)
T cd05099 309 EQYSPS 314 (314)
T ss_pred hhcCCC
Confidence 777663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.89 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=209.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999964 7899999987542 2333457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||+++|+|.+++... ....+++..++.++.|+++||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2345788999999999999999999998 99999999999999999999999999886542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||............. +...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--------~~~~ 223 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--------IEQC 223 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--------HhcC
Confidence 21 11123457889999999998889999999999999999999999996543211111111 1111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 858 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 858 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
..+. .+...+..+.+++.+||+.+|++||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1222 2345678899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.91 Aligned_cols=257 Identities=30% Similarity=0.500 Sum_probs=211.8
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
...++|++.+.||+|+||.||+|..++++.||||.+..... ..+++.+|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34678999999999999999999988888999999875433 34678999999999999999999999998889999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.......+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999998765567899999999999999999999998 99999999999999999999999999876542110
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ..... +.....
T Consensus 159 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~---------~~~~~~ 222 (261)
T cd05034 159 ------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ---------VERGYR 222 (261)
T ss_pred ------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---------HHcCCC
Confidence 11112234568999999998889999999999999999999 99998654321 11111 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
...+...+..+.+++.+|+..+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22344456789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.17 Aligned_cols=269 Identities=23% Similarity=0.376 Sum_probs=213.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 478999999987655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999998643 4789999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||............. . . .......
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~-~------~~~~~~~ 237 (296)
T cd06655 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T-N------GTPELQN 237 (296)
T ss_pred ----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h-c------CCcccCC
Confidence 11223457889999999998889999999999999999999999997544322111000 0 0 0000000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
+... .+...+++.+|+..||++|+++++++.||||+.....
T Consensus 238 ~~~~---------------------------------------~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 238 PEKL---------------------------------------SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred cccC---------------------------------------CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 1111 1122356777888888999999999999999888887
Q ss_pred Cccccccccc
Q 002178 943 SNLVSGVIPT 952 (956)
Q Consensus 943 ~~~~~~~~~~ 952 (956)
+.+..+..|+
T Consensus 279 ~~~~~~~~~~ 288 (296)
T cd06655 279 SSLTPLILAA 288 (296)
T ss_pred ccCCccccch
Confidence 7777666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.54 Aligned_cols=279 Identities=27% Similarity=0.393 Sum_probs=204.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 689999998864322 2245788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
++ ++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 69999886543 256899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.||............. . ..
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~-~------~~---- 218 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF-R------IL---- 218 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-H------Hh----
Confidence 112233568899999998754 57889999999999999999999997554332211110 0 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
+......+.....+... -...+. ..+. ........++...+++++||..||++|||+++++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 219 GTPTEDVWPGVTSLPDY-KNTFPKWKKGS----------LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCChhhhhcchhhHHH-HhhccccCcch----------hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01111111111110000 000000 0000 001112234455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.32 Aligned_cols=264 Identities=22% Similarity=0.389 Sum_probs=210.3
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcC-CCceeeeeccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH-HRNLVSLVGYC 689 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 689 (956)
++....++|.+.++||+|+||.||+|+++ .++.||+|+++..... ..+.+.+|++++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35556677888999999999999999853 3468999999764322 2357889999999997 99999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCC-----------------------------------------------------
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKSK----------------------------------------------------- 716 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 716 (956)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred -------------------------------------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 717 -------------------------------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 717 -------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
..+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 23677788999999999999999988 99999999
Q ss_pred ccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCC
Q 002178 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPI 832 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf 832 (956)
+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999986532211 011122346788999999998889999999999999999998 88888
Q ss_pred CCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 833 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
............ +..+.....|..++..+.+++.+||..+|.+||++.++++.|+++
T Consensus 343 ~~~~~~~~~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 343 PELPMNEQFYNA---------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCCchHHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 643321111111 111112234555678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.34 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999742 356899999887666667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC-------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 698 VYEFMSNGTLRDQLSAKSK-------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
||||+++++|.+++..... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975432 34788999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~ 843 (956)
||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ..
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IE 235 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HH
Confidence 9999999875432210 111122335678999999999999999999999999999998 8889865433211 11
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
....+.....+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ---------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11122222334556778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=333.31 Aligned_cols=241 Identities=23% Similarity=0.309 Sum_probs=188.7
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHH-HHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 578999999875321 22234444544 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+.+.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----
Confidence 99999997643 4778888889999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..... .. .....+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i---------~~-~~~~~~~ 217 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNI---------LN-KPLQLKP 217 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHH---------Hh-CCcCCCC
Confidence 12234568999999999999999999999999999999999999997544321 11111 11 1112233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
..+..+.+++.+|++.+|.+||+..+.+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 45567778888888888888888775443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=337.02 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=212.5
Q ss_pred CCCCCeeeeeCCeEEEEEEe-CCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 626 FNSSTQIGQGGYGKVYKGIL-PDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
....++||+|+||+||||.| ++| -+||+|++... ..+..+++.+|+-.|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467899999999999996 344 46899988754 3445678999999999999999999999998765 88999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
+||+.|+|.+|++.+ +..+.....+.|..|||+||.|||++. +|||||.++|||+.+-..+||.|||+|+.+...+
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999874 456888899999999999999999998 9999999999999999999999999999887554
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.+ .......-.+.|||-|.+....|+.++|||||||.+||++| |..|++...- +.+.. -+-.+.
T Consensus 853 ~e-----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~eI~d--------lle~ge 917 (1177)
T KOG1025|consen 853 KE-----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EEIPD--------LLEKGE 917 (1177)
T ss_pred cc-----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HHhhH--------HHhccc
Confidence 22 11222334568999999999999999999999999999999 9999975321 11111 122345
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.+.|+.|...++.++.+||..|+..||+++++...+.++..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 567789999999999999999999999999999998887754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.50 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=211.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7899999987632 2223567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998652 3345889999999999999999999999 99999999999999999999999999876542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||............ ....+
T Consensus 159 ~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08224 159 KTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEKC 223 (267)
T ss_pred CCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh--------hhhcC
Confidence 211 112345788999999999888999999999999999999999999654321111111 11112
Q ss_pred CCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 858 NMGSYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 858 ~~~~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.....+. ..+..+.+++.+|+..+|++||++.++++.++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2233343 66778999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.60 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=204.5
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-C---CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc-----
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 694 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 694 (956)
|++.+.||+|+||.||+|... + +..||+|+++... ......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 3789999987533 2334678999999999999999999998865443
Q ss_pred -EEEEEecCCCCCHHHHHhhc----CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 695 -QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 695 -~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 2346889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 848 (956)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....+. +...
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~----- 226 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYD----- 226 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-----
Confidence 999865432211 01112234678999999988889999999999999999999 88888654321 1111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1122233345666778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.08 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=207.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45688999999999999999999753 24589999886543 233456888999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
..++||||+++|+|.+++.... ....++..+..++.|++.||.|||+++ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 233566778899999999999999998 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~ 844 (956)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLK- 232 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-
Confidence 999999986533221 111122235678999999999899999999999999999999 7778864332 12111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+.++.....+..++..+.+++.+|++.+|++||++.++++.+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1122223334555678899999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.46 Aligned_cols=192 Identities=26% Similarity=0.427 Sum_probs=167.6
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||.||++..+ +|+.||+|.+..... ...+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 689999999864322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--------
Confidence 99987766667899999999999999999999999 9999999999999999999999999987653211
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
......|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 12234588999999999998899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.03 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=205.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.+++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+..+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4577899999999999999999974 35789999887543 3345678999999999999999999999988889
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEE
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKV 766 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl 766 (956)
.++||||+++++|.++++.... ..+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 25889999999999999999999998 99999999999998765 6999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.....
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFV 234 (277)
T ss_pred ccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH
Confidence 999999865322110 01112233568999999999999999999999999999997 99998754321 111111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
........+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 ---------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111122345556788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.47 Aligned_cols=254 Identities=22% Similarity=0.250 Sum_probs=192.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 68899999986422 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997632 35788899999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~---- 225 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHEE---- 225 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HHHHHcCCC----
Confidence 111223569999999999875 4678899999999999999999999975443221 111110000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDA--RPSMSEVMR 893 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~--RPs~~~v~~ 893 (956)
....+....+.+..+.+++.+|+...+++ |++++++++
T Consensus 226 -~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 -RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00011111234566777777777654433 345555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.32 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 46899999998654 333456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 3677888899999999999999999 999999999999999999999999999765321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-------------------~ 203 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------------------L 203 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-------------------c
Confidence 122346889999999999999999999999999999999999999642110000 0
Q ss_pred CChHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 862 YPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~-~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
.+ ... ..|+ ..++...|. ........+++.+|+..||++||+++|+++||||....
T Consensus 204 ~~----~~~----~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 204 MP----LQL----LQCIVDEDPPVLPV---------------GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ch----HHH----HHHHhccCCCCCCC---------------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 00 000 0111 111111110 01122335788889999999999999999999998776
Q ss_pred CCC
Q 002178 941 SGS 943 (956)
Q Consensus 941 ~~~ 943 (956)
.++
T Consensus 261 ~~~ 263 (279)
T cd06619 261 DGN 263 (279)
T ss_pred Ccc
Confidence 654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.07 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CC--cEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DG--TVVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999865 33 35788888743 233456789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 699 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
|||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 124788999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~ 843 (956)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYE 229 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence 99999998643211 00111223457999999998899999999999999999997 9999965432 11111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
. +..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+.+.
T Consensus 230 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 230 K---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred H---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 111112233455677899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.42 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=209.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688899999999999999998642 3689999987543 3345678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 695 QMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999996532 224688899999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+...
T Consensus 161 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~-- 232 (277)
T cd05032 161 GDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLK-- 232 (277)
T ss_pred CCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHHH--
Confidence 99999876543221 111223346788999999998889999999999999999998 8888864332 11111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
.+..+.....|..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11122233455666889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.94 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=203.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|++.+.||+|+||+||+|.+. +++ .|++|.+..... ....++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56788899999999999999964 444 477887764332 223567888889999999999999998864 46789
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 35889999999999999999999998 99999999999999999999999999986542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... ........++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ...... .
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~--------~ 226 (279)
T cd05111 162 DDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE--------K 226 (279)
T ss_pred CCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------C
Confidence 211 111233457778999999999999999999999999999998 999986543211 111111 1
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.....+..+...+..++.+||..+|.+||++.++++.++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11222334456678889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.58 Aligned_cols=266 Identities=27% Similarity=0.412 Sum_probs=205.6
Q ss_pred cCC-CCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccC--Cc
Q 002178 624 NNF-NSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 694 (956)
Q Consensus 624 ~~y-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 694 (956)
++| ++.+.||+|+||+||++.. .+++.||+|.++.... .....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988653 3578999999876432 3456788999999999999999999987553 46
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++++|.+++... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 78999999999999999653 4899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH-HHHHHh---hccc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR-EVNIAY---QSSM 850 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~-~~~~~~---~~~~ 850 (956)
....... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...... ....
T Consensus 157 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 5432110 0111223356679999999988899999999999999999999999864332111 000000 0001
Q ss_pred chhhccC-CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 851 MFSVIDG-NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 851 ~~~~~~~-~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
....++. ...+.+..++..+.+++..||+.+|.+||+++++++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111 122335567789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.88 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=210.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC-----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccccc-CCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 694 (956)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999999765 6889999887543 3345678899999999999999999998765 567
Q ss_pred EEEEEecCCCCCHHHHHhhcCC------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
.++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999975422 45899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhh
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~ 847 (956)
||+++.+...+. ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+.....
T Consensus 161 ~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-- 232 (280)
T cd05043 161 NALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYL-- 232 (280)
T ss_pred CCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHH--
Confidence 999986532221 011122345678999999998889999999999999999999 9999975432 2211111
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+.....+..+++.+.+++.+||..+|++||++.++++.|+++.+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 -------KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -------HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111122334456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.44 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=210.7
Q ss_pred CCCCeeeeeCCeEEEEEEeC--CCc--EEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 627 NSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
...++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|+|++++||+..+ ...++|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999986 344 5899999876555 46799999999999999999999999987 678899999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++.|||.+.|++.....|-......++.|||.||.||..++ +|||||.++|+|+-..-.|||+|||+.+-+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999999866678889999999999999999999999 999999999999999999999999999987654321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
- .......-...|+|||.+....++.++|||+|||++|||+| |..||...... +.+ ..+-++++.
T Consensus 269 Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-qIL---------~~iD~~erL 334 (1039)
T KOG0199|consen 269 Y----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-QIL---------KNIDAGERL 334 (1039)
T ss_pred e----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-HHH---------HhccccccC
Confidence 1 11122334568999999999999999999999999999999 78888654321 111 112234556
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
.-|+.|++.++++++.||..+|++||++.++.+.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 67899999999999999999999999999997544
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.06 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=200.0
Q ss_pred eeeeeCCeEEEEEEeC---CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 631 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
.||+|+||+||+|.++ ++..||+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57899999986543 233567899999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 999999654 35889999999999999999999998 999999999999999999999999999865432210
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
........++..|+|||.+....++.++|||||||++|||++ |+.||...... ..... +..+.....|.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~---------i~~~~~~~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQM---------IESGERMECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---------HHCCCCCCCCC
Confidence 011122234578999999988889999999999999999998 99999754321 11111 11122234556
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.++.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.10 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=209.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999986544 4568899999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998766557899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.....+..|+|||.+.+..++.++||||||+++||+++ |+.||..... .+ ...... ......
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~~--------~~~~~~ 219 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD-VVPHVE--------KGYRME 219 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHHh--------cCCCCC
Confidence 12234568999999998889999999999999999997 9999865432 11 111111 111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
.+..+++.+.+++.+|+..+|++||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 345567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.07 Aligned_cols=283 Identities=23% Similarity=0.368 Sum_probs=205.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 6899999998654322 2346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+. +++.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 78887775433 34778888899999999999999998 9999999999999999999999999987543221
Q ss_pred CCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......+.....+. .
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~------~---- 220 (291)
T cd07870 158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT------V---- 220 (291)
T ss_pred -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH------H----
Confidence 111233468899999998764 5788999999999999999999999765443322222110 0
Q ss_pred CCCCChHHHHHHHHHHH---HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 859 MGSYPSECVEKFIKLAL---KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~---~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.+....+....+..+-. ...... .++... .+..... ......+++.+|+..||++|+|++|++.|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~-~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPC--KPQQLR-------VVWKRLS-RPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred cCCCChhhhhhhhhcccccchhcccc--CCcchh-------hhccccC-CChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 01111111111111000 000000 011111 1111111 1344568999999999999999999999999
Q ss_pred c
Q 002178 936 V 936 (956)
Q Consensus 936 f 936 (956)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.85 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=182.2
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
+..+.|..-++||+||||.||-++.+ +|+.+|.|.+.+... .++...++|-.++++++.+.||.+--.|+..+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567888899999999999999865 699999998765433 34567789999999999999999998999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|+..|.||+|.-+|...+...+++..++.++.+|+.||++||++. ||.||+||+|||+|+.|++.|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999998877778999999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
... ......||.+|||||++..+.|+.+.|.||+||++|||+.|+.||...
T Consensus 339 ~g~--------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 EGK--------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCC--------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 332 223347999999999999999999999999999999999999999643
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=322.78 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=209.3
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
...++|.+.+.||+|+||.||+|... ++..||||.++... ....+.+.+|+++++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567999999999999999999741 35589999887543 23345788999999999 799999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
+..++||||+++|+|.++++......+++.++..++.|++.||+|||+++ |+|+||||+||+++.++.+|++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997655455899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||............ ..
T Consensus 189 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~-~~---- 258 (302)
T cd05055 189 RDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-IK---- 258 (302)
T ss_pred ccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH-HH----
Confidence 76542210 011122345678999999999999999999999999999998 99998654322111111 00
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+.....+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 259 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122334567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.98 Aligned_cols=263 Identities=25% Similarity=0.489 Sum_probs=211.3
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 690 (956)
...++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44678889999999999999999741 24579999887533 33456789999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 691 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 691 ~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
..+..++||||+++|+|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997642 235788889999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 002178 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~ 835 (956)
++++++.+||+|||.++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999986643221 111222345678999999998889999999999999999998 77777543
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
. ..+..... ..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 244 ~-~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 P-VEELFKLL---------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred C-HHHHHHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2 22222211 11112233556778899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.81 Aligned_cols=261 Identities=26% Similarity=0.486 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
.++|.+.+.||+|+||.||+|... +...||+|.++... .....++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 23579999987542 33345788899999999 799999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC--------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976421 34888999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~ 837 (956)
+.++.+||+|||.++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 99999999999998765322110 11112234568999999998889999999999999999998 888885432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
..+.... .. .......+..++..+.+++.+|+..+|++||++.++++.|+++...
T Consensus 248 ~~~~~~~-~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKL-LK--------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHH-HH--------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2221111 11 1112234556678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.65 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=207.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999965 6899999988643 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999987655566889999999999999999999998 9999999999999999999999999987654221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .... .+..+.....
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~ 220 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLIL---------KVCQGSYKPL 220 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-HHHH---------HHhcCCCCCC
Confidence 1122345888999999999888999999999999999999999999754321 1111 1112223344
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
+...+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 55667789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=350.08 Aligned_cols=270 Identities=25% Similarity=0.357 Sum_probs=209.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.++||+|+||.||+|... +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 58999999987532 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcC---------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 700 EFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
||+++|+|.+++.... ....++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123566778899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCc-----------cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhH
Q 002178 771 LSRLAPVPDIEGI-----------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (956)
Q Consensus 771 la~~~~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~ 839 (956)
+++.......... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986622110000 00011123469999999999999999999999999999999999999996533211
Q ss_pred HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhhCCC
Q 002178 840 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPE 904 (956)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~~~ 904 (956)
.... . ....+.......+.+..+.+++.+|+..+|++|| +++++.+.|+.+....++
T Consensus 239 i~~~-----~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYR-----D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhh-----h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 1000 0 0011110111234567788999999999999995 677788888887665444
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.00 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=199.8
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999965 78999999876433 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----cc
Confidence 99996543 35889999999999999999999998 99999999999999999999999999875432110 00
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHH
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 866 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 866 (956)
......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... +........+..+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~--------~~~~~~~~~~~~~ 221 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REA--------IEQGVRLPCPELC 221 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHH--------HHcCCCCCCcccC
Confidence 0111123457999999999889999999999999999998 8888864332111 111 1111122345566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 867 VEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 867 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.53 Aligned_cols=258 Identities=30% Similarity=0.488 Sum_probs=206.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+|++.+.||+|+||+||+|... ....+|+|.+..... .....+.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235789998875433 334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC----------------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCccc
Q 002178 698 VYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 755 (956)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 135788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 002178 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (956)
Q Consensus 756 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~ 834 (956)
|++++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999765322110 11122345678999999988889999999999999999998 9888864
Q ss_pred CchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 835 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.. ..+.... .. .......+..++..+.+++..|++.+|++||++.++++.|+++..
T Consensus 233 ~~-~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IA-PERLFNL-LK--------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CC-HHHHHHH-Hh--------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 33 2221111 11 111223355667789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.80 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=196.2
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEec---C-CChhhHHHHHHHHHHHHhcCCCceeeeecccccCC--cEEEEEec
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQ---E-GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYEF 701 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV~e~ 701 (956)
..+||+|+|-+||||.+. +|..||--.++ . ......++|..|+++|+.|+|+||+++++++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999975 57777632221 1 13334478999999999999999999999997654 57899999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~ 780 (956)
|..|+|+.|.++.++ ++....+.|++||++||.|||++ +|||||||||.+||+|+. -|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 999999999987654 67778999999999999999997 589999999999999985 589999999999876432
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
....+.|||.|||||... ..|++.+||||||++++||+|+..||....+..+.++.. +.|..+
T Consensus 200 -------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---------~SGiKP 262 (632)
T KOG0584|consen 200 -------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---------TSGIKP 262 (632)
T ss_pred -------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---------HcCCCH
Confidence 234478999999999987 789999999999999999999999998777666544432 222111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
. .+. ...+++..+||.++|.. .++|+||.|+|.||||..+
T Consensus 263 ---~----sl~-------------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 ---A----ALS-------------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---H----Hhh-------------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 0 000 01133344566666666 7788888888888888776
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.21 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=200.0
Q ss_pred eeeeeCCeEEEEEEeC---CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCC
Q 002178 631 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876533 23467899999999999999999999886 457899999999999
Q ss_pred HHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 002178 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (956)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 786 (956)
|.+++... ...+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 99998653 345889999999999999999999998 999999999999999999999999999765432210 0
Q ss_pred ceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChH
Q 002178 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865 (956)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 865 (956)
.......++..|+|||.+.+..++.++|||||||++||+++ |..||....... ... .+..+.....+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---------~~~~~~~~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMS---------FIEQGKRLDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH---------HHHCCCCCCCCCC
Confidence 11122234578999999988889999999999999999996 999997543321 111 1112223344566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 866 ~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+++++.+++.+||..+|++||++.++.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.68 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=208.3
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 456889999999999999999998778889999887543 234578899999999999999999999887 788999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 99999999998765566889999999999999999999998 99999999999999999999999999976532211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|+|||++....++.++|||||||++||+++ |+.||........ ... . ..+...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-~~~-~--------~~~~~~ 222 (260)
T cd05073 158 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-IRA-L--------ERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-HHH-H--------hCCCCC
Confidence 11122335678999999998889999999999999999999 8889865432211 111 0 111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2344566789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=327.88 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=206.9
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHH
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 708 (956)
-+||+|.||+||.|++. +...+|||.+.....+..+-+.+|+.+.++++|.|||+++|.+.+++..-+.||.++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999965 46679999998776666677889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCc--hhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEEEeeccccccCCCCCCCccc
Q 002178 709 DQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 709 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
++++.+ ..++ .+.+.-.+.+||++||.|||+.. |||||||-+|||++ -.|.+||+|||-++.+..-
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------- 729 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------- 729 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------
Confidence 999754 3445 77888889999999999999999 99999999999996 5789999999999876532
Q ss_pred cceecccccCCCcccccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
........||..|||||++..+ .|..++|||||||++.||.||++||..-.+....... . -+-...+++|
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---V-----GmyKvHP~iP 801 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---V-----GMYKVHPPIP 801 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---h-----cceecCCCCc
Confidence 1234456799999999999764 5889999999999999999999999754433221111 0 1123457789
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
++.+.+...++.+|+.++|..||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999999999999875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.50 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccc-ccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|... |+.||+|.++... ..+.+.+|+.++++++|+|++++++++ ..++..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888999999999999999864 7789999886533 345788999999999999999999976 455678999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998766556889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..... ..+...
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~---------~~~~~~ 218 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRV---------EKGYKM 218 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH---------hcCCCC
Confidence 12234568999999998889999999999999999998 988886432 21111111 011112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..++.++..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 3345667889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=314.86 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=209.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 478999999876422 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 2346889999999999999999999999 99999999999999999999999999876542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.. .......|+..|+|||++.+..++.++||||||+++|||++|..||............ .+...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEQC 223 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--------hhhcC
Confidence 21 1112345888999999999888999999999999999999999999643321111111 11111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 858 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 858 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
..+. .+...+..+.+++.+||..+|++||++.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1222 2345778899999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=328.31 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=205.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccC-
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 692 (956)
..++|++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|++++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 356899999999999999999973 2478999999875432 2345788999999999 689999999988554
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 715 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 715 (956)
...++||||+++|+|.++++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986431
Q ss_pred --------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 716 --------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 716 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YV 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hh
Confidence 123678888999999999999999998 99999999999999999999999999976532110 01
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHH
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 866 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 866 (956)
......++..|+|||.+.+..++.++||||||+++|||++ |..||........... . +..+.....|...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~--------~~~~~~~~~~~~~ 307 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-R--------LKEGTRMRAPDYT 307 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH-H--------HhccCCCCCCCCC
Confidence 1122335678999999999899999999999999999997 8889865332111111 1 1111222233344
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 867 VEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 867 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
...+.+++..||+.+|++||++.++++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.33 Aligned_cols=290 Identities=21% Similarity=0.311 Sum_probs=213.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 692 (956)
..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998642 233345678899999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
...++||||+. ++|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6898888543 788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....+...
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-------- 229 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI-------- 229 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------
Confidence 8653221 122345788999999999999999999999999999999999999765433222111
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh---CCCCCCCCccccccccCCCCCCCCCCc
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNM---MPESDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~---~~~~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
-...+..+.+....+...........+..++ .+.++.......... .........+++.+||.+||++|||++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 230 ---IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred ---HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 1112334445544444433333333332221 222221110000000 001123346899999999999999999
Q ss_pred cCCCCCcccc
Q 002178 929 SMLKHPYVSS 938 (956)
Q Consensus 929 e~L~HP~f~~ 938 (956)
|+|+||||..
T Consensus 307 eiL~~~~~~~ 316 (353)
T cd07850 307 DALQHPYINV 316 (353)
T ss_pred HHhcChhHhh
Confidence 9999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=322.98 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc--EEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999964 454 46788776432 33456788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
||||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 135788999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELY 233 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHH
Confidence 999999998642210 01111224567999999988889999999999999999998 99998643321 111
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.. ...+.....+...+..+.+++.+|++.+|++||++.++++.++++..
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11111122334456678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.80 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=208.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhh--HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.-|...+.||+|.|+.|-+|++ -+|..||||++.+..... ...+.+|+++|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999984 489999999998754443 4578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE-cCCCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DfGla~~~~~~~ 779 (956)
.-++|+|++||-++. ..+.+....+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|-|||+|||.+..+.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 999999999997653 35899999999999999999999999 9999999999977 556899999999987654
Q ss_pred CCCccccceecccccCCCcccccccccCCCCC-cccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
+.......+|+..|-|||++.+..|+. ++||||+|||||-+++|+.||+...+... +
T Consensus 171 -----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------L------- 228 (864)
T KOG4717|consen 171 -----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------L------- 228 (864)
T ss_pred -----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------h-------
Confidence 344566778999999999999999875 68999999999999999999976543211 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
..|+.|-.--|. .| .++..++|.+||+.||.+|.|.+|+..|+|++.
T Consensus 229 -------------TmImDCKYtvPs------hv--------------S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 229 -------------TMIMDCKYTVPS------HV--------------SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -------------hhhhcccccCch------hh--------------hHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 122233222111 11 122236888889999999999999999999865
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
--.
T Consensus 276 ~D~ 278 (864)
T KOG4717|consen 276 GDR 278 (864)
T ss_pred CCC
Confidence 443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.07 Aligned_cols=267 Identities=28% Similarity=0.432 Sum_probs=205.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 696 (956)
.+|++.+.||+|+||+||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 2578999999887666666789999999999999999999998643 34689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996542 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhH-HHHHHHhh----cccc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQ----SSMM 851 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~-~~~~~~~~----~~~~ 851 (956)
..... ........++..|+|||++.+..++.++|||||||++|||++|..++....... +....... ...+
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32210 001111224456999999998889999999999999999999877764322110 00000000 0000
Q ss_pred hhhcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 852 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 852 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+.+. ......+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 112233455677899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.25 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=207.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567999999999999999999853 46789999987543 3335678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKS--------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 754 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~ 754 (956)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996431 124778889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 002178 755 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833 (956)
Q Consensus 755 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~ 833 (956)
||++++++.+||+|||+++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998754322110 11112234567999999998999999999999999999998 888886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
.... .+... .+.++.....+..++.++.+++.+|++.+|++||++.++++.|+
T Consensus 235 ~~~~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH-EEVIY---------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH-HHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 4332 12111 11122223334556788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.67 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=207.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999964 33 379999887543 3345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 45889999999999999999999998 99999999999999999999999999876542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... .........+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +..
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~~~~~---------i~~ 225 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKA---------IND 225 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHH---------Hhc
Confidence 2110 111112223457999999998889999999999999999998 99999654321 11111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
....+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112233445677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=334.42 Aligned_cols=235 Identities=23% Similarity=0.275 Sum_probs=178.5
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhc---CCCceeeeecccccCCcEEEEEecCCC
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
||+|+||+||+|+.. +++.||||++....... ...+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999986432221 23445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 9999998754 35889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||...... +.... +..+......
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~~~~---------i~~~~~~~~~ 218 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QMYRN---------IAFGKVRFPK 218 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-HHHHH---------HHcCCCCCCC
Confidence 112345689999999998764 4789999999999999999999999754321 11111 0111111111
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSM 888 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~ 888 (956)
......+.+++.+|++.+|.+||+.
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 1234555666677777777777643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.20 Aligned_cols=244 Identities=30% Similarity=0.472 Sum_probs=205.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.|..++.||.|+||.||-|.+ ++..+||||++.....+ .-.++..|++.|++++|||++.+.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455577899999999999995 47899999998754433 34688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|| -||-.|++.-. +.++.+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|.....
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 67999988654 457999999999999999999999999 99999999999999999999999999987542
Q ss_pred CCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
....+|||.|||||++. .+.|+-++||||+|++..|+...++|++...-+...+. +...
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH----------IAQN 240 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IAQN 240 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH----------HHhc
Confidence 23567999999999986 47899999999999999999999999876543332222 2222
Q ss_pred CCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 858 NMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 858 ~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
..+.. ..+++..+..++..|+++-|.+||+.+++++.
T Consensus 241 esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 33333 56788999999999999999999999887653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=322.14 Aligned_cols=288 Identities=25% Similarity=0.398 Sum_probs=225.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999864 444 578898875432 2345788999999999999999999998654 567
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999987543 35788899999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. ......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~-~~~~~~-------- 225 (303)
T cd05110 161 GDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-RE-IPDLLE-------- 225 (303)
T ss_pred Cccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH-HHHHHH--------
Confidence 2211 111122345678999999999999999999999999999998 8889864321 11 111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.+.....+..++..+.+++..||..+|++||++.++++.++.+... -.+.+...++.|+.+...-.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 294 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD-----------PQRYLVIQGDDRMKLPSPNDSKF 294 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc-----------hhhheeeccCCcCCCCCCchhhH
Confidence 1111222344567889999999999999999999999999876432 12346778999999999999999
Q ss_pred cccCCC
Q 002178 936 VSSDVS 941 (956)
Q Consensus 936 f~~~~~ 941 (956)
|..-+.
T Consensus 295 ~~~~~~ 300 (303)
T cd05110 295 FQNLLD 300 (303)
T ss_pred Hhcccc
Confidence 987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.36 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=200.3
Q ss_pred CCCCCeeeeeCCeEEEEEEeCC-Cc--EEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------Cc
Q 002178 626 FNSSTQIGQGGYGKVYKGILPD-GT--VVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 694 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 694 (956)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999754 33 6899988753 233456788999999999999999999986321 25
Q ss_pred EEEEEecCCCCCHHHHHhhc----CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 695 QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
.++||||+++|+|.+++... ....+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 849 (956)
+++....... ........+++.|+|||+..+..++.++|||||||++|||++ |+.||...... +....
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~----- 226 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYDY----- 226 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-----
Confidence 9987543221 011122345678999999999999999999999999999999 78888653321 11111
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+..+.....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 ----LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111222233455667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.01 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=172.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45789999999999999999996 46899999998755444455778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999998654 35789999999999999999999998 9999999999999999999999999998653211
Q ss_pred CccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1112345788999999984 345788999999999999999999998644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.17 Aligned_cols=247 Identities=29% Similarity=0.480 Sum_probs=201.2
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHH
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 708 (956)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876443 23457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccce
Q 002178 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (956)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 788 (956)
+++.... ..+++..+..++.|++.||.|+|+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc------cc
Confidence 9986543 35789999999999999999999998 99999999999999999999999999875432110 11
Q ss_pred ecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 002178 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867 (956)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 867 (956)
.....++..|+|||++.+..++.++||||||+++||+++ |..||........ ... +..+.....+..++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~---------~~~~~~~~~~~~~~ 220 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQ---------VEKGYRMSCPQKCP 220 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHH---------HHcCCCCCCCCCCC
Confidence 112234568999999998899999999999999999998 9999965432211 111 11111223445567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 868 EKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 868 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
..+.+++.+|++.+|++||++.++.+.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 88999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.23 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=205.4
Q ss_pred hcCCCCC-CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeeccccc----CCcE
Q 002178 623 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 695 (956)
Q Consensus 623 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 695 (956)
+++|.+. ++||-|-.|+|-.+..+ +++.+|+|++.+. ....+|++..-.. .|||||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4555553 57999999999999865 7899999998752 2455688754443 69999999999843 4578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeeccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 772 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla 772 (956)
.+|||.|+||.|.+.++.++...+++.++-.|++||+.|+.|||+.+ |.||||||+|+|.+. +..+||+|||.|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999999999999999999999999999999999 999999999999964 557999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||....... -...+.
T Consensus 212 K~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk 276 (400)
T KOG0604|consen 212 KETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMK 276 (400)
T ss_pred cccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHH
Confidence 86432 123455678999999999999999999999999999999999999997533210 000111
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
..+...-..||.++|..+.+ .+.|+|+.+|+.+|.+|+|.+|.++
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe-----------------------------------~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSE-----------------------------------AAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHH-----------------------------------HHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111222345544444332 2347889999999999999999999
Q ss_pred CCccccCCC
Q 002178 933 HPYVSSDVS 941 (956)
Q Consensus 933 HP~f~~~~~ 941 (956)
|||+.+...
T Consensus 322 hpwi~~~~~ 330 (400)
T KOG0604|consen 322 HPWINQYEA 330 (400)
T ss_pred Cchhccccc
Confidence 999987655
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.91 Aligned_cols=265 Identities=25% Similarity=0.472 Sum_probs=210.4
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecc
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 688 (956)
+.....+|++.+.||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3344567899999999999999999742 12368999887533 23356789999999999 79999999999
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcc
Q 002178 689 CDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 754 (956)
Q Consensus 689 ~~~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~ 754 (956)
+...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997532 234788899999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 002178 755 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833 (956)
Q Consensus 755 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~ 833 (956)
||+++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999976532211 111122234567999999999999999999999999999998 888886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.... .+..... ..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus 239 ~~~~-~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 239 GIPV-EELFKLL---------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CCCH-HHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 4332 2221111 11122233455667899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.53 Aligned_cols=204 Identities=29% Similarity=0.439 Sum_probs=173.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-----hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999964 689999998764321 123568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999997643 4788889999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.... ........++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 2110 111123457789999999999889999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.62 Aligned_cols=279 Identities=24% Similarity=0.368 Sum_probs=207.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999976 58999999886432 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888877543 34899999999999999999999998 99999999999999999999999999987643221
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||................. ..+.
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~--- 222 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG---DLIP--- 222 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CCCh---
Confidence 1123357789999999876 5578899999999999999999999975543222111100000 0000
Q ss_pred CCCChHHHHHHHH---HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIK---LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~---l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
. ...+.. .........+..+++... .++.......+|+.+|+..||++||++.|++.||||
T Consensus 223 -----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 223 -----R-HQQIFSTNQFFKGLSIPEPETREPLES----------KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred -----H-HhhhcccccccccccCCCcccccCHHH----------HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000 000001112222222211 122234556689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.16 Aligned_cols=283 Identities=27% Similarity=0.398 Sum_probs=208.3
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-----hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 6899999998764332 235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+ +|+|.+++.... ..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997644 36899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|..||....+.. ....... .
T Consensus 156 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~------~--- 218 (298)
T cd07841 156 N-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE------A--- 218 (298)
T ss_pred C-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH------H---
Confidence 1 11122346778999999865 467889999999999999999977765443322 1111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
..............+...+... ..+... ....++.......+++.+|+..||++|+|++|+++||||+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 219 -LGTPTEENWPGVTSLPDYVEFK---PFPPTP--------LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred -cCCCchhhhhhccccccccccc---ccCCcc--------hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 0111111111111111111110 011100 0111223344556899999999999999999999999998
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
+.-.
T Consensus 287 ~~~~ 290 (298)
T cd07841 287 NDPA 290 (298)
T ss_pred CCCC
Confidence 7543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.50 Aligned_cols=284 Identities=24% Similarity=0.334 Sum_probs=204.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC---CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 696 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 696 (956)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999988633 22345678899999999999999999999877 7899
Q ss_pred EEEecCCCCCHHHHHhhc---CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC----CCcEEEEee
Q 002178 697 LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 769 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Df 769 (956)
+||||++ ++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 5787776532 2236889999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~ 848 (956)
|++......... ........++..|+|||++.+. .++.++|||||||+++||++|+.||........ ...
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~---- 227 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK-KSN---- 227 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc-ccc----
Confidence 999865432210 1112334578899999988764 578899999999999999999999964332110 000
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH----------------HHHHhHhhCCCCCCCCccc
Q 002178 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR----------------ELESIWNMMPESDTKTPEF 912 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~----------------~L~~~~~~~~~~~~~~~~l 912 (956)
+ .....+.+++..+-...+..++.+.+..+ .+..........+....++
T Consensus 228 --------------~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 228 --------------P-FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred --------------h-hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 0 00011111111111111111111111100 0111111112344556789
Q ss_pred cccccCCCCCCCCCCccCCCCCcc
Q 002178 913 INSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 913 l~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
+.+||..||++|||++|+++||||
T Consensus 293 i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.15 Aligned_cols=198 Identities=36% Similarity=0.588 Sum_probs=172.4
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHH--HHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
|++.+.||+|+||+||++... +++.||+|.+......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999975 5779999999876554432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----- 150 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE----- 150 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-----
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-----
Confidence 99999999973 235899999999999999999999998 99999999999999999999999999875411
Q ss_pred ccccceecccccCCCcccccccc-cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.........++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122334556889999999998 888999999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.84 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=175.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999964 68999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 999999998643 4788899999999999999999999 9999999999999999999999999987643221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.55 Aligned_cols=280 Identities=26% Similarity=0.385 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 589999998764322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.++.... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 34889999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------~~---- 217 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK-------CL---- 217 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-------Hh----
Confidence 11223457889999999875 4577899999999999999999988865443221111110 00
Q ss_pred CCCChHHHHHHH--HHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFI--KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~--~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
....+.....+. .+..... .|... +. .......+.......+++.+|+..+|++||+++++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~--~~~~~----~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMR--LPEVK----EI----EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCCchhhHHHhccchHhhccc--ccccc----Cc----chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000110000000 0000011 11100 00 01111233445556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.30 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC---------------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeee
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD---------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 686 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~ 686 (956)
.++|++.+.||+|+||.||++...+ ...||+|.++... ......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987532 2358999987543 33346789999999999999999999
Q ss_pred cccccCCcEEEEEecCCCCCHHHHHhhcC----------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 687 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532 123688899999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh--CCCCCCC
Q 002178 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 834 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt--g~~pf~~ 834 (956)
++++++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999976532211 111223345678999999998899999999999999999998 5667754
Q ss_pred CchhH--HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 835 GKNIV--REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 835 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
..... ......+... ........+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQ-----GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhc-----cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 32211 1111101000 001111223345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=348.65 Aligned_cols=291 Identities=20% Similarity=0.240 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC--CcEEEEE------------------EecCCChhhHHHHHHHHHHHHhcCCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVK------------------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 681 (956)
..++|++.+.||+|+||+||+|..+. +..+++| .+. ........+.+|++++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11123456789999999999999
Q ss_pred eeeeecccccCCcEEEEEecCCCCCHHHHHhhcC---CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 682 Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
|+++++++...+..++|+|++ .++|.+++.... ...........|+.||+.||+|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 568888775432 112335567789999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCC-CCc-
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS-HGK- 836 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~-~~~- 836 (956)
+.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..++. ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 999999999999998764321 111223568999999999999999999999999999999999876443 221
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 915 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~~~~~~~~~~ll~~ 915 (956)
....+........ ..... .+|+. ...+.+.+.. ......+ .....+..+ .......+++.+
T Consensus 375 ~~~~~~~~~~~~~---~~~~~---~~p~~-~~~~~~~i~~---~~~~~~~~~~~~~~~~~--------~~~~~~~~li~k 436 (501)
T PHA03210 375 KPGKQLLKIIDSL---SVCDE---EFPDP-PCKLFDYIDS---AEIDHAGHSVPPLIRNL--------GLPADFEYPLVK 436 (501)
T ss_pred CHHHHHHHHHHhc---ccChh---hcCCc-HHHHHHHhhh---hhcccCccchhhHHHhc--------CCChHHHHHHHH
Confidence 2222221111100 00111 11211 1112222111 1111111 222222111 123345678999
Q ss_pred ccCCCCCCCCCCccCCCCCccccCCC
Q 002178 916 EHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 916 ~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
||++||++|||++|+|+||||+....
T Consensus 437 mL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 437 MLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred HhccCcccCcCHHHHhhChhhhcCCc
Confidence 99999999999999999999987554
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.42 Aligned_cols=281 Identities=25% Similarity=0.356 Sum_probs=206.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV 698 (956)
++|++.+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999976 5899999998753322 234567899999999999999999998776 899999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999887643 36899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..... .
T Consensus 160 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~----------~ 221 (293)
T cd07843 160 L-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIF----------K 221 (293)
T ss_pred c-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH----------H
Confidence 1 111234577899999998764 468899999999999999999999975443221 11110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC--CCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~--~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
..+...+..+..+..+...- .....++.... +...++.. .+...+++++|+..||++|||++|+|+|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAK--KKTFTKYPYNQ-------LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HhCCCchHHHHHhhccchhc--ccccccccchh-------hhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 11111122222221111000 00001111111 12223332 455678999999999999999999999999
Q ss_pred c
Q 002178 936 V 936 (956)
Q Consensus 936 f 936 (956)
|
T Consensus 293 f 293 (293)
T cd07843 293 F 293 (293)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.38 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=206.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|+..+.||+|++|+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999975 5899999998754332 3457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998665567899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCcc----------------------ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 780 IEGIV----------------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 780 ~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
..... .........|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10000 00011234578899999999998899999999999999999999999964432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccc
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L 917 (956)
...... +..... ..|... .......+++.+|+
T Consensus 238 ~~~~~~----------~~~~~~------------------------~~~~~~--------------~~~~~~~~li~~~l 269 (316)
T cd05574 238 DETFSN----------ILKKEV------------------------TFPGSP--------------PVSSSARDLIRKLL 269 (316)
T ss_pred HHHHHH----------HhcCCc------------------------cCCCcc--------------ccCHHHHHHHHHHc
Confidence 111100 000000 000000 01122346777788
Q ss_pred CCCCCCCCC----CccCCCCCccccCCC
Q 002178 918 TSKEETPPS----SSSMLKHPYVSSDVS 941 (956)
Q Consensus 918 ~~dP~~R~s----a~e~L~HP~f~~~~~ 941 (956)
..||++|+| ++|+|+||||++-..
T Consensus 270 ~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred cCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 888888888 999999999987544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.25 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-C---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
..+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999863 2 3479999887543 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997653 35788999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... ........++..|+|||++.+..++.++|||||||++||+++ |+.||....... .... +.+
T Consensus 159 ~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~~---------~~~ 224 (267)
T cd05066 159 DPEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIKA---------IEE 224 (267)
T ss_pred ccce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHHH---------HhC
Confidence 2210 011112223568999999998899999999999999999887 999996543211 1111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+...+.+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111223345667889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.34 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=203.8
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 6899999998765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++.......
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 9999988542 4788999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ..
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~--------------------- 228 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MR--------------------- 228 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---------------------
Confidence 111234588999999999888899999999999999999999999864332110 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCCCc
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSN 944 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~~~ 944 (956)
.+............. ......+++.+|+..||++|||++|+++||||......+-
T Consensus 229 --------~~~~~~~~~~~~~~~-----------------~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 229 --------RIRDNLPPRVKDSHK-----------------VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred --------HHHhcCCCccccccc-----------------cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 001111000000000 0111235777788899999999999999999987776654
Q ss_pred cc
Q 002178 945 LV 946 (956)
Q Consensus 945 ~~ 946 (956)
.+
T Consensus 284 ~~ 285 (292)
T cd06658 284 IV 285 (292)
T ss_pred cc
Confidence 33
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.93 Aligned_cols=262 Identities=29% Similarity=0.443 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC-----------------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 684 (956)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999988542 2468999987543 334568899999999999999999
Q ss_pred eecccccCCcEEEEEecCCCCCHHHHHhhcC---------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCccc
Q 002178 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (956)
Q Consensus 685 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 755 (956)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997643 125889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh--CCCCCC
Q 002178 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 833 (956)
Q Consensus 756 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt--g~~pf~ 833 (956)
|+++.++.++|+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999876533221 111223446778999999998889999999999999999998 667776
Q ss_pred CCchhHHHHHHHhhcccchhhcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 834 HGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
....... ...... ...... ......+..++.++.+++.+|++.+|.+||++.++++.|+
T Consensus 236 ~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQV-IENAGH---FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHH-HHHHHh---ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 4332211 111100 000000 0111223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.55 Aligned_cols=203 Identities=31% Similarity=0.465 Sum_probs=172.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccC------C
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~ 693 (956)
+++.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5678899999999999999999965 68899999987543 3345788999999998 699999999998642 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+++++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6899999999999999998755567899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 160 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 653211 1123456889999999986 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.63 Aligned_cols=295 Identities=23% Similarity=0.331 Sum_probs=213.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc--------C
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 692 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 692 (956)
..|+...+||+|.||.||+|+.+ +|+.||+|+.--+. ..-.....+|++++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34566778999999999999965 58889998653221 1123467889999999999999999998843 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
...++||++|+. +|.-++... ...++..++.++++++..||.|+|... |+|||+|++|+|++.+|.+||+|||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999965 888888543 346888999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+.+...+.. .....+....|..|++||.+.+ ..|+++.|||.-||++.||.||.+.++...+. ++...
T Consensus 172 r~fs~~~n~---~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~------- 240 (376)
T KOG0669|consen 172 RAFSTSKNV---VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHL------- 240 (376)
T ss_pred cceeccccc---CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHH-------
Confidence 877654422 1223455667999999999987 56999999999999999999997777654432 22221
Q ss_pred hhhccCCCCCCChHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
+....+.+..+.++.+.++-. .-++..|--.-+...| +...+.+ ..++.+.|++.+||++||.+|+.++++
T Consensus 241 ---Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv----~n~~kp~-~kd~~a~dLle~ll~~DP~kR~~ad~a 312 (376)
T KOG0669|consen 241 ---ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKV----KNRLKPY-VKDDEALDLLEKLLKLDPTKRIDADQA 312 (376)
T ss_pred ---HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhh----hhhcccc-cCChhHHHHHHHHhccCcccCcchHhh
Confidence 122223333333322222111 0111111111122222 2222211 236778999999999999999999999
Q ss_pred CCCCccccCCCC
Q 002178 931 LKHPYVSSDVSG 942 (956)
Q Consensus 931 L~HP~f~~~~~~ 942 (956)
|+|.||..|.-.
T Consensus 313 lnh~~F~kdp~p 324 (376)
T KOG0669|consen 313 LNHDFFWKDPMP 324 (376)
T ss_pred hchhhhhcCCcc
Confidence 999999877664
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.26 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=175.4
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999964 6899999988643 233346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997755556889999999999999999999998 9999999999999999999999999997654321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|+..|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1122345788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.56 Aligned_cols=253 Identities=31% Similarity=0.500 Sum_probs=196.6
Q ss_pred CeeeeeCCeEEEEEEeC----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccc-cCCcEEEEEecCC
Q 002178 630 TQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEFMS 703 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~LV~e~~~ 703 (956)
+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2467999988643 2334567889999999999999999999764 4567899999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++.... ....+..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-- 154 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-- 154 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce--
Confidence 999999997643 23567778899999999999999998 999999999999999999999999999754322110
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCC-CCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.........++..|+|||.+.+..++.++|||||||++|||++|.. ||... +....... +..+.....
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~ 223 (262)
T cd05058 155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVY---------LLQGRRLLQ 223 (262)
T ss_pred -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH---------HhcCCCCCC
Confidence 0011123345678999999998899999999999999999999654 55432 22222111 112222233
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
+...+..+.+++..||+.+|++||++.++++.++++.
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 4455678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.12 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=208.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568888999999999999998643 3578999887654 3445688999999999999999999999875 46789
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997643 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... .......++..|+|||.+....++.++||||||+++||+++ |+.||........... +..
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----------~~~ 223 (270)
T cd05056 160 ESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----------IEN 223 (270)
T ss_pred ccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------HHc
Confidence 211 11112234568999999988889999999999999999996 9999976543221111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.....+..++..+.+++.+|+..+|.+||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22223455667889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.70 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=203.6
Q ss_pred CeeeeeCCeEEEEEEeCC--C--cEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILPD--G--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987665 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997754356899999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ....... .......+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~--------~~~~~~~~ 223 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK--------EGERLERP 223 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh--------cCCcCCCC
Confidence 111123456789999999999899999999999999999998 999996543321 1111110 11112234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 456678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.23 Aligned_cols=205 Identities=27% Similarity=0.400 Sum_probs=174.0
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455667777789999999999999954 688999999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCc--hhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRL 774 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~ 774 (956)
|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999997642 234 78888899999999999999998 999999999999976 67999999999876
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
..... .......|+..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 159 LAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 53211 1112235788999999986643 78899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.54 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-----------------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-----------------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 684 (956)
.++|++.+.||+|+||.||++... ++..||+|.+.... .....++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 24579999987543 334568899999999999999999
Q ss_pred eecccccCCcEEEEEecCCCCCHHHHHhhcCC---------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCccc
Q 002178 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK---------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (956)
Q Consensus 685 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 755 (956)
+++++...+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976421 23677889999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh--CCCCCC
Q 002178 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 833 (956)
Q Consensus 756 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt--g~~pf~ 833 (956)
|+++.++.++|+|||+++....... ........++..|+|||...++.++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999976532211 011122334678999999988889999999999999999998 677886
Q ss_pred CCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
..... +....... .............+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDE-QVIENTGE--FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChH-HHHHHHHH--HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 43321 11111000 00000001111223456688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.59 Aligned_cols=248 Identities=26% Similarity=0.443 Sum_probs=210.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+-|.+.++||+|+||+||||.++ .|++||+|.+... ...+++..|+.+|++...+++|++||.|......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34667889999999999999976 6999999988743 34568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
.-|++.+.++.+ +.++++.++..+.++.++||+|||... -||||||+.|||++-+|.+||+|||.|-.+...
T Consensus 111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---- 182 (502)
T KOG0574|consen 111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---- 182 (502)
T ss_pred CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh----
Confidence 999999999765 457999999999999999999999988 799999999999999999999999999765321
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
......+.||+.|||||++..-.|+.++||||+|+...||..|++||.+-..+. .++.+-....+.+
T Consensus 183 ---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------AIFMIPT~PPPTF 249 (502)
T KOG0574|consen 183 ---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------AIFMIPTKPPPTF 249 (502)
T ss_pred ---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------eeEeccCCCCCCC
Confidence 233466789999999999999999999999999999999999999997644321 1222222223333
Q ss_pred --ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 863 --PSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 863 --~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
|++++.++.++++.|+-+.|++|-++.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 78899999999999999999999988777653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.14 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 468999999876432 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.......+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998765566899999999999999999999998 99999999999999999999999999986543221
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
......+++.|+|||...+..++.++||||||+++|||++|..||..... .+... .+..+.+..
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~---------~~~~~~~~~ 220 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVV---------KIVQGNYTP 220 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHH---------HHHcCCCCC
Confidence 12334588999999999988889999999999999999999999865332 11111 111222223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.+...+..+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 33445566777777777777777777776664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.67 Aligned_cols=267 Identities=25% Similarity=0.422 Sum_probs=205.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 695 (956)
..|++.+.||+|+||.||++.. .++..||+|.++... ......+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 257899999987543 33346789999999999999999999998765 568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhH-HHHH---HHhh-ccc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVN---IAYQ-SSM 850 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~-~~~~---~~~~-~~~ 850 (956)
...... ........++..|+|||++.+..++.++|||||||++|||++++.|........ +... .... ...
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 432210 111223456778999999998889999999999999999999877653221100 0000 0000 000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
...+..+...+.+..++..+.+++.+|++.+|++||++.++++.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111222233455778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.76 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=200.4
Q ss_pred CeeeeeCCeEEEEEEeCC----CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
++||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999886544 34568899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 99999997654 5889999999999999999999998 999999999999999999999999999865432210
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... .. .......+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~-~~--------~~~~~~~~ 220 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAM-LE--------SGERLPRP 220 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHH-HH--------cCCcCCCC
Confidence 011112224568999999998899999999999999999998 99998654331 11111 11 11122345
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
..++..+.+++.+|++.+|.+||++.++.+.|+++
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 56678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.92 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=172.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
-|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677788999999999999975 578899999876665566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++... ..++++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999988653 346899999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1123345889999999984 345778999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.73 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.++||+|+||+||+|.+. +++ .||+|.++... ....+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467888999999999999999853 444 48999987543 33456788999999999999999999998754 578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
++|||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997543 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........++..|+|||...+..++.++|||||||++|||++ |..||....... ......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~-------- 225 (279)
T cd05109 161 IDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLE-------- 225 (279)
T ss_pred cccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------
Confidence 3211 011112234678999999999999999999999999999998 888886433211 111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.+.....+..++..+.+++.+||+.+|++||++.++++.++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122334456778899999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.76 Aligned_cols=205 Identities=28% Similarity=0.506 Sum_probs=174.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+|.+.+.||+|+||+||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999876432 11234688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 4788999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 156 GLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 11110 111123346889999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.35 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=172.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc-CCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e 700 (956)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 57899999986432 2334578899999999999999999998764 446789999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.......+++.+++.++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998755566899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1123345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.49 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=198.0
Q ss_pred CeeeeeCCeEEEEEEeC-CCc--EEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 57888887533 33456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 705 GTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 705 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
|+|.+++.... ...+++..+++++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 124788999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 849 (956)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... .+....
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~----- 223 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEK----- 223 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHH-----
Confidence 98632210 00111223567999999988889999999999999999997 9999864332 111111
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
+..+.....+..++..+.+++.+||..+|.+||++.++++.|+++.
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111112234445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.07 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=205.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CC---cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..|++.+.||+|+||.||+|... ++ ..||+|.+... .....++|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999964 33 36999998754 233456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999997643 35889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
..... .........+..|+|||.+.+..++.++|||||||++||+++ |..||...... +..... ...
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i---------~~~ 227 (269)
T cd05065 160 TSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI---------EQD 227 (269)
T ss_pred ccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH---------HcC
Confidence 21100 000011112457999999999999999999999999999887 99999754322 111111 011
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
...+.+.+++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223456677889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=310.18 Aligned_cols=253 Identities=27% Similarity=0.350 Sum_probs=192.5
Q ss_pred CeeeeeCCeEEEEEEeCC---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 630 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.||+|+||.||+|.+.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 4679999887543 233457889999999999999999999999989999999999999
Q ss_pred CHHHHHhhcC---CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 706 TLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 706 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+|.++++... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++++||+|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997532 224567788899999999999999999 99999999999999999999999999875432211
Q ss_pred ccccceecccccCCCcccccccccC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
........++..|+|||++.+. .++.++||||||+++|||++ |+.||........... ...... ...
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~-~~~ 230 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVREQQ-LKL 230 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hhhccc-CCC
Confidence 1111234567889999998642 35789999999999999996 9999975443221111 111000 001
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
. .+......+..+.+++..|| .+|++||+++++++.|+
T Consensus 231 ~---~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 P---KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C---CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 11112234567888999999 57999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.71 Aligned_cols=198 Identities=27% Similarity=0.440 Sum_probs=174.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 68999999986532 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999765 35889999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223458899999999988888999999999999999999999996544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.31 Aligned_cols=248 Identities=35% Similarity=0.546 Sum_probs=206.3
Q ss_pred CeeeeeCCeEEEEEEeCC----CcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7899999988654433 56889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 705 GTLRDQLSAKS-------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 705 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
++|.+++.... ...+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 356899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... ........++..|+|||.+....++.++||||+|+++|||++ |..||..... .+... .+..
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~---------~~~~ 222 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLE---------YLRK 222 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHH---------HHHc
Confidence 321 112233457889999999998889999999999999999999 6899876532 11111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
+.....+..++.++.+++.+|++.+|.+||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 233345666788999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=324.16 Aligned_cols=286 Identities=25% Similarity=0.344 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~L 697 (956)
.++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999965 6899999998743322 123567899999999999999999998654 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999995 58998886542 46899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~--------- 223 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQ--------- 223 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH---------
Confidence 21 11122345778999999876 5578999999999999999999999975543222 111110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+......+..+..+........+... .. .+...++...+...+++.+||.+||++|+|++|+++||||
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 224 -LLGTPNESIWPGFSDLPLVGKFTLPKQP--YN-------NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred -hcCCCChhhchhhhcccccccccccCCC--CC-------chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0111111111111111110000001000 00 0111122234556789999999999999999999999999
Q ss_pred ccCC
Q 002178 937 SSDV 940 (956)
Q Consensus 937 ~~~~ 940 (956)
....
T Consensus 294 ~~~~ 297 (309)
T cd07845 294 KEKP 297 (309)
T ss_pred ccCC
Confidence 7443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.57 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=189.3
Q ss_pred CeeeeeCCeEEEEEEeCC-------------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 630 TQIGQGGYGKVYKGILPD-------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358899877655555567888999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc-------EEEEee
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-------AKVADF 769 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~Df 769 (956)
+||||+++|+|..+++.+. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 35889999999999999999999998 999999999999987664 899999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccc-cCCCCCcccchhHHHHHHHHH-hCCCCCCCCchhHHHHHHHhh
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~G~ll~ell-tg~~pf~~~~~~~~~~~~~~~ 847 (956)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||..... .+.... .
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~-~- 222 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERF-Y- 222 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHHHH-H-
Confidence 998654211 2234778999999987 467899999999999999998 57777754321 111110 0
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
.+.. .........+.+++.+||+.+|.+||++.++++.+
T Consensus 223 --------~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 --------EGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------hcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0011 11122346788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.03 Aligned_cols=278 Identities=26% Similarity=0.402 Sum_probs=205.9
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
|++.+.||.|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999965 799999999875432 22357888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+++|.+++.......+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 579999997765556899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||............ .. . ...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~---------~-~~~ 218 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI-FR---------T-LGT 218 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HH---------H-hCC
Confidence 111223467899999988764 5788999999999999999999999765443222111 00 0 011
Q ss_pred CChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 862 YPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
...........+.... ..-+.. .+... ...+.......+++.+|+..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 219 PDEDVWPGVTSLPDYK-PTFPKWARQDLS----------KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChHHhhhhhhchhhh-hhcccccccchh----------hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111111111110000 000100 11111 1122233445689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.90 Aligned_cols=200 Identities=26% Similarity=0.427 Sum_probs=170.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 6899999988753 223346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
+++++|.+++.... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999986532 23689999999999999999999974 6 999999999999999999999999998765321
Q ss_pred CCCccccceecccccCCCcccccccccCC------CCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 --------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred --------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 112335788999999986543 478999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=308.36 Aligned_cols=206 Identities=27% Similarity=0.479 Sum_probs=173.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---------hHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
+|.+...||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777889999999999999864 6889999988643221 12467889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999764 35788899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 642211100 0111223457889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.48 Aligned_cols=281 Identities=24% Similarity=0.367 Sum_probs=204.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcC-CCceeeeecccccCCc-----
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGE----- 694 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 694 (956)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999965 6899999987653222 2357888999999995 6999999999876655
Q ss_pred EEEEEecCCCCCHHHHHhhcC---CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeec
Q 002178 695 QMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 770 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfG 770 (956)
.++||||+++ +|.+++.... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8999886532 246899999999999999999999998 999999999999998 8999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||............ +.
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~-- 226 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FK-- 226 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HH--
Confidence 987653221 11122346788999998865 45789999999999999999999999765443322211 10
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
.+ ...+.........+.... ..|..+|. ......+.......+||.+||..||++|++++|
T Consensus 227 ----~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 227 ----LL----GTPTEQVWPGVSKLRDWH--EFPQWKPQ---------DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred ----Hh----CCCChhhCcchhhccchh--hcCcccch---------hHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00 000111111111110000 00111111 011122344555678999999999999999999
Q ss_pred CCCCCccc
Q 002178 930 MLKHPYVS 937 (956)
Q Consensus 930 ~L~HP~f~ 937 (956)
++.||||.
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.94 Aligned_cols=251 Identities=31% Similarity=0.515 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999987788999998875433 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999997543 35788999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
........++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ..+.....
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~---------~~~~~~~~ 222 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETI---------NAGFRLYK 222 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH---------hCCCCCCC
Confidence 011122235678999999998889999999999999999998 8999865432 1111110 11111112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 333567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=304.66 Aligned_cols=248 Identities=30% Similarity=0.484 Sum_probs=201.5
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHH
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 708 (956)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988764443 4568899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccce
Q 002178 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (956)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 788 (956)
+++.... ..+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||.+........ ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9996643 35788999999999999999999998 99999999999999999999999999976532110 001
Q ss_pred ecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 002178 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867 (956)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 867 (956)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... +........+...+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-~~~---------~~~~~~~~~~~~~~ 221 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-RER---------IESGYRMPAPQLCP 221 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-HHH---------HhcCCCCCCCccCC
Confidence 111223567999999998899999999999999999999 8888865432111 111 00111223455667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 868 EKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 868 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
..+.+++.+|+..+|++||++.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 88999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.16 Aligned_cols=206 Identities=30% Similarity=0.412 Sum_probs=176.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+......++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999964 68899999987533 23456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56899999999999999999999998 99999999999999999999999999877653321
Q ss_pred CCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
. .........|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 158 ~---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 R---TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred c---cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 1 01122344688999999998876 7899999999999999999999999643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.14 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=195.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHH-HHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||.||+|... +|+.||+|+++... .....++..|+.. ++..+|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 69999999987543 2234456667664 666789999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|++ |+|.+++... ....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7998888652 235689999999999999999999987 6 99999999999999999999999999876532
Q ss_pred CCCCCccccceecccccCCCccccccccc----CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......+....
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------- 219 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ--------- 219 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH---------
Confidence 1 11122457889999998865 45688999999999999999999998643221111110
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
...+.....+. .+ ......+++.+|+..+|++||+++++++|
T Consensus 220 ~~~~~~~~~~~-------------------~~-------------------~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLPA-------------------EK-------------------FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCCc-------------------cc-------------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00 01122357777888888888899999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||.....
T Consensus 262 ~~~~~~~~ 269 (283)
T cd06617 262 PFFELHLS 269 (283)
T ss_pred chhhhccc
Confidence 99987764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=311.88 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=174.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.+.|++.++||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999975 5899999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|..++.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999998876543 35889999999999999999999998 999999999999999999999999998653221
Q ss_pred CccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
........++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 ----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11122345788999999985 345678999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.87 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=175.1
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999975 58999999987532 2345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999764 46889999999999999999999998 9999999999999999999999999987654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1233457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.35 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=202.6
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 447999999999999964 6899999998765445556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 998754 34789999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 867 (956)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----------------------- 228 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKR----------------------- 228 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-----------------------
Confidence 12234588999999999988899999999999999999999999974432111 000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCCCcccc
Q 002178 868 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 947 (956)
Q Consensus 868 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~~~~~~ 947 (956)
+........... ........+++++|++.+|++||+++|+++||||......+.+++
T Consensus 229 ------~~~~~~~~~~~~-----------------~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~ 285 (297)
T cd06659 229 ------LRDSPPPKLKNA-----------------HKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285 (297)
T ss_pred ------HhccCCCCcccc-----------------CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccccc
Confidence 000000000000 011122346778888888999999999999999877665555544
Q ss_pred c
Q 002178 948 G 948 (956)
Q Consensus 948 ~ 948 (956)
.
T Consensus 286 ~ 286 (297)
T cd06659 286 L 286 (297)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.48 Aligned_cols=193 Identities=26% Similarity=0.417 Sum_probs=167.7
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||+||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 689999998865322 2244667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.......+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+...... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 99998765557899999999999999999999999 999999999999999999999999998765321 1
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 112345778999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=314.63 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=191.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecC--CChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 699 (956)
...|++.+.||+||.++||++...+.+.||+|++.. ...+....|.+|++.|.+++ |.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888999999999999999988888999887654 33444578999999999995 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||= ..+|..+|..+......| .++.+..|++.++.++|++| |||.||||.|.|+-+ |.+||+|||+|.......
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 976 679999998876655555 77889999999999999999 999999999999875 699999999998775432
Q ss_pred CCCccccceecccccCCCcccccccccCC-----------CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----------LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~ 848 (956)
..-.....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||..-.+...
T Consensus 514 -----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-------- 580 (677)
T KOG0596|consen 514 -----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-------- 580 (677)
T ss_pred -----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH--------
Confidence 122345568999999999996432 45689999999999999999999975333221
Q ss_pred ccchhhccCCC-CCCChHHH-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 849 SMMFSVIDGNM-GSYPSECV-EKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 849 ~~~~~~~~~~~-~~~~~~~~-~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.+..+.++.. .+||+.-. .++.++|+.|+..||.+||+..++++
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2223344322 12221100 11566666666655555555555543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.01 Aligned_cols=276 Identities=26% Similarity=0.338 Sum_probs=206.9
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCC----
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 693 (956)
...++|++.+.||+|+||.||+|..+ +|+.||+|.++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 589999999875332 22356778999999999999999999986544
Q ss_pred ------cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 694 ------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 694 ------~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999965 787777654 346899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~ 846 (956)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~------- 225 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA------- 225 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-------
Confidence 9999986543221 11122345778999998865 457889999999999999999999986443211
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHHhHhhCCCCCCCCcccccccc
Q 002178 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE---------LESIWNMMPESDTKTPEFINSEH 917 (956)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~---------L~~~~~~~~~~~~~~~~ll~~~L 917 (956)
.+..+...|....+..+|.+.+.... ...+............+++.+|+
T Consensus 226 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 283 (302)
T cd07864 226 ----------------------QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283 (302)
T ss_pred ----------------------HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHc
Confidence 12222223333333333322211100 00111112223445578999999
Q ss_pred CCCCCCCCCCccCCCCCcc
Q 002178 918 TSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 918 ~~dP~~R~sa~e~L~HP~f 936 (956)
..||++||++++++.||||
T Consensus 284 ~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 284 TLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cCChhhCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.46 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
..+|++.+.||+|+||+||+|.++ +|+ .||+|....... .....+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356888899999999999999864 333 689998876543 345678899999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997643 34889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........++..|+|||.+....++.++|||||||++||+++ |+.||..... .+.... +.
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~---------~~ 225 (279)
T cd05057 161 VDEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDL---------LE 225 (279)
T ss_pred Cccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHH---------Hh
Confidence 2211 011112224568999999988889999999999999999999 9999865432 111111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..+...+.+++.+||..+|..||++.++++.++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122223344566788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=306.09 Aligned_cols=200 Identities=31% Similarity=0.475 Sum_probs=176.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|+..+.||+|+||.||+|...+ ++.|++|.+..... .+++.+|++++++++|+||+++++++.+....++|+||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678999999999999999999764 88999999875432 56899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999999996533 46899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122344788999999999989999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.00 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=175.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999975 6899999998876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999986543 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1123345888999999975 345778999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.40 Aligned_cols=249 Identities=32% Similarity=0.505 Sum_probs=200.1
Q ss_pred CeeeeeCCeEEEEEEeCC-------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999876543 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-----CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-----cEEEEeecc
Q 002178 702 MSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-----TAKVADFGL 771 (956)
Q Consensus 702 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~DfGl 771 (956)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234788999999999999999999998 99999999999999887 899999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||....+... ...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-~~~------ 225 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-LQH------ 225 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-HHH------
Confidence 9765332211 11122345678999999999999999999999999999998 9999865443221 111
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+..+.....+...+..+.+++.+||..+|.+||++.++.+.|+
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ---VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111222345566788999999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.59 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999996 478999999987655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 999999998643 4788899999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC--
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-- 860 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 860 (956)
.......+++.|+|||.+.+..++.++|||||||++|++++|+.||......... .........
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----------~~~~~~~~~~~ 235 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------YLIATNGTPEL 235 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----------eeeccCCCCCC
Confidence 1122345788999999999988999999999999999999999999654321110 000000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
..+...+ ....+++.+|+..+|++|++++++++||||....
T Consensus 236 ~~~~~~~---------------------------------------~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 236 QNPERLS---------------------------------------AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CCccccC---------------------------------------HHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 0011111 1122567778888888888888999999987766
Q ss_pred CCCccc
Q 002178 941 SGSNLV 946 (956)
Q Consensus 941 ~~~~~~ 946 (956)
.-+.+.
T Consensus 277 ~~~~~~ 282 (297)
T cd06656 277 PLSSLT 282 (297)
T ss_pred cccccC
Confidence 654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.85 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=194.5
Q ss_pred HHHHHhcCCCCCCee--eeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCC
Q 002178 618 EMALATNNFNSSTQI--GQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (956)
Q Consensus 618 ~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 693 (956)
+.....++|++.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444445677777777 99999999999964 688999999865322211 22222222 6999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLS 772 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla 772 (956)
..++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 6899999999999999999999999 99999999999999998 9999999998
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.......-.
T Consensus 158 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----------- 215 (267)
T PHA03390 158 KIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD----------- 215 (267)
T ss_pred eecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-----------
Confidence 765321 1235788999999999989999999999999999999999999633211000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCC-ccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-~e~L 931 (956)
...+. ...... +. ..+..+..+.+||.+||+.||.+|+++ +|+|
T Consensus 216 --------------~~~~~----~~~~~~----~~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 216 --------------LESLL----KRQQKK----LP-------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred --------------HHHHH----Hhhccc----CC-------------cccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00000 000000 00 001223344578999999999999974 9999
Q ss_pred CCCcccc
Q 002178 932 KHPYVSS 938 (956)
Q Consensus 932 ~HP~f~~ 938 (956)
+||||.+
T Consensus 261 ~h~~~~~ 267 (267)
T PHA03390 261 KHPFLKI 267 (267)
T ss_pred cCCcccC
Confidence 9999964
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.99 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=212.1
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
.+.||+|.||+||-|+.+ +|+.||||++.+... ..+..+.+|+.+|+.++||.||.+.-.|+..+..+.|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999964 799999999876443 34578899999999999999999999999999999999999 67
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC---CcEEEEeeccccccCCCCCCC
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~~ 782 (956)
+..+++-...+..+++...+.++.||+.||.|||.++ |+|+||||+|||+.+. .++||+|||.|+..+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch-----
Confidence 7777776666677999888999999999999999999 9999999999999654 4799999999998763
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
......+.||+.|+|||+++...|...-|+||.||++|--++|..||..+++..++.+.+. . -+
T Consensus 720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------F-My 783 (888)
T KOG4236|consen 720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------F-MY 783 (888)
T ss_pred ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------c-cc
Confidence 3456678899999999999999999999999999999999999999987776655544210 0 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
|. + .+.+....++|||+.+|+..-++|.|.+..|.|||++.-.-
T Consensus 784 Pp----------------~-------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 784 PP----------------N-------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred CC----------------C-------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 11 1 11233455678999999999999999999999999976543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.21 Aligned_cols=246 Identities=30% Similarity=0.485 Sum_probs=201.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|+||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 67889999986532 235788999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999998765556889999999999999999999998 999999999999999999999999998754211
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... .. .+.....
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~-~~--------~~~~~~~ 218 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKEC-VE--------KGYRMEP 218 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHH-Hh--------CCCCCCC
Confidence 111234567999999998899999999999999999998 88888654321 11111 11 1112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+..++..+.+++.+||+.+|++||+++++++.|+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 4556788899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.86 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=173.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356777889999999999999864 6899999998765444445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++...+ .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999999986543 5889999999999999999999999 9999999999999999999999999987653211
Q ss_pred CccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346889999999974 456888999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=310.51 Aligned_cols=199 Identities=31% Similarity=0.429 Sum_probs=175.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999987543 33345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999754 6889999999999999999999998 9999999999999999999999999998764321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1123345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=307.52 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=190.6
Q ss_pred eeeeeCCeEEEEEEeCC---CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCC
Q 002178 631 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.||+|+||+||+|...+ ...+|+|.+..... .....+.+|++.++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 45788888764432 334578899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC---CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 707 LRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 707 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
|.+++..... ...++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999976432 23467788899999999999999998 999999999999999999999999998654322110
Q ss_pred cccceecccccCCCccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||....+....... ..... .
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~----~ 228 (269)
T cd05042 157 ---ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQD----I 228 (269)
T ss_pred ---eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hhccC----c
Confidence 01122345678999999743 356789999999999999999 77788654432211111 11100 0
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
....+..+..++..+.+++..|| .+|++||++++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11112234456677888899999 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.84 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=188.1
Q ss_pred eeeeeCCeEEEEEEeCC-------------------------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeee
Q 002178 631 QIGQGGYGKVYKGILPD-------------------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 685 (956)
.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998876554445678889999999999999999
Q ss_pred ecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---
Q 002178 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF--- 762 (956)
Q Consensus 686 ~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--- 762 (956)
++++......++||||+++|+|..++... ...+++..+..++.||++||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 335788889999999999999999998 99999999999997644
Q ss_pred ----cEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHH-hCCCCCCCCc
Q 002178 763 ----TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELL-TGMQPISHGK 836 (956)
Q Consensus 763 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~ell-tg~~pf~~~~ 836 (956)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999987643211 12246788999998875 56889999999999999995 6888886543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
.... ...+. . ....+......+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~--~~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEK--ERFYE---------K-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHH--HHHHH---------h-ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2111 11111 0 1112223345788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=344.97 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=202.6
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc--C
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--E 692 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 692 (956)
+.....++|.+.+.||+|+||+||+|... ++..||+|.+.... ......+..|+.++++++||||++++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 33445578999999999999999999965 57899999887432 2335678899999999999999999998854 4
Q ss_pred CcEEEEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCC----CCEeccCCCcccEEEcC------
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEAD----PPVFHRDIKASNILLDH------ 760 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlk~~NILl~~------ 760 (956)
...++||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999999753 23468999999999999999999998542 34999999999999964
Q ss_pred -----------CCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHh
Q 002178 761 -----------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLT 827 (956)
Q Consensus 761 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~ellt 827 (956)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3459999999997653221 1234568999999999864 458899999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 828 GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 828 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
|+.||............. ...........+..+.+++..||..+|.+||++.+++.
T Consensus 239 Gk~PF~~~~~~~qli~~l----------k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISEL----------KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCCcCCcHHHHHHHH----------hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999997655433322211 10111111234577889999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.10 Aligned_cols=239 Identities=24% Similarity=0.420 Sum_probs=191.5
Q ss_pred CeeeeeCCeEEEEEEeCC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 234888887655545556788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc--------EEEEeecccc
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKVADFGLSR 773 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~DfGla~ 773 (956)
+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997643 35889999999999999999999998 999999999999987765 6999999886
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCC-CCCCCCchhHHHHHHHhhcccc
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGM-QPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~-~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... ...... .
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~-~----- 218 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF-Y----- 218 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-H-----
Confidence 5421 122457789999999987 45789999999999999999995 44433222 111111 0
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
......|...+.++.+++.+||+.+|++||+++++++.|
T Consensus 219 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 -----EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112234444567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=305.95 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=173.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 68899999886543 23356788999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.+++.......+++..+++++.|+++||+|||+++ ++|+||||+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998765566899999999999999999999998 9999999999999855 468999999998654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112345788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.49 Aligned_cols=279 Identities=26% Similarity=0.378 Sum_probs=206.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999975 58899999886532 2234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++++.+..+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887676655432 34889999999999999999999998 99999999999999999999999999987643221
Q ss_pred CCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||.............. . .
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------~----~ 218 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK-------C----L 218 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-------H----h
Confidence 122334578899999999887 889999999999999999999999875433221111000 0 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhHhhCCCC-CCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPES-DTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~----~RPs~~~v~~~L~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
+..+......+ ..++. +.|...+. ..+...++.. .....+|+++|+..+|++||+++++++||
T Consensus 219 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 219 GPLPPSHQELF--------SSNPRFAGVAFPEPSQP----ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred CCCCHHHhhhc--------ccCccccccccCCCCCc----HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 11111100000 00000 00111100 0111122222 55667899999999999999999999999
Q ss_pred cc
Q 002178 935 YV 936 (956)
Q Consensus 935 ~f 936 (956)
||
T Consensus 287 ~f 288 (288)
T cd07833 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.24 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=175.6
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccc-
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD- 690 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~- 690 (956)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566678899999999999999999999864 68899999876432 2235678899999999 6999999999873
Q ss_pred ----cCCcEEEEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 691 ----EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 691 ----~~~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
.++..++||||+++++|.++++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988642 2346888999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
||+|||+++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999987653221 11223458899999999853 457889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.53 Aligned_cols=280 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEEEEe
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVYE 700 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV~e 700 (956)
|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999976 58999999998653 23345788999999999999999999999887 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 59998886543 46899999999999999999999998 99999999999999999999999999986643321
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......... .
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~----------~ 218 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFEL----------C 218 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH----------h
Confidence 11223356788999998765 45788999999999999999999999754432 111111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..........+.++ +.......++.....+ ... +.. ......+++++|+..+|++||+++++++||||
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 219 GSPTDENWPGVSKL---PWFENLKPKKPYKRRL---REF---FKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCCchhhccccccc---hhhhhccccccchhHH---HHH---hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111111111111 1111111111111111 111 111 14456789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=320.49 Aligned_cols=289 Identities=24% Similarity=0.372 Sum_probs=208.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC-----CcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 695 (956)
+++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68999999986422 22345678899999999999999999886543 357
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++|+||++ ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588888754 35889999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
...... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ..... ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~------~~~ 225 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLI------LGV 225 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH------HHH
Confidence 432211 111233468899999998765 568899999999999999999999996543221 11110 001
Q ss_pred ccCCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
++..+.+....+.... ...+...|.. +... .....+..+....+++.+||..||++|||++|+++|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 ----LGTPSQEDLNCIISLRARNYIKSLPFK-PKVP--------WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred ----cCCCCHHHHHHhhchhhhhHHhhcCcC-Cccc--------HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111111111 1111111111 1110 001123345667799999999999999999999999
Q ss_pred CccccCCCC
Q 002178 934 PYVSSDVSG 942 (956)
Q Consensus 934 P~f~~~~~~ 942 (956)
|||..-...
T Consensus 293 p~~~~~~~~ 301 (336)
T cd07849 293 PYLEQYHDP 301 (336)
T ss_pred ccccccCCC
Confidence 999766554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=311.65 Aligned_cols=280 Identities=24% Similarity=0.403 Sum_probs=207.1
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+|++.++||+|++|.||+|+.. +|+.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 6899999998754332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 703 SNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 703 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 7 58999886543 346899999999999999999999998 9999999999999999999999999997543211
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||....... ....... . ..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~------~----~~ 218 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFR------I----MG 218 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH------H----hC
Confidence 11123346789999999866 457889999999999999999999997554322 1111110 0 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
.........+... .. +..+...+ ..... ....+..+....+++.+|++.||++|++++|+++||||
T Consensus 219 ~~~~~~~~~~~~~-~~-~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 219 TPTESTWPGISQL-PE-YKPTFPRY-PPQDL-------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChhhHHHHhcC-ch-hcccccCC-ChHHH-------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1111111111110 00 11111111 11111 11123335566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=311.88 Aligned_cols=199 Identities=31% Similarity=0.454 Sum_probs=173.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999965 68999999876543 3345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999998664 358899999999999999999997 46 999999999999999999999999998654211
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......|+..|+|||++.+..++.++|||||||++||+++|+.||...
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 112345889999999998889999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.92 Aligned_cols=286 Identities=24% Similarity=0.324 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCC------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 693 (956)
-++|++.++||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999965 689999998864322 22345678999999999999999999876543
Q ss_pred --cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 694 --EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 694 --~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
..++||||+. ++|.+++.... ..+++.+++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 58988886543 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
+.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~----- 237 (310)
T cd07865 166 ARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS----- 237 (310)
T ss_pred cccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 98664332110 1112234577899999988764 47889999999999999999999987544321111100
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCc
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~--~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
.+ .+..+.+.......+ .++.. .|.. ....+...+. ....+....+++.+|+..||++|||++
T Consensus 238 --~~----~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~l~-----~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 238 --QL----CGSITPEVWPGVDKL--ELFKKMELPQG--QKRKVKERLK-----PYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred --HH----hCCCChhhcccccch--hhhhhccCCCc--cchhhHHhcc-----cccCCHHHHHHHHHHhcCChhhccCHH
Confidence 00 111111111111000 00000 0110 0000111110 011234456899999999999999999
Q ss_pred cCCCCCcc
Q 002178 929 SMLKHPYV 936 (956)
Q Consensus 929 e~L~HP~f 936 (956)
|+|+||||
T Consensus 303 e~l~h~~f 310 (310)
T cd07865 303 TALNHDFF 310 (310)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=315.67 Aligned_cols=293 Identities=20% Similarity=0.216 Sum_probs=199.8
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555544 6899999998754 33345688999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 002178 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (956)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 786 (956)
|.+++.......+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+..............
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999998765556889999999999999999999999 99999999999999999999999999875532221111111
Q ss_pred ceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 787 HVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. ......++... .+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKST--YPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCc--hhh
Confidence 12233457788999999876 4588899999999999999999999976543322211110 00001111000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 865 ECVEKFIKLALKCCQDETDARPSMSE-VMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 865 ~~~~~l~~l~~~c~~~~p~~RPs~~~-v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
.. ..... .+ .+...+.... .-..... .......+|+.+||.+||++|||++|+|+||||+....+
T Consensus 239 ~~-~~~~~---~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 239 YE-DSMSQ---SR---SSNEHPNNRDSVDHPYTR------TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred hc-CCcCc---cc---ccccccchhhhhhcchhh------HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 00 00000 00 0000000000 0000000 001234578999999999999999999999999866544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.46 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=177.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999964 5789999998865555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999998764 245889999999999999999999998 9999999999999999999999999987653211
Q ss_pred CccccceecccccCCCcccccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 -----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578899999999876 88999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.93 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=204.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++|++...||+|+||+||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999864 2467999988754433 3567899999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcCC-------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 697 LVYEFMSNGTLRDQLSAKSK-------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
+||||+++|+|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976441 25899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 848 (956)
|++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+...
T Consensus 162 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~--- 231 (275)
T cd05046 162 SLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRL--- 231 (275)
T ss_pred ccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHH---
Confidence 99875432211 11122345678999999988888999999999999999999 77888643321 111111
Q ss_pred ccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 849 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 849 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
..+.. ...+..++..+.+++.+|++.+|.+||++.++++.|.
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10111 1223456678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.11 Aligned_cols=203 Identities=31% Similarity=0.450 Sum_probs=170.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 695 (956)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999964 58999999876422 1233568889999999999999999998865 3567
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997543 4788889999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 321111 11112345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.40 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=173.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+-|.++..||.|+||+||+|..++ +-..|.|++...+.....+|.-|+++|....||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345567789999999999999764 5556778887767777789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
.||-.+..+-.-+ .++.+.++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----- 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----- 182 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-----
Confidence 9999999886643 46999999999999999999999999 99999999999999999999999999754321
Q ss_pred ccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.........||+.|||||+.+ ..+|++++||||||++|.||..+.+|...
T Consensus 183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 233456678999999999986 46899999999999999999999888754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.47 Aligned_cols=284 Identities=23% Similarity=0.347 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|++|+||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999975 689999998865332 223568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 779 (956)
|++ ++|.+++.......+++..+..++.||+.||+|||+++ ++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 68988886655555688888899999999999999998 999999999999985 5679999999997643211
Q ss_pred CCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......++..|+|||++.+ ..++.++||||+||++|||+||+.||............ +. ..
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~-~~------~~--- 220 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI-FR------IL--- 220 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HH------Hh---
Confidence 11123356789999999876 45788999999999999999999999754432221111 00 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+......+.....+-.. ....|..++.. .....+.....+.+++.+|++.+|++||+++++++||||..
T Consensus 221 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 221 -GTPNEETWPGVTSLPDY-KSAFPKWPPKD---------LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred -CCCChhhccccccchhh-hhhcccCCCCC---------HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00001010000000000 00011111110 01112344555678999999999999999999999999975
Q ss_pred C
Q 002178 939 D 939 (956)
Q Consensus 939 ~ 939 (956)
-
T Consensus 290 ~ 290 (294)
T PLN00009 290 L 290 (294)
T ss_pred H
Confidence 3
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.33 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=198.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556778999999999999865 58899999887433 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.. ..+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++++|||++.......
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999854 35788999999999999999999998 9999999999999999999999999997654221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+........
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~---------~~~~~~~~~~ 221 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-LF---------LIPKNSPPTL 221 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-Hh---------hhhcCCCCCC
Confidence 111224578899999999998899999999999999999999999864322110 00 1111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
+..++..+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 44556677888888888888888888888763
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.56 Aligned_cols=210 Identities=29% Similarity=0.452 Sum_probs=176.0
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeeccccc-
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 691 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 691 (956)
++.++....+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555667789999999999999999999964 68999999886533 2345678899999998 69999999999843
Q ss_pred -----CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 692 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 692 -----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999997765566888889999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987543211 1122345888999999986 346788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.04 Aligned_cols=267 Identities=27% Similarity=0.444 Sum_probs=207.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeeccccc--CCcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 695 (956)
..|+..+.||+|+||.||+|.+. +++.||||.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999853 3689999998865443 45689999999999999999999999876 5578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHH-HHH---hhcccc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV-NIA---YQSSMM 851 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~-~~~---~~~~~~ 851 (956)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ... .....+
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 422110 111112335567999999998899999999999999999999999986432111000 000 000000
Q ss_pred hhhcc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 852 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 852 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+.+. ......+..++.++.+++.+|++.+|++||++.+++++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 112233455668899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.04 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=197.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++++.|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999965 58899999887543 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999999864 34788889999999999999999998 9999999999999999999999999997654321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||++.+..++.++|||||||++|||++|..||........ .. .+.......
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~---------~~~~~~~~~ 220 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-LF---------LIPKNNPPT 220 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-hh---------hhhcCCCCC
Confidence 112234578899999999988899999999999999999999999865432111 00 011111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 44556666777777777777777777666654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.54 Aligned_cols=200 Identities=28% Similarity=0.378 Sum_probs=170.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV~ 699 (956)
++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 689999998875332 345678999999999999999999998854 34789999
Q ss_pred ecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||+++++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998764 23345788999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.. .....++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 12334778999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.92 Aligned_cols=257 Identities=21% Similarity=0.375 Sum_probs=202.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
+|...+.||+|++|.||+|... +++.|++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445678999999999999964 689999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 9999999866 34788999999999999999999999 9999999999999999999999999887543211
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-~~~~------------------- 226 (285)
T cd06648 170 ---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AMKR------------------- 226 (285)
T ss_pred ---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-HHHH-------------------
Confidence 11223458899999999998889999999999999999999999986433211 1100
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+.... .|...+ .........+++++|+..+|++||+++|+++||||.....
T Consensus 227 ----------~~~~~------~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 227 ----------IRDNL------PPKLKN-----------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ----------HHhcC------CCCCcc-----------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00000 000000 0001122346888889999999999999999999977554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.17 Aligned_cols=190 Identities=27% Similarity=0.391 Sum_probs=158.0
Q ss_pred eeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHh---cCCCceeeeecccccCCcEEEEEecCC
Q 002178 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSR---LHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.||+|+||.||++... +++.||+|.+..... .....+.+|..+++. .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 689999998865322 122334455444433 479999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999987543 5899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 122358999999999864 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.88 Aligned_cols=203 Identities=29% Similarity=0.433 Sum_probs=170.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 695 (956)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 58999999875321 12235788899999999999999999988653 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... .+++...++++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999997543 4778888999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 322110 11122345888999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=319.71 Aligned_cols=204 Identities=24% Similarity=0.302 Sum_probs=164.8
Q ss_pred Ceeeee--CCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
..||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999964 79999999987533 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556889999999999999999999998 999999999999999999999999865433211110000
Q ss_pred ccceecccccCCCcccccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 00001112355679999999763 47889999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.15 Aligned_cols=211 Identities=30% Similarity=0.444 Sum_probs=174.7
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
+...++..++++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334455556889999999999999999999964 68999999986532 2245678899999998 79999999999854
Q ss_pred C-----CcEEEEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 692 E-----GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 692 ~-----~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
. +..++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3689999999999999988642 3346889999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
||+|||++....... .......|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999987654221 111234578899999998643 3688999999999999999999999654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.88 Aligned_cols=199 Identities=30% Similarity=0.480 Sum_probs=172.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 78999999876433 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997643 4789999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
. ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 123345788999999987766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.25 Aligned_cols=250 Identities=34% Similarity=0.550 Sum_probs=203.9
Q ss_pred CCCCCeeeeeCCeEEEEEEeCC-----CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 626 FNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+++.+.||+|+||.||++...+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 388999999765443 4678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.. ......++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ...... +....
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~---------~~~~~ 221 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEY---------LKKGY 221 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---------HhcCC
Confidence 11 1112236789999999988889999999999999999998 7777764322 111111 11122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
....+...+.++.+++.+|+..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 233445577889999999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=319.28 Aligned_cols=290 Identities=22% Similarity=0.355 Sum_probs=212.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc----CCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 695 (956)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999965 68999999987532 2234567889999999999999999998753 3468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999988654 34899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
...... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~--------- 224 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLI--------- 224 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHH---------
Confidence 432211 1112233468889999999865 568899999999999999999999996543321 11110
Q ss_pred ccCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 855 IDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
....+..+.+..... .+.+..+++..+...+... ....+.......+++.+|+..||++||++++++.|
T Consensus 225 -~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 225 -LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW---------SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH---------HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111222221111 1122233333333222111 01123335556789999999999999999999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||..-..
T Consensus 295 ~~~~~~~~ 302 (334)
T cd07855 295 PFLAQYHD 302 (334)
T ss_pred hhhhhccC
Confidence 99964443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.74 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=188.6
Q ss_pred eeeeeCCeEEEEEEeCCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCC
Q 002178 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.||+|+||+||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985432 356677766433 3345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 707 LRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 707 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|.++++... ....++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997642 234667778899999999999999998 99999999999999999999999999864321110
Q ss_pred ccceecccccCCCccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
........++..|+|||++.. ..++.++|||||||++|||++ |..||...... +........ ......+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD-QQVKLFK 231 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh-cccccCC
Confidence 111123457889999999753 245778999999999999997 56677544332 211111111 1111111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
+..+....+.+.+++..|| .+|++||++.++++.|
T Consensus 232 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 ---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2223345677888999999 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=319.48 Aligned_cols=284 Identities=23% Similarity=0.360 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccC---------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------- 692 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------- 692 (956)
..+|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999964 6899999998766555567788999999999999999999876543
Q ss_pred -----CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEE
Q 002178 693 -----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 766 (956)
Q Consensus 693 -----~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 766 (956)
...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 699888853 24788999999999999999999999 99999999999997 4567899
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 157 ~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~- 231 (342)
T cd07854 157 GDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI- 231 (342)
T ss_pred CCcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 999999765322110 111122357889999998754 56788999999999999999999999765443221111
Q ss_pred hhcccchhhccCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 924 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 924 (956)
++. .+....+....+ ..+...+.......+.+..+ ..+..+....+|+.+||+.||++|
T Consensus 232 ---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 232 ---------LES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD----------LLPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred ---------HHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHH----------HccCCCHHHHHHHHHHhCCCchhc
Confidence 111 111111111111 12222222112111212221 123344556689999999999999
Q ss_pred CCCccCCCCCcccc
Q 002178 925 PSSSSMLKHPYVSS 938 (956)
Q Consensus 925 ~sa~e~L~HP~f~~ 938 (956)
+|++|++.||||+.
T Consensus 292 ~t~~ell~h~~~~~ 305 (342)
T cd07854 292 LTAEEALMHPYMSC 305 (342)
T ss_pred cCHHHHhCCCcccc
Confidence 99999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=306.74 Aligned_cols=192 Identities=24% Similarity=0.382 Sum_probs=167.8
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||.|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 489999999865332 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 9999764 34888999999999999999999998 9999999999999999999999999998654321
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......++..|+|||.+.+..++.++|+||+|+++|||++|..||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.88 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=199.7
Q ss_pred CCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCC------
Q 002178 626 FNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 693 (956)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987542 233567889999999999999999999875432
Q ss_pred cEEEEEecCCCCCHHHHHhhc----CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 694 EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
..++++||+++|+|.+++... ....+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 1235788899999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 848 (956)
|.++....... ........++..|++||.+....++.++|||||||++|||++ |+.||..... .+....
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~---- 227 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNY---- 227 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHH----
Confidence 99986532211 011122335678999999998889999999999999999999 8888864432 111111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+........+...+..+.+++.+|++.+|++||++.++.+.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 -----LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111223345667899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.14 Aligned_cols=203 Identities=32% Similarity=0.468 Sum_probs=174.5
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 6899999998765442 457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++... ..+++..++.++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999764 34788899999999999999999999 999999999999999999999999999876433211
Q ss_pred CccccceecccccCCCcccccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
. ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11012345788999999998766 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.78 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=174.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999976 68999999887643 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997643 568889999999999999999999 88 9999999999999999999999999987543211
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11156788999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.96 Aligned_cols=251 Identities=20% Similarity=0.361 Sum_probs=201.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeCC--CcEEEEEEecCCC----------hhhHHHHHHHHHHHHh-cCCCceeeeeccccc
Q 002178 625 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS----------LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE 691 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 691 (956)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 7889999875321 1223457788888765 799999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998854 234468899999999999999999996 56 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~ 848 (956)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~---- 224 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATK---- 224 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHH----
Confidence 99997654221 223445888999999999888999999999999999999999999654322 11111
Q ss_pred ccchhhccCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 849 SMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+..+...+.+ ..++..+.+++.+||+.+|++||++.++..+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111222 245678999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=315.65 Aligned_cols=288 Identities=26% Similarity=0.361 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccC-------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------- 692 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 692 (956)
.++|++.++||+|+||.||+|... +++.||+|++...... ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6899999988643322 234677899999999999999999987443
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 693 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
...++||||++ +++...+... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999995 5787777543 346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcc----ccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002178 772 SRLAPVPDIEGIV----PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 772 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~ 846 (956)
++........... .........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9765432211110 1112234467889999998865 45788999999999999999999998654432 2111111
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCC
Q 002178 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
. .. ...++........+.... +...+...+...+ .++.......+|+.+||..||++||
T Consensus 241 ~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 241 K------LC----GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE----------RFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred H------Hh----CCCChhhchhhhhcccccccccCCCCCccHHH----------HcccCChhHHHHHHHHcccCcccCc
Confidence 0 00 001111011000000000 0001111111111 1223335567899999999999999
Q ss_pred CCccCCCCCcc
Q 002178 926 SSSSMLKHPYV 936 (956)
Q Consensus 926 sa~e~L~HP~f 936 (956)
|+.|++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.19 Aligned_cols=284 Identities=21% Similarity=0.335 Sum_probs=208.1
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
.+++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666789999999999999999999985 478999999987532 22345678899999999999999999987532
Q ss_pred ------CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 693 ------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 693 ------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
...++|++++ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3478888887 88999888543 4889999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 162 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~ 230 (345)
T cd07877 162 LDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 230 (345)
T ss_pred ecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999875421 1123457889999999876 5688899999999999999999999965433211 1110
Q ss_pred hhcccchhhccCCCCCCChHHHHHH----HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKF----IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 921 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l----~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP 921 (956)
.. . .+..+......+ ......+....|..+. . +......+...+++.+||..||
T Consensus 231 ~~---------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~li~~~L~~dp 288 (345)
T cd07877 231 LR---------L-VGTPGAELLKKISSESARNYIQSLTQMPKMNF--A----------NVFIGANPLAVDLLEKMLVLDS 288 (345)
T ss_pred HH---------H-hCCCCHHHHhhcccHhHHHHHHHhcccCCcch--h----------hhcCCCCHHHHHHHHHHcCCCh
Confidence 00 0 001111111111 1111112222221111 0 0111234456789999999999
Q ss_pred CCCCCCccCCCCCccccC
Q 002178 922 ETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 922 ~~R~sa~e~L~HP~f~~~ 939 (956)
++|+++.|+++||||..-
T Consensus 289 ~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 289 DKRITAAQALAHAYFAQY 306 (345)
T ss_pred hhcCCHHHHhcChhhhhc
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.67 Aligned_cols=276 Identities=24% Similarity=0.350 Sum_probs=198.8
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcC-CCceeeeecccccC--CcEEEEEe
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVYE 700 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~LV~e 700 (956)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999964 689999999875322 22234567889999885 99999999999877 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++ |+|.+.+.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888886543 46899999999999999999999998 999999999999999 999999999997653221
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.... ...
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~----------~~~ 215 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIH----------DVL 215 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHH----------HHc
Confidence 1122357889999998654 557889999999999999999999996544321 111100 001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
+..++.....+..- ...-...|..-+. .+....+.......+++.+||..+|++||+++++++||||
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 216 GTPDAEVLKKFRKS-RHMNYNFPSKKGT---------GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CCCCHHHHHhhccc-ccccccCcccccc---------cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11122221110000 0000000100000 0111122334556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.94 Aligned_cols=237 Identities=24% Similarity=0.410 Sum_probs=189.5
Q ss_pred CeeeeeCCeEEEEEEeCC-C----------cEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 630 TQIGQGGYGKVYKGILPD-G----------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+.||+|+||.||+|.+.+ + ..|++|.+...... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999754 3 25788877654433 5788999999999999999999999987 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-------cEEEEeecc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-------TAKVADFGL 771 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~DfGl 771 (956)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976542 5888899999999999999999998 99999999999999888 799999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccC--CCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 848 (956)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||..... ..... .+.
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~-~~~- 220 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKER-FYQ- 220 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHH-HHh-
Confidence 876432 1123466789999999876 78999999999999999999 5667754432 11111 111
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
.......+ ....+.+++.+||..+|.+||++.++++.|
T Consensus 221 -------~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -------DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111111 127889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=300.45 Aligned_cols=202 Identities=25% Similarity=0.435 Sum_probs=172.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 478999999886432 1124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 776 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~ 776 (956)
||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999754 35788999999999999999999998 99999999999998776 69999999997764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
..... .........++..|+|||.+.+..++.++||||+|++++||++|+.||..
T Consensus 156 ~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 156 AKGTG---AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccc---CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 32111 01112234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=302.33 Aligned_cols=201 Identities=27% Similarity=0.455 Sum_probs=169.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh----------hHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ----------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
+|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999854 6899999987532111 1246788999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 35888999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... .........|+..|+|||.+.... ++.++||||||+++||+++|..||...
T Consensus 157 ~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 157 KSDDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred cccccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 643211 011123345888999999987654 788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.05 Aligned_cols=203 Identities=32% Similarity=0.452 Sum_probs=172.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCC------
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG------ 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------ 693 (956)
++++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999975 578999999875443 346789999999999 6999999999986543
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987533 456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87653211 11233458889999998754 34678899999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.72 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=195.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 578999998875432 23457789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999664 35888999999999999999999998 9999999999999999999999999987422111
Q ss_pred CCCc--------cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 780 IEGI--------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 780 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.... ..........++..|+|||.+.+..++.++|||||||++|||++|..||..... .+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~~~~~~~~~--- 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISD--- 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc---
Confidence 0000 000111224578899999999988899999999999999999999999974432 1111111000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
....+..+...+..+.+++.+|++.+|++||++.++.+.+
T Consensus 232 ----~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 232 ----DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ----ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 0001111123455667777777777777777654444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.01 Aligned_cols=202 Identities=25% Similarity=0.423 Sum_probs=171.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV~ 699 (956)
+|++.+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 68899999886432 3335678899999999999999999998753 45679999
Q ss_pred ecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhh-----hcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLH-----TEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 700 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
||+++++|.+++... ...++++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999653 2456899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
....... .......++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 158 ~~~~~~~-------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDS-------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCc-------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 8764322 11223458899999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=318.87 Aligned_cols=281 Identities=23% Similarity=0.363 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 693 (956)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 68999999886532 12235678999999999999999999998644 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999995 57777652 34788999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~------ 228 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL------ 228 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------
Confidence 54211 123356788999999876 4688899999999999999999999975433221 11111
Q ss_pred hhccCCCCCCChHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
. ..+...+.....+..... ......|. .|. ..+...++..+....+++.+|++.||++|++++|++
T Consensus 229 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 229 ---K-VTGVPGPEFVQKLEDKAAKSYIKSLPK-YPR--------KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred ---H-hcCCCCHHHHHHhcccchHHHHhhcCC-ccc--------chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 011111222111111000 00000000 000 011112234455567899999999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
.||||..-..
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 9999976543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.53 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=173.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999975 58899999886532 22345778999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.+++.......+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997765556899999999999999999999998 99999999999999885 56999999987654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122345888999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=299.43 Aligned_cols=201 Identities=30% Similarity=0.429 Sum_probs=176.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 599999999876544 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999764 458999999999999999999999 88 99999999999999999999999999886543221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1123457889999999999899999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=295.27 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=177.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHH---HHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|+.+++||+|.||+|-+++-+ .++.+|+|++++.......+ -..|-++|+.-+||.+..+--.|+..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467788899999999999999854 79999999998765444333 35688999999999999999899999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||..||.|.-++.+. ..+++...+.+-..|+.||.|||+++ ||.||||.+|.|+|.+|.+||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999988653 45888888899999999999999998 9999999999999999999999999997532
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.........+||+.|+|||++....|..++|.|.+||++|||++|+.||...
T Consensus 320 -----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 320 -----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred -----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2344567789999999999999999999999999999999999999999754
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.80 Aligned_cols=199 Identities=28% Similarity=0.439 Sum_probs=168.9
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999875443 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC-cccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPA 786 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 786 (956)
.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 5899999999999999999999998 9999999999999999999999999987643321100 0001
Q ss_pred ceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......++..|+|||......++.++||||||+++||+++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1223445788999999999888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.58 Aligned_cols=290 Identities=25% Similarity=0.367 Sum_probs=212.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCC-----cEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 696 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 696 (956)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58999999987643 334567899999999999999999999997765 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||++ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 58999886543 6899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ......
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~--------- 220 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIV--------- 220 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH---------
Confidence 33210 0112334578899999999887 78999999999999999999999997554321 111110
Q ss_pred cCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 856 DGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
...+..+.+..... ...+.......+..++ . .+....+.......+++.+||..+|++||+++++++||
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 221 -EVLGTPSEEDLKFITSEKARNYLKSLPKKPK-K--------PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred -HhcCCCChhHhhhccccchhhHHhhcccCCc-c--------hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00111111111100 0000000000011000 0 01112233445567899999999999999999999999
Q ss_pred ccccCCCCCc
Q 002178 935 YVSSDVSGSN 944 (956)
Q Consensus 935 ~f~~~~~~~~ 944 (956)
||++-...++
T Consensus 291 ~~~~~~~~~~ 300 (330)
T cd07834 291 YLAQLHDPED 300 (330)
T ss_pred cHHhhccccc
Confidence 9976555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.06 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=175.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68889999999999999999854 68899999987555455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999999653 3778899999999999999999999 9999999999999999999999999987553221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......+++.|+|||.+.+..++.++||||||+++||+++|+.||....
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=334.77 Aligned_cols=209 Identities=27% Similarity=0.319 Sum_probs=182.6
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
..++..-.++|++.++||+|+||.|..++.+ ++++||.|++++..+- ...-|..|-.+|..-..+-|+.++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4466667789999999999999999999975 6899999999874332 23567888889999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
+.+.|+|||||+||+|-.++.+.. .+++..++.++..|+-||.-+|+.| +|||||||+|||+|..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999997765 6888889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
+-.+.... .-.+....|||-|++||++.. +.|+..+|.||+||++|||+.|..||...
T Consensus 222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 87665332 234456779999999999853 56899999999999999999999999643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.96 Aligned_cols=292 Identities=21% Similarity=0.292 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC--------CCceeeeeccccc--
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCDE-- 691 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~~-- 691 (956)
..+|.+.++||.|.|++||+|.+ ++.+.||+|+.+... ...+..+.|+++|++++ ..+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 47899999999999999999985 468999999988633 33456788999999984 3479999999954
Q ss_pred --CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC--------
Q 002178 692 --EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------- 761 (956)
Q Consensus 692 --~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-------- 761 (956)
+.+.|+|+|++ |-+|..+|.....+.++...+++|++||+.||.|||+++. |||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhhh
Confidence 45899999999 8899999998877889999999999999999999999874 9999999999999210
Q ss_pred --------------------------------------------------------------------------------
Q 002178 762 -------------------------------------------------------------------------------- 761 (956)
Q Consensus 762 -------------------------------------------------------------------------------- 761 (956)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 002178 762 ------------------------------------------------------------------------------FT 763 (956)
Q Consensus 762 ------------------------------------------------------------------------------~~ 763 (956)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc--hh-HH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NI-VR 840 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~--~~-~~ 840 (956)
+||+|||-|+... ...+.-+.|..|+|||++.+..|+..+||||++|++|||.||...|.... +. .+
T Consensus 393 vKIaDlGNACW~~----------khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 393 VKIADLGNACWVH----------KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred EEEeeccchhhhh----------hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 3444444444321 11233457889999999999999999999999999999999999996421 11 11
Q ss_pred HHHHHhhcccchhhccCCCCCCChHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccc
Q 002178 841 EVNIAYQSSMMFSVIDGNMGSYPSEC------VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 914 (956)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~ 914 (956)
....+. +-..++.+|... +.++..---.... -.|-.+--+.+.|.+.++...+...++.+||.
T Consensus 463 EDHiA~--------i~ELLG~iPr~ia~~Gk~SRdFFnr~G~Lrh---I~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~ 531 (590)
T KOG1290|consen 463 EDHIAL--------IMELLGKIPRKIALGGKYSRDFFNRRGELRH---IRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS 531 (590)
T ss_pred HHHHHH--------HHHHHhhccHHHHhcCcchHhhhccccceec---ccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence 111110 001112222211 1111110000000 01222223334444555555556677889999
Q ss_pred cccCCCCCCCCCCccCCCCCccccC
Q 002178 915 SEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 915 ~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
.||+++|++|+||.++|+|||+..-
T Consensus 532 PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 532 PMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred HHHhcCccccccHHHHhcCccccCC
Confidence 9999999999999999999999743
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.94 Aligned_cols=278 Identities=26% Similarity=0.401 Sum_probs=208.7
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
|++.+.||+|++|.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999965 6899999998754332 3567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 6 58988886643 46899999999999999999999999 9999999999999999999999999997664321
Q ss_pred ccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ ...... ..+.
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~----------~~~~ 217 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFR----------TLGT 217 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH----------HcCC
Confidence 112234577899999998876 789999999999999999999999976544322 111110 0111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 862 YPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
...+....+.+.+..+....|... ....++. +..+....+|+.+|+..||.+||+++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF----------PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhh----------hhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111222222222222211112211 1221111 2234455689999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=314.39 Aligned_cols=292 Identities=25% Similarity=0.339 Sum_probs=207.3
Q ss_pred hcCCCC-CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh--------------HHHHHHHHHHHHhcCCCceeeee
Q 002178 623 TNNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------------EKEFLTEIQFLSRLHHRNLVSLV 686 (956)
Q Consensus 623 ~~~y~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~ 686 (956)
.++|.. .+.||+|+||+||+|... +++.||||.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 346654 467999999999999965 68999999886432221 12577899999999999999999
Q ss_pred cccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 687 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
+++..++..++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 99999999999999996 6999998653 34888999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCCCc-------cccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchh
Q 002178 767 ADFGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~ 838 (956)
+|||++........... ..........++..|+|||.+.+. .++.++|||||||++|||++|+.||....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976542111000 001111223467889999998764 4688999999999999999999999755432
Q ss_pred HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccC
Q 002178 839 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 918 (956)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~ 918 (956)
.. ...... .. +..+...+.....+... ....+...+... ...+.......+++.+|+.
T Consensus 241 ~~-~~~i~~------~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~ 298 (335)
T PTZ00024 241 DQ-LGRIFE------LL----GTPNEDNWPQAKKLPLY-TEFTPRKPKDLK----------TIFPNASDDAIDLLQSLLK 298 (335)
T ss_pred HH-HHHHHH------Hh----CCCchhhCcchhhcccc-cccCcCCcccHH----------HhCcCCChHHHHHHHHHcC
Confidence 21 111100 00 00000000000000000 000111111111 1123334556789999999
Q ss_pred CCCCCCCCCccCCCCCccccCCCC
Q 002178 919 SKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 919 ~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
.||++|++++|+|.||||+.+..-
T Consensus 299 ~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 299 LNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CCchhccCHHHHhcCcccCCCCCC
Confidence 999999999999999999987664
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.33 Aligned_cols=279 Identities=27% Similarity=0.386 Sum_probs=205.0
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
|++.+.||+|++|+||+|+.. +++.||+|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 588999998875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999997765556899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
......++..|+|||++.+ ..++.++||||||++++||++|+.||............. .. .+.
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~-------~~----~~~ 217 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC-------SV----LGT 217 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH-------Hh----cCC
Confidence 1123457889999998854 557899999999999999999999986543322111100 00 111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
...+....-..+.. .+...-..++.. . + ....+.......+++++|++.||++||+++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~-~----~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 218 PTKQDWPEGYKLAS-KLGFRFPQFAPT-S----L---HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CChhhhhhHhhhhc-cccccccccccc-c----H---HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11111111111110 111100000000 0 0 11223334556789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.04 Aligned_cols=207 Identities=25% Similarity=0.372 Sum_probs=176.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV 698 (956)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999965 68999999987532 233467889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997653 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCCcc-------------ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIV-------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... .........++..|+|||...+..++.++||||||++++|+++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 211000 011223345788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=302.42 Aligned_cols=276 Identities=26% Similarity=0.380 Sum_probs=199.7
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhc---CCCceeeeecccccCCc-----
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGE----- 694 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 694 (956)
|++.+.||+|+||.||+|+.+ +++.||+|++...... ....+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 4899999998743221 234566788777666 59999999999987766
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.+++|||+. ++|.+++.......+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 58999987655556899999999999999999999998 99999999999999999999999999977
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~--- 224 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL--- 224 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC---
Confidence 64321 11223467899999999998999999999999999999999888865432 2222211110000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
......+.. ......+....+. +.+.++. ++......+++.+|+..||++||+++|+++||
T Consensus 225 --~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 225 --PSEEEWPRN-----VSLPRSSFPSYTP--RSFKSFV----------PEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred --CChHhcCCC-----cccchhhcccccc--cchhhhh----------hhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 000000000 0000000100010 1111111 12233445799999999999999999999999
Q ss_pred cc
Q 002178 935 YV 936 (956)
Q Consensus 935 ~f 936 (956)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=315.30 Aligned_cols=284 Identities=25% Similarity=0.376 Sum_probs=207.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC-----Cc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 694 (956)
.++|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999964 6899999988653 222345677899999999999999999988543 35
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7999988654 35889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ....... .
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~------~ 223 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLIT------E 223 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHH------H
Confidence 54221 11223457889999998865 46889999999999999999999999654321 1111100 0
Q ss_pred hccCCCCCCChHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCc
Q 002178 854 VIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
.. +..+.+... ...+.+. ......++... ...+...+...+++++||+.||++|||++
T Consensus 224 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 224 LL----GSPSEEDLGFIRNEKARRYIR---SLPYTPRQSFA----------RLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred Hh----CCCChHHhhhcCchhhhHHHH---hcCcccccCHH----------HHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 00 111111000 0000000 00011112211 11233445567899999999999999999
Q ss_pred cCCCCCccccCCCCC
Q 002178 929 SMLKHPYVSSDVSGS 943 (956)
Q Consensus 929 e~L~HP~f~~~~~~~ 943 (956)
|+++||||......+
T Consensus 287 ell~h~~~~~~~~~~ 301 (337)
T cd07858 287 EALAHPYLASLHDPS 301 (337)
T ss_pred HHHcCcchhhhcCcc
Confidence 999999997655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=341.79 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=208.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.+-+++...+||.|.||.||.|. ..+|...|+|-++... ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 35677788999999999999999 4579999999776432 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||||++|+|.+.+.... ..++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999996533 3677777889999999999999999 999999999999999999999999999877543
Q ss_pred CCCCccccceecccccCCCcccccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
- ...+ .......||+.|||||++.+. ...-+.||||+||++.||.||++||..-++.. ..++.+-
T Consensus 1388 ~--~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---------aIMy~V~ 1455 (1509)
T KOG4645|consen 1388 A--QTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---------AIMYHVA 1455 (1509)
T ss_pred h--hcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---------HHHhHHh
Confidence 1 1111 223456799999999999763 35668999999999999999999997544322 2344555
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.+..+++|+..+.+-.+++..|+..||.+|.++.|+++
T Consensus 1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 66677888888888888888999888888866665543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.58 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=177.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++.|+..+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 689999999876544 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997754 46899999999999999999999988 9999999999999999999999999987543221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 171 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 ------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999998889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.55 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=168.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEe----CCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 3689999999875322 2235678899999999 599999999999988899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999764 35788889999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCcccccccccC--CCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
..... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 32211 111234588899999998753 467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.82 Aligned_cols=277 Identities=28% Similarity=0.422 Sum_probs=206.3
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987643 223457788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 7 69999997653 35899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......++..|+|||.+.+. .++.++|||||||++||+++|+.||........ ...... ....
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~----------~~~~ 217 (282)
T cd07829 153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQ----------ILGT 217 (282)
T ss_pred ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHH----------HhCC
Confidence 112223456789999998776 789999999999999999999988865443221 111100 0111
Q ss_pred CChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 862 YPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 862 ~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
..+..+..+.++. ..+..+....++ ....++..+....+++++|+..||++||++++++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPKD-----------LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CcHHHHHhhcccccccccccccCccc-----------hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1122222221111 000000000000 012233335556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=301.30 Aligned_cols=198 Identities=29% Similarity=0.470 Sum_probs=170.7
Q ss_pred CCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC---CCceeeeecccccCCcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.... ....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999996 478999999986542 233467889999999997 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 5889999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223458889999999875 45688999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.15 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=196.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 68999999876433 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch---
Confidence 99999999864 34789999999999999999999998 9999999999999999999999999987654221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......++..|+|||.+.+..++.++|||||||++|||++|..||...... ..... +........
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~---------~~~~~~~~~ 221 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFL---------IPKNNPPTL 221 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHH---------HhcCCCCCC
Confidence 1112345788999999998888899999999999999999999998643321 11111 111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
+..++..+.+++.+|++.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 4445566777777787777777777777776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=302.30 Aligned_cols=245 Identities=30% Similarity=0.465 Sum_probs=191.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|+..+.||+|+||+||+|... +++.||+|.+.... ....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999965 68999999886432 22345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99996 68888775432 35899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
....++..|+|||++. ...++.++||||||+++|||++|+.||............ .
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----------~ 227 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----------A 227 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH----------h
Confidence 1235778999999984 356888999999999999999999999754432221111 1
Q ss_pred cCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 856 DGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 856 ~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
...... .+..++..+.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111 12345556666677777766666666666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=310.59 Aligned_cols=290 Identities=26% Similarity=0.395 Sum_probs=208.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhc-CCCceeeeecccccC--CcE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE--GEQ 695 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 695 (956)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 6889999987542 223345677899999999 999999999998643 368
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||++ ++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 6999988654 5788899999999999999999998 999999999999999999999999999866
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
....... .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~------- 227 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIE------- 227 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-------
Confidence 4322110 0112233468899999998865 4578899999999999999999999965433221 111100
Q ss_pred ccCCCCCCChHHHHHHH-HHHHHhcccCC-CCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 855 IDGNMGSYPSECVEKFI-KLALKCCQDET-DARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~-~l~~~c~~~~p-~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
..+..+.+....+. .....++...+ ..++.+.+ ..+.......+++.+|++.||++|||+.++++
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 228 ---VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE----------LLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred ---HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh----------hccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111222222111 11111111111 11122211 12333455568999999999999999999999
Q ss_pred CCccccCCC
Q 002178 933 HPYVSSDVS 941 (956)
Q Consensus 933 HP~f~~~~~ 941 (956)
||||+....
T Consensus 295 ~~~~~~~~~ 303 (337)
T cd07852 295 HPYVAQFHN 303 (337)
T ss_pred Chhhhhhcc
Confidence 999966543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.17 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=197.7
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHH
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 708 (956)
.+||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999864 78999999987555555667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccce
Q 002178 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (956)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 788 (956)
+++... .+++.....++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ..
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~~ 172 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------PR 172 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------cc
Confidence 987542 4788899999999999999999998 9999999999999999999999999987543211 11
Q ss_pred ecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHH
Q 002178 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 868 (956)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (956)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||...... +...
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~------------------------- 226 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK------------------------- 226 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-------------------------
Confidence 22345788999999998888899999999999999999999998643221 1000
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 869 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 869 ~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+..++.... + ..........+++.+|+..||.+|++++++++||||.....
T Consensus 227 ----~~~~~~~~~~---~--------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 227 ----MIRDNLPPKL---K--------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ----HHHhhCCccc---C--------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0000000000 0 00011112235677888888999999999999999876665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.09 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=198.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.+.+..||.|..|.||++..+ .|..+|||.+... +.+..++++..+.++..-+ +|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3444667999999999999976 5899999998764 3444577888888766654 89999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
| .-..+.++++ -..++++...-++...+.+||.||.+++. |+|||+||+|||+|+.|++|++|||++-.+..
T Consensus 173 M-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---- 244 (391)
T KOG0983|consen 173 M-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD---- 244 (391)
T ss_pred H-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec----
Confidence 8 3455555544 45679999999999999999999998764 99999999999999999999999999976542
Q ss_pred CccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
+...+...|.+.|||||.+.- ..|+.++||||||+.++|+.||+.||...+...+.+. .+++..
T Consensus 245 ----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---------kvln~e 311 (391)
T KOG0983|consen 245 ----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---------KVLNEE 311 (391)
T ss_pred ----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH---------HHHhcC
Confidence 233455679999999999964 4688899999999999999999999986544333222 223323
Q ss_pred CCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 859 MGSY--PSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 859 ~~~~--~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.+.. ...++..+.+++..|+.+|+.+||...++++.
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 3322 23478899999999999999999999888753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=311.93 Aligned_cols=281 Identities=23% Similarity=0.362 Sum_probs=206.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCC-----
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 693 (956)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 78999999986432 223456889999999999999999999886543
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 694 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 694 -~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7899988853 35889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
...... .....++..|+|||.+.+ ..++.++||||+||++|++++|+.||............ ..
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~-~~---- 230 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI-MK---- 230 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HH----
Confidence 764321 122356889999999876 45888999999999999999999999755432211111 00
Q ss_pred hhhccCCCCCCChHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
.....+.+....+..- ...-...-|..++. + +....+.......+++.+||..||++|+|+.++
T Consensus 231 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 231 ------VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK--D-------FRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred ------hcCCCCHHHHHhhcchhHHHHHHhccccCcc--h-------HHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 0011122222221110 00000001111111 0 111223444556789999999999999999999
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
++||||+..
T Consensus 296 l~~~~~~~~ 304 (343)
T cd07880 296 LAHPYFEEF 304 (343)
T ss_pred hcCccHhhh
Confidence 999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=314.34 Aligned_cols=281 Identities=22% Similarity=0.351 Sum_probs=207.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc----
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 694 (956)
..++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999975 58899999886432 2234567889999999999999999998866554
Q ss_pred --EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 695 --QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 695 --~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799999864 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
...... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...... ..+.....
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~---- 230 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN---- 230 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH----
Confidence 765321 123357788999999865 46788999999999999999999999755432 22211110
Q ss_pred hhhccCCCCCCChHHHHHHHHHH--HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLA--LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~--~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
..+..++.....+..-. ..+.......++...++ .+..+....+++++||..||++|||++|
T Consensus 231 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 231 ------LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV----------FSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred ------hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH----------hccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 01112222222111000 00000011112222211 1223455678999999999999999999
Q ss_pred CCCCCccccCC
Q 002178 930 MLKHPYVSSDV 940 (956)
Q Consensus 930 ~L~HP~f~~~~ 940 (956)
+++||||..-.
T Consensus 295 ll~h~~~~~~~ 305 (343)
T cd07851 295 ALAHPYLAEYH 305 (343)
T ss_pred HhcCCCccccC
Confidence 99999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=302.58 Aligned_cols=191 Identities=27% Similarity=0.383 Sum_probs=158.8
Q ss_pred eeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHH---HHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6899999988653322 1223444443 4445579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999988653 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1234588999999999754 6889999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.27 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=176.5
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 699 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV~ 699 (956)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999876443 4456889999999999999999999999887 8899999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 6899999999999999999999988 9999999999999999999999999998765332
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.. .......++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 01234568889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.29 Aligned_cols=282 Identities=24% Similarity=0.354 Sum_probs=214.2
Q ss_pred CCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC-----CcEEEEE
Q 002178 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQMLVY 699 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~LV~ 699 (956)
..+.||.|+||.||...+. +|+.||.|++... +....+.+.+|++++..++|.|++..++..+.. .++|.|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 4578999999999999964 7999999988642 334567899999999999999999998876543 3678899
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|.|. .+|...+- +.+.++.+.++-+..||++||.|||+.+ |.||||||.|.|++++...||+|||+|+..+..+
T Consensus 137 ELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 9984 57877773 3556888889999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
....+...-|..|+|||.+++ ..|+.+.||||.||++.|++.++..|..... .++.+. +...
T Consensus 211 ------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~l----------ItdL 273 (449)
T KOG0664|consen 211 ------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQM----------IIDL 273 (449)
T ss_pred ------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHH----------HHHH
Confidence 334455667889999999998 5699999999999999999988777765433 333222 2223
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
++....+.+..-.+-++.-+-..+.+-|+..-+.. |. .......++.+++..|+.+||++|++.++++.|+|..
T Consensus 274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt-ls----S~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK-IA----SPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee-ec----CCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 44444555554444444444444555565543221 11 1112334457899999999999999999999999963
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.75 Aligned_cols=190 Identities=27% Similarity=0.367 Sum_probs=160.5
Q ss_pred CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHH-HHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||.||+|... +++.||+|.+....... ...+..|..+ ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 68999999987543222 2334455544 3455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9999999754 35788889999999999999999998 99999999999999999999999999875421
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12335788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=350.00 Aligned_cols=298 Identities=30% Similarity=0.515 Sum_probs=269.5
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|+|++|.+.+.+|..+.++++|++|+|++|.+++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|+|
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~- 418 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG- 418 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
.+|..|.++++|+.|+|++|.+++..+. +..+++|+.|+|++|++.+.+|......+|+.|+|++|++++..|..|.++
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhh
Confidence 6888999999999999999999987764 778899999999999999888887766789999999999998899889999
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCC-CCCC-CCCCCcEEEecCCccc
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l-~~~~-~~~~l~~l~l~~Np~~ 385 (956)
++|+.|+|++|++.+.+|..+..+.+ |+.|+|++|++++. |..+ .++.++.|+|++|.+.
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~-----L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKK-----LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccC-----CCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence 99999999999999888888765544 55888898888864 4444 5788888888888764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=290.39 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=176.6
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999975 689999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999987643 46899999999999999999999988 99999999999999999999999999876543210
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23446788999999999888999999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.89 Aligned_cols=199 Identities=29% Similarity=0.412 Sum_probs=165.1
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999965 68999999987533 234567889999999996 99999999999988999999999
Q ss_pred CCCCCHHHHH---hhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 702 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 702 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
+. +++.++. .......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 5665543 333345689999999999999999999975 6 99999999999999999999999999976532
Q ss_pred CCCCCccccceecccccCCCcccccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 21 11233578899999999776 6889999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.71 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=176.4
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999975 689999999876433 4456788999999999999999999999888999999999
Q ss_pred CCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
+++++|.+++.... ...+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 357899999999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223345888999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=290.68 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=175.4
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788899999999999999865 688999999876543 3456789999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999765 45899999999999999999999998 99999999999999999999999999987643221
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......++..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1233457889999999988888999999999999999999999996543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.72 Aligned_cols=264 Identities=14% Similarity=0.159 Sum_probs=187.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCChh--hH---------HHHHHHHHHHHhcCCCceeeeec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ--GE---------KEFLTEIQFLSRLHHRNLVSLVG 687 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~---------~~~~~E~~~l~~l~h~nIv~l~~ 687 (956)
.++|++.+.||+|+||+||+|...+ +..+|+|+....... .+ .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999653 456677754322211 11 11223344556678999999998
Q ss_pred ccccCC----cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 688 YCDEEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 688 ~~~~~~----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 765433 447888887 457777775432 3567788899999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~ 843 (956)
+||+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987643221110011112334699999999999999999999999999999999999999975432211111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 895 (956)
... ......+..+.. ....++..+.+++..|++.+|++||+++++.+.+
T Consensus 245 ~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAK-CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhH-HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100 000111111111 1233467899999999999999999999998765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=284.10 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=198.1
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHH-HhcCCCceeeeecccccCCcEEEEEecCCCC
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFL-SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
...||.|+||+|+|-.++ .|+..|||++..... ...++++.|.+.. +.-++||||+++|.+..++..++.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 457999999999998865 699999999987655 4567889998854 4457999999999999999999999999 56
Q ss_pred CHHHHHh---hcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 706 TLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 706 sL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
||+.+.. ...+..+++...-+|+.....||.||-+.. .|||||+||+|||++..|.+||+|||.+-.+.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv------ 219 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV------ 219 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH------
Confidence 7766543 334456888888899999999999998765 49999999999999999999999999986543
Q ss_pred ccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.+-..+...|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+....+..+++... ..+..+
T Consensus 220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V---------v~gdpp 288 (361)
T KOG1006|consen 220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV---------VIGDPP 288 (361)
T ss_pred --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH---------HcCCCC
Confidence 1223455678899999999964 458999999999999999999999998766655554432 222222
Q ss_pred --CCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 861 --SYPS---ECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 861 --~~~~---~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.++. ++...+...+..|+-++-..||++.++.+.
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2233 367789999999999999999999988753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=298.90 Aligned_cols=274 Identities=24% Similarity=0.384 Sum_probs=210.4
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC-Chhh------HHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQG------EKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
|-....++|-.++.||+|||+.||||.+ ...+.||||+-... +... .+...+|.++.+.+.||.||++|+||
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3344567888899999999999999994 56899999975432 1111 24567899999999999999999999
Q ss_pred c-cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc---CCCcEE
Q 002178 690 D-EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAK 765 (956)
Q Consensus 690 ~-~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~k 765 (956)
. +.+.+|-|+|||+|.+|+-||+.+. .+++.+++.|+.||+.||.||.+. .+||||-||||.|||+. .-|.+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 5 5568899999999999999997643 589999999999999999999987 48899999999999995 457899
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 841 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~ 841 (956)
|+|||+++..+.................||..|++||.+.-+ +.+.++||||+||++|.++.|+.||.+.....+.
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999999876654444444555667899999999998643 5788999999999999999999999765432222
Q ss_pred HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCC
Q 002178 842 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 921 (956)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP 921 (956)
++. ..+ +...--.+| .-|.-..++.+||+++|.+.-
T Consensus 694 Lqe----NTI---lkAtEVqFP-------------------------------------~KPvVsseAkaFIRRCLaYRK 729 (775)
T KOG1151|consen 694 LQE----NTI---LKATEVQFP-------------------------------------PKPVVSSEAKAFIRRCLAYRK 729 (775)
T ss_pred Hhh----hch---hcceeccCC-------------------------------------CCCccCHHHHHHHHHHHHhhh
Confidence 111 111 000000111 112234445678888888888
Q ss_pred CCCCCCccCCCCCcccc
Q 002178 922 ETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 922 ~~R~sa~e~L~HP~f~~ 938 (956)
++|+.+.++-.||||.-
T Consensus 730 eDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 730 EDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhhhhHHHHccCccccc
Confidence 99999999999999843
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=291.28 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=196.5
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+|++.++||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999854 68899999987533 23345778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998662 2346889999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... +... ....+..
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~ 218 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRY---------KVQRGKY 218 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHhcCCC
Confidence 112245788999999999999999999999999999999999999754321 1111 1111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
+..+..+...+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3334455566666666666666666666665543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=325.83 Aligned_cols=264 Identities=28% Similarity=0.477 Sum_probs=217.0
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC----C----CcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeec
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----D----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVG 687 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~ 687 (956)
.++...++..+.+.||+|.||.||+|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555666677779999999999999843 1 45799999986443 3457899999999998 5999999999
Q ss_pred ccccCCcEEEEEecCCCCCHHHHHhhcC------------C--CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKS------------K--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 688 ~~~~~~~~~LV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
+|...+..++|+||++.|+|.++++... . ..+...+.+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998754 0 23888999999999999999999998 99999999
Q ss_pred ccEEEcCCCcEEEEeeccccccCCCCCCCccccceeccccc--CCCcccccccccCCCCCcccchhHHHHHHHHHh-CCC
Q 002178 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~ 830 (956)
+|||+.++..+||+|||+|+.....+... .....| ...|||||.+....|+.++||||||++||||+| |..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYR------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceE------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 99999999999999999999655433221 111112 345999999999999999999999999999999 888
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 831 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 831 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
||.......+.. ..+.++.+...|..|..+++++|+.||+.+|++||++.++++.++...
T Consensus 521 PYp~~~~~~~l~---------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 521 PYPGIPPTEELL---------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCcHHHHH---------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 886522111111 123456667789999999999999999999999999999999998843
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=291.20 Aligned_cols=203 Identities=29% Similarity=0.430 Sum_probs=170.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 695 (956)
.+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999964 6899999987532 122345788999999999999999999998654 457
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++|+||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999997543 4788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... ........++..|+|||++.+..++.++|||||||++||+++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 321110 11112345888999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=299.18 Aligned_cols=245 Identities=29% Similarity=0.471 Sum_probs=195.1
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999964 68999999986432 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ |+|.+.+... ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5888877543 345899999999999999999999999 99999999999999999999999999875432
Q ss_pred CccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||........... +....
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----------~~~~~ 240 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IAQNE 240 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----------HHhcc
Confidence 12235788999999974 45688899999999999999999999875432221111 11111
Q ss_pred C-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 859 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 859 ~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
. ...+..++..+.+++.+|++.+|.+||++.++++...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1 1223445667888888888888888888888876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=305.66 Aligned_cols=282 Identities=24% Similarity=0.326 Sum_probs=201.3
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-C--CcEEEEEEecCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeccccc----CCc
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-D--GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGE 694 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~ 694 (956)
+|++.+.||+|+||.||++... + +..||+|++.... ....+.+.+|+++++++ +|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999964 4 7899999886432 22345778899999999 59999999987532 245
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999985 7999988643 45889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
....... .........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~------ 224 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ------ 224 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH------
Confidence 5432211 1111233568899999998866 56889999999999999999999998654422 11111000
Q ss_pred hccCCCCCCChHHHHHHHHH----HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 854 VIDGNMGSYPSECVEKFIKL----ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l----~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
..+..+++....+..- ...-....+ ++.+ ....+..+....+|+.+|+..||++|+|++|
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 225 ----VLGTPDEETLSRIGSPKAQNYIRSLPNIP--KKPF----------ESIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred ----HhCCCCHHHHHhhhhhhHHHHHHhccccC--Ccch----------HhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 0111122211111100 000000000 0111 1112333455678999999999999999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
++.||||+.
T Consensus 289 ll~~~~~~~ 297 (332)
T cd07857 289 ALEHPYLAI 297 (332)
T ss_pred HhcChhhhh
Confidence 999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=313.91 Aligned_cols=271 Identities=20% Similarity=0.311 Sum_probs=186.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-----------------CCCcEEEEEEecCCChhhHHH--------------HHHH
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-----------------PDGTVVAVKRAQEGSLQGEKE--------------FLTE 670 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 670 (956)
..++|++.++||+|+||+||+|.+ .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235789999987543322223 3346
Q ss_pred HHHHHhcCCCce-----eeeeccccc--------CCcEEEEEecCCCCCHHHHHhhcCC---------------------
Q 002178 671 IQFLSRLHHRNL-----VSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 716 (956)
Q Consensus 671 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~LV~e~~~~gsL~~~l~~~~~--------------------- 716 (956)
+.++.+++|.++ +++++||.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677787743 3578999999999999999874311
Q ss_pred -CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccC
Q 002178 717 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795 (956)
Q Consensus 717 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt 795 (956)
..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ........++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------~~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------NFNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC------ccCccccCCC
Confidence 12456778899999999999999998 9999999999999999999999999997543211 0111122357
Q ss_pred CCcccccccccCC--------------------C--CCcccchhHHHHHHHHHhCCC-CCCCCchhHHHHHHHhhcccch
Q 002178 796 PGYLDPEYFLTHK--------------------L--TDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 796 ~~y~aPE~~~~~~--------------------~--~~~sDVwS~G~ll~elltg~~-pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
+.|+|||.+.... + ..+.||||+||+++||++|.. ||............
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-------- 445 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-------- 445 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--------
Confidence 8999999985432 1 124799999999999999875 55422111110000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCC---CCCCCCcc
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE---ETPPSSSS 929 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP---~~R~sa~e 929 (956)
. ...... |......+..+. .+........|++.+||+.+| .+|+|++|
T Consensus 446 ---------~-~~~~~~--------~r~~~~~~~~~~-----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 446 ---------Y-DNDLNR--------WRMYKGQKYDFS-----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred ---------c-cchHHH--------HHhhcccCCCcc-----------cccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 0 000000 011111111111 122334556789999999766 68999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
+|+||||..
T Consensus 497 aL~Hp~f~~ 505 (507)
T PLN03224 497 ALSHRFFLP 505 (507)
T ss_pred HhCCCCcCC
Confidence 999999964
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.99 Aligned_cols=287 Identities=24% Similarity=0.362 Sum_probs=207.5
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc-CC
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 693 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 693 (956)
++...+++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999855 78999999875422 2234677889999999999999999998865 56
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||.+.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 6799988854 24778888899999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~-------- 218 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII-------- 218 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 54211 122356788999999866 56899999999999999999999999654321111000
Q ss_pred hhccCCCCCCChHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
....+..+++....+.. -....+...+...+.. .....+..+....+++.+|+..+|++|++++|++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 219 ---TDLLGTPPDDVINTICSENTLRFVQSLPKREPVP---------FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ---HHHhCCCCHHHHHhccchhhHHHHhhccccCCCc---------HHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111222222111100 0000111111111100 0111233345566899999999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
.||||.....
T Consensus 287 ~~~~~~~~~~ 296 (328)
T cd07856 287 AHPYLAPYHD 296 (328)
T ss_pred cCCccccccC
Confidence 9999965443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.38 Aligned_cols=318 Identities=23% Similarity=0.248 Sum_probs=206.1
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
+..++.|++++|.|+..-...|-++++|+.++|.+|.++ .||...+...+|+.|+|.+|.|+..-.+.+..++.|+.||
T Consensus 77 p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 77 PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 456778889888888777777777777777777777777 6665444445566666666666655555566666666666
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
||.|.|+.+...+|..-.++++|+|++|.|+..-...|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-
T Consensus 156 LSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iri 235 (873)
T KOG4194|consen 156 LSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRI 235 (873)
T ss_pred hhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceee
Confidence 66666664444455555556666666666655555555555566666666666665555555555566666555555542
Q ss_pred C-----------------------CCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCC-CC
Q 002178 241 T-----------------------TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG-RL 295 (956)
Q Consensus 241 ~-----------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~-~~ 295 (956)
+ .-...|-.+.++++|+|+.|+++..-.. +.++++|+.|+||+|.|...-+.. .+
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 1 1223455555566666666666554443 566777777777777776433333 34
Q ss_pred ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccC----------------------CCCcce
Q 002178 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL----------------------NATETF 353 (956)
Q Consensus 296 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l----------------------~~~~L~ 353 (956)
..+|++|+|++|+|+...+.+|..|..|++|+|++|.++..-...|..+++| .+++|+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 4478888888888887777777766666666666666653333333333322 355677
Q ss_pred EEEccCCCCCCCCCC-C-CCCCCcEEEecCCc-----------------------ccccCCcccccCCCCC
Q 002178 354 ILDFQNNNLTNISGS-F-NIPPNVTVRLRGNP-----------------------FCLNTNAEQFCGSHSD 399 (956)
Q Consensus 354 ~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np-----------------------~~c~c~~~~~~~~~~~ 399 (956)
.|+|.+|+|..++.. | .++.+..|+|.+|+ +.|||++.||-+|+..
T Consensus 396 kL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~ 466 (873)
T KOG4194|consen 396 KLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYR 466 (873)
T ss_pred heeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHHh
Confidence 899999999988865 3 58888888888886 5799999999999954
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=297.55 Aligned_cols=199 Identities=29% Similarity=0.457 Sum_probs=165.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 699 (956)
-++|++.+.||+|+||.||+|.+++ ++.||||.++.... .....+..|+.++.+.. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3668889999999999999999864 89999999875432 23456677887776665 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||+ ++++.+++.... ..+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 998 457877775533 368999999999999999999997 46 999999999999999999999999998765321
Q ss_pred CCCCccccceecccccCCCcccccccccCC----CCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 K--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred C--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 112234778999999987654 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=284.65 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=223.9
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~ 688 (956)
.+++.+...+++....+-+|.||.||.|.|.+ .+.|-||.++.... -....+..|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45777778899999999999999999998753 34577787765433 334578889999999999999999999
Q ss_pred ccc-CCcEEEEEecCCCCCHHHHHhh------cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC
Q 002178 689 CDE-EGEQMLVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 689 ~~~-~~~~~LV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
+.+ .+..+.+|.++.-|+|..++.. ...+.++..+...++.|++.|++|||+++ |||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 854 5577999999999999999972 34456888889999999999999999999 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHH
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 840 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~ 840 (956)
.++||+|=.+++.+-..++.. ..........||+||.+....|+.++||||||+++|||+| |+.|+..-+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eeEEeccchhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999876655432 1233345678999999999999999999999999999999 999997654321
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
....+.|+.+...|-+|++++..+|..||...|++||++++++.-|.++..+
T Consensus 507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1123566777788999999999999999999999999999999999887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=285.76 Aligned_cols=282 Identities=23% Similarity=0.323 Sum_probs=216.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 693 (956)
..+|.....+|.|.- .|..|.+. .++.||+|+.... .....++..+|..++..+.|+||++++.+|... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999987 66666543 5899999987643 233456788999999999999999999998543 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
+.|+|||+| .++|...++- .++-.....|..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 679999999 6799998863 3666778899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
.... ....+....|..|+|||++.+..+.+.+||||+||++.||++|+..|.......+|.+..
T Consensus 167 ~e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~-------- 230 (369)
T KOG0665|consen 167 TEDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII-------- 230 (369)
T ss_pred ccCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH--------
Confidence 6432 234566778999999999999889999999999999999999999987554444443322
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh-hC-------CCCCCCCccccccccCCCCCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN-MM-------PESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~-~~-------~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
..++...+.+..++...+..... .||.... ...-+.+.+ .+ +.....+.+++.+||..||++|+
T Consensus 231 ---~~lgtpd~~F~~qL~~~~r~yv~----~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri 302 (369)
T KOG0665|consen 231 ---EQLGTPDPSFMKQLQPTVRNYVE----NRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI 302 (369)
T ss_pred ---HHhcCCCHHHHHHhhHHHHHHhh----cChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc
Confidence 23455667777777777766555 3333222 111111111 01 11223346799999999999999
Q ss_pred CCccCCCCCccc
Q 002178 926 SSSSMLKHPYVS 937 (956)
Q Consensus 926 sa~e~L~HP~f~ 937 (956)
|++++|+|||+.
T Consensus 303 sv~daL~HPY~~ 314 (369)
T KOG0665|consen 303 SVDDALRHPYIK 314 (369)
T ss_pred cHHHHhcCCeee
Confidence 999999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=305.38 Aligned_cols=200 Identities=30% Similarity=0.453 Sum_probs=177.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
...|.+...||+|.|++|..|+.. ++..||+|.+.+.... ..+.+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457888999999999999999965 6999999998865433 3345889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+.+|.+++++...+. ..+..+..++.|+.+|++|||+++ |||||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999987665 445788889999999999999999 99999999999999999999999999988763
Q ss_pred CCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+..
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 234566789999999999999776 46799999999999999999999753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=290.97 Aligned_cols=192 Identities=31% Similarity=0.429 Sum_probs=167.7
Q ss_pred eeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
||+|+||.||++... +++.||+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 5899999998754332 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 787 (956)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99997643 5889999999999999999999988 9999999999999999999999999997654321 1
Q ss_pred eecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......++..|+|||...+..++.++|+||||+++||+++|+.||...
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123445788999999999888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=295.46 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=168.0
Q ss_pred CCCCCCeeeeeCCeEEEEEEe----CCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
+|++.+.||+|++|.||++.. .+++.||||.++.... ...+.+.+|+++++++ +|+||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999984 2578899999874322 2235678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998653 35788899999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|..||..
T Consensus 156 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 4321 11112345788999999987655 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.84 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=165.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+|.+.+.||+|+||.||++... .+..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999864 3455666655432 122234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998865 23456899999999999999999999998 999999999999986 569999999987653
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
... .......|+..|+|||...+..++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 221 1122345788999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=305.10 Aligned_cols=200 Identities=31% Similarity=0.465 Sum_probs=171.6
Q ss_pred CCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccccc------CCcEEE
Q 002178 626 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 697 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~L 697 (956)
+...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|++++++++|+|||++++.-.+ .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34467899999999999995 479999999988643 3345677899999999999999999988644 346799
Q ss_pred EEecCCCCCHHHHHhh-cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc--CCC--cEEEEeeccc
Q 002178 698 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLS 772 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~DfGla 772 (956)
|||||.+|||+..+.+ .+...+++.+.+.+..+++.||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999976 34467999999999999999999999999 99999999999983 223 5899999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
+.++.. .......||..|.+||.+.. +.|+..+|.|||||++||+.||..||.+..
T Consensus 172 rel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 987532 24567889999999999984 888999999999999999999999997543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=269.05 Aligned_cols=279 Identities=16% Similarity=0.340 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccC--CcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~LV 698 (956)
.++|++.+++|+|.++.||.|. ..+.+.++||+++.. ..+.+.+|+++|+.+. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5789999999999999999998 557889999999853 2457889999999997 99999999998654 467899
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeeccccccCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPV 777 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~ 777 (956)
+||+.+.+...+.. .++...+..+..+++.||.|+|++| |+|||+||.|+++|.. -.++|+|+|+|.++..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999888777653 3677788899999999999999999 9999999999999965 4799999999998753
Q ss_pred CCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. .......+..|.-||.+.. ..|+.+-|+|||||++.+|+..+.||+++.+-.++...... ++
T Consensus 186 ~~--------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak------VL- 250 (338)
T KOG0668|consen 186 GK--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK------VL- 250 (338)
T ss_pred Cc--------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH------Hh-
Confidence 32 1223345567888999876 56899999999999999999999999987765544332211 10
Q ss_pred CCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHH--hHhhCCC-----CCCCCccccccccCCCCCCCCCCc
Q 002178 857 GNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELES--IWNMMPE-----SDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~v~~~L~~--~~~~~~~-----~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
+. .++..-+ +.-+. --|.+.+++..-.+ +....+. ..+++.||+.++|.+|-.+|+||+
T Consensus 251 ---Gt------~el~~Yl~KY~i~----Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 251 ---GT------DELYAYLNKYQID----LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred ---Ch------HHHHHHHHHHccC----CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 00 0111111 11111 12334443322211 1112221 146678999999999999999999
Q ss_pred cCCCCCccccCC
Q 002178 929 SMLKHPYVSSDV 940 (956)
Q Consensus 929 e~L~HP~f~~~~ 940 (956)
||+.||||..-.
T Consensus 318 Eam~HpyF~~~~ 329 (338)
T KOG0668|consen 318 EAMAHPYFAPVR 329 (338)
T ss_pred HHhcCchHHHHH
Confidence 999999996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=318.28 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=188.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccccc--------
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 691 (956)
-.++|+..+.||+||||.|||++.+ ||+.||||++.... ...-..+.+|+.++++++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456778889999999999999965 89999999987643 2233578899999999999999998721100
Q ss_pred --------------------------------------------------------------------------------
Q 002178 692 -------------------------------------------------------------------------------- 691 (956)
Q Consensus 692 -------------------------------------------------------------------------------- 691 (956)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh
Q 002178 692 -----------------------E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740 (956)
Q Consensus 692 -----------------------~--------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 740 (956)
+ ...||=||||+..+++++++++.... .....++++.+|++||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 12578899999888888887653221 467788999999999999999
Q ss_pred cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC----CC-------CCCCccccceecccccCCCcccccccccC--
Q 002178 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP----VP-------DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-- 807 (956)
Q Consensus 741 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~----~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 807 (956)
+| ||||||||.||++|++..|||+|||+|+... .. ...........+...||.-|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99 9999999999999999999999999998722 00 00011122245667899999999999764
Q ss_pred -CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC---CChHHHHHHHHHHHHhcccCCC
Q 002178 808 -KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS---YPSECVEKFIKLALKCCQDETD 883 (956)
Q Consensus 808 -~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~p~ 883 (956)
.|+.|+|+||+|++++||+ .||.....-... +..+-++..+. +..+....=.+++.++++.||.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~i---------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASI---------LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHH---------HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 5999999999999999999 567543221111 11222233322 2344445556777777777888
Q ss_pred CCCCHHHHHH
Q 002178 884 ARPSMSEVMR 893 (956)
Q Consensus 884 ~RPs~~~v~~ 893 (956)
+||++.+++.
T Consensus 861 kRPtA~eLL~ 870 (1351)
T KOG1035|consen 861 KRPTATELLN 870 (1351)
T ss_pred cCCCHHHHhh
Confidence 8887777764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=327.14 Aligned_cols=146 Identities=25% Similarity=0.381 Sum_probs=131.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|.+.++||+|+||+||+|... +++.||+|+++.... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 689999999875332 22357888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
||+++++|.+++.... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999997543 4788889999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=305.07 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=196.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++.|.....+|.|+|+.|-.+... +++..+||++.... .+..+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777778999999999999854 68899999987652 2334577665555 69999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE-cCCCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DfGla~~~~~~~ 779 (956)
++.++-+.+.+..... +. ..+..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887755432 23 677789999999999999999 9999999999999 68999999999999876422
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
....+-|..|.|||+.....|+.++|+||||++||+|++|+.||....+-.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------------------- 520 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------------------- 520 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------------
Confidence 223346779999999999999999999999999999999999997543210
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc-cc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV-SS 938 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f-~~ 938 (956)
-+..|+ .+|+++ ......+.|++++||+.||++|+++.+++.|||| +.
T Consensus 521 -------------ei~~~i-----~~~~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 521 -------------EIHTRI-----QMPKFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred -------------HHHHhh-----cCCccc-------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 011111 122222 1224456789999999999999999999999999 44
Q ss_pred CC
Q 002178 939 DV 940 (956)
Q Consensus 939 ~~ 940 (956)
+.
T Consensus 570 ~t 571 (612)
T KOG0603|consen 570 PT 571 (612)
T ss_pred CC
Confidence 33
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=286.62 Aligned_cols=179 Identities=23% Similarity=0.214 Sum_probs=152.7
Q ss_pred eCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHHHHHhh
Q 002178 635 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 713 (956)
Q Consensus 635 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~ 713 (956)
|.+|+||++... +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 68999999987543 233455555566799999999999999999999999999999999865
Q ss_pred cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccc
Q 002178 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793 (956)
Q Consensus 714 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 793 (956)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 43 4889999999999999999999998 999999999999999999999999987654321 11233
Q ss_pred cCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 002178 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 794 gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~ 833 (956)
++..|+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 5678999999988889999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=321.23 Aligned_cols=277 Identities=23% Similarity=0.316 Sum_probs=178.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-C----CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecc------cc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-D----GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY------CD 690 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~ 690 (956)
..++|++.+.||+|+||.||+|.+. + +..||+|++...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 4 689999987643211 111111 1222223333332222 24
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCC------------------CchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCC
Q 002178 691 EEGEQMLVYEFMSNGTLRDQLSAKSKE------------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752 (956)
Q Consensus 691 ~~~~~~LV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 752 (956)
.+...++||||+++++|.+++...... ......+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999998754211 1123345679999999999999998 9999999
Q ss_pred cccEEEcC-CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC----------------------CC
Q 002178 753 ASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----------------------KL 809 (956)
Q Consensus 753 ~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 809 (956)
|+|||++. ++.+||+|||+|+...... ........+++.|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999986 5799999999997653221 1222345688999999966422 23
Q ss_pred CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002178 810 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 889 (956)
Q Consensus 810 ~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 889 (956)
+.++|||||||++|||+++..++.. .... ....... ...+.. .+... ..+..++...
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~-~~~~l~~-----------~~~~~~---~~~~~------~~~~~~~~~~ 413 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQ-FNRQLKR-----------NDYDLV---AWRKL------VEPRASPDLR 413 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHH-HHHHHHh-----------cCCcHH---HHHHh------hccccchhhh
Confidence 4467999999999999987555421 1111 1110000 000000 01110 0111122211
Q ss_pred HHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 890 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 890 ~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+.. +.+........+|+.+||+.||++|+|++|+|+||||+....
T Consensus 414 ~~~-------~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 414 RGF-------EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhh-------hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 111 111112223458999999999999999999999999977544
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.10 Aligned_cols=196 Identities=31% Similarity=0.509 Sum_probs=166.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+.|+..+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999965 6889999987642 2233457888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+. |++.+++.... .++++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9995 68888775433 45889999999999999999999998 999999999999999999999999998764321
Q ss_pred CCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2235788999999975 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=291.97 Aligned_cols=195 Identities=33% Similarity=0.522 Sum_probs=165.7
Q ss_pred CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
|...++||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556778999999999999964 689999999864322 2335688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+. |++.+++... ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888887653 345889999999999999999999999 99999999999999999999999999864321
Q ss_pred CccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999984 4568889999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=282.98 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=194.1
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHH---HHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
+-..+|..+.+||+|+||+|.+|..+ +.+.+|||+++++...... --..|-++|... +-|.+++++.+|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457888999999999999999865 4678999998875433222 224566666665 478899999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
|+||||+.||+|-.+++.-++ +.+..+..+|..||-||-+||+++ ||.||||.+||++|.+|.+||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999988876543 777888899999999999999999 999999999999999999999999999753
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
..........+||+.|+|||++..++|+.++|.|||||+||||+.|+.||+..+. .+..+ .+
T Consensus 501 -------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~elF~----------aI 562 (683)
T KOG0696|consen 501 -------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQ----------AI 562 (683)
T ss_pred -------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHH----------HH
Confidence 2234455678899999999999999999999999999999999999999976542 22111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARP 886 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP 886 (956)
....-.+|...+.+...+....+.+.|.+|-
T Consensus 563 ~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2222356776777777777766777777663
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=299.91 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=213.6
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccc--
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD-- 690 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-- 690 (956)
.++.+...++-|++.+.||+|.+|.||+++ .++++.+|+|+..... ..++++..|.++++.. +|||++.++|+|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344555567889999999999999999999 4579999999887543 3345778899999888 6999999999983
Q ss_pred ---cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 691 ---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 691 ---~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
.+++++||||||.+||..|+++.-....+.|..+..|++.++.|+.+||... ++|||||-.|||++.++.||+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 3578999999999999999998766778999999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCcccccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~ 842 (956)
|||.+..++.. ........||+.|||||++... .|+.++|+||+|++..||--|.+|+.+.....
T Consensus 166 DFGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--- 235 (953)
T KOG0587|consen 166 DFGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--- 235 (953)
T ss_pred eeeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---
Confidence 99999876532 2344567899999999999653 47789999999999999999999997654321
Q ss_pred HHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 843 NIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.++.+.....+. -|..+.+++.+.+..|+.+|.++||++.++++
T Consensus 236 -------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 -------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122222222222 27889999999999999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=281.29 Aligned_cols=296 Identities=22% Similarity=0.333 Sum_probs=215.7
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccC
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 692 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 692 (956)
++....+.|...++||.|.|++||+|.+. ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 44556688999999999999999999853 468999998875433 346889999999984 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeecc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 771 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGl 771 (956)
+...+|+||++...-.++... ++..++..+.+.+..||+++|+.| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999998888854 567888999999999999999999 999999999999975 46789999999
Q ss_pred ccccCCCC------C------C-------------C------------ccccceecccccCCCccccccccc-CCCCCcc
Q 002178 772 SRLAPVPD------I------E-------------G------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKS 813 (956)
Q Consensus 772 a~~~~~~~------~------~-------------~------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s 813 (956)
|...+... . . + ...........||++|+|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321100 0 0 0 000112234569999999999875 5678899
Q ss_pred cchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 002178 814 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK--CCQDETDARPSMSEV 891 (956)
Q Consensus 814 DVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~p~~RPs~~~v 891 (956)
||||.|++++-+++++.||....+..+....... .+......+...+-.+ -|++ ..+|+..++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~t-------------ifG~~~mrk~A~l~g~~~l~~k--sn~~~~~e~ 324 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIAT-------------IFGSAEMRKCAALPGRILLWQK--SNIPTIPEL 324 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHH-------------HhChHHHHHHhhcCCceeeecc--ccccccHHH
Confidence 9999999999999999999875543221111000 0011111111111111 2222 446666666
Q ss_pred HHHHHHhH-hhCCC--------------CCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 892 MRELESIW-NMMPE--------------SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 892 ~~~L~~~~-~~~~~--------------~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
....+... ..... ....+.||++++|..||.+|+||+|||+||||..
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 65555441 11111 1124578999999999999999999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=305.86 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=196.5
Q ss_pred CCCCCeeeeeCCeE-EEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecCC
Q 002178 626 FNSSTQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 626 y~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
|...+.+|.|+.|+ ||+|.. +|+.||||++-... ..-..+|+..++.- .|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456789999985 799998 67899999886433 23557899998887 5999999999999999999999999
Q ss_pred CCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---C--CcEEEEeeccccccC
Q 002178 704 NGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---K--FTAKVADFGLSRLAP 776 (956)
Q Consensus 704 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~--~~~kl~DfGla~~~~ 776 (956)
..+|.+++... ..........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.++
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999763 1111121445778999999999999988 999999999999976 2 579999999999886
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... .-.......||.+|+|||.+....-+.++||||+||++|+.++| .+||.+ ...++.++.-....+
T Consensus 663 ~~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L---- 732 (903)
T KOG1027|consen 663 GGKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTL---- 732 (903)
T ss_pred CCcc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccce----
Confidence 4331 22235667899999999999998888899999999999999995 889954 333333321110000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.+++ ++.+..+.|+|.+|+..||..||+|.++|.||+
T Consensus 733 --------------------~~L~-----------------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 733 --------------------VHLE-----------------------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred --------------------eeec-----------------------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 0111 111114568999999999999999999999999
Q ss_pred cccCCCC
Q 002178 936 VSSDVSG 942 (956)
Q Consensus 936 f~~~~~~ 942 (956)
|....+.
T Consensus 770 FW~~ekr 776 (903)
T KOG1027|consen 770 FWDSEKR 776 (903)
T ss_pred cCChHHH
Confidence 9876653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=285.75 Aligned_cols=213 Identities=24% Similarity=0.276 Sum_probs=179.7
Q ss_pred cccccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC------CCcee
Q 002178 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH------HRNLV 683 (956)
Q Consensus 611 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv 683 (956)
...|.+.-.++...+|.+....|+|-|++|..|.+. .|..||||++...... .+.=+.|+++|++|+ --|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 345666666777899999999999999999999975 4889999999864332 345578999999996 34889
Q ss_pred eeecccccCCcEEEEEecCCCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-
Q 002178 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK- 761 (956)
Q Consensus 684 ~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~- 761 (956)
+++..|....++|||+|-+ .-+|.+.|+..+. ..+....+..++.|+.-||..|-..+ |+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999988 5799999987543 46888999999999999999999988 9999999999999865
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
..+||||||.|......+. +....+..|+|||++.|.+|+...|+||+||+|||+.||+..|....+
T Consensus 574 ~iLKLCDfGSA~~~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ceeeeccCccccccccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 5799999999987654332 223345689999999999999999999999999999999999976543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=248.20 Aligned_cols=215 Identities=26% Similarity=0.382 Sum_probs=174.5
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC-ChhhHHHHHHHHHHHH-hcCCCceeeeecccccCCcE
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~ 695 (956)
+.+..+.......||+|++|.|-+-++ .+|+..|+|++... ..+..++..+|+.+.. ...+|.+|.|+|.+..++..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 445555566677899999999988874 58999999998753 3344567888888644 45799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 696 MLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
++.||.| .-||+.+-.+ .....+++...-+||..+.+||.|||++-+ +||||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4588776654 344568899999999999999999999764 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc----CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
.+.. +-..+...|...|||||.+.. ..|+-++||||+|+.+.||.+++.||.......+++..
T Consensus 198 ~L~d--------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 198 YLVD--------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eehh--------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 6532 112233568889999999864 36889999999999999999999999876665555443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=262.53 Aligned_cols=187 Identities=35% Similarity=0.548 Sum_probs=165.3
Q ss_pred CCeEEEEEEeC-CCcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHHHHHhh
Q 002178 636 GYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 713 (956)
Q Consensus 636 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~ 713 (956)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999988655544 67899999999999999999999999998999999999999999999976
Q ss_pred cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccc
Q 002178 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793 (956)
Q Consensus 714 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 793 (956)
... +++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 443 788999999999999999999998 9999999999999999999999999998764321 223445
Q ss_pred cCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 794 gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
++..|++||.+.+..++.++||||||++++++++|..||...
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 788999999999888999999999999999999999999653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=277.02 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=200.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.+++.+..||-|+||.|-++..+. ...+|+|++++.. ...++.+..|-++|...+.|.||++|..|.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 455567789999999999988654 3358888877543 333456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|-|-||.|+..+++++ .++....+.++..+.+|++|||+++ ||.|||||+|+++|.+|-+||.|||.|+.+..
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 9999999999997654 5889999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
...+...+||+.|.|||++.....+.++|.||+|+++||+++|.+||...+.+..+..+.-. ++ .
T Consensus 573 ------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------id--~ 637 (732)
T KOG0614|consen 573 ------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------ID--K 637 (732)
T ss_pred ------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-------hh--h
Confidence 34566789999999999999999999999999999999999999999876655433222110 00 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPS 887 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs 887 (956)
..+|......-.+++++.+..+|.+|-.
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 2356666667777787777888888753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=277.39 Aligned_cols=210 Identities=22% Similarity=0.304 Sum_probs=173.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..-|..++.||-|+||.|.++.. ++...+|.|.+.+...-. ...+..|-.+|.....+-||+||-.|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35566788999999999999984 457789999887654332 23457788999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||++||++-.+|-+.+ .|.+..++.++..+..|+++.|..| +|||||||+|||||.+|.+||+|||++.-+...
T Consensus 708 MdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999887643 5888889999999999999999999 999999999999999999999999998543221
Q ss_pred C---CCC------------------ccc--------------cceecccccCCCcccccccccCCCCCcccchhHHHHHH
Q 002178 779 D---IEG------------------IVP--------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 823 (956)
Q Consensus 779 ~---~~~------------------~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ 823 (956)
. ++. ... ........||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 000 000 00112346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCch
Q 002178 824 ELLTGMQPISHGKN 837 (956)
Q Consensus 824 elltg~~pf~~~~~ 837 (956)
||+.|+.||.....
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999976544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.85 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=198.4
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhc-CCCceeeeecccccCCc
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 694 (956)
.+.-++|..+++||+|+|++|-.+.+. +.+.+|+|++++.-.. ....++.|-.+.... +||.+|.++.+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345578999999999999999999964 6789999998864322 234566777777666 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++|.||++||+|--+++++. .+++..++.+...|.-||.|||++| ||.||||.+|||+|..|.+|++|+|+++.
T Consensus 326 lffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999987776654 4888999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC------chhHHHHHHHhhc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG------KNIVREVNIAYQS 848 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~------~~~~~~~~~~~~~ 848 (956)
-- .+.......+||+.|+|||++++..|..++|.|++||+++||+.|+.||.-. .+..+++
T Consensus 401 ~l-------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl------ 467 (593)
T KOG0695|consen 401 GL-------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL------ 467 (593)
T ss_pred CC-------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH------
Confidence 32 2344566788999999999999999999999999999999999999999621 1112211
Q ss_pred ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 002178 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 886 (956)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP 886 (956)
+.++-..-..+|...+-+...+.+..+++||.+|-
T Consensus 468 ---fqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 468 ---FQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---HHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 12222222345666666667777777888888763
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-30 Score=277.09 Aligned_cols=290 Identities=27% Similarity=0.391 Sum_probs=203.2
Q ss_pred eeeEEEeCCCCccc-cCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCC-ccCCCcccceee
Q 002178 83 HLRELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE-ELGYLPKLDRIQ 160 (956)
Q Consensus 83 ~~~~L~L~~~~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 160 (956)
++++++++.|+|.. -+|+.+.+|..|+.||||+|+++ ..|..+..-+++-+|+||+|+|. .||. -|-+|+.|-.||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 45666666666654 36667777777777777777776 66767777777777777777776 4443 355677777777
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccC-CCCCcccCCcchhhhhcccCCcCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT-GYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
||+|++. .+|..+..|..|++|+|++|.+...--..+..+++|+.|++++.+-+ .-+|.++..+.+|..+|||.|.+.
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence 7777776 66666677777777777777665333333445566667777766544 456677777777777777777775
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc-ccCEEEccCCcCCC-CCchhc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTG-TIPSNF 317 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~Ls~N~l~~-~~p~~~ 317 (956)
.+|+.+-++.+|+.|+||+|+|+........+.+|++|+||.|+|+ .+|+..+.. .|+.|++.+|+|+- -+|..+
T Consensus 236 --~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 236 --IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI 312 (1255)
T ss_pred --cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence 5677777777777777777777766666666667777777777777 666665544 67777777776643 467777
Q ss_pred CCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCC-CCCCcEEEecCCcc
Q 002178 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN-IPPNVTVRLRGNPF 384 (956)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~-~~~l~~l~l~~Np~ 384 (956)
+.|.+|+.+..++|+|. .+|+++..+.+| +.|.|+.|+|-++|.... ++.+..|++..||-
T Consensus 313 GKL~~Levf~aanN~LE-lVPEglcRC~kL-----~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKL-----QKLKLDHNRLITLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hhhhhhHHHHhhccccc-cCchhhhhhHHH-----HHhcccccceeechhhhhhcCCcceeeccCCcC
Confidence 77777777777777776 777777665554 479999999999999885 78899999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=261.97 Aligned_cols=196 Identities=25% Similarity=0.374 Sum_probs=168.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhH--------HHHHHHHHHHHhcC---CCceeeeeccccc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE--------KEFLTEIQFLSRLH---HRNLVSLVGYCDE 691 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 691 (956)
..|.....+|.|+||.|+.|.++ +...|+||.+.+.+.-.. ..+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999976 467899998876432211 23456999999997 9999999999999
Q ss_pred CCcEEEEEecC-CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 692 EGEQMLVYEFM-SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 692 ~~~~~LV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
++.+||+||-. ++.+|.+++..+. .+++.+...|++||+.|+++||+.+ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999975 5679999997654 4889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCC-CcccchhHHHHHHHHHhCCCCCC
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~G~ll~elltg~~pf~ 833 (956)
.|...... ......||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 716 saa~~ksg---------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99765422 23456799999999999998875 45899999999999999888885
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=263.50 Aligned_cols=292 Identities=22% Similarity=0.268 Sum_probs=229.6
Q ss_pred eeEEEeCCCCccccCCcCcCCC--CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 84 LRELQLLNLNLSGNLSPEIGRL--SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
...|+.+.+.|...--..+..+ +.-+.|||++|.++..-+..|.++++|+.++|..|.++ .+|...+...+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 4456666666554322233222 34577999999999888889999999999999999999 89988888888999999
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
.+|.|+..-.+.+..++.|+.|||+.|.|+...-..|..-.++++|+|++|+|+..-...|..+.+|..|.|+.|+++.
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt- 211 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT- 211 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc-
Confidence 9999998888999999999999999999996666778888999999999999998888999999999999999999984
Q ss_pred CCcccccCCCCCcEEeccCCCCccC-CCCCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccCCcCCCCCchhcC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
..+..|+++++|+.|+|..|+|.-. .-.|..+++|+.|.|..|.+. .+.++.+- .++++|+|+.|+++..-..++-
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lf 290 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLF 290 (873)
T ss_pred cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhccccc
Confidence 4556899999999999999999765 335777788888888888777 55555442 2677777777777776677777
Q ss_pred CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCc
Q 002178 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNP 383 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np 383 (956)
+|+.|+.|+||+|.|+..-+++....++|+ +|||++|+|+.++.. + .+..+.+|.|++|.
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~-----~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLK-----ELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccce-----eEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 777777777777777766666665555443 677777777777654 2 25555666666665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=232.21 Aligned_cols=210 Identities=37% Similarity=0.605 Sum_probs=182.0
Q ss_pred eeeeCCeEEEEEEeCC-CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHHH
Q 002178 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 709 (956)
Q Consensus 632 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~ 709 (956)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++||||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998865443 34678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCCCCCCccccce
Q 002178 710 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (956)
Q Consensus 710 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~ 788 (956)
++.... ..+++..+..++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 997642 35889999999999999999999998 999999999999999 89999999999986543210 1
Q ss_pred ecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHH
Q 002178 789 STVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867 (956)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 867 (956)
.....+...|++||..... .++.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334577899999999887 888999999999999998
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 868 EKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 868 ~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457788999999999999999988753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-29 Score=272.35 Aligned_cols=294 Identities=26% Similarity=0.367 Sum_probs=236.9
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcc-cCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+..|.+.+|+|. .+-.+++.|+.|+.+++..|++.. -||..+..+..|.+||||+|+++ +.|..+..-+++-.|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 4556667777665 344567777778888888887742 57777888888888888888887 77888888888888888
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
|+|+|..+....|.+|+-|-.||||+|++. .+|+.+..+..|++|+|++|.+.-.--..+..+++|+.|.+++.+-+-.
T Consensus 134 S~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~ 212 (1255)
T KOG0444|consen 134 SYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLD 212 (1255)
T ss_pred ccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhh
Confidence 888888554455778888888888888887 6677777888888888888877644445566677788888887766545
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCC-CCccccCEEEccCCcCCCCCchhcCCC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-RLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
.+|.++..+.+|..+|||.|+|...|..+..+++|+.|+||+|+|+ .+... ....+|++|+||.|+|+ .+|.+++.|
T Consensus 213 N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 213 NIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred cCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 7899999999999999999999988888999999999999999998 44333 23348999999999999 899999999
Q ss_pred CcCCeEecccccCCC-cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcccc
Q 002178 321 PRLQRLFIANNSLSG-SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~-~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~c 386 (956)
++|+.|++.+|+|+- -||+.++++.+|. ++..++|+|.-+|..+ ..+.++.|.|+.|.+.-
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Le-----vf~aanN~LElVPEglcRC~kL~kL~L~~NrLiT 353 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLE-----VFHAANNKLELVPEGLCRCVKLQKLKLDHNRLIT 353 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhH-----HHHhhccccccCchhhhhhHHHHHhcccccceee
Confidence 999999999999984 4899999877765 8999999999999887 68888899998887643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=254.47 Aligned_cols=342 Identities=20% Similarity=0.219 Sum_probs=220.6
Q ss_pred CCCCCCCC---CceeecCCCC----CCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCccc
Q 002178 60 GDPCTSNW---TGVLCFNTTM----DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL 132 (956)
Q Consensus 60 ~~~c~~~w---~gv~C~~~~~----~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L 132 (956)
+.+|.|+- .-|.|..... .+.+...++|+|..|+|+...+.+|+.+++|+.||||+|+|+.+-|.+|..+.+|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 45676654 2388876543 2456778899999999998888899999999999999999998889999999887
Q ss_pred chhhccC-cCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccc
Q 002178 133 ELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (956)
Q Consensus 133 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (956)
..|-+.+ |+|+...-+.|++|..|+.|.+.-|++.-...+.|..+++|..|.|-+|.+...--..|..+.+++.+++..
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~ 197 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQ 197 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhc
Confidence 7776665 899977677899999999999999999988888899999999999999999844444888899999999998
Q ss_pred cccC------------CCCCcccCCcchhhhhcccCCcCCCCCCcccc-cCCCCCcEEeccCCCCccCCCC--CCCCCCc
Q 002178 212 NNLT------------GYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD--LSRIPNL 276 (956)
Q Consensus 212 N~l~------------~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~--l~~l~~L 276 (956)
|.+. ...|.+++++.-..-..|.++++.. .-+..| ..+..+..--.+.+...++-|. |..+++|
T Consensus 198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q-~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQ-EDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred CccccccccchhhhHHhhchhhcccceecchHHHHHHHhcc-cchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 8843 1223334444444444444444432 111112 1111221111111222222221 5555555
Q ss_pred cEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEE
Q 002178 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356 (956)
Q Consensus 277 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~ 356 (956)
+.|+|++|+|+ .+-+.+|.++..|++|.|..|+|...--..|..+ ..|..|+
T Consensus 277 ~~lnlsnN~i~-----------------------~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~l-----s~L~tL~ 328 (498)
T KOG4237|consen 277 RKLNLSNNKIT-----------------------RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGL-----SGLKTLS 328 (498)
T ss_pred eEeccCCCccc-----------------------hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcc-----ccceeee
Confidence 55555555555 4444555555555555555555542222222222 2233455
Q ss_pred ccCCCCCCCCC-CC-CCCCCcEEEecCCcccccCCcccccCCCCCCCcccCcCCCCCCccccCcCCCCCccCCCCCCcce
Q 002178 357 FQNNNLTNISG-SF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCF 434 (956)
Q Consensus 357 L~~N~L~~l~~-~~-~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~c~~~~~~~p~~~~~~~ 434 (956)
|.+|+|+.+.. .| ....+.+|.|-.|||+|||.+.|+-+|++... ......|.+|.-..+...+......+.
T Consensus 329 L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~------~~~~~~Cq~p~~~~~~~~~dv~~~~~~ 402 (498)
T KOG4237|consen 329 LYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS------VVGNPRCQSPGFVRQIPISDVAFGDFR 402 (498)
T ss_pred ecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC------CCCCCCCCCCchhccccchhccccccc
Confidence 55555555432 23 25566789999999999999999999998655 123345665544444444444455555
Q ss_pred ee
Q 002178 435 CA 436 (956)
Q Consensus 435 c~ 436 (956)
|.
T Consensus 403 c~ 404 (498)
T KOG4237|consen 403 CG 404 (498)
T ss_pred cC
Confidence 54
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=261.55 Aligned_cols=298 Identities=20% Similarity=0.284 Sum_probs=221.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|+...++|.|.||.||||++. .++..|||+++-.....-+-..+|+-+++.-+|+||+.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999954 6899999999876555556677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
|.+|+|.+..+. ..++++.++..+++..++||+|||+.+ =+|||||-.||++++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh---
Confidence 999999997754 457999999999999999999999999 799999999999999999999999998654321
Q ss_pred CccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
-.......||+.|||||+.. .+.|.+.+|||+.|+...|+-.-+.|.++-..+.. .+.. .....++.
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~----l~Lm--TkS~~qpp 235 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA----LFLM--TKSGFQPP 235 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH----HHHh--hccCCCCC
Confidence 23345678999999999974 46799999999999999999887777654332211 1100 01112222
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCC-ccCCCCCccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSMLKHPYVS 937 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-~e~L~HP~f~ 937 (956)
...-+..+.+.+.++++.|+-++|.+||+.+.+++. . +-..+.....+.++|.++=..+|.-|--- .|.=.++|+.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h--~-fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH--P-FVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheec--e-eeccchhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 223356677888899999999999999998866541 1 11112233334455555544443333222 2222245554
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
..+.
T Consensus 313 ~~i~ 316 (829)
T KOG0576|consen 313 MRIC 316 (829)
T ss_pred hhhh
Confidence 4444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=233.96 Aligned_cols=199 Identities=36% Similarity=0.527 Sum_probs=172.6
Q ss_pred CCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 626 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999999764 899999999875554 56788999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+++|.+++...... +++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 99999999764322 788999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccceecccccCCCccccccc-ccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0012334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=223.04 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=186.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecc-cccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-CDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~LV~ 699 (956)
.+.|.+.+.+|+|.||.+-++.++ ..+.+|+|.+.... ...++|.+|...--.+ .|.||+.-|+. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467888999999999999999976 57889999887533 3356899998754445 58999987765 67788999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc--CCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DfGla~~~~~ 777 (956)
||++.|+|.+-+... .+.+...++++.|++.|+.|+|+++ +||||||.+|||+- +..++||+|||..+..+.
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999988553 4788889999999999999999999 99999999999993 334899999999875432
Q ss_pred CCCCCccccceecccccCCCcccccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHH--HHHHhhccc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSM 850 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~--~~~~~~~~~ 850 (956)
. -....-+-.|.+||+.... ...+.+|||.||+++|.++||+.||+........ ....|+...
T Consensus 176 t----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 176 T----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred e----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 1 1112244579999987542 3567899999999999999999999843221111 111122111
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
. ...+..-.-..+...++.++-+..++.+|-...++.++..
T Consensus 246 ~-----~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 N-----PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred C-----ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 1112112234567778888888999999966655555443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-27 Score=245.50 Aligned_cols=346 Identities=28% Similarity=0.386 Sum_probs=183.8
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccCCCCC--C----CCCCCCCCCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCC
Q 002178 26 ADDDSITDPIEVSALRSIKKSLVDDYSK--L----SNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLS 99 (956)
Q Consensus 26 ~~~~~~~~~~~~~al~~~k~~~~~~~~~--l----~~W~~~~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~ 99 (956)
..+.....|.+...|.++|+-.+..... + -+-..--.|-|+.....|..... .....+..++..+|+++ .+|
T Consensus 76 ~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~i-~~~~~l~dl~~~~N~i~-slp 153 (565)
T KOG0472|consen 76 HDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDSI-GRLLDLEDLDATNNQIS-SLP 153 (565)
T ss_pred ccchhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCchH-HHHhhhhhhhccccccc-cCc
Confidence 3444555677777777777554432111 1 01111122333344433322211 11123444555566665 455
Q ss_pred cCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCcccccccc
Q 002178 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (956)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (956)
+.+.++.+|..|++.+|++. ..|+..-+++.|++||+.+|-++ .+|..++.|.+|..|+|..|+|. ..| .|.+++.
T Consensus 154 ~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~ 229 (565)
T KOG0472|consen 154 EDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSL 229 (565)
T ss_pred hHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHH
Confidence 55666666666666666665 33333333556666666665555 55555666666666666666655 444 5555555
Q ss_pred CCeeecccCcCCCCCccccC-CCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEec
Q 002178 180 TRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258 (956)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~L 258 (956)
|++|+++.|+|. .+|.... ++++|..|||.+|+++ ..|+.+.-+.+|++||+|+|.|++ +|.+++++ .|+.|-+
T Consensus 230 L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~--Lp~sLgnl-hL~~L~l 304 (565)
T KOG0472|consen 230 LKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS--LPYSLGNL-HLKFLAL 304 (565)
T ss_pred HHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc--CCcccccc-eeeehhh
Confidence 555555555555 3343332 5555555555555555 455555555555555555555552 45555555 5555555
Q ss_pred cCCCCc-----------------------------------------------------------------cCCCCC---
Q 002178 259 RNCSLQ-----------------------------------------------------------------GPMPDL--- 270 (956)
Q Consensus 259 s~N~l~-----------------------------------------------------------------~~~~~l--- 270 (956)
.+|.+. ..|.+.
T Consensus 305 eGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea 384 (565)
T KOG0472|consen 305 EGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEA 384 (565)
T ss_pred cCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHH
Confidence 555442 110000
Q ss_pred CCCCCccEEEccCCcCCcCCCCC------------------------CCc-cccCEEEccCCcCCCCCchhcCCCCcCCe
Q 002178 271 SRIPNLGYLDLSSNQLNGSIPPG------------------------RLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQR 325 (956)
Q Consensus 271 ~~l~~L~~L~Ls~N~l~~~~p~~------------------------~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 325 (956)
..-.-....+++.|++. ++|.. ... .+|..|+|++|-+. .+|..++.+..|+.
T Consensus 385 ~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~ 462 (565)
T KOG0472|consen 385 AKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQT 462 (565)
T ss_pred hhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhhe
Confidence 00001334444444444 33321 111 15666666666665 55666666666666
Q ss_pred EecccccCCCcCChhhhhhcc-------------------CCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 002178 326 LFIANNSLSGSIPSSIWQSRT-------------------LNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 326 L~L~~N~l~~~~p~~~~~l~~-------------------l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~ 385 (956)
||++.|++. .+|..+..+.. .++.+|..|||++|.|..+|... .+.+++.|.+.||||.
T Consensus 463 LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 463 LNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 666666654 44443321111 12344669999999999999988 5899999999999986
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-27 Score=243.98 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=165.8
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccc
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (956)
+..+.+++|.+. .+.+.+.+|..|.+|++.+|+++ ..|.+++.+..++.|+.|+|+++ .+|.+++.+.+|..|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 345566666655 34455666666666666666666 56666666666666666666666 6666666666666666666
Q ss_pred ccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCC
Q 002178 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (956)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (956)
|.+. .+|+.++.+-.|..++..+|+++ . .|+.+..+.+|..|++.+|.++ ..
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-s------------------------lp~~~~~~~~l~~l~~~~n~l~--~l 175 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-S------------------------LPEDMVNLSKLSKLDLEGNKLK--AL 175 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-c------------------------CchHHHHHHHHHHhhccccchh--hC
Confidence 6665 44444555555555555555554 3 4444444555555555555554 23
Q ss_pred cccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchh-cCCCCc
Q 002178 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPR 322 (956)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~ 322 (956)
|...-+++.|++||.-.|-++..|++++.+.+|+.|+|..|+|. .+|+......|++|+++.|+|+ .+|.. ..+|++
T Consensus 176 ~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~ 253 (565)
T KOG0472|consen 176 PENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNS 253 (565)
T ss_pred CHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHH-hhHHHHhccccc
Confidence 33333355555555555555555555555555555555555555 5554444445666666666666 44444 448999
Q ss_pred CCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 002178 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 323 L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
|..|||.+|+++ ++|..+..+++|+ .||+|+|.++++|.++.--.++.|-+.|||..
T Consensus 254 l~vLDLRdNklk-e~Pde~clLrsL~-----rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 254 LLVLDLRDNKLK-EVPDEICLLRSLE-----RLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ceeeeccccccc-cCchHHHHhhhhh-----hhcccCCccccCCcccccceeeehhhcCCchH
Confidence 999999999998 8888888777665 89999999999998885338888999999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=215.41 Aligned_cols=247 Identities=17% Similarity=0.346 Sum_probs=197.6
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
..+|.+...|..|+|+|+. ..+++|+++.. .....++|..|.-.++.+.||||..++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3468899999999999964 45566766532 23334689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 002178 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (956)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 786 (956)
|+..+++......+..++.+++.+||+|++|||+.. +-|-.--|.+..|++|++.+++|+ .+-+++ +
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf-----------s 340 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----------S 340 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee-----------e
Confidence 999999988878899999999999999999999975 334455689999999999998875 111111 1
Q ss_pred ceecccccCCCcccccccccCCC---CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 787 HVSTVVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.......-.+.||+||.+...+- -.++|+|||++++||+.|...||.+-.++.--. .-.+++.+..+|
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------kialeglrv~ip 411 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------KIALEGLRVHIP 411 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------hhhhccccccCC
Confidence 11122334679999999987553 347899999999999999999998655433222 223455566788
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
+..+..+.+++.-|.+.||.+||.++.++-.||++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999999999999999999988875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=268.19 Aligned_cols=201 Identities=18% Similarity=0.173 Sum_probs=135.6
Q ss_pred hcCC-Cceeeeeccc-------ccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEe
Q 002178 676 RLHH-RNLVSLVGYC-------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (956)
Q Consensus 676 ~l~h-~nIv~l~~~~-------~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 747 (956)
.++| +||++++++| .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3445 5888888887 2334677888988 67999999653 345899999999999999999999999 99
Q ss_pred ccCCCcccEEEcCCCcE-------------------EEEeeccccccCCCCC---------CCccccceecccccCCCcc
Q 002178 748 HRDIKASNILLDHKFTA-------------------KVADFGLSRLAPVPDI---------EGIVPAHVSTVVKGTPGYL 799 (956)
Q Consensus 748 H~Dlk~~NILl~~~~~~-------------------kl~DfGla~~~~~~~~---------~~~~~~~~~~~~~gt~~y~ 799 (956)
||||||+|||++..+.+ |++|||+++....... .............||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999665554 4555555543210000 0000000111245888999
Q ss_pred cccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcc
Q 002178 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ 879 (956)
Q Consensus 800 aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 879 (956)
|||++.+..++.++|||||||++|||++|..|+............ .. .+............++.+|++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--------RV----LPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--------hh----cChhhhhcCHHHHHHHHHhCC
Confidence 999999999999999999999999999998876432111111100 00 111111122334566777888
Q ss_pred cCCCCCCCHHHHHH
Q 002178 880 DETDARPSMSEVMR 893 (956)
Q Consensus 880 ~~p~~RPs~~~v~~ 893 (956)
.+|.+||++.++++
T Consensus 251 ~~P~~Rps~~eil~ 264 (793)
T PLN00181 251 PEPSCRPSMSELLQ 264 (793)
T ss_pred CChhhCcChHHHhh
Confidence 88888888887764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=204.04 Aligned_cols=167 Identities=22% Similarity=0.285 Sum_probs=125.2
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|||.++++.+ ..++++..++.|+.||++||+|||+++ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999754 346999999999999999999999876 999999999999999 9998765321
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCCh
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (956)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.................. . ........+.
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~ 133 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--A-DDPRDRSNLE 133 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--c-CCccccccHH
Confidence 125889999999999999999999999999999999999999654332222211110000 0 0000011223
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 865 ECVE--KFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 865 ~~~~--~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.... .+.+++.+|+..+|.+||++.++++.+...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 3333 588888889999999999988888877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=222.88 Aligned_cols=172 Identities=19% Similarity=0.204 Sum_probs=132.0
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC--CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceee-eeccccc
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDE 691 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~ 691 (956)
....++|.+.+.||+|+||+||+|.++ +++.||||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5788899986532 1223457899999999999999985 5442
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCC-CcccEEEcCCCcEEEEeec
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFG 770 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DfG 770 (956)
+..++||||++|++|.. +... . ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999973 2111 1 1457889999999999999 999999 9999999999999999999
Q ss_pred cccccCCCCCCCcccc-ceecccccCCCcccccccccC
Q 002178 771 LSRLAPVPDIEGIVPA-HVSTVVKGTPGYLDPEYFLTH 807 (956)
Q Consensus 771 la~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 807 (956)
+|+............. .......++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754332111111 111356788899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=217.62 Aligned_cols=265 Identities=21% Similarity=0.267 Sum_probs=199.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeCC--CcEEEEEEecCCChhhHHHHHHHHHHHHhcCC----Cceeeeeccc-ccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH----RNLVSLVGYC-DEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~L 697 (956)
+|.+.++||+|+||.||++.... ...+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999654 35789998765433332367778888888863 6888999888 57788999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-----CcEEEEeeccc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLS 772 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~DfGla 772 (956)
||+.+ |.+|.++........++..+...|+.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 899999887666677999999999999999999999999 9999999999999765 46999999999
Q ss_pred cccC--CCCCCCccccce-ecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH--HHHHHhh
Q 002178 773 RLAP--VPDIEGIVPAHV-STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR--EVNIAYQ 847 (956)
Q Consensus 773 ~~~~--~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~--~~~~~~~ 847 (956)
+... ........+... .....||..|.++....+...+.+.|+||++.++.|++.|..||........ .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8332 222111111111 2345699999999999999999999999999999999999999965442211 1111100
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
. ..... .....+..+.++...+-..+...+|....+...++.....
T Consensus 255 ~----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 255 K----LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred h----hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 00000 2223345566666666668999999999999888776554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=237.19 Aligned_cols=256 Identities=27% Similarity=0.335 Sum_probs=206.7
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccc
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (956)
-..|+|++++|+ .+|+.+. .+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 346899999998 6788776 48999999999999 57742 579999999999999 56653 46899999999
Q ss_pred ccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCC
Q 002178 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (956)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (956)
|.|+ .+|..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|... .+|+.|++++|.+++ +
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~--L 337 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS--L 337 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc--c
Confidence 9998 455433 57889999999998 55653 4789999999999996 44422 468899999999984 5
Q ss_pred cccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcC
Q 002178 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323 (956)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 323 (956)
|.. ..+|+.|+|++|+|++.++. ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|++ +|.. .++|
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l~--~~L~~LdLs~N~Lt~-LP~l---~s~L 404 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPALP--SGLKELIVSGNRLTS-LPVL---PSEL 404 (788)
T ss_pred ccc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCcccc--cccceEEecCCcccC-CCCc---ccCC
Confidence 542 25899999999999986653 357889999999999 577543 479999999999995 5543 3679
Q ss_pred CeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcccc
Q 002178 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~c 386 (956)
+.|++++|+|++ +|... ..|+.|+|++|+|+.+|..+ .++.+..|+|++||+..
T Consensus 405 ~~LdLS~N~Lss-IP~l~--------~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 405 KELMVSGNRLTS-LPMLP--------SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred CEEEccCCcCCC-CCcch--------hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence 999999999984 67543 24567999999999999887 58899999999999875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-24 Score=243.05 Aligned_cols=186 Identities=24% Similarity=0.330 Sum_probs=118.5
Q ss_pred ccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCC-C--
Q 002178 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-S-- 271 (956)
Q Consensus 195 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l-~-- 271 (956)
|++++.+.+|+.|...+|+|+ .+|..+....+|+.|.+..|.++ .+|.....++.|++|+|..|+|...++.+ .
T Consensus 257 p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~--yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~ 333 (1081)
T KOG0618|consen 257 PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE--YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVL 333 (1081)
T ss_pred hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh--hCCCcccccceeeeeeehhccccccchHHHhhh
Confidence 344444445555555555543 34444444445555555555554 35555556666666666666665544321 0
Q ss_pred -----------------------CCCCccEEEccCCcCCcC-CCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEe
Q 002178 272 -----------------------RIPNLGYLDLSSNQLNGS-IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 327 (956)
Q Consensus 272 -----------------------~l~~L~~L~Ls~N~l~~~-~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 327 (956)
.++.|+.|.+.+|.|+.. +|......+|+.|+|++|+|.......+.+|..|++|+
T Consensus 334 ~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~ 413 (1081)
T KOG0618|consen 334 NASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELN 413 (1081)
T ss_pred hHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHh
Confidence 112345555555555532 23333444788899999988866667788888999999
Q ss_pred cccccCCCcCChhhhhhccC-----------------CCCcceEEEccCCCCCCCCC--CCCCCCCcEEEecCCcc
Q 002178 328 IANNSLSGSIPSSIWQSRTL-----------------NATETFILDFQNNNLTNISG--SFNIPPNVTVRLRGNPF 384 (956)
Q Consensus 328 L~~N~l~~~~p~~~~~l~~l-----------------~~~~L~~L~L~~N~L~~l~~--~~~~~~l~~l~l~~Np~ 384 (956)
||||+|+ .+|..+..+..| +++.|+.+|||.|+|+.+-. ....|+|+.|+++||+|
T Consensus 414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999988 677766544333 56778999999999997544 44568999999999997
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=234.80 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=197.9
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeec
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (956)
.+...|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45789999999998 5776664 57999999999999 6676654 58999999999998 5666553 47999999
Q ss_pred ccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCcc
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (956)
++|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~--LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT--LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc--Ccccch--hhHHHHHhcCCcccc
Confidence 999998 6777664 58999999999999 4676664 589999999999984 555443 478999999999997
Q ss_pred CCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhc
Q 002178 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345 (956)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 345 (956)
.+..+. ++|+.|++++|.++ .+|.... .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~-~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~-- 388 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALT-SLPASLP-PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPA-- 388 (754)
T ss_pred CCcccc--ccceeccccCCccc-cCChhhc-CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHH--
Confidence 665443 68999999999998 4675443 58999999999998 4676553 68999999999999 56766532
Q ss_pred cCCCCcceEEEccCCCCCCCCCCC-----CCCCCcEEEecCCcccc
Q 002178 346 TLNATETFILDFQNNNLTNISGSF-----NIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 346 ~l~~~~L~~L~L~~N~L~~l~~~~-----~~~~l~~l~l~~Np~~c 386 (956)
.|+.|++++|+|+.+|..+ ..+.+..+++.+||+..
T Consensus 389 -----sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 389 -----ALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred -----HHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 4678999999999998764 24778899999999874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=195.74 Aligned_cols=272 Identities=19% Similarity=0.275 Sum_probs=207.5
Q ss_pred CCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEecC
Q 002178 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.|.+.++||+|.||..+.|+ +-++++||||.-...+ ...++..|.+.++.|. .+.|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68899999999999999998 5589999999765433 2346778999888884 789999988888888999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-----CCcEEEEeeccccccCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLAPV 777 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DfGla~~~~~ 777 (956)
|.||.|++.-. ...++..++..+|.|++.-++|+|++. .|.|||||+|.||.. ...+.++|||+|+.+..
T Consensus 107 -GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 89999988643 446999999999999999999999999 999999999999964 34699999999999887
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhhcccchhhc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 855 (956)
++...-.+.+......||.+||+--...+.+.+.+.|+-|+|-++.+.+-|..||..-. ...+..+..-+..... .+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T-~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST-PI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC-CH
Confidence 77655555566677889999999999999999999999999999999999999998532 2222222111111000 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 908 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~ 908 (956)
+ ..-+..+.++..-+..--..+-++-|..+-+...+.+.++..-+.++.
T Consensus 261 ~----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg 309 (449)
T KOG1165|consen 261 E----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG 309 (449)
T ss_pred H----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence 0 011223445555555555667778888888777777776655544443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-23 Score=243.63 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=189.5
Q ss_pred CCCeeeeeCCeEEEEEEeC-CCcEEEEEEec----C-CCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ----E-GSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
..+.+|.|++|.|+..... .....+.|.+. . ... .....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988877643 34444444332 1 111 112235667888888999999988888877776666799
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||++ +|...+... ..+...++..+.+|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9998 999998664 34777888899999999999999999 99999999999999999999999999987654432
Q ss_pred CCccccceecccccCCCcccccccccCCCCCc-ccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
. .........|+..|+|||++.+..|+.. .||||.|+++..|.+|+.||........... ...
T Consensus 476 ~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~---- 539 (601)
T KOG0590|consen 476 K---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNN---- 539 (601)
T ss_pred h---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhc----
Confidence 1 1245567789999999999999999875 8999999999999999999964332111100 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
...+| .+....+.+...+|. .....|.+||++||.+|+|++++++++||++-
T Consensus 540 ---------------------~~~~~----~~~~~~~~~~~~lp~---~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 540 ---------------------YSDQR----NIFEGPNRLLSLLPR---ETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ---------------------ccccc----ccccChHHHHHhchh---hHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00000 000011111111121 12357889999999999999999999999753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=191.26 Aligned_cols=269 Identities=20% Similarity=0.277 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEE-eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|.+.++||.|+||.+|.|. ..+|..||||+-..... ...+..|.++.+.+++ ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999999 67899999998764332 2367789999999974 677788888888999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~ 777 (956)
.+ |.||.+++.-. ...++..+++-+|-|++.-++|+|.++ +|||||||+|.|..- ...+.++|||+|+.+-.
T Consensus 92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99 89999988543 345899999999999999999999999 999999999999953 35799999999988755
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH-HHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR-EVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 856 (956)
.....-.+........||.+|.+--...+...+.+.|+-|+|.++...--|..||+.-....+ +......+..+...+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 443333344455667899999998888888888899999999999999999999986432211 1111111111100010
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
..-...+.++.-.+..|-...-++.|...-+-+.+..++..+
T Consensus 247 ----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 247 ----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred ----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 112334566777778888888888898887777666555443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=224.72 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=203.1
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
+.+.|++.+++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 36789999998884 566554 58999999999999 6777664 58999999999999 6777654 589999999
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCC
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (956)
+|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|+|++|.++.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-- 318 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-- 318 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc--
Confidence 99998 6777664 58999999999999 5777664 589999999999995 565553 589999999999984
Q ss_pred CcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCc
Q 002178 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322 (956)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 322 (956)
+|..+. ++|+.|++++|.+++.+..+. ++|+.|+|++|+|+ .+|... ..+|+.|+|++|+|+. +|..+. ..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~l-p~~L~~LdLs~N~Lt~-LP~~l~--~s 389 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETL-PPTITTLDVSRNALTN-LPENLP--AA 389 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhh-cCCcCEEECCCCcCCC-CCHhHH--HH
Confidence 555443 689999999999998766554 69999999999998 677644 3589999999999994 565554 37
Q ss_pred CCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCC
Q 002178 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (956)
Q Consensus 323 L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~ 364 (956)
|+.|++++|+|+ .+|..+..+.. ..+.+..|+|.+|.|+.
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~-~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRG-EGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhh-cCCCccEEEeeCCCccH
Confidence 999999999998 67877655433 23567799999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-19 Score=198.48 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=196.9
Q ss_pred CCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCC-ceeeeecccccCCcEEEEEec
Q 002178 626 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHR-NLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~LV~e~ 701 (956)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999976 78899988754332 356889999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~ 779 (956)
+.++++.+++..... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977755432 25888899999999999999999999 99999999999999988 79999999998554332
Q ss_pred CCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCch---hHHHHHHHhhcccchh
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVNIAYQSSMMFS 853 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~ 853 (956)
..... ........|+..|+|||.+.+ ..+....|+||+|++++++++|..||..... ............
T Consensus 157 ~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---- 231 (384)
T COG0515 157 STSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP---- 231 (384)
T ss_pred ccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC----
Confidence 11000 013456679999999999988 5788899999999999999999999765442 112111111110
Q ss_pred hccC-CCCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 854 VIDG-NMGSYP----SECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 854 ~~~~-~~~~~~----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.+ ...... ......+.+++..|+..+|..|.+..+....
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 --TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 001111 2223577888899999999999988876654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=219.40 Aligned_cols=239 Identities=26% Similarity=0.310 Sum_probs=188.7
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|++.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.++ .+|..+ ++|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 478999999999985 443 2588999999999999 56743 468999999999998 566533 67889999
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
++|+|+ .+|. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 290 s~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 290 FGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS- 356 (788)
T ss_pred cCCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence 999998 4554 34789999999999995 55432 468889999999985 5532 2579999999999984
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (956)
+|.. ..+|+.|++++|+|+..+.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+. +|.. ..
T Consensus 357 -LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt-~LP~l~--s~L~~LdLS~N~Lss-IP~l---~~ 422 (788)
T PRK15387 357 -LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT-SLPVLP--SELKELMVSGNRLTS-LPML---PS 422 (788)
T ss_pred -CCCC---CcccceehhhccccccCccc---ccccceEEecCCccc-CCCCcc--cCCCEEEccCCcCCC-CCcc---hh
Confidence 5543 35788899999999975542 357999999999998 466532 479999999999995 5653 34
Q ss_pred cCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCC
Q 002178 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (956)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l 365 (956)
+|+.|+|++|+|+ .+|..+..+.. |..|+|++|.|++.
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~-----L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSS-----ETTVNLEGNPLSER 460 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccC-----CCeEECCCCCCCch
Confidence 6888999999998 78988876554 55899999999863
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=227.58 Aligned_cols=278 Identities=19% Similarity=0.247 Sum_probs=146.8
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccc
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (956)
++.|++.++.+. .+|..+ .+.+|++|+|++|++. .++..+..+++|++|+|++|...+.+|. ++.+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 344444443332 233333 3456666666666665 4555566666666666666544445553 55666666666666
Q ss_pred ccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCC
Q 002178 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (956)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (956)
|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|...+.+|.. ..+|++|+|++|.+. .+
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~--~l 740 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE--EF 740 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc--cc
Confidence 55445566666666666666666654333555443 5566666666666544444432 235566666666654 23
Q ss_pred cccccCCCCCcEEeccCCCCccC-------CCC-CCCCCCccEEEccCCcCCcCCCCCCCcc-ccCEEEccCCcCCCCCc
Q 002178 244 PASYSNMSKLLKLSLRNCSLQGP-------MPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIP 314 (956)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~-------~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~Ls~N~l~~~~p 314 (956)
|..+ .+++|+.|++.++..... .+. ....++|+.|+|++|...+.+|..+... +|+.|+|++|..-+.+|
T Consensus 741 P~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 741 PSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred cccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 4332 234444444433221110 000 1123456666666666555566554332 56666666654333455
Q ss_pred hhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecC
Q 002178 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRG 381 (956)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~ 381 (956)
..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++.+|..+ .++.+..|++.+
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~--------~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI--------STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc--------ccccCEeECCCCCCccChHHHhcCCCCCEEECCC
Confidence 444 5666666666665544344432 123456666666666666554 356666666665
|
syringae 6; Provisional |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.9e-21 Score=222.09 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=178.9
Q ss_pred CCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC-hhhHHHHH---HHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS-LQGEKEFL---TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+|...+.||.+.|=+|.+|++++|. |+||++-... ......|. +|++ ...++|||.+++...-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998887 8899876543 22233443 3444 556689999999888888888899999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+. -+|+|.+..+. -+...+.++|+.|++.||.-+|+.+ |+|||||.+|||+++-.-+.|+||..-+..--++.
T Consensus 102 yvk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 995 59999996543 4888899999999999999999999 99999999999999999999999987654333322
Q ss_pred CCccccceecccccCCCcccccccccC----------C-CCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHH-Hhh
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH----------K-LTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI-AYQ 847 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~-~~~ 847 (956)
.................|+|||.+... . .+++-||||+||++.|+++ |++||.-. .+..+... .+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-QL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-QLLAYRSGNADD 254 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-HHHhHhccCccC
Confidence 211112222333445689999988542 1 5678999999999999999 67777421 11110000 000
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
.+...+ .++ ...+++++..|++.||.+|-++++.++.-.
T Consensus 255 ~e~~Le-------~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 255 PEQLLE-------KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHHHH-------hCc---CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 000000 001 125677888888888888888888776533
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=184.90 Aligned_cols=140 Identities=19% Similarity=0.152 Sum_probs=108.7
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--h------------------------HHHHHHHHHHHHhcCCCce
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--G------------------------EKEFLTEIQFLSRLHHRNL 682 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI 682 (956)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998753211 0 1122459999999988776
Q ss_pred eeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHh-hhcCCCCEeccCCCcccEEEcCC
Q 002178 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 683 v~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333222 234899999988877654322 23578889999999999999999 6888 99999999999998 4
Q ss_pred CcEEEEeeccccccC
Q 002178 762 FTAKVADFGLSRLAP 776 (956)
Q Consensus 762 ~~~kl~DfGla~~~~ 776 (956)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=188.44 Aligned_cols=172 Identities=15% Similarity=0.115 Sum_probs=133.9
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHH---H------HHHHHHHHHhcCCCceeeeeccccc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK---E------FLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
...++|+..+.+|.|+||.||.+.. ++..+|+|.+.......++ . +.+|++.+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3478999999999999999999766 5778999999754333222 2 6789999999999999999888643
Q ss_pred C--------CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 692 E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 692 ~--------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
. +..++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 2 36899999999999988742 222 24568999999999999 99999999999999988
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 826 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ell 826 (956)
++|+|||..+....... ...+.....+..++|+|+||+.+.-..
T Consensus 173 i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865432110 011344555677999999999876554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=221.70 Aligned_cols=270 Identities=20% Similarity=0.230 Sum_probs=163.8
Q ss_pred CCcCcCCCC-CCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccc
Q 002178 98 LSPEIGRLS-YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN 176 (956)
Q Consensus 98 ~~~~l~~l~-~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 176 (956)
+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .++..+..+++|++|+|++|...+.+|. +..
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~ 655 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM 655 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc
Confidence 444454442 3666666665554 455544 3456666666666655 4555556666666666665543334442 555
Q ss_pred cccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEE
Q 002178 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256 (956)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 256 (956)
+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|...+ .+|.. .++|+.|
T Consensus 656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~-~~p~~---~~nL~~L 730 (1153)
T PLN03210 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLK-SFPDI---STNISWL 730 (1153)
T ss_pred CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcc-ccccc---cCCcCee
Confidence 6666666666655444566666666666666666654333444443 45566666666654332 23322 3455666
Q ss_pred eccCCCCccCCCCCCCCCCccEEEccCCcCC---c----CCCCC-CCccccCEEEccCCcCCCCCchhcCCCCcCCeEec
Q 002178 257 SLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN---G----SIPPG-RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328 (956)
Q Consensus 257 ~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~---~----~~p~~-~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 328 (956)
+|++|.++..+..+ .+++|+.|+++++... + ..+.. ....+|+.|+|++|...+.+|..++++++|+.|+|
T Consensus 731 ~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 731 DLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred ecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 66666665444332 4556666666553221 0 00111 11237999999999888899999999999999999
Q ss_pred ccccCCCcCChhhhhhccCCCCcceEEEccCC-CCCCCCCCCCCCCCcEEEecCCccc
Q 002178 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNN-NLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 329 ~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N-~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
++|+..+.+|..+ ..++|+.|+|++| ++..+|.. ..++..|+|++|.+.
T Consensus 810 s~C~~L~~LP~~~------~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls~n~i~ 859 (1153)
T PLN03210 810 ENCINLETLPTGI------NLESLESLDLSGCSRLRTFPDI--STNISDLNLSRTGIE 859 (1153)
T ss_pred CCCCCcCeeCCCC------CccccCEEECCCCCcccccccc--ccccCEeECCCCCCc
Confidence 9987666788764 3567889999996 45666543 356788999998754
|
syringae 6; Provisional |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=177.70 Aligned_cols=139 Identities=20% Similarity=0.155 Sum_probs=110.3
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh---------------------h-----HHHHHHHHHHHHhcCCCce
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---------------------G-----EKEFLTEIQFLSRLHHRNL 682 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~nI 682 (956)
...||+|++|.||+|...+|+.||||+++..... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1224578999999999987
Q ss_pred eeeecccccCCcEEEEEecCCCCCHHHH-HhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcC
Q 002178 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 760 (956)
Q Consensus 683 v~l~~~~~~~~~~~LV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~ 760 (956)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433322 34899999988865443 322 346778889999999999999999 88 99999999999999
Q ss_pred CCcEEEEeeccccccC
Q 002178 761 KFTAKVADFGLSRLAP 776 (956)
Q Consensus 761 ~~~~kl~DfGla~~~~ 776 (956)
++.++|+|||+|+...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=174.88 Aligned_cols=191 Identities=14% Similarity=0.074 Sum_probs=139.9
Q ss_pred CCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh----HHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEec
Q 002178 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 67888877776543311 235789999999995 5889999886 457999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCC-CcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
++|.+|.+.... ....+..|++++|.++|+.| |+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999999765421 11346788999999999999 999999 79999999999999999999985442210
Q ss_pred C-Cccc----cc-eecccccCCCcccccccccC-CCC-CcccchhHHHHHHHHHhCCCCCCC
Q 002178 781 E-GIVP----AH-VSTVVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 781 ~-~~~~----~~-~~~~~~gt~~y~aPE~~~~~-~~~-~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
- .... .+ .......++.|++|+...-- ..+ ...+.++-|+.+|.++|++.+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0000 00 01123367788888865432 222 567899999999999999887643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.6e-21 Score=177.22 Aligned_cols=165 Identities=30% Similarity=0.494 Sum_probs=103.6
Q ss_pred cccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccc
Q 002178 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205 (956)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 205 (956)
+.++...+.|-||+|+++ .+|..++.|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445666777777777777 66667777777777777777776 56666666666666666666665 5555566666666
Q ss_pred eecccccccC-CCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCC
Q 002178 206 HMLLDNNNLT-GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284 (956)
Q Consensus 206 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 284 (956)
.|||..|++. ..+|..|..+..|+-|+|++|.| .-.+++++.+++|+.|.+..|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndf-------------------------e~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF-------------------------EILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCc-------------------------ccCChhhhhhcceeEEeeccC
Confidence 6665555554 33445555555555555555555 444444444445555544444
Q ss_pred cCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 285 ~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
.+- ..|..++.|..|++|.+.+|+++ .+|..++.
T Consensus 161 dll------------------------~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 161 DLL------------------------SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred chh------------------------hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 443 55677777778888888888877 66666554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=194.63 Aligned_cols=217 Identities=26% Similarity=0.416 Sum_probs=161.5
Q ss_pred HHhcCCCceeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 674 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 674 l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
|+.+.|.|+.+|+|.+.++...+.|.+||..|+|.|.+.. ....+++.....++++|+.||+|+|... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 3567899999999999999999999999999999999976 3456899999999999999999999865 238999999
Q ss_pred ccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-------CCCCcccchhHHHHHHHHH
Q 002178 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELL 826 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~G~ll~ell 826 (956)
+|+++|....+|++|||+......... ........-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccceeeeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999877642100 0111122234579999999763 1467799999999999999
Q ss_pred hCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 827 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP--SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 827 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.+.||.......+.......... .-....++... .+..+.+..++..||..+|.+||++.++-..++.+..
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccCChHHHHHHHHh--cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999753322211111111000 00001112111 1455579999999999999999999999888776644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-20 Score=173.07 Aligned_cols=166 Identities=26% Similarity=0.524 Sum_probs=144.6
Q ss_pred CcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccC
Q 002178 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180 (956)
Q Consensus 101 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 180 (956)
.+.++++++.|.||+|+++ .+|..+..+++|+.|++++|++. .+|.+++.|++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4556778888899999998 67778999999999999999998 88889999999999999999988 889999999999
Q ss_pred CeeecccCcCC-CCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEecc
Q 002178 181 RHFHMNNNSIS-GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (956)
Q Consensus 181 ~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (956)
+.|||++|++. ..+|..|..+..|+-|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+.
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll--~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL--SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh--hCcHHHHHHHHHHHHhcc
Confidence 99999999886 357888889999999999999998 88889999999999999999985 688999999999999999
Q ss_pred CCCCccCCCCCCC
Q 002178 260 NCSLQGPMPDLSR 272 (956)
Q Consensus 260 ~N~l~~~~~~l~~ 272 (956)
+|+++-.+|+++.
T Consensus 182 gnrl~vlppel~~ 194 (264)
T KOG0617|consen 182 GNRLTVLPPELAN 194 (264)
T ss_pred cceeeecChhhhh
Confidence 9998887776543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-20 Score=209.39 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=153.8
Q ss_pred EEEeCCCCccc-cCCcCcCCCCCCCEEEccCCCCcc----cCCcccccCcccchhhccCcCCCC------CCCCccCCCc
Q 002178 86 ELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTG------SLPEELGYLP 154 (956)
Q Consensus 86 ~L~L~~~~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 154 (956)
.|+|.++++++ .....+..+..|+.|+|+++.++. .++..+...++|++|++++|.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 36677777773 344556677778888888888854 355566677778888888888762 2234566677
Q ss_pred ccceeecccccccCCCCcccccccc---CCeeecccCcCCC----CCccccCCC-cccceecccccccCCC----CCccc
Q 002178 155 KLDRIQIDQNYISGSLPKSFANLNK---TRHFHMNNNSISG----QIPPELSRL-PSLVHMLLDNNNLTGY----LPPEL 222 (956)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~l 222 (956)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|+++. .+...+..+ ++|+.|+|++|.+++. +...+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887666666655555 8888888887763 223344555 7778888888877742 23344
Q ss_pred CCcchhhhhcccCCcCCCCC---CcccccCCCCCcEEeccCCCCccCCC-----CCCCCCCccEEEccCCcCCcCCCCCC
Q 002178 223 SELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPPGR 294 (956)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~p~~~ 294 (956)
..+++|++|+|++|.+++.. ++..+..+++|+.|+|++|.+++... .+..+++|++|++++|.+++......
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 55566777777777776421 22234445577777777777654221 24556667777777776653111110
Q ss_pred ------CccccCEEEccCCcCCC----CCchhcCCCCcCCeEecccccCCCc
Q 002178 295 ------LSLNITTIKLSNNKLTG----TIPSNFSGLPRLQRLFIANNSLSGS 336 (956)
Q Consensus 295 ------~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (956)
...+|++|++++|.++. .+...+..+++|++|++++|++...
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 01255555555555541 2233344445555555555555533
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-20 Score=211.15 Aligned_cols=269 Identities=24% Similarity=0.267 Sum_probs=215.3
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
..++.|+..+|-+..... -..-.+|+++|+++|+++ .+|..++.+.+|+.|+..+|+|+ .+|..+..+++|+.|++
T Consensus 219 ~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 355666666666662211 123357999999999999 67899999999999999999996 89999999999999999
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcc-cceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS-LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
.+|.++ .+|.....+++|+.|+|..|+|....+..+..+.. |..|+.+.|++.....-.=..++.|+.|.+.+|.++.
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 999998 88888899999999999999998443334444443 8889999999885442223346789999999999987
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
..-..+.++++|+.|+|++|+|...+.. +.+++.|+.|+||+|+|+ .+|.... ...|++|...+|+|. ..| .+.
T Consensus 374 -~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~ 449 (1081)
T KOG0618|consen 374 -SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA 449 (1081)
T ss_pred -cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh
Confidence 4556788999999999999999987765 899999999999999999 7776544 348999999999999 667 899
Q ss_pred CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCC
Q 002178 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~ 364 (956)
.++.|+.+|++.|+|+...-.. .+..++|++|||++|.-..
T Consensus 450 ~l~qL~~lDlS~N~L~~~~l~~-----~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 450 QLPQLKVLDLSCNNLSEVTLPE-----ALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred hcCcceEEecccchhhhhhhhh-----hCCCcccceeeccCCcccc
Confidence 9999999999999998532221 1234778899999997433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=169.64 Aligned_cols=136 Identities=17% Similarity=0.209 Sum_probs=105.8
Q ss_pred CCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-----CCCceeeeecccccCC---cEE-E
Q 002178 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-----HHRNLVSLVGYCDEEG---EQM-L 697 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-L 697 (956)
...+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 2224444 69988765444567899999999999 5799999999997763 333 7
Q ss_pred EEec--CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHH-HHhhhcCCCCEeccCCCcccEEEcC----CCcEEEEeec
Q 002178 698 VYEF--MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI-LYLHTEADPPVFHRDIKASNILLDH----KFTAKVADFG 770 (956)
Q Consensus 698 V~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DfG 770 (956)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999653 24444 35577888777 9999999 999999999999974 3489999955
Q ss_pred cc
Q 002178 771 LS 772 (956)
Q Consensus 771 la 772 (956)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=198.89 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=186.8
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeeecccccCCc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGE 694 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 694 (956)
+..+..+.|.+.+.||+|+||+||+|...+|+.||+|+-+..+.. +|.-=.+++.||+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 556667889999999999999999999888999999987764433 1211223444444 2344555556666778
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-------CCCcEEEE
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-------HKFTAKVA 767 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~~kl~ 767 (956)
-+||+||.+-|+|.+++. ....++|..++.++.|+++.+++||..+ |||+||||+|.++. ...-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 4556999999999999999999999999 99999999999994 24469999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
|||.+-.+..-. ........++|-.+-.+|...+..|++..|-|.++.+++-|+.|+..= ..
T Consensus 844 DfG~siDm~lfp-----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFP-----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VK 905 (974)
T ss_pred ecccceeeeEcC-----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hc
Confidence 999986543221 123445677899999999999999999999999999999999885421 01
Q ss_pred cccchhhccCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 848 SSMMFSVIDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+..+.+ ...+..+ ..+.+.++..++.. .+-..-|...++...++.+..
T Consensus 906 ~g~~~~~-~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWMV-KTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcceec-cccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHH
Confidence 1111111 1112222 34556666665544 666666788888877776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.2e-19 Score=196.44 Aligned_cols=225 Identities=26% Similarity=0.290 Sum_probs=178.0
Q ss_pred eeeeeCCeEEEEEE----eCCCcEEEEEEecCCChhh--HHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEecCC
Q 002178 631 QIGQGGYGKVYKGI----LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
.+|+|.||.|+.+. .+.|..+|.|+.+...... ......|-.++...+ ||.++++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998754 2347788988877543222 123455777888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|.|...+... ..+.+.....+...++-|++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-..+
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99998888543 34677777778888999999999999 9999999999999999999999999998653221
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
..+||..|||||++. ....+.|.||||++++||+||..||.. +.. . .|-..-..+|
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~---~----------~Il~~~~~~p 207 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTM---K----------RILKAELEMP 207 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHH---H----------HHhhhccCCc
Confidence 117899999999998 567889999999999999999999975 111 1 1112223567
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSM 888 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~ 888 (956)
.+.+.....++......+|..|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 8888888888888888888888543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-17 Score=172.08 Aligned_cols=229 Identities=22% Similarity=0.266 Sum_probs=146.2
Q ss_pred CCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcC----------CCceeeeeccc----
Q 002178 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLH----------HRNLVSLVGYC---- 689 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------h~nIv~l~~~~---- 689 (956)
..+.||.|+++.||.+++. +++.+|||++..... ...+++.+|.-....+. |-.++..++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999976 589999998764332 22356666655444432 21222111111
Q ss_pred -----ccC---C-----cEEEEEecCCCCCHHHHHhh---c--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCC
Q 002178 690 -----DEE---G-----EQMLVYEFMSNGTLRDQLSA---K--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751 (956)
Q Consensus 690 -----~~~---~-----~~~LV~e~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 751 (956)
... . ..+++|+-+ -+||.+++.. . ....+....++.+..|+++.+++||+.| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 1 347788888 5799887642 2 2224666777888899999999999999 999999
Q ss_pred CcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC--------CCCCcccchhHHHHHH
Q 002178 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--------KLTDKSDVYSLGVVFL 823 (956)
Q Consensus 752 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDVwS~G~ll~ 823 (956)
||+|++++.+|.++|+||+.....+. . ......+..|.+||..... .++.+.|.|++|+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~---------~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT---------R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE---------E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc---------e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999998765431 1 1113455789999987542 4788999999999999
Q ss_pred HHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 002178 824 ELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 885 (956)
Q Consensus 824 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 885 (956)
.|.+|+.||........ .+..+.... +.++.+..++...++.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~--------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD--------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGST--------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccc--------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975432110 000122233 777888888888888888776
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-19 Score=200.78 Aligned_cols=273 Identities=20% Similarity=0.250 Sum_probs=202.6
Q ss_pred EEEccCCCCc-ccCCcccccCcccchhhccCcCCCCC----CCCccCCCcccceeecccccccC------CCCccccccc
Q 002178 110 ILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISG------SLPKSFANLN 178 (956)
Q Consensus 110 ~L~Ls~N~l~-~~ip~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 178 (956)
.|+|..+.++ ......+..+.+|++|+|++|.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788889887 45566677888999999999998643 55667778889999999998873 2345677889
Q ss_pred cCCeeecccCcCCCCCccccCCCcc---cceecccccccCC----CCCcccCCc-chhhhhcccCCcCCCC---CCcccc
Q 002178 179 KTRHFHMNNNSISGQIPPELSRLPS---LVHMLLDNNNLTG----YLPPELSEL-PKLLILQLDNNNFEGT---TIPASY 247 (956)
Q Consensus 179 ~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~Ls~N~l~~~---~~p~~~ 247 (956)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. .+...+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998766766666655 9999999999983 333455666 8999999999999842 234456
Q ss_pred cCCCCCcEEeccCCCCccC-----CCCCCCCCCccEEEccCCcCCcCCCCC-----CCccccCEEEccCCcCCCCCchhc
Q 002178 248 SNMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLNGSIPPG-----RLSLNITTIKLSNNKLTGTIPSNF 317 (956)
Q Consensus 248 ~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~~~p~~-----~~~~~L~~L~Ls~N~l~~~~p~~~ 317 (956)
..+++|++|+|++|.+++. ...+..+++|+.|+|++|.+++..... ....+|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 7788999999999999852 123556689999999999987433221 112479999999999986444333
Q ss_pred C-----CCCcCCeEecccccCCCcCChhhh-hhccCCCCcceEEEccCCCCCCCCCC-----C-CC-CCCcEEEecCCcc
Q 002178 318 S-----GLPRLQRLFIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLTNISGS-----F-NI-PPNVTVRLRGNPF 384 (956)
Q Consensus 318 ~-----~l~~L~~L~L~~N~l~~~~p~~~~-~l~~l~~~~L~~L~L~~N~L~~l~~~-----~-~~-~~l~~l~l~~Np~ 384 (956)
. ..+.|+.|++++|.++......+. .+.. .+.|+.+++++|.++.-+.. . .. +.+..+++.+|||
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~--~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE--KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhc--CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 3 247999999999999743222222 2222 25788999999999865322 1 23 6788899999987
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-19 Score=189.07 Aligned_cols=280 Identities=18% Similarity=0.193 Sum_probs=201.0
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccc-cc
Q 002178 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ-NY 165 (956)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~ 165 (956)
++-++-+|. .+|..+. ..-+.|+|..|+|+.+-|.+|+.+++|+.||||+|+|+.+-|++|.+|.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 455555555 2333332 2457888999999977778899999999999999999988999999999988877766 89
Q ss_pred ccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcc
Q 002178 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (956)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~ 245 (956)
|+......|.+|..|+.|.+.-|++.-...+.|..+++|..|.|-+|.+...-...|..+..++.+.+..|.+..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence 997777789999999999999999987778889999999999999999985444478888999999999888632
Q ss_pred cccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCE----EEccCCcCCCCCchhcCCCC
Q 002178 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITT----IKLSNNKLTGTIPSNFSGLP 321 (956)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~----L~Ls~N~l~~~~p~~~~~l~ 321 (956)
..+++.|.. ++.-|.+ .++...-..-..|.++++. .+++..+.-.++. +....+...-.....|..|+
T Consensus 203 -dCnL~wla~-~~a~~~i-----etsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 203 -DCNLPWLAD-DLAMNPI-----ETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred -ccccchhhh-HHhhchh-----hcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 122332221 1111111 1223333333444555554 3333322222222 22222233323346799999
Q ss_pred cCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCccccc
Q 002178 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLN 387 (956)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~l~l~~Np~~c~ 387 (956)
+|+.|+|++|+|++.-+.+|..+.. ++.|.|..|+|..+.... .+..+.+|+|.||...|-
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~-----l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~ 337 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAE-----LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV 337 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhh-----hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE
Confidence 9999999999999988889877555 458999999999987764 588999999999999884
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=194.51 Aligned_cols=172 Identities=28% Similarity=0.438 Sum_probs=121.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..+|+.++.|-.|+||.||..+++ ..+.+|.|+ ++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence 457888999999999999999876 367788843 32211 1110 22222233222
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC---
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP--- 778 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~--- 778 (956)
|+=.+.++.-+. ++... +.+++|+|+.+ |+|||+||+|.+++.-|.+|++|||+++..-..
T Consensus 136 ---gDc~tllk~~g~--lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444555543333 22222 67899999999 999999999999999999999999998653211
Q ss_pred -----CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 779 -----DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 779 -----~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.............++||+.|+|||++..+.|...+|+|++|+++||.+-|+.||+...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 0111011112234589999999999999999999999999999999999999998653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=165.84 Aligned_cols=202 Identities=21% Similarity=0.253 Sum_probs=144.6
Q ss_pred CCCceeeeeccccc---------------------------CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHH
Q 002178 678 HHRNLVSLVGYCDE---------------------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730 (956)
Q Consensus 678 ~h~nIv~l~~~~~~---------------------------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 730 (956)
+|||||++.++|.+ ....|+||..+ ..+|+.++..+. .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 49999999887633 23579999988 469999996543 344556678889
Q ss_pred HHHHHHHhhhcCCCCEeccCCCcccEEE--cCCC--cEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc
Q 002178 731 SSRGILYLHTEADPPVFHRDIKASNILL--DHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806 (956)
Q Consensus 731 ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 806 (956)
+++|+.|||+++ |.|||+|++|||+ |+|+ ...|+|||.+--.+.....-. .........|.-..||||+...
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp-y~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP-YESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc-cccccccCCCcceecchhhhhc
Confidence 999999999999 9999999999999 3443 578899998743221100000 0111233457778999999865
Q ss_pred CC------CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhccc
Q 002178 807 HK------LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQD 880 (956)
Q Consensus 807 ~~------~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~ 880 (956)
.+ --.|.|.|+.|.+.||+++...||.......-.... +++ ..++..|+.++..+.+++...++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe--------~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQE--------SQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhh--------hhCCCCcccCChHHHHHHHHHhcC
Confidence 32 124799999999999999999999763322111111 222 235677888999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 002178 881 ETDARPSMSEVMRELE 896 (956)
Q Consensus 881 ~p~~RPs~~~v~~~L~ 896 (956)
+|.+|++..-....++
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999998765544443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=164.21 Aligned_cols=134 Identities=20% Similarity=0.330 Sum_probs=113.3
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--------hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976543211 124578899999999999988777777777788999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 1 78889999999999999999 99999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=161.44 Aligned_cols=144 Identities=19% Similarity=0.183 Sum_probs=112.4
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh----------------------hHHHHHHHHHHHH
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLS 675 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 675 (956)
++......|.+.+.||+|+||.||+|..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999999888999999986642200 1123577889999
Q ss_pred hcCCCc--eeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 676 RLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 676 ~l~h~n--Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
.+.|++ +.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 998774 4444432 356899999999999776421 234578899999999999998 99999999
Q ss_pred ccEEEcCCCcEEEEeeccccccC
Q 002178 754 SNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-16 Score=164.61 Aligned_cols=143 Identities=20% Similarity=0.159 Sum_probs=110.3
Q ss_pred CCCCCCeeeeeCCeEEEEEE--eCCCcEEEEEEecCCChh------------------------hHHHHHHHHHHHHhcC
Q 002178 625 NFNSSTQIGQGGYGKVYKGI--LPDGTVVAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 678 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 678 (956)
-|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36678899999999999998 468999999988743210 0123568999999997
Q ss_pred CCc--eeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 679 HRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 679 h~n--Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
+.. +.+++++ ...++||||+++++|....... ..........++.|++.++.|||+.+. |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhE
Confidence 533 3344443 2358999999998887654222 235556678899999999999998763 99999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 002178 757 LLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~ 776 (956)
+++ +++++|+|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-16 Score=186.43 Aligned_cols=157 Identities=35% Similarity=0.566 Sum_probs=117.0
Q ss_pred CCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC---CCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCC
Q 002178 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT---SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL 105 (956)
Q Consensus 29 ~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~---~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l 105 (956)
...+.+.|++||+++|+++.++. ..+|+ +++|+ +.|.||.|..... .....++.|+|.++++.|.+|+.++.|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~--~~~W~-g~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPL--RFGWN-GDPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcc--cCCCC-CCCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhCC
Confidence 45678899999999999986543 24896 46774 3699999953211 122357888888888888888888888
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCcccccc-ccCCeee
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL-NKTRHFH 184 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ 184 (956)
++|+.|+|++|+|+|.+|..++++++|++|||++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 888888888888888888888888888888888888888888888888888888888888877777766543 2344455
Q ss_pred cccCc
Q 002178 185 MNNNS 189 (956)
Q Consensus 185 L~~N~ 189 (956)
+.+|.
T Consensus 522 ~~~N~ 526 (623)
T PLN03150 522 FTDNA 526 (623)
T ss_pred ecCCc
Confidence 55443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.2e-16 Score=159.58 Aligned_cols=130 Identities=22% Similarity=0.337 Sum_probs=106.5
Q ss_pred eeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--------hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.||+|+||+||+|.+ ++..|++|........ ...++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5788999986532211 1256778999999999887665555555666779999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
+|++|.+++..... .++.+++.+|.++|+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754211 78999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=184.18 Aligned_cols=145 Identities=20% Similarity=0.270 Sum_probs=114.8
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCC-Ch------hhHHHHHHHHHHHHhcCCCceeeeecc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG-SL------QGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 688 (956)
+.........|...+.||+|+||+||+|.+.+...++.++.... .. ...+.+.+|+++++.++|++++....+
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 33333445566778999999999999998755433332222211 11 123568899999999999999988877
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 689 ~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
+......++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 777778899999999999999885 35678999999999999999 9999999999999 578999999
Q ss_pred eccccc
Q 002178 769 FGLSRL 774 (956)
Q Consensus 769 fGla~~ 774 (956)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-16 Score=171.63 Aligned_cols=128 Identities=27% Similarity=0.401 Sum_probs=108.8
Q ss_pred CcEEEEEecCCCCCHHHHHhh-cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
.+.++.|++|...+|.+|+.+ ......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999974 344567888899999999999999 66 89999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt 827 (956)
........ .........+...||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665433 11112334456779999999999999999999999999999999996
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=147.11 Aligned_cols=136 Identities=23% Similarity=0.212 Sum_probs=97.5
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh--HHH----------------------HHHHHHHHHhcCCCc--e
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKE----------------------FLTEIQFLSRLHHRN--L 682 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--I 682 (956)
.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999877532211 111 134555565654432 3
Q ss_pred eeeecccccCCcEEEEEecCCCCCHHH-HHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcC
Q 002178 683 VSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 760 (956)
Q Consensus 683 v~l~~~~~~~~~~~LV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~ 760 (956)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344433 24589999999854322 111110 11 5577899999999999999 87 99999999999999
Q ss_pred CCcEEEEeeccccccC
Q 002178 761 KFTAKVADFGLSRLAP 776 (956)
Q Consensus 761 ~~~~kl~DfGla~~~~ 776 (956)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-14 Score=139.40 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=114.0
Q ss_pred CCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeeecccccCCcEEEEEecCCCC
Q 002178 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999754 7899998865433 4578899999999976 58899999888888999999999887
Q ss_pred CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.+..+ +......++.+++++++++|......++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 4456677899999999999986444599999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-15 Score=177.98 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=193.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC--CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~L 697 (956)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777788999999999887753 34567777665433 222334445777766776 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhh-hcCCCCEeccCCCcccEEEcCCC-cEEEEeecccccc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 775 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~ 775 (956)
+++|.+++++.+-+........+......+..|+..++.|+| ..+ +.|+|+||+|.+++..+ ..|++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999883222223555666778999999999999 888 99999999999999999 9999999999887
Q ss_pred CC-CCCCCccccceeccccc-CCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 776 PV-PDIEGIVPAHVSTVVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 776 ~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
.. .. .........| ++.|+|||...+. -.....|+||.|+++.-+++|..|+........ .
T Consensus 176 ~~~~g-----~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---------~-- 239 (601)
T KOG0590|consen 176 RNKNG-----AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---------R-- 239 (601)
T ss_pred cccCC-----cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------c--
Confidence 65 22 1233444567 9999999999885 445679999999999999999999864322110 0
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
....+..| .|.. ...+........+++.++++.+|..|.+.+++-.
T Consensus 240 -----------------~~~~~~~~------~~~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 -----------------YSSWKSNK------GRFT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----------------ceeecccc------cccc-----------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 00000000 0000 0111223444567888999999999999999999
Q ss_pred CCcccc
Q 002178 933 HPYVSS 938 (956)
Q Consensus 933 HP~f~~ 938 (956)
|||+..
T Consensus 286 d~~~~~ 291 (601)
T KOG0590|consen 286 DNWLSS 291 (601)
T ss_pred cccccc
Confidence 999987
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=146.31 Aligned_cols=135 Identities=23% Similarity=0.294 Sum_probs=104.8
Q ss_pred CCeee-eeCCeEEEEEEeCCCcEEEEEEecCCCh-------------hhHHHHHHHHHHHHhcCCCce--eeeecccccC
Q 002178 629 STQIG-QGGYGKVYKGILPDGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNL--VSLVGYCDEE 692 (956)
Q Consensus 629 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 692 (956)
...|| .|+.|+||++... +..++||++..... .....+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999874 67889988753211 123567889999999998875 6677664332
Q ss_pred -C---cEEEEEecCCC-CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 693 -G---EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 693 -~---~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
+ ..++|||++++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988542 23332 3568899999999999 9999999999999999999999
Q ss_pred eeccccc
Q 002178 768 DFGLSRL 774 (956)
Q Consensus 768 DfGla~~ 774 (956)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-14 Score=159.11 Aligned_cols=180 Identities=29% Similarity=0.495 Sum_probs=100.9
Q ss_pred cccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecc
Q 002178 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209 (956)
Q Consensus 130 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 209 (956)
+.-...||+.|++. ++|..+..+..|+.|.|..|.+. .+|..+.++..|++|+|+.|+++ .+|..+..| -|+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEE
Confidence 33344455555554 44444444444555555555444 44445555555555555555554 444444443 3556666
Q ss_pred cccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcC
Q 002178 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289 (956)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 289 (956)
++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++++.+|+.|.+..|++...++++.
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~~lp~El~------------------ 209 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLEDLPEELC------------------ 209 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhhhCCHHHh------------------
Confidence 666666 55556666666666666666665 455556665555555555555554444433
Q ss_pred CCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 290 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
...|..||+|.|+++ .+|-.|.+|..|++|-|.+|.|+ ..|..+.
T Consensus 210 ------~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 210 ------SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred ------CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 223444444444444 67778888888888888888887 5555553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-14 Score=155.52 Aligned_cols=196 Identities=25% Similarity=0.404 Sum_probs=173.4
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
-.|+.-...||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 44666788999999999 89999999999999999999998 99999999999999999999998 7788877775 899
Q ss_pred eecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCC
Q 002178 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (956)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (956)
|-+++|+++ .+|..++.++.|..||.+.|++. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~--~lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE--DLPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh--hCCHHHhCC-ceeeeecccCc
Confidence 999999999 88999999999999999999999 67889999999999999999997 688888854 68999999999
Q ss_pred CccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc----ccCEEEccCCc
Q 002178 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLSNNK 308 (956)
Q Consensus 263 l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~L~~L~Ls~N~ 308 (956)
+..++-.|..+..|++|-|.+|.|+ ..|..++.. -.++|+..-++
T Consensus 223 is~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 223 ISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eeecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 9999999999999999999999998 666655433 24666666664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-12 Score=148.86 Aligned_cols=140 Identities=22% Similarity=0.254 Sum_probs=101.2
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh----------------------------------------HHHHH
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFL 668 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 668 (956)
.+.||.|++|.||+|++++|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999976532110 01245
Q ss_pred HHHHHHHhcC-----CCceeeeecc-cccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHH-HHHHhhhc
Q 002178 669 TEIQFLSRLH-----HRNLVSLVGY-CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GILYLHTE 741 (956)
Q Consensus 669 ~E~~~l~~l~-----h~nIv~l~~~-~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 741 (956)
+|++.+.+++ ++++ .+-.. ....+..+|||||++|++|.++...... .. .+.+++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666555552 3333 22222 2334567999999999999987653211 11 24456766666 47889998
Q ss_pred CCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 742 ~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
| ++|+|+||.||+++.+++++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.5e-13 Score=152.44 Aligned_cols=201 Identities=31% Similarity=0.463 Sum_probs=113.3
Q ss_pred EEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCc-ccceeecccccccCCCCccccccccCCeeecccC
Q 002178 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (956)
Q Consensus 110 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (956)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 455555555322 223444455666666666665 5555555553 6666666666665 44455566666666666666
Q ss_pred cCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC
Q 002178 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (956)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (956)
+++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+.+++++..|.+++|++...+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--~~~~~~~~~~~l~~l~l~~n~~~~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSLSNLKNLSGLELSNNKLEDLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--ecchhhhhcccccccccCCceeeeccc
Confidence 666 44444445566666666666666 44444444455666666666432 345556666666666666666655544
Q ss_pred CCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcC
Q 002178 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 269 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
.+..+++|++|++++|.++ .++......+++.|++++|.+....|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccc-ccccccccCccCEEeccCccccccchhhhc
Confidence 5556666666666666666 444433333666666666666655444433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1e-12 Score=150.80 Aligned_cols=199 Identities=33% Similarity=0.454 Sum_probs=135.2
Q ss_pred hhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccc-cCCeeecccCcCCCCCccccCCCcccceeccccc
Q 002178 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN-KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (956)
Q Consensus 134 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 212 (956)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5777777764 23344555577777777777777 5566666664 7777788887777 55566777777888888888
Q ss_pred ccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCC
Q 002178 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292 (956)
Q Consensus 213 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 292 (956)
+++ .+|...+.+++|+.|++++|+++ .+|........|++|++++|.+...+..+..+.++..|.+++|++.. ++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~--~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS--DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc--cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccc
Confidence 777 44544546677777788888776 45665555666777777777665566667777777777777777763 233
Q ss_pred CCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhh
Q 002178 293 GRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341 (956)
Q Consensus 293 ~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 341 (956)
... ..+++.|++++|+++...+ ++.+.+|+.|++++|.+....|...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 222 2357777888887774444 7777777888888877776555543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.5e-12 Score=131.73 Aligned_cols=154 Identities=25% Similarity=0.392 Sum_probs=114.3
Q ss_pred HHHhcCCCceeeeecccccC-----CcEEEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCC
Q 002178 673 FLSRLHHRNLVSLVGYCDEE-----GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745 (956)
Q Consensus 673 ~l~~l~h~nIv~l~~~~~~~-----~~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 745 (956)
-+-.+.|.||++++.|+.+. ....++.|||..|++..+|++ +....+....-.+++.||..||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34455799999999998554 357899999999999999986 2334566777788999999999999986 689
Q ss_pred EeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHH
Q 002178 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825 (956)
Q Consensus 746 ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~el 825 (956)
|+|+++..+-|++..+|-+|++--.-... .+..... .........+-++|.|||.-.....+.++|||+||....||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~--h~s~~~~-~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDST--HPSVNST-REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcccc--chhhhhh-hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999999999999888752111000 0000000 01111223466899999998777778899999999999999
Q ss_pred HhCCC
Q 002178 826 LTGMQ 830 (956)
Q Consensus 826 ltg~~ 830 (956)
.-+..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 87644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-11 Score=140.69 Aligned_cols=166 Identities=19% Similarity=0.195 Sum_probs=127.8
Q ss_pred eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHH
Q 002178 645 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 724 (956)
Q Consensus 645 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~ 724 (956)
..++.+|.|...+...........+-++.++.++||||+++++.+..++..|||+|.+ ..|..++.+.+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHH
Confidence 3478888888887655433455677889999999999999999999999999999998 47888886643 5566
Q ss_pred HHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccc
Q 002178 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804 (956)
Q Consensus 725 ~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 804 (956)
...+.||+.||.|||..++ ++|++|.-+.|+++..|+.||++|.++........ ......--..|..|+.+
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhc
Confidence 7788999999999997664 99999999999999999999999998865432110 00111112246667655
Q ss_pred ccCCCCCcccchhHHHHHHHHHhC
Q 002178 805 LTHKLTDKSDVYSLGVVFLELLTG 828 (956)
Q Consensus 805 ~~~~~~~~sDVwS~G~ll~elltg 828 (956)
.... -..|.|.|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4333 346999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=140.74 Aligned_cols=143 Identities=21% Similarity=0.207 Sum_probs=94.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChh----------------------------------hHH---
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ----------------------------------GEK--- 665 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 665 (956)
..|+. +.||+|++|.||+|++++ |+.||||+.+..... -.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999887 999999998753210 011
Q ss_pred ---HHHHHHHHHHhcC----CCceeeeecccc-cCCcEEEEEecCCCCCHHHH--HhhcCC--CCchhHHHHHHHHHHHH
Q 002178 666 ---EFLTEIQFLSRLH----HRNLVSLVGYCD-EEGEQMLVYEFMSNGTLRDQ--LSAKSK--EPLGFAMRLSIALGSSR 733 (956)
Q Consensus 666 ---~~~~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~LV~e~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia~ 733 (956)
++.+|+..+.+++ +.+.+.+-.++. .....+|||||++|+++.++ +...+. ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2344444444432 333333323322 24567899999999999874 322221 123333333444443
Q ss_pred HHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeeccccccCC
Q 002178 734 GILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGLSRLAPV 777 (956)
Q Consensus 734 gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGla~~~~~ 777 (956)
...| ++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3567 99999999999999988 999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.5e-11 Score=119.79 Aligned_cols=131 Identities=16% Similarity=0.115 Sum_probs=96.8
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCcee-eeecccccCCcEEEEEecCCCCCH
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
.+.++.|.++.||++... ++.|++|....... ....+..|+++++.+.+.+++ +++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999874 77899998765432 223567899999988655544 4554433 345899999999887
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC--CCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.+.. . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 1 11245678999999999876 22359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-11 Score=135.49 Aligned_cols=249 Identities=21% Similarity=0.228 Sum_probs=179.2
Q ss_pred cCCCCCCeeee--eCCeEEEEEEe---CCCcEEEEEEecC--CChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcE
Q 002178 624 NNFNSSTQIGQ--GGYGKVYKGIL---PDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 695 (956)
..|.+...+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...++++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999986 3688899997332 11122233356777777774 99999988899999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHH----HHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeec
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFG 770 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfG 770 (956)
++-+|++ +.+|.++.+.... .++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999998 6788888876432 3666777788888888 999999998 9999999999999999 899999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
+...+........ ........|...|++||...+ .++...|+|++|.+..|..++..+...+.+. .|
T Consensus 269 ~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W--------- 335 (524)
T KOG0601|consen 269 LVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-SW--------- 335 (524)
T ss_pred eeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-Cc---------
Confidence 9988765543221 111223357788999998754 4588999999999999999987776544210 00
Q ss_pred chhhccCCC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002178 851 MFSVIDGNM--GSYPSECVEKFIKLALKCCQDETDARPSMSEVM 892 (956)
Q Consensus 851 ~~~~~~~~~--~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~ 892 (956)
.-+++.. ..+-+.....+......+++.++..|++.+.+.
T Consensus 336 --~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 --SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0011111 011112234555577888888888888776554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-12 Score=136.92 Aligned_cols=209 Identities=19% Similarity=0.225 Sum_probs=96.4
Q ss_pred CCCCCCEEEccCCCCcccCC--cccccCcccchhhccCcCCCCCC--CCccCCCcccceeecccccccCCCCcc-ccccc
Q 002178 104 RLSYLTILDFMWNKISGSIP--KEIGNIKSLELLLLNGNELTGSL--PEELGYLPKLDRIQIDQNYISGSLPKS-FANLN 178 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip--~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~ 178 (956)
++.+|+.+.|.+..+. ..+ .....|++++.||||.|-|...- -.....|++|+.|+|+.|++....... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4555566666555544 222 23445555666666665555221 122344555555555555554222211 12344
Q ss_pred cCCeeecccCcCCCC-CccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEe
Q 002178 179 KTRHFHMNNNSISGQ-IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257 (956)
Q Consensus 179 ~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 257 (956)
+|+.|.|+.|.|+-. +-..+..+|+|+.|+|..|...+........+..|++|||++|++.....-...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 555555555555411 1112233455555555555322222222333444555555555543221113344444455555
Q ss_pred ccCCCCccCC-CC------CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCC-CCchhcCCCCcCCeEecc
Q 002178 258 LRNCSLQGPM-PD------LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTG-TIPSNFSGLPRLQRLFIA 329 (956)
Q Consensus 258 Ls~N~l~~~~-~~------l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~ 329 (956)
++.|.+..+. ++ ...++ +|++|+++.|++.. ..-..+..+++|+.|.+.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~-----------------------kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFP-----------------------KLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred ccccCcchhcCCCccchhhhcccc-----------------------cceeeecccCccccccccchhhccchhhhhhcc
Confidence 5544444311 11 12233 45555555555531 112345567778888888
Q ss_pred cccCCCc
Q 002178 330 NNSLSGS 336 (956)
Q Consensus 330 ~N~l~~~ 336 (956)
.|.|..+
T Consensus 335 ~n~ln~e 341 (505)
T KOG3207|consen 335 LNYLNKE 341 (505)
T ss_pred ccccccc
Confidence 8888743
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.2e-12 Score=134.74 Aligned_cols=206 Identities=22% Similarity=0.220 Sum_probs=157.4
Q ss_pred ceeeEEEeCCCCccccCC-cCcCCCCCCCEEEccCCCCcc--cCCcccccCcccchhhccCcCCCCCCCCc-cCCCcccc
Q 002178 82 LHLRELQLLNLNLSGNLS-PEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLD 157 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~ 157 (956)
..++++.|.++.....-. .....+++++.||||.|-|.. .+-.-...|++|+.|+|+.|++.--.... -..+++|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 457777888876654322 356789999999999998875 23344577899999999999987333322 23578999
Q ss_pred eeecccccccCC-CCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCC-CcccCCcchhhhhcccC
Q 002178 158 RIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL-PPELSELPKLLILQLDN 235 (956)
Q Consensus 158 ~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~ 235 (956)
.|.|+.|.|+.. +......+|+|+.|+|..|............+..|++|+|++|++.... -...+.++.|+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 999999999832 2344667899999999999643344445566789999999999988432 14578899999999999
Q ss_pred CcCCCCCCccc-----ccCCCCCcEEeccCCCCccC--CCCCCCCCCccEEEccCCcCC
Q 002178 236 NNFEGTTIPAS-----YSNMSKLLKLSLRNCSLQGP--MPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 236 N~l~~~~~p~~-----~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+.+..+..|+. ...+++|++|+++.|++... ...+..+++|+.|.+..|.|+
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 99988777776 56789999999999999653 334677778888888888886
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-12 Score=129.12 Aligned_cols=131 Identities=22% Similarity=0.305 Sum_probs=63.7
Q ss_pred CCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEE
Q 002178 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL 279 (956)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L 279 (956)
....|++||||+|.|+ .+.++..-+|+++.|++|+|.+.. + ..+..+++|+.||||+|.++....--..+-+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--V-QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--e-hhhhhcccceEeecccchhHhhhhhHhhhcCEeee
Confidence 3445555555555555 344444445555555555555542 1 22445555555555555554433322333445555
Q ss_pred EccCCcCCcCCCCCCCccccCEEEccCCcCCCCC-chhcCCCCcCCeEecccccCCC
Q 002178 280 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSG 335 (956)
Q Consensus 280 ~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 335 (956)
.|+.|.|. .+....-.-+|..||+++|+|.... -..+++||-|+.|.|.+|.|.+
T Consensus 358 ~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 358 KLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 55555554 1111111114555555555554322 2445666666666666666664
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7e-13 Score=138.44 Aligned_cols=180 Identities=19% Similarity=0.293 Sum_probs=93.2
Q ss_pred cccceeecccccccCCCCcc----ccccccCCeeecccCcCCCCCc-------------cccCCCcccceecccccccCC
Q 002178 154 PKLDRIQIDQNYISGSLPKS----FANLNKTRHFHMNNNSISGQIP-------------PELSRLPSLVHMLLDNNNLTG 216 (956)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p-------------~~l~~l~~L~~L~L~~N~l~~ 216 (956)
++|++||||+|-|...-+.. +.++..|+.|+|.+|.+...-- .....-+.|+++..++|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 45555555555554332222 2345555666666665541111 112334566777777777663
Q ss_pred CC----CcccCCcchhhhhcccCCcCC--CC-CCcccccCCCCCcEEeccCCCCccCCC-----CCCCCCCccEEEccCC
Q 002178 217 YL----PPELSELPKLLILQLDNNNFE--GT-TIPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSN 284 (956)
Q Consensus 217 ~~----p~~l~~l~~L~~L~Ls~N~l~--~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N 284 (956)
-. ...|...+.|+.+.++.|.|. |+ .+...|..+++|+.|||.+|.++.... .+..++.|+.|++++|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 22 233455566777777777663 11 123345667777777777777654221 2566666777777777
Q ss_pred cCCcCCCCCCC------ccccCEEEccCCcCCC----CCchhcCCCCcCCeEecccccC
Q 002178 285 QLNGSIPPGRL------SLNITTIKLSNNKLTG----TIPSNFSGLPRLQRLFIANNSL 333 (956)
Q Consensus 285 ~l~~~~p~~~~------~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 333 (956)
.+...-...+. ..+|+.|.|.+|.++. .+.......+.|+.|+|++|.+
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 66533222111 1245555555555543 2223334455555555555555
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.7e-11 Score=142.74 Aligned_cols=110 Identities=26% Similarity=0.426 Sum_probs=97.7
Q ss_pred ccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceeccc
Q 002178 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (956)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (956)
.++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccCCc-chhhhhcccCCcCCC
Q 002178 211 NNNLTGYLPPELSEL-PKLLILQLDNNNFEG 240 (956)
Q Consensus 211 ~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~ 240 (956)
+|+++|.+|..+..+ .++..+++++|...+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999888763 467788888887643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.7e-10 Score=112.49 Aligned_cols=137 Identities=17% Similarity=0.104 Sum_probs=98.2
Q ss_pred CCeeeeeCCeEEEEEEeCC-------CcEEEEEEecCCC---------------h-------hhHHHH----HHHHHHHH
Q 002178 629 STQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGS---------------L-------QGEKEF----LTEIQFLS 675 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~---------------~-------~~~~~~----~~E~~~l~ 675 (956)
...||.|.-+.||.|...+ +..+|||+.+... . ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4799999765210 0 001222 37999999
Q ss_pred hcCC--CceeeeecccccCCcEEEEEecCCCCCHHH-HHhhcCCCCchhHHHHHHHHHHHHHHHHh-hhcCCCCEeccCC
Q 002178 676 RLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDI 751 (956)
Q Consensus 676 ~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl 751 (956)
++.. -++.+++++ ...++||||+.+..+.. .++. ..++..+...+..+++.+|.++ |+.+ +||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 355566654 46789999996643322 2322 1244455667889999999999 7888 999999
Q ss_pred CcccEEEcCCCcEEEEeeccccccC
Q 002178 752 KASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 752 k~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
++.||++++ +.++|+|||.|....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=125.47 Aligned_cols=132 Identities=27% Similarity=0.347 Sum_probs=74.5
Q ss_pred cccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcccc
Q 002178 220 PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI 299 (956)
Q Consensus 220 ~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 299 (956)
.....+..|++||||+|.|+ .+..+..-+++++.|++|+|.|..... +..+++|+.||||+|.++
T Consensus 278 ~~~dTWq~LtelDLS~N~I~--~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls------------ 342 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT--QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA------------ 342 (490)
T ss_pred EecchHhhhhhccccccchh--hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH------------
Confidence 33444455666666666665 344555555566666666665553332 555555555555555554
Q ss_pred CEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC--C-CCCCCcE
Q 002178 300 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--F-NIPPNVT 376 (956)
Q Consensus 300 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~--~-~~~~l~~ 376 (956)
.+-.+-..|-+.+.|.|++|.|. .+..+.+| -+|..||+++|++..+..- . .+|-+..
T Consensus 343 ------------~~~Gwh~KLGNIKtL~La~N~iE-----~LSGL~KL--YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~ 403 (490)
T KOG1259|consen 343 ------------ECVGWHLKLGNIKTLKLAQNKIE-----TLSGLRKL--YSLVNLDLSSNQIEELDEVNHIGNLPCLET 403 (490)
T ss_pred ------------hhhhhHhhhcCEeeeehhhhhHh-----hhhhhHhh--hhheeccccccchhhHHHhcccccccHHHH
Confidence 22233334555566666666654 23333332 2455677777777666542 2 4788888
Q ss_pred EEecCCccc
Q 002178 377 VRLRGNPFC 385 (956)
Q Consensus 377 l~l~~Np~~ 385 (956)
+.|.+||..
T Consensus 404 l~L~~NPl~ 412 (490)
T KOG1259|consen 404 LRLTGNPLA 412 (490)
T ss_pred HhhcCCCcc
Confidence 999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=131.24 Aligned_cols=246 Identities=20% Similarity=0.227 Sum_probs=174.0
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC--CCcEEEEEEecCCChhhH--HHHHHHHHHHHhc-CCCceeeeecccccCC
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 693 (956)
......+|..+..||.|.|+.|++...+ ++..+++|.......... ..-..|+-+...+ .|.+++..+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3344567888999999999999998744 578899998775433322 2224566666665 4888888888887777
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeeccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 772 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla 772 (956)
..++=-||++++++.... .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-+++|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 888999999999987766 22345778889999999999999999998 9999999999999886 88999999998
Q ss_pred cccCCCCCCCccccceecccccCCCcc--cccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
..+... ........++. +++......+..+.|++|||.-+.|.+++...-.... .
T Consensus 415 t~~~~~----------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------~ 471 (524)
T KOG0601|consen 415 TRLAFS----------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------Q 471 (524)
T ss_pred ccccee----------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------c
Confidence 643211 11122333444 5555566778899999999999999998854322211 1
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
+..+..+.....+... ..+..+.+.....++..||.+.+...
T Consensus 472 ~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 472 SLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcc
Confidence 1122223333333333 66666666677777777777665543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.8e-12 Score=130.02 Aligned_cols=256 Identities=21% Similarity=0.226 Sum_probs=169.8
Q ss_pred cCcCCCCCCCEEEccCCCCcc----cCCcccccCcccchhhccCcC---CCCCCCCccCCCcccceeecccccccCCCCc
Q 002178 100 PEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNE---LTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172 (956)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 172 (956)
+.+..+..++.|+||+|.|.. .+-..+.+.++|+..++|+=- +...+|+.+. .+..
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~-----------------~l~~ 86 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK-----------------MLSK 86 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH-----------------HHHH
Confidence 456677788888888888753 334455666677777776521 1122222221 1224
Q ss_pred cccccccCCeeecccCcCCCCCccc----cCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCccccc
Q 002178 173 SFANLNKTRHFHMNNNSISGQIPPE----LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248 (956)
Q Consensus 173 ~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (956)
++...++|++|+||+|-|...-+.. +.++.+|++|+|.+|.+.-.--..++ ..|..|. .|.. ..
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk--------~~ 154 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK--------AA 154 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc--------cC
Confidence 5566778999999999887544433 45678888888888887732222222 2344444 2222 12
Q ss_pred CCCCCcEEeccCCCCccCCC-----CCCCCCCccEEEccCCcCCcCCCC-----CCCccccCEEEccCCcCCC----CCc
Q 002178 249 NMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPP-----GRLSLNITTIKLSNNKLTG----TIP 314 (956)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~p~-----~~~~~~L~~L~Ls~N~l~~----~~p 314 (956)
+-++|+.+..++|++..... .|...+.|+.+.+++|.|...--. .....+|+.|||.+|-++. .+.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 23678899999998876443 267778999999999988622110 1123489999999998874 345
Q ss_pred hhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCC-----CCC-CCCCCcEEEecCCcc
Q 002178 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~-----~~~-~~~~l~~l~l~~Np~ 384 (956)
..+..+++|+.|+++++.+...--.+|..--.=..+.|++|.|++|.++.=. ... ..|.+..|+|++|-+
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 6788899999999999999977766665433333678999999999998521 112 378889999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=104.38 Aligned_cols=143 Identities=22% Similarity=0.233 Sum_probs=104.7
Q ss_pred CCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
....+-||+-+.|+++.+ .|+...||.-..... -..++..+|++.+.+.+--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 567777774322111 11346678999998886444444444555556667999
Q ss_pred ecCCC-CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEEeeccccc
Q 002178 700 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DfGla~~ 774 (956)
||+++ .++.+++................+.+|-+.+.-||..+ |||+||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99965 48888887654433333444678888999999999999 99999999999997665 458999999864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-11 Score=138.20 Aligned_cols=247 Identities=26% Similarity=0.301 Sum_probs=121.0
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
.+..++.++++.|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 34445555555555552 2233555556666666666655 33333555566666666666655332 23444446666
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCC-cccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (956)
++++|.|+.. ..+..+++|+.+++++|++...-+ . +..+.+|+.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~---i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE---IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc---ccchHHHHHHHHhhccccc
Confidence 6666666521 223345566666666666663322 1 3555566666666666642 2333334444444555555
Q ss_pred CccCCCCCCCCC--CccEEEccCCcCCcCCC-CCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCCh
Q 002178 263 LQGPMPDLSRIP--NLGYLDLSSNQLNGSIP-PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (956)
Q Consensus 263 l~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p-~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 339 (956)
++..-+ +..+. .|+.+++++|.+. .++ ......++..|++++|++... ..+...+.+..+.+..|.+... ..
T Consensus 220 i~~~~~-l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~ 294 (414)
T KOG0531|consen 220 ISKLEG-LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALS-EA 294 (414)
T ss_pred ceeccC-cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcch-hh
Confidence 543222 11111 2566666666665 331 111223566666666665532 2234455566666666665522 11
Q ss_pred hhhhhccCCCCcceEEEccCCCCCCC
Q 002178 340 SIWQSRTLNATETFILDFQNNNLTNI 365 (956)
Q Consensus 340 ~~~~l~~l~~~~L~~L~L~~N~L~~l 365 (956)
....-.......+..+.+..|.+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred hhccccccccccccccccccCccccc
Confidence 11110112334455666666666553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.6e-11 Score=139.00 Aligned_cols=210 Identities=21% Similarity=0.270 Sum_probs=144.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|.......- .-+....+-.+.-..++|-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4466667778888999999877632 3433444433221111 11112222222222345766666555556678899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|++|..+++|...++..+ ..+..........+.++++|||... +.|+|++|.|.+...++..+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999997654 3444445556666788999999987 89999999999999999999999984432211
Q ss_pred C----CC-----------------CCcc---ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 002178 778 P----DI-----------------EGIV---PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 778 ~----~~-----------------~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~ 833 (956)
- +. .... .........||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0000 1122345679999999999999999999999999999999999999997
Q ss_pred CCc
Q 002178 834 HGK 836 (956)
Q Consensus 834 ~~~ 836 (956)
...
T Consensus 1037 a~t 1039 (1205)
T KOG0606|consen 1037 AET 1039 (1205)
T ss_pred Ccc
Confidence 543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.7e-11 Score=118.70 Aligned_cols=118 Identities=32% Similarity=0.504 Sum_probs=27.4
Q ss_pred cCCCCcccCCcccccCcccchhhccCcCCCCCCCCccC-CCcccceeecccccccCCCCccccccccCCeeecccCcCCC
Q 002178 114 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192 (956)
Q Consensus 114 s~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 192 (956)
..+.|. .++ .+.+..++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+.. +.+..+++|++|++++|+|+.
T Consensus 5 t~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~ 78 (175)
T PF14580_consen 5 TANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS 78 (175)
T ss_dssp -----------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S
T ss_pred cccccc-ccc-ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc
Confidence 334444 333 3555667788888888887 333 454 467777888888877733 245566666677777776663
Q ss_pred CCcccc-CCCcccceecccccccCCCCC-cccCCcchhhhhcccCCcC
Q 002178 193 QIPPEL-SRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNF 238 (956)
Q Consensus 193 ~~p~~l-~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 238 (956)
+...+ ..+++|++|+|++|+|...-. ..+..+++|+.|+|.+|++
T Consensus 79 -i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 79 -ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred -cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 32222 345666666666666653211 2233344444444444444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-09 Score=113.97 Aligned_cols=142 Identities=23% Similarity=0.349 Sum_probs=109.6
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCC--ceeeeecccccC---CcEEEEEecCC
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEE---GEQMLVYEFMS 703 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~LV~e~~~ 703 (956)
+.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765332 1345778899999999763 456777777654 36789999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA----------------------------------------- 742 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 742 (956)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888775531 23666777788888888888888521
Q ss_pred ------------CCCEeccCCCcccEEEcC--CCcEEEEeeccccc
Q 002178 743 ------------DPPVFHRDIKASNILLDH--KFTAKVADFGLSRL 774 (956)
Q Consensus 743 ------------~~~ivH~Dlk~~NILl~~--~~~~kl~DfGla~~ 774 (956)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.3e-11 Score=115.85 Aligned_cols=109 Identities=31% Similarity=0.436 Sum_probs=31.1
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccc-cCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccc-ccccc
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF-ANLNK 179 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 179 (956)
+.+...+++|+|++|.|+. |. .++ .+.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 3344456677777777662 32 344 3566777777777766 332 45666677777777777763 33333 35667
Q ss_pred CCeeecccCcCCCCC-ccccCCCcccceecccccccC
Q 002178 180 TRHFHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 180 L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 215 (956)
|++|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 777777777665321 134555667777777777665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=103.40 Aligned_cols=131 Identities=22% Similarity=0.305 Sum_probs=98.8
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--------hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..+++|+-+.+|.+.+. |..+++|.-...... ...+-.+|++++++++--.|...+=|..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 344667643322211 123557899999998765555555566677788899999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
++|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 2345666667778899999 99999999999998765 99999999875
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-11 Score=138.93 Aligned_cols=217 Identities=22% Similarity=0.278 Sum_probs=126.2
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeec
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (956)
+.++.++...+.+.+.--. ...+..++.+++..|.+. .+-..+..+++|+.|++.+|+|... ...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheec
Confidence 3455566655554421111 145677788888888887 3445577778888888888888733 333667777777788
Q ss_pred ccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCccc-ccCCCCCcEEeccCCCCc
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~Ls~N~l~ 264 (956)
++|.|+...+ +..++.|+.|++++|.|+.. ..+..++.|+.+++++|++... ... ...+.+|+.+++.+|.+.
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~i--e~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDI--ENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhh--hhhhhhhccchHHHhccCCchh
Confidence 8777774433 44556677777777777732 3455567777777777777642 221 456666777777777665
Q ss_pred cCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc--ccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
... .+..+..+..+++..|.++ .+-...... .|+.+++++|.+. ..+..+..+..+..|++.+|++.
T Consensus 200 ~i~-~~~~~~~l~~~~l~~n~i~-~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 200 EIE-GLDLLKKLVLLSLLDNKIS-KLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccc-chHHHHHHHHhhcccccce-eccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 322 2233334444466666665 222111111 2556666666555 22244445555555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.2e-10 Score=136.46 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=112.9
Q ss_pred eeEEEeCCCC--ccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 84 LRELQLLNLN--LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 84 ~~~L~L~~~~--l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
+++|-+..+. +.......|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..+. .+|..+.+|.+|.+|++
T Consensus 547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl 625 (889)
T KOG4658|consen 547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL 625 (889)
T ss_pred cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence 4444444443 22222223555666666666655444456666666666666666666665 55666666666666666
Q ss_pred ccccccCCCCccccccccCCeeecccCcCC--CCCccccCCCcccceecccccccCCCCCcccCCcchhh----hhcccC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL----ILQLDN 235 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~Ls~ 235 (956)
..+.-...+|.....+.+|++|.+..-... ...-..+.++.+|+.+....... .+-..+..+..|. .+.+.+
T Consensus 626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~ 703 (889)
T KOG4658|consen 626 EVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEG 703 (889)
T ss_pred ccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcc
Confidence 655544344444555666666655443311 11122223333333333322221 1111222233333 222222
Q ss_pred CcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCC------CCCccEEEccCCcCCcCCCCCCCccccCEEEccCCc
Q 002178 236 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSR------IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308 (956)
Q Consensus 236 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~------l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 308 (956)
+... ..+..+..+.+|+.|.+.++.+...... ... ++++..+...++..-..+....+..+|+.|.+..+.
T Consensus 704 ~~~~--~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~ 781 (889)
T KOG4658|consen 704 CSKR--TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCR 781 (889)
T ss_pred cccc--eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEeccc
Confidence 2222 3444556666666666666665432211 000 112222222222111111122344466666666666
Q ss_pred CCCCCchhcCCCCcCCeEecccccCCCc
Q 002178 309 LTGTIPSNFSGLPRLQRLFIANNSLSGS 336 (956)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (956)
....+......+..++.+-+..+.+.+.
T Consensus 782 ~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 782 LLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccccCCCHHHHhhhcccEEecccccccc
Confidence 5555555555555555555555555544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1e-07 Score=105.25 Aligned_cols=167 Identities=19% Similarity=0.254 Sum_probs=127.3
Q ss_pred CeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccc----cCCcEEEEEecCCC-CCHHHH
Q 002178 637 YGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQMLVYEFMSN-GTLRDQ 710 (956)
Q Consensus 637 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~LV~e~~~~-gsL~~~ 710 (956)
..+.||+.. .||..|++|+++.........-..-+++++++.|.|||+|.+++. .+..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899985 489999999996544333323344678999999999999999886 34578999999875 577775
Q ss_pred Hhhc-------------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 711 LSAK-------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 711 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
-... .....++...|.++.|+..||.++|+.| ..-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4321 1224678899999999999999999999 88899999999999999999998888766543
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~ 830 (956)
++. |-+.+ -++-|.-.||.+++.+.||..
T Consensus 446 d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 220 11111 235688899999999999954
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.5e-08 Score=103.88 Aligned_cols=140 Identities=14% Similarity=0.133 Sum_probs=100.0
Q ss_pred eeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh-H----------HHHHHHHHHHHhcCCCcee--eeeccccc-----C
Q 002178 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-E----------KEFLTEIQFLSRLHHRNLV--SLVGYCDE-----E 692 (956)
Q Consensus 631 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~nIv--~l~~~~~~-----~ 692 (956)
.+-......|++..+ +|+.|.||......... . ..+.+|.+.+.++...+|. +++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333345667665 67889999775433211 1 1477899988888544333 34445432 2
Q ss_pred CcEEEEEecCCCC-CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-------CCcE
Q 002178 693 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------KFTA 764 (956)
Q Consensus 693 ~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------~~~~ 764 (956)
...+||||++++. +|.+++......+.+...+..++.+++..+.-||..| |+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999875 8999985432334556677789999999999999999 999999999999975 4689
Q ss_pred EEEeeccccc
Q 002178 765 KVADFGLSRL 774 (956)
Q Consensus 765 kl~DfGla~~ 774 (956)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.5e-08 Score=99.30 Aligned_cols=126 Identities=25% Similarity=0.311 Sum_probs=83.3
Q ss_pred EEEEEEeCCCcEEEEEEecCCCh-------------h-------------hHHHHHHHHHHHHhcCCC--ceeeeecccc
Q 002178 639 KVYKGILPDGTVVAVKRAQEGSL-------------Q-------------GEKEFLTEIQFLSRLHHR--NLVSLVGYCD 690 (956)
Q Consensus 639 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 690 (956)
.||.|...+|..+|||+.+.... . ......+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999997653110 0 123467899999999765 456666543
Q ss_pred cCCcEEEEEecCC--CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHH-hhhcCCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 691 EEGEQMLVYEFMS--NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY-LHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 691 ~~~~~~LV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
..++||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 55554433221 2234456677788775555 57888 9999999999999988 99999
Q ss_pred eeccccccC
Q 002178 768 DFGLSRLAP 776 (956)
Q Consensus 768 DfGla~~~~ 776 (956)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.4e-11 Score=132.27 Aligned_cols=179 Identities=25% Similarity=0.326 Sum_probs=107.2
Q ss_pred CccccccccCCeeecccCcCCCCCccccCCC-cccceecccccccC----------CCCCcccCCcchhhhhcccCCcCC
Q 002178 171 PKSFANLNKTRHFHMNNNSISGQIPPELSRL-PSLVHMLLDNNNLT----------GYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 171 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~----------~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
|-.+..+.+|+.|.|.++.|+. . ..+..+ ..|++|-- .|.+. |.+.+++. ..+|...+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 5566777788888888887762 1 111111 12333321 12211 11111111 245777788888886
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCC-CCccccCEEEccCCcCCCCCchhcC
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-RLSLNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
.+..++.-++.|+.|+|++|+++... .+..++.|+.|||++|.|. .+|.. ...-.|+.|.|++|.++.. ..+.
T Consensus 178 --~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 --LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred --hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHH
Confidence 46667777888888888888887655 6777888888888888887 55542 2222577777777766632 2344
Q ss_pred CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC---CCCCCcEEEecCCcccccC
Q 002178 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNT 388 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~---~~~~l~~l~l~~Np~~c~c 388 (956)
+|.+|+.|||++|-|.+ ...-. .+..+..|+|.|||.||.-
T Consensus 252 ~LksL~~LDlsyNll~~-----------------------------hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSE-----------------------------HSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhhhccchhHhhhhc-----------------------------chhhhHHHHHHHHHHHhhcCCccccCH
Confidence 56666666666666553 22211 2445577889999999863
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1e-08 Score=117.22 Aligned_cols=184 Identities=19% Similarity=0.311 Sum_probs=121.7
Q ss_pred HHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC--CccccceecccccCCCcccccccccC
Q 002178 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTPGYLDPEYFLTH 807 (956)
Q Consensus 730 ~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~ 807 (956)
+++.|+.|+|... .+||++|.|++|.++..+.+||+.|+.+.....+... ............-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999854 5999999999999999999999999988655431110 00011122223345689999999998
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002178 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 887 (956)
Q Consensus 808 ~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs 887 (956)
..+.++|+||+||++|.+..|..+................ ..+-....+..+.+.++.+-+.+.+..++.-||+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 8999999999999999999554444322211111111100 0111112234566778888888889999999997
Q ss_pred HHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 888 MSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 888 ~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
+..+... ..+.+....++.|+..+.++||.+--+
T Consensus 259 ~~~l~~~-----~ff~D~~~~aLrfLD~l~~kdn~qKs~ 292 (700)
T KOG2137|consen 259 LDLLLSI-----PFFSDPGLKALRFLDDLPQKDNSQKSS 292 (700)
T ss_pred hhhhhcc-----cccCCchhhhhhhcccccccCcHHHHH
Confidence 7655432 233444555678888888888865543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-07 Score=95.88 Aligned_cols=137 Identities=22% Similarity=0.201 Sum_probs=97.2
Q ss_pred CCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh----------------------hhHHHHHHHHHHHHhcCCC--c
Q 002178 626 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------------------QGEKEFLTEIQFLSRLHHR--N 681 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 681 (956)
+.+.+.||-|.-+.||.|..+.|.++|||.=+.... -......+|+++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999995321110 1123457899999998754 5
Q ss_pred eeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC
Q 002178 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 682 Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
|.+.+++ +...+||||++|-.|...- ++....-.++..|++-+.-.-..| |||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 5555544 4678999999886664432 112223334445555555455677 9999999999999999
Q ss_pred CcEEEEeeccccccC
Q 002178 762 FTAKVADFGLSRLAP 776 (956)
Q Consensus 762 ~~~kl~DfGla~~~~ 776 (956)
|.+.++||--+....
T Consensus 239 g~~~vIDwPQ~v~~~ 253 (304)
T COG0478 239 GDIVVIDWPQAVPIS 253 (304)
T ss_pred CCEEEEeCcccccCC
Confidence 999999998776543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-08 Score=82.46 Aligned_cols=59 Identities=32% Similarity=0.475 Sum_probs=27.3
Q ss_pred CCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccc
Q 002178 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (956)
Q Consensus 107 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (956)
+|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444455444443333344444444444444444444444444444444444444443
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.3e-08 Score=120.49 Aligned_cols=271 Identities=22% Similarity=0.236 Sum_probs=176.0
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCC--CcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK--ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~--l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
.++...+-++.+... +... ..+.|++|-+.+|. +.......|..++.|++||||+|.=.+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 455566666555422 2222 22369999999996 5533344578899999999999987789999999999999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccc--cCCCCCcccCCcchhhhhcccCCcC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN--LTGYLPPELSELPKLLILQLDNNNF 238 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (956)
|++..++ .+|..+.+|.+|.+|++..+.-...+|.....+++|++|.|..-. .+...-..+..+.+|+.|.......
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 9999999 899999999999999999988766677778889999999987654 2333344555666666666543332
Q ss_pred CCCCCcccccCCCCCc----EEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc-------ccCEEEccCC
Q 002178 239 EGTTIPASYSNMSKLL----KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-------NITTIKLSNN 307 (956)
Q Consensus 239 ~~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-------~L~~L~Ls~N 307 (956)
.+-..+..+.+|. .+.+.++........+..+.+|+.|.+.++.+........... ++..+...++
T Consensus 681 ---~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 ---LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred ---HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1112233333333 4444445555566678889999999999998863222211110 1111111111
Q ss_pred cCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCC
Q 002178 308 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (956)
Q Consensus 308 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l 365 (956)
..- ..+....-.++|+.|++.+......+.+....+..+. .+-+..+.+..+
T Consensus 758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~-----~~i~~f~~~~~l 809 (889)
T KOG4658|consen 758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELK-----ELILPFNKLEGL 809 (889)
T ss_pred ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcc-----cEEecccccccc
Confidence 111 1223334568999999998887766666555544433 244555555554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2e-08 Score=81.58 Aligned_cols=58 Identities=31% Similarity=0.537 Sum_probs=24.3
Q ss_pred cceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccc
Q 002178 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (956)
Q Consensus 156 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 213 (956)
|++|+|++|+|+...+..|.++++|++|++++|.++...+..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333344444444444444444443333344444444444444443
|
... |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.3e-09 Score=105.64 Aligned_cols=198 Identities=22% Similarity=0.237 Sum_probs=134.6
Q ss_pred eeEEEeCCCCccccCC-cCcC-CCCCCCEEEccCCCCcc--cCCcccccCcccchhhccCcCCCCCCCCccCCCccccee
Q 002178 84 LRELQLLNLNLSGNLS-PEIG-RLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~-~~l~-~l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (956)
+..|.+.++.|...-. ..|+ ..++++.|||.+|.|+. .|-.-+.+++.|++|+|+.|++...|-..-..+.+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 4456677776654321 2233 35789999999999985 444456788999999999999985544433577899999
Q ss_pred ecccccccCC-CCccccccccCCeeecccCcCCCCC--ccc----------cCCCcccceecccccccCCCCCcccCCcc
Q 002178 160 QIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQI--PPE----------LSRLPSLVHMLLDNNNLTGYLPPELSELP 226 (956)
Q Consensus 160 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~--p~~----------l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 226 (956)
.|.+..+.-. ....+..++++++|+++.|.+.... .+. +..++.+..++++-|++.. -++
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fp 199 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFP 199 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcc
Confidence 9999887633 3455678899999999998443111 111 1122334444444444442 246
Q ss_pred hhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC--CCCCCCCCCccEEEccCCcCCc
Q 002178 227 KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP--MPDLSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~Ls~N~l~~ 288 (956)
++..+.+..|.+.....-..+..++.+..|.|+.|+|..- ...+..++.|..|.+++|.|..
T Consensus 200 nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 200 NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 7788888888887655556677778888888888888763 3357788888888888888763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-06 Score=91.23 Aligned_cols=259 Identities=16% Similarity=0.169 Sum_probs=159.8
Q ss_pred CCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecc------cccCC-cEEEEE
Q 002178 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY------CDEEG-EQMLVY 699 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~------~~~~~-~~~LV~ 699 (956)
..+.||+|+-+.+|-.- +-+..+.|++.........+. +..|... .||-+-.=+.+ ..+.+ ...+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35779999999998532 112234566665433333222 2233332 45533221111 11222 367888
Q ss_pred ecCCCC-CHHHHHh----hcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 700 EFMSNG-TLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
+.+.+. .+.+++. ++.-....|...++.++.+|.+-+-||..| .+-+|+.++|+|+.+++.|.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 887654 2222322 123345889999999999999999999999 89999999999999999999987554332
Q ss_pred cCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhC-CCCCCCCch---hHHHHHHH
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTG-MQPISHGKN---IVREVNIA 845 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg-~~pf~~~~~---~~~~~~~~ 845 (956)
.. .........|...|.+||... +..-+...|-|.+|+++++++.| ++||..... ........
T Consensus 167 ~~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NA--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cc--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 21 122334556888999999865 34456789999999999999986 999964210 00000000
Q ss_pred hhcccchhhccCCCC------CCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhHhhC
Q 002178 846 YQSSMMFSVIDGNMG------SYP-SECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~------~~~-~~~~~~l~~l~~~c~~~~--p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.....+....+...+ ..| .-.+..+..+..+|+... +.-||+.+..+..|......+
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 111111111111111 112 233467788888888764 568999999998888776544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.8e-09 Score=118.81 Aligned_cols=125 Identities=24% Similarity=0.323 Sum_probs=55.7
Q ss_pred cchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCcc-ccCCCcccceeccc
Q 002178 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLD 210 (956)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~ 210 (956)
|.+.+.+.|.+. .+..++.-++.|+.|+|++|+++... .+..+++|+.|||+.|++. .+|. ....+ .|..|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 444444555544 44444444455555555555554221 4444555555555555554 2222 11122 25555555
Q ss_pred ccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
+|.++.. ..+.+|.+|+.|||++|-|.+..--..+..+..|+.|+|.+|.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 5554422 22344445555555555544322222333444445555555544
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-08 Score=101.88 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=137.2
Q ss_pred cCCCCCCCEEEccCCCCccc----CCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCcccccc
Q 002178 102 IGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 177 (956)
+..+..++.+|||+|.|... +...+.+-++|++.++|+-- +|..-+.+- .+|+ .+-.++..+
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~f-tgr~kde~~--~~L~-----------~Ll~aLlkc 91 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAF-TGRDKDELY--SNLV-----------MLLKALLKC 91 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhh-hcccHHHHH--HHHH-----------HHHHHHhcC
Confidence 44467778888888877643 22334444666666665532 222111100 0000 112344556
Q ss_pred ccCCeeecccCcCCCCCccc----cCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCC
Q 002178 178 NKTRHFHMNNNSISGQIPPE----LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253 (956)
Q Consensus 178 ~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 253 (956)
++|+..+||+|.|....|.. +++-+.|++|.|++|.+...--.-++ ..|.+| ..|+ ...+-+.|
T Consensus 92 p~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rig--kal~~l--a~nK--------Kaa~kp~L 159 (388)
T COG5238 92 PRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIG--KALFHL--AYNK--------KAADKPKL 159 (388)
T ss_pred CcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHH--HHHHHH--HHHh--------hhccCCCc
Confidence 66666666666666555443 45567788888888877622212222 122222 2222 12344678
Q ss_pred cEEeccCCCCccCCCC-----CCCCCCccEEEccCCcCCcCCCCCC---------CccccCEEEccCCcCCCC----Cch
Q 002178 254 LKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPPGR---------LSLNITTIKLSNNKLTGT----IPS 315 (956)
Q Consensus 254 ~~L~Ls~N~l~~~~~~-----l~~l~~L~~L~Ls~N~l~~~~p~~~---------~~~~L~~L~Ls~N~l~~~----~p~ 315 (956)
+.++...|++..-+.. +....+|+.+.+.+|.|. |.+. ...+|+.|||++|-++-. ...
T Consensus 160 e~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIr---pegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~ 236 (388)
T COG5238 160 EVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIR---PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLAD 236 (388)
T ss_pred eEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcC---cchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHH
Confidence 8888888888654332 445578888899888876 4322 223799999999988643 345
Q ss_pred hcCCCCcCCeEecccccCCCcCChhhh-hhccCCCCcceEEEccCCCCC
Q 002178 316 NFSGLPRLQRLFIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLT 363 (956)
Q Consensus 316 ~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~l~~~~L~~L~L~~N~L~ 363 (956)
.+..++.|+.|.+.++-++..-..++. .......+.|+.|-+.+|...
T Consensus 237 al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 237 ALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred HhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 677888999999999999877665543 334445566667777777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-06 Score=86.58 Aligned_cols=137 Identities=19% Similarity=0.185 Sum_probs=103.5
Q ss_pred eeeCCeEEEEEEeCCCcEEEEEEecCC---C---hhhHHHHHHHHHHHHhcCCCc--eeeeecccc-c----CCcEEEEE
Q 002178 633 GQGGYGKVYKGILPDGTVVAVKRAQEG---S---LQGEKEFLTEIQFLSRLHHRN--LVSLVGYCD-E----EGEQMLVY 699 (956)
Q Consensus 633 G~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~----~~~~~LV~ 699 (956)
|+||-+.|++-... |..+-+|.-... + ..++..|.+|+..+.++...+ +.++. ++. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888889987764 446888865421 1 335678999999999986333 44444 332 1 12468999
Q ss_pred ecCCC-CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc--EEEEeeccccc
Q 002178 700 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DfGla~~ 774 (956)
|-+++ .||.+++......+.+...+..+..++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97743 68999987655556778888899999999999999999 999999999999986666 99999987654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.1e-08 Score=100.68 Aligned_cols=201 Identities=19% Similarity=0.258 Sum_probs=139.7
Q ss_pred ceeeEEEeCCCCccc--cCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCC-CCCCccCCCcccce
Q 002178 82 LHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG-SLPEELGYLPKLDR 158 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~--~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~ 158 (956)
.+|+++||.+|.|+. .+-.-+.+|++|+.|+|+.|.+...|-..--.+++|++|-|.+..+.- .....+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 578999999999885 344557899999999999999986554322467899999999888762 34455778899999
Q ss_pred eecccccccCCC--Ccccccc-ccCCeeecccCcCCC--CCccccCCCcccceecccccccCCCC-CcccCCcchhhhhc
Q 002178 159 IQIDQNYISGSL--PKSFANL-NKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNLTGYL-PPELSELPKLLILQ 232 (956)
Q Consensus 159 L~Ls~N~l~~~~--p~~~~~l-~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~ 232 (956)
|.+|.|++.... .+..... +.+++|++..|.... .+-..-.-+|++..+.+..|.|.... .+.+..++.+..|+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~Ln 230 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLN 230 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhh
Confidence 999999654221 1111111 234444444332210 00001123568888889999887433 34567788888999
Q ss_pred ccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-------CCCCCCccEEEcc
Q 002178 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-------LSRIPNLGYLDLS 282 (956)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-------l~~l~~L~~L~Ls 282 (956)
|+.|+|.....-+.+.++++|..|.+++|.|...... ++.+++++.|+=|
T Consensus 231 L~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNGs 287 (418)
T KOG2982|consen 231 LGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNGS 287 (418)
T ss_pred hcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEecCc
Confidence 9999998766667899999999999999998765442 5677888877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-06 Score=90.02 Aligned_cols=107 Identities=25% Similarity=0.299 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHHhcCCCc--eeeeecccccC----CcEEEEEecCCCC-CHHHHHhhcCCCCchhHHHHHHHHHHHHHHH
Q 002178 664 EKEFLTEIQFLSRLHHRN--LVSLVGYCDEE----GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736 (956)
Q Consensus 664 ~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~----~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 736 (956)
.....+|.+.+.++.... +.+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788888887775333 34555555432 2458999999874 89999876332 556667889999999999
Q ss_pred HhhhcCCCCEeccCCCcccEEEcCCC---cEEEEeecccccc
Q 002178 737 YLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 775 (956)
Q Consensus 737 yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DfGla~~~ 775 (956)
-||+.| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 956 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-26 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 1sq0_B | 288 | Crystal Structure Of The Complex Of The Wild-Type V | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-05 | ||
| 1m0z_A | 290 | Crystal Structure Of The Von Willebrand Factor Bind | 7e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-05 | ||
| 1m10_B | 290 | Crystal Structure Of The Complex Of Glycoprotein Ib | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-153
Identities = 122/314 (38%), Positives = 174/314 (55%), Gaps = 17/314 (5%)
Query: 596 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR 655
SS + + ++ ATNNF+ IG G +GKVYKG+L DG VA+KR
Sbjct: 12 INDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 656 AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SA 713
S QG +EF TEI+ LS H +LVSL+G+CDE E +L+Y++M NG L+ L S
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773
+ + RL I +G++RG+ YLHT + HRD+K+ NILLD F K+ DFG+S+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
D H+STVVKGT GY+DPEYF+ +LT+KSDVYS GVV E+L I
Sbjct: 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 834 HGK-----NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPS 887
N+ ++ + + ++D N+ E + KF A+KC ++ RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 888 MSEVMRELESIWNM 901
M +V+ +LE +
Sbjct: 303 MGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (986), Expect = e-126
Identities = 123/298 (41%), Positives = 184/298 (61%), Gaps = 17/298 (5%)
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLT 669
++ F+ E+ +A++NF++ +G+GG+GKVYKG L DGT+VAVKR +E QG E +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSI 727
E++ +S HRNL+ L G+C E++LVY +M+NG++ L +S+ PL + R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
ALGS+RG+ YLH DP + HRD+KA+NILLD +F A V DFGL++L D H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI-------SHGKNIVR 840
V+T V+GT G++ PEY T K ++K+DV+ GV+ LEL+TG + ++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 841 EVNIAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
V + + +++D ++ Y E VE+ I++AL C Q RP MSEV+R LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-124
Identities = 100/304 (32%), Positives = 164/304 (53%), Gaps = 25/304 (8%)
Query: 610 GVRSFTYGEMALATNNFNSSTQ------IGQGGYGKVYKGILPDGTVVAVKR----AQEG 659
SF++ E+ TNNF+ +G+GG+G VYKG + + T VAVK+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 660 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL-SAKSKEP 718
+ + +++F EI+ +++ H NLV L+G+ + + LVY +M NG+L D+L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 719 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778
L + MR IA G++ GI +LH + HRDIK++NILLD FTAK++DFGL+R +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
+++ + GT Y+ PE L ++T KSD+YS GVV LE++TG+ + +
Sbjct: 187 AQT-----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 839 VREVNIAY----QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894
++I + + ID M S VE +A +C ++ + RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 895 LESI 898
L+ +
Sbjct: 301 LQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 3e-81
Identities = 88/319 (27%), Positives = 134/319 (42%), Gaps = 18/319 (5%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSG--NLSPEIGRLSYLTILDFM-WNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
LNL + + L YL L N + G IP I + L L + ++G++
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ L + L + N +SG+LP S ++L + N ISG IP L
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 207 ML-LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ + N LTG +PP + L L + L N EG + + K+ L SL
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPS--NFSGLP 321
+ + NL LDL +N++ G++P +L + ++ +S N L G IP N
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQGGNLQRFD 294
Query: 322 RLQRLFIANNSLSGSIPSS 340
+ N L GS +
Sbjct: 295 VSA--YANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRN-CSLQGPMP 268
N G L ++ ++ L L N IP+S +N+ L L + +L GP+P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 269 D-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
++++ L YL ++ ++G+IP ++ + T+ S N L+GT+P + S LP L
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIK-TLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 373
+ N +SG+IP S L + N L +G IPP
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFT----SMTISRNRL---TGK--IPP 192
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-76
Identities = 64/316 (20%), Positives = 109/316 (34%), Gaps = 44/316 (13%)
Query: 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 673
+ + +G +G V+K VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 674 LSRLHHRNLVSLVGYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
L + H N++ +G + + L+ F G+L D L + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 730 GSSRGILYLHTEAD-------PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+RG+ YLH + P + HRDIK+ N+LL + TA +ADFGL+ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 783 IVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ GT Y+ PE + D+Y++G+V EL +
Sbjct: 189 -----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG--- 240
Query: 838 IVREVNIAYQS---------SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDET 882
V E + ++ M V+ + + +C +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 883 DARPSMSEVMRELESI 898
+AR S V + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-70
Identities = 78/334 (23%), Positives = 129/334 (38%), Gaps = 45/334 (13%)
Query: 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--I 671
E +L +N IG+G YG VYKG L D VAVK S + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 672 QFLSRLHHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
+ + H N+ + D E +LV E+ NG+L LS +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 727 IALGSSRGILYLHTEAD------PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPD 779
+A +RG+ YLHTE P + HRD+ + N+L+ + T ++DFGLS L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ + + GT Y+ PE + D+Y+LG+++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 833 SHGKNIVREVNIAYQS---------SMMFSVIDGNM-------GSYPSECVEKFIKLALK 876
G++ V E +A+Q+ M V S V +
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 877 CCQDETDARPSMSEVMRELESIWNMMPESDTKTP 910
C + +AR + + + + + + +P
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-70
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 25/303 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G V K VA+K+ + S K F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 691 EEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
LV E+ G+L + L A+ A +S L S+G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 750 DIKASNILLDHKFT-AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
D+K N+LL T K+ DFG + T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 868
++K DV+S G++ E++T +P + M++V +G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--------MWAVHNGTRPPLIKNLPK 231
Query: 869 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 928
L +C + RPSM E+++ + + P +D E+
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291
Query: 929 SML 931
Sbjct: 292 VDF 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-68
Identities = 90/322 (27%), Positives = 142/322 (44%), Gaps = 40/322 (12%)
Query: 80 GYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
LQ L L +G + P + S L L +N +SG+IP +G++ L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 196
L N L G +P+EL Y+ L+ + +D N ++G +P +N ++NN ++G+IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK- 255
+ RL +L + L NN+ +G +P EL + L+ L L+ N F GT IPA+ S +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT-IPAAMFKQSGKIAA 567
Query: 256 ---------------------LSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP- 292
+ QG L+R+ +++S G P
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 293 -GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351
++ + +S N L+G IP +P L L + +N +SGSIP + R LN
Sbjct: 628 FDNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN--- 683
Query: 352 TFILDFQNNNLTNISGSFNIPP 373
ILD +N L G IP
Sbjct: 684 --ILDLSSNKL---DGR--IPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-66
Identities = 89/314 (28%), Positives = 132/314 (42%), Gaps = 23/314 (7%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
EL+ L + +SG++ + R L LD N S IP +G+ +L+ L ++G
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG 232
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
N+L+G + +L + I N G +P L ++ + N +G+IP LS
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLS 290
Query: 200 -RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLS 257
+L + L N+ G +PP L L L +NNF G +P M L L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG-ELPMDTLLKMRGLKVLD 349
Query: 258 LRNCSLQGPMPD-LSRI-PNLGYLDLSSNQLNGSIPP--GRLSL-NITTIKLSNNKLTGT 312
L G +P+ L+ + +L LDLSSN +G I P + + + L NN TG
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNI 371
IP S L L ++ N LSG+IPSS+ L L N L I
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-----DLKLWLNMLEGEIPQELMY 464
Query: 372 PPN-VTVRLRGNPF 384
T+ L N
Sbjct: 465 VKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-62
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 17/287 (5%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L +L+ L L L G + E+ + L L +N ++G IP + N +L + L+ N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
LTG +P+ +G L L +++ N SG++P + +N N +G IP + +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLR 259
+ N + G + N E + +S ++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 260 NCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSN 316
+ G ++ +LD+S N L+G IP G + + + L +N ++G+IP
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP-YLFILNLGHNDISGSIPDE 675
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
L L L +++N L G IP ++ L +D NNNL+
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLT-----EIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-61
Identities = 66/337 (19%), Positives = 126/337 (37%), Gaps = 51/337 (15%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K L D + L +W+ +PC + GV C + + + L + L
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDWSSNKNPC--TFDGVTCRDD-------KVTSIDLSSKPL 62
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP 154
+ ++ + ++ LE L L+ + + GS+
Sbjct: 63 NVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSA 100
Query: 155 KLDRIQIDQNYISGSLP--KSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDN 211
L + + +N +SG + S + + + ++++N++ +L SL + L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 212 NNLTGYLPPEL---SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
N+++G +L L + N G + S L L + + + +P
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISG-DVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
L L +LD+S N+L+G + + + +S+N+ G IP L LQ L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPP--LPLKSLQYL 274
Query: 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
+A N +G IP + LD N+
Sbjct: 275 SLAENKFTGEIPDFLSG----ACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-27
Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 3/158 (1%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWN--KISGSIPKEIGNIKSLELLLLNGNELTGSL 146
+ ++G I N + G +++ + + + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
+ + + N +SG +PK ++ ++ +N ISG IP E+ L L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ L +N L G +P +S L L + L NNN G IP
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG-PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-26
Identities = 41/142 (28%), Positives = 66/142 (46%)
Query: 78 DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+DG L G S ++ RLS + G N S+ L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ N L+G +P+E+G +P L + + N ISGS+P +L +++N + G+IP
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 198 LSRLPSLVHMLLDNNNLTGYLP 219
+S L L + L NNNL+G +P
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIP 721
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-68
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 23/272 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G V++ G+ VAVK Q+ + EFL E+ + RL H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 689 CDEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G+L L + ++E L RLS+A ++G+ YLH +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HR++K+ N+L+D K+T KV DFGLSRL + S GTP ++ PE
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-------SKSAAGTPEWMAPEVLRDE 214
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-SYPSEC 866
+KSDVYS GV+ EL T QP + ++ +V P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKCKRLEIPRNL 264
Query: 867 VEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ + C +E RPS + +M L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-66
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNL 682
QIG+GG+G V+KG + D +VVA+K G +GE +EF E+ +S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V L G +V EF+ G L +L P+ ++++L + L + GI Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 743 DPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+PP+ HRD+++ NI L AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 798 YLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
++ PE + T+K+D YS ++ +LTG P + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--------KIKFINMIR 243
Query: 856 DGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ + + P +C + + C + RP S +++EL +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-65
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLV 686
IG GG+GKVY+ G VAVK A+ + + E + + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G C +E LV EF G L L S + + + ++ A+ +RG+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 747 FHRDIKASNILLDHKF--------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
HRD+K+SNIL+ K K+ DFGL+R G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAW 180
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
+ PE + SDV+S GV+ ELLTG P + ++ + V
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------AVAYGVAMNK 230
Query: 859 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ PS C E F KL C + +RPS + ++ +L +I
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-64
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 20/306 (6%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G +G+ K G V+ +K + ++ FL E++ + L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + E++ GTLR + ++ R+S A + G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 750 DIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGYLDPE 802
D+ + N L+ VADFGL+RL V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
+K DV+S G+V E++ + + +V
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY--------LPRTMDFGLNVRGFLDRYC 244
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 922
P C F + ++CC + + RPS ++ LE++ + P+ + E
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304
Query: 923 TPPSSS 928
S
Sbjct: 305 YRRGES 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 54/278 (19%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 630 TQIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
T++ + G+++KG G + VK + ++ S + ++F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 688 YCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
C L+ +M G+L + L + + + + AL +RG+ +LHT +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ + + ++++D TA+++ + S P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------------FQSPGRMYAPAWVAPE-AL 180
Query: 806 THK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG- 860
K +D++S V+ EL+T P + N+ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----------EIGMKVALEGLRP 230
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ P KL C ++ RP ++ LE +
Sbjct: 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-60
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G VYKG G V AVK + + + F E+ L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ +V ++ +L L S+ + IA ++RG+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---YFL 805
RD+K++NI L T K+ DFGL+ +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM----GS 861
++ + +SDVY+ G+V EL+TG P S+ N ++ V G++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---------DQIIEMVGRGSLSPDLSK 249
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
S C ++ +L +C + + D RPS ++ E+E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 31/280 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
IG+G +G+VY G G V A++ + K F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
C ++ TL + +K L IA +G+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
+D+K+ N+ D+ + DFGL ++ V + G +L PE
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLS 210
Query: 809 L---------TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
+ SDV++LG ++ EL P ++++ + G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EAIIWQMGTGMK 260
Query: 860 GSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ ++ + L C E + RP+ +++M LE +
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-57
Identities = 66/300 (22%), Positives = 108/300 (36%), Gaps = 46/300 (15%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 688
+G+G YG+V++G G VAVK S + EK + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ L+ + G+L D L L L I L + G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ +AD GL+ + + V + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRYM 184
Query: 800 DPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ------ 847
PE + D+++ G+V E+ M IV + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPFYDVVPND 240
Query: 848 ---SSMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
M V + + KL +C AR + + + L I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-55
Identities = 74/304 (24%), Positives = 113/304 (37%), Gaps = 46/304 (15%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 688
QIG+G YG+V+ G G VAVK E + TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ L+ ++ NG+L D L L L +A S G+ +LHTE
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ T +AD GL+ E +P GT Y+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRYM 213
Query: 800 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 848
PE H + +D+YS G++ E+ IV E + Y
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269
Query: 849 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
M V + EC+ + KL +C +R + V + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 899 WNMM 902
Sbjct: 330 SESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-53
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--IQFLSRLHHRNLVSLVGY 688
IG+G +G+V++G G VAVK S + E+ + E I L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ T +AD GL+ D GT Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYM 218
Query: 800 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 848
PE + H + ++D+Y++G+VF E+ + + Y
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI----HEDYQLPYYDLVPSD 274
Query: 849 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
M V + + E + K+ +C AR + + + L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-51
Identities = 59/335 (17%), Positives = 109/335 (32%), Gaps = 58/335 (17%)
Query: 87 LQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG-------------------SIP 123
L+ + N +S + RL+ L + +
Sbjct: 183 LKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI--------SGSLPKSFA 175
+ N+K L + + LP L LP++ I + N
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 176 NLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
K + ++ N++ + + L ++ L + N L G P KL L L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLA 361
Query: 235 NNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG--- 288
N T IPA+ ++ LS + L+ + D + + +D S N++
Sbjct: 362 YNQI--TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 289 ----SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG-------S 336
+ P N+++I LSNN+++ FS L + + N L+
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 371
+ + L +D + N LT +S F
Sbjct: 480 ENENFKNTYLLT-----SIDLRFNKLTKLSDDFRA 509
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-50
Identities = 47/323 (14%), Positives = 104/323 (32%), Gaps = 34/323 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ L + + + ++ T + + N I+ + K + + L + +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNS 216
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
E + + + NL + N ++P L
Sbjct: 217 PFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 201 LPSLVHMLLDNNNLTGY--------LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
LP + + + N + K+ I+ + NN + + S M K
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLT 310
L L L+G +P L L+L+ NQ+ IP + + ++NKL
Sbjct: 332 LGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK 390
Query: 311 GTIPSNFS--GLPRLQRLFIANNSLSG-------SIPSSIWQSRTLNATETFILDFQNNN 361
IP+ F + + + + N + + + ++ ++ ++ NN
Sbjct: 391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS-----SINLSNNQ 444
Query: 362 LT-NISGSFNIPPNVTV-RLRGN 382
++ F+ ++ L GN
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGN 467
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-45
Identities = 53/314 (16%), Positives = 116/314 (36%), Gaps = 39/314 (12%)
Query: 84 LRELQLLNLN----LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
++Q++ + + + + ++ L +L+ ++N++ G +P G+ L L L
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA--NLNKTRHFHMNNNSISG----- 192
N++T G+ +++ + N + +P F +++ + N I
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 193 --QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG------TTIP 244
+ P + ++ + L NN ++ + S L + L N
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPPGRLSLN---- 298
++ N L + LR L D + +P L +DLS N + P L+ +
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 299 ---ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
N+ P + P L +L I +N + + I + ++ +L
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN--IS-----VL 592
Query: 356 DFQNNNLTNISGSF 369
D ++N +I S+
Sbjct: 593 DIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 49/355 (13%), Positives = 99/355 (27%), Gaps = 58/355 (16%)
Query: 28 DDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLREL 87
D+++TD V S + DY L L
Sbjct: 9 DNALTDDAIVPIKLSRTAEYIKDYLALKEIWDA--------------------------L 42
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
N + G + ++ LD MW G + + + L L G +G +P
Sbjct: 43 NGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGV---SLNSNGRVTGLSLEGFGASGRVP 98
Query: 148 EELGYLPKLDRIQIDQNYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-- 201
+ +G L +L+ + + + PK + R
Sbjct: 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+ ++++ + K + +NN T + + ++KL + + N
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI--TFVSKAVMRLTKLRQFYMGNS 216
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSG 319
+ Q + L ++T +++ N +P+
Sbjct: 217 PFVAENI----CEAWENENSEYAQQYKTEDLKWDNLK-DLTDVEVYNCPNLTKLPTFLKA 271
Query: 320 LPRLQRLFIANNSL--------SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
LP +Q + +A N + + I+ NNL
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ-----IIYIGYNNLKTFP 321
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-30
Identities = 34/264 (12%), Positives = 75/264 (28%), Gaps = 53/264 (20%)
Query: 84 LRELQLLNL----------NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133
+ + ++ L P + ++ ++ N+IS + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
+ L GN LT +P+ ++F N + N ++
Sbjct: 461 SINLMGNMLTE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKLTK- 502
Query: 194 IPPEL--SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
+ + + LP LV + L N+ + P + L + N
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ--------------- 546
Query: 252 KLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
+ P+ ++ P+L L + SN + + NI+ + + +N
Sbjct: 547 ----RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP-NISVLDIKDNPNI 600
Query: 311 GTIPSNFSGLPRLQRLFIANNSLS 334
S + +
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 39/226 (17%), Positives = 75/226 (33%), Gaps = 31/226 (13%)
Query: 75 TTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG-------SIPK 124
+D + +NL +S S L+ ++ M N ++ +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
N L + L N+LT L ++ LP L I + N S P N + +
Sbjct: 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 183 FHMNN------NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
F + N N + P ++ PSL + + +N++ + ++ P + +L + +N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
+ + L Q I LD+
Sbjct: 598 PNIS-IDLSYVCPYIEAGMYMLFYDKTQ-------DIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 14/126 (11%), Positives = 35/126 (27%), Gaps = 15/126 (11%)
Query: 270 LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTG----TIPSNFSGLPRL 323
L+ + L L +G +P G+L+ + + L ++ P S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLT-ELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
++ + D + + + +I + + L+
Sbjct: 136 EQKQKMRMHYQKTFVDYD--------PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 384 FCLNTN 389
+N
Sbjct: 188 IGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 11/100 (11%), Positives = 27/100 (27%), Gaps = 4/100 (4%)
Query: 81 YLHLRELQLLNLN-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+R + N I LT L N I + ++I ++ +L +
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKD 596
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
N + + + + ++ +
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-49
Identities = 67/317 (21%), Positives = 117/317 (36%), Gaps = 16/317 (5%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
++ L L + L + R S LT LD +N IS P+ + L++L L NEL
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ + + L + + N I F +++N +S +L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 203 SLVHMLLDNNNLTGYLPPELS--ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+L +LL NN + EL L L+L +N + P + + +L L L N
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNN 204
Query: 261 CSLQGPMPD----LSRIPNLGYLDLSSNQLNGSIPP---GRLSLNITTIKLSNNKLTGTI 313
L + + ++ L LS++QL+ + G N+T + LS N L
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN----ATETFILDFQNNNLTNI-SGS 368
+F+ LP+L+ F+ N++ S+ + +L I S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 369 FNIPPNVTV-RLRGNPF 384
F + + N
Sbjct: 325 FQWLKCLEHLNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-46
Identities = 66/325 (20%), Positives = 117/325 (36%), Gaps = 32/325 (9%)
Query: 88 QLLNLNLSGN----LSPE---IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L L LS N L E I S L L+ N+I P I L L LN
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 141 ELTGSLPEELGY---LPKLDRIQIDQNYISGSLPKSFANLNKT--RHFHMNNNSISGQIP 195
+L SL E+L + + + + +S + +F L T ++ N+++
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT--------IPASY 247
+ LP L + L+ NN+ L L + L L + + + S+
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 248 SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-----SLNITT 301
+ L L++ + + G + + + NL YL LS++ + +
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 302 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+ L+ NK++ FS L L+ L + N + + W+ F + N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR----GLENIFEIYLSYNK 441
Query: 362 LTNI-SGSFNIPPNVTV-RLRGNPF 384
+ SF + P++ LR
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-42
Identities = 61/321 (19%), Positives = 108/321 (33%), Gaps = 24/321 (7%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ + +L L L L+ N I G + +L+ L L+ +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 143 TGSLPEELG----YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-E 197
+ L + + +N IS +F+ L + N I ++ E
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTIPASYSNMSKLLKL 256
L ++ + L N + +P L L L + + P+ + + L L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 257 SLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL-------NGSIPPGRLS--LNITTIKLSN 306
L N ++ D L + L LDL N L N P L ++ + L +
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
N F L L+ + + N+L+ S +L L+ Q N +T++
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK-----SLNLQKNLITSVE 600
Query: 367 GSF--NIPPNVTV-RLRGNPF 384
N+T +R NPF
Sbjct: 601 KKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-41
Identities = 70/311 (22%), Positives = 114/311 (36%), Gaps = 30/311 (9%)
Query: 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSY--LTILDFMWNKISGSIP 123
L ++ +R L L N LS + L + LT+LD +N ++
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183
+ LE L N + L L + + + +++ S+
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI------------- 312
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
+ S+ L L H+ +++N++ G + L L L L N+ T+
Sbjct: 313 --SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 244 PA---SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
S L L+L + D S + +L LDL N++ +
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG--SIPSSIWQSRTLNATETFIL 355
NI I LS NK ++F+ +P LQRL + +L S PS R L IL
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT-----IL 485
Query: 356 DFQNNNLTNIS 366
D NNN+ NI+
Sbjct: 486 DLSNNNIANIN 496
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-21
Identities = 39/257 (15%), Positives = 72/257 (28%), Gaps = 41/257 (15%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLL 137
L + + L + L L + S P +++L +L L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYIS--------GSLPKSFANLNKTRHFHMNNNS 189
+ N + + L L KL+ + + N ++ G L+ ++ +N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
L L + L NNL + L L L N T++
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI--TSVEKK--- 602
Query: 250 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR-----LSLNITTIKL 304
NL LD+ N + + ++ T I
Sbjct: 603 ------------VFGPAF------RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPE 644
Query: 305 SNNKLTGTIPSNFSGLP 321
++ P ++ G P
Sbjct: 645 LSSHYLCNTPPHYHGFP 661
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-47
Identities = 51/313 (16%), Positives = 110/313 (35%), Gaps = 22/313 (7%)
Query: 81 YLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L + E +L L+ + ++ L+ ++ + I + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPE 197
+ +L L +L G S +L ++ N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
SL ++ L N + + L +L L ++N + + + + ++ L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 258 LRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIP 314
+ + + + + +L L ++ N + P + N+T + LS +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--FNIP 372
+ F+ L LQ L +++N+ +L +LD+ N++ + P
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ-----VLDYSLNHIMTSKKQELQHFP 542
Query: 373 PN-VTVRLRGNPF 384
+ + L N F
Sbjct: 543 SSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-42
Identities = 45/282 (15%), Positives = 103/282 (36%), Gaps = 13/282 (4%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L+L+N + ++ L LT G ++ SLE L L+ N L+
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 144 --GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSR 200
G + L + + N + + +F L + H ++++
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L +L+++ + + + + L L +L++ N+F+ +P ++ + L L L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 261 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFS 318
C L+ P + + +L L++S N L ++ + S N + +
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 319 GLPR-LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
P L L + N + + + + +++ +
Sbjct: 540 HFPSSLAFLNLTQNDFACTCE-HQSFLQWIKDQRQLLVEVER 580
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-38
Identities = 48/261 (18%), Positives = 88/261 (33%), Gaps = 10/261 (3%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGY----LDLSSNQLNGSIPPGRL 295
+P +SN++ L L L + +Q DL + + LDLS N +N P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 296 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+ + + L NN + + GL L+ + + L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN-- 256
Query: 355 LDFQNNNLTNISGSFNIPPNV 375
L + L + + ++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 47/312 (15%), Positives = 94/312 (30%), Gaps = 19/312 (6%)
Query: 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
Q + LN + + LD +N + + L++L L+ E+
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L L + + N I +F+ L+ + +++ + L +L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 206 HMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL----LKLSLRN 260
+ + +N + + LP S L L L L +N + + ++ L L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSL 186
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKL----SNNKLTGT 312
+ P + L L L +N + ++ + L + + L + L
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
S GL L L + I L + + + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS--FSLVSVTIERVKDFSYNF 304
Query: 373 PNVTVRLRGNPF 384
+ L F
Sbjct: 305 GWQHLELVNCKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 38/243 (15%), Positives = 77/243 (31%), Gaps = 32/243 (13%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
L L+LS N +S L L LDF + + + ++++L L ++
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
+ L L+ +++ N + P F L ++ + P + L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
SL + + +NN L L +L N+ + +
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPS--------- 543
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI---TTIKLSNNKLTGTIPSNFS 318
+L +L+L+ N + I + + ++ PS+
Sbjct: 544 -------------SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
Query: 319 GLP 321
G+P
Sbjct: 591 GMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-18
Identities = 26/151 (17%), Positives = 55/151 (36%), Gaps = 7/151 (4%)
Query: 83 HLRELQLLNL---NLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L L++L + + N P+I L LT LD ++ P ++ SL++L ++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT-RHFHMNNNSISGQIPPE 197
N L L + N+I S + + + ++ N + +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 198 --LSRLPSLVHMLLDNNNLTGYLPPELSELP 226
L + +L++ + P + +P
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-46
Identities = 64/338 (18%), Positives = 120/338 (35%), Gaps = 59/338 (17%)
Query: 82 LHLRELQLLNL-NLSGNLSPEIGRLSYLTILDFMWNKISG-------------------S 121
+ L++ Q+ NL N +S I RL+ L I+ F + + +
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG---------SLPK 172
N+K L + L LP+ L LP+L + I N L
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 173 SFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 230
K + F+M N++ P L ++ L + +N + KL
Sbjct: 543 DEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTD 599
Query: 231 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLN 287
L+LD N IP + + ++ L + L+ + + + +G +D S N++
Sbjct: 600 LKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI- 656
Query: 288 GSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS------ 334
GS +N +T+ LS N++ F+ + + ++NN ++
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 335 -GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 371
+ + L +D + N LT++S F
Sbjct: 717 LKPKDGNYKNTYLLT-----TIDLRFNKLTSLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-36
Identities = 54/328 (16%), Positives = 110/328 (33%), Gaps = 46/328 (14%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
++ + N S + ++ L +LD + NK+ + G L L L+ N+
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ 606
Query: 142 LTGSLPEELGY-LPKLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPEL 198
+ +PE+ +++ + N + +P + ++ + N I +
Sbjct: 607 IE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNI 663
Query: 199 S------RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE------GTTIPAS 246
S + + + L N + + + + + L NN +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 247 YSNMSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPPGRLSLN------ 298
Y N L + LR L D + +P L +D+S N + S P L+ +
Sbjct: 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFG 782
Query: 299 -ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
N++ P+ + P L +L I +N + + + L ILD
Sbjct: 783 IRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ--LY-----ILDI 834
Query: 358 QNNNLTNISGSFNIP--PNVTVRLRGNP 383
+N +I + P L +
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-26
Identities = 32/250 (12%), Positives = 82/250 (32%), Gaps = 29/250 (11%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ ++ + + + S + + + + +N+I + + ++L+ N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-- 198
+T S+PE ++ N + N ++ + +
Sbjct: 708 LMT-SIPEN----------------SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRA 749
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN-----NFEGTTIPASYSNMSKL 253
+ LP L +M + N + P + +L + + N P + L
Sbjct: 750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL-NGSIPPGRLSLNITTIKLSNNKLTGT 312
++L + + ++ L+ P L LD++ N + + + L +K
Sbjct: 809 IQLQIGSNDIRKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
Query: 313 IPSNFSGLPR 322
+ G+ R
Sbjct: 867 RGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 27/236 (11%), Positives = 62/236 (26%), Gaps = 34/236 (14%)
Query: 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221
+ + N + + G++P + +L L + ++ T
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 281
E + + + +L L ++ P++ I + L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 282 SSNQLNG------SIPP--GRLSLNITTIKLSNNKLTGTIP------------------- 314
Q+ I RL+ + I +N+ T
Sbjct: 426 KDTQIGNLTNRITFISKAIQRLT-KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484
Query: 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
++S L L + + N +P ++ L L+ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-----SLNIACNRGISAAQLKA 535
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 29/211 (13%), Positives = 58/211 (27%), Gaps = 32/211 (15%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK--LSLRNC--SLQGP 266
+ + E + +DN + +P ++ +K +L+ +L G
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 267 MPDLSRIPNLGYLDLSSNQLN------GSIPPGRLSLN--ITTIKLSNNKLTGTIPSNFS 318
+ + N G P L N +T + L+ G +P
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--------------------LDFQ 358
L L+ L +S + S + T + +E D
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 359 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 389
+ + I + + L+ TN
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-46
Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 30/314 (9%)
Query: 591 NYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGT 649
++ +++ + K+ + + R+ + L + QIG+G +G+V+ G L D T
Sbjct: 83 DHLLSTQQPLTKKSGVVL--HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 650 VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK +E + +FL E + L + H N+V L+G C ++ +V E + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768
L L L + ++ G+ YL ++ HRD+ A N L+ K K++D
Sbjct: 201 TFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD 256
Query: 769 FGLSRLAPVPDIEGIVPAHVSTV---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
FG+SR +G+ A VK T PE + + +SDV+S G++ E
Sbjct: 257 FGMSREEA----DGVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWET 308
Query: 826 LT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA 884
+ G P + N ++ V G P C + +L +C E
Sbjct: 309 FSLGASPYPNLSN--QQT--------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 885 RPSMSEVMRELESI 898
RPS S + +EL+SI
Sbjct: 359 RPSFSTIYQELQSI 372
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-43
Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 22/317 (6%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
L E+ + ++NL + +S S L LD +S +P + + +L+ L+L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSI--SGQI 194
+ N+ P L + I N L NL R ++++ I S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
+L L L + L N E P+L +L L + + + N+ L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 255 KLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLSNNKL 309
L+L + L +P L +L+L N SL + + LS L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GS 368
+ F+ L + + +++N L+ S ++ + + L+ +N+++ I
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI------YLNLASNHISIILPSL 542
Query: 369 FNIPPN-VTVRLRGNPF 384
I T+ LR NP
Sbjct: 543 LPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-42
Identities = 59/324 (18%), Positives = 100/324 (30%), Gaps = 14/324 (4%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L + RL LT LD +I + L+ L+L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
L L + Q IS N ++ +N IS P+
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + NN + ++S L + L L+ N + I + + L+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 263 LQGPMP---DLSRIPNLGYLDLSSNQLNG---SIPPGRLSLNITTIKLSNNKLTGTIPSN 316
+ S I +L ++ G +++ +I L + +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNV 375
F LQ L + LS +PS + TL L N N+ S + P++
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-----KLVLSANKFENLCQISASNFPSL 327
Query: 376 TV-RLRGNPFCLNTNAEQFCGSHS 398
T ++GN L +
Sbjct: 328 THLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-41
Identities = 64/322 (19%), Positives = 102/322 (31%), Gaps = 17/322 (5%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTI-----LDFMWNKISGSIPKEIGNI 129
++ G Q LN + NL L TI F P +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 130 K--SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
S+E + L + L + + ++S LP L+ + ++
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI-PA 245
N S PSL H+ + N L L L L L L +++ E +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTI 302
N+S L L+L + P L LDL+ +L + +
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 303 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
LS++ L + F GLP LQ L + N +TL E L +L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI--LVLSFCDL 488
Query: 363 TNIS-GSFNIPPNVTV-RLRGN 382
++I +F + L N
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 21/300 (7%)
Query: 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGN--IKSLELLL 136
L++ L+LNL+GN + P + L+F + I K + N I+SL L
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 137 LNGNELTGSLPEELGYLPKLDRIQID--QNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
+ P L ++ I+ ++Y +F + + + +S ++
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
P L L +L ++L N S P L L + N N+ L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 255 KLSLRNCSLQGPMPD---LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKL 309
+L L + ++ L + +L L+LS N+ S+ + + L+ +L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRL 412
Query: 310 TGTIP-SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368
S F L L+ L ++++ L S L L+ Q N+ +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ-----HLNLQGNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 52/328 (15%), Positives = 103/328 (31%), Gaps = 23/328 (7%)
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISGSIPKEIGN 128
+ F + L +++ E + ++ +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L+ L L L+ LP L L L ++ + N S +N H + N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ ++ L L +L + L ++++ +L L L L L N ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP--LSLKT 393
Query: 246 SY-SNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NIT 300
+L L L L+ + L L+LS + L+ +
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-ISSEQLFDGLPALQ 452
Query: 301 TIKLSNNKLTGTI---PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
+ L N ++ L RL+ L ++ LS + + +N +D
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-----HVDL 507
Query: 358 QNNNLTNIS-GSFNIPPNVTVRLRGNPF 384
+N LT+ S + + + + L N
Sbjct: 508 SHNRLTSSSIEALSHLKGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-38
Identities = 56/296 (18%), Positives = 107/296 (36%), Gaps = 13/296 (4%)
Query: 75 TTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKE-IGNIK 130
+ + G + L L+ L L+ LT L N + + N++
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 131 SLELLLLNGNELTGS--LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
+L L L+ +++ S +L L L + + N ++F + +
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI--PA 245
+ + L L + L ++ L LP L L L N+F I
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIK 303
S + +L L L C L + + + ++DLS N+L S LS L +
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIYLN 529
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
L++N ++ +PS L + + + + N L + S+I+ + D ++
Sbjct: 530 LASNHISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEWYKENMQKLEDTED 584
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 26/311 (8%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G +VAVK+ Q +++F EIQ L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G G Q LV E++ +G LRD L + + L + L + +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR- 147
Query: 744 PPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+ A NIL++ + K+ADFGL++L P+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
+ + +SDV+S GVV EL T + S +R + + +++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 862 Y----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917
P C + +L C RPS S + +L+ +W+ +T F + H
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG--SRGCETHAF--TAH 316
Query: 918 TSKEETPPSSS 928
+ S S
Sbjct: 317 PEGKHHSLSFS 327
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 65/307 (21%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALG 730
G C + ++V+E+M +G L L A K LG + L IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--------- 781
+ G++YL A HRD+ N L+ K+ DFG+SR D+
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 193
Query: 782 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGK 836
++P ++ P PE + K T +SDV+S GV+ E+ T G QP +S+
Sbjct: 194 HTMLP------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 241
Query: 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
EV + + G + P C ++ + L C Q E R ++ E+ + L
Sbjct: 242 ---TEV--------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 897 SIWNMMP 903
++ P
Sbjct: 291 ALGKATP 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC- 689
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+E+G +V E+M+ G+L D L ++ + LG L +L + YL HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A N+L+ AKV+DFGL++ A G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 864
+ KSDV+S G++ E+ + G P ++V + V G Y P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV--------VPRVEKG----YKMDAPD 237
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C ++ C + RPS ++ +LE I
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGI 735
L+G + +++ E M+ G L+ L + P + + +A + G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIVP 785
YL HRD+ A N ++ FT K+ DFG++R DI +G++P
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844
V+ PE T SDV+S GVV E+ T QP N +V
Sbjct: 204 ------VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV-- 249
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
+ V++G + P C + +L C Q RPS E++ ++ E
Sbjct: 250 ------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE----EME 299
Query: 905 SDTKTPEFINSEHTSKEETP 924
+ F SE E
Sbjct: 300 PGFREVSFYYSEENKLPEPE 319
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-42
Identities = 83/321 (25%), Positives = 128/321 (39%), Gaps = 37/321 (11%)
Query: 585 VRAHMKNYHAISRR-RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 643
V + + + R + F AL IG+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 644 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFM 702
G VAVK + + + FL E +++L H NLV L+G +E+G +V E+M
Sbjct: 213 DY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762
+ G+L D L ++ + LG L +L + YL HRD+ A N+L+
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 326
Query: 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 822
AKV+DFGL++ A G +P VK T PE K + KSDV+S G++
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFSTKSDVWSFGILL 376
Query: 823 LELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSECVEKFIKLALKC 877
E+ + G P Y + V+ Y P C + C
Sbjct: 377 WEIYSFGRVP--------------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422
Query: 878 CQDETDARPSMSEVMRELESI 898
+ RP+ ++ +LE I
Sbjct: 423 WHLDAATRPTFLQLREQLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 25/283 (8%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 684
+G+G +GKV G VAVK + S + EI+ L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C E+G L+ EF+ +G+L++ L K+K + +L A+ +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLD 800
HRD+ A N+L++ + K+ DFGL++ + + V
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKA--IETDKEYYTVKDDRDSPVFWYA---- 197
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID--- 856
PE + K SDV+S GV ELLT S ++ + + + +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 857 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
G P C ++ +L KC + + R S ++ E++
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 54/302 (17%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + +VAVK +E S ++F E + L+ L H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQL-------------SAKSKEPLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + PLG L++A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPA 786
+ G++YL A HRD+ N L+ K+ DFG+SR D ++P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREV 842
++ P PE L K T +SDV+S GVV E+ T G QP +S+ E
Sbjct: 224 -----IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEA 269
Query: 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902
+ + G P C + + C Q E R S+ +V L+++
Sbjct: 270 --------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
Query: 903 PE 904
P
Sbjct: 322 PV 323
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-41
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 251 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 307 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 812 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 870
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 410
Query: 871 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
L +C + E + RP+ + LE +
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 38/289 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G D A+K + + FL E + L+H N+++L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G EG ++ +M +G L + + +S L +RG+ YL A+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGY 798
HRD+ A N +LD FT KVADFGL+R + +P VK T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------VKWTA-- 196
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
E T++ T KSDV+S GV+ ELLT G P H ++ + G
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDL--------THFLAQG 244
Query: 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
P C + ++ +C + + RP+ ++ E+E I + +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-41
Identities = 84/284 (29%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
++ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 868
+ KSDV++ GV+ E+ T GM P +V + P C E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPEGCPE 446
Query: 869 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
K +L C Q RPS +E+ + E+++ SD E
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK + GE +FLTE + H N++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G C EG ++V +M +G LR+ + + L ++G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------------GIVPAHVSTVVK 793
HRD+ A N +LD KFT KVADFGL+R D+ +P VK
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKLP------VK 197
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 852
E T K T KSDV+S GV+ EL+T G P ++
Sbjct: 198 WMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TV 243
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
++ G P C + ++ LKC + + RPS SE++ + +I++
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+IG G +G V+ G + VA+K +EG++ E++F+ E + + +L H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E+ LV EFM +G L D L + L + L G+ YL + V HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L+ KV+DFG++R V D + P VK PE F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP------VKWAS----PEVF 177
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ + KSDV+S GV+ E+ + G P + N EV + + G P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV--------VEDISTGFRLYKP 227
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
++ C ++ + RP+ S ++R+L I
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 56/314 (17%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G+G +G V + L VAVK + + +EFL E + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 685 LVGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRG 734
LVG + M++ FM +G L L ++ L + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIV 784
+ YL + HRD+ A N +L T VADFGLSR I +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843
P VK E + T SDV++ GV E++T G P + +N E+
Sbjct: 202 P------VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI- 248
Query: 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMM 902
+I GN P EC+E+ L +C + RPS + + ELE+I ++
Sbjct: 249 -------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 903 PESDTKTPEFINSE 916
S ++ P +IN E
Sbjct: 302 VLSTSQDPLYINIE 315
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ ++ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAP----VPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
D+ A N L+ KVADFGLSRL P +K T PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTA----PESLA 185
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
+K + KSDV++ GV+ E+ T GM P +V + P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPE 235
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
C EK +L C Q RPS +E+ + E+++ SD E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 25/285 (8%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 134
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 801
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA----P 186
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS-VIDGNM 859
E K + SDV+S GVV EL T + S +R + Q M+ +I+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 860 GSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900
+ P C ++ + +C + + RPS ++ ++ I +
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 35/288 (12%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 684
+G+G +GKV G +VAVK + + + EI L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C++ G LV E++ G+LRD L + +G A L A G+ YLH +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 743 DPPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL-- 799
+ HRD+ A N+LLD+ K+ DFGL++ VP G
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKA---------VPEGHEYYRVREDGDSPV 201
Query: 800 ---DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855
PE +K SDV+S GV ELLT S + + IA + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 856 DGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
+ P +C + L C + E RP+ ++ L+++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-41
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+G+G +G V +G L VAVK + S + +EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 685 LVGYCDEEGEQ-----MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 735
L+G C E Q M++ FM G L L + + L + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIVP 785
YL ++ HRD+ A N +L T VADFGLS+ I +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844
VK E T KSDV++ GV E+ T GM P +N E+
Sbjct: 213 ------VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEM-- 258
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
++ G+ P +C+++ ++ C + + RP+ S + +LE + +P+
Sbjct: 259 ------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VAVK ++GS+ FL E + +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M NG+L D L S L L +A + G+ ++ + HRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
++A+NIL+ + K+ADFGL+RL + D E P +K T PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP------IKWTA----PEAI 182
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
T KSDV+S G++ E++T G P N EV + ++ G P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV--------IQNLERGYRMVRP 232
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 25/287 (8%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 165
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 801
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWYA----P 217
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM-----MFSVI 855
E K + SDV+S GVV EL T + S +R + Q M + +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902
+ P C ++ + +C + + RPS ++ ++ I + M
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 34/275 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VAVK +EGS+ E EF E Q + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E +V E++SNG L + L + K L + L + G+ +L HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L+D KV+DFG++R V D + P VK + PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP------VKWSA----PEVF 177
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
K + KSDV++ G++ E+ + G P N EV + V G+ P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV--------VLKVSQGHRLYRP 227
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ ++ C + + RP+ +++ +E +
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 390 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 812 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 870
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 493
Query: 871 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
L +C + E + RP+ + LE +
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+G G +G+V+ T VAVK + GS+ + FL E + L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E ++ EFM+ G+L D L + + + + G+ ++ HRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 311 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 812 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 866
KSDV+S G++ +E++T G P N EV + ++ G Y P C
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSN--PEV--------IRALERG----YRMPRPENC 410
Query: 867 VEKFIKLALKCCQDETDARPSMSEVMRELESI 898
E+ + ++C ++ + RP+ + L+
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VA+K +EGS+ E EF+ E + + L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ ++ E+M+NG L + L + + L + + YL HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L++ + KV+DFGLSR V D E P V+ +P PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP------VRWSP----PEVL 193
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ K + KSD+++ GV+ E+ + G P N E + G P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET--------AEHIAQGLRLYRP 243
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901
EK + C ++ D RP+ ++ + + +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 44/313 (14%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G + P VAVK E + ++ +FL E +S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 738
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 739 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI-----EGIVPAHVST 790
+ HRDI A N LL AK+ DFG++R ++P
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 208
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 849
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 209 -VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV------- 254
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 909
+ V G P C ++ +C Q + + RP+ + ++ +E +T
Sbjct: 255 -LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 910 PEFINSEHTSKEE 922
P +E+
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-40
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 26/283 (9%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK + +FLTE + H N++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G C EG ++V +M +G LR+ + + L ++G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 804
HRD+ A N +LD KFT KVADFGL+R + + + + + VK E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
T K T KSDV+S GV+ EL+T G P ++ ++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TVYLLQGRRLLQP 318
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
C + ++ LKC + + RPS SE++ + +I++
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 66/305 (21%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
++G+ +GKVYKG L VA+K ++ +EF E +RL H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIAL 729
L+G ++ +++ + S+G L + L +S K L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------- 781
+ G+ YL + V H+D+ N+L+ K K++D GL R ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLL 187
Query: 782 --GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHG 835
++P ++ PE + K + SD++S GVV E+ + G+QP S+
Sbjct: 188 GNSLLP------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 236
Query: 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
++V + + + + P +C L ++C + RP ++ L
Sbjct: 237 ----QDV--------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 896 ESIWN 900
+ N
Sbjct: 285 RAWGN 289
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 74/331 (22%), Positives = 136/331 (41%), Gaps = 62/331 (18%)
Query: 631 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V T VAVK + + + + + ++E++ + + H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L S +E L +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 837
G +P VK PE T +SDV+S GV+ E+ T G P +
Sbjct: 253 GRLP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299
Query: 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
E+ + +G+ PS C + + C RP+ +++ +L+
Sbjct: 300 --EEL--------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD- 348
Query: 898 IWNMMPESDTKTPEFINSEHTSKEETPPSSS 928
++ + + + + H + P + +
Sbjct: 349 --RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-39
Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 24/299 (8%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L LNL+GN + L LT L NKI+ + N+ +L L LN + ++
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L K+ + + N+ S +N+ + + + + ++ L L
Sbjct: 125 --ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDL 179
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L+ N + L+ L L N T I +NM++L L + N +
Sbjct: 180 YSLSLNYNQIED--ISPLASLTSLHYFTAYVNQI--TDIT-PVANMTRLNSLKIGNNKIT 234
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + L +L++ +NQ++ L+ + + + +N+++ S + L +L
Sbjct: 235 D-LSPLANLSQLTWLEIGTNQISDINAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
LF+ NN L I L L N++T+I ++ +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLT-----TLFLSQNHITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 61/279 (21%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L NL + N + L+ L L + IS P + N+ + L L N
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL- 145
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
S L + L+ + + ++ + P ANL +N N I P L+ L SL
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ N +T ++ + +L L++ NN T + +N+S+L L + +
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKI--TDLSP-LANLSQLTWLEIGTNQIS 256
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ + L L++ SNQ++ LS + ++ L+NN+L GL L
Sbjct: 257 DI-NAVKDLTKLKMLNVGSNQISDISVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
LF++ N ++ P + + ++ DF N +
Sbjct: 315 TLFLSQNHITDIRPLA-------SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-37
Identities = 55/284 (19%), Positives = 121/284 (42%), Gaps = 25/284 (8%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L ++ + P L+ ++ + ++S+ L++ G ++
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ + YL L+ + ++ N I+ P +NL K + ++ N I+ L L +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L+ +N++ L+ L K+ L L N+ + + SNM+ L L++ +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN--LSDLSPLSNMTGLNYLTVTESKV 167
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+ + ++ + +L L L+ NQ+ P L+ ++ N++T P + + RL
Sbjct: 168 KD-VTPIANLTDLYSLSLNYNQIEDISPLASLT-SLHYFTAYVNQITDITP--VANMTRL 223
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
L I NN ++ P + N ++ L+ N +++I+
Sbjct: 224 NSLKIGNNKITDLSPLA-------NLSQLTWLEIGTNQISDINA 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 58/301 (19%), Positives = 116/301 (38%), Gaps = 28/301 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ L ++G I L+ L L+ N+I+ P + N+ L L + N++T
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD 102
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L L + ++++ IS ANL K ++ N LS + L
Sbjct: 103 --ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ + + + ++ L L L L+ N I ++++ L + +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQI--EDISPL-ASLTSLHYFTAYVNQIT 212
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ ++ + L L + +N++ P LS +T +++ N+++ + L +L+
Sbjct: 213 D-ITPVANMTRLNSLKIGNNKITDLSPLANLS-QLTWLEIGTNQISD--INAVKDLTKLK 268
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGN 382
L + +N +S S + LN L NN L N + T+ L N
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLN-----SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 383 P 383
Sbjct: 322 H 322
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 33/294 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G+GG+ V L DG A+KR Q +E E +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 690 DEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEAD 743
E L+ F GTL +++ + L + LG RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLA--PVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K +NILL + + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 802 EYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
E F + +++DV+SLG V ++ G P ++ +Q ++ N
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----------DMVFQKGDSVALAVQN 262
Query: 859 MGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 907
S P S + + + + RP + ++ +LE++ P T
Sbjct: 263 QLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-39
Identities = 78/344 (22%), Positives = 134/344 (38%), Gaps = 42/344 (12%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTIL 111
C++ VLC + + L+L N + +L L
Sbjct: 9 CSAQDRAVLC-------HRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGS 169
+ N +S ++ N+ +L L L N L +P L L ++ I +N I
Sbjct: 62 ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVIL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPK 227
L F +L + + +N + I S L SL + L+ NLT +P E LS L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
Query: 228 LLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL-RNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
L++L+L + N I S+ + +L L + L P+ NL L ++
Sbjct: 178 LIVLRLRHLNI--NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 286 LNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIW 342
L ++P + + + + LS N ++ TI + L RLQ + + L+ + +
Sbjct: 236 LT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAF 292
Query: 343 QSRTLNATETFILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 384
+ LN +L+ N LT + F+ N T+ L NP
Sbjct: 293 RG--LNYLR--VLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 50/260 (19%), Positives = 104/260 (40%), Gaps = 20/260 (7%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L L L N + + LS LT LD NKI + + ++ +L+ L + N+
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND 139
Query: 142 LTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LS 199
L + L L+++ +++ ++ ++ ++L+ + + +I+ I
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL 258
RL L + + + + P L L + + N T +P + ++ L L+L
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL--TAVPYLAVRHLVYLRFLNL 255
Query: 259 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPS 315
+ L + L + L QL + P + + +S N+LT T+
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEE 313
Query: 316 N-FSGLPRLQRLFIANNSLS 334
+ F + L+ L + +N L+
Sbjct: 314 SVFHSVGNLETLILDSNPLA 333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 80/318 (25%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G + VAVK E S Q E +FL E +S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 738
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 739 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI----------EGIVP 785
+ HRDI A N LL AK+ DFG++R DI ++P
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 844
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 250 ------VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV-- 295
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
+ V G P C ++ +C Q + + RP+ + ++ +E
Sbjct: 296 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 905 SDTKTPEFINSEHTSKEE 922
+T P +E+
Sbjct: 350 INTALPIEYGPLVEEEEK 367
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-39
Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 632 IGQGGYGKVYKGIL-PDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ P+G VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C + KC + D+RP E++ E +
Sbjct: 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-39
Identities = 55/310 (17%), Positives = 110/310 (35%), Gaps = 20/310 (6%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
+ + E +L N + + L+ ++ + I +++ + L + +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQ 318
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELS 199
L +L +L L + N S S L + ++ N++S G
Sbjct: 319 LKQFPTLDLPFLKSLT---LTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
SL H+ L N + L +L L ++ + T +++ ++ KLL L +
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 260 NCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSN 316
+ + + +L L ++ N + + N+T + LS +L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN- 374
F L RLQ L +++N+L S Q +L+ LD N + + P +
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS-----TLDCSFNRIETSKGILQHFPKSL 547
Query: 375 VTVRLRGNPF 384
L N
Sbjct: 548 AFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 49/281 (17%), Positives = 104/281 (37%), Gaps = 13/281 (4%)
Query: 87 LQLLNLNLSGNLSPEI--GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ +L++ + L +L L NK S I + + SL L L+ N L+
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 145 SLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRL 201
S L + + N + +F L + +H ++++ L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+++ + N L L L++ N+F+ T+ ++N + L L L C
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFS 318
L+ + L L++S N L + + +++T+ S N++ +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
L + NNS++ I + + + F+++ +
Sbjct: 543 FPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-35
Identities = 65/354 (18%), Positives = 113/354 (31%), Gaps = 52/354 (14%)
Query: 88 QLLNLNLSGN----LSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L NL L+GN SP L+ L L + K++ IG + +L+ L + N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 143 TG-SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF----HMNNNSISGQIPPE 197
LP L L + + NYI L + M+ N I I +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQ 199
Query: 198 LSRLPSLVHMLLDNNNLTGYL-------------------------------PPELSELP 226
+ L + L N + + P + L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 227 KLLILQLDNNNFEGTTI-PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
+ I + + + ++ + +SL S++ + D+ + L + Q
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQ 318
Query: 286 LNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
L P L + ++ L+ NK + I LP L L ++ N+LS S S
Sbjct: 319 LK-QFPTLDLP-FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 346 TLNATETFILDFQNNNLTNISGSFNIPPN-VTVRLRGNPFCLNTNAEQFCGSHS 398
T + LD N +S +F + + + T F
Sbjct: 375 TNSLRH---LDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-34
Identities = 60/336 (17%), Positives = 100/336 (29%), Gaps = 41/336 (12%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGN----LSPE-IGRLSYLT 109
+PC N T L ++ N++LS N L S L
Sbjct: 5 NPCIEV-----VPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
LD +I K + L L+L GN + P L L+ + + ++
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
L + ++ +N I ++P S L +LVH+ L N + +L L +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 229 ----LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLS 282
L L + N I KL +L+LR + L + L L
Sbjct: 180 PQVNLSLDMSLNPI--DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 283 SNQLNG---------SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ SI G + I +L+ F L + + +A S+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 369
+ + L L
Sbjct: 298 K-YLEDVPKHFKWQ------SLSIIRCQLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 17/299 (5%)
Query: 96 GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK 155
G+L+P I + +T M K+S +P +I + S + + L+ N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + + I K++ L+ + + N I P S L SL +++ L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIP 274
+ +L L L + +N +PA +SN++ L+ + L +Q + DL +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 275 NLG----YLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFI 328
LD+S N ++ I + + + L N + I L L +
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 329 ANNSLSGSIPSSIWQSRT---LNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 382
I++ L N + F+ NV+ L G
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 4/137 (2%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLN 138
L +L L++ N + L+ L L N + + N +L L L+
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
+L L +L + + N + + L + N I
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 199 SRLPSLVHMLLDNNNLT 215
SL L NN++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-39
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 631 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V + VAVK ++ + + + + ++E++ + + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 837
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311
Query: 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 312 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 898 I 898
I
Sbjct: 362 I 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
+G+G +G+VY+G+ + VAVK ++ K +F++E + L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G +EE ++ E G L L ++K L + +L + + YL E+ V
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL--ESINCV 135
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE---------GIVPAHVSTVVKGTPG 797
HRDI NIL+ K+ DFGLSR IE +P +K
Sbjct: 136 -HRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKASVTRLP------IKWMS- 182
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856
PE + T SDV+ V E+L+ G QP +N ++V + +
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDV--------IGVLEK 229
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901
G+ P C L +C + RP +E++ L ++ M
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-39
Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 32/306 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 684
IG G +G+VYKG+L + VA+K + G + ++ +FL E + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L G + M++ E+M NG L L + + + G + G+ YL A+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 803
HRD+ A NIL++ KV+DFGLSR+ D E + ++ T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
K T SDV+S G+V E++T G +P N EV M ++ DG
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV--------MKAINDGFRLPT 271
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 922
P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADFDPRVSIR--- 327
Query: 923 TPPSSS 928
PS+S
Sbjct: 328 -LPSTS 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G + VYKG+ VA Q+ L + F E + L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 688 YC-DEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTE 741
+ + E M++GTL+ L K +++ S +G+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 742 ADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
PP+ HRD+K NI + + K+ D GL+ + A + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPEFMA 198
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE + K + DVY+ G+ LE+ T P S +N + + V G
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKP 248
Query: 861 SYP----SECVEKFIKLALKCCQDETDARPSMSE 890
+ V++ I+ C + D R S+ +
Sbjct: 249 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 72/320 (22%), Positives = 132/320 (41%), Gaps = 64/320 (20%)
Query: 631 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V VAVK ++ + + + + ++E++ + + H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 837
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 219 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265
Query: 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 266 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 898 IWNMMPESDTKTPEFINSEH 917
I + T E+++
Sbjct: 316 IL-----TLTTNEEYLDLSQ 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 74/297 (24%), Positives = 118/297 (39%), Gaps = 51/297 (17%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G+G +G+V + VAVK +EG+ E ++E++ L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 683 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSI 727
V+L+G C G M++ EF G L L K+ L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EG 782
+ ++G+ +L A HRD+ A NILL K K+ DFGL+R +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 841
+P +K PE T +SDV+S GV+ E+ + G P G I E
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 842 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 260 F--------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 630 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L +E + + + S G+ YL +
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 236
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
EC + L C + + RP V + + + + +
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G+G +GKV K T VAVK +E + E + L+E L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------------SAKSKEPLGF 721
L G C ++G +L+ E+ G+LR L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
+S A S+G+ YL A+ + HRD+ A NIL+ K++DFGLSR D+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+G +P VK E H T +SDV+S GV+ E++T G
Sbjct: 202 EEDSYVKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 831 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 887
P I + + G+ P C E+ +L L+C + E D RP
Sbjct: 252 PYPGIPP-----ERL--------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 888 MSEVMRELESI 898
+++ ++LE +
Sbjct: 299 FADISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNLVSL 685
IG+G +G+V K + A+KR +E + + + +F E++ L +L HH N+++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSIALGS 731
+G C+ G L E+ +G L D L + + L L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------GIV 784
+RG+ YL + HRD+ A NIL+ + AK+ADFGLSR E G +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVR 840
P V+ E T SDV+S GV+ E+++ G P ++
Sbjct: 204 P------VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248
Query: 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
E+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 249 EL--------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
IG G G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G M+V E+M NG+L L + + G G+ YL +D
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 804
HRD+ A N+L+D KV+DFGLSR+ D + + ++ T PE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PEAI 226
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ SDV+S GVV E+L G +P + N R+V + SV +G P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDV--------ISSVEEGYRLPAP 276
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C +L L C + RP S+++ L+++
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 65/336 (19%), Positives = 123/336 (36%), Gaps = 30/336 (8%)
Query: 600 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE 658
H +S G + + M + +IG+G +GK DG +K
Sbjct: 4 HHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI 59
Query: 659 GSL-QGEKEF-LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
+ E+E E+ L+ + H N+V +E G +V ++ G L +++A+
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
L + + ++H D + HRDIK+ NI L T ++ DFG++R+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
+ GTP YL PE +KSD+++LG V EL T
Sbjct: 177 STV------ELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAG 228
Query: 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE-- 894
++ +++ +I G+ L + + RPS++ ++ +
Sbjct: 229 SM---------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 895 -LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929
+ I + + + + P+
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG VAVK + + + E L E + +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C+ E MLV E G L L + + + + S G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNF 138
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEY 803
V HRD+ A N+LL + AK++DFGLS+ + E A VK PE
Sbjct: 139 V-HRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA----PEC 191
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
+K + KSDV+S GV+ E + G +P K EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV--------TAMLEKGERMGC 241
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P+ C + L C + + RP + V L +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-38
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 68/304 (22%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + EK ++E++ +S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------SAKSKEPLGFAMRLSIALG 730
V+L+G C G +++ E+ G L + L A + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI---------- 780
++G+ +L A HRD+ A N+LL + AK+ DFGL+R DI
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 839
+P VK PE T +SDV+S G++ E+ + G+ P
Sbjct: 225 NARLP------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-------- 266
Query: 840 REVNIAYQSSM-----MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894
Y + V DG + P+ + + C E RP+ ++
Sbjct: 267 ------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
Query: 895 LESI 898
L+
Sbjct: 321 LQEQ 324
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL--ESKRFV 138
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 800
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 139 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 185
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 235
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C L KC + RP +E+ +L +I
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 54/310 (17%)
Query: 631 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
+GQG + K++KG+ T V +K + + F +S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V G C E +LV EF+ G+L L K+K + +L +A + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 743 DPPVFHRDIKASNILLDHKFT--------AKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H ++ A NILL + K++D G+S +P +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQER------IPW 183
Query: 795 TPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 852
P PE K +D +S G E+ + G +P+S + + +
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRK--------LQ 229
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
D + P + L C E D RPS ++R+L S++ TP+
Sbjct: 230 FYEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLF---------TPDL 278
Query: 913 INSEHTSKEE 922
+
Sbjct: 279 VPRGSHHHHH 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
IG+G +G+V++ P T+VAVK +E S + +F E ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----------------------PLGF 721
L+G C L++E+M+ G L + L + S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
A +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR +I
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIY 225
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+P ++ P PE ++ T +SDV++ GVV E+ + G+Q
Sbjct: 226 SADYYKADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 831 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 887
P ++H EV I Y V DGN+ + P C + L C RPS
Sbjct: 276 PYYGMAH-----EEV-IYY-------VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 888 MSEVMRELESI 898
+ R L+ +
Sbjct: 323 FCSIHRILQRM 333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 55/309 (17%), Positives = 100/309 (32%), Gaps = 23/309 (7%)
Query: 82 LHLRELQLLNL--NLSGNLSPEIGR-LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + + + + + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNF 317
+ + + L LDLSSN+L + P S +T I L NNKL I
Sbjct: 177 QYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV 377
L+ + N + S+ + + ++G V
Sbjct: 234 RFSQNLEHFDLRGNGFH-CGTLRDFFSKNQR-----VQTVAKQTVKKLTGQNEEECTVPT 287
Query: 378 RLRGNPFCL 386
+C
Sbjct: 288 LGHYGAYCC 296
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 49/269 (18%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---S 296
+ + S + L N + D + YLDL N+++ ++ L S
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 357 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 40/240 (16%), Positives = 78/240 (32%), Gaps = 11/240 (4%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L L+L+ N E+ + L N IS + G + + + L N++T
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 148 EELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
+ G ++ + + N I + + A+ + H ++ N I + ++ L
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKT 195
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
+ L +N L ++ PE + + L NN I + L LR
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL--VLIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
N ++ + + T+ +P+ F RL L
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPF--ADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 35/200 (17%), Positives = 62/200 (31%), Gaps = 11/200 (5%)
Query: 89 LLNLNLSGN----LSP-EIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNEL 142
N+ L+ N L + G S + LD N+I + + + +LE L L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ ++ KL + + N ++ + F + + NN + I L
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
+L H L N + + + T L C
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 263 LQGPMPDLSRIPNLGYLDLS 282
P P R+ LG+
Sbjct: 297 EDLPAPFADRLIALGHHHHH 316
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 48/304 (15%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
+F IG GG+G+V+K DG +KR + ++ E++ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 683 VSLVGYCDEEGEQM----------------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
V G D + EF GTL + + E L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ ++G+ Y+H + +RD+K SNI L K+ DFGL +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--------LKND 175
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846
T KGT Y+ PE + + D+Y+LG++ ELL ++
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL---- 231
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
G +K L K + + RP+ SE++R L +W PE +
Sbjct: 232 -----------RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT-VWKKSPEKN 279
Query: 907 TKTP 910
+
Sbjct: 280 ERHT 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 72/311 (23%), Positives = 124/311 (39%), Gaps = 42/311 (13%)
Query: 632 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G V+KG+ V +K ++ S Q + + + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C LV +++ G+L D + + + LG + L+ + ++G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HR++ A N+LL +VADFG++ L P D + P +K
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMA---- 185
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E K T +SDV+S GV EL+T G +P + + EV + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEV--------PDLLEKGER 235
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
+ P C + +KC + + RP+ E+ E + P I E
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV-----IKRESGP 290
Query: 920 KEETPPSSSSM 930
P +
Sbjct: 291 GIAPGPEPHGL 301
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 45/310 (14%)
Query: 632 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
P C + +KC + D+RP E++ E + + P+
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 289
Query: 920 KEETPPSSSS 929
+ PS +
Sbjct: 290 ERMHLPSPTD 299
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 34/311 (10%)
Query: 631 QIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G+V G L VA+K + G + ++ +FL E + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G + M+V E+M NG+L L K + + G + G+ YL +D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLD 800
HRD+ A NIL++ KV+DFGL R +E A +T ++ T
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTS---- 218
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE K T SDV+S G+V E+++ G +P N ++V + +V +G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDV--------IKAVDEGYR 268
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
P +C +L L C Q + + RP +++ L+ + T +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLL 328
Query: 920 KEETPPSSSSM 930
+++ ++
Sbjct: 329 LDQSNVDITTF 339
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + E+ ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------SAKSKEPLGFAMRLS 726
V+L+G C G +++ E+ G L + L + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+ ++G+ +L A HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 840
+P VK PE T +SDV+S G+ EL + G P G +
Sbjct: 207 ARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDS 255
Query: 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ + +G P + + C + RP+ ++++ +E
Sbjct: 256 KF--------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 59/306 (19%), Positives = 106/306 (34%), Gaps = 26/306 (8%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 141 ELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL- 198
++ + Y + ++ + N I P F N+ + N +S +P +
Sbjct: 80 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 199 SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
P L + + NNNL + + L LQL +N T + S + L +
Sbjct: 138 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDL--SLIPSLFHAN 192
Query: 258 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNF 317
+ L L+ + LD S N +N + +T +KL +N LT
Sbjct: 193 VSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNNLT-DTAW-L 244
Query: 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV 377
P L + ++ N L I + L NN L ++ P + V
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFV----KMQRLERLYISNNRLVALNLYGQPIPTLKV 299
Query: 378 -RLRGN 382
L N
Sbjct: 300 LDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 57/291 (19%), Positives = 119/291 (40%), Gaps = 33/291 (11%)
Query: 83 HLRELQLLNL--NLSGNLSPEIGR-LSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLN 138
+ +Q L + N L P + + + LT+L N +S S+P+ I N L L ++
Sbjct: 91 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 149
Query: 139 GNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
N L + ++ L +Q+ N ++ +L H +++ N +S
Sbjct: 150 NNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL---FHANVSYNLLS-----T 200
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
L+ ++ + +N++ + + +L IL+L +NN T N L+++
Sbjct: 201 LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAW-LLNYPGLVEVD 254
Query: 258 LRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPS 315
L L+ ++ L L +S+N+L ++ + + + LS+N L +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 316 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
N RL+ L++ +NS+ ++ S + L +N+ S
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 51/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
I + + ++ E L + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
++N+ I +I + ++ + + N + YLPP +P L +L L+ N+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
+++P + N KL LS+ N +L+ +L L LSSN+L + +
Sbjct: 130 --SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
++ +S N L+ + ++ L ++NS++ + + T IL
Sbjct: 187 -SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT-------ILK 232
Query: 357 FQNNNLTNISGSFNIPPNVTVRLRGN 382
Q+NNLT+ + N P V V L N
Sbjct: 233 LQHNNLTDTAWLLNYPGLVEVDLSYN 258
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLV 683
++G G +G V +G P G VAVK + L + +F+ E+ + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G +V E G+L D+L K + A+ + G+ YL E+
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL--ESK 140
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+ A N+LL + K+ DFGL R P D ++ H PE
Sbjct: 141 RFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
T + SD + GV E+ T G +P ++ + +G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI-------LHKIDKEGERLPR 246
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
P +C + + ++C + + RP+ + L ++
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 70/308 (22%), Positives = 114/308 (37%), Gaps = 67/308 (21%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV VAVK +E + E+ ++E++ +++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL---------------------SAKSKEPLGF 721
V+L+G C G L++E+ G L + L + L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R DI
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+P VK PE T KSDV+S G++ E+ + G+
Sbjct: 224 SDSNYVVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 831 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 890
P G + + +G P E+ + C ++ RPS
Sbjct: 274 P-YPGIPVDANF--------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324
Query: 891 VMRELESI 898
+ L
Sbjct: 325 LTSFLGCQ 332
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 50/303 (16%), Positives = 99/303 (32%), Gaps = 23/303 (7%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134
+ + H + L S L P LS N + ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQI 60
Query: 135 LLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G L + + L P +++ + P L+ +H ++ +
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN--------FEGTTIP 244
++P + + L + L N L LP ++ L +L L + T
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTI 302
+ + L L L ++ ++ + NL L + ++ L+ ++ P L + +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP-KLEEL 234
Query: 303 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
L P F G L+RL + + S ++P I + L E L NL
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL---EKLDLR-GCVNL 290
Query: 363 TNI 365
+ +
Sbjct: 291 SRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 53/296 (17%), Positives = 98/296 (33%), Gaps = 28/296 (9%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL--LLLNGNE 141
+ + N + + I + + + + L L
Sbjct: 35 WQRHYNADRNRWHSAW-RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP 92
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L P++ L L + ID + LP + + N + +P ++ L
Sbjct: 93 LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 202 PSLVHMLLDNNNLTGYLPPEL---------SELPKLLILQLDNNNFEGTTIPASYSNMSK 252
L + + LP L L L L+L+ ++PAS +N+
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQN 207
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN-NKL 309
L L +RN L P + +P L LDL + PP G + + + L + + L
Sbjct: 208 LKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNL 266
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
T+P + L +L++L + +PS I Q I+ + +
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC-----IILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 28/146 (19%), Positives = 52/146 (35%), Gaps = 7/146 (4%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L +L L L I L L L + +S ++ I ++ LE L L G
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 144 GSLPEELGYLPKLDRIQI-DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ P G L R+ + D + + +LP L + + ++P +++LP
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKL 228
+ +L+ + P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 2/90 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNE 141
L EL L N P G + L L + + ++P +I + LE L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
LP + LP I + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L L + + L +I RL+ L LD +P I + + ++L+ +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 143 TGSLPEELGYLPKL 156
P
Sbjct: 314 AQLDQHRPVARPAE 327
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 30/289 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV 686
+IG+G + +VY+ L DG VA+K+ Q L K + EI L +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEADP 744
E+ E +V E G L + K+ + + ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRDIK +N+ + K+ D GL R ++V GTP Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLV-GTPYYMSPERI 208
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ KSD++SLG + E+ P N+ S+ + + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLCKKIEQCDYPPLP 259
Query: 864 SECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 911
S+ E+ +L C + + RP ++ V + M + +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEH 305
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 58/316 (18%), Positives = 101/316 (31%), Gaps = 23/316 (7%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + +L L+ + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNF 317
+ + + L LDLSSN+L + P S +T I L NNKL I
Sbjct: 177 QYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV 377
L+ + N R + + + ++G V
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTL------RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 378 RLRGNPFCLNTNAEQF 393
+C F
Sbjct: 288 LGHYGAYCCEDLPAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-34
Identities = 48/269 (17%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-- 297
+ + S + L N + D + YLDL N+++ ++ L+
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 298 -NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 357 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 50/301 (16%), Positives = 92/301 (30%), Gaps = 17/301 (5%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L LNLS N+ + ++ LS L LD N + E+ S+E L N ++
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPS 203
+ I + N I+ ++ ++ + N I + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L H+ L N + + ++ KL L L +N + + + + + +SLRN L
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKL 226
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
L NL + DL N + S N ++ + N
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVRLRGN 382
+ L E +L Q + + N +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 383 P 383
Sbjct: 347 Q 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 48/333 (14%), Positives = 94/333 (28%), Gaps = 56/333 (16%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L L+L+ N E+ + L N IS + G + + + L N++T
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 148 EELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISG-------------- 192
+ G ++ + + N I + + A+ + H ++ N I
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
Query: 193 -------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ PE + + L NN L + L L L N F T+
Sbjct: 198 LSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 246 SYSNMSKLLKLSLR-----------------------NCSLQGPMPDLSRIPNLGYLDLS 282
+S ++ ++ + C P P R+ L + +
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316
Query: 283 SNQLNGS----IPPGRLSLN-ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
GS + R + I + I L +L +
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
+ L+ T + L + + +
Sbjct: 377 SNGRRAHAELDGTLQQAV--GQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 38/284 (13%), Positives = 83/284 (29%), Gaps = 14/284 (4%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L +LNL N + ++ + L LD NK++ + E + + + L N+L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 144 GSLPEELGYLPKLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMN-NNSISGQIPPELSRL 201
+ + L + L+ + N G+L F+ + + ++GQ E +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
+ +L L L + L E + N ++ ++
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 262 SLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320
+ R L+ L+ + GR + +L
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH----AELDGTLQQAVGQIELQHA 402
Query: 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
Q ++ + +++ D + T
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQ 446
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 27/269 (10%), Positives = 57/269 (21%), Gaps = 37/269 (13%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEI----------------- 126
+ ++L N + + L D N ++
Sbjct: 215 GVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 127 ------GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS----LPKSFAN 176
L L L R + GS L N
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
+ R I R + + + L + +L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
+ +LL+ ++ + + D+ ++ +L+
Sbjct: 395 GQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET------QLA 448
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
+K N + + S + L L
Sbjct: 449 EENARLKKLNGEADLALASANATLQELVV 477
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 619 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFL-TEIQFLS 675
M ++ IG G YG+ K DG ++ K GS+ + EK+ L +E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 676 RLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGS 731
L H N+V + L V E+ G L ++ +KE L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 732 SRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+ + H +D V HRD+K +N+ LD K K+ DFGL+R+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAK 174
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
T V GTP Y+ PE +KSD++SLG + EL M P +
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ---------KE 223
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + +G P ++ ++ + + RPS+ E++
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-36
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 630 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L +E + + + S G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HR++ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 562
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905
EC + L C + + RP V + + + + +
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL--ESKRFV 513
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 800
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 560
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 610
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C L KC + RP +E+ +L +I
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 686
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 148
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 253
Query: 856 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
D N P + ++ +K C + + R S+ E++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 40/295 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
++F +GQG +G+V K D A+K+ + + L+E+ L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 682 LVSLVG-YCDEEGEQM------------LVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSI 727
+V + + + E+ NGTL D + S + RL
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDI 780
+ + Y+H++ + HRD+K NI +D K+ DFGL++ + +
Sbjct: 124 QILE--ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 838
+ T GT Y+ E L K D+YSLG++F E++ P S G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234
Query: 839 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
V + S+ F + + +K I+ + + RP ++
Sbjct: 235 VNILKKLRSVSIEF---PPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 28/283 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + L + L +T L I + + +L + + N+LT
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD 82
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL I ++ N I+ ANL + NN I+ L L +L
Sbjct: 83 I--TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L +N ++ LS L L L N T +N++ L +L + + +
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFGNQV----TDLKPLANLTTLERLDISSNKVS 190
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
L+++ NL L ++NQ++ P G L+ N+ + L+ N+L + L L
Sbjct: 191 DI-SVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLT 246
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
L +ANN +S P + L L N ++NIS
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLT-----ELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 79/300 (26%), Positives = 122/300 (40%), Gaps = 28/300 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L L L N + L+ L L+ N IS + + SL+ L N++T
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD 169
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
P L L L+R+ I N +S A L NN IS P L L +L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L+ N L L+ L L L L NN + + S ++KL +L L +
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQI--SNLAP-LSGLTKLTELKLGANQIS 278
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + L L+L+ NQL P L N+T + L N ++ P S L +LQ
Sbjct: 279 N-ISPLAGLTALTNLELNENQLEDISPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQ 334
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
RLF NN +S SS+ +N L +N +++++ N+ + L +
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNIN-----WLSAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 60/297 (20%), Positives = 117/297 (39%), Gaps = 24/297 (8%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L LQ L+ + L+ L LD NK+S + + +LE L+ N++
Sbjct: 154 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ LG L LD + ++ N + + A+L + NN IS LS L
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLT 265
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + L N ++ L+ L L L+L+ N I SN+ L L+L +
Sbjct: 266 KLTELKLGANQISN--ISPLAGLTALTNLELNENQL--EDISPI-SNLKNLTYLTLYFNN 320
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
+ + +S + L L +N+++ L+ NI + +N+++ P + L R
Sbjct: 321 ISD-ISPVSSLTKLQRLFFYNNKVSDVSSLANLT-NINWLSAGHNQISDLTP--LANLTR 376
Query: 323 LQRLFIANNSLSGSIPSSI------WQSRTLNATETFILDFQNN-NLTNISGSFNIP 372
+ +L + + + + + + + + + + T ++N+P
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-29
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 18/250 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L +L + N +G L+ L L N++ + ++ +L L L N+++
Sbjct: 200 NLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL +++ N IS P A L + +N N + +S L +L
Sbjct: 258 L--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNL 311
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ L NN++ +S L KL L NN + +S +N++ + LS + +
Sbjct: 312 TYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKV---SDVSSLANLTNINWLSAGHNQIS 366
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + + L L+ + + +++I + P+ S
Sbjct: 367 D-LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYT 424
Query: 325 RLFIANNSLS 334
I N S
Sbjct: 425 EPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 41/195 (21%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ L + + +++ + + L + + D + + L L +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292
NN T I N++KL+ + + N + L+ + NL L L +NQ+ P
Sbjct: 75 FSNNQL--TDITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDIDPL 130
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
L+ N+ ++LS+N ++ S SGL LQ+L N + TL
Sbjct: 131 KNLT-NLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE---- 180
Query: 353 FILDFQNNNLTNISG 367
LD +N +++IS
Sbjct: 181 -RLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-13
Identities = 26/159 (16%), Positives = 54/159 (33%), Gaps = 10/159 (6%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L ++ ++ ++ + + AN++ ++ P +S S
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
+ N + Y + + + F GT
Sbjct: 424 TEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 73/328 (22%), Positives = 116/328 (35%), Gaps = 47/328 (14%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+L L +SGN L L L+I + L L + GN+LT
Sbjct: 82 ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT 134
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
SLP L +L + N ++ SLP + L NN ++ +P S
Sbjct: 135 -SLPVLPPGLQELS---VSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPS---G 182
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + + +N L LP SEL KL NN T++PA S L +L + L
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKL---WAYNNRL--TSLPAL---PSGLKELIVSGNRL 233
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+P L L L +S N+L S+P L ++ + N+LT +P + L
Sbjct: 234 TS-LPVL--PSELKELMVSGNRLT-SLPMLPSGL--LSLSVYRNQLT-RLPESLIHLSSE 286
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
+ + N LS + T + + + P T L
Sbjct: 287 TTVNLEGNPLS-ERTLQALREITS-------APGYSGPIIRFDMAGASAPRETRALHLAA 338
Query: 384 FCLNTNAEQFCGSHSDDDNEIDRSTNST 411
A + + +D + + N+
Sbjct: 339 ADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-25
Identities = 49/246 (19%), Positives = 85/246 (34%), Gaps = 30/246 (12%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+EL + + L+ +L L L + N+++ S+P L+ L ++ N+L
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
SLP L KL N ++ SLP + L + ++ N ++ +P S L
Sbjct: 194 A-SLPTLPSELYKLW---AYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELK 244
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L+ + N LT LP S L L + N T +P S ++S ++L
Sbjct: 245 ELM---VSGNRLT-SLPMLPSGLLSL---SVYRNQL--TRLPESLIHLSSETTVNLEGNP 295
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLN--GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320
L R + S + + + L +
Sbjct: 296 LSERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
Query: 321 PRLQRL 326
R
Sbjct: 354 DRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 11/154 (7%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L+EL + L+ +L L L + N+++ S+P L L + N+LT
Sbjct: 223 LKELIVSGNRLT-SLPVLPSELKELMVSG---NRLT-SLPMLPSG---LLSLSVYRNQLT 274
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
LPE L +L + ++ N +S + + R
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETR 332
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+H L + L E + + + ++N
Sbjct: 333 ALH-LAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 23/111 (20%), Positives = 46/111 (41%), Gaps = 19/111 (17%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L++ + L ++P + +ITT+ + +N LT ++P+ P L+ L ++ N L+
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT 94
Query: 335 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
S+P L+ I +L +P + + GN
Sbjct: 95 -SLPVLPPGLLELS-----IFSNPLTHLP------ALPSGLCKLWIFGNQL 133
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 28/124 (22%)
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 305
+ L++ L + +P ++ L + N L S+P + T+++S
Sbjct: 40 NGNAVLNVGESGL-------TTLPDCLPAHITTLVIPDNNLT-SLPA-LPP-ELRTLEVS 89
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
N+LT ++P GL L L L N LT++
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--LCK----------LWIFGNQLTSL 136
Query: 366 SGSF 369
Sbjct: 137 PVLP 140
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 70/275 (25%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G YG VY G L + +A+K E + + EI L H+N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 691 EEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVF 747
E + ++ E + G+L L +K PL + G+ YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 748 HRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRDIK N+L++ K++DFG S+ + GI P + GT Y+ PE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 807 HKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP- 863
+D++SLG +E+ TG P MF V G +P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AMFKV--GMFKVHPE 246
Query: 864 -----SECVEKFIKLALKCCQDETDARPSMSEVMR 893
S + FI KC + + D R ++++
Sbjct: 247 IPESMSAEAKAFIL---KCFEPDPDKRACANDLLV 278
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 37/279 (13%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL--HHRNLVSLV 686
QIG GG KV++ + + A+K + + EI +L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 129
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 234
Query: 856 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
D N +P + + C + + R S+ E++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 39/292 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRN 681
+F +G+GG+G V++ D A+KR + + + +E + E++ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 682 LVSLVGYCDEEGEQM------------LVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 728
+V E+ + + L+D ++ + E ++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDIE 781
L + + +LH + HRD+K SNI KV DFGL V
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
H V GT Y+ PE + + K D++SLG++ ELL P S VR
Sbjct: 182 PAYARHTGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 842 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ V + ++ + RP ++
Sbjct: 237 LTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 58/307 (18%)
Query: 617 GEMALATN---NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTE 670
G M + + F+ +IG G +G V+K + DG + A+KR E+ L E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 671 IQFLSRL-HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGF--AMRLS 726
+ + L H ++V E + ML+ E+ + G+L D +S + F A
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------------KFTAKVA 767
+ L RG+ Y+H+ + + H DIK SNI + K K+
Sbjct: 120 LLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELL 826
D G P V +G +L E + K+D+++L + +
Sbjct: 177 DLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 827 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 886
+G + G + P ++F +L + + RP
Sbjct: 226 GAEPLPRNG-------------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 887 SMSEVMR 893
S +++
Sbjct: 273 SAMALVK 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 64/330 (19%), Positives = 117/330 (35%), Gaps = 47/330 (14%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 141 ELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL- 198
++ + Y + ++ + N I P F N+ + N +S +P +
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 143
Query: 199 SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
P L + + NNNL + + L LQL +N T + S + L +
Sbjct: 144 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDLS--LIPSLFHAN 198
Query: 258 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG------RLSL-------------- 297
+ L L+ + LD S N +N + L L
Sbjct: 199 VSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNY 253
Query: 298 -NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+ + LS N+L I + F + RL+RL+I+NN L ++ TL +L
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VL 306
Query: 356 DFQNNNLTNI-SGSFNIPPNVTVRLRGNPF 384
D +N+L ++ + L N
Sbjct: 307 DLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
Q+ LNL+ + + L +N I +P + N+ L +L+L N+
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 142 LTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L+ SLP + PKL + + N + +F ++ +++N ++ + S
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 190
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+PSL H + N L+ L+ + L +N+ + +L L L++
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI--NVVRGP--VNVELTILKLQH 241
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---------RLSL-------------- 297
+L L P L +DLS N+L I RL +
Sbjct: 242 NNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQP 299
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+ + LS+N L + N RL+ L++ +NS+ ++ S + L
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NL 350
Query: 356 DFQNNNLTNIS 366
+N+ S
Sbjct: 351 TLSHNDWDCNS 361
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 3e-16
Identities = 50/323 (15%), Positives = 109/323 (33%), Gaps = 47/323 (14%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI--------------------G 127
L + N+S NL + + LD N I+ + +
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLL 251
Query: 128 NIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
N L + L+ NEL + + +L+R+ I N + +L + + ++
Sbjct: 252 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
+N + + + L ++ LD+N++ L L L L +N+++ ++ A
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL 365
Query: 247 YSNMSKL------------LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
+ N+++ +L C + P L R+ L ++ +
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQ----RLFIANNSLSGSIPSSIWQSRTLNAT 350
+ I +++ ++ +T G +L+ L L+ + L+A
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE 485
Query: 351 ETFILD---FQNNNLTNISGSFN 370
L + L S + N
Sbjct: 486 IDTNLRRYRLPKDGLARSSDNLN 508
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 64/340 (18%), Positives = 119/340 (35%), Gaps = 47/340 (13%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 686
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 176
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 281
Query: 856 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPESDTKT 909
D N P + ++ +K C + + R S+ E++ ++ + + + T
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338
Query: 910 PEFINS--EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 947
E + +P S K Y S+ S
Sbjct: 339 TEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 36/270 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSL 685
++G G YG+V+K DG + AVKR+ +G K+ L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
EEG + L E +L+ L A + + +LH++
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ H D+K +NI L + K+ DFGL + A V +G P Y+ PE
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--------LGTAGAGEVQEGDPRYMAPE-L 227
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYP 863
L +DV+SLG+ LE+ M+ + + G + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL-------------PHGGEGWQQLRQGYLPPEFT 274
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + + + + + R + ++
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 41/321 (12%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688
+ +GG+ VY+ + G A+KR + + + E+ F+ +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 689 C-------DEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHT 740
D + L+ + G L + L +S+ PL L I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGT 795
PP+ HRD+K N+LL ++ T K+ DFG + + V T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 796 PGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
P Y PE + + +K D+++LG + L P ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--------------FEDGAKL 259
Query: 853 SVIDGN--MGSYP--SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 908
+++G + + I+ Q + R S++EV+ +L+ I + K
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI-AAARNVNPK 315
Query: 909 TPEFINSEHTSKEETPPSSSS 929
+P E + S
Sbjct: 316 SPITELLEQNGGYGSATLSRG 336
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 72/323 (22%), Positives = 117/323 (36%), Gaps = 55/323 (17%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGN----------- 128
L+E + NL+ + E + T W++ + P G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 129 --IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
+ L LN L+ SLPE +L L N ++ LP+ +L + N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
++S P L ++ + NN L PEL L I+ +DNN+ +P
Sbjct: 123 LKALSDLP-------PLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSL--KKLP-- 169
Query: 247 YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN 306
L ++ N L+ P+L +P L + +N L +P LSL +I N
Sbjct: 170 -DLPPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK-KLPDLPLSL--ESIVAGN 224
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------ 354
N L LP L ++ NN L ++P LN + ++
Sbjct: 225 NIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281
Query: 355 LDFQNNNLTNISGSFNIPPNVTV 377
LD N + +S +PPN+
Sbjct: 282 LDVSENIFSGLS---ELPPNLYY 301
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 77/324 (23%), Positives = 126/324 (38%), Gaps = 42/324 (12%)
Query: 45 KSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGR 104
KS + Y+ S W R P + + + D EL+L NL LS +L
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 92
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L L N ++ +P+ ++KSL + N L+ LP L YL + N
Sbjct: 93 LESLVASC---NSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEYL------GVSNN 141
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
+ LP N + + ++NNS+ ++P PSL + NN L PEL
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE--LPELQN 193
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
LP L + DNN+ +P L + N L+ P+L +P L + +N
Sbjct: 194 LPFLTAIYADNNSL--KKLPDL---PLSLESIVAGNNILEEL-PELQNLPFLTTIYADNN 247
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
L ++P L ++ + + +N LT +P L L + LS P+
Sbjct: 248 LLK-TLPD--LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN----- 298
Query: 345 RTLNATETFILDFQNNNLTNISGS 368
L L+ +N + ++
Sbjct: 299 --LY-----YLNASSNEIRSLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 51/266 (19%), Positives = 97/266 (36%), Gaps = 47/266 (17%)
Query: 88 QLLNLNLSGN-LS--PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L ++ N L PE+ L +LT + N + ++P ++++L + N LT
Sbjct: 216 SLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR---DNYLT- 270
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
LPE L LD + +N S L + NL + + ++N I + L L
Sbjct: 271 DLPELPQSLTFLD---VSENIFS-GLSELPPNL---YYLNASSNEIR-SLCDLPPSLEEL 322
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ NN L LP + P+L L N+ +P L +L + L+
Sbjct: 323 N---VSNNKLI-ELP---ALPPRLERLIASFNHL--AEVPEL---PQNLKQLHVEYNPLR 370
Query: 265 ------GPMPDL----------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308
+ DL NL L + +N L P + ++ +++++ +
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD--IPESVEDLRMNSER 427
Query: 309 LTGTIPSNFSGLPRLQRLFIANNSLS 334
+ +L+ ++
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 54/273 (19%), Positives = 90/273 (32%), Gaps = 49/273 (17%)
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL----- 177
P+ + N L+ L + + LT +P E + + + P
Sbjct: 5 PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 178 --------NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229
+ +NN +S +P L SLV N+LT LP L LL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLL 117
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289
+ + L L + N L+ +P+L L +D+ +N L
Sbjct: 118 VDNNNLKALS--------DLPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-K 167
Query: 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 349
+P L ++ I NN+L +P LP L ++ NNSL +P ++ A
Sbjct: 168 LPD--LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVA 222
Query: 350 TETFI--------------LDFQNNNLTNISGS 368
+ + NN L +
Sbjct: 223 GNNILEELPELQNLPFLTTIYADNNLLKTLPDL 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-14
Identities = 34/172 (19%), Positives = 57/172 (33%), Gaps = 28/172 (16%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
I P L L ++NLT +P E + + +E P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWER-NAPPGNGEQREM 60
Query: 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 313
LR+C + L+L++ L+ S+P L ++ ++ S N LT +
Sbjct: 61 AVSRLRDCLDR----------QAHELELNNLGLS-SLPE--LPPHLESLVASCNSLT-EL 106
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
P L L +LS P + L NN L +
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPLLEY------------LGVSNNQLEKL 146
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 66/313 (21%), Positives = 123/313 (39%), Gaps = 33/313 (10%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G G G V+K P G V+A K E + + E+Q L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+GE + E M G+L L K + + +++ +G+ YL + + HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+K SNIL++ + K+ DFG+S ++ + ++ V GT Y+ PE
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 810 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
+ +SD++S+G+ +E+ G PI + + + + +E +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIP-----------PPDAKELELMFGCQVEGDAAETPPR 256
Query: 870 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP------EFINSEHTSKEET 923
+ D+RP M+ + L+ I N P +F+N
Sbjct: 257 PRTPGRPLNKFGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 924 PPSSSSMLKHPYV 936
++ H ++
Sbjct: 316 RADLKQLMVHAFI 328
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 631 QIGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRN 681
++G GG VY IL VA+K + ++E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+VS++ +E+ LV E++ TL + + +S PL ++ GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK NIL+D T K+ DFG+++ + + V+ GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVL-GTVQYFSP 181
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
E + +D+YS+G+V E+L G P + G+ V+IA + I ++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GET---AVSIAIKH------IQDSVPN 231
Query: 862 YPSECV----EKFIKLALKCCQDETDARP-SMSEVMRELESI 898
++ + + L+ + + R ++ E+ +L S+
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 53/265 (20%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+PK++ LL L N++T + L L + + N IS P +FA L K
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+++ N + ++P ++ +L + + N +T + + L ++++++L N +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 240 GTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-- 296
+ I ++ M KL + + + ++ L P+L L L N++ + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGL 215
Query: 297 LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
N+ + LS N ++ + + + P L+ L + NN L +P + + + ++
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VV 268
Query: 356 DFQNNNLTNISGSFNIPPNVTVRLR 380
NNN++ I + PP +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 74/337 (21%), Positives = 128/337 (37%), Gaps = 64/337 (18%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L ++ L+L N EI L L L + NKIS
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
I + LE L L+ N+L LPE++ L +++ +N I+ F LN+
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 180 TRHFHMNNNSI-SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ N + S I + L ++ + + N+T +P L P L L LD N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
T + A+ L + NL L LS N ++ ++ G L+
Sbjct: 204 I--TKVDAA----------------------SLKGLNNLAKLGLSFNSIS-AVDNGSLAN 238
Query: 297 -LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI- 354
++ + L+NNKL +P + +Q +++ NN++S +I S+ + N +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 355 -LDFQNNNLTNISGSFNIPPNV--------TVRLRGN 382
+ +N + I P+ V+L
Sbjct: 297 GVSLFSNPVQYWE----IQPSTFRCVYVRAAVQLGNY 329
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++PKEI LL L N+++ ++ L L + + N IS K+F+ L K
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+ +++ N + +IPP L SLV + + +N + +P S L + +++ N E
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
+ + KL L + L G DL L L L N++ +I L
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 298 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L +N++ I + S LP L+ L + NN LS +P+ + + L ++
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ-----VVY 270
Query: 357 FQNNNLTNIS-GSF-------NIPPNVTVRLRGNP 383
NN+T + F + L NP
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 66/321 (20%), Positives = 111/321 (34%), Gaps = 55/321 (17%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L+ + L+L N E+ L +L L + NKIS
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
I ++ ++ L+ L ++ N L +P L L ++I N I F+ L
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 180 TRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
M N + + P L ++ + LT +P +L L L LD+N
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI 205
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-- 296
I DL R L L L NQ+ I G LS
Sbjct: 206 --QAIELE----------------------DLLRYSKLYRLGLGHNQIR-MIENGSLSFL 240
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI-- 354
+ + L NNKL+ +P+ L LQ +++ N+++ + + + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 355 LDFQNNNLTNISGSFNIPPNV 375
+ NN + + P
Sbjct: 299 ISLFNNPVPYWE----VQPAT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 89 LLNLNLSGN----LSPEI-GRLSYLTILDFMWNKI-SGSIPKEIGNIKSLELLLLNGNEL 142
L+ L + N + + L + ++ N + + + L L ++ +L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRL 201
T +P++L L+ + +D N I + +K + +N I I LS L
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFL 240
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-------YSNMSKLL 254
P+L + LDNN L+ +P L +L L ++ L NN T + + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI--TKVGVNDFCPVGFGVKRAYYN 297
Query: 255 KLSLRNCSLQGPM--PDL-SRIPNLGYLDLSSNQ 285
+SL N + P + + + + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 333
+L + S L ++P +S + T + L NN ++ + + F GL L L + NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKE-ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 334 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 382
S I + R L L N+L I N+P ++ R+ N
Sbjct: 91 S-KIHEKAFSPLRKLQ-----KLYISKNHLVEIPP--NLPSSLVELRIHDN 133
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 41/315 (13%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 682
+G GG +V+ VAVK RA L + F E Q + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 683 VSL--VGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
V++ G + + +V E++ TLRD + ++ P+ + + + + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + + HRD+K +NI++ KV DFG++R + + V GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIGTAQY 185
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ--SSMMFSVID 856
L PE + +SDVYSLG V E+LTG P + G + V++AYQ
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDS---PVSVAYQHVREDPIPPSA 241
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 915
+ G ++ + LK + R + +E+ +L + N P K ++
Sbjct: 242 RHEGLSAD--LDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT--DA 294
Query: 916 EHTSKEETPPSSSSM 930
E TS + + S
Sbjct: 295 ERTSLLSSAAGNLSG 309
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G+V++ G AVK+ + + E E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 691 EEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + E + G+L + E L AL G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 749 RDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
D+KA N+LL A + DFG + + + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYPSE 865
K D++S + L +L G P + ++ + + + P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ----------YFRGPLCLKIASEPPPIREIPPS 281
Query: 866 CVEKFIKLALKCCQDETDARPSMSE 890
C + + + E R S E
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAME 306
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 682
+G+GG G VY+ + +VA+K L + F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V + + + +G+ + ++ L L + + PL ++I + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+K NIL+ A + DFG++ + + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTV-GTLYYMAPE 205
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
F T ++D+Y+L V E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-31
Identities = 57/248 (22%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P I + LL L+ N++ +L L+ +Q+ +N+I +F L
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L L L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
+ I ++ +S L L+L C+L+ +P+L+ + L LDLS N L+ +I PG
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 297 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+++ + + +++ I N F L L + +A+N+L+ +P ++ L+ E
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP--LHHLER-- 283
Query: 355 LDFQNNNL 362
+ +N
Sbjct: 284 IHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 35/153 (22%), Positives = 51/153 (33%), Gaps = 49/153 (32%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL+ EI L+ L L+ L L+GN L+ ++
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLI---------------------KLDELDLSGNHLS-AIR 223
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVH 206
SF L + M + I I L SLV
Sbjct: 224 PG-----------------------SFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 207 MLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ L +NNLT LP + + L L + L +N +
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-31
Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P+ I + L L N + + +L L+ +Q+ +N I +F L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L+ L L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK- 182
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
+ I ++ + L L+L C+++ MP+L+ + L L++S N I PG
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRPGSFHG 240
Query: 297 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
++ + + N++++ I N F GL L L +A+N+LS S+P ++ L
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP--LRYLVE-- 294
Query: 355 LDFQNNNL 362
L +N
Sbjct: 295 LHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 49/153 (32%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL ++ L+ L LE L ++GN +
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLV---------------------GLEELEMSGNHFP-EIR 234
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVH 206
SF L+ + + N+ +S I L SLV
Sbjct: 235 PG-----------------------SFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 207 MLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ L +NNL+ LP + + L L+ L L +N +
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ + L+ +P G + N + L N + F L L+ L + NS+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQG-IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 334 SGSIPSSI-WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
I +LN L+ +N LT I SG+F + LR NP
Sbjct: 112 R-QIEVGAFNGLASLN-----TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 71/314 (22%), Positives = 118/314 (37%), Gaps = 53/314 (16%)
Query: 601 SSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-E 658
S +KI + + + +IG+G YG V K + P G ++AVKR +
Sbjct: 4 ESSGKLKISPEQHWD-----FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 659 GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 717
+ +K+ L ++ + R +V G EG+ + E MS + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 718 PLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RL 774
+ I L + + + +L + HRDIK SNILLD K+ DFG+S +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 775 APVPDIEGIVPAHVSTVVK----GTPGYLDPEYFLTHKLTD----KSDVYSLGVVFLELL 826
V ++ K G Y+ PE +SDV+SLG+ EL
Sbjct: 177 -------------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 827 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-------FIKLALKCCQ 879
TG P ++ + V+ G+ + + F+ C
Sbjct: 224 TGRFPYPKWNSVFD---------QLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLT 271
Query: 880 DETDARPSMSEVMR 893
+ RP E+++
Sbjct: 272 KDESKRPKYKELLK 285
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-30
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL- 685
I GG G +Y + +G V +K G + + + E QFL+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 686 -VGYCDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ + Y E++ +L+ + L A ++ L + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ + D+K NI+L + K+ D G + GTPG+ P
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLY-GTPGFQAP 246
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + T +D+Y++G L +
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ +V E +L + + A + G YLH V
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 137
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 189
Query: 808 KLTD-KSDVYSLGVVFLELLTGMQP 831
K + DV+S+G + LL G P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ +V E +L + + A + G YLH V
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 163
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 215
Query: 808 KLTD-KSDVYSLGVVFLELLTGMQP 831
K + DV+S+G + LL G P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVK-----------------RAQEGSLQGEKEFLTEIQFL 674
+ QG + K+ D A+K + +F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS-- 732
+ + + ++ G E ++YE+M N ++ + + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 733 ----RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
Y+H E + + HRD+K SNIL+D K++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--------DKKI 207
Query: 789 STVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 838
GT ++ PE+F + K D++SLG+ + + P S ++
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 690 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 743
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 744 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 800 DPEYFLTHKLTD--------KSDVYSLGVVFLELLTGMQP 831
P+ + L D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 54/341 (15%), Positives = 109/341 (31%), Gaps = 48/341 (14%)
Query: 82 LHLRELQLLNLNLSGNLSPE-IGRLSYLTILD------FMWNKISGSIPKEIGNIKSLEL 134
+ L +L L N S N+ I L+ L + + + + +L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 135 LLLNGNELTGS---LPEELGYLPKLDRIQIDQNYISGSLPKSF----------------- 174
L + + L + + I S+
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 175 --ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLI 230
L + +N LPSL + L N L+ G L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG 288
L L N T+ +++ + +L L ++ +L+ + NL YLD+S
Sbjct: 378 LDLSFNGV--ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 434
Query: 289 SIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
G + ++ +K++ N + F+ L L L ++ L + + +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN-- 491
Query: 346 TLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 384
+ + +L+ +N L ++ G F+ + + L NP+
Sbjct: 492 --SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-28
Identities = 53/280 (18%), Positives = 108/280 (38%), Gaps = 39/280 (13%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L+L+N P + L L L F NK + + ++ SLE L L+ N L+
Sbjct: 306 WQHLELVNCKF--GQFPTLK-LKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLS 360
Query: 144 --GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LS 199
G + L + + N + ++ +F L + H ++++ Q+
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418
Query: 200 RLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
L +L+++ + + + + L L +L++ N+F+ +P ++ + L
Sbjct: 419 SLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT---- 473
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN 316
+LDLS QL + P + ++ + +++N+L
Sbjct: 474 -------------------FLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
F L LQ++++ N S P + SR LN
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 59/344 (17%), Positives = 117/344 (34%), Gaps = 55/344 (15%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
L L L L+GN L+ LS L L + ++ IG++K+L+ L +
Sbjct: 74 SLSHLS--TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 138 NGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF----HMNNNSISG 192
N + LPE L L+ + + N I L++ ++ N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPE------------------------------- 221
I P + L + L NN + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 222 LSELPKLLILQLDNN--NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL 279
L L L I + ++ I ++ ++ + SL + +++ + D S +L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHL 309
Query: 280 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339
+L + + P +L ++ + ++NK LP L+ L ++ N LS
Sbjct: 310 ELVNCKFG-QFPTLKLK-SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLS-FKGC 364
Query: 340 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 382
+ + LD N + +S +F + + +
Sbjct: 365 CSQSDFGTTSLKY--LDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 50/262 (19%), Positives = 90/262 (34%), Gaps = 12/262 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPPGRL 295
+P +SN++ L L L + +Q DL + + LDLS N +N I PG
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 296 S-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 353
+ + + L NN + + GL L+ + + L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN- 256
Query: 354 ILDFQNNNLTNISGSFNIPPNV 375
L + L + + ++
Sbjct: 257 -LTIEEFRLAYLDYYLDDIIDL 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 66/381 (17%), Positives = 119/381 (31%), Gaps = 50/381 (13%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLT 109
+PC N T L+ ++ NL+LS N + L
Sbjct: 1 EPCVEV-----VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQ 55
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
+LD +I ++ L L+L GN + L L ++ + ++
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 170 LPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
+L + ++ +N I S ++P S L +L H+ L +N + +L L ++
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 229 ----LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLS 282
L L L N I +L KL+LRN + + + L L
Sbjct: 176 PLLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 283 SNQLNG-----SIPPGRL----SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNS 332
+ L +L I +L+ I F+ L + + + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 333 LSGSIPSSIWQS--------------RTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
+ S TL L F +N N ++P +
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
Query: 379 LRGNPF-CLNTNAEQFCGSHS 398
L N ++ G+ S
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTS 374
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 48/281 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQF-LSRLHHRNLVSLVGY 688
+G+G YG V K +P G ++AVKR + Q +K L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPV 746
EG+ + E M + +L + + IA+ + + +LH++ V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 747 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDP 801
HRD+K SN+L++ K+ DFG+S L V V K G Y+ P
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-------------VDDVAKDIDAGCKPYMAP 178
Query: 802 EYFLTHKLTD----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
E KSD++SLG+ +EL P + + V++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEE 229
Query: 858 NM-----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ +E V+ F +C + + RP+ E+M+
Sbjct: 230 PSPQLPADKFSAEFVD-FTS---QCLKKNSKERPTYPELMQ 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 45/265 (16%), Positives = 101/265 (38%), Gaps = 23/265 (8%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
S + N LT S+P + R++++ N + F L + +++N +
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 191 SGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-- 246
S + SL ++ L N + + L +L L ++N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSV 121
Query: 247 YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIK 303
+ ++ L+ L + + + + + +L L ++ N + P + N+T +
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 304 LSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
LS +L + F+ L LQ L +++N+ S+ + ++ +LD+ N++
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK----CLNSLQVLDYSLNHI 235
Query: 363 TNISGS--FNIPPN-VTVRLRGNPF 384
+ P + + L N F
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 47/252 (18%), Positives = 93/252 (36%), Gaps = 22/252 (8%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--GSLPKSFANLN 178
S+P I S L L N+L L +L ++ + N +S G +S
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNN 236
++ ++ N + + L L H+ ++NL + L L+ L + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 237 NFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPG 293
+ ++ +S L L + S Q + + NL +LDLS QL + P
Sbjct: 137 HT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 294 RLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 350
+ ++ + +S+N ++ + + L LQ L + N + + Q +
Sbjct: 194 AFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA 251
Query: 351 ETFILDFQNNNL 362
L+ N+
Sbjct: 252 F---LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 41/236 (17%), Positives = 90/236 (38%), Gaps = 13/236 (5%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNY 165
T L+ NK+ + L L L+ N L+ G + L + + N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE-L 222
+ ++ +F L + H ++++ Q+ L +L+++ + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDL 281
+ L L +L++ N+F+ +P ++ + L L L C L+ P + + +L L++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206
Query: 282 SSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPR-LQRLFIANNSLS 334
S N S+ ++ + S N + + P L L + N +
Sbjct: 207 SHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 44/259 (16%), Positives = 90/259 (34%), Gaps = 26/259 (10%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKIS- 119
C T + L + L L N L + +L+ LT L N +S
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 120 -GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANL 177
G + SL+ L L+ N + ++ L +L+ + + + S F +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDN 235
+ +++ + L SL + + N+ P+ +EL L L L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 236 NNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 293
+ +++++S L L++ + + + +L LD S N + +
Sbjct: 185 CQL--EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 294 ---RLSLNITTIKLSNNKL 309
++ + L+ N
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 20/112 (17%), Positives = 41/112 (36%), Gaps = 4/112 (3%)
Query: 83 HLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
L L++ + N P+I L LT LD ++ + ++ SL++L ++ N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT-RHFHMNNNSIS 191
L L + N+I S + + + ++ N +
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 29/239 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLV--- 686
+G GG+G V + I G VA+K+ ++ +E EIQ + +L+H N+VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 687 ---GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLH 739
+L E+ G LR L+ G L + S + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS--ALRYLH 138
Query: 740 TEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K NI+L + K+ D G ++ + + T GT
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCTEFVGTL 187
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
YL PE K T D +S G + E +TG +P V+ + S V+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 41/277 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY 688
+G G G+V+K G V+AVK+ + G+ + K L ++ + + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ + E M GT ++L + + P+ + + + + + YL + V H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 749 RDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDPEY 803
RD+K SNILLD + K+ DFG+S RL V K G Y+ PE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-------------VDDKAKDRSAGCAAYMAPER 195
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
T ++DV+SLG+ +EL TG P + K ++ V+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------VLTKVLQEE 246
Query: 859 MGSYPSECV--EKFIKLALKCCQDETDARPSMSEVMR 893
P F C + RP ++++
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 39/296 (13%)
Query: 82 LHLRELQLLNL--NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L + N + + + N+ + + I L LN
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNR 68
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
L+ SLP+ L P++ ++I QN + SLP+ A+L + +N +S +P
Sbjct: 69 LNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELP- 119
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
SL H+ +DNN LT LP + L + DNN T +P + L LS+R
Sbjct: 120 --ASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQL--TMLPEL---PTSLEVLSVR 168
Query: 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-----RLSLNITTIKLSNNKLTGTIP 314
N L +P+L +L LD+S+N L S+P + N++T IP
Sbjct: 169 NNQLTF-LPEL--PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223
Query: 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
N L + + +N LS I S+ Q T + G N
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQ-----TAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 71/321 (22%), Positives = 114/321 (35%), Gaps = 50/321 (15%)
Query: 38 SALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL-HLRELQLLNLNLSG 96
S +I + D +S W + N + + + + + ELQL LNLS
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAV---SLLKECLINQFSELQLNRLNLS- 72
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
+L + +T+L+ N + S+P+ + LE L N L+ +LPE L L
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
D +D N ++ LP+ A L + + +NN ++ +P + L L + NN LT
Sbjct: 126 D---VDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT- 173
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
+LP L L + N ++PA +
Sbjct: 174 FLPELPE---SLEALDVSTNLL--ESLPAVPVRNHHSEET-------------------E 209
Query: 277 GYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335
+ N++ IP LSL TI L +N L+ I + S S
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 336 SIPSSIWQSRTLNATETFILD 356
S R L T
Sbjct: 269 SDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 30/278 (10%)
Query: 75 TTMDDGYLHLREL-----QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKE 125
+D L L L +L++ N L L ++ N+++ +P+
Sbjct: 103 EYLDACDNRLSTLPELPASLKHLDVDNNQLTMLPELPALL---EYINADNNQLT-MLPEL 158
Query: 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR---- 181
+ LE+L + N+LT LPE L LD + N + SLP + +
Sbjct: 159 PTS---LEVLSVRNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEI 210
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
F N I+ IP + L ++L++N L+ + LS+ F +
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--S 267
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITT 301
+ + + L ++ + D+S+I + + +N + + +++
Sbjct: 268 MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARN 327
Query: 302 IKLSNNKLTGTIPSNFSGLPRL-QRLFIANNSLSGSIP 338
++ S L Q+ F + S
Sbjct: 328 TSGFREQVA-AWLEKLSASAELRQQSFAVAADATESCE 364
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG G V P VA+KR E E L EIQ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS---IAL---GSSRGILYLHTEAD 743
+ E LV + +S G++ D + + + L IA G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+KA NILL + ++ADFG+S LA DI T V GTP ++ PE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK--TFV-GTPCWMAPE 196
Query: 803 YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 834
+ D K+D++S G+ +EL TG P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY ++A+K +AQ E + E++ S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
Y + L+ E+ GT+ +L SK E +A + Y H++
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRDIK N+LL K+ADFG S A P+ T + GT YL PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEMIE 180
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+K D++SLGV+ E L G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 690 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 743
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 744 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 800 DPEYF--------LTHKLTDKSDVYSLGVVFLELLTGMQP 831
P+ + K D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 40/284 (14%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRL-HH 679
+F +G G G + + D VAVKR E + E+Q L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 680 RNLVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
N++ +C E+ Q + E + TL++ + K LG ++ ++ G+ +
Sbjct: 78 PNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 738 LHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
LH+ + HRD+K NIL+ A ++DFGL + G + V
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA----VGRHSFSRRSGV 186
Query: 793 KGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
GT G++ PE T D++S G VF +++ GK++ R+ NI +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGAC 245
Query: 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + + + I+ K + RPS V++
Sbjct: 246 SLDCLHPEK---HEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-28
Identities = 60/320 (18%), Positives = 111/320 (34%), Gaps = 30/320 (9%)
Query: 632 IGQG--GYGKVYKGI-LPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G V P G V V+R + S + E+ +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ E +V FM+ G+ +D + + + I G + + Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 747 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HR +KAS+IL+ ++ + + + +V V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 806 THKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS-MMFSVIDGNM--- 859
+ KSD+YS+G+ EL G P ++ M+ ++G +
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD-----------MPATQMLLEKLNGTVPCL 257
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
+ E+ + + + + R P T +P F +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 920 KEETP---PSSSSMLKHPYV 936
+ P PS+S++L H +
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G + VY+ + G VA+K + + E++ +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADP 744
Y ++ LV E NG + L + K E I G+LYLH+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG-- 132
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRD+ SN+LL K+ADFGL+ +P + GTP Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-------EKHYTLCGTPNYISPE-I 183
Query: 805 LTHKLTD-KSDVYSLGVVFLELLTGMQP 831
T +SDV+SLG +F LL G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-27
Identities = 62/336 (18%), Positives = 108/336 (32%), Gaps = 38/336 (11%)
Query: 88 QLLNLNLSGNLSPEIGR-------LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
++ + + + S + LD + + +K L++L L N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
++ E L L + + N + +F L K + + N I+
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 201 LPSLVHMLLDNNNLT--GYLPP---------ELSELPKLLI----LQLDNNNFEGTTIPA 245
L L + L +N LT ++P +L LPK+ + + L N E I
Sbjct: 361 LEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILY 420
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNG----SIPPGRLSL-- 297
+ L L L D S P+L L L N L +
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
++ + L++N L P FS L L+ L + +N L+ + + + ILD
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLE------ILDI 533
Query: 358 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 393
N L + + + N F F
Sbjct: 534 SRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-26
Identities = 46/301 (15%), Positives = 105/301 (34%), Gaps = 36/301 (11%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
I + + ++ +P+ + + E LLL+ N + +L +L +++ Y +
Sbjct: 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 170 L-PKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSEL 225
+ ++F NL R + ++ I + P+ L L + L L+ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLS--RIPNLGYLDLS 282
L L L N + S+ ++ L + + + +L + L + L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 283 SNQLNGSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFS------------GLPRL 323
+N L + + + + +S N T I NFS +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRG 381
+++ + + ++ LD + + ++ S F ++ V L
Sbjct: 243 MGAGFGFHNIK-DPDQNTFAGLARSSVRH--LDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 382 N 382
N
Sbjct: 300 N 300
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 67/335 (20%), Positives = 113/335 (33%), Gaps = 36/335 (10%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L+ L+L + + E L L ILD +KI P + L L L
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 139 GNELTGSL--PEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIP 195
L+ ++ L L R+ + +N I L SF LN + ++N I
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 196 PELSRL--PSLVHMLLDNNNLTGYLPPELSELPKLL------ILQLDNNNFEGTTIPASY 247
EL L +L L N+L + + + IL + N +
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 248 SNMSKLLKLSLRN----CSLQGPMPDLSRIP----------NLGYLDLSSNQLNGSIPPG 293
+ +SK SL ++ ++ +LDLS + S+
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSR 284
Query: 294 RLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351
++ + L+ NK+ F GL LQ L ++ N L S+ + +
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA--- 341
Query: 352 TFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 384
+D Q N++ I +F + LR N
Sbjct: 342 --YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-24
Identities = 46/258 (17%), Positives = 93/258 (36%), Gaps = 28/258 (10%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+ LT +P+ L +R+ + NYI SF L + + + +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 191 SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY- 247
I E LP+L + L ++ + +L P+ L L L+L + Y
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 248 SNMSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITT 301
N+ L +L L ++ P ++ +L +D SSNQ+ + L ++
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSF 178
Query: 302 IKLSNNKLTGTIPSNFSGLP------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFI- 354
L+ N L + ++ L+ L ++ N + I + + + + + I
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 355 ------LDFQNNNLTNIS 366
F +N+ +
Sbjct: 239 AHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 72/291 (24%), Positives = 111/291 (38%), Gaps = 30/291 (10%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
L LQ+LNL S NL E+ L + +D N I+ + ++ L+ L L
Sbjct: 312 GLDNLQVLNL--SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPP 196
N LT + ++P + I + N + +LPK N H++ N + I
Sbjct: 370 RDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN---LIHLSENRLENLDILY 420
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTI----PASYSNM 250
L R+P L ++L+ N + + SE P L L L N + + +
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 251 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 309
S L L L + L P S + L L L+SN+L + L N+ + +S N+L
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQL 538
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
P F L L I +N S LN T I +
Sbjct: 539 LAPNPDVF---VSLSVLDITHNKFICECELS-TFINWLNHTNVTIAGPPAD 585
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
IG+G +G+V+KGI VVA+K + E E + EI LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + ++ E++ G+ D L PL +I +G+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIKA+N+LL K+ADFG++ + D + +T V GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQ----IKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 810 TDKSDVYSLGVVFLELLTGMQPISH 834
K+D++SLG+ +EL G P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE 221
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 29/267 (10%)
Query: 89 LLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
+ +L+LS N +S R L L N I+ +I ++ ++ SLE L L+ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 143 TGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-L 198
+ +L L L + + N +L ++ F++L K + + N +I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLS 257
+ L L + +D ++L Y P L + + L L + S + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH--ILLLEIFVDVTSSVECLE 228
Query: 258 LRNCSLQ---------GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNN 307
LR+ L G L + + ++ L + + + ++ S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 308 KLTGTIPSN-FSGLPRLQRLFIANNSL 333
+L ++P F L LQ++++ N
Sbjct: 288 QLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 56/280 (20%), Positives = 109/280 (38%), Gaps = 27/280 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
SIP + ++++ L L+ N +T +L L + + N I+ SF++L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNN 237
H ++ N +S + L SL + L N L S L KL IL++ N +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
++ ++ L +L + LQ L I N+ +L L Q + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 297 L--NITTIKLSNNKLTGT----IPS----NFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346
+ ++ ++L + L + + + + + I + SL + + Q
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 347 LNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
L L+F N L ++ G F+ ++ + L NP+
Sbjct: 279 LL-----ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 23/143 (16%), Positives = 46/143 (32%), Gaps = 15/143 (10%)
Query: 84 LRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L EL++ +L + P+ + ++ L + + + S+E L L +
Sbjct: 176 LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233
Query: 142 LTG----SLPE----ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
L L L ++I + + K ++ + N +
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS- 291
Query: 194 IPPE-LSRLPSLVHMLLDNNNLT 215
+P RL SL + L N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
G SS LN SIP G L+ + ++ LSNN++T S+ LQ L + +N +
Sbjct: 31 DRNGICKGSSGSLN-SIPSG-LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 334 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
+ +I + S +L LD N L+N+ S F ++T L GNP+
Sbjct: 89 N-TIEEDSFSSLGSLE-----HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY + ++A+K ++Q E + EI+ S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
Y + L+ EF G L +L + + L + Y H V
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD--ALHYCHERK---VI 136
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDPEYF 804
HRDIK N+L+ +K K+ADFG S AP S + GT YL PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP------------SLRRRTMCGTLDYLPPEMI 184
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+K D++ GV+ E L GM P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 14/220 (6%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++P I + + + L+GN ++ L + + N ++ +F L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+++N+ + P L L + LD L L P L L L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS 296
+P ++ ++ L L L + + +L L L N++ + P
Sbjct: 142 --QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 297 --LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 333
+ T+ L N L+ +P+ + L LQ L + +N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +GKVYK G + A K + S + ++++ EI+ L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+G+ ++ EF G + + + L + + +LH++ + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTPGYLDPEY 803
+KA N+L+ + ++ADFG+S A + + GTP ++ PE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-------------AKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 834
+ + D K+D++SLG+ +E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 54/287 (18%), Positives = 104/287 (36%), Gaps = 32/287 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + +L+ LT LD + I+ + I + L L+ N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+L L L + D N ++ +L L K + + + N ++ ++ +S+ P
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L ++ N LT ++S +L L N + ++L L +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKI 182
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
D+S+ L L+ +N + + + +T + S+NKLT I + L +L
Sbjct: 183 TE--LDVSQNKLLNRLNCDTNNIT-KLDLNQNI-QLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
+ N L+ + S T L +L I + N
Sbjct: 236 TYFDCSVNPLT-ELDVSTLSKLT-------TLHCIQTDLLEIDLTHN 274
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 54/304 (17%), Positives = 106/304 (34%), Gaps = 33/304 (10%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L LN + N ++ + LT LD NK + + L L + N++T
Sbjct: 128 LLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + L+R+ D N I+ L + ++N ++ +I ++ L L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ N LT L +S L KL L + I + + ++L+ C +
Sbjct: 237 YFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL--LEIDLT--HNTQLIYFQAEGCR-KI 288
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
D++ L LD + + + + + + L+N +LT + S +L+
Sbjct: 289 KELDVTHNTQLYLLDCQAAGIT-ELDLSQNP-KLVYLYLNNTELT-ELD--VSHNTKLKS 343
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385
L N + S + + LN + ++T+ + +
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALN-----NNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396
Query: 386 LNTN 389
N
Sbjct: 397 QFGN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 52/287 (18%), Positives = 105/287 (36%), Gaps = 27/287 (9%)
Query: 88 QLLNLNLSGN---LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
QL L+ N ++ + LT LD +NKI+ + + K L L + N +T
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT- 204
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L +L + N ++ + L + +F + N ++ ++ +S L L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKL 256
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ +L + L+ +L+ Q + ++ ++L L + +
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK---IKELDVTHNTQLYLLDCQAAGIT 310
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
DLS+ P L YL L++ +L + + + ++ N + S +P L
Sbjct: 311 --ELDLSQNPKLVYLYLNNTELT-ELDVSHNT-KLKSLSCVNAHIQ-DFSS-VGKIPALN 364
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 371
F A ++ + A +LD N + G +
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 52/304 (17%), Positives = 102/304 (33%), Gaps = 51/304 (16%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L L + N + ++ + + LT L NK++ ++ + + L L + N+LT
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-K 120
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + P L + +N ++ + ++ + + N +++ L
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLT 173
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ N +T ++S+ L L D NN T + + +L L + L
Sbjct: 174 TLDCSFNKITEL---DVSQNKLLNRLNCDTNNI--TKLDLN--QNIQLTFLDCSSNKLT- 225
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT--------------- 310
D++ + L Y D S N L + LS +TT+ L
Sbjct: 226 -EIDVTPLTQLTYFDCSVNPLT-ELDVSTLS-KLTTLHCIQTDLLEIDLTHNTQLIYFQA 282
Query: 311 ----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
+ + +L L ++ + S + L N LT +
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS-------QNPKLVYLYLNNTELTELD 334
Query: 367 GSFN 370
S N
Sbjct: 335 VSHN 338
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 52/297 (17%), Positives = 101/297 (34%), Gaps = 34/297 (11%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
+L LN N ++ + LT L+ N ++ I + + L L + N+
Sbjct: 107 KLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + +L + N I+ L + + + N+I+ +L++ L
Sbjct: 164 LD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLT 215
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ +N LT +++ L +L N T + S +SKL L L
Sbjct: 216 FLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL--TELDVS--TLSKLTTLHCIQTDLLE 268
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
DL+ L Y + + + + + +T + S P+L
Sbjct: 269 I--DLTHNTQLIYFQAEGCRKIKELDVTHNT-QLYLLDCQAAGIT-ELD--LSQNPKLVY 322
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
L++ N L+ + S + T+ L N ++ + S IP
Sbjct: 323 LYLNNTELT-ELDVS-------HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 28/169 (16%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
LH + LL ++L+ N L Y KI ++ + L LL
Sbjct: 258 TLHCIQTDLLEIDLTHNTQ-----LIYFQAEG--CRKIK---ELDVTHNTQLYLLDCQAA 307
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+T L L PKL + ++ ++ L ++ K + N I + +
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGK 359
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
+P+L + L+ + + D + G + +
Sbjct: 360 IPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+ +IGQG G VY + + G VA+++ ++ + EI + + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ E +V E+++ G+L D ++ + A ++ + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ-- 136
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDP 801
V HRDIK+ NILL + K+ DFG + S T+V GTP ++ P
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITPEQSKRSTMV-GTPYWMAP 185
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E K D++SLG++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 29/300 (9%), Positives = 59/300 (19%), Gaps = 55/300 (18%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+ G V+ + A+K E S + +RL +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 688 YC--------------------------DEEGEQMLVYEFMSNGTLRDQLSA-----KSK 716
+L+ S L S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
G + R L ++ + H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISH 834
Y E+ T + + LG+ + P
Sbjct: 243 -------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 835 GKNIVRE-VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
++ + + + V+ I + + R E M
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVS----- 684
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 685 LVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTP 796
V HRDIK N+LL K+ DFG+S A + T + GTP
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVS-------------AQLDRTVGRRNTFI-GTP 193
Query: 797 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 834
++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 49/302 (16%), Positives = 105/302 (34%), Gaps = 25/302 (8%)
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSG---------NLSPEIGRLS--YLTILDFMWNKIS 119
+ L L E++ + L+G ++ E+G++ + L +
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 120 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS---FAN 176
+ ++ ++ + + +++ +L L+ + + +N + K+
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 177 LNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+ ++ N + + L L +L + + N +P K+ L L
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
+ + L L + N +L L P L L +S N+L ++P
Sbjct: 419 STGI--RVVKTCI--PQTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TLPDAS 470
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
L + +K+S N+L F L LQ++++ N S P + SR LN
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE 530
Query: 355 LD 356
Sbjct: 531 QG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 40/310 (12%), Positives = 101/310 (32%), Gaps = 19/310 (6%)
Query: 83 HLRELQLLNLNLSGNLSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
+L+ L++ N+ + L+ L L+ + + + +I+ + L L+ +E
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L L + +++ ++ + S + L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+ +L+ + + E + + + + + + ++ + +L +
Sbjct: 244 LKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVT-IRRLHIPQF 296
Query: 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSN-- 316
L + S + + + + ++++ +P ++ + LS N + N
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 317 -FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 375
P LQ L ++ N L S+ + TL + LD N + S P +
Sbjct: 356 CKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS--LDISRNTFHPMPDSCQWPEKM 412
Query: 376 TV-RLRGNPF 384
L
Sbjct: 413 RFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-23
Identities = 52/340 (15%), Positives = 117/340 (34%), Gaps = 45/340 (13%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L EL++ L+L S + + + L ++ + + + S+ L L L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 143 TGSLPEELGYLPKLDRIQIDQNYIS-------GSLPKSFANLNKTRHFHMNNNSISG--- 192
L ++ S L K + + ++ +++G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 193 ------QIPPELSRL--PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ EL ++ ++ + + L L S L K+ + ++N+ +P
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV--FLVP 326
Query: 245 ASY-SNMSKLLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-- 297
S+ ++ L L L + P+L L LS N L S+ L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT 385
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFI 354
N+T++ +S N +P + +++ L +++ + + + I Q+ L+ + +
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNL 443
Query: 355 ------------LDFQNNNLTNISGSFNIPPNVTVRLRGN 382
L N L + + P + +++ N
Sbjct: 444 DSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-20
Identities = 39/300 (13%), Positives = 100/300 (33%), Gaps = 22/300 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + LD +NKI+ ++ +L++L+L + + + L L+ + + N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE-L 222
++S F L+ ++ ++ N + L +L + + N +
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 223 SELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLD 280
+ L L L++ + + ++ + L+L + + ++ YL+
Sbjct: 145 AGLTSLNELEIKALSL--RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 281 LSSNQLN----GSIPPGRLSLNITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNS 332
L L +P +S + + + LT + + L + + +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 333 LSG------SIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
L+G S + + + L L S +++ V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
G D S SIP G L+ + ++ LS NK+T + LQ L + ++ +
Sbjct: 5 DASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 384
+ + + +L LD +N+L+++S F ++ L GNP+
Sbjct: 63 NTIEGDAFYSLGSLE-----HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+S +IG+G G V G VAVK Q + E+ + H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRG 734
+ E ++ EF+ G L D Q++ + L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------------QA 153
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLH + V HRDIK+ +ILL K++DFG A + ++V G
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDV----PKRKSLV-G 203
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE + D++SLG++ +E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G G + +V+ G + A+K ++ + EI L ++ H N+V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ LV + +S G L D++ + E + + + YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----SAVKYLHENG---IV 128
Query: 748 HRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K N+L + DFGLS++ +ST GTPGY+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTAC-GTPGYVAPEVL 179
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D +S+GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 680
F+ ++G+G YG VYK I G +VA+K+ ++ + +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
++V G + + +V E+ G++ D + ++K L +I + +G+ YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF 143
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
HRDIKA NILL+ + AK+ADFG++ + D A +TV+ GTP ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTM----AKRNTVI-GTPFWMA 193
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
PE +D++SLG+ +E+ G P +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 599 RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ 657
H +S G + + M + + +G+G YG V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 658 EGSLQGEKEF-----LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 712
E + + + EI+ L +L H NLV+L+ C ++ LV+EF+ + T+ D L
Sbjct: 60 ESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 713 AKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770
P G ++ GI + H+ + HRDIK NIL+ K+ DFG
Sbjct: 116 LF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGM 829
+R P + V T Y PE + K+ DV+++G + E+ G
Sbjct: 170 FARTLAAP-----GEVYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 830 QPISHGKN 837
+P+ G +
Sbjct: 222 EPLFPGDS 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 677
+ +IG+G YG V+K +VA+KR + L + E L EI L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGI 735
H+N+V L + + LV+EF D + L + S +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H+ V HRD+K N+L++ K+A+FGL+R +P V + + VV T
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVV--T 164
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ KL S D++S G +F EL +P+ G +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-26
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 55/352 (15%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNL 682
N S +G G G V G VAVKR + L EI+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 683 VSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGI 735
+ YC E ++ + E N L+D + +K+ ++ +S+ + G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 736 LYLHTEADPPVFHRDIKASNILLDHK-------------FTAKVADFGLSRLAPVPDIEG 782
+LH+ + HRD+K NIL+ ++DFGL + + +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQS 183
Query: 783 IVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHG 835
+++ GT G+ PE +LT D++S+G VF +L+ +
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR-E 894
K RE NI + + I + + RP+ +V+R
Sbjct: 243 KYS-RESNI-IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRHP 297
Query: 895 LESIWNMMPESDTKTPEFIN--SEHTSKEETPPSSSSMLKHPYVSSDVSGSN 944
L W +K EF+ S+ E P S+ ++K S V S
Sbjct: 298 L--FWP-----KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLHHRNLVSL 685
++G G Y VYKG+ G VA+K + L E+ + EI + L H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 686 VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E + LV+EFM N + + + L + +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L++ + K+ DFGL+R +P V S VV T Y P+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEVV--TLWYRAPD 178
Query: 803 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
+ + S D++S G + E++TG +P+ G N
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 63/250 (25%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 646
H ++H+ R + ++ F + + + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQA-TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 647 DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704
A+K ++ S+ L E+ L L H N++ L + +++ LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--- 761
G L D++ + K A + + S G+ YLH + HRD+K N+LL+ K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLS--GVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
K+ DFGLS + GT Y+ PE L K +K DV+S+GV+
Sbjct: 176 ALIKIVDFGLSAV--------FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 822 FLELLTGMQP 831
LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +G V++ + G V K + EI +++LHH L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPV 746
++ E +L+ EF+S G L D+++A+ + M + + R G+ ++H + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 747 FHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
H DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIV 222
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 54/249 (21%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
IGQG YG V I + A+K + ++ + + + TE++ + +LHH N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----------- 733
L ++E LV E G L D+L+ + G +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 734 ---------------------------GILYLHTEADPPVFHRDIKASNILLDHKFTA-- 764
+ YLH + + HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVF 822
K+ DFGLS+ + ++T GTP ++ PE K D +S GV+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYG--MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 823 LELLTGMQP 831
LL G P
Sbjct: 267 HLLLMGAVP 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
+ ++G+G YG VYK G +VA+KR + L E E + EI L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+VSL+ E LV+EFM D ++ ++K L + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ H + HRD+K N+L++ K+ADFGL+R +P V ++ VV T
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVV--TL 183
Query: 797 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ + K S D++S+G +F E++TG +P+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 56/339 (16%), Positives = 108/339 (31%), Gaps = 45/339 (13%)
Query: 83 HLRELQLLNL--NLSGNLSPEI-GRLSYLTILDFMWNKI-SGSIPKEI-GNIKSLELLLL 137
L L +L L N L L+ L +L + + + SLE+L+L
Sbjct: 77 GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 138 NGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTR----------HFHMN 186
N + P + + + + N + + N MN
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ-LDNNNFEGTTIPA 245
+ + + S+ + L N + + +Q L +N
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 246 SYSN-------------MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIP 291
++N S + L + S +L L L+ N++N I
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 292 PG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
L+ ++ + LS N L +I S F L +L+ L ++ N + ++ +
Sbjct: 316 DNAFWGLT-HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL---- 368
Query: 348 NATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNPF 384
L N L ++ G F+ ++ + L NP+
Sbjct: 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 46/241 (19%), Positives = 88/241 (36%), Gaps = 20/241 (8%)
Query: 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNN 212
++ + + N I+ SF+ L + + + I L SL+ + LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 213 NLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQ--GPMP 268
L + L L +L L N +G + ++ ++ L L LR+ +++ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLT--------GTIPSN 316
+ LDL+ N++ SI L + T ++LS+ L N
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNV 375
+ L ++ N S+ + + ++ IL N ++ +F P N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 376 T 376
T
Sbjct: 268 T 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 43/312 (13%), Positives = 93/312 (29%), Gaps = 43/312 (13%)
Query: 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQN 164
+++ +D N I+ ++ L+ L + + L L +++D N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSI-SGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE- 221
+F L + ++ + L SL ++L +NN+ + P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148
Query: 222 -LSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQ-----------GPMP 268
+ + +L L N +I N LR S+
Sbjct: 149 FFLNMRRFHVLDLTFNKV--KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--------------NITTIKLSNNKLTGTIP 314
+ + ++ LDLS N S+ +
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 315 SNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNI 371
F GL ++ ++ + + ++ S++ + T+ L N + I +F
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIF-ALLKSVFS----HFTDLEQLTLAQNEINKIDDNAFWG 321
Query: 372 PPNVTV-RLRGN 382
++ L N
Sbjct: 322 LTHLLKLNLSQN 333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 35/201 (17%), Positives = 73/201 (36%), Gaps = 19/201 (9%)
Query: 198 LSRLPSL----VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
L ++P L ++ L N++ S L L L+++ ++ +S L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 254 LKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGS-IPPG---RLSLNITTIKLSNNK 308
+ L L + + NL L L+ L+G+ + L+ ++ + L +N
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNN 140
Query: 309 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
+ P++ F + R L + N + SI + +L + L +++
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN--FQGKHFTLLRLSSITLQDMN- 196
Query: 368 SFNIPPNVTVRLRGNPFCLNT 388
+ GNPF +
Sbjct: 197 ----EYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 8/92 (8%)
Query: 280 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339
+ L+ +P L ++ + LS N + ++FS L LQ L + + I +
Sbjct: 16 ICINRGLH-QVPE--LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 340 SIWQSRTLNATETFILDFQNNNLTNI-SGSFN 370
+ ++ + IL N + +G+FN
Sbjct: 73 NTFR----GLSSLIILKLDYNQFLQLETGAFN 100
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G+G +G+V G AVK + Q ++ L E+Q L +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ +++G LV E + G L D++ ++ + A R+ + S GI Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS--GITYMHKNK---I 147
Query: 747 FHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+K N+LL+ K ++ DFGLS + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--------FEASKKMKDKIGTAYYIAPE- 198
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L +K DV+S GV+ LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G +G VY + + VVA+K+ + + S + ++ + E++FL +L H N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
E LV E+ G+ D L K PL ++ G+ +G+ YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDPEYF 804
HRD+KA NILL K+ DFG + + ++ + V GTP ++ PE
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPANSFV-GTPYWMAPEVI 222
Query: 805 LTHKLTD---KSDVYSLGVVFLELLTGMQPISH 834
L K DV+SLG+ +EL P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
++ +IG+G YG VYK G A+K+ + L+ E E + EI L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+V L + +LV+E + D +L + L S L GI
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y H V HRD+K N+L++ + K+ADFGL+R +P V + +V T
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEIV--TL 164
Query: 797 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ + K + D++S+G +F E++ G P+ G +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSRL 677
+ + +IGQG +G+V+K G VA+K+ ++ EKE F L EI+ L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 678 HHRNLVSLVGYCDEEGEQM--------LVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSI 727
H N+V+L+ C + LV++F + D L + + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRV 129
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
G+ Y+H + HRD+KA+N+L+ K+ADFGL+R + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRY 185
Query: 788 VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846
+ VV T Y PE L D++ G + E+ T PI G E +
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT---EQH--- 236
Query: 847 QSSMMFSVIDGNMGSYPSE 865
Q +++ + GS +
Sbjct: 237 QLALISQL----CGS-ITP 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLSRL 677
+ +IG+G YG V+K G +VA+K+ E + L EI+ L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGI 735
H NLV+L+ + LV+E+ + T+ +L G L SI + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQAV 115
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H HRD+K NIL+ K+ DFG +RL P + V T
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----SDYYDDEVA--T 165
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y PE + DV+++G VF ELL+G P+ GK+
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 810 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRLHHRNLVSLV 686
+G+G YGKV + + AVK ++ L+ EIQ L RL H+N++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 687 GYCDEEGEQM--LVYEFMSNGT--LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E +Q +V E+ G + D + K + P+ A L G+ YLH++
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLID--GLEYLHSQG 129
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ H+DIK N+LL T K++ G++ + S G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQ---GSPAFQPPE 181
Query: 803 YFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVR 840
K D++S GV + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 44/305 (14%), Positives = 93/305 (30%), Gaps = 46/305 (15%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEI 671
E L + +G+G + +VY+ + +K + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-----PLGFAMRLS 726
+ L + + +LV E S GTL + ++ P G + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA-----------KVADFGLSRLA 775
+ + I +H + H DIK N +L + F + D G S
Sbjct: 179 MRM--LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-- 231
Query: 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835
D++ + T T G+ E + D + + +L G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---- 284
Query: 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 895
V+ + +F + +F + L + PS+ + ++L
Sbjct: 285 --KVKNEGGECKPEGLFR------RLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKL 334
Query: 896 ESIWN 900
+ ++
Sbjct: 335 KKVFQ 339
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ + +G G +G+V+K G +A K + ++ ++E EI +++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGIL 736
L + + + +LV E++ G L D++ +S + + F M+ GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-MKQICE-------GIR 201
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
++H + H D+K NIL ++ K+ DFGL+R P V G
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--------YKPREKLKVNFG 250
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP +L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G+G +G V++ + K + + + EI L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTEA 742
+ E ++++EF+S + ++++ F + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 743 DPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H DI+ NI+ + ++ K+ +FG +R + P ++ P Y
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------LKPGDNFRLLFTAPEYYA 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE ++ +D++SLG + LL+G+ P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK-------------RAQEGSLQGEKEFLTEIQFLSR 676
++G G YG+V + A+K + + +E EI L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
L H N++ L +++ LV EF G L +Q+ + K A + + S GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--GIC 160
Query: 737 YLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
YLH + HRDIK NILL++K K+ DFGLS +
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--------FSKDYKLRDRL 209
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GT Y+ PE L K +K DV+S GV+ LL G P
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+G+G + VYK +VA+K+ + G K+ L EI+ L L H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
L+ + LV++FM D + + L + + L + +G+ YLH
Sbjct: 77 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K +N+LLD K+ADFGL++ P A+ VV T Y PE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVV--TRWYRAPE 182
Query: 803 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
++ D++++G + ELL P G +
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
++G G +G V+ G +K + Q E EI+ L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 744
++ +V E G L +++ + L + + + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN--ALAYFHSQH-- 144
Query: 745 PVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V H+D+K NIL K+ DFGL+ L ST GT Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--------FKSDEHSTNAAGTALYMAP 195
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E +T K D++S GVV LLTG P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG+G +G+V + A K+ + ++ F EI+ + L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + LV E + G L +++ K A R+ + S + Y H V HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS--AVAYCHKLN---VAHR 130
Query: 750 DIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
D+K N L K+ DFGL+ P + GTP Y+ P+ L
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--------FKPGKMMRTKVGTPYYVSPQ-VLE 181
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
+ D +S GV+ LL G P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +G V++ G A K ++ EIQ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGILYLHTEAD 743
++ E +++YEFMS G L ++++ + E + + MR G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHENN- 275
Query: 744 PPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
H D+K NI+ K + K+ DFGL+ + P V GT + P
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAAP 325
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + +D++S+GV+ LL+G+ P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 58/220 (26%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---------RAQEGSLQGEKEFLTEIQFLSRL-HH 679
+G+G V + I P AVK + E + + L E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILY 737
N++ L + LV++ M G L D L+ K E + ++ I
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICA 139
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
LH + HRD+K NILLD K+ DFG S + P V GTP
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVCGTPS 188
Query: 798 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D++S GV+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 810 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 32/240 (13%), Positives = 63/240 (26%), Gaps = 49/240 (20%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL---------- 677
+GQ + G V + K+ E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 678 ------------HHRNLVSLVGYCDEEGEQMLVYEF-------MSNGTLRDQLSAKSK-- 716
++ +E + ++ F + T + L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ L RL + L R + LH + H ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVFLELLTGMQP 831
+G P + +T D ++LG+ + P
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
++ +V E + G L D++ + + A R+ + S GI Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKHN---IV 143
Query: 748 HRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE-V 194
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
L +K DV+S GV+ LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
++ +V E + G L D++ + + E + + GI Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN--- 141
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE 193
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L +K DV+S GV+ LL+G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLV 683
++G G + V K G A K R S +G +E E+ L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILY 737
+L + + + +L+ E +S G L D L+ K E F ++ L G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
LH++ + H D+K NI+L K K+ DFG++ I + +
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------IEAGNEFKNIF 172
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/267 (20%), Positives = 91/267 (34%), Gaps = 34/267 (12%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
++ L L L + P L +L I L+ L L E+T
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVL----------------GISGLQELTLENLEVT 108
Query: 144 GSLPEELG--YLPKLDRIQIDQNYISG---SLPKSFANLNKT-RHFHMNNNSISGQIPPE 197
G+ P L P L+ + + + L + L + + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELS----ELPKLLILQLDNNNFE--GTTIPASYSNMS 251
+ P+L + L +N G + + P L +L L N E A +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 252 KLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 309
+L L L + SL+ P L L+LS L +P G L ++ + LS N+L
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG-LPAKLSVLDLSYNRL 286
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGS 336
PS LP++ L + N S
Sbjct: 287 D-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 42/279 (15%)
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
EL G L ++D + + + I +I R
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTD------IIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 201 L---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
+ L + L+N +TG PP L E + L+ N T A + + + LK
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 258 LRNCSLQG------PMPDLSRIPNLGYLDLSSNQLNG------SIPPGRLSLNITTIKLS 305
L+ S+ + P L LDLS N G ++ P + + + L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALR 209
Query: 306 NNKLT---GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLNATETFI---- 354
N + G + + +LQ L +++NSL + + +LN + T +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 355 ---------LDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
LD N L +P + L+GNPF
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 685
IG+G + V + I G AVK S E E L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTE 741
+ +G +V+EFM L ++ ++ ++ ++ R IL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--MRQILEALRYCHDN 149
Query: 742 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K +LL K K+ FG++ + V GTP +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV------AGGRV-GTPHF 199
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE DV+ GV+ LL+G P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 38/282 (13%), Positives = 72/282 (25%), Gaps = 74/282 (26%)
Query: 598 RRHSSKTSIKIDGVRSFTY--GEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK 654
G R T G + +GQ + G V
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVH 104
Query: 655 ------RAQEGSLQGEKE----------------------FLTEIQFLSRLHHRNLVSLV 686
R +++ KE F+ + + ++ +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 687 GYCDEEGEQMLVYEFM----SNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHT 740
+ + + + T + L + S + L RL + L R + LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H ++ +I+LD + + F V V + G+
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----------VRDGARVVSSVSRGFEP 270
Query: 801 PEYFLTHKL-----------TDKSDVYSLGVVFLELLTGMQP 831
PE T D ++LG+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 125
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 177
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D+++ GV+ LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFN-SSTQIGQGGYGKVYKGI-LPDGTVVAVK 654
HSS + + + + N + +S ++G+G + V + I G A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 655 --RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 711
+ + E L EI L +++L + E +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 712 SAKSKEPLG-----FAMR--LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764
+ E + ++ L G+ YLH + H D+K NILL +
Sbjct: 121 LPELAEMVSENDVIRLIKQILE-------GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 765 ---KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
K+ DFG+SR I A + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSRK--------IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 822 FLELLTGMQP 831
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLH 678
+ ++G+G Y VYKG +VA+K + L+ E+ + E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLK 58
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+V+L E LV+E++ +D Q + RG+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y H V HRD+K N+L++ + K+ADFGL+R +P + + VV T
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEVV--TL 164
Query: 797 GYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y P+ L + + + D++ +G +F E+ TG +P+ G
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 65/233 (27%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----------------------RAQEGSLQGEKEFL 668
IG+G YG V D T A+K R G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 669 T----EIQFLSRLHHRNLVSL--VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGF 721
EI L +L H N+V L V E +V+E ++ G + + + K E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781
A L GI YLH + + HRDIK SN+L+ K+ADFG+S D
Sbjct: 139 ARFYFQDLIK--GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVFLELLTGMQP 831
A +S V GTP ++ PE T K+ DV+++GV + G P
Sbjct: 192 ----ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 65/233 (27%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT--------EIQ 672
AT+ + +IG G YG VYK G VA+K + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 673 FLSRLH---HRNLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 724
L RL H N+V L+ D E + LV+E + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ RG+ +LH + HRD+K NIL+ T K+ADFGL+R+
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------ 173
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
A VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+G G G+V VA++ TEI+ L +L+H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 256
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 257 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 305
Query: 797 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
YL PE T D +SLGV+ L+G P S +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R + S +G ++ E+ L + H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + + +L+ E ++ G L D L+ K +E F ++ L+ G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
H+ + H D+K NI+L + K+ DFGL+ I + + G
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFG 179
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 31/254 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G+G + +V I L AVK ++ E++ L + HRN++ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+EE LV+E M G++ + + E A + + S + +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----ASVVVQDVAS--ALDFLH---NKG 131
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K NIL +H K+ DF L + D I + T G+ Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 802 EYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP-----ISHGKNIVREVNIAYQSSMM 851
E D++SLGV+ LL+G P S E A Q+ +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 852 FSVIDGNMGSYPSE 865
S+ +G +P +
Sbjct: 251 ESIQEGKY-EFPDK 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 34/254 (13%)
Query: 631 QIGQGGYGKVYKGI---LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
++G+G YG VYK D A+K+ + + EI L L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 688 YCDEEGEQ--MLVYEFMSN------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ L++++ + R + K L M S+ GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 740 TEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
V HRD+K +NIL+ + K+AD G +RL P + VV T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVV--T 198
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY---QSSMM 851
Y PE L + K+ D++++G +F ELLT +PI H + + + Y Q +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 852 FSVIDGNMGSYPSE 865
F+V MG P++
Sbjct: 258 FNV----MGF-PAD 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH-HR 680
IG+G V + + G AVK + E + + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYL 738
++++L+ + LV++ M G L D L+ K E ++ S+ + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----EAVSFL 216
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVKGTPG 797
H + HRD+K NILLD +++DFG S + P + GTPG
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--------LEPGEKLRELC-GTPG 264
Query: 798 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D+++ GV+ LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 677
+ + T++G+G YG+VYK I VA+KR + L+ E+E + E+ L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
HRN++ L L++E+ N L+ + + + S G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNF 147
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTA-----KVADFGLSRLAPVPDIEGIVPAHVSTVV 792
H HRD+K N+LL + K+ DFGL+R +P + ++
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-----IRQFTHEII 199
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
T Y PE L + S D++S+ ++ E+L P+ G +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 46/269 (17%)
Query: 596 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ----------IGQGGYGKVYKGIL 645
++ S+ S+K+ + + +AT IG G +G VY+ L
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKL 75
Query: 646 -PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM------LV 698
G +VA+K+ LQ ++ E+Q + +L H N+V L + GE+ LV
Sbjct: 76 CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIK 752
+++ + + ++ L + R + Y+H+ + HRDIK
Sbjct: 132 LDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIK 183
Query: 753 ASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-T 810
N+LLD K+ DFG ++ V +VS + + Y PE T
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAK-QLVRG-----EPNVSYIC--SRYYRAPELIFGATDYT 235
Query: 811 DKSDVYSLGVVFLELLTGMQPISHGKNIV 839
DV+S G V ELL G QPI G + V
Sbjct: 236 SSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILPD 647
++ +K++ + LA++ + IG G +G V++ L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 648 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL------VGYCDEEGEQMLVYEF 701
VA+K+ LQ ++ E+Q + + H N+V L G +E LV E+
Sbjct: 64 SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASN 755
+ T+ +K + + L R + Y+H+ + HRDIK N
Sbjct: 120 VPE-TVYRASRHYAKLK----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 756 ILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKS 813
+LLD K+ DFG ++ + +VS + + Y PE T
Sbjct: 172 LLLDPPSGVLKLIDFGSAK-ILIAG-----EPNVSYIC--SRYYRAPELIFGATNYTTNI 223
Query: 814 DVYSLGVVFLELLTGMQPISHGKNIV 839
D++S G V EL+ G QP+ G++ +
Sbjct: 224 DIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH----HR 680
+G+GG+G V+ G L D VA+K L E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRG 734
++ L+ + + + MLV E L D ++ K E F ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------A 151
Query: 735 ILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
I + H+ V HRDIK NIL+D + AK+ DFG L +
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD- 199
Query: 794 GTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
GT Y PE+ H+ + V+SLG++ +++ G P + I+
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSR 676
+ +IG+G YGKV+K + G VA+KR + +Q +E + E+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 677 LH---HRNLVSL-----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
L H N+V L V D E + LV+E + L L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+ A
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALT 177
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
S VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 178 SVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLHHR--NL 682
+G GG+G VY GI + D VA+K + G L E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 683 VSLVGYCDEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ L+ + + +L+ E L D ++ + A + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--AVRHCHNC 168
Query: 742 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V HRDIK NIL+D ++ K+ DFG L + GT Y
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFD-GTRVYSP 216
Query: 801 PEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
PE+ H+ + V+SLG++ +++ G P H + I+R
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G L D + + A RL + S + Y H V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--AVDYCHRHM---VV 133
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 184
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
+L + D++S GV+ LL G P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-22
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 148
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 200
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D+++ GV+ LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL--VG 687
+G+G Y +V++ I + + V VK + +K+ EI+ L L N+++L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADPP 745
LV+E ++N + + + F M L + + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--- 150
Query: 746 VFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRD+K N+++DH+ ++ D+GL+ P V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--------FYHPGQEYNVRVASRYFKGPELL 202
Query: 805 LTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
+ +++ D S D++SLG + ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG+G + KV + G VA+K + Q +K F E++ + L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ E L+ E+ S G + D L A + A + S + Y H + +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AVQYCHQKR---IV 136
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+KA N+LLD K+ADFG S + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVG------GKLDAFC-GAPPYAAPELFQ-G 187
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
K D + DV+SLGV+ L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 13/173 (7%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239
T H++ N + L L + LD LT LP L L L +N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQL- 89
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---RL 295
++P + L L + L + L L L N+L ++PPG
Sbjct: 90 -QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 296 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
+ + L+NN LT +P+ +GL L L + NSL +IP + S L
Sbjct: 148 P-KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 54/203 (26%), Positives = 73/203 (35%), Gaps = 33/203 (16%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167
TIL N + + L L L+ ELT L + LP L + + N +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ 90
Query: 168 GSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SEL 225
SLP L ++ N ++ +P L L + L N L LPP L +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
PKL L L NNN T +PA L+ + NL L L N
Sbjct: 148 PKLEKLSLANNNL--TELPAGL----------------------LNGLENLDTLLLQENS 183
Query: 286 LNGSIPPGRL-SLNITTIKLSNN 307
L +IP G S + L N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 16/178 (8%)
Query: 91 NLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L+LS N S + LT L+ +++ + G + L L L+ N+L S
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-S 91
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPS 203
LP LP L + + N ++ SLP L + + ++ N + +PP L + P
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 204 LVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L + L NNNLT LP L + L L L L N+ TIP + L L
Sbjct: 150 LEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL--YTIPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ ++ L ++PP L + T + LS N L + RL +L + L
Sbjct: 10 ASHLEVNCDKRNL-TALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 382
+ + TL T LD +N L ++ P +TV + N
Sbjct: 68 -----TKLQVDGTLPVLGT--LDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLT---EIQFLSRLHHRNL 682
+G G +G V+ + V VK + E + + EI LSR+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRGIL 736
+ ++ + +G LV E +G L + + EPL F +S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL + + HRDIK NI++ FT K+ DFG + T GT
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG------KLFYTFC-GTI 193
Query: 797 GYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQP 831
Y PE L + +++SLGV L+ P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 56/292 (19%), Positives = 112/292 (38%), Gaps = 22/292 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + + + L +T L ++ +I + + +L L L N++T
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD 77
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L K+ +++ N + + A L + + + I+ P L+ L +L
Sbjct: 78 --LAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNL 131
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ LD N +T L+ L L L + N + + +N+SKL L + +
Sbjct: 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV--SDLTP-LANLSKLTTLKADDNKIS 186
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ +PNL + L +NQ++ P S N+ + L+N +T + L
Sbjct: 187 D-ISPLASLPNLIEVHLKNNQISDVSPLANTS-NLFIVTLTNQTITNQPVFYNNNLVVP- 243
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVT 376
+ S + P++I S + + + N+S +FN
Sbjct: 244 -NVVKGPSGAPIAPATI--SDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 42/234 (17%), Positives = 90/234 (38%), Gaps = 20/234 (8%)
Query: 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209
L +I ++ ++ + A+L+ ++ I + L +L+ + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 269
+N +T L L K+ L+L N + A + + + L L + + +
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPL--KNVSA-IAGLQSIKTLDLTSTQITD-VTP 124
Query: 270 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
L+ + NL L L NQ+ +I P N+ + + N +++ + + L +L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD 181
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
+N +S P + + + +NN ++++S N V L
Sbjct: 182 DNKISDISPLA-------SLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-22
Identities = 45/242 (18%), Positives = 83/242 (34%), Gaps = 25/242 (10%)
Query: 660 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEP 718
S +I+ + +N V + + + + L+D ++ S E
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 719 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 773
+ L I + + + +LH++ + HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 774 --LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
V H V GT Y+ PE + + K D++SLG++ ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 832 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 891
I+ +V + ++ + + RP +++
Sbjct: 276 QMERVRIITDVR------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 892 MR 893
+
Sbjct: 324 IE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 681
+F +G+GG+G V++ D A+KR ++ + E++ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 682 LVSLVGYCDEEGEQMLVYEFMSN 704
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+G G G+V VA+K TEI+ L +L+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 131
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 180
Query: 797 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE T D +SLGV+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + + G A L ++ E + L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EEG L+++ ++ G L + + A+ E I +L+ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQMG--- 130
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
V HR++K N+LL K K+ADFGL+ GTPGYL PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFA-GTPGYLSPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D+++ GV+ LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 17/221 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNK 179
IP + S + L L+ N L P+L + + + I ++ ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 180 TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
+ N I + S L SL ++ NL L L L L + +N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPP 292
+ +P +SN++ L L L + +Q DL + + LDLS N +N I P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 293 GRL-SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 331
G + + + L N+L ++P F L LQ++++ N
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 37/208 (17%), Positives = 69/208 (33%), Gaps = 32/208 (15%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T++ ++ N + + P L + L + + L L L L N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 238 FEGTTIPA-SYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 295
++ ++S +S L KL +L + + L L+++ N + S
Sbjct: 88 I--QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK---- 140
Query: 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+P FS L L+ L +++N + SI + + L
Sbjct: 141 -----------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL 182
Query: 356 DFQNNNLTNI-SGSFNIPPNVTVRLRGN 382
D N + I G+F + L N
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLKELALDTN 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 289 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
IP L + + LS N L + S F P LQ L ++ + +I +QS L
Sbjct: 21 KIPDN-LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS--L 75
Query: 348 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 383
+ T L N + ++ G+F+ ++
Sbjct: 76 SHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 52/292 (17%), Positives = 96/292 (32%), Gaps = 25/292 (8%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSG-------NLSPEIGRLSYLTILDFMWNKISGSIPKE 125
F+ ++ L LQL N+ L+ E+ R L + + + +
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268
Query: 126 IGNI---KSLELLLLNGNELTGSLPEELG-----YLPKLDRIQIDQNYISGSLPKSFANL 177
+ + +E L + +T + E L L + S ++
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ ++ + S + N T + S L +L L L N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQ----GPMPDLSRIP-NLGYLDLSSNQLNGSIPP 292
+ L + SL ++ L+LSSN L GS+
Sbjct: 389 L--KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
L + + L NN++ +IP + + L LQ L +A+N L S+P ++
Sbjct: 447 -CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 9e-17
Identities = 61/322 (18%), Positives = 111/322 (34%), Gaps = 32/322 (9%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL-LNGN 140
L +L+LS N + E G L+ LT L K + ++ +LL L
Sbjct: 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ------- 193
+ G E L + + + S + ++N H ++N ++ +
Sbjct: 182 HIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSEL---PKLLILQLDNNNFEGTTIPASYSNM 250
EL+R P+L+++ L + T +L + + L + N ++
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 251 SKLLK----LSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG--SIPPGRLSLNITTIK 303
LK ++N L S + LS + + P S + T +
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS-SFTFLN 359
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
+ N T ++ S L RLQ L + N L + T N + LD N+L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA--LMTKNMSSLETLDVSLNSLN 416
Query: 364 NI--SGSFNIPPNVTV-RLRGN 382
+ + ++ V L N
Sbjct: 417 SHAYDRTCAWAESILVLNLSSN 438
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 41/257 (15%), Positives = 85/257 (33%), Gaps = 34/257 (13%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+ L + NL ++ + E L L I S + + +L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ ++ + QN + S+ + + L + + + N
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG-------- 388
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
L + M + L L + N+ + + +L L+
Sbjct: 389 LKNFFKVALM--------------TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 258 LRNCSLQ-GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPS 315
L + L L P + LDL +N++ SIP L + + +++N+L ++P
Sbjct: 435 LSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD 490
Query: 316 N-FSGLPRLQRLFIANN 331
F L LQ +++ +N
Sbjct: 491 GVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 33/196 (16%), Positives = 77/196 (39%), Gaps = 14/196 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F + + Y E+ + L + S T L+F N + S+ + +
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI----SGSLPKSFANLNKTRHFHM 185
K L+ L+L N L + + + ++ + S + ++ A ++
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP- 244
++N ++G + L P + + L NN + +P +++ L L L + +N ++P
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL--KSVPD 490
Query: 245 ASYSNMSKLLKLSLRN 260
+ ++ L + L +
Sbjct: 491 GVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 57/340 (16%), Positives = 107/340 (31%), Gaps = 56/340 (16%)
Query: 91 NLNLSGN----LSP-EIGRLSYLTILDFMWNKISGSIPKEI------------------- 126
L+LS N L +I LS L +L N+I S+ +
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 127 ---GNIKSLELLLLNGNELTGSLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLN-KT 180
+ SL L L+ N+ LP E G L KL + + A+L+
Sbjct: 115 ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ + I G L + V L+ + N + +S + L LQL N
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-VNALGHLQLSNIKLND 232
Query: 241 TTIPASYS------NMSKLLKLSLRNCSLQGP----MPDLSRIPNLGYLDLSSNQLNGSI 290
+ LL ++L++ + + YL++ + + I
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 291 PPGRLSLNITTIK------LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
+ + T +K + N + + +S + ++ + I S
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPS 351
Query: 345 RTLNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGN 382
+ L+F N T+ + + + L+ N
Sbjct: 352 P----SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 49/297 (16%), Positives = 98/297 (32%), Gaps = 46/297 (15%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
+PK++ + L L+ N ++ ++ +L +L +++ N I SL F
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNN 237
+ +++N + I + SL H+ L N+ LP E L KL L L
Sbjct: 102 LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAK 157
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
F + + L L + ++G + +IPN L L + + +S+
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 298 N-ITTIKLSNNKLTGTIPSNFSGL----------------------------------PR 322
N + ++LSN KL
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 378
++ L I N +++ I + I +N +++ + ++
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 278 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
+D S+ L +P L + LS N ++ + S L L+ L +++N + S+
Sbjct: 35 MVDYSNRNLT-HVPKD-LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNIS 366
++ E LD +N L NIS
Sbjct: 92 DFHVFLF--NQDLEY--LDVSHNRLQNIS 116
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 36/214 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + G A+K L + E+ + ++V ++ Y
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 740
+ + + E M G L ++ + + MR I I +LH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLHS 146
Query: 741 EADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ HRD+K N+L K K+ DFG ++ + T TP
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--------TTQNALQTPC-YTPY 194
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE K D++SLGV+ LL G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G L D + + + RL + S G+ Y H V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHM---VV 138
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 189
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
+L + D++S GV+ LL G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL 685
+G+G + K + AVK + E + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTE 741
++ LV E ++ G L +++ K E A + L S + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLVS--AVSHMHDV 125
Query: 742 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
V HRD+K N+L + K+ DFG +RL P + + T T Y
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPC-FTLHY 175
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + + D++SLGV+ +L+G P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAV----KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G VY+ A+ K + ++ TEI L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKL 113
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEAD 743
+ E LV E ++ G L D++ K E I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG- 168
Query: 744 PPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+K N+L K+ADFGLS++ + + V GTPGY
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------VEHQVLMKTVCGTPGYCA 218
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D++S+G++ LL G +P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688
IG G Y + I AVK + +E I+ L R H N+++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDV 84
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 744
D+ +V E M G L D++ + F A + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITK--TVEYLHAQG-- 136
Query: 745 PVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V HRD+K SNIL + + ++ DFG ++ + + T T ++
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPC-YTANFVA 188
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
PE L + D + D++SLGV+ +LTG P
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRL 677
+ F GQG +G V G G VA+K+ + + F L +Q L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 678 HHRNLVSLVGYCDEEGEQ-------MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
HH N+V L Y GE+ +V E++ D L + + L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 731 SS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGI 783
R I LH + V HRDIK N+L++ T K+ DFG ++ P
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS---- 185
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
+V+ + + Y PE ++ T D++S+G +F E++ G +PI G N
Sbjct: 186 -EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 5e-20
Identities = 67/344 (19%), Positives = 113/344 (32%), Gaps = 95/344 (27%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNL 682
+G+G +G+V + VAVK +EG+ E + ++E++ L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 683 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR----------------- 724
V+L+G C G M++ EF G L L +K E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 725 --------------LSIALGSSRGILYLHTEADPPVFHRDIKASNILL------------ 758
S + + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 759 ------------------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
K K+ DFGL+R DI V+ L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIY-----KDPDYVRKGDARLP 258
Query: 801 -----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 854
PE T +SDV+S GV+ E+ + G P + +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKIDEEFCRRL 309
Query: 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+G P + + L C E RP+ SE++ L ++
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 36/325 (11%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
L +L+LS N + E G +S L L + S I ++ ++LL+ G
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN-----------LNKTRHFHMNNNSI 190
E+ L + + + + + N N S
Sbjct: 151 YG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPK---LLILQLDNNNFEG----TTI 243
I +L P L ++ L+N T + +L + + N +G
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPGRLSLNIT 300
S +++ L + + P + I N+ +S ++ + P ++S
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS-PFL 327
Query: 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
+ SNN LT T+ N L L+ L + N L + T LD N
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA--EMTTQMKSLQQLDISQN 384
Query: 361 NLTNIS--GSFNIPPNVTV-RLRGN 382
+++ G + ++ + N
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSN 409
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 37/255 (14%), Positives = 85/255 (33%), Gaps = 27/255 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
Y + ++L + L L+I + + ++ + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+ + N ++ ++ ++ +L + + N L
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ--------LKE 362
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L + M +++ L L + N+ S LL L++ +
Sbjct: 363 LSKIAEM--------------TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSN-FS 318
L + P + LDL SN++ SIP + L + + +++N+L ++P F
Sbjct: 409 NILTDTIFR-CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
Query: 319 GLPRLQRLFIANNSL 333
L LQ++++ N
Sbjct: 466 RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 42/220 (19%), Positives = 85/220 (38%), Gaps = 31/220 (14%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSGN---LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F Y + + N +SG ++S LDF N ++ ++ + G++
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
LE L+L N+L L + + + + + ++ NS
Sbjct: 348 TELETLILQMNQLK-ELSK---------------------IAEMTTQMKSLQQLDISQNS 385
Query: 190 ISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248
+S S SL+ + + +N LT + L P++ +L L +N +IP
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI--KSIPKQVV 441
Query: 249 NMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 287
+ L +L++ + L+ P R+ +L + L +N +
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 45/330 (13%), Positives = 99/330 (30%), Gaps = 38/330 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L++ +L++ + E + +++ ++S I + + L
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS-----NIKCVLEDNKCSYFLSILA 214
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR--- 200
L+ I+ N L +F ++N + GQ+
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 201 --LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
L +L + ++ + I + + S +S L L
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP-SKISPFLHLDF 331
Query: 259 RNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLSNNKLTGTI 313
N L + + L L L NQL + ++ + +S N ++
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 314 PSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL----------------NATETFILD 356
S L L +++N L+ +I + + L+
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELN 450
Query: 357 FQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
+N L ++ G F+ ++ + L NP+
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 56/343 (16%), Positives = 101/343 (29%), Gaps = 60/343 (17%)
Query: 91 NLNLSGN----LSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
LN+S N L I LS L IL N+I + LE L L+ N+L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ L + + N +LP F N+++ + ++ + ++ L
Sbjct: 84 IS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 204 LVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEG-------------------- 240
+L+ PE L I+ N F
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 241 ---------TTIPASYSNMSKLLKLSLRNCSLQGP----MPDLSRIPNLGYLDLSSNQLN 287
+I A KL L+L N + L + Y +S+ +L
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 288 GSIPPGRLSLNITTIK------LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341
G + + T++K + ++ + + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLC 319
Query: 342 WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 382
++ LDF NN LT+ + + L+ N
Sbjct: 320 PSK--ISPFLH--LDFSNNLLTDTVFENCGHLTELETLILQMN 358
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 44/274 (16%), Positives = 84/274 (30%), Gaps = 19/274 (6%)
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 196
+ N L +P++L K + I QNYIS +L+K R +++N I +
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI 62
Query: 197 E-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
L ++ L +N L + L L L N F+ I + NMS+L
Sbjct: 63 SVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 256 LSLRNCSLQ-GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITTIKLSNNKLT 310
L L L+ + ++ + L + P L ++ + +N +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF------ILDFQNNNLTN 364
+ + + L+ I + L ++ N+
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398
I + + F S +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 32/233 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
+ + IG G G V VA+K+ + K E+ + ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 680 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 730
+N++ L V + E+ +V E M ++ +L + L + M
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------ 137
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
GI +LH+ A + HRD+K SNI++ T K+ DFGL+R + + T
Sbjct: 138 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMT 184
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843
T Y PE L + D++S+G + E++ G + G + + + N
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWN 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+ F +G+GG+G+V+ + G + A K+ + L+ K + + E + L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 732
R +VSL Y E + LV M+ G +R + ++ GF + I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ +LH + +RD+K N+LLD +++D GL+ E +
Sbjct: 302 --LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-------ELKAGQTKTKGY 349
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTPG++ PE L + D ++LGV E++ P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 60/271 (22%), Positives = 91/271 (33%), Gaps = 45/271 (16%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHR 680
I G YG V G+ +G VA+KR G K L EI+ L+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 681 NLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
N++ L + LV E M T Q+ + + G+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST--VVK 793
LH A V HRD+ NILL + DF L+R T V
Sbjct: 148 HVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANKTHYVT- 195
Query: 794 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
Y PE + K K D++S G V E+ + + G Q + +
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYN------QLNKIV 247
Query: 853 SVI----DGNMGSYPSECVEKFIKLALKCCQ 879
V+ ++ + S +++ +L
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 20/205 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
IG G +G +VAVK + G+ E EI L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ E+ S G L +++ + A L S G+ Y H+ + HRD
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCHSMQ---ICHRD 141
Query: 751 IKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
+K N LLD K+ DFG S+ V + + V GTP Y+ PE L +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKS-SVLH------SQPKSTV-GTPAYIAPE-VLLRQ 192
Query: 809 LTD--KSDVYSLGVVFLELLTGMQP 831
D +DV+S GV +L G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV VA+K R EI +L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++V E+ + G L D + K + R + I Y H +
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--AIEYCHRHK---IV 130
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD K+ADFGLS + + T G+P Y PE +
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI-MTDG------NFLKTSC-GSPNYAAPE-VING 181
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
KL + DV+S G+V +L G P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 4e-19
Identities = 54/285 (18%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
L +T L +D+I + + I S+ + L +N
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247
N ++ I P L+ L +L + LD N + L +L KL L L++N + I
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI--SDING-L 127
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 307
++ +L L L N + + LSR+ L L L NQ++ I P + + LS N
Sbjct: 128 VHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN 185
Query: 308 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
+ + +GL L L + + N + N G
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQEC------------LNKPINHQSNLVVPNTVKNTDG 231
Query: 368 SFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTL 412
S P ++ + + +F S + +
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 2e-18
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 21/291 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 78
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N I L S +L K + + +N IS I L LP L
Sbjct: 79 DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 133
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T LS L KL L L++N + I + ++KL L L +
Sbjct: 134 ESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 188
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + NL L+L S + + P S + + N + P S +
Sbjct: 189 -DLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
Query: 325 RLFIANNSLSGSIPSS---IWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
+ + + + S A F + S+++
Sbjct: 247 KPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 23/295 (7%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + + + + I L +T L NK++ I K + N+K+L L L+ N++
Sbjct: 44 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK 100
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L L L KL + ++ N IS + +L + ++ NN I+ I LSRL
Sbjct: 101 -DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTK 154
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L++N ++ L+ L KL L L N+ + + A + + L L L +
Sbjct: 155 LDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRAL-AGLKNLDVLELFSQEC 209
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
++ NL + N + P +S + + +P + + +
Sbjct: 210 L--NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD---YEKPNVKWHLPEFTNEVSFI 264
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
+ + Q T ++ +D +G+ P +
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTK 319
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 30/195 (15%), Positives = 71/195 (36%), Gaps = 26/195 (13%)
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
+ + + + P + + L + + + ++ + ++ N +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDI 55
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+ + + +PN+ L L+ N+L I P N+ + L NK+ + S+ L +L
Sbjct: 56 KS-VQGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKL 111
Query: 324 QRLFIANNSLSGSIP--SSIWQSRTLNATETFI--------------LDFQNNNLTNISG 367
+ L + +N +S I + Q +L I L ++N +++I
Sbjct: 112 KSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 170
Query: 368 SFNIPPNVTVRLRGN 382
+ + L N
Sbjct: 171 LAGLTKLQNLYLSKN 185
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 59/342 (17%), Positives = 109/342 (31%), Gaps = 57/342 (16%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
IP ++ ++ L +L L++I+I QN + + F+NL K
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 180 TRHFHM-NNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 236
+ N++ I PE LP+L ++L+ N + +LP + ++L + +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG--R 294
N+ + + S S L L+ N + I
Sbjct: 139 I-----------NIHTIERNSFVGLS-----------FESVILWLNKNGIQ-EIHNSAFN 175
Query: 295 LSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 353
+ NN L +P++ F G L I+ + S+PS + N +
Sbjct: 176 GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE----NLKKLR 229
Query: 354 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC--------LNTNAEQFCGSHSDDDNEID 405
NL + + + L C + C + S E+D
Sbjct: 230 ARS--TYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPIC-NKSILRQEVD 286
Query: 406 RSTN------STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLV 441
T S + S ++ + T C + V
Sbjct: 287 YMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDV 328
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 43/257 (16%), Positives = 78/257 (30%), Gaps = 37/257 (14%)
Query: 83 HLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSL-ELLLLNG 139
+ EL+ + L + L ++ N + I ++ N+ L E+ +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-L 198
N L PE LP L + I I + + + +N I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 199 SRLPSLVHML-LDNNNLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPASYSNMSKLLKL 256
L +L L+ N + + +L + DNNN +P
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL--EELPND---------- 196
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK-LSNNKLTGTIPS 315
LD+S +++ S+P L N+ ++ S L +P+
Sbjct: 197 ------------VFHGASGPVILDISRTRIH-SLPSYGLE-NLKKLRARSTYNLK-KLPT 241
Query: 316 NFSGLPRLQRLFIANNS 332
L L + S
Sbjct: 242 -LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 21/209 (10%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIP 244
+ ++ +IP +L + + + L + S L +++ N+ I
Sbjct: 17 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL-EVIE 71
Query: 245 AS-YSNMSKLLKLSLRNC-SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNI 299
A +SN+ KL ++ + +L P+ +PNL YL +S+ + +P SL
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQK 130
Query: 300 TTIKLSNNKLTGTIPSN-FSGLP-RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
+ + +N TI N F GL L++ N + I +S + E + D
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG--TQLDELNLSD- 186
Query: 358 QNNNLTNIS-GSF-NIPPNVTVRLRGNPF 384
NNNL + F V + +
Sbjct: 187 -NNNLEELPNDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 22/107 (20%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 279 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSI 337
+++ IP L N ++ KL I FSG L+++ I+ N + I
Sbjct: 14 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 382
+ ++ + L ++ + NNL I +F PN+ +
Sbjct: 71 EADVFSN--LPKLHEIRIE-KANNLLYINPEAFQNLPNLQYLLISNT 114
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 740
+ + + E + G L ++ + + M+ SI I YLH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 179
Query: 741 EADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ HRD+K N+L K K+ DFG ++ + ++T TP
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPC-YTPY 228
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE K D++SLGV+ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 45/267 (16%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
+ S T +G G YG V I G VA+K+ S K E+ L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 680 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 730
N++ L V LV FM + + S + + L + M
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+G+ Y+H+ A V HRD+K N+ ++ K+ DFGL+R A ++ G V
Sbjct: 137 --KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV------ 184
Query: 791 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849
T Y PE L+ +++ D++S+G + E+LTG + + GK+ + Q +
Sbjct: 185 ---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLD------QLT 234
Query: 850 MMFSVI----DGNMGSYPSECVEKFIK 872
+ V + + + +I+
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQ 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 32/264 (12%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 646
+ I++ + SK+ + + + IG G G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 647 DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LV 698
VA+K+ + K E+ + ++H+N++SL V + E+ LV
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 699 YEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
E M ++ +L + L + M GI +LH+ A + HRD+K SN
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQML--------CGIKHLHS-AG--IIHRDLKPSN 194
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
I++ T K+ DFGL+R A + + T T Y PE L + D+
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 816 YSLGVVFLELLTGMQPISHGKNIV 839
+S+G + E++ + + G++ +
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYI 269
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 27/164 (16%), Positives = 59/164 (35%), Gaps = 7/164 (4%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
+ SL + L +T L + Y + + I+ + + + L+
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ ++ P LS L SL + + ++ + +++ LPK+ + L N T
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG--AITDI 152
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 288
+ +L L+++ + + P L L S + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 34/162 (20%), Positives = 67/162 (41%), Gaps = 11/162 (6%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+ + + +S + +++ SL ++ L N N+T L + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTIN 74
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG 293
N + S +S L +L + + +P+LS + +L LD+S + + SI
Sbjct: 75 NIHATNYN---PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 294 RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+L + +I LS N I LP L+ L I + +
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 27/168 (16%), Positives = 62/168 (36%), Gaps = 14/168 (8%)
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+ ++ LL ++ +++ L + L N N T + L++ N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLT---GIEYAHNIKDLTINN 75
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG 319
P +S + NL L + + P L ++T + +S++ +I + +
Sbjct: 76 IHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 320 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
LP++ + ++ N I + L L+ Q + + + G
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELK-----SLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 12/146 (8%)
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
S L L ++ T + + M+ L ++L N ++ + + N+ L ++
Sbjct: 20 STFKAYLNGLLGQSS----TANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTIN 74
Query: 283 SNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342
+ P LS N+ +++ +T N SGL L L I++++ SI + I
Sbjct: 75 NIHATNYNPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 343 QSRTLNATETFILDFQNNN-LTNISG 367
+N +D N +T+I
Sbjct: 134 TLPKVN-----SIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 21/110 (19%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+L L+++ +++ + P + L+ LT+LD + SI +I + + + L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ L LP+L + I + + + K + + +I G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 23/207 (11%), Positives = 51/207 (24%), Gaps = 49/207 (23%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVK--RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVS 684
G + ++ + D VA+ Q + L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
++ ++V E++ G+L++ + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V S + + +A + +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
D+ +G LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 45/230 (19%), Positives = 100/230 (43%), Gaps = 15/230 (6%)
Query: 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163
+ + ++ ++ + S++ ++ N +++ S+ + + YLP + ++ ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
N ++ + K ANL ++ N + + L L L + L++N ++ + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
LP+L L L NN T I S ++KL LSL + + + L+ + L L LS
Sbjct: 132 HLPQLESLYLGNNKI--TDITVL-SRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSK 187
Query: 284 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
N ++ + N+ ++L + + ++ S L + + SL
Sbjct: 188 NHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 18/250 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 81
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N + L S +L K + + +N IS I L LP L
Sbjct: 82 DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T + LS L KL L L++N + I + ++KL L L +
Sbjct: 137 ESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 191
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + NL L+L S + + P S + + N + P S +
Sbjct: 192 D-LRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
Query: 325 RLFIANNSLS 334
+ + +
Sbjct: 250 KPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 24/239 (10%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + + + + I L +T L NK++ I K + N+K+L L L+ N++
Sbjct: 47 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK 103
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L L L KL + ++ N IS + +L + ++ NN I+ I LSRL
Sbjct: 104 -DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTK 157
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L++N ++ + P L+ L KL L L N+ + + A + + L L L +
Sbjct: 158 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRAL-AGLKNLDVLELFSQEC 212
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNIT----TIKLSNNKLTGTIPSNFS 318
++ NL + N + P +S + +K + T + F
Sbjct: 213 L--NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 39/218 (17%), Positives = 81/218 (37%), Gaps = 18/218 (8%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+T ++ S++ + + L S+ ++ +N+++ + LP + L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
N T I +N+ L L L ++ + L + L L L N ++ I
Sbjct: 77 GNKL--TDIK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DINGLV 131
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+ ++ L NNK+T + S L +L L + +N +S I L +
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN-- 182
Query: 355 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQ 392
L N+++++ + + L Q
Sbjct: 183 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQ 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 27/237 (11%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L L+GN + P + L L L NK+ + + ++K L+ L L N ++
Sbjct: 69 NVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS 125
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ L +LP+L+ + + N I+ + L K + +N IS I P L+ L
Sbjct: 126 -DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTK 179
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCS 262
L ++ L N+++ L+ L L +L+L + P ++ SN+ +
Sbjct: 180 LQNLYLSKNHISDL--RALAGLKNLDVLELFSQEC--LNKPINHQSNLVVPNTVKN---- 231
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
G + I + G D + +P N + G + F G
Sbjct: 232 TDGSLVTPEIISDDG--DYEKPNVKWHLPE---FTNEVSFIFYQPVTIGKAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 270 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
+L + ++ L+ +I I +N+ + ++ LP + +LF+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 76
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
N L+ I + + L L N + ++S
Sbjct: 77 GNKLT-DI-KPLANLKNLG-----WLFLDENKVKDLSS 107
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 6e-18
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 19/184 (10%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 268
L +P L +L L +NN + + A + + ++ L L L + L
Sbjct: 27 KQQLPN-VPQSLP--SYTALLDLSHNNL--SRLRAEWTPTRLTNLHSLLLSHNHLNFISS 81
Query: 269 D-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQ 324
+ +PNL YLDLSSN L+ ++ S + + L NN + + N F + +LQ
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPN---VTVRLR 380
+L+++ N +S P + + + +LD +N L + P + L
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGN-KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 381 GNPF 384
NP
Sbjct: 198 NNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 91 NLNLSGN----LSPEI--GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELT 143
L+LS N L E RL+ L L N ++ I E + +L L L+ N L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 144 GSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE----L 198
+L E L L+ + + N+I +F ++ + + +++ N IS + P E
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKL--LILQLDNNNF 238
++LP L+ + L +N L +L +LP L L NN
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 61/268 (22%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 686
+G+G YG V P G +VA+K+ + L EI+ L H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 687 --GYCDEEGEQMLVYEFM--------SNGTLRD--------QLSAKSKEPLGFAMRLSIA 728
+ E ++ E M S L D Q
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT----------------- 121
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
L R + LH ++ V HRD+K SN+L++ KV DFGL+R+ + P
Sbjct: 122 L---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 789 STVVKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNI 844
+ + T Y PE LT ++ DV+S G + EL +PI G++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRH---- 230
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIK 872
Q ++F +I G+ S+ + I+
Sbjct: 231 --QLLLIFGII----GTPHSDNDLRCIE 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
++F IG+G +GKV + A+K + E E+Q +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 677 LHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGS 731
L H LV+L Y ++ E M +V + + G LR L E F L +AL
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD- 129
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
YL + + HRD+K NILLD + DF ++ + + T
Sbjct: 130 -----YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM--------LPRETQITT 173
Query: 792 VKGTPGYLDPEYFLTHKLT--DKS-DVYSLGVVFLELLTGMQP 831
+ GT Y+ PE F + K + D +SLGV ELL G +P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
N F +G+GG+G+V + G + A K+ ++ ++ K L E Q L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 732
R +VSL Y E + + LV M+ G L+ + + GF + I G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCG-- 298
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ LH E + +RD+K NILLD +++D GL+ + V
Sbjct: 299 --LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRV 346
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GT GY+ PE + T D ++LG + E++ G P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY----KG 643
R S S + S + + N F +G+G +GKV K
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 644 ILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVY 699
G A+K ++ + + E LTE + L H L +L Y + +++ V
Sbjct: 172 ---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 700 EFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
E+ + G L LS + E + + AL YLH+E + V +RD+K N
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLEN 279
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 814
++LD K+ DFGL + EGI GTP YL PE L ++ D
Sbjct: 280 LMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 815 VYSLGVVFLELLTGMQP 831
+ LGVV E++ G P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+F +G+G + V A+K ++ + E + E +SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
L H V L ++ + + NG L + E + + AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE-- 144
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH + + HRD+K NILL+ ++ DFG +++ + A+ + V
Sbjct: 145 ----YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARAN--SFV 193
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GT Y+ PE LT K KS D+++LG + +L+ G+ P
Sbjct: 194 -GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 686
IG G YG V + + VVA+K+ L K L EI L+RL+H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 687 ---GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ E +V E + D ++ L ++ G+ Y+H+
Sbjct: 121 VIPKDVEKFDELYVVLEIA--DS--D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
A + HRD+K +N L++ + KV DFGL+R P+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 802 EYFLTHKLTD--------------------KS-DVYSLGVVFLELLTGMQP 831
L +LT ++ DV+S+G +F ELL ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 673
N+F+ IG+GG+G+VY D G + A+K + E E+ L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 674 LSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------ 726
S +V + Y +++ + + M+ G L LS F+
Sbjct: 247 -STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAE 300
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
I LG + ++H V +RD+K +NILLD +++D GL+ V
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 841
GT GY+ PE D S D +SLG + +LL G P K +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 17/208 (8%)
Query: 131 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHM-NN 187
S + L L L ++P LP + RI + + L SF NL+K H + N
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 188 NSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIP 244
+++ I P+ L LP L + + N L P + IL++ +N + T+IP
Sbjct: 91 RNLT-YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM-TSIP 147
Query: 245 A-SYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNI 299
++ + L L N L + L+ N+ I +
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 300 TTIKLSNNKLTGTIPSN-FSGLPRLQRL 326
+ + +S +T +PS L L
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 39/198 (19%), Positives = 73/198 (36%), Gaps = 18/198 (9%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T+ + + IP S LP++ + + + L L K+ +++ N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 238 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPG 293
T I + L L + N L+ PDL+++ L+++ N SIP
Sbjct: 92 NL-TYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 294 ---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 349
L T+KL NN T ++ F+G +L +++ N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 350 TETFILDFQNNNLTNISG 367
+ LD ++T +
Sbjct: 208 SL---LDVSQTSVTALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 39/214 (18%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDN 211
P +++ + ++ +F+NL +++ + Q+ L + H+ + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 212 NNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 268
Y+ P+ L ELP L L + N P + L + + +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 269 D--LSRIPN-LGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPR- 322
+ N L L +N S+ + + + L+ NK I + F G+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 323 LQRLFIANNSLSGSIPSSIWQS-RTLNATETFIL 355
L ++ S++ ++PS + + L A T+ L
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 27/191 (14%), Positives = 68/191 (35%), Gaps = 18/191 (9%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEI-GNIKSLELLL 136
+L + + +++ L ++ LS +T ++ + I + + L+ L
Sbjct: 53 NLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 137 LNGNELTGSLPEE--LGYLPKLDRIQIDQNYISGSLPK-SFANL-NKTRHFHMNNNSISG 192
+ L P+ + ++I N S+P +F L N+T + NN +
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL-ILQLDNNNFEGTTIPA-SYSN 249
+ L + L+ N + + + +L + + T +P+ +
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV--TALPSKGLEH 227
Query: 250 MSKLLKLSLRN 260
+ +L+ +
Sbjct: 228 LKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 35/152 (23%), Positives = 59/152 (38%), Gaps = 15/152 (9%)
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
IP S L L L+ P S +PN+ + +S + +
Sbjct: 24 QRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 298 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+T I++ N + I + LP L+ L I N L P ++ + FIL+
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL---TKVYSTDIFFILE 136
Query: 357 FQNNN-LTNIS-GSFNIPPN--VTVRLRGNPF 384
+N +T+I +F N +T++L N F
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 333
++ + IP L + T+KL L TIPS+ FS LP + R++++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIP--SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
+ S + + L+ + NLT I
Sbjct: 68 LQQLESHSFYN--LSKVTHIEI-RNTRNLTYID 97
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 51/256 (19%), Positives = 96/256 (37%), Gaps = 70/256 (27%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRNLVSLVGY- 688
+G G +G V + + G A+K+ + + + E+ + L H N++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 689 -------------------------------------CDEEGEQMLVYEFMSNGTLRDQL 711
+ ++ E++ D L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTL 124
Query: 712 SAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTA 764
K + + + L S R + ++H+ + HRDIK N+L++ T
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181
Query: 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFL 823
K+ DFG ++ +P V+ + + Y PE L + T D++S+G VF
Sbjct: 182 KLCDFGSAKKL-IPS-----EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 824 ELLTGMQPISHGKNIV 839
EL+ G +P+ G+ +
Sbjct: 234 ELILG-KPLFSGETSI 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 686
+G G YG V + G VA+K+ S K E++ L + H N++ L V
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 687 GYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYL 738
DE + LV FM ++ + L + L + M +G+ Y+
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H A + HRD+K N+ ++ K+ DFGL+R VV T Y
Sbjct: 145 HA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVV--TRWY 191
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-- 855
PE L ++ D++S+G + E++TG + + G + + Q + V
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLD------QLKEIMKVTGT 244
Query: 856 --DGNMGSYPSECVEKFIK 872
+ S+ + ++K
Sbjct: 245 PPAEFVQRLQSDEAKNYMK 263
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T+ + +N +S +P + RL L + L++N L LP + EL L L + +N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 238 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG-- 293
+P + + L +L L L+ P + + L YL L N+L S+P G
Sbjct: 97 L--QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 294 -RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 341
+L+ ++ ++L NN+L +P F L L+ L + NN L +P
Sbjct: 154 DKLT-SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
++ + N +S K+F L K R ++N+N + +P + L +L + + +N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 215 TGYLPPEL-SELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPD--L 270
LP + +L L L+LD N ++P + +++KL LSL LQ +P
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQL--KSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVF 153
Query: 271 SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 327
++ +L L L +NQL +P G +L+ + T+KL NN+L F L +L+ L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLT-ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211
Query: 328 IANN 331
+ N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 13/138 (9%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLL 136
L+ L+ L ++ N L + +L L L N++ S+P + ++ L L
Sbjct: 83 ELKNLE--TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 137 LNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQI 194
L NEL SLP+ + L L +++ N + +P+ F L + + ++NN +
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 195 PPELSRLPSLVHMLLDNN 212
L L + L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
N +D SS +L +IP + + + L +NKL+ F L +L+ L++ +N L
Sbjct: 17 NKNSVDCSSKKLT-AIPSN-IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 335 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
++P+ I++ L ET L +N L + G F+ N+ RL N
Sbjct: 75 -TLPAGIFKE--LKNLET--LWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 57/250 (22%), Positives = 82/250 (32%), Gaps = 64/250 (25%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 686
IG+G YG VY VA+K+ L K L EI L+RL ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 687 ---GYCDEEGEQMLVYEFM---------SNGTLRD--------QLSAKSKEPLGFAMRLS 726
+ E +V E + L + L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL--------------- 138
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
L G ++H + + HRD+K +N LL+ + KV DFGL+R IV
Sbjct: 139 --L---LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 787 HVSTVVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 830
G PE L + KS D++S G +F ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 831 PISHGKNIVR 840
+
Sbjct: 251 SHINDPTNRF 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 53/302 (17%)
Query: 589 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPD 647
M ++H + + +++ + + + + +G G YG V
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTI-WE------VPERYQNLSPVGSGAYGSVCAAFDTKT 53
Query: 648 GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LVY 699
G VAVK+ S+ K E++ L + H N++ L V E+ LV
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 700 EFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
M N ++ Q L+ + L + + RG+ Y+H+ AD + HRD+K SN
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHS-AD--IIHRDLKPSN 162
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 814
+ ++ K+ DFGL+R ++ G V T Y PE L +++ D
Sbjct: 163 LAVNEDCELKILDFGLARHT-ADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVD 212
Query: 815 VYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI----DGNMGSYPSECVEKF 870
++S+G + ELLTG + + G + + Q ++ ++ + SE +
Sbjct: 213 IWSVGCIMAELLTG-RTLFPGTDHID------QLKLILRLVGTPGAELLKKISSESARNY 265
Query: 871 IK 872
I+
Sbjct: 266 IQ 267
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL----- 685
+G GG G V+ + VA+K+ Q K L EI+ + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 686 ---------VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
VG E +V E+M L L + + +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL-------- 130
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSR-LAPVPDIEGIVPAHVST 790
RG+ Y+H+ A+ V HRD+K +N+ ++ + K+ DFGL+R + P +G + +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 791 VVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
T Y P L+ + T D+++ G +F E+LTG + + G + +
Sbjct: 187 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 40/258 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 686
IG+G YG V + VA+K+ + L EI+ L R H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 687 --GYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
++ + +V + M L+ Q LS + + L RG+ Y+H+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI-----L---RGLKYIHS 146
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGYL 799
A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 147 -AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-----TRWYR 198
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI--- 855
PE L K KS D++S+G + E+L+ +PI GK+ + Q + + ++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLD------QLNHILGILGSP 251
Query: 856 -DGNMGSYPSECVEKFIK 872
++ + ++
Sbjct: 252 SQEDLNCIINLKARNYLL 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 85/343 (24%), Positives = 138/343 (40%), Gaps = 61/343 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSL-- 685
+G+G YG V+K I G VVAVK+ + + + EI L+ L H N+V+L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 686 VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
V D + + LV+++M + +R L K+ + + + + + I YLH+
Sbjct: 77 VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVIKYLHS- 127
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD- 800
+ HRD+K SNILL+ + KVADFGLSR
Sbjct: 128 GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 801 -------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846
PE L K D++SLG + E+L G +PI G + +
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMN------ 238
Query: 847 QSSMMFSVI----DGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNM 901
Q + VI + ++ S S + I+ L K +++ R ++ L I
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 902 MPESD------TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938
++ K +F ++ S + LKHP+VS
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISAND-------ALKHPFVSI 334
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 19/198 (9%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
I+ Q+ P L + V L ++T + EL + DN+N ++
Sbjct: 5 RPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLA- 57
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 305
+ L +L L + + + L + L L ++ N+L ++ ++ + L
Sbjct: 58 GMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLK-NLNGIPS-ACLSRLFLD 114
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
NN+L T + L L+ L I NN L SI + L +LD N +TN
Sbjct: 115 NNELRDT--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLE-----VLDLHGNEITNT 165
Query: 366 SGSFNIPPNVTVRLRGNP 383
G + + L G
Sbjct: 166 GGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 40/246 (16%), Positives = 77/246 (31%), Gaps = 17/246 (6%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
+ + P L+ + ++ + + ++ + + + SL
Sbjct: 3 IQRPTPINQVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ + L + + N IS L +L K +N N + + L +
Sbjct: 58 GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLF 112
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNN L L L L IL + NN +I +SKL L L +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIV-MLGFLSKLEVLDLHGNEITN-TG 166
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
L+R+ + ++DL+ + + P T + + P S +
Sbjct: 167 GLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCV 225
Query: 329 ANNSLS 334
Sbjct: 226 LWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 44/236 (18%), Positives = 74/236 (31%), Gaps = 26/236 (11%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ N N + L+ + + L L N+IS + + ++ LE L +N N L
Sbjct: 42 GVQNFNGDNSNIQSLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK 98
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L R+ +D N + S +L + NN + I L L
Sbjct: 99 NLNGIP---SACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSK 151
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L N +T L+ L K+ + L L ++
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK-----CVNEPVKYQPELYITNTVKDP 204
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
G I N G + +P + + + K S G + F G
Sbjct: 205 DGRWISPYYISNGG--SYVDGCVLWELP---VYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/146 (23%), Positives = 51/146 (34%), Gaps = 16/146 (10%)
Query: 84 LRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ L L L N + L L IL NK+ SI +G + LE+L L+G
Sbjct: 103 IPSACLSRLFLDNNELRDTDS-LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
NE+T + L L K++ I + K L T + P +S
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYIS 215
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSEL 225
S + + LP E+
Sbjct: 216 NGGS-----YVDGCVLWELPVYTDEV 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 5e-15
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 48/241 (19%)
Query: 613 SFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQE 658
S G + F +G+GGYGKV+ K + G + A+K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 659 GSLQGEKEFLTEIQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKS 715
+ E+ L E++ F+ L Y + G ++ L+ E++S G L QL +
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI---------YAFQTGGKLYLILEYLSGGELFMQLEREG 116
Query: 716 K--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771
E + +S+ALG +LH + + +RD+K NI+L+H+ K+ DFGL
Sbjct: 117 IFMEDTACFYLAEISMALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 830
+ E I V+ GT Y+ PE L +++ D +SLG + ++LTG
Sbjct: 168 CK-------ESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 831 P 831
P
Sbjct: 220 P 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
N+F+ +G+G +GKV K G A+K + + E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 671 IQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAM 723
+ FL+ L Y + +++ V E+ + G L LS + E +
Sbjct: 62 TRHPFLTALK---------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ AL YLH+ V +RDIK N++LD K+ DFGL + EGI
Sbjct: 113 EIVSALE------YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGI 156
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP YL PE L ++ D + LGVV E++ G P
Sbjct: 157 SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F+ IG+G Y KV K + A+K +Q EK +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 671 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH C + E V E+++ G L + + K E ++
Sbjct: 66 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 117 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 160
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 161 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 607 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQ 662
+I G + F +GQG +GKV+ K D + A+K ++ +L+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 663 --GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--E 717
E L ++H +V L Y + ++ L+ +F+ G L +LS + E
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 718 PLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775
+ L++AL +LH+ + +RD+K NILLD + K+ DFGLS+
Sbjct: 126 EDVKFYLAELALALD------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-- 174
Query: 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
E I + GT Y+ PE + + +S D +S GV+ E+LTG P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+NF +G+G +GKV K G + AVK EK L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
+ FL++L C + +++ V EF++ G L + + E +A
Sbjct: 80 ARNHPFLTQLF---------CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+ AL +LH + + +RD+K N+LLDH+ K+ADFG+ + EG
Sbjct: 131 AEIISALM------FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EG 174
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE L L + D +++GV+ E+L G P
Sbjct: 175 ICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-14
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+FN +G+G +GKV KG + AVK EK L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLS--AKSKEPLG--FA 722
FL++LH C + +++ V E+++ G L + + KEP +A
Sbjct: 398 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 449 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 492
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+FN +G+G +GKV KG + AVK EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL++LH C + +++ V E+++ G L + + EP +A
Sbjct: 77 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 128 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 172 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 670
E+ L ++F IG+G + +V K G V A+K + + E F E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 724
L R + L + ++ + LV E+ G L LS + + +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ +A+ +H HRDIK NILLD ++ADFG +
Sbjct: 171 IVMAID------SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 785 PAHVST-VVKGTPGYLDPEYFLTHKLTDKSDVY-------SLGVVFLELLTGMQP 831
V + V GTP YL PE + Y +LGV E+ G P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F+ IG+G Y KV K + A++ +Q EK +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 671 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH C + E V E+++ G L + + K E ++
Sbjct: 109 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 160 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 203
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 204 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 54/213 (25%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTE 741
+ + + E + G L ++ + + F A + ++G I YLH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGE--AIQYLHSI 136
Query: 742 ADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K N+L K K+ DFG A Y
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE-------------TTGE--KY 175
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D D++SLGV+ LL G P
Sbjct: 176 -DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 39/233 (16%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 670
+M L +F IG+G +G+V K V A+K + + E F E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 724
L + + +L Y ++ + LV ++ G L LS E + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ IA+ +H HRDIK NIL+D ++ADFG + +
Sbjct: 184 MVIAID------SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KLME 227
Query: 785 PAHVSTVVK-GTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 831
V + V GTP Y+ PE + D +SLGV E+L G P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F +G+G +GKV +K A+K EK L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL+ + + E + V E+++ G L + + K +A
Sbjct: 74 AWEHPFLTHMF---------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+ + L +LH++ + +RD+K NILLD K+ADFG+ + E
Sbjct: 125 AEIILGLQ------FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-------EN 168
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
++ + GTP Y+ PE L + + S D +S GV+ E+L G P
Sbjct: 169 MLGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 43/286 (15%), Positives = 83/286 (29%), Gaps = 14/286 (4%)
Query: 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
L P + W N L L +
Sbjct: 272 GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC 331
Query: 112 DFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
+ ++ ++ + L L+ + T L EL +L ++ + + ++
Sbjct: 332 VLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII 389
Query: 172 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 231
L+ + S + R L + + E + +L
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL---RSKFLLENSVLKMEYADVRVL 446
Query: 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 291
L + + T + + + L L + L+ P L+ + L L S N L ++
Sbjct: 447 HLAHKDL--TVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD 502
Query: 292 P-GRLSLNITTIKLSNNKLTGTIPS--NFSGLPRLQRLFIANNSLS 334
L + + L NN+L + PRL L + NSL
Sbjct: 503 GVANLP-RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 49/325 (15%), Positives = 96/325 (29%), Gaps = 24/325 (7%)
Query: 72 CFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131
L + LS S + S + L M ++ S+ + ++
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--------GSLPKSFANLNKTRHF 183
+ + SL ++L + + A +
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
++ + + EL L + +N + + L LL + F
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK 303
M LR+ L ++ L L+ L + L +T +
Sbjct: 414 V---DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLD 469
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
LS+N+L +P + L L+ L ++N+L ++ + L L NN L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ-----ELLLCNNRLQ 521
Query: 364 NISGSFNIPPN---VTVRLRGNPFC 385
+ + V + L+GN C
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
++F+ IG+G +GKV K + AVK + +E + E+ L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH + + +++ V ++++ G L L + EP +A
Sbjct: 95 NVKHPFLVGLH---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++ ALG YLH+ + +RD+K NILLD + + DFGL + E
Sbjct: 146 AEIASALG------YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-------EN 189
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I ++ GTP YL PE L + D++ D + LG V E+L G+ P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 30/159 (18%), Positives = 65/159 (40%), Gaps = 35/159 (22%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 289
L+L+NN F + + +L K++ N + + + L+SN+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 290 IPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
+ L ++ T+ L +N++T + ++ F GL ++ L + +N ++ ++
Sbjct: 96 VQHKMFKGLE-SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP------ 146
Query: 346 TLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
F + L ++S T+ L NPF
Sbjct: 147 -----GAF------DTLHSLS---------TLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 18/154 (11%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLN 178
IP+ I + L LN NE T L + LP+L +I N I+ +F +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 179 KTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 236
+ +N + + ++ L SL ++L +N +T + + L + +L L +N
Sbjct: 82 GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 237 NFEGTTIPA-SYSNMSKLLKLSLRN------CSL 263
TT+ ++ + L L+L C L
Sbjct: 140 QI--TTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 21/164 (12%)
Query: 62 PCTSNWTGVLCFN---TTMDDG------YLHLRELQLLNLNLSGNLSPEIGRLSYLTILD 112
C T V C N + + L L + L +G +L L ++
Sbjct: 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFK----KLPQLRKIN 63
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSL 170
F NKI+ I + + +LL N L ++ ++ L L + + N I+ +
Sbjct: 64 FSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CV 120
Query: 171 PK-SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
SF L+ R + +N I+ + P L SL + L N
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+ F+ +G G +G+V K G A+K + + K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
++ LV L + +V E+++ G + L + EP +A ++ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH+ + +RD+K N+L+D + +V DFG ++ V T+
Sbjct: 156 ----YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLC 199
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP L PE + K +K+ D ++LGV+ E+ G P
Sbjct: 200 -GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 38/160 (23%)
Query: 231 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 288
++L+ N IP S KL ++ L N + PD + +L L L N++
Sbjct: 37 IRLEQNTI--KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 344
+P L ++ + L+ NK+ + + F L L L + +N L +I
Sbjct: 94 ELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK----- 145
Query: 345 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
TF + L I T+ L NPF
Sbjct: 146 ------GTF------SPLRAIQ---------TMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 33/157 (21%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
+ N+I IPP S L + L NN ++ L P+ L L L L N
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---R 294
T +P S + +L L L++N++N +
Sbjct: 92 I--TELPKS----------------------LFEGLFSLQLLLLNANKIN-CLRVDAFQD 126
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
L N+ + L +NKL FS L +Q + +A N
Sbjct: 127 LH-NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 6/134 (4%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
T + N I P K L + L+ N+++ L + L L+ + + N I+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSEL 225
LPKS F L + +N N I+ + + L +L + L +N L S L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 226 PKLLILQLDNNNFE 239
+ + L N F
Sbjct: 152 RAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 19/156 (12%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISG 120
C N +D L E+ + + L N + P L +D N+IS
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPK-SFANL 177
+ + ++SL L+L GN++T LP+ L L L + ++ N I+ L +F +L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
+ + +N + I S L ++ M L N
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 11/84 (13%)
Query: 289 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-WQSRT 346
IP L IT I+L N + IP FS +L+R+ ++NN +S + R+
Sbjct: 25 EIPTN-LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 347 LNATETFILDFQNNNLTNI-SGSF 369
LN L N +T + F
Sbjct: 82 LN-----SLVLYGNKITELPKSLF 100
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 66/284 (23%)
Query: 575 TISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQ 634
+ A+V L A KN + + T KI +R + ++ IG+
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR--------MKAEDYEVVKVIGR 79
Query: 635 GGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTEIQ--FLSRLHH 679
G +G+V K V A+K R+ E++ + ++ +L +
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 680 -----RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLG--FAMRLSIALGS 731
R L Y +V E+M G L + +S E + + +AL
Sbjct: 137 AFQDDRYL-----Y--------MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+H+ HRD+K N+LLD K+ADFG + EG+V T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCD--TA 229
Query: 792 VKGTPGYLDPEYFLTHKLT---DKS-DVYSLGVVFLELLTGMQP 831
V GTP Y+ PE + + D +S+GV E+L G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+F +G G +G+V+ + +G A+K ++ + K+ E LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
+ H ++ + G + + ++ +++ G L L + P+ +A + +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH++ + +RD+K NILLD K+ DFG ++ VP T+
Sbjct: 121 ----YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLC 164
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP Y+ PE ++ K +KS D +S G++ E+L G P
Sbjct: 165 -GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 624 NNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQEGSLQGEKEFLT 669
NF +G G YGKV+ K D G + A+K + E++ L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 670 EIQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--F 721
I+ FL LH Y + ++ L+ ++++ G L LS + + E +
Sbjct: 114 HIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781
+ +AL +LH + +RDIK NILLD + DFGLS+ E
Sbjct: 165 VGEIVLALE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-------E 208
Query: 782 GIVPAHVSTV-VKGTPGYLDPEYFLTHKL-TDKS-DVYSLGVVFLELLTGMQP 831
+ GT Y+ P+ DK+ D +SLGV+ ELLTG P
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 9e-12
Identities = 96/623 (15%), Positives = 181/623 (29%), Gaps = 185/623 (29%)
Query: 7 AVLFLFLCLCWSSSKIVVAADDDS-------ITDPIEVSALRSIKKSLV-DDYSKLSN-- 56
L LF L ++V ++ + PI+ + S++ Y + +
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT---EQRQPSMMTRMYIEQRDRL 119
Query: 57 WNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPE----IGR--LSYLTI 110
+N +N + YL LR+ LL L + N+ + G+ ++
Sbjct: 120 YNDNQVFAK-------YNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 111 LDFMWNKISGSIPKEI-----GNIKSLELLLLNGNEL--------------TGSLPEELG 151
L + K+ + +I N S E +L +L + ++ +
Sbjct: 172 LSY---KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 152 YL-PKLDRIQIDQNY-----I-----SGSLPKSFAN----LNKTRHFHMNNNSISGQIPP 196
+ +L R+ + Y + + +F L TR ++ +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR-----FKQVTDFLSA 283
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256
+ SL H + P E+ LL+ LD + +P + L
Sbjct: 284 ATTTHISLDHHSM------TLTPDEVKS---LLLKYLDCRPQD---LPREVLTTNPRR-L 330
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN 316
S+ S++ L+ N + ++ ++L T I+ S N L P+
Sbjct: 331 SIIAESIR---DGLATWDN--WKHVNCDKLT------------TIIESSLNVLE---PAE 370
Query: 317 FSGLPRLQRLFIANNSLSGSIPSS----IWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
+ RL + S IP+ IW + + +L P
Sbjct: 371 YR--KMFDRLSVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----P 421
Query: 373 PNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDR-STNSTLDCRAQSCPTDYEYSPTSPI 431
T+ + L E H + +D + T D P +Y
Sbjct: 422 KESTISIPSIYLELKVKLENEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQY-----F 473
Query: 432 RCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRW--------- 482
+G+ LK+ LF ++ LD FR+
Sbjct: 474 YSH------IGHHLKNIEHP---ERMTLFRM---------VF-LD---FRFLEQKIRHDS 511
Query: 483 ----EKGP------RLKMYLKLF----PVYDNSSGN--SYVFNASEVGRIRSMFTGWNIP 526
G +LK Y P Y+ ++ E I S
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN-LICS-------K 563
Query: 527 DSDIFGPYELINFTLQGPYRDVF 549
+D+ + L +F
Sbjct: 564 YTDL------LRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 1e-10
Identities = 77/461 (16%), Positives = 138/461 (29%), Gaps = 126/461 (27%)
Query: 77 MDDGYLHLRELQLLNLN-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS---- 131
MD E Q + LS + + D + +S I K
Sbjct: 7 MD---FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 132 ----LELLLLNGNE-----LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
LL E + L +L + I+ +Q S ++
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQRDRL-- 119
Query: 183 FHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF--- 238
N+N + +SR +L + L L+L
Sbjct: 120 --YNDNQV---FAKYNVSR------------------LQPYLKLRQAL-LELRPAKNVLI 155
Query: 239 EG------TTIPASYSNMSKLLK--------LSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
+G T + K+ L+L+NC P L + L + N
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEMLQKL-LYQIDPN 212
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA---NNSLSGSIPSSI 341
+ S + L I +I+ L+RL + N L + ++
Sbjct: 213 WTSRSDHSSNIKLRIHSIQ-----------------AELRRLLKSKPYENCLL--VLLNV 253
Query: 342 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDD 400
++ NA F + L +T R + L+ H
Sbjct: 254 QNAKAWNA---F--NLSCKIL------------LTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 401 DNEIDRSTN---STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYK 457
D + LDCR Q P E T+P R ++ ++ GL+ + +K
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPR--EVLTTNPRRL-----SIIAESIR-DGLATWDNWK 348
Query: 458 NLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKL--FP 496
++ + +T+ ++ +L L+ +R KM+ +L FP
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYR-------KMFDRLSVFP 382
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 57/350 (16%), Positives = 104/350 (29%), Gaps = 97/350 (27%)
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692
G G GK T VA+ +Q + +F +I +L+ + C+
Sbjct: 157 GVLGSGK---------TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSP 195
Query: 693 GE-----QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
Q L+Y+ N T R S+ K +R+ R +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLL----------K 239
Query: 748 HRDIKASNILLDHKFTAKVAD-FGL-------SRLAPVPD-IEGIVPAHVSTVVKGTPGY 798
+ + ++L + AK + F L +R V D + H+S + +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTL 298
Query: 799 LDPEYFLTHKLTDKSDVYSLGVV--FLELLTGMQPISHGKNIVREVN------IAYQSSM 850
E ++ +L+ P V N IA
Sbjct: 299 TPDE--------------VKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRD 339
Query: 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE--VMRE--------LESIWN 900
+ D N + + I+ +L + + R V L IW
Sbjct: 340 GLATWD-NWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 901 MMPESDTKTPEFINSEHTSK---EETPPSSSSMLKHPYVSSDVSGSNLVS 947
+ +SD + ++ E+ P S+ + Y+ V N +
Sbjct: 398 DVIKSD---VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 231 LQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNG 288
L L + T+ + + ++KL L+L LQ + LG L L++NQL
Sbjct: 40 LDLQSTGL--ATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 344
S+P G L+ + + L N+L ++PS F L +L+ L + N L SIP+ +
Sbjct: 97 SLPLGVFDHLT-QLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 345 RTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
T L N L ++ G+F+ + + L GN F
Sbjct: 154 ----LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
T + + ++ L L + LD N L L + +L +L L L NN
Sbjct: 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG--- 293
++P + ++++L KL L L+ P R+ L L L++NQL SIP G
Sbjct: 96 --ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 294 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
+L+ N+ T+ LS N+L F L +LQ + + N
Sbjct: 153 KLT-NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 90 LNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLP 147
L LS L+ LT L+ +N++ ++ + ++ L L L N+L SLP
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 148 EEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSL 204
+ +L +LD++ + N + SLP F L K + +N N + IP +L +L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ L N L L KL + L N F
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 36/163 (22%), Positives = 66/163 (40%), Gaps = 15/163 (9%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
LD ++ + L L L+ N+L +L + L +L + + N ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SE 224
SLP F +L + ++ N + +P + RL L + L+ N L +P +
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 225 LPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN----CS 262
L L L L N ++P ++ + KL ++L CS
Sbjct: 154 LTNLQTLSLSTNQL--QSVPHGAFDRLGKLQTITLFGNQFDCS 194
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 49/264 (18%), Positives = 94/264 (35%), Gaps = 49/264 (18%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---------- 678
+G G + V+ + + T VA+K R + + EI+ L R++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 679 -HRNLVSLVG---YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGS 731
+++ L+ + G + +V+E + L + K E G + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--KKYEHRGIPLIYVKQISKQL 140
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDH------KFTAKVADFGLSRLAPVPDIEGIVP 785
G+ Y+H + H DIK N+L++ K+AD G +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---------YD 189
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845
H + ++ T Y PE L +D++S + EL+TG +
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDD 247
Query: 846 YQSSMMFSVIDGNMGSYPSECVEK 869
+ + ++ G PS +
Sbjct: 248 DHIAQIIELL----GELPSYLLRN 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 38/217 (17%), Positives = 61/217 (28%), Gaps = 56/217 (25%)
Query: 609 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVK--------RAQEGS 660
G F++ L T +IG+G +G+V++ I D T VA+K
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 661 LQGEKEFLTEIQFLSRLH---------HRNLVSLVGYCDEEGE----------------- 694
+ +E L EI L + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 695 -------------QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V EF G L + A SI + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778
HRD+ N+LL K+ + + +P
Sbjct: 181 --LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 54/321 (16%), Positives = 101/321 (31%), Gaps = 57/321 (17%)
Query: 83 HLRELQLLNLNLS----GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI-----KSLE 133
+ ++L + L+ ++S + L L+ N++ + ++
Sbjct: 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88
Query: 134 LLLLNGNELT----GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L LT G L L LP L + + N + + +
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ------- 141
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQLDNNNFEGTTI-- 243
RL L L+ +L+ L L P L + NN+ +
Sbjct: 142 ---------CRLEKLQ---LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRV 189
Query: 244 --PASYSNMSKLLKLSLRNCSL--QGPMPDLSRI----PNLGYLDLSSNQLNGS----IP 291
+ +L L L +C + DL I +L L L SN+L +
Sbjct: 190 LCQGLKDSPCQLEALKLESCGVTSDN-CRDLCGIVASKASLRELALGSNKLGDVGMAELC 248
Query: 292 PGRLSLN--ITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
PG L + + T+ + +T G + L+ L +A N L + ++
Sbjct: 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308
Query: 346 TLNATETFILDFQNNNLTNIS 366
+ L ++ + T
Sbjct: 309 LEPGCQLESLWVKSCSFTAAC 329
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 48/290 (16%), Positives = 94/290 (32%), Gaps = 49/290 (16%)
Query: 108 LTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELT----GSLPEELGYLPKLDRIQID 162
+ LD ++S + E+ ++ +++ L+ LT + L P L + +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 163 QNYISGSLPKSFANLNKTRHFH-----MNNNSISGQ----IPPELSRLPSLVHMLLDNNN 213
N + +T + N ++G + L LP+L + L +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL-----QGPMP 268
L + L L LD +L KL L CSL +
Sbjct: 125 LGD------AGLQLLCEGLLDPQ--------------CRLEKLQLEYCSLSAASCEPLAS 164
Query: 269 DLSRIPNLGYLDLSSNQLNGS----IPPG--RLSLNITTIKLSNNKLT----GTIPSNFS 318
L P+ L +S+N +N + + G + +KL + +T + +
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368
L+ L + +N L + + ++ L +T
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 49/273 (17%), Positives = 85/273 (31%), Gaps = 48/273 (17%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL-----QLLNLNLSGN-LSPEIGRL--------- 105
DP L + + L + L +S N ++ R+
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 106 SYLTILDFMWNKISGSIPKEIGNI----KSLELLLLNGNELTGS-----LPEELGYLPKL 156
L L ++ +++ I SL L L N+L P L +L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 157 DRIQIDQNYIS----GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-----PSLVHM 207
+ I + I+ G L + + + N + + L L +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 208 LLDNNNLTG----YLPPELSELPKLLILQLDNNNFEGTTIP----ASYSNMSKLLKLSLR 259
+ + + T + L++ LL LQ+ NN E + S L L L
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 260 NCSL--QGPMPDLSRI----PNLGYLDLSSNQL 286
+C + L+ +L LDLS+N L
Sbjct: 379 DCDVSDSS-CSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 32/157 (20%), Positives = 53/157 (33%), Gaps = 15/157 (9%)
Query: 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP-MPDLSRI----PNLGYLDLS 282
+ L + + + + L +C L D+S P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 283 SNQLNGS----IPPG--RLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNS 332
SN+L + G S I + L N LTG + S LP LQ L +++N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 333 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 369
L + + + L + +L+ S
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 1e-09
Identities = 26/170 (15%), Positives = 46/170 (27%), Gaps = 23/170 (13%)
Query: 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQ 324
L NL L + + Q + L + + + + L + + F PRL
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-------------NISGSFNI 371
RL ++ N+L S+ Q +L L N L G
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQ-----ELVLSGNPLHCSCALRWLQRWEEEGLGGVPE 137
Query: 372 PPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPT 421
N + + +D + L C+ +
Sbjct: 138 QKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGL 187
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 18/105 (17%), Positives = 40/105 (38%), Gaps = 6/105 (5%)
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI 243
+ ++ L +L + ++N +L L L +L L + + +
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL--RFV 71
Query: 244 PA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287
++ +L +L+L +L+ + +L L LS N L+
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 17/96 (17%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 121 SIPKEIGNIKSL-ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
+ ++L EL + N L +L L +L + I ++ + P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+++ N++ + + + SL ++L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 61 DPCTSNW-TGVLCFNTTMDD------GYLHLRELQLLNLNLSGNLSPE-IGRLSYLTILD 112
D C + +G+ C D G +L EL + N +L + L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + + + + L L L+ N L SL + L + + N
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
P + L +T + L +D+I + + I S+ L
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNV 65
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFE 239
R+ + N + L L +L +++L N L LP + +L L L L N
Sbjct: 66 RYLALGGNKL--HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL- 121
Query: 240 GTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---R 294
++P + ++ L L+L + LQ + ++ NL LDLS NQL S+P G +
Sbjct: 122 -QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 295 LSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 331
L+ + ++L N+L ++P F L LQ +++ +N
Sbjct: 180 LT-QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 32/147 (21%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 290
L + T + ++ + ++ N ++ + + +PN+ YL L N+L+ I
Sbjct: 24 ANLKKKSV--TDAVT-QNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH-DI 78
Query: 291 PP-GRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 348
L+ N+T + L+ N+L ++P+ F L L+ L + N L S+P ++
Sbjct: 79 SALKELT-NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK---- 131
Query: 349 ATETFILDFQNNNLTNISGSFNIPPNV 375
T L+ +N L ++P V
Sbjct: 132 LTNLTYLNLAHNQLQ------SLPKGV 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 21/161 (13%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+G LEL +++ +EL LD + ++ + G +
Sbjct: 2 EMGRRIHLELRNRTPSDV-----KEL----VLDNSRSNEGKLEGLT----DEFEELEFLS 48
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
N ++ I L +L L + L +N ++G L + P L L L N + +
Sbjct: 49 TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 280
+ L L L NC + + D +P L YLD
Sbjct: 107 EPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 11/142 (7%)
Query: 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI---KSLELLLLNGNELTGSLPEELGYLP 154
+ E+ + + + + + + K G + LE L LT S+ L L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNN 212
KL ++++ N +SG L H +++ N I I P L +L +L + L N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
Query: 213 ---NLTGYLPPELSELPKLLIL 231
NL Y LP+L L
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 25/146 (17%), Positives = 54/146 (36%), Gaps = 22/146 (15%)
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 306
M + + L LRN + ++ L L +++ N G + + N
Sbjct: 2 EMGRRIHLELRNRTPS----------DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN 51
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
LT +I +N L +L++L +++N +SG + + L L+ N + ++S
Sbjct: 52 VGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT-----HLNLSGNKIKDLS 104
Query: 367 GSFNIPPN---VTVRLRGNPFCLNTN 389
+ ++ L +
Sbjct: 105 TIEPLKKLENLKSLDLFNCEVTNLND 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 42/167 (25%), Positives = 60/167 (35%), Gaps = 21/167 (12%)
Query: 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178
SGS ++ LEL + EL LD + + I G L F NL
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVR-----EL----VLDNCKSNDGKIEG-LTAEFVNL- 51
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ N + + L +LP L + L N + G L +LP L L L N
Sbjct: 52 --EFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 280
+ + + L L L NC + + D +P L YLD
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 11/111 (9%)
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
++ + + L+L N + L L + + NL +L L +
Sbjct: 9 DMKRRIHLELRNRTPAAV----------RELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 284 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L S+ + ++LS N++ G + LP L L ++ N L
Sbjct: 59 VGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 22/142 (15%)
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 306
+M + + L LRN + + L L + + N G + N+ + L N
Sbjct: 9 DMKRRIHLELRNRTPA----------AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
L ++ SN LP+L++L ++ N + G + + L L+ N L +IS
Sbjct: 59 VGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT-----HLNLSGNKLKDIS 111
Query: 367 GSFNIPPN---VTVRLRGNPFC 385
+ ++ L
Sbjct: 112 TLEPLKKLECLKSLDLFNCEVT 133
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 13/115 (11%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-P--MPDLSRIPNLGYLDLSSNQL 286
IL L +N P + ++ L +L L + L P + D + L LDL +NQL
Sbjct: 44 ILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQL 100
Query: 287 NGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338
+P RL ++ + + NKLT +P L L L + N L SIP
Sbjct: 101 T-VLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 12/146 (8%)
Query: 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-Y 247
S+ IP L L +N +T P L L L L +N +P +
Sbjct: 33 SVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQL--GALPVGVF 84
Query: 248 SNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLS 305
++++L L L L P R+ +L L + N+L +P G L ++T + L
Sbjct: 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANN 331
N+L F L L ++ N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
+ ++++N I+ P L +L + L +N L LP + L +L +L L N
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL 100
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---R 294
T +P++ + + L +L + L + R+ +L +L L NQL SIP G R
Sbjct: 101 --TVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157
Query: 295 LSLNITTIKLSNN 307
LS ++T L N
Sbjct: 158 LS-SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 34/130 (26%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
IL N+I+ P ++ +L+ L L N+L +LP + L +L + + N ++
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 226
LP + F L + M N ++ +P + RL L H+ LD N L L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 227 KLLILQLDNN 236
L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 631 QIGQGGYGKVYKGI---------LPDGTVVAVKR-AQEGSLQGEKEFLT------EIQFL 674
+ G +Y+ P ++K A++G L E+ F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 675 SRLHHRNLV---SLVGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+L+ L+ + +G+ + + + LV + +L+ L K L L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLS-RLAP----VPDIEGI 783
+ +LH H ++ A NI +D + ++V A +G + R P V +EG
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 784 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
H G + +D HK + +SD+ SLG L+ L G P
Sbjct: 225 RSPHE-----GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 255 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 311
+L L +LS +L +DLS+N+++ ++ ++ + T+ LS N+L
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT-QLLTLILSYNRLR- 91
Query: 312 TIPSN-FSGLPRLQRLFIANNSLSGSIP 338
IP F GL L+ L + N +S +P
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 16/121 (13%)
Query: 271 SRIP-NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 326
IP ++ L L NQ ++ P LS ++T I LSNN+++ T+ + FS + +L L
Sbjct: 27 KGIPRDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTL 83
Query: 327 FIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNP 383
++ N L IP + L +L N+++ + G+FN ++ + + NP
Sbjct: 84 ILSYNRLR-CIPPRTFDGLKSLR-----LLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137
Query: 384 F 384
Sbjct: 138 L 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 25/140 (17%)
Query: 63 CTSNWTGVLCFN-----------TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
CT T V C N + + YL + L+ E+ +LT++
Sbjct: 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLV--------PKELSNYKHLTLI 59
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGS 169
D N+IS ++ + N+ L L+L+ N L +P L L + + N IS
Sbjct: 60 DLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-V 116
Query: 170 LPK-SFANLNKTRHFHMNNN 188
+P+ +F +L+ H + N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 28/154 (18%), Positives = 59/154 (38%), Gaps = 7/154 (4%)
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
+ + ++L + A+ S + L+L +++ + LS + NL L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS 76
Query: 281 LSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340
L N + ++ + + +S N++ ++ S L L+ L+++NN ++
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN--WGE 132
Query: 341 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 374
I + L+ E L N L N N
Sbjct: 133 IDKLAALDKLED--LLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 26/127 (20%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 111 LDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL 170
L M I + + +K+ + L L+ N + + L + L + + +N I +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 171 PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL 229
A + ++ N I+ + + +L +L + + NN +T + + L+ L KL
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 230 ILQLDNN 236
L L N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 30/161 (18%)
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLT---GYLPPELSELPKLLILQLDNNNFEG 240
H I + LS L + H+ L NN+ LS + L IL L N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI-- 82
Query: 241 TTIPASYSNMSKLLKLSLRN---CSLQGPMPDLSRIPNLGYLDLSSNQLN--GSIPPGRL 295
I + L +L + SL G + ++ NL L +S+N++ G I
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 296 SLNITTIKLSNNKLTGTIPSNFSG----------LPRLQRL 326
+ + L+ N L N + LP L++L
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 22/166 (13%)
Query: 82 LHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+ E + + L+ + + L L N I I + +++L +L L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIP 195
N + + L+ + I N I+ SL L R +M+NN I+ G+I
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPE----------LSELPKLLIL 231
L+ L L +LL N L + LP L L
Sbjct: 135 K-LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 14/145 (9%)
Query: 252 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNKLT 310
+ ++L ++ LS + +L LS+N + I + N+ + L N +
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKISSLSGME-NLRILSLGRNLIK 83
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
I + + L+ L+I+ N ++ S+ S I + L +L NN +TN
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR-----VLYMSNNKITNWGEIDK 135
Query: 371 IPPN---VTVRLRGNPFCLNTNAEQ 392
+ + L GNP +
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENN 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------N 681
IG+G +G+V K + VA+K + ++ Q E++ L ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V L + LV+E +S L D L + + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 742 ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ + H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---------QLGQRIYQYIQ-SRFYR 225
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE L D++SLG + +E+ TG +P+ G N
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSL-QGEKEFLTEIQFLSRLHHR------N 681
IG+G +G+V K VA+K R ++ Q EI+ L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLH 739
++ ++ + +E +S L + + K + GF++ L A + + LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 740 TEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ H D+K NILL + KV DFG S V T ++ +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---------YEHQRVYTYIQ-SRF 264
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
Y PE L + D++SLG + ELLTG P+ G++ E + Q + M ++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED---EGD---QLACMIELL-- 315
Query: 858 NMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVM---RELESIWNMMPESDTK 908
G + ++ F+ S V+ R PES
Sbjct: 316 --GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373
Query: 909 TPEFINSEH 917
+
Sbjct: 374 GNALKGCDD 382
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 50/271 (18%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQ---FLSRLHH 679
IGQGG+G +Y + V + G L E +F + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 680 RNLVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMR--L 725
+ +G + Y FM + + + + F+ + L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------FSRKTVL 155
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGI 783
++L + Y+H H DIKASN+LL++K +V D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 784 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGM---QPISHG 835
A GT + +D H + + D+ LG ++ LTG +
Sbjct: 213 YAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 836 KNIVREVNIAYQ-SSMMFSVIDGNMGSYPSE 865
VR+ I Y+ + + P E
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGE 298
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G +Y G + G VA+K E + E + + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 690 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 744
EG+ ++V E + S L + S K F+++ L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 745 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 802 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ SLG V + G P
Sbjct: 185 N---THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 52/335 (15%)
Query: 632 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 680
+G+G +GKV + + + VA+K R EI L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKF 82
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYL 738
V + + + G + +E + + L K + + +A + +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHV 788
H + + H D+K NIL + + + S I H
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848
+T+V T Y PE L DV+S+G + E G +
Sbjct: 197 TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE---NRE---HL 248
Query: 849 SMMFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMM 902
MM ++ G PS + + F K L ++ +D R + E + L+S
Sbjct: 249 VMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR-YVKENCKPLKSYMLQD 303
Query: 903 PESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937
+ + + + + L HP+ +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 18/209 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G++Y G + VA+K E + L E + L + V +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 690 DEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
EG+ +LV + + G + L L L +A + ++H+++ H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 749 RDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
RDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---VN 183
Query: 806 THKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ SLG V + L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 690 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 744
+EG +LV + + S L D K F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 745 PVFHRDIKASNILLDHKFTAK-----VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 800 DPEYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ +LG VF+ L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 13/140 (9%)
Query: 148 EELGYLPKLDRIQIDQNYIS--GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
+ + + + I +L + ++N I ++ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQF---DAIDFSDNEIR-KLDG-FPLLRRLK 67
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+L++NN + LP L L L NN+ +++ L L + +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
Query: 266 PMPD-----LSRIPNLGYLD 280
+ ++P + LD
Sbjct: 128 -KKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
A Y+N + +L LR + + + +D S N++ + L + T+ +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 71
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+NN++ LP L L + NNSL
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/163 (18%), Positives = 57/163 (34%), Gaps = 40/163 (24%)
Query: 79 DGYLHLRELQLLNLNLSGNLSPEI----GRLSYLTILDFMWNKISGSIPKEIGNI---KS 131
Y + + L+L G P I L +DF N+I +++ +
Sbjct: 13 AQYTNAVRDR--ELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRR 65
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
L+ LL+N N + LP L + + N + +L+
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDP------------ 108
Query: 192 GQIPPELSRLPSLVHMLLDNN---NLTGYLPPELSELPKLLIL 231
L+ L SL ++ + N N Y + ++P++ +L
Sbjct: 109 ------LASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 288
L L++N + + + L+KL L+ L G P+ ++ L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
I L + T+ L +N+++ +P +F L L L +A+N
Sbjct: 92 EISNKMFLGLH-QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 20/135 (14%)
Query: 260 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 312
+C+ +G L IP + L L+ N+L G ++ ++L N+LT
Sbjct: 14 DCTGRG----LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 313 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFN 370
I N F G +Q L + N + I + ++ L+ +N ++ + GSF
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLH-QLKT---LNLYDNQISCVMPGSFE 123
Query: 371 IPPNVT-VRLRGNPF 384
++T + L NPF
Sbjct: 124 HLNSLTSLNLASNPF 138
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVA-----VKRAQEGSLQGEKEFLTEIQ---FLSRLHHRN 681
+IG GG+G +Y A V+ + G L E +F + + + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 682 LVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMRLSIAL 729
+ +G + Y FM L+ ++L I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIRM 160
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGIVPAH 787
+ Y+H H DIKA+N+LL +K +V AD+GLS +
Sbjct: 161 LDV--LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 788 VSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
GT + LD HK L+ +SDV LG L L G P
Sbjct: 216 PRKGHNGTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 54/305 (17%), Positives = 96/305 (31%), Gaps = 91/305 (29%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL-----HHRNLV 683
+G G + V+ + VA+K ++ E + + EI+ L + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 684 SLVGYCDE------EGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+V D+ G + +V+E + + L + + + L I +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 737 YLHTEADPPVFHRDIKASNILL-------------------------------------- 758
YLHT+ + H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 759 -----------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
K K+AD G + E I Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----------YRSLEVLIGS 268
Query: 808 KLTDKSDVYSLGVVFLELLTG---MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
+D++S + EL TG +P S + E +IA ++ + +G P
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA----LIIEL----LGKVPR 320
Query: 865 ECVEK 869
+ +
Sbjct: 321 KLIVA 325
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 8e-06
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 16/175 (9%)
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNM 250
+ P L +P L ++ + N L L I+ + I S N+
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 251 SKL-LKLSLRNCSLQGPMPDLS------RIPNLGYLDLSSNQLNGSIPPGRLSL----NI 299
KL L + + + G M R PNL +L + + + L +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 300 TTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 350
T+ +S LT + + + L+ + + N LS + + +S +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 9e-05
Identities = 23/161 (14%), Positives = 53/161 (32%), Gaps = 21/161 (13%)
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL--SRL 201
L L +P L+ ++I K NL + + + + + ++ S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 202 PSLVHMLLD---NNNLTGYLPPELSEL------PKLLILQLDNNNF--EGTTIPASYSNM 250
P+L ++L + L P L L + + + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 251 SKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQL 286
+L + + L + + +I +L ++++ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 8/68 (11%)
Query: 275 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 330
L L LS NQ+ S+P G +L+ +T + L NKL ++P+ F L +L+ L +
Sbjct: 53 QLTKLSLSQNQIQ-SLPDGVFDKLT-KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109
Query: 331 NSLSGSIP 338
N L S+P
Sbjct: 110 NQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 230 ILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 287
L+L++N ++P + +++L KLSL +Q P ++ L L L N+L
Sbjct: 32 RLELESNKL--QSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 288 GSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
S+P G +L+ + + L N+L F L LQ++++ N
Sbjct: 90 -SLPNGVFDKLT-QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-P 266
L++N L +L +L L L N ++P + ++KL L L LQ P
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQI--QSLPDGVFDKLTKLTILYLHENKLQSLP 92
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNN 307
++ L L L +NQL S+P G RL+ ++ I L N
Sbjct: 93 NGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT-SLQKIWLHTN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSL 297
T++P + L L N P + +L L L N+L S+P G +L+
Sbjct: 20 TSVPTGIPAQTTYLDLE-TNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT- 76
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
++T + LS N+L F L +L+ L + N L S+P ++ T+ L
Sbjct: 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFD----KLTQLKDLRL 131
Query: 358 QNNNLTNI-SGSFNIPPNVT-VRLRGNPF 384
N L ++ G F+ ++ + L NP+
Sbjct: 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 45/340 (13%), Positives = 91/340 (26%), Gaps = 92/340 (27%)
Query: 89 LLNLNLSGN---------LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELL 135
+ +L + + + + + N I + + I + K LE+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 136 LLNGNEL----------TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL---NKT-R 181
+ L + L PKL +++ N + + + +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 182 HFHMNNNSIS-------------GQIPPELSRLPSLVHMLLDNNNLTG----YLPPELSE 224
H +++NN + + + P L ++ N L
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 225 LPKLLILQLDNNNF--EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
L +++ N EG + LL L C L LDL
Sbjct: 186 HRLLHTVKMVQNGIRPEG---------IEHLLLEGLAYC------------QELKVLDLQ 224
Query: 283 SNQLNGSIPPGRLSL--------NITTIKLSNNKLTG----------TIPSNFSGLPRLQ 324
N G +L N+ + L++ L+ + N LQ
Sbjct: 225 DNTFT---HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN----IGLQ 277
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
L + N + ++ + L+ N +
Sbjct: 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 40/254 (15%), Positives = 76/254 (29%), Gaps = 52/254 (20%)
Query: 88 QLLNLNLSGN---------LSPEIGRLSYLTILDFMWNKIS-------------GSIPKE 125
+L + LS N L + + + L L N + ++ K+
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154
Query: 126 IGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYI-----SGSLPKSFAN 176
N L ++ N L + L +++ QN I L + A
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 177 LNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTG----YLPPELSEL--P 226
+ + + +N+ + + L P+L + L++ L+ + S+L
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 227 KLLILQLDNNNFEGTTIP----ASYSNMSKLLKLSLRNCSL--QGPMPD-----LSRIPN 275
L L+L N E + M LL L L + + D S
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 334
Query: 276 LGYLDLSSNQLNGS 289
+L +
Sbjct: 335 GELDELDDMEELTD 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 48/333 (14%)
Query: 632 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 680
+G+G +GKV + I G VAVK + + +EIQ L L+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V ++ + + G +V+E + + D + P +A + + +LH
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHVST 790
+ H D+K NIL + + + R I H ST
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850
+V T Y PE L + DV+S+G + +E G + + +M
Sbjct: 194 LVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHD---SKE---HLAM 245
Query: 851 MFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
M ++ G P ++K F L + + R +S + L+
Sbjct: 246 MERIL----GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR-YVSRACKPLKEFMLSQDV 300
Query: 905 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937
+ + I + LKHP+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
NF +IG G +G++ G L VA+K E + E +F +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 683 VSLVGYCDEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILY 737
+ V Y G+ +V E + S L D F+++ L IA+ + Y
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEY 120
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAK-----VADFGLSR 773
+H++ + +RD+K N L+ + DF L++
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 51/303 (16%), Positives = 97/303 (32%), Gaps = 48/303 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRL-----HHRNL 682
+G G +G+V + + AVK R + + E L ++ ++ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V G L++E + +L + ++ + + + + YL
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--- 154
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA---------------- 786
+ H D+K NILLD + K +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846
+ +++ T Y PE L SD++S G V EL TG + +
Sbjct: 215 YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHE---HME--- 266
Query: 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI---WNMMP 903
+MM S+I P + + K ++ + + + E + SI +P
Sbjct: 267 HLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 904 ESD 906
Sbjct: 323 LYK 325
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 31/140 (22%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L ++ D + ++ ++ LN+ I +P L+ + L NN L
Sbjct: 134 LKGLRSDPDLVAQNI---DVVLNRRSCMAATLRIIE-------ENIPELLSLNLSNNRLY 183
Query: 216 G--YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-----LLKLSLRNCSLQGPMP 268
+ + + P L IL L N + S + K L +L L SL
Sbjct: 184 RLDDMSSIVQKAPNLKILNLSGNELK------SERELDKIKGLKLEELWLDGNSLCDTFR 237
Query: 269 D--------LSRIPNLGYLD 280
D R P L LD
Sbjct: 238 DQSTYISAIRERFPKLLRLD 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 956 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.44 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.16 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.72 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.7 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.6 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.1 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.21 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.74 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.29 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 95.28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 95.15 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 94.34 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 94.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.47 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 93.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 92.7 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 92.54 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 92.08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 92.03 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 91.65 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 91.63 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 91.36 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 91.15 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 90.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 90.59 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 90.38 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.08 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 90.02 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 89.83 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 89.27 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 89.18 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 89.08 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 88.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 88.91 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.89 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 88.56 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 88.22 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 88.14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 87.88 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 86.32 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 85.53 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.66 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 82.42 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=456.52 Aligned_cols=262 Identities=30% Similarity=0.486 Sum_probs=223.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 478899999988777777899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-----------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 698 VYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
|||||++|+|.++++..+ ...++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 356999999999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~ 845 (956)
+|||+|+.....+ .........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +..
T Consensus 170 ~DFGla~~~~~~~-----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~--- 240 (299)
T 4asz_A 170 GDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVI--- 240 (299)
T ss_dssp CCCSCHHHHTGGG-----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHH---
T ss_pred CCcccceecCCCC-----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHH---
Confidence 9999998654322 1122234569999999999999999999999999999999999 89999765432 111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
..+..+.....|+.+++++.+++.+||+.+|++||++.++.+.|+++.+..|
T Consensus 241 ------~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 241 ------ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp ------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 1223344556678888999999999999999999999999999999877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=457.82 Aligned_cols=262 Identities=29% Similarity=0.498 Sum_probs=216.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666789999999999999864 478999999988777777899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 698 VYEFMSNGTLRDQLSAKS-------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
|||||++|+|.++++... ..+++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 246899999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~ 843 (956)
||+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||....... ...
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AID 271 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-HHH
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-HHH
Confidence 9999999987643321 122344579999999999999999999999999999999999 899997654321 111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
.+..+.....|+.+++++.+++.+||+.+|++||++.+|++.|+.+.+..|
T Consensus 272 ---------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 272 ---------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp ---------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred ---------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 223334456677888999999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=452.94 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=216.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+++..++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455789999999999999863 468999999975432 335789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
|||||++|+|.++|+.+. ...++|..+++|+.|||+||+|||+++ ||||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999997532 235899999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~ 842 (956)
+||+|||+|+.....+. ........||+.|||||++.++.|+.++|||||||++|||+| |+.||...... +..
T Consensus 184 ~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-~~~ 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVV 257 (308)
T ss_dssp EEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-HHH
T ss_pred EEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 99999999986543221 122344679999999999999999999999999999999999 89999764432 111
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
. .+..+...+.|++++..+.+++.+||+.+|.+||+|.+|++.|+.+.
T Consensus 258 ~---------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 E---------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H---------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 22334455678889999999999999999999999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=455.54 Aligned_cols=264 Identities=22% Similarity=0.378 Sum_probs=215.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999975 69999999997544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 999999999753 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||...... +...
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~------------------- 280 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK------------------- 280 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHH-------------------
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHH-------------------
Confidence 2234567999999999999999999999999999999999999999754321 1111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
.+.... +..-+.. +...+.+.+||.+||+.||++|+|++|+|+||||+....-
T Consensus 281 ----------~i~~~~---~~~~~~~--------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 281 ----------MIRDNL---PPRLKNL--------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ----------HHHHSS---CCCCSCG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ----------HHHcCC---CCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 011000 0000000 0112234578899999999999999999999999877654
Q ss_pred Ccccc
Q 002178 943 SNLVS 947 (956)
Q Consensus 943 ~~~~~ 947 (956)
+.+++
T Consensus 334 ~~l~p 338 (346)
T 4fih_A 334 ASIVP 338 (346)
T ss_dssp GGTGG
T ss_pred cccCc
Confidence 44444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=439.12 Aligned_cols=266 Identities=26% Similarity=0.450 Sum_probs=214.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..++|++.++||+|+||+||+|++++ .||||+++.. .....+.|.+|++++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34677888999999999999999753 5999998743 33445789999999999999999999999865 5689999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|||++|+|.++++... ..+++.++..|+.|||+||+|||+++ ||||||||+|||+++++++||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp ECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999997643 46999999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....+.......... ....
T Consensus 187 -----~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~-----~~~~ 256 (307)
T 3omv_A 187 -----GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR-----GYAS 256 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----TCCC
T ss_pred -----cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----CCCC
Confidence 1223345679999999999964 45899999999999999999999999765443222221111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
+.....+.+++..+.+++.+||+.+|++||+|.++++.|+.+...+|+
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 233345677889999999999999999999999999999988776664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=444.05 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=209.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 69999999987532 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997653 5899999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+.... +....
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~---------i~~~~- 250 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAK---------IIKLE- 250 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HHHTC-
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH---------HHcCC-
Confidence 1 1233456799999999999999999999999999999999999999975432 111110 00000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC------CCC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 933 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~------L~H 933 (956)
..+|+ ...+.+.+||.+||+.||++|+|++|+ ++|
T Consensus 251 ~~~p~---------------------------------------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 251 YDFPE---------------------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp CCCCT---------------------------------------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred CCCCc---------------------------------------ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 01111 112233478888999999999999985 789
Q ss_pred CccccC
Q 002178 934 PYVSSD 939 (956)
Q Consensus 934 P~f~~~ 939 (956)
|||++-
T Consensus 292 p~F~~i 297 (311)
T 4aw0_A 292 PFFESV 297 (311)
T ss_dssp GGGTTC
T ss_pred CCcCCC
Confidence 999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=457.05 Aligned_cols=265 Identities=22% Similarity=0.370 Sum_probs=217.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 6999999999765555556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
|+||+|.++++.. .+++..+..|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999999753 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ...
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~------------------ 357 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMK------------------ 357 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHH------------------
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHH------------------
Confidence 22345679999999999999999999999999999999999999997543211 111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+......... ..+...+.+.+||.+||+.||++|+|++|+|+||||+....
T Consensus 358 -----------~i~~~~~~~~~-----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 358 -----------MIRDNLPPRLK-----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp -----------HHHHSCCCCCS-----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------HHHcCCCCCCc-----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 11110000000 00111233457899999999999999999999999987765
Q ss_pred CCcccc
Q 002178 942 GSNLVS 947 (956)
Q Consensus 942 ~~~~~~ 947 (956)
-+.+++
T Consensus 410 p~~l~p 415 (423)
T 4fie_A 410 PASIVP 415 (423)
T ss_dssp GGGTGG
T ss_pred Cccccc
Confidence 555554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=444.80 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=209.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999965 69999999987543 3345689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
||+||+|.+++..+....+++..++.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998776667899999999999999999999999 999999999999999999999999999875311
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
........||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+... .+..+..+
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~---------~i~~~~~~ 243 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVL---------KIISGSFP 243 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH---------HHHHTCCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH---------HHHcCCCC
Confidence 1223456799999999999999999999999999999999999999976543 22211 22333444
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
..+..++.++.+++.+|++.||.+||++.++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 556667788899999999999999999998875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=433.85 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=195.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999964 699999999875432 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+ +|+|.+++..++ .+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 789999997653 5899999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|||||++.+..+ +.++||||+||++|||+||+.||..... .....
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~--------------- 222 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFK--------------- 222 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH---------------
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHH---------------
Confidence 22344679999999999998876 5799999999999999999999965321 11111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
.+..+.-.-|. ..++.+.+|+.+||+.||++|+|++|+|+||||+.
T Consensus 223 --------------~i~~~~~~~p~--------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 223 --------------NISNGVYTLPK--------------------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------HHHHTCCCCCT--------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------HHHcCCCCCCC--------------------CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11111000000 01223347888999999999999999999999987
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
+.+
T Consensus 269 ~~p 271 (275)
T 3hyh_A 269 DLP 271 (275)
T ss_dssp TCC
T ss_pred CCC
Confidence 653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=440.34 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=208.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+.|++.++||+|+||+||+|++. +|+.||||+++.... ..+|++++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46778889999999999999975 699999999975432 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~ 781 (956)
+||+|.++++..+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 5899999999999999999999999 99999999999999988 6999999999876533211
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC--
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-- 859 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 859 (956)
. .........||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+..+.....
T Consensus 208 ~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------~~~~i~~~~~~~ 275 (336)
T 4g3f_A 208 K--SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----------LCLKIASEPPPI 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----------CHHHHHHSCCGG
T ss_pred c--ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----------HHHHHHcCCCCc
Confidence 1 0112234579999999999999999999999999999999999999997543211 1111111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
...++.++..+.+++.+||+.||.+||++.|+++.+....
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 2346677889999999999999999999999999887664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=431.58 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=198.6
Q ss_pred CCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeeccccc----CCcEEEEE
Q 002178 627 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 699 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~LV~ 699 (956)
+..++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45668999999999999975 6899999998653 23345679999999999999999999999854 34689999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~ 778 (956)
|||++|+|.+++++.. .+++..+..|+.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997653 5889999999999999999999875 46999999999999985 79999999999986432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||....+........ ..+.
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i---------~~~~ 246 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGV 246 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTTC
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH---------HcCC
Confidence 12345679999999998865 69999999999999999999999997544332211111 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
. | +... +...+.+.+|+.+||+.||++|||++|+|+||||+.
T Consensus 247 ~---~----------------------~~~~-------------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 247 K---P----------------------ASFD-------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp C---C----------------------GGGG-------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred C---C----------------------CCCC-------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0 0 0000 001122346788889999999999999999999986
Q ss_pred C
Q 002178 939 D 939 (956)
Q Consensus 939 ~ 939 (956)
+
T Consensus 289 ~ 289 (290)
T 3fpq_A 289 E 289 (290)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=440.71 Aligned_cols=271 Identities=25% Similarity=0.418 Sum_probs=225.1
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCC-Cceeee
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHH-RNLVSL 685 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~nIv~l 685 (956)
+...+++...++|++.+.||+|+||+||+|.+.. ++.||||+++..... ..+.|.+|+++|+++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445677778899999999999999999998642 468999999865443 35679999999999965 899999
Q ss_pred ecccccC-CcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccC
Q 002178 686 VGYCDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750 (956)
Q Consensus 686 ~~~~~~~-~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 750 (956)
+|+|.+. +..++|||||++|+|.++|+... ...+++..++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998664 57899999999999999997532 345899999999999999999999999 99999
Q ss_pred CCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CC
Q 002178 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829 (956)
Q Consensus 751 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~ 829 (956)
|||+|||+++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 999999999999999999999987643321 123345679999999999999999999999999999999998 89
Q ss_pred CCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 830 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 830 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.||........... .+..+.....|+.+++++.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 286 ~Pf~~~~~~~~~~~---------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 286 SPYPGVKIDEEFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSSTTCCCSHHHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99975432221111 1223344566778889999999999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=439.23 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=170.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|++.+.||+|+||+||+|+.. .++.||||+++.... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 478999999875322 223468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|||||+||+|.+++.+.. .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 5899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.. .......||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 179 ~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 179 HE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 21 2234567999999999999999999999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=436.01 Aligned_cols=303 Identities=19% Similarity=0.276 Sum_probs=212.5
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
...++|++.++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++++.+ +||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34688999999999999999999853 46899999987543 345688999999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeeccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRL 774 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla~~ 774 (956)
++||||+++|+|.+++. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 3888999999999999999999999 9999999999999877 7999999999986
Q ss_pred cCCCCCCCc---------------------cccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCC
Q 002178 775 APVPDIEGI---------------------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPI 832 (956)
Q Consensus 775 ~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf 832 (956)
......... ..........||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543221100 001122345799999999999875 5899999999999999999999999
Q ss_pred CCCchhHHHHHHHhhccc----------chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 833 SHGKNIVREVNIAYQSSM----------MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
..+.+..++......... ....... ....|......+.+.+...-... |...............+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~----p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILC-SKEVPAQDLRKLCERLRGMDSST----PKLTSDIQGHATNLEGW 322 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEE-SSCCCCCCHHHHHHHHC--------------------------C
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccc-cccCcchhhhHHHHhhccccccc----ccccccccccccccccc
Confidence 877665444332211000 0000000 00111111111111111111111 11111111111111223
Q ss_pred CCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 903 PESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 903 ~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+...+++.|||++||++||++|+||+|+|+||||++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 344556789999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=437.88 Aligned_cols=287 Identities=22% Similarity=0.365 Sum_probs=215.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccc------cCCc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD------EEGE 694 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~------~~~~ 694 (956)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999965 79999999997543 334567889999999999999999999864 3468
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.|||||||+ |+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999654 46999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
+...... .........||+.|||||++.+. .++.++||||+||++|||++|+.||...... +........
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~----- 278 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV----- 278 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH-----
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh-----
Confidence 6432211 12234456899999999998875 5689999999999999999999999755432 222221110
Q ss_pred hccCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 854 VIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
.+.++......+ .......+...|...|.. +...++..++.+.|||.+||++||++|+||+|+|+
T Consensus 279 -----~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 -----LGTPSPAVIQAVGAERVRAYIQSLPPRQPVP---------WETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----HCCCCGGGTC-----CHHHHHHSSCCCCCCC---------HHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCCCChHHhhhhhhhhhhhhhhcCCCcCCCC---------HHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 011111110000 001112222334333321 11234555667789999999999999999999999
Q ss_pred CCccccC
Q 002178 933 HPYVSSD 939 (956)
Q Consensus 933 HP~f~~~ 939 (956)
||||+.-
T Consensus 345 Hp~f~~~ 351 (398)
T 4b99_A 345 HPFLAKY 351 (398)
T ss_dssp SGGGTTT
T ss_pred CHhhCcC
Confidence 9999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=417.93 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC----cEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~LV~ 699 (956)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567788999999999999998 689999999975322 2223345666677899999999999997653 579999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-----CCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
|||++|+|.++++.. ++++..+.+++.|+++||+|||++ ..++||||||||+|||++.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 489999999999999999999987 234599999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccC------CCCCcccchhHHHHHHHHHhCCCCCCCCch-----------
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN----------- 837 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~G~ll~elltg~~pf~~~~~----------- 837 (956)
....... .........||+.|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 158 ~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 158 HDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 6432211 11122345799999999999764 467799999999999999999877642211
Q ss_pred --hHHHHHHHhhcccchhhccCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 838 --IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 838 --~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
........... ....+..+. .+.+++..+.+++.+||+.+|++||+|.++++.|+++.+
T Consensus 235 ~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 235 DPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111100 011111111 123577889999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=418.02 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=190.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCC--------
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-------- 693 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 693 (956)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999965 699999999875443 34568899999999999999999999986543
Q ss_pred ----cEEEEEecCCCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 694 ----EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 694 ----~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
..|+|||||++|+|.+++..+.. ...++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 23455668899999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCCCcc-----ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002178 769 FGLSRLAPVPDIEGIV-----PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843 (956)
Q Consensus 769 fGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~ 843 (956)
||+|+........... .....+...||+.|||||++.+..|+.++|||||||++|||++ ||....+......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543211110 0112344579999999999999999999999999999999996 7753221111100
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCC
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 923 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 923 (956)
.+.. ..+|+. ..+. .+...+|+.+||+.||++
T Consensus 239 ---------~~~~---~~~p~~----------------------~~~~--------------~~~~~~li~~~L~~dP~~ 270 (299)
T 4g31_A 239 ---------DVRN---LKFPPL----------------------FTQK--------------YPCEYVMVQDMLSPSPME 270 (299)
T ss_dssp ---------HHHT---TCCCHH----------------------HHHH--------------CHHHHHHHHHHTCSSGGG
T ss_pred ---------HHhc---CCCCCC----------------------Cccc--------------CHHHHHHHHHHcCCChhH
Confidence 0000 011111 0000 011236888899999999
Q ss_pred CCCCccCCCCCccccC
Q 002178 924 PPSSSSMLKHPYVSSD 939 (956)
Q Consensus 924 R~sa~e~L~HP~f~~~ 939 (956)
|||++|+|+||||.+-
T Consensus 271 Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 271 RPEAINIIENAVFEDL 286 (299)
T ss_dssp SCCHHHHHTSGGGCCC
T ss_pred CcCHHHHhcCHhhCCC
Confidence 9999999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=432.11 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=213.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|..+ +|+.||+|++........+.+.+|+++|+.++||||++++++|.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC--CcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DfGla~~~~~~~ 779 (956)
|+||+|.+++..+ ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999653 345999999999999999999999999 9999999999999854 89999999999876432
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||........ ... +.....
T Consensus 311 -------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~---------i~~~~~ 373 (573)
T 3uto_A 311 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRN---------VKSCDW 373 (573)
T ss_dssp -------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH---------HHTTCC
T ss_pred -------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHH---------HHhCCC
Confidence 223455799999999999999999999999999999999999999975433211 110 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
.++ +. .++...+.+.+||.+||+.||++|+|++|+|+||||+..
T Consensus 374 -~~~------------------~~-----------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 374 -NMD------------------DS-----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp -CCC------------------SG-----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -CCC------------------cc-----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 000 00 011122334589999999999999999999999999754
Q ss_pred C
Q 002178 940 V 940 (956)
Q Consensus 940 ~ 940 (956)
.
T Consensus 418 ~ 418 (573)
T 3uto_A 418 N 418 (573)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=428.58 Aligned_cols=197 Identities=27% Similarity=0.395 Sum_probs=171.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHH---HHHHHHhcCCCceeeeecccccCCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLT---EIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+ ++++++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999965 699999999864321 11223333 466777789999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|||||+||+|.+++...+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997654 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22 1234579999999999975 5799999999999999999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.63 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=211.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999995 47899999998765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 4889999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............... . .....
T Consensus 171 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~-------~~~~~ 237 (297)
T 3fxz_A 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G-------TPELQ 237 (297)
T ss_dssp -----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-C-------SCCCS
T ss_pred -----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C-------CCCCC
Confidence 1233456999999999999999999999999999999999999999754432211111000 0 00000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+..+ .....+++.+||..||++|||++|+|+||||+....
T Consensus 238 ~~~~~---------------------------------------~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 238 NPEKL---------------------------------------SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp CGGGS---------------------------------------CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred Ccccc---------------------------------------CHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 01111 111236788889999999999999999999987665
Q ss_pred CC
Q 002178 942 GS 943 (956)
Q Consensus 942 ~~ 943 (956)
-+
T Consensus 279 ~~ 280 (297)
T 3fxz_A 279 LS 280 (297)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=382.31 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999997 57999999998653 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999997653 4889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCccccceecccccCCCcccccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|+|||++.+..+. .++||||+||++|||++|+.||..... .....
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~--------------- 224 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-KELRE--------------- 224 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH---------------
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-HHHHH---------------
Confidence 123455799999999999988775 789999999999999999999975432 11111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
.+.......|. ...+...+++++||..||++|||++|+++||||..
T Consensus 225 --------------~i~~~~~~~p~--------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 225 --------------RVLRGKYRIPF--------------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp --------------HHHHCCCCCCT--------------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred --------------HHHhCCCCCCC--------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 00000000010 01122346788889999999999999999999976
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
...
T Consensus 271 ~~~ 273 (328)
T 3fe3_A 271 GHE 273 (328)
T ss_dssp TCT
T ss_pred CCc
Confidence 543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=380.66 Aligned_cols=285 Identities=43% Similarity=0.752 Sum_probs=233.6
Q ss_pred ccCCcccccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeee
Q 002178 607 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSL 685 (956)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l 685 (956)
.......+++.++....++|++.+.||+|+||+||+|...+++.||||++...... ....+.+|++++++++||||+++
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 34456778999999999999999999999999999999888999999998764332 23468999999999999999999
Q ss_pred ecccccCCcEEEEEecCCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 686 ~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+...++|+||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998643 345899999999999999999999992223999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC-------Cc
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-------GK 836 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~-------~~ 836 (956)
+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ..
T Consensus 173 ~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp EEECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred EEeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 9999999998764322 2233445699999999999999999999999999999999999999952 11
Q ss_pred hhHHHHHHHhhcccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
...++..............+... ...+.+.+..+.+++..|++.+|.+||++.++++.|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 12233222222233333333332 35678899999999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=378.46 Aligned_cols=279 Identities=43% Similarity=0.716 Sum_probs=232.1
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.+.++...+++|++.+.||+|+||+||+|.+++++.||||++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33444557789999999999999999999988899999999887666666789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
.++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999997543 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch-----hHHHHHHHhh
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQ 847 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~-----~~~~~~~~~~ 847 (956)
+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+......
T Consensus 187 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 187 KKGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp EECSSSS-----CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccc-----ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 8654222 11223345689999999999999999999999999999999999999965321 2222222222
Q ss_pred cccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 848 SSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 848 ~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
...+...+++.. ...+.+++..+.+++.+|++.+|++||++.++++.|+.+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 333334444433 345788999999999999999999999999999999988653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=378.24 Aligned_cols=276 Identities=25% Similarity=0.352 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4689999999999999999999988999999998754322 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 996 5898888654 345899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 174 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------------- 231 (311)
T 3niz_A 174 ------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---------------- 231 (311)
T ss_dssp ------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH----------------
T ss_pred ------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH----------------
Confidence 12234568999999999976 5689999999999999999999999975433211111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH---------HhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE---------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~---------~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
+...+-...|...+...++....+ .+....+.......+|+.+||.+||++|||++|+
T Consensus 232 -------------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 232 -------------IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp -------------HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred -------------HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 001111111111111110000000 0011122333445689999999999999999999
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
|+||||++-
T Consensus 299 l~hp~f~~~ 307 (311)
T 3niz_A 299 MNHPYFKDL 307 (311)
T ss_dssp HTSGGGTTS
T ss_pred hcCcccccC
Confidence 999999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.57 Aligned_cols=298 Identities=30% Similarity=0.509 Sum_probs=252.3
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC-CCCCceeecCCCCCCCcceeeEEEeCCCCccc--cCCcCcCCCCC
Q 002178 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (956)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~--~~~~~l~~l~~ 107 (956)
.|.+.|++||++||+++.++. .+.+|..+++|| +.|.||+|...+ ...+++.|+|+++++++ .+|+.|+++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~---~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCC---CCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 588999999999999998765 688998765554 459999997532 22589999999999999 89999999999
Q ss_pred CCEEEccC-CCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecc
Q 002178 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (956)
Q Consensus 108 L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (956)
|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 99999995 99999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCccccCCCc-ccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCcc
Q 002178 187 NNSISGQIPPELSRLP-SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (956)
Q Consensus 187 ~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (956)
+|++++.+|..+..++ +|++|+|++|++++.+|..+..+. |++|+|++|.+++ ..|..|.++++|+.|+|++|.+++
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC-cCCHHHhcCCCCCEEECCCCceee
Confidence 9999999999999998 999999999999988998888887 9999999999987 578888888888888888888887
Q ss_pred CCCCCCCCCCccEEEccCCcCCcCCCCCCCcc-ccCEEEccCCcCCCCCchhcCCCCcCCeEeccccc-CCC
Q 002178 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS-LSG 335 (956)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~ 335 (956)
.++.+..+++|++|+|++|++++.+|..+... +|+.|+|++|++++.+|.. ..+++|+.|++++|+ +.|
T Consensus 236 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred ecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 77777777788888888777776666654432 5666666666666666654 666666666666665 443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=392.03 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=212.1
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh---HHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
+.+.++....++|++.++||+|+||+||+|+.. +++.||+|+++...... ...+.+|..++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566677899999999999999999999976 58999999987422211 23478899999999999999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 345899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
|+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...
T Consensus 220 Gla~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~ 292 (437)
T 4aw2_A 220 GSCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGK 292 (437)
T ss_dssp TTCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH
T ss_pred hhhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHh
Confidence 9997654322 12234467999999999997 46789999999999999999999999975432111 110
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCC
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 923 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 923 (956)
++.... -.-|.. .+...+.+.+||++||..+|++
T Consensus 293 ----------------------------i~~~~~~~~~p~~-----------------~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 293 ----------------------------IMNHKERFQFPTQ-----------------VTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp ----------------------------HHTHHHHCCCCSS-----------------CCCSCHHHHHHHHTTSSCGGGC
T ss_pred ----------------------------hhhccccccCCcc-----------------cccCCHHHHHHHHHHhcccccc
Confidence 000000 000110 0112233457888888888888
Q ss_pred --CCCCccCCCCCccccC
Q 002178 924 --PPSSSSMLKHPYVSSD 939 (956)
Q Consensus 924 --R~sa~e~L~HP~f~~~ 939 (956)
|++++|+++||||++-
T Consensus 328 ~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 328 LGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp TTTTTTHHHHTSGGGTTC
T ss_pred cCCCCHHHHhCCCccCCC
Confidence 8999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=372.11 Aligned_cols=270 Identities=22% Similarity=0.322 Sum_probs=215.4
Q ss_pred ccccHHHHHHHhcC----------CCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC
Q 002178 612 RSFTYGEMALATNN----------FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 680 (956)
Q Consensus 612 ~~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 680 (956)
+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777888777764 667789999999999999976 7999999999866655667899999999999999
Q ss_pred ceeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC
Q 002178 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 760 (956)
Q Consensus 681 nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~ 760 (956)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999999864 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH
Q 002178 761 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840 (956)
Q Consensus 761 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~ 840 (956)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999998654321 112345699999999999999999999999999999999999999975432111
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCC
Q 002178 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 920 (956)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~d 920 (956)
.... .... .|... .. ....+...+++.+||..|
T Consensus 250 -~~~~---------~~~~----------------------~~~~~-~~--------------~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 250 -MKRL---------RDSP----------------------PPKLK-NS--------------HKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp -HHHH---------HHSS----------------------CCCCT-TG--------------GGSCHHHHHHHHHHSCSS
T ss_pred -HHHH---------hcCC----------------------CCCcC-cc--------------ccCCHHHHHHHHHHccCC
Confidence 1000 0000 00000 00 000112236778889999
Q ss_pred CCCCCCCccCCCCCccccCCC
Q 002178 921 EETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 921 P~~R~sa~e~L~HP~f~~~~~ 941 (956)
|++|||++|+++||||.....
T Consensus 283 p~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCCC
T ss_pred hhhCcCHHHHhcChhhccCCC
Confidence 999999999999999976543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=377.62 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999975 6899999998754322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGl 771 (956)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 45899999999999999999999999 99999999999998877 799999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~------- 229 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------- 229 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH-------
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------
Confidence 98764321 12345699999999999999999999999999999999999999975432111 110
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
+... ...++...+ +.....+.+||.+||..||++|||++|+|
T Consensus 230 --i~~~-~~~~~~~~~-----------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 230 --ITAV-SYDFDEEFF-----------------------------------SQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp --HHTT-CCCCCHHHH-----------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --HHhc-CCCCCchhc-----------------------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000 111111110 11122345789999999999999999999
Q ss_pred CCCcccc
Q 002178 932 KHPYVSS 938 (956)
Q Consensus 932 ~HP~f~~ 938 (956)
+||||..
T Consensus 272 ~hp~~~~ 278 (361)
T 2yab_A 272 RHPWITP 278 (361)
T ss_dssp TSTTTSC
T ss_pred cCcCcCC
Confidence 9999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=378.79 Aligned_cols=262 Identities=25% Similarity=0.476 Sum_probs=217.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
.++|++.+.||+|+||+||+|.+. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 356899999976533 3456789999999999 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC--------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 35789999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~ 837 (956)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999866433211 11233457789999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
. +... .+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 312 ~-~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 E-ELFK---------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp G-GHHH---------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-HHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111 12223334556677889999999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=373.58 Aligned_cols=276 Identities=24% Similarity=0.392 Sum_probs=210.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 689999999875332 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|++ |++.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 996 5776666543 345899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||....+..+.......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~------------ 217 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------------ 217 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH------------
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH------------
Confidence 2233456899999999998765 899999999999999999999998766554433332211
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--------HHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--------LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~--------L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
.+-...+...+.+...... ........+..+....+|+.+||+.||++|||++|+|
T Consensus 218 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 218 ----------------LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp ----------------HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----------------HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 1111111111111100000 0000111222333446899999999999999999999
Q ss_pred CCCccccC
Q 002178 932 KHPYVSSD 939 (956)
Q Consensus 932 ~HP~f~~~ 939 (956)
+||||+.-
T Consensus 282 ~hp~f~~~ 289 (292)
T 3o0g_A 282 QHPYFSDF 289 (292)
T ss_dssp TSGGGTTC
T ss_pred cCcccccC
Confidence 99999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=382.05 Aligned_cols=203 Identities=26% Similarity=0.405 Sum_probs=173.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 696 (956)
..++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999975 68999999987532 22345678899999988 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999997653 4889999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 176 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 176 CN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 21 122345679999999999999999999999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=382.59 Aligned_cols=301 Identities=19% Similarity=0.243 Sum_probs=226.6
Q ss_pred CcccccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----CCcee
Q 002178 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLV 683 (956)
Q Consensus 610 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv 683 (956)
....+++++.....++|++.++||+|+||+||+|... +++.||||++.. .....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 4556777788888899999999999999999999974 689999999975 3344557788999999996 99999
Q ss_pred eeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---
Q 002178 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--- 760 (956)
Q Consensus 684 ~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--- 760 (956)
++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 999999998876667999999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhH
Q 002178 761 ----------------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSL 818 (956)
Q Consensus 761 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~ 818 (956)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999864321 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHH-------hcccCCCCCCCHHHH
Q 002178 819 GVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK-------CCQDETDARPSMSEV 891 (956)
Q Consensus 819 G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~-------c~~~~p~~RPs~~~v 891 (956)
||++|||++|+.||............ .......|............. .....|.........
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~-----------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMM-----------ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHH-----------HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHH-----------HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 99999999999999765432211111 011123333322221110000 001112222222221
Q ss_pred HHHHHHhHh-hCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 892 MRELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 892 ~~~L~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
. .+..... .....++.+.+|+.+||+.||++|||++|+|+||||+
T Consensus 315 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 315 K-HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp H-HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred h-hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1 1111100 0011233445899999999999999999999999995
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=375.01 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=195.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367889999999999999999975 69999999987532 22345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999997643 4889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... .. .
T Consensus 159 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i---------~~-~ 220 (337)
T 1o6l_A 159 G-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELI---------LM-E 220 (337)
T ss_dssp T-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH---------HH-C
T ss_pred C-------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HHHHHH---------Hc-C
Confidence 1 1234457999999999999999999999999999999999999999754321 111111 11 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARP 886 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP 886 (956)
...+|...+..+.+++.+|++.+|.+||
T Consensus 221 ~~~~p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhc
Confidence 1223444455666666666666666665
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=385.13 Aligned_cols=307 Identities=19% Similarity=0.216 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeee--CCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+| +||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 69999999987533 3334678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998776667999999999999999999999999 99999999999999999999999999865432
Q ss_pred CCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
................||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. . .......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-N-GTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-c-CCCCccc
Confidence 21111111122233468999999999987 679999999999999999999999997543322111100 0 0000000
Q ss_pred cCCCCCCChHH-HH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 856 DGNMGSYPSEC-VE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 856 ~~~~~~~~~~~-~~----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
+.. ..+.+. .. ................||...+.. .........+.+.+|+.+||+.||++|||++|+
T Consensus 259 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 259 DTS--TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP-----SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ccc--ccccccccccccccccccccccccccCccccccCCCC-----CCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 000 000000 00 000000000000001111111000 000111223445679999999999999999999
Q ss_pred CCCCccccCCC
Q 002178 931 LKHPYVSSDVS 941 (956)
Q Consensus 931 L~HP~f~~~~~ 941 (956)
|+||||+....
T Consensus 332 l~hp~f~~~~~ 342 (389)
T 3gni_B 332 LNHSFFKQIKR 342 (389)
T ss_dssp TTSGGGGGC--
T ss_pred hcCHHHHHHhh
Confidence 99999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=370.24 Aligned_cols=275 Identities=23% Similarity=0.352 Sum_probs=205.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||+||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578899999999999999999888999999998754332 236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ ++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 96 59999987542 45889999999999999999999999 9999999999999999999999999998654221
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~------------- 215 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI-FR------------- 215 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HH-------------
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HH-------------
Confidence 12234468999999999976 45899999999999999999999999765432221111 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--------HHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL--------ESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L--------~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
..-...+...|...+....- ..+....+..++...+++.+||..||++|||++|+|+
T Consensus 216 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 216 ---------------ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp ---------------HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------------HHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000001000000000 0000111222334458999999999999999999999
Q ss_pred CCccccC
Q 002178 933 HPYVSSD 939 (956)
Q Consensus 933 HP~f~~~ 939 (956)
||||++.
T Consensus 281 hp~f~~~ 287 (288)
T 1ob3_A 281 HAYFKEN 287 (288)
T ss_dssp SGGGGC-
T ss_pred Ccchhhc
Confidence 9999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=386.14 Aligned_cols=209 Identities=22% Similarity=0.307 Sum_probs=180.1
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
..++....++|++.+.||+|+||+||+|+.. +++.||+|+++..... ..+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999976 5899999998642211 12357889999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
++..++||||+++|+|.++++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999753 4788999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
|+...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 215 a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 215 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 98754321 11233567999999999998765 7899999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=382.56 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=175.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.++||+|+||+||+|+.+ +++.||+|+++..... ..+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467899999999999999999975 5889999998754222 224578899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997653 4899999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 1 1223456799999999999999999999999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.36 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=216.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||+||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999974 3557999999864 33445689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999654 345899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+..
T Consensus 204 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~---------~~~~ 269 (325)
T 3kul_A 204 DPDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-IS---------SVEE 269 (325)
T ss_dssp ---C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HH---------HHHT
T ss_pred Cccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-HH---------HHHc
Confidence 2211 112233456778999999999999999999999999999999 9999975543221 11 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
+.....+..++..+.+++..||..+|.+||++.++++.|+.+....+
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 22334566778899999999999999999999999999999876544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.63 Aligned_cols=280 Identities=35% Similarity=0.612 Sum_probs=231.8
Q ss_pred CcccccHHHHHHHhcCCCCC------CeeeeeCCeEEEEEEeCCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhcCC
Q 002178 610 GVRSFTYGEMALATNNFNSS------TQIGQGGYGKVYKGILPDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHH 679 (956)
Q Consensus 610 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 679 (956)
....|++.++..++++|... +.||+|+||+||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 67899999986532 2335688999999999999
Q ss_pred CceeeeecccccCCcEEEEEecCCCCCHHHHHhhc-CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 680 ~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
|||+++++++.+.+..++||||+++|+|.+++... ...++++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999999753 2356899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~ 838 (956)
+.++.+||+|||+++...... .........||+.|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFA-----QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCS-----SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cCCCcEEEeeccccccccccc-----ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999998654322 1122234568999999998865 5789999999999999999999999754321
Q ss_pred ---HHHHHHH-hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 839 ---VREVNIA-YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 839 ---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
....... .....+...++......+..++..+.+++..||+.+|.+||++.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 112223444555666678889999999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=366.54 Aligned_cols=267 Identities=32% Similarity=0.498 Sum_probs=211.7
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.++....++|++.+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444567899999999999999999987 68899999987644 3334678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
.++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999976432 24889999999999999999999875 459999999999999999999999999997
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 188 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------- 252 (309)
T 3p86_A 188 LKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------- 252 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------
T ss_pred cccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence 543221 12234569999999999999999999999999999999999999997654322111111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
........+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 253 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 -FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11223345667778899999999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=371.67 Aligned_cols=199 Identities=24% Similarity=0.417 Sum_probs=176.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999975 699999999875322 2345778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999997643 5889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1234569999999999999999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=372.23 Aligned_cols=260 Identities=19% Similarity=0.342 Sum_probs=208.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 68999999987543 3445788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--CCcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~ 779 (956)
+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999654 345899999999999999999999999 999999999999987 789999999999876432
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +..+.
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~---------i~~~~- 219 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIEN---------IMNAE- 219 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH---------HHHTC-
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHH---------HHcCC-
Confidence 12344568999999999999889999999999999999999999997543211 1110 00000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..++... ++.....+.+++.+||..||++|||++|+|+||||...
T Consensus 220 ~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 220 YTFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCChhh-----------------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 0111100 01122233478888999999999999999999998765
Q ss_pred CC
Q 002178 940 VS 941 (956)
Q Consensus 940 ~~ 941 (956)
..
T Consensus 265 ~~ 266 (321)
T 1tki_A 265 IE 266 (321)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=373.66 Aligned_cols=203 Identities=26% Similarity=0.425 Sum_probs=176.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 695 (956)
...++|++.+.||+|+||+||+|+.+ +|+.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999999999999975 68999999987532 12345678899999887 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999997643 4889999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 169 MLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp CCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 3211 1234567999999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=380.56 Aligned_cols=305 Identities=25% Similarity=0.341 Sum_probs=207.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcC-CCceeeeecccccC--CcE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQ 695 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~ 695 (956)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++++. ||||+++++++..+ ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 6899999998643 3344567889999999997 99999999998644 478
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++|||||+ |+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999763 5888999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCC--------------ccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH
Q 002178 776 PVPDIEG--------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840 (956)
Q Consensus 776 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~ 840 (956)
....... ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311100 001122344579999999999987 6789999999999999999999999976544322
Q ss_pred HHHHHhhcccc--hhhccCCCCCCChHHHHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccc
Q 002178 841 EVNIAYQSSMM--FSVIDGNMGSYPSECVEKFIKLALKCCQD-ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917 (956)
Q Consensus 841 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~c~~~-~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L 917 (956)
.......... .+.+......+.. .+.+-....... ....+..+......+... ...+...+.+.+|+.+||
T Consensus 240 -~~~i~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 240 -LERIIGVIDFPSNEDVESIQSPFAK----TMIESLKEKVEIRQSNKRDIFTKWKNLLLKI-NPKADCNEEALDLLDKLL 313 (388)
T ss_dssp -HHHHHHHHCCCCHHHHHTSCCSSHH----HHHHHHHHHCC-----CCCCHHHHHHHHHHH-CTTCCCCHHHHHHHHHHC
T ss_pred -HHHHHHhcCCCCHHHHHhccCHHHH----HHHHhCcccccccCCCHHHhCcchhhhcccc-cccccCCHHHHHHHHHhh
Confidence 2221110000 0000000011111 111111111111 111222333333222221 112234556789999999
Q ss_pred CCCCCCCCCCccCCCCCccccC
Q 002178 918 TSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 918 ~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
++||++|+|++|+|+||||+.-
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999998653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=411.95 Aligned_cols=335 Identities=25% Similarity=0.391 Sum_probs=287.3
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCCCceeecCCCCCCCcceeeEEEeCCCCcccc---CC---------
Q 002178 32 TDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN---LS--------- 99 (956)
Q Consensus 32 ~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~---~~--------- 99 (956)
+.+.|++||++||+++.|+. .+++|+.+++|| .|+||+|.. .+|+.|+|+++++.|. ++
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C-~w~gv~C~~-------~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSSNKNPC-TFDGVTCRD-------DKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGG-GSTTEEEET-------TEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCc-CCcceEECC-------CcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 35789999999999999877 899998776765 799999961 4899999999998886 43
Q ss_pred --------------cCcCCCCCCCEEEccCCCCcccCCc--ccccCcccchhhccCcCCCCCCCCcc-CCCcccceeecc
Q 002178 100 --------------PEIGRLSYLTILDFMWNKISGSIPK--EIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQID 162 (956)
Q Consensus 100 --------------~~l~~l~~L~~L~Ls~N~l~~~ip~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls 162 (956)
+.|+++++|++|+|++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|+|+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 5778888889999999988888887 88888999999999998888888776 788899999999
Q ss_pred cccccCCCCcc---ccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 163 QNYISGSLPKS---FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 163 ~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
+|++++..|.. +.++++|++|+|++|.+++..+. ..+++|++|+|++|++++.+|. ++.+++|++|+|++|.++
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 236 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence 99988887776 78888999999999998876664 7889999999999999988877 999999999999999998
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccCCcCCCCCchhc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNF 317 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~ 317 (956)
+ .+|..+.++++|++|+|++|.+++..+.. .+++|++|+|++|++++.+|..... .+|++|+|++|.+++.+|..|
T Consensus 237 ~-~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 237 G-DFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp S-CHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred C-cccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 7 68889999999999999999999877766 8899999999999999999987654 589999999999999999999
Q ss_pred CCCCcCCeEecccccCCCcCChh-hhhhccCCCCcceEEEccCCCCC-CCCCCC-CCC-CCcEEEecCCccc
Q 002178 318 SGLPRLQRLFIANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLT-NISGSF-NIP-PNVTVRLRGNPFC 385 (956)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~l~~~~L~~L~L~~N~L~-~l~~~~-~~~-~l~~l~l~~Np~~ 385 (956)
+++++|+.|+|++|+++|.+|.. +..+ ++|+.|+|++|+++ .+|..+ .++ .++.|++++|.+.
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l-----~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~ 381 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKM-----RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTC-----TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEE
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcC-----CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcC
Confidence 99999999999999999888876 6554 44568999999988 566665 354 8888999888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=372.71 Aligned_cols=290 Identities=22% Similarity=0.401 Sum_probs=198.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999965 6899999998754332 33678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC----CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 701 FMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
|++ |+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999986532 245889999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... ..
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~------~~ 225 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFD------IM 225 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH------HH
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH------Hh
Confidence 221 11234468999999999986 4689999999999999999999999976543221 111110 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARP--SMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP--s~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
.. .+...+..+.++. -+..+...++ ...+. +.. ......+....+|+.+||+.||++|||++|+|+|
T Consensus 226 ~~----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GT----PNESLWPSVTKLP--KYNPNIQQRPPRDLRQV---LQP--HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CS----CCTTTCGGGGGCT--TCCTTCCCCCCCCSHHH---HGG--GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----CChhHhhhhhhhh--hcccccccccchhHHHh---hcc--cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 0000000000000 0000011111 11111 110 0111223445689999999999999999999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||+....
T Consensus 295 p~f~~~~~ 302 (317)
T 2pmi_A 295 PWFAEYYH 302 (317)
T ss_dssp GGGGGGCC
T ss_pred hhhhcccc
Confidence 99976433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.41 Aligned_cols=283 Identities=25% Similarity=0.352 Sum_probs=206.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcC---CCceeeeeccccc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 691 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 691 (956)
...++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999996 468999999986322 111245667877777664 9999999999876
Q ss_pred CC-----cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEE
Q 002178 692 EG-----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 692 ~~-----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
.. ..++||||++ |+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 54 5799999996 69999998776666999999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~ 846 (956)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 162 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~ 232 (308)
T 3g33_A 162 ADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIF 232 (308)
T ss_dssp CSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH-HHHH
T ss_pred eeCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 9999998654221 224457899999999999999999999999999999999999999765432221 1111
Q ss_pred hcccchhhccCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCC
Q 002178 847 QSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 923 (956)
Q Consensus 847 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 923 (956)
..... .....+. ..+. . ...+....... ...++......+++.+||..||++
T Consensus 233 ~~~~~--~~~~~~~~~~~~~~-----------~--~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~ 287 (308)
T 3g33_A 233 DLIGL--PPEDDWPRDVSLPR-----------G--AFPPRGPRPVQ----------SVVPEMEESGAQLLLEMLTFNPHK 287 (308)
T ss_dssp HHHCC--CCTTTSCSSCSSCG-----------G--GSCCCCCCCHH----------HHSCSCCHHHHHHHHHHTCSSTTT
T ss_pred HHhCC--CChhhccchhhccc-----------c--ccCCCCCCcHH----------HhCccccHHHHHHHHHHhcCCCcc
Confidence 10000 0000000 0000 0 00011111111 122444455568999999999999
Q ss_pred CCCCccCCCCCccccCCC
Q 002178 924 PPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 924 R~sa~e~L~HP~f~~~~~ 941 (956)
|||++|+|+||||+.+..
T Consensus 288 R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 288 RISAFRALQHSYLHKDEG 305 (308)
T ss_dssp SCCHHHHHTSTTC-----
T ss_pred CCCHHHHhcCccccCCCC
Confidence 999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=390.30 Aligned_cols=284 Identities=21% Similarity=0.314 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 693 (956)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999965 6899999998753 333456788999999999999999999998554 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999964 67777743 3888999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ +.....
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~------ 277 (464)
T 3ttj_A 213 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIE------ 277 (464)
T ss_dssp ----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH------
T ss_pred ecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH------
Confidence 65421 123446799999999999999999999999999999999999999976544332 222111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCC-------CCCCccccccccCCCCCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~-------~~~~~~ll~~~L~~dP~~R~ 925 (956)
..+..+.+....+...........|... ..+..... ...++.. .+.+.+||.+||++||++|+
T Consensus 278 ----~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 278 ----QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP-----DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp ----HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC-----GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred ----hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc-----ccccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 0122222222222222222222222211 12111100 0000000 12356899999999999999
Q ss_pred CCccCCCCCcccc
Q 002178 926 SSSSMLKHPYVSS 938 (956)
Q Consensus 926 sa~e~L~HP~f~~ 938 (956)
|++|+|+||||+.
T Consensus 349 ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 349 SVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHTSTTTGG
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=375.17 Aligned_cols=260 Identities=22% Similarity=0.395 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999975 6899999999876665667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--CCcEEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~ 779 (956)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999654 345899999999999999999999999 999999999999974 5789999999998764321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 206 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~--------------- 261 (387)
T 1kob_A 206 --------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQN--------------- 261 (387)
T ss_dssp --------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH---------------
T ss_pred --------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHH---------------
Confidence 12334699999999999999999999999999999999999999975432111 110
Q ss_pred CCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 860 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+..+ +...+.. ++...+.+.+|+.+||..||++|||++|+|+||||..
T Consensus 262 --------------i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 262 --------------VKRCDWEFDEDA-----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp --------------HHHCCCCCCSST-----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred --------------HHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 0111 0000000 0111222346888889999999999999999999976
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
+..
T Consensus 311 ~~~ 313 (387)
T 1kob_A 311 DHS 313 (387)
T ss_dssp CCT
T ss_pred Ccc
Confidence 543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=371.23 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=175.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|.++++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999975 68999999987532 23345678899999988 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997643 4889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 G-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1 223455799999999999999999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.96 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999975 6899999998754322 356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGl 771 (956)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999653 45899999999999999999999999 99999999999999887 899999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------- 229 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-------
Confidence 98764221 123456999999999999999999999999999999999999999754321111000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
... ...++... .+.......+|+.+||..||++|||++|+|
T Consensus 230 ---~~~-~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 230 ---SAV-NYEFEDEY-----------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp ---HHT-CCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---Hhc-CCCcCccc-----------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000 00111100 011122234788889999999999999999
Q ss_pred CCCccccC
Q 002178 932 KHPYVSSD 939 (956)
Q Consensus 932 ~HP~f~~~ 939 (956)
+||||...
T Consensus 271 ~hp~~~~~ 278 (326)
T 2y0a_A 271 QHPWIKPK 278 (326)
T ss_dssp HSTTTSCC
T ss_pred cCCCccCC
Confidence 99999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=364.69 Aligned_cols=268 Identities=23% Similarity=0.426 Sum_probs=215.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 6899999998776667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999764 345899999999999999999999999 999999999999999999999999999876433211
Q ss_pred Ccc-------ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 782 GIV-------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 782 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+.......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~ 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhcc
Confidence 000 0111124579999999999999999999999999999999999999986422100000 0000000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.. ...+..++..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 240 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 LD---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HH---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 1123445567899999999999999999999999999887654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=370.75 Aligned_cols=204 Identities=27% Similarity=0.412 Sum_probs=174.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 789999999865432 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC-
Confidence 99999999998653 45899999999999999999999999 9999999999999999999999999998654222
Q ss_pred CCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122334579999999999988775 778999999999999999999997543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=380.20 Aligned_cols=213 Identities=28% Similarity=0.314 Sum_probs=182.8
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
+.+++.....++|++.+.||+|+||+||+|+.+ +|+.||+|+++..... ..+.+.+|.+++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667789999999999999999999975 6999999998753221 123578899999999999999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
.+.+..++||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997643 35889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccc-------cCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
|+++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9998764321 11223457999999999997 3568999999999999999999999997544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.90 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=202.0
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCC-C---cEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPD-G---TVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
+.....++|++.+.||+|+||+||+|.+.. + ..||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456789999999999999999999653 3 28999998764 23345689999999999999999999999977
Q ss_pred CCcE------EEEEecCCCCCHHHHHhhcC----CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC
Q 002178 692 EGEQ------MLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 692 ~~~~------~LV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
.+.. ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 6654 99999999999999996532 225899999999999999999999999 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHH
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 840 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~ 840 (956)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp SCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999986543221 112233456788999999999999999999999999999999 8999975443211
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
. ..+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+++..
T Consensus 249 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 Y----------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp H----------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 1122233344566677889999999999999999999999999997754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=373.51 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=206.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999975 68999999987543 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DfGla~~~ 775 (956)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999999654 35889999999999999999999999 99999999999998654 5999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +.
T Consensus 182 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~---------i~ 243 (362)
T 2bdw_A 182 NDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQ---------IK 243 (362)
T ss_dssp TTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH---------HH
T ss_pred cCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH---------HH
Confidence 4221 12345699999999999999999999999999999999999999975432111 100 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.+.. .++ . +.. +...+.+.+++.+||..||++|||++|+|+|||
T Consensus 244 ~~~~-~~~-------------------~--~~~--------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 244 AGAY-DYP-------------------S--PEW--------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HTCC-CCC-------------------T--TGG--------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred hCCC-CCC-------------------c--ccc--------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0000 000 0 000 011122346888899999999999999999999
Q ss_pred ccc
Q 002178 936 VSS 938 (956)
Q Consensus 936 f~~ 938 (956)
|..
T Consensus 288 ~~~ 290 (362)
T 2bdw_A 288 ICN 290 (362)
T ss_dssp HHT
T ss_pred cCC
Confidence 964
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.22 Aligned_cols=270 Identities=26% Similarity=0.426 Sum_probs=214.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 695 (956)
.++|++.+.||+|+||+||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46888999999999999999984 2689999999987766667789999999999999999999998854 4568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997643 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-------
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS------- 848 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~------- 848 (956)
...... ........++..|+|||++.+..++.++||||||+++|||++|..|+....... .......
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 165 PQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQGQMIV 238 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HHHHCTTCCTHHHH
T ss_pred cCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--HhhhcCccccchhH
Confidence 432210 112233457778999999999999999999999999999999999986432111 0000000
Q ss_pred -ccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 849 -SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 849 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.....+........+..++..+.+++.+||+.+|.+||++.++++.|+++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 011112223344557778889999999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.61 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=216.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.+.||+|+||+||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467888999999999999999988889999999986443 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 160 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc---
Confidence 9999999996543 45899999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ... .+..+....
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~---------~~~~~~~~~ 227 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVE---------DISTGFRLY 227 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH---------HHHTTCCCC
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---------HHhcCccCC
Confidence 112233456778999999999999999999999999999999 999997644321 111 111222233
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+...+..+.+++..|++.+|.+||++.++++.|+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 455567889999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=372.45 Aligned_cols=271 Identities=25% Similarity=0.431 Sum_probs=221.5
Q ss_pred cccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceee
Q 002178 613 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVS 684 (956)
Q Consensus 613 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~ 684 (956)
.+...++....++|++.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355667777889999999999999999999983 2468999999986433 3346799999999999 7999999
Q ss_pred eecccccCC-cEEEEEecCCCCCHHHHHhhcCC-----------------------------------------------
Q 002178 685 LVGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK----------------------------------------------- 716 (956)
Q Consensus 685 l~~~~~~~~-~~~LV~e~~~~gsL~~~l~~~~~----------------------------------------------- 716 (956)
+++++.+.+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987755 48999999999999999976432
Q ss_pred -----------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 717 -----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 717 -----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12889999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ +..+.
T Consensus 248 -----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---------~~~~~ 313 (359)
T 3vhe_A 248 -----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---------LKEGT 313 (359)
T ss_dssp -----TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---------HHHTC
T ss_pred -----cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---------HHcCC
Confidence 1123345568899999999999999999999999999999998 99999764432221111 11122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
....+..++..+.+++..|++.+|.+||++.++++.|+.+..
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 334456667889999999999999999999999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=368.42 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=168.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe----CCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 4689999999976432 233567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997643 4788899999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 171 SIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 4321 112234569999999999999999999999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.48 Aligned_cols=203 Identities=23% Similarity=0.338 Sum_probs=176.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999965 68999999986321 113567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc---EEEEeecc
Q 002178 697 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 771 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DfGl 771 (956)
+||||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653 3345899999999999999999999999 999999999999987655 99999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98764321 1123456999999999999999999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=371.80 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=176.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 699999999865322 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997653 4889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 234569999999999999999999999999999999999999997543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=374.73 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=217.4
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
+....++|.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3345678889999999999999999976 789999999875432 33457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.++++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999997542 35889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 265 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~--------~~~ 329 (377)
T 3cbl_A 265 DGVY-----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--RE--------FVE 329 (377)
T ss_dssp TSEE-----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HH--------HHH
T ss_pred CCce-----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH--------HHH
Confidence 2110 111112235678999999999999999999999999999998 9999976543211 11 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+.....|..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2223345667788999999999999999999999999999988653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=380.56 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=206.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999864 789999999876443 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc---CCCcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DfGla~~~ 775 (956)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997653 4899999999999999999999999 99999999999998 4678999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~----------- 224 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQ----------- 224 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-----------
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHH-----------
Confidence 4321 122345799999999999999999999999999999999999999975432111 100
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
+........+.. ++...+.+.+++.+||..||++|||++|+|+|||
T Consensus 225 -----------------i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 225 -----------------IKAGAYDFPSPE-----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp -----------------HHHTCCCCCTTT-----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred -----------------HHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 000000000000 0111223347888899999999999999999999
Q ss_pred ccc
Q 002178 936 VSS 938 (956)
Q Consensus 936 f~~ 938 (956)
|+.
T Consensus 271 ~~~ 273 (444)
T 3soa_A 271 ISH 273 (444)
T ss_dssp THH
T ss_pred ccC
Confidence 964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.03 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=216.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.+.||+|+||+||+|..+++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4568899999999999999999998888999999986443 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 99999999997642 35889999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... +..+...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------~~~~~~~ 224 (268)
T 3sxs_A 159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------VSQGHRL 224 (268)
T ss_dssp ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----------HHTTCCC
T ss_pred ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH----------HHcCCCC
Confidence 112233446778999999999999999999999999999999 9999975543222111 1112223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+...+..+.+++..|++.+|.+||++.++++.|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 3345566789999999999999999999999999987743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.10 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|.+.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999996 4789999999864321 12357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+ +|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 789999987653 4889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+...
T Consensus 162 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~~ 223 (336)
T 3h4j_B 162 -------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNSC 223 (336)
T ss_dssp -------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCSS
T ss_pred -------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHcC
Confidence 12234569999999999988776 67899999999999999999999643210 011111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
....|... .+...+++++||..||++|||++|+++||||+.
T Consensus 224 ~~~~p~~~---------------------------------------s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 VYVMPDFL---------------------------------------SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCCCTTS---------------------------------------CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCCCcccC---------------------------------------CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11111111 112236788888889999999999999999876
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
...
T Consensus 265 ~~~ 267 (336)
T 3h4j_B 265 NLP 267 (336)
T ss_dssp TCC
T ss_pred CCc
Confidence 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=404.67 Aligned_cols=337 Identities=21% Similarity=0.288 Sum_probs=272.2
Q ss_pred CCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCC------CCCCCCC------------CceeecCCCCCCCcceeeEEEe
Q 002178 28 DDSITDPIEVSALRSIKKSLVDDYSKLSNWNRG------DPCTSNW------------TGVLCFNTTMDDGYLHLRELQL 89 (956)
Q Consensus 28 ~~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~------~~c~~~w------------~gv~C~~~~~~~~~~~~~~L~L 89 (956)
..+.+...|+.||++||+++.++ +|+.. ++|+|.| .||+|... .+|+.|+|
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~------~~V~~L~L 330 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN------GRVTGLSL 330 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT------SCEEEEEC
T ss_pred cccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCC------CCEEEEEC
Confidence 34455678999999999999765 67543 4655689 99999752 58999999
Q ss_pred CCCCccccCCcCcCCCCCCCEEEc-cCCCCccc-----------------------------------------------
Q 002178 90 LNLNLSGNLSPEIGRLSYLTILDF-MWNKISGS----------------------------------------------- 121 (956)
Q Consensus 90 ~~~~l~~~~~~~l~~l~~L~~L~L-s~N~l~~~----------------------------------------------- 121 (956)
++++|+|.+|++|++|++|++|+| ++|.++|.
T Consensus 331 s~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~ 410 (876)
T 4ecn_A 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410 (876)
T ss_dssp TTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHT
T ss_pred ccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhh
Confidence 999999999999999999999999 77765444
Q ss_pred -----------------------------CCcccccCcccchhhccCcCCCC-----------------CCCCccC--CC
Q 002178 122 -----------------------------IPKEIGNIKSLELLLLNGNELTG-----------------SLPEELG--YL 153 (956)
Q Consensus 122 -----------------------------ip~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l 153 (956)
+|..|+++++|++|+|++|+|++ .+|..++ ++
T Consensus 411 ~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L 490 (876)
T 4ecn_A 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL 490 (876)
T ss_dssp CTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred CccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccC
Confidence 88899999999999999999998 3999988 99
Q ss_pred cccceeecccccccCCCCccccccccCCeeecccCc-CCC-CCccccCCCc-------ccceecccccccCCCCCc--cc
Q 002178 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRLP-------SLVHMLLDNNNLTGYLPP--EL 222 (956)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~l 222 (956)
++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .|
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 999999999999999999999999999999999998 998 7888776665 9999999999999 7888 89
Q ss_pred CCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCC-ccEEEccCCcCCcCCCCCCCcc---c
Q 002178 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLDLSSNQLNGSIPPGRLSL---N 298 (956)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~~---~ 298 (956)
.++++|+.|+|++|+++ .+| .|+++++|+.|+|++|+++..+..+..+++ |+.|+|++|+|+ .+|..+... +
T Consensus 570 ~~L~~L~~L~Ls~N~l~--~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR--HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645 (876)
T ss_dssp TTCTTCCEEECTTSCCC--BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred hcCCCCCEEECCCCCcc--cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence 99999999999999998 577 889999999999999999966667888888 999999999998 777655433 3
Q ss_pred cCEEEccCCcCCCCCchhc---C--CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CC-
Q 002178 299 ITTIKLSNNKLTGTIPSNF---S--GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NI- 371 (956)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~- 371 (956)
|+.|+|++|++++.+|... . .+++|+.|+|++|+++ .+|..+.. ..+.|+.|+|++|+|+.+|... ..
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~----~l~~L~~L~Ls~N~L~~ip~~~~~~~ 720 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFA----TGSPISTIILSNNLMTSIPENSLKPK 720 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHH----TTCCCSEEECCSCCCSCCCTTSSSCT
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHc----cCCCCCEEECCCCcCCccChHHhccc
Confidence 8888888888887665332 2 3347777777777777 56655431 1233446677777666666543 11
Q ss_pred -------CCCcEEEecCCccc
Q 002178 372 -------PPNVTVRLRGNPFC 385 (956)
Q Consensus 372 -------~~l~~l~l~~Np~~ 385 (956)
+.++.|+|++|.+.
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~ 741 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT 741 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC
T ss_pred cccccccCCccEEECCCCCCc
Confidence 15666666666554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=388.65 Aligned_cols=296 Identities=22% Similarity=0.299 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeeccccc-----CCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 694 (956)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999965 6899999998653 33345688999999999999999999999843 357
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+ +|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 68999999654 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCcc--------------------ccceecccccCCCccccccc-ccCCCCCcccchhHHHHHHHHHhC-----
Q 002178 775 APVPDIEGIV--------------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTG----- 828 (956)
Q Consensus 775 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~G~ll~elltg----- 828 (956)
.......... .........||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6533211000 01123456789999999987 456799999999999999999994
Q ss_pred ------CCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH--------HHH
Q 002178 829 ------MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV--------MRE 894 (956)
Q Consensus 829 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v--------~~~ 894 (956)
+.+|............ ................+..+...+ . .|+..++ ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~i~~~~-g-----~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQ---------KAGNDFKFHTRGNRDQLNVIFNIL-G-----TPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp SSGGGCCCSCC-----------------------------CHHHHHHHHHHHHHH-C-----CCCHHHHHTSSCHHHHHH
T ss_pred cccccccccCCCCccccccccc---------cccccccccccCCHHHHHHHHHHc-C-----CCCHHHHhhcCCHHHHHH
Confidence 4444322110000000 000000000111122222221111 0 1111111 000
Q ss_pred HH--------HhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 895 LE--------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 895 L~--------~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
++ .+...++...+.+.+||++||++||++|+|++|+|+||||..-
T Consensus 351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00 0122334445667789999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=388.46 Aligned_cols=264 Identities=24% Similarity=0.440 Sum_probs=219.7
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
+++....++|++.+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44556678899999999999999999999888999999998644 34568999999999999999999999986 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.++++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999997654445788899999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........++..|+|||++....++.++|||||||++|||++ |+.||....... ... .+.
T Consensus 336 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-~~~---------~i~ 399 (454)
T 1qcf_A 336 DNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIR---------ALE 399 (454)
T ss_dssp CHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH---------HHH
T ss_pred CCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHH
Confidence 211 111223346788999999999999999999999999999999 999997544321 111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+.....|..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 400 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 2223345667788999999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=374.64 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=194.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
-++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367889999999999999999965 58999999986432 12346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999764 35899999999999999999999999 999999999999999999999999999875422
Q ss_pred CCCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcccchh
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 853 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 853 (956)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---------- 230 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---------- 230 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----------
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----------
Confidence 22345679999999999974 4589999999999999999999999974322 111111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 887 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs 887 (956)
.+......+|..++..+.+++.+|++.+|.+||+
T Consensus 231 ~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s 264 (384)
T 4fr4_A 231 TFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFS 264 (384)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence 1111122344445556666666666666666665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=399.32 Aligned_cols=340 Identities=21% Similarity=0.291 Sum_probs=291.5
Q ss_pred CCCCCHHHHHHHHHHHHhccCCCC--------CCCCCCCCCCCCCCC---CceeecCCCCCCCcceeeEEEeCCCCcccc
Q 002178 29 DSITDPIEVSALRSIKKSLVDDYS--------KLSNWNRGDPCTSNW---TGVLCFNTTMDDGYLHLRELQLLNLNLSGN 97 (956)
Q Consensus 29 ~~~~~~~~~~al~~~k~~~~~~~~--------~l~~W~~~~~c~~~w---~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~ 97 (956)
.+.++..|+.||.++++++.++.. ...+|+...+|| .| .||+|+.. .+|+.|+|++++++|.
T Consensus 24 ~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~------~~V~~L~L~~~~l~g~ 96 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN------GRVTGLSLEGFGASGR 96 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT------CCEEEEECTTSCCEEE
T ss_pred hhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC------CCEEEEEecCcccCCc
Confidence 344556899999999999875522 234798776665 69 99999643 5899999999999999
Q ss_pred CCcCcCCCCCCCEEEccCCC------------------------------------------------------------
Q 002178 98 LSPEIGRLSYLTILDFMWNK------------------------------------------------------------ 117 (956)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~------------------------------------------------------------ 117 (956)
+|++|++|++|++|+|++|.
T Consensus 97 lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~ 176 (636)
T 4eco_A 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176 (636)
T ss_dssp ECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCC
T ss_pred CChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccc
Confidence 99999999999999999883
Q ss_pred ------------------CcccCCcccccCcccchhhccCcCCCCC-----------------CCCccC--CCcccceee
Q 002178 118 ------------------ISGSIPKEIGNIKSLELLLLNGNELTGS-----------------LPEELG--YLPKLDRIQ 160 (956)
Q Consensus 118 ------------------l~~~ip~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~ 160 (956)
++| +|..|+++++|++|+|++|++++. +|..++ ++++|++|+
T Consensus 177 ~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 445 888999999999999999999986 999999 999999999
Q ss_pred cccccccCCCCccccccccCCeeecccCc-CCC-CCccccCCC------cccceecccccccCCCCCc--ccCCcchhhh
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRL------PSLVHMLLDNNNLTGYLPP--ELSELPKLLI 230 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~ 230 (956)
|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .++.+++|++
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~ 334 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGM 334 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCE
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCE
Confidence 99999999999999999999999999998 998 899988876 99999999999999 7888 8999999999
Q ss_pred hcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCC-ccEEEccCCcCCcCCCCCCCcc---ccCEEEccC
Q 002178 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLDLSSNQLNGSIPPGRLSL---NITTIKLSN 306 (956)
Q Consensus 231 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~~---~L~~L~Ls~ 306 (956)
|+|++|.++| .+| .|.++++|+.|+|++|+++..+..+..+++ |+.|++++|.++ .+|..+... +|+.|+|++
T Consensus 335 L~L~~N~l~g-~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 335 LECLYNQLEG-KLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp EECCSCCCEE-ECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred EeCcCCcCcc-chh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 9999999987 678 899999999999999999977777889998 999999999999 788765543 699999999
Q ss_pred CcCCCCCchhcC-------CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-C-CC-----
Q 002178 307 NKLTGTIPSNFS-------GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-N-IP----- 372 (956)
Q Consensus 307 N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~-~~----- 372 (956)
|.+++.+|..|. .+++|+.|+|++|+++ .+|..+.. ..+.|+.|+|++|+++.+|... . ..
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~----~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~ 486 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFS----TGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHH----TTCCCSEEECCSSCCSBCCSSSSEETTEECTT
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHc----cCCCCCEEECCCCCCCCcCHHHhccccccccc
Confidence 999999998888 8889999999999999 56655433 1234568888888888877654 2 22
Q ss_pred --CCcEEEecCCccc
Q 002178 373 --PNVTVRLRGNPFC 385 (956)
Q Consensus 373 --~l~~l~l~~Np~~ 385 (956)
.++.|+|++|.+.
T Consensus 487 l~~L~~L~Ls~N~l~ 501 (636)
T 4eco_A 487 TYLLTSIDLRFNKLT 501 (636)
T ss_dssp GGGCCEEECCSSCCC
T ss_pred cCCccEEECcCCcCC
Confidence 7788888888765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=378.66 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=215.0
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC-cEEEEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVY 699 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~LV~ 699 (956)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44578889999999999999999985 7899999998654 3468999999999999999999999986654 799999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999998776666889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+.
T Consensus 343 ---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~---------~~i~~~~ 403 (450)
T 1k9a_A 343 ---------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV---------PRVEKGY 403 (450)
T ss_dssp -------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HH---------HHHHTTC
T ss_pred ---------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH---------HHHHcCC
Confidence 112356889999999999999999999999999999998 999997543211 11 1122233
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
....|..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 3456777889999999999999999999999999999988653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=371.47 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=204.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999864 57789999997643 3345689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.++++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999754 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .... +..
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-~~~~---------i~~ 265 (373)
T 2qol_A 200 DPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-VIKA---------VDE 265 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-HHHH---------HHT
T ss_pred CCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH---------HHc
Confidence 2210 111122345778999999999999999999999999999998 999997554321 1111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 112234556778899999999999999999999999999988653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.20 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=200.3
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 6999999999877666677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE--cCCCcEEEEeeccccccCCCCCCCccc
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL--DHKFTAKVADFGLSRLAPVPDIEGIVP 785 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~ 785 (956)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 9988653 235889999999999999999999999 9999999999999 567899999999998764322
Q ss_pred cceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChH
Q 002178 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865 (956)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 865 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------------------- 296 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------------------------- 296 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------------------
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------------------
Confidence 12334699999999999999999999999999999999999999975433211
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 866 ~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
+.++....+...+.. ++...+.+.+|+.+||..||++|||++|+|+||||...
T Consensus 297 ----~~~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 297 ----LNNILACRWDLEDEE-----------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----HHHHHHTCCCSCSGG-----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----HHHHHhccCCCChhh-----------------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 111111111111100 11122334578889999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=370.49 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=194.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
..++|++.+.||+|+||+||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3568999999999999999999976 58899999987543 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~ 777 (956)
|+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999654 35889999999999999999999999 999999999999975 88999999999986532
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 204 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------- 262 (349)
T 2w4o_A 204 Q--------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------- 262 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-------------
T ss_pred c--------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-------------
Confidence 1 1223456899999999999999999999999999999999999999754332111111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
+..+....+. |. .+.......+++.+||..||++|||++|+|+||||.
T Consensus 263 ----------------i~~~~~~~~~--~~--------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 263 ----------------ILNCEYYFIS--PW--------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp ----------------HHTTCCCCCT--TT--------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred ----------------HHhCCCccCC--ch--------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 0011000000 00 011122334788999999999999999999999998
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
....
T Consensus 311 ~~~~ 314 (349)
T 2w4o_A 311 GKAA 314 (349)
T ss_dssp STTC
T ss_pred CCcc
Confidence 7654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=389.20 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=180.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
..++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 699999999865322 234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998766666999999999999999999999999 99999999999999999999999999987642
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 339 ~~--------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 339 GQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TC--------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred Cc--------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 21 223457999999999999999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=369.81 Aligned_cols=203 Identities=22% Similarity=0.355 Sum_probs=177.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 696 (956)
..++|++.+.||+|+||+||+|... +++.||+|+++.... ...+.+..|.++++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999976 488999999875321 2345678899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997643 4889999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 WDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CTT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 211 12344579999999999999999999999999999999999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=363.43 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=184.3
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEecCCCCC
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.+.||+|+||+||+|... +++.||||++... ....+.+|+++++.+. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999998643 3457788999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEEeeccccccCCCCCCCc
Q 002178 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DfGla~~~~~~~~~~~ 783 (956)
|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 163 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---- 163 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----
Confidence 99999764 35899999999999999999999999 99999999999998765 89999999998654321
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------------------~~~ 220 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--------------------CTS 220 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------------------------CCC
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--------------------ccc
Confidence 122345689999999999999999999999999999999999999964321100 000
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
..+++...........+ . . .+...+...+++.+||..||++|||++|+++||||.....-
T Consensus 221 ------~~~~~~~i~~~~~~~~~--~-~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 221 ------AVEIMKKIKKGDFSFEG--E-A----------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp ------HHHHHHHHTTTCCCCCS--H-H----------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred ------HHHHHHHHHcCCCCCCc--c-c----------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 00000000111110000 0 0 00112234478899999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=367.19 Aligned_cols=264 Identities=29% Similarity=0.477 Sum_probs=218.3
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
....++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999974 34899999998643 33456889999999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC----------------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccC
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 750 (956)
+..++||||+++|+|.+++.... ...+++.+++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 99999999999999999997642 156899999999999999999999999 99999
Q ss_pred CCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CC
Q 002178 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829 (956)
Q Consensus 751 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~ 829 (956)
|||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999976532211 112234457889999999999999999999999999999999 99
Q ss_pred CCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 830 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 830 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.||....... ... .+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 275 ~p~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 275 QPYYGMAHEE-VIY---------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CTTTTSCHHH-HHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CcCCCCChHH-HHH---------HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9997544321 111 1223334455667778999999999999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=363.18 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=207.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC----cEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~L 697 (956)
..++|++.+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999875 7999999987533 23345667999999999999999999997644 4799
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc----------CCCCEeccCCCcccEEEcCCCcEEEE
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------ADPPVFHRDIKASNILLDHKFTAKVA 767 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlk~~NILl~~~~~~kl~ 767 (956)
||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999764 389999999999999999999998 7 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCchh----
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI---- 838 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~---- 838 (956)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.
T Consensus 174 DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 9999987653321 112234569999999999987 35566889999999999999999999643210
Q ss_pred -HHHHHHHhhcccchh-hccCC-CCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 839 -VREVNIAYQSSMMFS-VIDGN-MGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 839 -~~~~~~~~~~~~~~~-~~~~~-~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
............+.. ..... .+.. ...++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000000000 01111 1111 235677899999999999999999999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.98 Aligned_cols=288 Identities=22% Similarity=0.377 Sum_probs=207.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 78999999987543222 12456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 96 69999987653 45889999999999999999999999 9999999999999999999999999998654221
Q ss_pred CccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ........
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~------~~~~~~~~ 222 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIF------RILGTPTE 222 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH------HHHCCCCT
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------HHhCCCCh
Confidence 12234468999999999976 5689999999999999999999999976543221 11111 00000000
Q ss_pred -CCChHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 861 -SYPSECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 861 -~~~~~~~-~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
..+.... ..+.. ...|..+... .....+..+....+|+.+||.+||++|||++|+|+||||.+
T Consensus 223 ~~~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 223 ETWPGILSNEEFKT------YNYPKYRAEA---------LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TTSTTGGGCHHHHH------TCCCCCCCCC---------HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred Hhchhhhcchhhcc------cccccccchh---------hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0000000 00000 0111111110 11122334455578999999999999999999999999987
Q ss_pred CCCCCcc
Q 002178 939 DVSGSNL 945 (956)
Q Consensus 939 ~~~~~~~ 945 (956)
.......
T Consensus 288 ~~~~~~~ 294 (324)
T 3mtl_A 288 LGERIHK 294 (324)
T ss_dssp GCSTTSS
T ss_pred ccccccc
Confidence 7664333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=369.31 Aligned_cols=265 Identities=26% Similarity=0.464 Sum_probs=219.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
..++|.+.+.||+|+||+||+|... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578899999999999999999852 246899999976433 3456889999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998654 245899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~ 836 (956)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987653321 112234457889999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
. .+.... +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++......
T Consensus 299 ~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 V-EELFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H-HHHHHH---------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H-HHHHHH---------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2 111111 112223344566778899999999999999999999999999998766543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=365.25 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 697 (956)
..++|++.++||+|+||+||+|... +|+.||||++.... ......+..|+..+.++ +|+||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999976 79999999986532 23344556666666555 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 789999987653 46899999999999999999999998 99999999999999999999999999986542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+........ +..+
T Consensus 210 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------------~~~~ 267 (311)
T 3p1a_A 210 AG--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-------------LRQG 267 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-------------HTTT
T ss_pred CC--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-------------Hhcc
Confidence 21 2234568999999999876 789999999999999999999877754221100 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
..+.+.. +.......+++.+||..||++|||++|+|+||||+
T Consensus 268 ---~~~~~~~-----------------------------------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 268 ---YLPPEFT-----------------------------------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp ---CCCHHHH-----------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred ---CCCcccc-----------------------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 0111100 11122234688889999999999999999999997
Q ss_pred c
Q 002178 938 S 938 (956)
Q Consensus 938 ~ 938 (956)
.
T Consensus 310 ~ 310 (311)
T 3p1a_A 310 Q 310 (311)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.94 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999965 6899999988543 233346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... ++++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997653 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||............. .. .....
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~-~~~~~---- 232 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QD-SVPNV---- 232 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SS-CCCCH----
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hc-cCCCc----
Confidence 1 112234569999999999999999999999999999999999999997655432222111 10 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhH
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIW 899 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~ 899 (956)
....+..++..+.+++.+|++.+|.+|| +++++.+.|+.+.
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0112344567899999999999999998 8888888888654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=359.74 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--------------------------hHHHHHHHHHHHH
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLS 675 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 675 (956)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999964 6899999998754321 1246889999999
Q ss_pred hcCCCceeeeeccccc--CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 676 RLHHRNLVSLVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 676 ~l~h~nIv~l~~~~~~--~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999876 568899999999999988653 246899999999999999999999999 99999999
Q ss_pred ccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCC---CCCcccchhHHHHHHHHHhCCC
Q 002178 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQ 830 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~G~ll~elltg~~ 830 (956)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998754321 1233457999999999998765 3678999999999999999999
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCc
Q 002178 831 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP 910 (956)
Q Consensus 831 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~ 910 (956)
||........ .. .+.......|. . +...+...
T Consensus 239 pf~~~~~~~~-~~-----------------------------~~~~~~~~~~~-~-----------------~~~~~~l~ 270 (298)
T 2zv2_A 239 PFMDERIMCL-HS-----------------------------KIKSQALEFPD-Q-----------------PDIAEDLK 270 (298)
T ss_dssp SSCCSSHHHH-HH-----------------------------HHHHCCCCCCS-S-----------------SCCCHHHH
T ss_pred CCCCccHHHH-HH-----------------------------HHhcccCCCCC-c-----------------cccCHHHH
Confidence 9975432110 00 00000000000 0 01112234
Q ss_pred cccccccCCCCCCCCCCccCCCCCccc
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
+++.+||..||++|||++|+++||||+
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 678888999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=361.42 Aligned_cols=262 Identities=29% Similarity=0.475 Sum_probs=217.3
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3467899999999999999999985 245899999997643 334568899999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCC----------------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCC
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSK----------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 751 (956)
..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999976432 34889999999999999999999999 999999
Q ss_pred CcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCC
Q 002178 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830 (956)
Q Consensus 752 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~ 830 (956)
||+||+++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred chheEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999987643221 112233457788999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 831 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 831 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
||........ .. .+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+++..
T Consensus 252 p~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPERL-FN---------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGGGH-HH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH-HH---------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9975432111 11 111222334556677889999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=363.18 Aligned_cols=283 Identities=20% Similarity=0.305 Sum_probs=203.5
Q ss_pred hcCCCCC-CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++. +.||+|+||+||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999954 7899999999876555567899999999985 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc---EEEEeeccccccC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 776 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DfGla~~~~ 776 (956)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999997653 5889999999999999999999999 999999999999998776 9999999997654
Q ss_pred CCCCCCccccceecccccCCCccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~ 235 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----------CG 235 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC----------SC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc----------cc
Confidence 322111111112234569999999999975 568899999999999999999999997532110 00
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
+ ............+.+.+..... .-|. . ..+.......+++.+||..||++|||++|+|
T Consensus 236 ~-----~~~~~~~~~~~~~~~~i~~~~~----~~~~-~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 236 W-----DRGEACPACQNMLFESIQEGKY----EFPD-K-----------DWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp C---------CCHHHHHHHHHHHHHCCC----CCCH-H-----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred c-----cccccchhHHHHHHHHHhccCc----ccCc-h-----------hcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 0 0000111112222222221110 0110 0 0011223345799999999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=380.78 Aligned_cols=263 Identities=30% Similarity=0.468 Sum_probs=214.6
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.+....++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34455678899999999999999999998888899999986443 35689999999999999999999999876 67899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999997644456889999999999999999999999 99999999999999999999999999986542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 333 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~---------~i~~ 396 (452)
T 1fmk_A 333 NE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLD---------QVER 396 (452)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH---------HHHT
T ss_pred Cc------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHHc
Confidence 21 111223446789999999999999999999999999999999 999997544321 111 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
+.....|..+++.+.+++.+||+.+|++||++.++++.|+++...
T Consensus 397 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 233445667888999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=371.69 Aligned_cols=198 Identities=26% Similarity=0.396 Sum_probs=166.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 7899999999764332 35788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc--EEEEeeccccccCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRLAPVPD 779 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DfGla~~~~~~~ 779 (956)
+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999997643 4889999999999999999999999 999999999999987765 999999999743211
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCc-ccchhHHHHHHHHHhCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwS~G~ll~elltg~~pf~~ 834 (956)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 12234569999999999988887665 8999999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=354.69 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=208.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 567999999999999999999975 5789999998765555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccccCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~ 778 (956)
+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999987643 4889999999999999999999999 9999999999999 78899999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||............ ..+
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------~~~- 222 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI----------REG- 222 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------HHC-
T ss_pred c--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH----------HhC-
Confidence 1 22344689999999998654 899999999999999999999999754432111110 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
....+.... ....+...+++.+||..||++|||++|+|+||||+.
T Consensus 223 ~~~~~~~~~-----------------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 223 TFTFPEKDW-----------------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCCCCHHHH-----------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCchhh-----------------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 011111100 011222346888899999999999999999999975
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
...
T Consensus 268 ~~~ 270 (277)
T 3f3z_A 268 QLS 270 (277)
T ss_dssp HHC
T ss_pred ccc
Confidence 443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=370.92 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=214.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999953 4678999999754 344456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCC-----CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEE
Q 002178 696 MLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVA 767 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 767 (956)
++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 35889999999999999999999999 99999999999999555 59999
Q ss_pred eeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002178 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 768 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~ 846 (956)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~~--- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE--- 297 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---
Confidence 9999975432111 112234457899999999999999999999999999999998 99999765432 1111
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 298 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 ------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 112222334566677889999999999999999999999999988755
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.01 Aligned_cols=285 Identities=23% Similarity=0.331 Sum_probs=209.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999975 589999998865433 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988654 34889999999999999999999999 9999999999999999999999999998754221
Q ss_pred CCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~---- 219 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK-------TL---- 219 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------HH----
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-------Hh----
Confidence 12234568999999999976 6789999999999999999999999976544322211110 00
Q ss_pred CCCChHHHHHHHHH--HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 860 GSYPSECVEKFIKL--ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 860 ~~~~~~~~~~l~~l--~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
+...+.....+..- .......+|....... ...+.......+++.+||..||++|||++|+|+||||.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE----------LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH----------HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccccccccCcCCCccccchhh----------hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 11111111110000 0000011111111111 11233344456899999999999999999999999998
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
+-..
T Consensus 290 ~~~~ 293 (311)
T 4agu_A 290 NIRE 293 (311)
T ss_dssp TCC-
T ss_pred hccC
Confidence 7544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.13 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=214.0
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
...++|++.+.||+|+||+||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34568889999999999999999998888999999986443 34678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 999999999997632 35899999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... +..+..
T Consensus 175 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----------~~~~~~ 239 (283)
T 3gen_A 175 -----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----------IAQGLR 239 (283)
T ss_dssp -----HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----------HHTTCC
T ss_pred -----cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----------HhcccC
Confidence 111233446788999999999999999999999999999998 9999976543221111 111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
...+...++.+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 33455556789999999999999999999999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=376.47 Aligned_cols=285 Identities=20% Similarity=0.261 Sum_probs=211.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc------CCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL------HHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 695 (956)
..+|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999865 5899999999753 33345778888888887 577999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc--EEEEeecccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSR 773 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DfGla~ 773 (956)
++||||+. ++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 79999998876667999999999999999999999999 999999999999999987 9999999997
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~~i~~------ 313 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLACMIE------ 313 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH------
Confidence 64321 233568999999999999999999999999999999999999997654322 2111110
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCC---------------------------CCCHHHHHHHHHHhHhhCC-CC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDA---------------------------RPSMSEVMRELESIWNMMP-ES 905 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~---------------------------RPs~~~v~~~L~~~~~~~~-~~ 905 (956)
. .+..+.+....... ....+...... .|...+.. ..++ ..
T Consensus 314 ~----~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~~~ 381 (429)
T 3kvw_A 314 L----LGMPSQKLLDASKR-AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG-------NALKGCD 381 (429)
T ss_dssp H----HCCCCHHHHHTBTT-HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHH-------HHTTTCC
T ss_pred H----cCCCCHHHHHhhhh-hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhH-------hhccccc
Confidence 0 11122222211111 01111100000 00000110 1111 12
Q ss_pred CCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 906 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 906 ~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
++.+.+||.+||++||++|||++|+|+||||.....
T Consensus 382 ~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred hHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 344568999999999999999999999999987544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=353.07 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 357888999999999999999974 788999998753 334688999999999999999999999874 479999999
Q ss_pred CCCCHHHHHhhcCC-CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc-EEEEeeccccccCCCCC
Q 002178 703 SNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-AKVADFGLSRLAPVPDI 780 (956)
Q Consensus 703 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~DfGla~~~~~~~~ 780 (956)
++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976543 24678889999999999999999932223999999999999998886 799999999754321
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+...
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~ 223 (307)
T 2eva_A 160 --------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--------AVHNGTRP 223 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--------HHHTTCCC
T ss_pred --------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--------HHhcCCCC
Confidence 12345899999999999999999999999999999999999999754322111111 11122233
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 907 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 907 (956)
..+..++..+.+++.+|++.+|.+||++.++++.|+.+...++..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 44556677899999999999999999999999999999887765543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=370.78 Aligned_cols=276 Identities=22% Similarity=0.364 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 693 (956)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367899999999999999999974 6999999998653 233356789999999999999999999998665 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 88999999763 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~----- 240 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMK----- 240 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-----
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-----
Confidence 65321 234568999999999987 6799999999999999999999999976543322 221110
Q ss_pred hhccCCCCCCChHHHHHH-----HHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 853 SVIDGNMGSYPSECVEKF-----IKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l-----~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
..+..+.+....+ ...+.. .|.. +.. +...++...+.+.+|+.+||+.||++|+|
T Consensus 241 -----~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~ll~~mL~~dP~~R~t 301 (367)
T 1cm8_A 241 -----VTGTPPAEFVQRLQSDEAKNYMKG----LPELEKKD----------FASILTNASPLAVNLLEKMLVLDAEQRVT 301 (367)
T ss_dssp -----HHCCCCHHHHHTCSCHHHHHHHHH----SCCCCCCC----------GGGTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred -----hcCCCCHHHHHHhhhHHHHHHHHh----CCCCCCCC----------HHHHCCCCCHHHHHHHHHHccCChhHCCC
Confidence 0122232222111 111111 1111 111 11223344555678999999999999999
Q ss_pred CccCCCCCccccCC
Q 002178 927 SSSMLKHPYVSSDV 940 (956)
Q Consensus 927 a~e~L~HP~f~~~~ 940 (956)
++|+|+||||..-.
T Consensus 302 ~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 302 AGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSGGGTTTC
T ss_pred HHHHhcChHHHhhc
Confidence 99999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=378.21 Aligned_cols=205 Identities=29% Similarity=0.380 Sum_probs=167.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC-----Cc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 694 (956)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 6899999999753 333457889999999999999999999998765 57
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||++ |+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999654 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCcc---------------ccceecccccCCCccccccc-ccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 002178 775 APVPDIEGIV---------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (956)
Q Consensus 775 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~G~ll~elltg~~pf~ 833 (956)
.......... .........||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6533211000 00123556799999999986 45679999999999999999998655553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=382.72 Aligned_cols=261 Identities=30% Similarity=0.470 Sum_probs=219.5
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..++|.+|++++++++||||++++++|...+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456778889999999999999999764 89999999986433 35689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999998766667999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 371 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~---------~~~~ 434 (495)
T 1opk_A 371 DT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---------LLEK 434 (495)
T ss_dssp CC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH---------HHHT
T ss_pred Cc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHHc
Confidence 21 111223446788999999999999999999999999999999 999997543211 111 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
+.....|..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2233456777889999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=383.71 Aligned_cols=202 Identities=26% Similarity=0.342 Sum_probs=167.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 6899999998753 222335678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997643 58899999999999999999998 78 99999999999999999999999999975432
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 1 122344679999999999999999999999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.15 Aligned_cols=254 Identities=20% Similarity=0.350 Sum_probs=212.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccC--CcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV 698 (956)
.++|++.+.||+|+||+||+|.++ ++.||||+++... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999984 8899999987643 33456799999999999999999999999776 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 99999999999998766667999999999999999999999865 4599999999999999999999999998754321
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCC---cccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
....||+.|+|||++.+..++. ++|||||||++|||++|+.||............ ..
T Consensus 166 -----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------~~ 225 (271)
T 3kmu_A 166 -----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---------AL 225 (271)
T ss_dssp -----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---------HH
T ss_pred -----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---------Hh
Confidence 2235789999999998766554 799999999999999999999765433221111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.+.....+..++..+.+++..||+.+|.+||++.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22233456667788999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.82 Aligned_cols=285 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh--HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||+||+|... +++.||||+++...... .+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999964 78999999997543322 35678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE-----cCCCcEEEEeecccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-----DHKFTAKVADFGLSR 773 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-----~~~~~~kl~DfGla~ 773 (956)
|||++ |+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99996 59999997654 4889999999999999999999999 9999999999999 455669999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ .....
T Consensus 186 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~-- 255 (329)
T 3gbz_A 186 AFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI-FEVLG-- 255 (329)
T ss_dssp HHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHHHC--
T ss_pred ccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH-HHHhC--
Confidence 654221 122345689999999999874 4899999999999999999999999765443222111 11000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
. +.....+. ...+ .......|..+ ......+. ...++...+|+.+||..||++|||++|+|
T Consensus 256 -~--~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 256 -L--PDDTTWPG-----VTAL-PDWKQSFPKFRGKTLKRVLG---------ALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp -C--CCTTTSTT-----GGGS-TTCCTTCCCCCCCCHHHHHG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -C--Cchhhhhh-----hhhh-hhhhhhhhhhccccHhhhcc---------cccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0 00000000 0000 00001111111 12221111 01233446899999999999999999999
Q ss_pred CCCccccCC
Q 002178 932 KHPYVSSDV 940 (956)
Q Consensus 932 ~HP~f~~~~ 940 (956)
+||||++..
T Consensus 318 ~hp~f~~~~ 326 (329)
T 3gbz_A 318 EHPYFSHND 326 (329)
T ss_dssp TSGGGSSSC
T ss_pred CCcccCCCC
Confidence 999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.11 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 457888999999999999999964 444 36888876433 33457899999999999999999999999875 478
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|+||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~---------~~~ 233 (327)
T 3poz_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS---------ILE 233 (327)
T ss_dssp TTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH---------HHH
T ss_pred CCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HH---------HHH
Confidence 3321 112233456889999999999999999999999999999999 9999975432111 00 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122334566677889999999999999999999999999988754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.54 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=208.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999975 6899999998754322 356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGl 771 (956)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999753 45899999999999999999999999 99999999999999888 799999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~------- 229 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------- 229 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH-------
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHH-------
Confidence 98764321 12344689999999999999999999999999999999999999975432111 110
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
+.. .....+... .+.......+++.+||..||++|||++|++
T Consensus 230 --i~~-~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 230 --ITS-VSYDFDEEF-----------------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp --HHT-TCCCCCHHH-----------------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred --HHh-cccccChhh-----------------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000 000111110 011122234788999999999999999999
Q ss_pred CCCccccC
Q 002178 932 KHPYVSSD 939 (956)
Q Consensus 932 ~HP~f~~~ 939 (956)
+||||...
T Consensus 272 ~hp~~~~~ 279 (321)
T 2a2a_A 272 RHPWITPV 279 (321)
T ss_dssp HSTTTSCS
T ss_pred cCccccCC
Confidence 99999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.31 Aligned_cols=264 Identities=30% Similarity=0.458 Sum_probs=222.2
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++....++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 44456788999999999999999999976 48899999997643 34568899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999998877777999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||........ .. .+.
T Consensus 163 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-~~---------~~~ 226 (288)
T 3kfa_A 163 GDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE---------LLE 226 (288)
T ss_dssp SSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HH---------HHH
T ss_pred CCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH---------HHh
Confidence 322 122344557889999999999999999999999999999999 9999875432111 11 011
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.......+..++..+.+++..|+..+|.+||++.++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122344566778899999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.81 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=217.8
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++....++|++.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3444567899999999999999999998888899999987643 235688999999999999999999999864 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999997543335889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ........++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... +..
T Consensus 162 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~---------~~~ 225 (279)
T 1qpc_A 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQN---------LER 225 (279)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHH---------HHT
T ss_pred cc------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-HHHH---------Hhc
Confidence 22 111233456789999999998889999999999999999999 899997544321 1111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
+.....+..++..+.+++..|++.+|.+||++.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 22233455667889999999999999999999999999999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=362.08 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=216.0
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeeccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 689 (956)
++....++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445678999999999999999999996 2467899999975432 2346789999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCC---------------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEec
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 748 (956)
...+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999976432 24789999999999999999999999 999
Q ss_pred cCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-
Q 002178 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT- 827 (956)
Q Consensus 749 ~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt- 827 (956)
|||||+||+++.++.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCc-----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999998654322 1122344567889999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 828 GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 828 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
|+.||............. ..+.....+..++..+.+++.+||..+|.+||++.++++.|+.+....
T Consensus 271 g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLI---------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SCCSSTTCCCSHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCcccCCcHHHHHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 999997654322211111 111123345566788999999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=358.93 Aligned_cols=280 Identities=18% Similarity=0.325 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeeccccc--CCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|.. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999986 478999999987533 457889999999997 9999999999977 6688999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPV 777 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~ 777 (956)
|||+++++|.+++.. +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999853 788899999999999999999999 99999999999999777 899999999986543
Q ss_pred CCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......+..........
T Consensus 184 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~------ 249 (330)
T 3nsz_A 184 GQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG------ 249 (330)
T ss_dssp TC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC------
T ss_pred CC--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC------
Confidence 22 1234468899999999987 67899999999999999999999999766544333322111000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--HhHhhCCC-----CCCCCccccccccCCCCCCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE--SIWNMMPE-----SDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~--~~~~~~~~-----~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
...+.+.+.. ......|...+....-. .+....+. ..+.+.+|+.+||..||++|||++|
T Consensus 250 ----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 250 ----------TEDLYDYIDK---YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp ----------HHHHHHHHHH---TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----------CchhhhHHHH---hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 0111111111 11111222221110000 00000010 1334467999999999999999999
Q ss_pred CCCCCccccCC
Q 002178 930 MLKHPYVSSDV 940 (956)
Q Consensus 930 ~L~HP~f~~~~ 940 (956)
+|+||||.+-.
T Consensus 317 ~l~hp~f~~~~ 327 (330)
T 3nsz_A 317 AMEHPYFYTVV 327 (330)
T ss_dssp HHTSGGGTTCC
T ss_pred HhcCccHhhhc
Confidence 99999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=354.64 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=218.5
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
...++|++.+.||+|+||+||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999984 2478999999976443 3456889999999999 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC----------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSK----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999976542 24899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 002178 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~ 835 (956)
+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999987653321 122234457889999999999999999999999999999999 99999754
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.......... . .......+..++..+.+++.+|++.+|.+||++.++++.|+++....
T Consensus 252 ~~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 252 PVDSKFYKMI-K--------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CSSHHHHHHH-H--------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchhHHHHHh-c--------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 4322211111 0 11112234556788999999999999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.45 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=203.8
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
...++|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345789999999999999999998642 5679999987643 334567899999999999999999999985 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999999764 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||........ . ..+
T Consensus 167 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~---------~~i 230 (281)
T 1mp8_A 167 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I---------GRI 230 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H---------HHH
T ss_pred Cccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-H---------HHH
Confidence 4322 111233456788999999999999999999999999999997 9999975443211 1 112
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2223344566777889999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.65 Aligned_cols=253 Identities=32% Similarity=0.514 Sum_probs=201.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999974 88999999875332 2246788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--------CCcEEEEeec
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------KFTAKVADFG 770 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~DfG 770 (956)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999953 35889999999999999999999988666899999999999986 7789999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............
T Consensus 162 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 227 (271)
T 3dtc_A 162 LAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----
T ss_pred ccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-----
Confidence 997653221 223468999999999999999999999999999999999999997654332211111
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
........+..++..+.+++.+|++.+|.+||++.++++.|++
T Consensus 228 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 ----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1112234456677889999999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=382.40 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=179.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 699999999875322 2245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 699 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 446899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 321 1123457999999999999999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.01 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999965 68999999986532 333467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc---EEEEeeccccccC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 776 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DfGla~~~~ 776 (956)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887653 4889999999999999999999999 999999999999987655 9999999997654
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------------ 219 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI------------ 219 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH------------
Confidence 321 123456899999999999999999999999999999999999999754322111100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
.......|. |. .+...+...+++.+||..||++|||++|+|+||||
T Consensus 220 ------------------~~~~~~~~~--~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 220 ------------------KAGAYDYPS--PE--------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp ------------------HHTCCCCCT--TT--------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred ------------------HhccccCCc--hh--------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 000000000 00 00111222367888899999999999999999999
Q ss_pred ccCCC
Q 002178 937 SSDVS 941 (956)
Q Consensus 937 ~~~~~ 941 (956)
.+...
T Consensus 266 ~~~~~ 270 (284)
T 3kk8_A 266 CNRER 270 (284)
T ss_dssp HSCCC
T ss_pred cCChh
Confidence 76544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.71 Aligned_cols=294 Identities=22% Similarity=0.308 Sum_probs=212.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeeccccc--------C
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 692 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 692 (956)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999997 47899999998654322 24578899999999999999999999866 4
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
+..++||||++ |+|.+.+.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46899999996 58888776543 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 172 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----- 243 (351)
T 3mi9_A 172 RAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ----- 243 (351)
T ss_dssp EECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----
T ss_pred ccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-----
Confidence 876532211 1222344568999999999976 4589999999999999999999999976543222111110
Q ss_pred hhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 852 FSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 852 ~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
........ .+...... .. .-+......++...+.+.... .++.+.+|+.+||..||++|+|++|+
T Consensus 244 --~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 244 --LCGSITPEVWPNVDNYE---LY-EKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp --HHCCCCTTTSTTGGGCG---GG-TSSCCCSSCCCCHHHHHHHHH--------CCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred --HhCCCChhhccccccch---hh-cccccccccccCHHHHhhhcc--------CChHHHHHHHHHhcCChhhCCCHHHH
Confidence 00000000 00000000 00 001111122223322222111 12335689999999999999999999
Q ss_pred CCCCccccCCCCCc
Q 002178 931 LKHPYVSSDVSGSN 944 (956)
Q Consensus 931 L~HP~f~~~~~~~~ 944 (956)
|+||||.++...+.
T Consensus 310 l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 310 LNHDFFWSDPMPSD 323 (351)
T ss_dssp HTSGGGGSSSCCCC
T ss_pred hCCCCcCCCCCccc
Confidence 99999988766543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.55 Aligned_cols=273 Identities=22% Similarity=0.313 Sum_probs=212.2
Q ss_pred ccccHHHHHHHhcCCCCC-CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcC-CCceeeee
Q 002178 612 RSFTYGEMALATNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLV 686 (956)
Q Consensus 612 ~~~~~~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~ 686 (956)
+...++......++|.+. +.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++++. ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 345556667778888887 88999999999999975 68999999987533 233568899999999994 69999999
Q ss_pred cccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCc
Q 002178 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFT 763 (956)
Q Consensus 687 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~ 763 (956)
+++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999997665667999999999999999999999999 999999999999998 789
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~ 843 (956)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 173 ~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp EEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 9999999998764221 12345699999999999999999999999999999999999999975443221111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCC
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 923 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 923 (956)
.. .......+... +.......+++.+||..||++
T Consensus 245 i~-----------------------------~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~dP~~ 278 (327)
T 3lm5_A 245 IS-----------------------------QVNVDYSEETF-----------------SSVSQLATDFIQSLLVKNPEK 278 (327)
T ss_dssp HH-----------------------------HTCCCCCTTTT-----------------TTSCHHHHHHHHHHSCSSGGG
T ss_pred HH-----------------------------hcccccCchhh-----------------cccCHHHHHHHHHHcCCChhh
Confidence 10 00000000000 011122336778888899999
Q ss_pred CCCCccCCCCCccccCCC
Q 002178 924 PPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 924 R~sa~e~L~HP~f~~~~~ 941 (956)
|||++|+|+||||+....
T Consensus 279 Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 279 RPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp SCCHHHHTTCGGGCCCCT
T ss_pred CcCHHHHhCCHhhccccc
Confidence 999999999999976544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=369.74 Aligned_cols=295 Identities=20% Similarity=0.318 Sum_probs=212.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999975 68999999987653 3345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999997653 488999999999999999999996 8 99999999999999999999999999865421
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ...+..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~-----~~~~~~ 250 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GC-----QVEGDA 250 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH--C------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--cc-----cccccC
Confidence 1223456899999999999999999999999999999999999999765432211110 00 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh-hCCC--CCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN-MMPE--SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~-~~~~--~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
...+..... ..... .-+..+........++.+.+..... ..+. ......+|+.+||..||++|||++|+|+||||
T Consensus 251 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 251 AETPPRPRT-PGRPL-NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCccc-CCCcc-cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 000000000 00000 0011111112233333333322111 0111 12234689999999999999999999999999
Q ss_pred ccCC
Q 002178 937 SSDV 940 (956)
Q Consensus 937 ~~~~ 940 (956)
....
T Consensus 329 ~~~~ 332 (360)
T 3eqc_A 329 KRSD 332 (360)
T ss_dssp HHHH
T ss_pred hcch
Confidence 6543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=356.50 Aligned_cols=270 Identities=17% Similarity=0.239 Sum_probs=214.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999996 4789999999875432 23678899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc-----EEEEeecccccc
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 775 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DfGla~~~ 775 (956)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999764 346899999999999999999999999 999999999999999887 999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhhcccchh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFS 853 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~ 853 (956)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--- 237 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR--- 237 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH---
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc---
Confidence 5433222112222345679999999999999999999999999999999999999997532 22221111100000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~ 905 (956)
..........++ .+.+++..||+.+|.+||++.++.+.|+++.+.....
T Consensus 238 --~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 238 --ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp --HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 000000011234 8999999999999999999999999999887765443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=350.92 Aligned_cols=270 Identities=19% Similarity=0.249 Sum_probs=216.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 5799999999875432 23678899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc-----EEEEeecccccc
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 775 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DfGla~~~ 775 (956)
|+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997643 35899999999999999999999999 999999999999987776 999999999877
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcccchh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 853 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 853 (956)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence 54432222122233456799999999999999999999999999999999999999976322 111111110000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
...........+++.+.+++..||+.+|.+||++.++++.|+++.+....
T Consensus 238 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 238 -QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00000011224567899999999999999999999999999998876543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=374.75 Aligned_cols=334 Identities=16% Similarity=0.216 Sum_probs=283.1
Q ss_pred CCCCCCCCceeecCCCC---CCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CcccccCcccchhh
Q 002178 61 DPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLL 136 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~---~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i-p~~~~~l~~L~~L~ 136 (956)
..|.|.+..|.|.+... +....+++.|+|++|.+++..+..|+++++|++|+|++|.+.+.+ +..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34554455588976542 234478999999999999998999999999999999999998665 56799999999999
Q ss_pred ccCcCCCCCCCCccCCCcccceeecccccccCCCCcc--ccccccCCeeecccCcCCCCCccc-cCCCcccceecccccc
Q 002178 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNN 213 (956)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~ 213 (956)
|++|++++..|..|+++++|++|+|++|++++..+.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999889999999999999999999999866555 999999999999999999887876 8999999999999999
Q ss_pred cCCCCCcccCCc----------------------------------chhhhhcccCCcCCCCCCcccccC----------
Q 002178 214 LTGYLPPELSEL----------------------------------PKLLILQLDNNNFEGTTIPASYSN---------- 249 (956)
Q Consensus 214 l~~~~p~~l~~l----------------------------------~~L~~L~Ls~N~l~~~~~p~~~~~---------- 249 (956)
+++..+..+..+ ++|++|+|++|.+++ ..|..+..
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE-SMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH-HHHHHHHHHTTTCCEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc-cchhhhhccccccceeeE
Confidence 998888777654 578888888887764 23332211
Q ss_pred -----------------------------CCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCc-cc
Q 002178 250 -----------------------------MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LN 298 (956)
Q Consensus 250 -----------------------------l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~ 298 (956)
.++|+.|++++|.+++.++. +..+++|+.|+|++|++++..|..+.. .+
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 25789999999999887664 889999999999999999777766544 48
Q ss_pred cCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcE
Q 002178 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVT 376 (956)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~ 376 (956)
|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+. +|+.|+|++|+|++++... .++.++.
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP-----NLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc-----cccEEECCCCccccCCHhHhccCCcccE
Confidence 99999999999999999999999999999999999988898887654 4569999999999998764 5899999
Q ss_pred EEecCCcccccCC-cccccCCCCCC
Q 002178 377 VRLRGNPFCLNTN-AEQFCGSHSDD 400 (956)
Q Consensus 377 l~l~~Np~~c~c~-~~~~~~~~~~~ 400 (956)
|++++|||.|+|+ +.++..|...+
T Consensus 400 L~l~~N~l~~~~~~~~~l~~~l~~~ 424 (455)
T 3v47_A 400 IWLHTNPWDCSCPRIDYLSRWLNKN 424 (455)
T ss_dssp EECCSSCBCCCTTTTHHHHHHHHHT
T ss_pred EEccCCCcccCCCcchHHHHHHHhC
Confidence 9999999999998 66666777543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.81 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=215.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467888999999999999999988889999999986443 3468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 9999999997643 45889999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ... .+..+....
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~---------~i~~~~~~~ 225 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVE---------DISTGFRLY 225 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH---------HHHTTCCCC
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHH---------HHhcCCcCC
Confidence 111233456788999999999999999999999999999999 899997544321 111 111122233
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+...+..+.+++.+|++.+|.+||++.++++.|+++.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 455567789999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.88 Aligned_cols=277 Identities=27% Similarity=0.433 Sum_probs=213.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC-----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.+.||+|+||+||+|.... +..||||+++... ......+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998642 2469999987643 334567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999764 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+.
T Consensus 199 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~---------~~~ 264 (333)
T 1mqb_A 199 DDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMK---------AIN 264 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH---------HHH
T ss_pred ccccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHH
Confidence 32210 111223346788999999999999999999999999999999 999997544321 111 112
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+++.... +.+..+..++|..|+
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~--------~~~~~~~~~~p~~~~ 326 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP--------DSLKTLADFDPRVSI 326 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG--------GGGGSBCCC------
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc--------hhhhhhcCCCccchh
Confidence 22233445667788999999999999999999999999999886532 445556677776654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=366.54 Aligned_cols=282 Identities=22% Similarity=0.356 Sum_probs=203.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh-----HHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
..++|++.+.||+|+||+||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 68999999987533221 24678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999975 899988654 346889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ....+....
T Consensus 163 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~---- 230 (346)
T 1ua2_A 163 GSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLG---- 230 (346)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC----
T ss_pred cCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcC----
Confidence 4322 122345689999999999764 588899999999999999999988875543222 111111000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhccc---CCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQD---ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~---~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
.......+.. |-.. ....+|... + ....+.......+++.+||..||++|||++|+|
T Consensus 231 -~~~~~~~~~~-----------~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 231 -TPTEEQWPDM-----------CSLPDYVTFKSFPGIP-----L---HHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp -CCCTTTSSST-----------TSSTTCCCCCCCCCCC-----H---HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred -CCChhhhhhh-----------ccCcccccccccCCCC-----h---HHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 0000000000 0000 000111100 0 011223334456799999999999999999999
Q ss_pred CCCccccCC
Q 002178 932 KHPYVSSDV 940 (956)
Q Consensus 932 ~HP~f~~~~ 940 (956)
+||||++..
T Consensus 291 ~h~~f~~~~ 299 (346)
T 1ua2_A 291 KMKYFSNRP 299 (346)
T ss_dssp TSGGGTSSS
T ss_pred cChhhhcCC
Confidence 999997643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=379.18 Aligned_cols=200 Identities=29% Similarity=0.435 Sum_probs=175.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999975 799999999875322 22457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999654 45899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 171 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 171 --------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp --------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 2234569999999999998765 678999999999999999999997543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=364.09 Aligned_cols=278 Identities=18% Similarity=0.199 Sum_probs=211.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC------CcEEEEEEecCCChhhH-----------HHHHHHHHHHHhcCCCceee
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHRNLVS 684 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~ 684 (956)
..++|++.+.||+|+||+||+|.+.+ ++.||||++........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 47899999876542211 12345666777888999999
Q ss_pred eecccccC----CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-
Q 002178 685 LVGYCDEE----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD- 759 (956)
Q Consensus 685 l~~~~~~~----~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~- 759 (956)
+++++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998664 4589999999 99999999764 346999999999999999999999999 99999999999999
Q ss_pred -CCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh
Q 002178 760 -HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (956)
Q Consensus 760 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~ 838 (956)
.++.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876533211111112223456999999999999999999999999999999999999999743221
Q ss_pred HHH---HHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002178 839 VRE---VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 907 (956)
Q Consensus 839 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 907 (956)
... ....+. ..+..+++..+. +..++..+.+++..||+.+|.+||++.++++.|+++........+
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 268 PKYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HHHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 111 111111 111222221111 123457889999999999999999999999999998876544433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.51 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=207.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888999999999999999976 5889999998653 233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987643 5889999999999999999999999 999999999999999999999999999875422
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------~~~- 230 (294)
T 2rku_A 169 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----------KKN- 230 (294)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------HTT-
T ss_pred c-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------hhc-
Confidence 1 1123456899999999999999999999999999999999999999754321111000 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
....+... +....+++.+||..||++|||++|+++||||.+
T Consensus 231 ~~~~~~~~---------------------------------------~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 231 EYSIPKHI---------------------------------------NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CCCCCTTS---------------------------------------CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred cCCCcccc---------------------------------------CHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 00011100 111235777889999999999999999999976
Q ss_pred CCC
Q 002178 939 DVS 941 (956)
Q Consensus 939 ~~~ 941 (956)
...
T Consensus 272 ~~~ 274 (294)
T 2rku_A 272 GYI 274 (294)
T ss_dssp SCC
T ss_pred CCc
Confidence 544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.76 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999965 68999999987543 2335688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeecccccc
Q 002178 701 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLA 775 (956)
Q Consensus 701 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~ 775 (956)
|+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 2356899999999999999999999999 9999999999999 45688999999999765
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... .......||+.|+|||++. ..++.++|||||||++|||++|+.||...............
T Consensus 178 ~~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------- 240 (285)
T 3is5_A 178 KSD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------- 240 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred CCc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--------
Confidence 422 1223456899999999985 56889999999999999999999999754321111000000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
........++- .+...+++.+||..||++|||++|+|+|||
T Consensus 241 ---------------------~~~~~~~~~~~------------------~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 241 ---------------------EPNYAVECRPL------------------TPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp ---------------------CCCCCC--CCC------------------CHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ---------------------CcccccccCcC------------------CHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000001111 112236788899999999999999999999
Q ss_pred ccc
Q 002178 936 VSS 938 (956)
Q Consensus 936 f~~ 938 (956)
|+.
T Consensus 282 f~~ 284 (285)
T 3is5_A 282 FKQ 284 (285)
T ss_dssp GGC
T ss_pred hhc
Confidence 975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=357.38 Aligned_cols=264 Identities=25% Similarity=0.482 Sum_probs=217.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
..++|++.+.||+|+||+||+|.+. +++.||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 46789999997643 33456789999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCC--------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
.+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 24889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~ 836 (956)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999987643221 112233457789999999999899999999999999999999 999997543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
. .+.... +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++....+
T Consensus 265 ~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 265 V-EELFKL---------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H-HHHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-HHHHHH---------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2 111111 11122234456677889999999999999999999999999999877544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=370.19 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=162.4
Q ss_pred cCCCCC-CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHh-cCCCceeeeeccccc----CCcEE
Q 002178 624 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQM 696 (956)
Q Consensus 624 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~ 696 (956)
++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 68999999999999965 6899999998642 356778887744 589999999998864 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeecccc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~ 773 (956)
+||||+++|+|.+++.......+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998766667999999999999999999999999 999999999999998 7899999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 65321 1223456899999999999999999999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=354.55 Aligned_cols=271 Identities=25% Similarity=0.429 Sum_probs=220.7
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeee
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSL 685 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l 685 (956)
+...++....++|++.+.||+|+||+||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556666788999999999999999999984 2468999999976443 3346789999999999 79999999
Q ss_pred ecccccCC-cEEEEEecCCCCCHHHHHhhcCC--------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccC
Q 002178 686 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750 (956)
Q Consensus 686 ~~~~~~~~-~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 750 (956)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999976542 23899999999999999999999999 99999
Q ss_pred CCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CC
Q 002178 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829 (956)
Q Consensus 751 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~ 829 (956)
|||+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCc-----cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999998654322 1122334567889999999999999999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 830 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 830 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.||............ +..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 249 ~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRR---------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHH---------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 999754432221111 111222334555677899999999999999999999999999988654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=364.81 Aligned_cols=285 Identities=21% Similarity=0.326 Sum_probs=205.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCC------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 693 (956)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999965 6899999998753 2334567889999999999999999999986654
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 589888853 3788999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 176 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------- 238 (371)
T 2xrw_A 176 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--------- 238 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred ccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence 65321 1223456899999999999999999999999999999999999999765543322111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCC-------CCCCccccccccCCCCCCCC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~-------~~~~~~ll~~~L~~dP~~R~ 925 (956)
+ ...+...++....+...+.......|... .++.+.... . .+|.. ...+.+|+.+||..||++||
T Consensus 239 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 239 -I-EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD---V--LFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp -H-C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCG---G--GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred -H-HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccc---c--cCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 1 11222233333322222222222223211 122211100 0 01110 12345899999999999999
Q ss_pred CCccCCCCCccccC
Q 002178 926 SSSSMLKHPYVSSD 939 (956)
Q Consensus 926 sa~e~L~HP~f~~~ 939 (956)
|++|+|+||||+..
T Consensus 312 t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 312 SVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhCCcchhhh
Confidence 99999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.40 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=193.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHH-HHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|++.+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999975 589999999875432 223456667766 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 4788899999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... ...
T Consensus 192 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i---------~~~ 254 (373)
T 2r5t_A 192 HN-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNI---------LNK 254 (373)
T ss_dssp CC-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHH---------HHS
T ss_pred CC-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH---------Hhc
Confidence 11 1234567999999999999999999999999999999999999999765432 211111 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
...++...+..+.+++.+|++.+|.+||++.+.++
T Consensus 255 -~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 255 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 12234445567777888888888888888754433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.74 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=199.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..++|++.+.||+|+||+||+|... +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 689999999976432 234688888888 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC----CcEEEEeecccccc
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRLA 775 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DfGla~~~ 775 (956)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999764 35899999999999999999999999 9999999999998543 35999999999875
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch-hHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~ 854 (956)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 171 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------------- 229 (342)
T 2qr7_A 171 RAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-------------- 229 (342)
T ss_dssp BCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH--------------
T ss_pred cCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH--------------
Confidence 4321 122345689999999999988899999999999999999999999974321 000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
++...+.......+.. ..+...+.+.+++++||..||++|+|++|+++||
T Consensus 230 --------------~~~~~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 230 --------------EILARIGSGKFSLSGG----------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp --------------HHHHHHHHCCCCCCST----------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred --------------HHHHHHccCCcccCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0001011000000000 0011122334688888999999999999999999
Q ss_pred cccc
Q 002178 935 YVSS 938 (956)
Q Consensus 935 ~f~~ 938 (956)
||..
T Consensus 280 ~~~~ 283 (342)
T 2qr7_A 280 WIVH 283 (342)
T ss_dssp HHHT
T ss_pred eecC
Confidence 9954
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=373.58 Aligned_cols=295 Identities=24% Similarity=0.319 Sum_probs=194.1
Q ss_pred cCCCC-CCeeeeeCCeEEEEEEeC---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccc--ccCCcEEE
Q 002178 624 NNFNS-STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQML 697 (956)
Q Consensus 624 ~~y~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~L 697 (956)
+.|++ .++||+|+||+||+|... +++.||||++..... ...+.+|++++++++||||+++++++ ......++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 458999999999999965 578999999975432 24678999999999999999999999 45678999
Q ss_pred EEecCCCCCHHHHHhhc-------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----cCCCcEEE
Q 002178 698 VYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKV 766 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl 766 (956)
||||++ |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 6898887532 1234899999999999999999999999 9999999999999 77899999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhH------
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV------ 839 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~------ 839 (956)
+|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 174 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 174 ADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999987643211 11223446789999999999874 58999999999999999999999996543210
Q ss_pred --HHHHHHhhcccchhhccCCCCCCChHH--HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002178 840 --REVNIAYQSSMMFSVIDGNMGSYPSEC--VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 915 (956)
Q Consensus 840 --~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~ 915 (956)
+.....+ ..+........... ......+... +........... +.+ .......+..+.+||.+
T Consensus 250 ~~~~l~~i~------~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 250 HHDQLDRIF------NVMGFPADKDWEDIKKMPEHSTLMKD-FRRNTYTNCSLI---KYM---EKHKVKPDSKAFHLLQK 316 (405)
T ss_dssp CHHHHHHHH------HHHCCCCTTTCGGGGGSTTHHHHHHH-CCGGGGTTCCHH---HHH---HTTTCCTTSHHHHHHHH
T ss_pred hHHHHHHHH------HhhCCCChhhcchhhcCcchhhhhhh-ccccCCCcchhh---hhH---hhcCCCCCHHHHHHHHH
Confidence 1111100 00000000000000 0000000000 111111111111 111 11222335566789999
Q ss_pred ccCCCCCCCCCCccCCCCCccccCCC
Q 002178 916 EHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 916 ~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
||++||++|+|++|+|+||||.....
T Consensus 317 ~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 317 LLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred HccCCcccCCCHHHHhcChhhccCCC
Confidence 99999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=370.32 Aligned_cols=277 Identities=21% Similarity=0.359 Sum_probs=195.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccC------C
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 693 (956)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999964 6899999998753 333456788999999999999999999998543 5
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899998864 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +......
T Consensus 181 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~----- 244 (367)
T 2fst_X 181 HTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR----- 244 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-----
T ss_pred cccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-----
Confidence 6431 1234568999999999987 678999999999999999999999997654322 2221111
Q ss_pred hhccCCCCCCChHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCC
Q 002178 853 SVIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 927 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa 927 (956)
. .+..+.+... .....+.. +...| +..+. ..++...+.+.+||.+||+.||++|+|+
T Consensus 245 -~----~g~p~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~----------~~~~~~~~~~~dLl~~mL~~dP~~R~t~ 306 (367)
T 2fst_X 245 -L----VGTPGAELLKKISSESARNYIQS-LTQMP--KMNFA----------NVFIGANPLAVDLLEKMLVLDSDKRITA 306 (367)
T ss_dssp -H----HCSCCHHHHTTCCCHHHHHHHHT-SCCCC--CCCHH----------HHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred -H----hCCCCHHHHHHhhhHHHHHHHhc-cCCCC--CCCHH----------HHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence 0 0111111111 11111111 11111 12222 1234445566789999999999999999
Q ss_pred ccCCCCCccccCC
Q 002178 928 SSMLKHPYVSSDV 940 (956)
Q Consensus 928 ~e~L~HP~f~~~~ 940 (956)
+|+|+||||+...
T Consensus 307 ~e~L~hp~~~~~~ 319 (367)
T 2fst_X 307 AQALAHAYFAQYH 319 (367)
T ss_dssp HHHHTSGGGTTTC
T ss_pred HHHhcChhhhhcc
Confidence 9999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.90 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=210.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCC--cEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV 698 (956)
.++|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367889999999999999999976 589999999875432 33567889999999999999999999987654 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----cCCCcEEEEeecccc
Q 002178 699 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 773 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DfGla~ 773 (956)
|||+++++|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997643 234899999999999999999999999 9999999999999 888899999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccc--------cCCCCCcccchhHHHHHHHHHhCCCCCCCCch---hHHHH
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 842 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~---~~~~~ 842 (956)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 165 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 764322 123456899999999986 57789999999999999999999999964322 11211
Q ss_pred HHHhhcc---cchhh---------ccCC---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 843 NIAYQSS---MMFSV---------IDGN---MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 843 ~~~~~~~---~~~~~---------~~~~---~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
....... .+..+ ..+. ....+......+.+++.+|++.||++||+++++++...+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111110 00000 0001 1134678888999999999999999999999999887754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=364.47 Aligned_cols=291 Identities=22% Similarity=0.276 Sum_probs=211.3
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh-----------hhHHHHHHHHHHHHhcCCCcee
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----------QGEKEFLTEIQFLSRLHHRNLV 683 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv 683 (956)
...++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677888999999999999999999999988899999998864221 1236789999999999999999
Q ss_pred eeecccc-----cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 684 SLVGYCD-----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 684 ~l~~~~~-----~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
++++++. .....++||||++ |+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999983 3346899999996 7999988754 346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999754321 12234568899999999987 6789999999999999999999999976543
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccc
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~l 912 (956)
... ...... .. +..+.+.. ....+.........|..+ .....+..++...++
T Consensus 240 ~~~-~~~i~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l 296 (362)
T 3pg1_A 240 YNQ-LNKIVE------VV----GTPKIEDVVMFSSPSARDYLRNSLSNVPARA------------WTAVVPTADPVALDL 296 (362)
T ss_dssp HHH-HHHHHH------HH----CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC------------HHHHSTTSCHHHHHH
T ss_pred HHH-HHHHHH------Hc----CCCChHHhhhccchhhhHHHHhhcccCChhh------------HHhhCCCCCHHHHHH
Confidence 221 111110 00 01111110 011111111111111110 111223344556789
Q ss_pred cccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 913 INSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 913 l~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+.+||..||++|||++|+|+||||++-..
T Consensus 297 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 297 IAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 99999999999999999999999987644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.89 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeeeccccc----CCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDE----EGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~ 696 (956)
.++|++.+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 6899999998643 34456667777666 799999999998643 34689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhh--------hcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
+||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999954 35899999999999999999999 777 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccccC------CCCCcccchhHHHHHHHHHhC----------CCCC
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG----------MQPI 832 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~G~ll~elltg----------~~pf 832 (956)
||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765432211 01112334699999999999876 455789999999999999999 8888
Q ss_pred CCCch---hHHHHHHHhhcccchhhccCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 833 SHGKN---IVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 833 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
..... .......... ........ +..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVC-------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHh-------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54211 1111111111 11112222 356788999999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=358.58 Aligned_cols=266 Identities=24% Similarity=0.406 Sum_probs=216.4
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCC-C-----cEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPD-G-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 689 (956)
++....++|++.+.||+|+||+||+|.... + +.||+|.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455567889999999999999999999642 2 489999997643 33456789999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcC------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999997532 345789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~ 836 (956)
++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT-----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECcccccccccccc-----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999998654322 1112234457889999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
......... . .+.....+..++..+.+++..||+.+|.+||++.++++.|+++..
T Consensus 272 ~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSKFYKLV-K--------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHHHHHHH-H--------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHH-h--------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 322111111 0 111123344556789999999999999999999999999988754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.84 Aligned_cols=285 Identities=25% Similarity=0.366 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999975 589999999865432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998887543 34889999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 241 (331)
T 4aaa_A 179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL---------- 241 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH----------
T ss_pred -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh----------
Confidence 122345689999999999875 78999999999999999999999997655433222111100
Q ss_pred CCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 859 MGSYPSECVEKFIKLALK--CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~--c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
+..++.....+...... ........+.... ...+...+...+|+.+||..||++|||++|+|+||||
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 242 -GNLIPRHQELFNKNPVFAGVRLPEIKEREPLE----------RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp -CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH----------HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -CCCChhhhhHhhhccccccccCccccccchhh----------hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 11111111111100000 0000001111111 1123334445689999999999999999999999999
Q ss_pred ccCC
Q 002178 937 SSDV 940 (956)
Q Consensus 937 ~~~~ 940 (956)
+.+.
T Consensus 311 ~~~~ 314 (331)
T 4aaa_A 311 QMDG 314 (331)
T ss_dssp HGGG
T ss_pred ccCC
Confidence 8764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=384.03 Aligned_cols=263 Identities=30% Similarity=0.470 Sum_probs=218.4
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
+++.+..++|++.++||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++|+||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 344455678899999999999999999998888899999986443 35689999999999999999999999876 6789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.++++......+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999997644455889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+.
T Consensus 415 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~~---------~i~ 478 (535)
T 2h8h_A 415 DNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLD---------QVE 478 (535)
T ss_dssp CHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HHH---------HHH
T ss_pred CCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHH
Confidence 211 111223346788999999999999999999999999999999 999997544321 111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 479 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 222334566778899999999999999999999999999997754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.35 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=198.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 697 (956)
..++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999976 79999999987532 33456788999999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC--------------
Q 002178 698 VYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------- 761 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-------------- 761 (956)
||||+++++|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997642 245899999999999999999999999 9999999999999844
Q ss_pred -----CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 762 -----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 762 -----~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 489999999998754321 23489999999999875 5668999999999999999998776533
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 915 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~ 915 (956)
..... +..+.....+..+ .+...+++.+
T Consensus 235 ~~~~~-------------~~~~~~~~~~~~~---------------------------------------~~~~~~li~~ 262 (289)
T 1x8b_A 235 DQWHE-------------IRQGRLPRIPQVL---------------------------------------SQEFTELLKV 262 (289)
T ss_dssp HHHHH-------------HHTTCCCCCSSCC---------------------------------------CHHHHHHHHH
T ss_pred hHHHH-------------HHcCCCCCCCccc---------------------------------------CHHHHHHHHH
Confidence 21110 1111111111111 1122357777
Q ss_pred ccCCCCCCCCCCccCCCCCccccCC
Q 002178 916 EHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 916 ~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
||..||++|||++|+++||||.+..
T Consensus 263 ~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 263 MIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTCSSGGGSCCHHHHHTCTTC----
T ss_pred HhCCCcccCCCHHHHhhChHhhhhc
Confidence 8888999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=367.79 Aligned_cols=281 Identities=21% Similarity=0.329 Sum_probs=202.8
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc-------
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 691 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------- 691 (956)
....++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 4799999999875432 22469999999999999999999843
Q ss_pred -------------------------------CCcEEEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHh
Q 002178 692 -------------------------------EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 738 (956)
Q Consensus 692 -------------------------------~~~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 738 (956)
....++||||++ |+|.+.+.. .....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 688887764 3445689999999999999999999
Q ss_pred hhcCCCCEeccCCCcccEEEc-CCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccch
Q 002178 739 HTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVY 816 (956)
Q Consensus 739 H~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVw 816 (956)
|+.+ |+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999 99999999999998 68899999999998654321 22345689999999998875 489999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 817 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 817 S~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
|+||++|||++|+.||.............. . .+..+.+....+. -......-|.... .
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~-------~----~g~p~~~~~~~~~------~~~~~~~~~~~~~-----~ 284 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQ-------I----MGTPTKEQMIRMN------PHYTEVRFPTLKA-----K 284 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------H----HCCCCHHHHHHHC------TTC--CCCCCCCC-----C
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHH-------H----hCCCCHHHHHHhC------cccccccCCccCc-----c
Confidence 999999999999999976544322221110 0 0111111111100 0000000000000 0
Q ss_pred HhHhhCCC-CCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 897 SIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 897 ~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
.+...++. ..+.+.+++.+||++||++|+|++|+|+||||..
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 01111222 2334568999999999999999999999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=347.25 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=183.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788999999999999999996 4799999999864322 12367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 346899999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~~~- 228 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNKVVLAD- 228 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSC-
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHHHhhcc-
Confidence 112335689999999999998999999999999999999999999965331100 00000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
...|.. ......+++.+||..||++|||++|+++||||...
T Consensus 229 ~~~~~~---------------------------------------~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 YEMPSF---------------------------------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CCCCTT---------------------------------------SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred cCCccc---------------------------------------cCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 000100 01122367888899999999999999999999765
Q ss_pred CC
Q 002178 940 VS 941 (956)
Q Consensus 940 ~~ 941 (956)
..
T Consensus 270 ~~ 271 (278)
T 3cok_A 270 SS 271 (278)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=354.63 Aligned_cols=270 Identities=26% Similarity=0.445 Sum_probs=209.2
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccc
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 690 (956)
+++....++|.+.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344456788999999999999999999853 34589999987542 334567899999999999999999999987
Q ss_pred cCC-----cEEEEEecCCCCCHHHHHhhc----CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC
Q 002178 691 EEG-----EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (956)
Q Consensus 691 ~~~-----~~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 761 (956)
+.+ ..++||||+++|+|.+++... ....+++..++.++.|+++||.|||+++ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 654 459999999999999998542 3356899999999999999999999998 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHH
Q 002178 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 840 (956)
Q Consensus 762 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~ 840 (956)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999986543221 112234457889999999999999999999999999999999 8888875443211
Q ss_pred HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 841 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
. . .+..+.....+..++..+.+++.+|+..+|.+||++.++++.|+++.+.+|+
T Consensus 259 ~-~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 Y-D---------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp H-H---------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred H-H---------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1 1 1222333445666778899999999999999999999999999999887664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=353.24 Aligned_cols=202 Identities=24% Similarity=0.397 Sum_probs=177.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 5889999998653 233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998764 35889999999999999999999999 999999999999999999999999999875422
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 195 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 1 11234568999999999999999999999999999999999999997543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.63 Aligned_cols=264 Identities=31% Similarity=0.479 Sum_probs=209.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccc-ccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~L 697 (956)
.+|++.+.||+|+||+||+|.+.+ +..||+|.+.... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998642 3368999987643 33456889999999999999999999985 55668899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999753 345789999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.... .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+....+..+... .+..+
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---------~~~~~ 248 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---------YLLQG 248 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---------HHHTT
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---------HHhcC
Confidence 2211 11223445678899999999999999999999999999999995554433322211111 11222
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
.....+..++..+.+++.+|++.+|.+||++.++++.|+++...+.
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 2333455567789999999999999999999999999999887654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.25 Aligned_cols=271 Identities=27% Similarity=0.416 Sum_probs=214.9
Q ss_pred cCC-CCCCeeeeeCCeEEEEEEeC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccccc--CCc
Q 002178 624 NNF-NSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGE 694 (956)
Q Consensus 624 ~~y-~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 694 (956)
++| ++.+.||+|+||+||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 88999999999999988642 58899999998643 3345678999999999999999999999976 457
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 89999999999999999764 3889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH----HHhhccc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN----IAYQSSM 850 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~----~~~~~~~ 850 (956)
...... .........+|..|+|||++.+..++.++|||||||++|||++|+.||........... .......
T Consensus 184 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 184 VPEGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CCTTCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 653221 11223345578889999999999999999999999999999999999864322110000 0000001
Q ss_pred chhh-ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 851 MFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 851 ~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
+... ..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 1111 12233445677788999999999999999999999999999998776543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=356.02 Aligned_cols=273 Identities=27% Similarity=0.389 Sum_probs=217.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccc--cCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 695 (956)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46788999999999999999984 368999999998777666778999999999999999999999875 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997642 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH-HHh----hccc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN-IAY----QSSM 850 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~-~~~----~~~~ 850 (956)
..... .........||..|+|||++.+..++.++|||||||++|||++|+.||........... ... ....
T Consensus 178 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKD----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCS----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCc----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 43321 11122344588889999999999999999999999999999999999864322110000 000 0000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
...+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11122233345567788899999999999999999999999999998765443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.20 Aligned_cols=268 Identities=26% Similarity=0.450 Sum_probs=219.4
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeee
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 686 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~ 686 (956)
+..+++....++|++.+.||+|+||.||+|.+. +++.||||.+.... ......+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334456667889999999999999999999854 36889999997543 33456789999999999999999999
Q ss_pred cccccCCcEEEEEecCCCCCHHHHHhhcC--------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE
Q 002178 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (956)
Q Consensus 687 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 758 (956)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997532 245788999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCch
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~ 837 (956)
+.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cCCCeEEECcCcccccccccc-----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999999997653221 0112233457889999999999999999999999999999999 8888865432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
. +... .+..+.....+..++..+.+++.+|++.+|.+||++.++++.|++..
T Consensus 247 ~-~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 247 E-QVLR---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H-HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-HHHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 2 1111 11222334455667788999999999999999999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=369.77 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=172.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC--------CCceeeeecccc---
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCD--- 690 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~--- 690 (956)
.++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999864 6899999999753 334567889999999985 788999999986
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCC------
Q 002178 691 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 762 (956)
Q Consensus 691 -~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~------ 762 (956)
.....++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 67888877666556799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------cEEEEeeccccccCCCCCCCccccceecccccCCCcc
Q 002178 763 -------------------------------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799 (956)
Q Consensus 763 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 799 (956)
.+||+|||+++..... .....||+.|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 7999999999865321 23346899999
Q ss_pred cccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 800 aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
|||++.+..++.++|||||||++|||++|+.||...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=361.00 Aligned_cols=270 Identities=15% Similarity=0.172 Sum_probs=209.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCC---------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceee---------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS--------- 684 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--------- 684 (956)
.++|++.+.||+|+||+||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999753 789999998754 36788999999999999998
Q ss_pred ------eeccccc-CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 685 ------LVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 685 ------l~~~~~~-~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
+++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 4555544 67889999999 999999998764567999999999999999999999999 999999999999
Q ss_pred EcCCC--cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 758 LDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 758 l~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
++.++ .+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876532211111111223457999999999999999999999999999999999999999754
Q ss_pred chhHHHHHHHhh--cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 836 KNIVREVNIAYQ--SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 836 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
............ ........... ......+..+.+++..|++.+|.+||++.++++.|+.+.+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 311111111100 00000000000 0012345789999999999999999999999999999877654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.01 Aligned_cols=199 Identities=25% Similarity=0.433 Sum_probs=173.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.++|.+.+.||+|+||+||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467899999999999999999975 7999999999865554556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccccCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~ 778 (956)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999987643 4889999999999999999999999 9999999999999 78899999999998754311
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 163 ---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp ---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123346899999999999999999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.52 Aligned_cols=262 Identities=27% Similarity=0.483 Sum_probs=201.5
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
+..++|++.++||+|+||+||+|.+.. .||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345789999999999999999998643 59999987543 33456789999999999999999999965 45578999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999654 345899999999999999999999999 999999999999999999999999999765422
Q ss_pred CCCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
. .........||+.|+|||++. +..++.++||||||+++|||++|+.||............... . ..
T Consensus 174 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~----~~ 243 (289)
T 3og7_A 174 S-----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR-G----SL 243 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-T----SC
T ss_pred c-----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-c----cc
Confidence 1 112233456899999999987 567888999999999999999999999765443332222111 1 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
.......+..++..+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 12222334567788999999999999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.94 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=211.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC--Cc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 694 (956)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688899999999999999983 368999999987543 23356889999999999999999999999776 67
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh-----hcc
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY-----QSS 849 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~-----~~~ 849 (956)
...... .........||..|+|||++.+..++.++|||||||++|||++|+.|+.............. ...
T Consensus 176 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 653321 11223345688889999999999999999999999999999999998643211100000000 000
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
....+..+.....+..+++.+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 01112223334456677889999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.30 Aligned_cols=264 Identities=31% Similarity=0.497 Sum_probs=202.3
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC--C--CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccc-cCCcEEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP--D--GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~LV 698 (956)
.|++.+.||+|+||+||+|.+. + +..||||.++... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999863 2 2468999987533 344578999999999999999999999864 45688999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999754 345788999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. .+..+
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~~---------~~~~~ 312 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TV---------YLLQG 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-HH---------HHHTT
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-HH---------HHHcC
Confidence 211 1112234457889999999999999999999999999999999 6666654322111 11 11222
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~ 905 (956)
.....|..++..+.+++.+||+.+|++||++.++++.|+.+...+...
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 333445667788999999999999999999999999999998766543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=363.21 Aligned_cols=286 Identities=23% Similarity=0.337 Sum_probs=211.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC-----CcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 695 (956)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 68899999987533 33346789999999999999999999998654 478
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 6999999653 4889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 179 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~- 246 (364)
T 3qyz_A 179 DPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-------G- 246 (364)
T ss_dssp CGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH-------H-
T ss_pred CCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-------H-
Confidence 42211 0111234579999999998765 458999999999999999999999997654322211110 0
Q ss_pred ccCCCCCCChHHHHHHHHHH-HHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLA-LKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
..+..+.+....+.... .......|. .+.... ...+..+..+.+|+.+||..||++|||++|+|+
T Consensus 247 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 247 ---ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN----------RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ---HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH----------HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH----------HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111222111110000 000011111 111111 122334455678999999999999999999999
Q ss_pred CCccccCC
Q 002178 933 HPYVSSDV 940 (956)
Q Consensus 933 HP~f~~~~ 940 (956)
||||+...
T Consensus 314 hp~~~~~~ 321 (364)
T 3qyz_A 314 HPYLEQYY 321 (364)
T ss_dssp SGGGTTTC
T ss_pred Ccchhhcc
Confidence 99998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.60 Aligned_cols=254 Identities=31% Similarity=0.521 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh-------HHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.++|++.+.||+|+||+||+|.+. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999974 78999999986533221 157899999999999999999999997655
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc-----EEEEee
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADF 769 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Df 769 (956)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||||+||+++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999999988654 346899999999999999999999875 45999999999999988776 999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccc--cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
|+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...............
T Consensus 174 g~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 174 GLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp TTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred Cccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 99975321 223456899999999984 456788999999999999999999999754332211111100
Q ss_pred cccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
..+.....+..++..+.+++..||+.+|.+||++.++++.|++
T Consensus 244 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 -------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1122234566778899999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=357.34 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcE----EEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999964 4443 8888875432 222346778999999999999999999986 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999754 346889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........|+..|+|||++.+..++.++|||||||++|||++ |+.||......... . .+.
T Consensus 167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---------~~~ 231 (325)
T 3kex_A 167 PDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-D---------LLE 231 (325)
T ss_dssp CCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-H---------HHH
T ss_pred cccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-H---------HHH
Confidence 4321 122344567889999999999999999999999999999999 99999754322111 1 011
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 122233455566788999999999999999999999999988743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.12 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCc----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 694 (956)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 4789999999976432 234578899999999999999999999866543
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++++|.++++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997653 5889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||............. ......
T Consensus 166 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~-- 238 (311)
T 3ork_A 166 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIP-- 238 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HCCCCC--
T ss_pred cccccc----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-cCCCCC--
Confidence 543221 1112234568999999999999999999999999999999999999997654332211111 100000
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhH
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIW 899 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~-~~L~~~~ 899 (956)
.......++..+.+++.+|++.+|.+||+..+++ ..+.+..
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0001223567889999999999999999766655 4444443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.30 Aligned_cols=263 Identities=24% Similarity=0.423 Sum_probs=207.8
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhc-CCCceeee
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRL-HHRNLVSL 685 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l 685 (956)
+.......++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556688999999999999999999975 799999999865431 1135678999999999 79999999
Q ss_pred ecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 686 ~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999764 35889999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCccccccccc------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhH
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~ 839 (956)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 241 l~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp ECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999998764321 1234569999999999864 358889999999999999999999997543211
Q ss_pred HHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCC
Q 002178 840 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919 (956)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~ 919 (956)
. ... +..+.. .++. .. ++.......+++.+||..
T Consensus 313 ~-~~~---------i~~~~~-~~~~------------------------~~-----------~~~~~~~~~~li~~~L~~ 346 (365)
T 2y7j_A 313 M-LRM---------IMEGQY-QFSS------------------------PE-----------WDDRSSTVKDLISRLLQV 346 (365)
T ss_dssp H-HHH---------HHHTCC-CCCH------------------------HH-----------HSSSCHHHHHHHHHHSCS
T ss_pred H-HHH---------HHhCCC-CCCC------------------------cc-----------cccCCHHHHHHHHHHcCC
Confidence 1 000 000000 0000 00 011122234688889999
Q ss_pred CCCCCCCCccCCCCCccc
Q 002178 920 KEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 920 dP~~R~sa~e~L~HP~f~ 937 (956)
||++|||++|+|+||||.
T Consensus 347 dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 347 DPEARLTAEQALQHPFFE 364 (365)
T ss_dssp STTTSCCHHHHHHSGGGC
T ss_pred ChhHCcCHHHHhcCcccC
Confidence 999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=371.36 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=194.8
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999965 689999999864321 112357899999999999999999999854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cEEEEe
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVAD 768 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~D 768 (956)
+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 4689999999999999988654 45899999999999999999999999 99999999999997544 599999
Q ss_pred eccccccCCCCCCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 286 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--- 354 (419)
T 3i6u_A 286 FGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--- 354 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH---
T ss_pred cccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH---
Confidence 9999875422 22334579999999999864 567889999999999999999999996532210000
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
..+......++.+. .+.....+.+|+.+||..||++||
T Consensus 355 -------~~i~~~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 355 -------DQITSGKYNFIPEV-----------------------------------WAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp -------HHHHTTCCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred -------HHHhcCCCCCCchh-----------------------------------hcccCHHHHHHHHHHccCChhHCc
Confidence 00000000111100 011122334788889999999999
Q ss_pred CCccCCCCCccccC
Q 002178 926 SSSSMLKHPYVSSD 939 (956)
Q Consensus 926 sa~e~L~HP~f~~~ 939 (956)
|++|+|+||||+..
T Consensus 393 s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 393 TTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHSGGGCCH
T ss_pred CHHHHhCCcccCCh
Confidence 99999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=381.16 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=209.6
Q ss_pred CCCCCC-eeeeeCCeEEEEEEeC---CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 625 NFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 625 ~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+++.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 467899999986432 346789999999999999999999999976 5699999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999654 346899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..+.
T Consensus 491 ~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~---------~i~~~~ 556 (613)
T 2ozo_A 491 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA---------FIEQGK 556 (613)
T ss_dssp ---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HHH---------HHHTTC
T ss_pred ce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHH---------HHHcCC
Confidence 11 111223346689999999999999999999999999999998 999997654321 111 122233
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
....|..++..+.+++..||+.+|++||++.++++.|+.+.....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 445677788999999999999999999999999999998866543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=352.65 Aligned_cols=289 Identities=21% Similarity=0.309 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-C-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc------eeeeecccccCCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-P-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 694 (956)
.++|++.+.||+|+||+||+|.. . +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6899999999753 334567889999999987665 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--------------
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 760 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------- 760 (956)
.++||||+ +++|.+++......++++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999998876667899999999999999999999999 999999999999987
Q ss_pred -----CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 761 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 761 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864321 23346899999999999999999999999999999999999999765
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh----hCC---CCCCC
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN----MMP---ESDTK 908 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~----~~~---~~~~~ 908 (956)
.......... .. .+..|......... ......+....+......+....... ... ...+.
T Consensus 238 ~~~~~~~~~~-------~~----~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 238 DSKEHLAMME-------RI----LGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp CHHHHHHHHH-------HH----HCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred ChHHHHHHHH-------HH----hCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 4322111100 00 11122222111000 00000000000000111111111100 000 00122
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+++.+||..||++|||++|+++||||..-
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 3479999999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=348.77 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=208.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CC-------cEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DG-------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
.++|.+.+.||+|+||+||+|... ++ +.||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467888999999999999999864 33 5799999977666667789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc--------EEE
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKV 766 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl 766 (956)
.++||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997643 34889999999999999999999999 999999999999998887 999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....+........
T Consensus 163 ~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp CCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999875421 123457899999999987 778999999999999999999666655443333222211
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
. .....+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 232 ~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 E-----------DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp H-----------TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred h-----------ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 1112233345678899999999999999999999999997754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=346.75 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 68999999986432 2345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc-
Confidence 99999999998643 45889999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.........|++.|+|||++.+..+ +.++||||||+++|||++|+.||.............
T Consensus 160 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------- 221 (276)
T 2yex_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------------- 221 (276)
T ss_dssp ----EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH--------------
T ss_pred ----chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh--------------
Confidence 1112234568999999999988765 778999999999999999999997543211111000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
.. .....+.. +..+....+++.+||..||++|||++|+++||||+..
T Consensus 222 --------------~~-----~~~~~~~~--------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 222 --------------KE-----KKTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp --------------HT-----TCTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------------hh-----cccccCch--------------hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 00 00000000 0011222367888899999999999999999999765
Q ss_pred CC
Q 002178 940 VS 941 (956)
Q Consensus 940 ~~ 941 (956)
..
T Consensus 269 ~~ 270 (276)
T 2yex_A 269 LK 270 (276)
T ss_dssp CC
T ss_pred hh
Confidence 44
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.12 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=209.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
..++|.+.+.||+|+||+||+|.+.+ +..||+|.+.... ....+.+.+|++++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45688899999999999999998542 3469999987653 34457899999999999999999999998754 568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 45889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......... . .+.
T Consensus 165 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~---------~~~ 228 (281)
T 3cc6_A 165 DED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-G---------VLE 228 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-H---------HHH
T ss_pred ccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-H---------HHh
Confidence 322 111233457789999999999999999999999999999998 99999754332111 1 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+.....+..+++.+.+++.+|+..+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1222334556678899999999999999999999999999987653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=359.95 Aligned_cols=202 Identities=24% Similarity=0.301 Sum_probs=173.7
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CC-----ceeeeecccccCC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEG 693 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~ 693 (956)
...++|++.+.||+|+||+||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34679999999999999999999965 6899999999753 333457788998888885 44 4999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh--cCCCCEeccCCCcccEEEc--CCCcEEEEee
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT--EADPPVFHRDIKASNILLD--HKFTAKVADF 769 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~ivH~Dlk~~NILl~--~~~~~kl~Df 769 (956)
..++||||++ |+|.+++.......+++..++.++.|++.||.|||. .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 699999987765679999999999999999999995 45 99999999999994 5788999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 206 G~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999875321 2335689999999999999999999999999999999999999986544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=344.15 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=214.0
Q ss_pred hcCCCCCC-eeeeeCCeEEEEEEeC---CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 8999999999999853 57889999998643 33457889999999999999999999999 4567999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999653 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 163 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~---------~i~~ 228 (287)
T 1u59_A 163 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA---------FIEQ 228 (287)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHH---------HHHT
T ss_pred Ccce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHhc
Confidence 2210 111233456889999999998889999999999999999999 999997644321 111 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 233445667788999999999999999999999999999988654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=389.17 Aligned_cols=203 Identities=22% Similarity=0.345 Sum_probs=177.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 696 (956)
..++|++.+.||+|+||+||+|... +++.||||+++... ....+.+..|.+++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999965 68999999987532 12235678899999887 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.++++... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998653 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 494 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 494 WDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 221 22345679999999999999999999999999999999999999997543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.67 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=205.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc-CCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e 700 (956)
..++|++.+.||+|+||+||+|.. +|+.||||+++... ..+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346789999999999999999987 48899999987543 34678999999999999999999998654 457899999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.......+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997654444788999999999999999999999 999999999999999999999999998754321
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+..+..
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~---------~~~~~~~ 232 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVP---------RVEKGYK 232 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHH---------HHTTTCC
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHhcCCC
Confidence 122357889999999999999999999999999999998 999997543211 111 1112223
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
...+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 345566778899999999999999999999999999988653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=344.34 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=198.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeeccccc----CCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 696 (956)
..|.+.+.||+|+||+||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677889999999999999965 6889999998753 23345678999999999999999999998754 45689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEEEeecccccc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLA 775 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DfGla~~~ 775 (956)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||||+||+++ .++.+||+|||++...
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999999764 34888999999999999999999875 4599999999999998 7899999999999754
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...............
T Consensus 183 ~~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------- 244 (290)
T 1t4h_A 183 RAS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------- 244 (290)
T ss_dssp CTT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------
T ss_pred ccc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--------
Confidence 321 123456899999999886 45899999999999999999999999764443322211100
Q ss_pred cCCCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 856 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 856 ~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
+... ..+. ...+...+++.+||..||++|||++|+++||
T Consensus 245 -~~~~~~~~~---------------------------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 245 -GVKPASFDK---------------------------------------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp -TCCCGGGGG---------------------------------------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -cCCccccCC---------------------------------------CCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 0000 0000 0011223677888999999999999999999
Q ss_pred ccccC
Q 002178 935 YVSSD 939 (956)
Q Consensus 935 ~f~~~ 939 (956)
||+++
T Consensus 285 ~f~~~ 289 (290)
T 1t4h_A 285 FFQEE 289 (290)
T ss_dssp GGC--
T ss_pred ccccC
Confidence 99875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=367.45 Aligned_cols=330 Identities=22% Similarity=0.215 Sum_probs=293.3
Q ss_pred CCCC--CCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchh
Q 002178 62 PCTS--NWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (956)
Q Consensus 62 ~c~~--~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L 135 (956)
.|.| .|..|.|...... +.+.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 85 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEE
Confidence 4544 4788999765432 345689999999999999989999999999999999999999889999999999999
Q ss_pred hccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccC
Q 002178 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 215 (956)
+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+++
T Consensus 86 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred ECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999999777778999999999999999999989999999999999999999999888999999999999999999999
Q ss_pred CCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC-CCCCCCCCCccEEEccCCcCCcCCCCC-
Q 002178 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPG- 293 (956)
Q Consensus 216 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~- 293 (956)
+..+..|..+++|+.|+|++|.+++ ..+..|.++++|+.|++++|.+.+. ++......+|+.|+|++|+++ .+|..
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~ 243 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCE-ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHH
T ss_pred ccChhHhcccCCCcEEeCCCCcCcE-eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHH
Confidence 8888889999999999999999986 5667899999999999999987664 444556679999999999999 56642
Q ss_pred C-CccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--C
Q 002178 294 R-LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--N 370 (956)
Q Consensus 294 ~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~ 370 (956)
+ ...+|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+. +|+.|+|++|+|++++... .
T Consensus 244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~ 318 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN-----YLRVLNVSGNQLTTLEESVFHS 318 (477)
T ss_dssp HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCT-----TCCEEECCSSCCSCCCGGGBSC
T ss_pred hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcc-----cCCEEECCCCcCceeCHhHcCC
Confidence 2 234899999999999999999999999999999999999998898887654 4569999999999998764 5
Q ss_pred CCCCcEEEecCCcccccCCcccccCCCC
Q 002178 371 IPPNVTVRLRGNPFCLNTNAEQFCGSHS 398 (956)
Q Consensus 371 ~~~l~~l~l~~Np~~c~c~~~~~~~~~~ 398 (956)
++.+..|+|++|||.|||.+.|+..|..
T Consensus 319 l~~L~~L~l~~N~l~c~c~~~~~~~~~~ 346 (477)
T 2id5_A 319 VGNLETLILDSNPLACDCRLLWVFRRRW 346 (477)
T ss_dssp GGGCCEEECCSSCEECSGGGHHHHTTTT
T ss_pred CcccCEEEccCCCccCccchHhHHhhhh
Confidence 8899999999999999999999887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.36 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=169.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCC-------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 693 (956)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999976 799999999875433 34568999999999999999999999885433
Q ss_pred --------------------------------------------------cEEEEEecCCCCCHHHHHhhcCC-CCchhH
Q 002178 694 --------------------------------------------------EQMLVYEFMSNGTLRDQLSAKSK-EPLGFA 722 (956)
Q Consensus 694 --------------------------------------------------~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~ 722 (956)
..++||||+++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999986533 234566
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc-----ccceecccccCCC
Q 002178 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV-----PAHVSTVVKGTPG 797 (956)
Q Consensus 723 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 797 (956)
.++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 999999999999999999999999999876543211000 0112234569999
Q ss_pred cccccccccCCCCCcccchhHHHHHHHHHhCCCCC
Q 002178 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832 (956)
Q Consensus 798 y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf 832 (956)
|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999986654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.64 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=211.4
Q ss_pred HHhcCCCCCC-eeeeeCCeEEEEEEeC---CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 621 LATNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 621 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
...++|.+.+ .||+|+||+||+|.+. +++.||||+++.... ...+.+.+|+++++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788887 9999999999999642 478999999875432 2356789999999999999999999999 5678
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 899999999999999997643 4889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. .
T Consensus 167 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~---------~ 232 (291)
T 1xbb_A 167 LRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA---------M 232 (291)
T ss_dssp CCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HH---------H
T ss_pred eccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HH---------H
Confidence 6433211 111223346788999999998889999999999999999999 9999976543211 11 1
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112223445667788999999999999999999999999999988764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.99 Aligned_cols=281 Identities=22% Similarity=0.314 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC------cEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------EQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 696 (956)
..+|++.+.||+|+||+||+|+..++..||+|++...... ..+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3578899999999999999999877667999887643322 236999999999999999999985433 378
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEEEeecccc
Q 002178 697 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSR 773 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DfGla~ 773 (956)
+||||+++ ++.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 44444332 23456899999999999999999999999 99999999999999 79999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..............
T Consensus 191 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~------ 256 (394)
T 4e7w_A 191 ILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK------ 256 (394)
T ss_dssp ECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred cccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH------
Confidence 764322 12345689999999999765 589999999999999999999999976544322221110
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC-CCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-PESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~-~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
. .+..+.+....+.. ...-..-|..++..- ...+ +...+.+.+|+.+||+.||++|+|++|+|
T Consensus 257 -~----~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 257 -V----LGTPSREQIKTMNP--NYMEHKFPQIRPHPF---------SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp -H----HCCCCHHHHHHHCG--GGSSSCCCCCCCCCH---------HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred -H----hCCCCHHHHHhhCh--hhhhhccccccCCcH---------HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0 11111111111100 000011122222110 0111 22344567899999999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
+||||..-..
T Consensus 321 ~hp~f~~~~~ 330 (394)
T 4e7w_A 321 CHPFFDELRT 330 (394)
T ss_dssp TSGGGSTTTS
T ss_pred cChhhhhhcc
Confidence 9999976443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=342.62 Aligned_cols=264 Identities=26% Similarity=0.381 Sum_probs=212.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-C---CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcE-EEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ-MLV 698 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~LV 698 (956)
.|...++||+|+||+||+|.+. + +..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556789999999999999853 2 33799999876433 3457889999999999999999999999766655 999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999763 346889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
... .........+++.|+|||.+.+..++.++|||||||++|||++|..|+....+....... +....
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---------~~~~~ 245 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---------LAQGR 245 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---------HHTTC
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---------hhcCC
Confidence 211 112223456788999999999999999999999999999999976666544332221111 11122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
....+..++..+.+++..|++.+|.+||++.++++.|+++...+..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2344556678899999999999999999999999999998876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=363.09 Aligned_cols=201 Identities=27% Similarity=0.346 Sum_probs=171.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe----CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhc-CCCceeeeecccccCC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 693 (956)
.++|++.+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 368999999987432 12234567899999999 6999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997653 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 208 EFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp ECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 653211 122334569999999999986 3478899999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.69 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=208.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc---------
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------- 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 691 (956)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999976 79999999987643 256789999999999999999998753
Q ss_pred -------CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 692 -------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 692 -------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445899999999999999998765567899999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+........
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH----
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH----
Confidence 999999998764321 12334689999999999999999999999999999999999988742211111
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+.. ...+..++..+.+++.+|++.+|.+||++.++++.++.+.+.
T Consensus 230 --------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 --------DLRD---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --------HHHT---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --------Hhhc---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0111 112334456788999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=367.79 Aligned_cols=277 Identities=22% Similarity=0.306 Sum_probs=198.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccC------CcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 696 (956)
.+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 699999999865322 234699999999999999999988432 2367
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-CcEEEEeecccc
Q 002178 697 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSR 773 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DfGla~ 773 (956)
+||||+++ +|.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999964 77776653 33456899999999999999999999999 9999999999999965 678999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. .
T Consensus 206 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~-~----- 271 (420)
T 1j1b_A 206 QLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII-K----- 271 (420)
T ss_dssp ECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H-----
T ss_pred hcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-H-----
Confidence 754221 12345689999999999764 78999999999999999999999997654332211111 0
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC-CCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-PESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~-~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
. .+....+....+ .-......-|.... ..+...+ +...+.+.+|+.+||..||++|+|++|+|
T Consensus 272 -~----lg~p~~~~~~~~------~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 272 -V----LGTPTREQIREM------NPNYTEFKFPQIKA-----HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp -H----HCSCCHHHHHHH------CSCCCCCCCCCCCC-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -H----hCCCCHHHHHhh------ChhhhhhccCccCC-----CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0 011111111110 00000000010000 0000111 12234556899999999999999999999
Q ss_pred CCCcccc
Q 002178 932 KHPYVSS 938 (956)
Q Consensus 932 ~HP~f~~ 938 (956)
+||||..
T Consensus 336 ~hp~f~~ 342 (420)
T 1j1b_A 336 AHSFFDE 342 (420)
T ss_dssp TSGGGGG
T ss_pred CCHhhcc
Confidence 9999965
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=352.38 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCC--CceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45789999999999999999998889999999987533 3344678999999999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||+ .+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 588999999764 35889999999999999999999999 99999999999997 578999999999876432
Q ss_pred CCCCccccceecccccCCCccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~ 847 (956)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......
T Consensus 161 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--- 232 (343)
T 3dbq_A 161 T-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA--- 232 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---
T ss_pred c-----ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH---
Confidence 2 1112334579999999999865 67888999999999999999999999764443222221
Q ss_pred cccchhhccCC-CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 848 SSMMFSVIDGN-MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 848 ~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.++.. ...++...+..+.+++..|++.+|.+||++.++++.
T Consensus 233 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111 223344455678888999999999999999888764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.02 Aligned_cols=275 Identities=23% Similarity=0.364 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ---- 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 695 (956)
.++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999965 68999999997542 23356788999999999999999999999776654
Q ss_pred --EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 696 --MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 696 --~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 789888732 3889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 193 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~----- 256 (371)
T 4exu_A 193 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-K----- 256 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-H-----
T ss_pred cccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-H-----
Confidence 6432 1234568999999999987 788999999999999999999999997654332211111 0
Q ss_pred hhccCCCCCCChHHHHH-----HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCC
Q 002178 853 SVIDGNMGSYPSECVEK-----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 927 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa 927 (956)
. .+..+.+.... ...... ......+....+ ..+...+.+.+|+.+||+.||++|||+
T Consensus 257 -~----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~ 318 (371)
T 4exu_A 257 -V----TGVPGTEFVQKLNDKAAKSYIQ---SLPQTPRKDFTQ----------LFPRASPQAADLLEKMLELDVDKRLTA 318 (371)
T ss_dssp -H----HCCCCHHHHTTCSCHHHHHHHH---HSCCCCCCCHHH----------HSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred -H----hCCCcHHHHHHhhhhhhhhhhh---ccCCCcchhHHH----------hccccChHHHHHHHHHCCCChhhcCCH
Confidence 0 01111111110 001111 011111222221 223445556789999999999999999
Q ss_pred ccCCCCCccccC
Q 002178 928 SSMLKHPYVSSD 939 (956)
Q Consensus 928 ~e~L~HP~f~~~ 939 (956)
+|+|+||||+.-
T Consensus 319 ~ell~hp~f~~~ 330 (371)
T 4exu_A 319 AQALTHPFFEPF 330 (371)
T ss_dssp HHHHTSGGGTTT
T ss_pred HHHhcCcccccC
Confidence 999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=373.87 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=204.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-------------hhHHHHHHHHHHHHhcCCCceeeeec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNLVSLVG 687 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 687 (956)
..++|++.++||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 589999999875332 22467889999999999999999999
Q ss_pred ccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC---cE
Q 002178 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TA 764 (956)
Q Consensus 688 ~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ 764 (956)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999997653 4899999999999999999999999 99999999999998776 69
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
||+|||+++..... .......||+.|+|||++. ..++.++||||+||++|||++|+.||...... +....
T Consensus 189 kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKK 258 (504)
T ss_dssp EECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred EEEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 99999999876432 1223456999999999987 46899999999999999999999999754321 11110
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCC
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 924 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 924 (956)
. ..+. ..++... ++...+.+.+|+++||+.||++|
T Consensus 259 i---------~~~~-~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~R 293 (504)
T 3q5i_A 259 V---------EKGK-YYFDFND-----------------------------------WKNISDEAKELIKLMLTYDYNKR 293 (504)
T ss_dssp H---------HHCC-CCCCHHH-----------------------------------HTTSCHHHHHHHHHHTCSSTTTS
T ss_pred H---------HcCC-CCCCccc-----------------------------------cCCCCHHHHHHHHHHcCCChhHC
Confidence 0 0000 0011000 01122334578899999999999
Q ss_pred CCCccCCCCCccccCCC
Q 002178 925 PSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 925 ~sa~e~L~HP~f~~~~~ 941 (956)
||++|+|+||||.....
T Consensus 294 ~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 294 CTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHHTSHHHHHTCC
T ss_pred CCHHHHhcCHhhhhchh
Confidence 99999999999975443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=374.48 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=198.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 68999999987543 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC---CcEEEEeeccccccC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 776 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DfGla~~~~ 776 (956)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.. +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999887653 4889999999999999999999999 9999999999999764 559999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.. .......||+.|+|||++. ..++.++||||+||++|||++|+.||...... +..... ..
T Consensus 191 ~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i---------~~ 251 (494)
T 3lij_A 191 NQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKV---------EK 251 (494)
T ss_dssp TT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH---------HH
T ss_pred CC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH---------Hh
Confidence 32 1223456999999999986 56899999999999999999999999754321 111100 00
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
+.. ... .|. ++...+.+.+|+.+||..||++|||++|+|+||||
T Consensus 252 ~~~-------------------~~~---~~~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 252 GKY-------------------TFD---SPE--------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp TCC-------------------CCC---SGG--------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred CCC-------------------CCC---chh--------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 000 000 000 01112223468888899999999999999999998
Q ss_pred cc
Q 002178 937 SS 938 (956)
Q Consensus 937 ~~ 938 (956)
..
T Consensus 296 ~~ 297 (494)
T 3lij_A 296 KE 297 (494)
T ss_dssp HH
T ss_pred cc
Confidence 65
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.02 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=201.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999976 589999999987665566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--- 169 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH---
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc---
Confidence 999999999987532 35899999999999999999999999 99999999999999999999999999754211
Q ss_pred CCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.........||+.|+|||++. +..++.++||||||+++|||++|+.||............ .
T Consensus 170 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~ 235 (302)
T 2j7t_A 170 ----TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----------A 235 (302)
T ss_dssp ----HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------H
T ss_pred ----cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----------h
Confidence 011123346899999999984 567889999999999999999999999754322111100 0
Q ss_pred cCCCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 856 DGNMG--SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 856 ~~~~~--~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
..... ..+..+ .....+++.+||..||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~---------------------------------------~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 236 KSDPPTLLTPSKW---------------------------------------SVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HSCCCCCSSGGGS---------------------------------------CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCcccc---------------------------------------CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 001111 1112357777888899999999999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||++...
T Consensus 277 ~~~~~~~~ 284 (302)
T 2j7t_A 277 PFVSSITS 284 (302)
T ss_dssp TTTTTCCC
T ss_pred hHHhhhcc
Confidence 99986543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.34 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=205.3
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc--CCCceeeeecccccC---
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE--- 692 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~--- 692 (956)
......++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999975 899999998643 233455566666554 899999999998776
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc--------CCCCEeccCCCcccEEEcCCCc
Q 002178 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 693 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 6889999999999999999654 489999999999999999999988 6 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCc------ccchhHHHHHHHHHhC---------
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVFLELLTG--------- 828 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwS~G~ll~elltg--------- 828 (956)
+||+|||+++........ .........||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp EEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred EEEEeCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 999999999765432211 0111224569999999999988776665 9999999999999999
Q ss_pred -CCCCCCCc---hhHHHHHHHhhcccchhhccCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 829 -MQPISHGK---NIVREVNIAYQSSMMFSVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 829 -~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
+.||.... ........... ........+ .+++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVC-------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHHh-------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 66664321 11111111111 111122222 478899999999999999999999999999999886
Q ss_pred hh
Q 002178 900 NM 901 (956)
Q Consensus 900 ~~ 901 (956)
+.
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 54
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=371.09 Aligned_cols=197 Identities=17% Similarity=0.185 Sum_probs=163.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC---ChhhHHHHHHHH---HHHHhcCCCceeeeec-------c
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEI---QFLSRLHHRNLVSLVG-------Y 688 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~~-------~ 688 (956)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 46999999998742 333457889999 4555668999999984 4
Q ss_pred cccCC-----------------cEEEEEecCCCCCHHHHHhhcC-----CCCchhHHHHHHHHHHHHHHHHhhhcCCCCE
Q 002178 689 CDEEG-----------------EQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPV 746 (956)
Q Consensus 689 ~~~~~-----------------~~~LV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 746 (956)
+...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 43332 378999999 689999997532 124556888999999999999999999 9
Q ss_pred eccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-----------CCCCcccc
Q 002178 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDV 815 (956)
Q Consensus 747 vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV 815 (956)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998532 12334557 999999999887 89999999
Q ss_pred hhHHHHHHHHHhCCCCCCC
Q 002178 816 YSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 816 wS~G~ll~elltg~~pf~~ 834 (956)
|||||++|||++|+.||..
T Consensus 297 wSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHHHHHHHSSCCC--
T ss_pred HHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999964
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.09 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|++++++++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467899999999999999999964 444 3577877543 333467899999999999999999999999865 488
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~---------~~~ 233 (327)
T 3lzb_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS---------ILE 233 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH---------HHH
T ss_pred Cccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HH---------HHH
Confidence 3221 112233456788999999999999999999999999999999 9999975432211 11 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222334566677889999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=351.82 Aligned_cols=214 Identities=27% Similarity=0.360 Sum_probs=176.0
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
++....++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45567889999999999999999999964 6899999998643 22335688999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--------------------------------------CCCCchhHHHHHHHHHHHH
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAK--------------------------------------SKEPLGFAMRLSIALGSSR 733 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 733 (956)
.+..++||||+++|+|.+++... ....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 1223577888999999999
Q ss_pred HHHHhhhcCCCCEeccCCCcccEEEcCCC--cEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc--CCC
Q 002178 734 GILYLHTEADPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKL 809 (956)
Q Consensus 734 gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 809 (956)
||+|||+.+ |+||||||+||+++.++ .+||+|||+++........ .........||+.|+|||++.+ ..+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCC
Confidence 999999999 99999999999998776 8999999999865432211 1112344569999999999975 678
Q ss_pred CCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 810 TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 810 ~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
+.++|||||||++|||++|+.||.....
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 9999999999999999999999975543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.15 Aligned_cols=286 Identities=22% Similarity=0.364 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccc-----------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----------- 690 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 690 (956)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 58999999998766666778999999999999999999998873
Q ss_pred ---cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEE
Q 002178 691 ---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 766 (956)
Q Consensus 691 ---~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 766 (956)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+++ |+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999954 35889999999999999999999999 99999999999997 5679999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++....... .........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 163 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLI 237 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred ccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999987542211 1112234457899999999876 6789999999999999999999999976543222 1111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 924 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 924 (956)
.. ..+....+...++...+......+ ...+.... ...+.......+++.+||..||++|
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 238 LE----------SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT----------QLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HH----------HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH----------HHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HH----------hcCCCchhhhhhhhhcCcccccccccCCCCChh----------HhcchhhHHHHHHHHHHcCCCcccc
Confidence 10 111222222222221110000000 00111111 1122334455689999999999999
Q ss_pred CCCccCCCCCccccCC
Q 002178 925 PSSSSMLKHPYVSSDV 940 (956)
Q Consensus 925 ~sa~e~L~HP~f~~~~ 940 (956)
||++|+|+||||+...
T Consensus 298 pt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 298 LTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCHHHHHTSHHHHTTC
T ss_pred CCHHHHhCCccccccc
Confidence 9999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.18 Aligned_cols=289 Identities=24% Similarity=0.348 Sum_probs=210.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe--CCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhc---CCCceeeeecccc----
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCD---- 690 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~---- 690 (956)
+.++|++.+.||+|+||+||+|.. .+|+.||+|++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3689999998864321 1123566777777766 8999999999986
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 691 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 691 -~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
.....++||||++ |+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999996 79999998776667899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
|+++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||............ ....
T Consensus 165 g~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-~~~~ 235 (326)
T 1blx_A 165 GLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI-LDVI 235 (326)
T ss_dssp CSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHH
T ss_pred cccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHHc
Confidence 99976532 11223456899999999999999999999999999999999999999765432221111 0000
Q ss_pred cchhhccCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 850 MMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 850 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
.... ...+. ..+. ..+. ....+. +....+.......+++.+||..||++|||
T Consensus 236 ~~~~--~~~~~~~~~~~~-----------~~~~--~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 290 (326)
T 1blx_A 236 GLPG--EEDWPRDVALPR-----------QAFH--SKSAQP----------IEKFVTDIDELGKDLLLKCLTFNPAKRIS 290 (326)
T ss_dssp CCCC--GGGSCTTCSSCG-----------GGSC--CCCCCC----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCC--cccCccccccch-----------hhhc--ccCcch----------hhhccccCCHHHHHHHHHHcCCCcccCCC
Confidence 0000 00000 0000 0000 000000 01112223334457999999999999999
Q ss_pred CccCCCCCccccCCCCCccccc
Q 002178 927 SSSMLKHPYVSSDVSGSNLVSG 948 (956)
Q Consensus 927 a~e~L~HP~f~~~~~~~~~~~~ 948 (956)
++|+|+||||+........+..
T Consensus 291 ~~e~l~hp~~~~~~~~~~~~~~ 312 (326)
T 1blx_A 291 AYSALSHPYFQDLERCKENLDS 312 (326)
T ss_dssp HHHHHTSGGGTTCCCCCCC---
T ss_pred HHHHhcCccccccchhhhhhcc
Confidence 9999999999876554333333
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=375.91 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=207.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
..++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 78999999986532 2345688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccc
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRL 774 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~ 774 (956)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999764 35899999999999999999999999 9999999999999 5678999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .....
T Consensus 179 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i--------- 239 (484)
T 3nyv_A 179 FEASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKV--------- 239 (484)
T ss_dssp BCCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---------
T ss_pred ccccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH---------
Confidence 64321 2234569999999999876 68999999999999999999999997543211 11100
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
..+... + ..|.. +...+.+.+|+.+||..||++|||++|+|+||
T Consensus 240 ~~~~~~-~---------------------~~~~~--------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 240 EKGKYT-F---------------------ELPQW--------------KKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHCCCC-C---------------------CSGGG--------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HcCCCC-C---------------------CCccc--------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000000 0 00000 01122234788899999999999999999999
Q ss_pred ccccCC
Q 002178 935 YVSSDV 940 (956)
Q Consensus 935 ~f~~~~ 940 (956)
||+...
T Consensus 284 ~~~~~~ 289 (484)
T 3nyv_A 284 WIQTYT 289 (484)
T ss_dssp HHHHHT
T ss_pred hhcccc
Confidence 997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=353.26 Aligned_cols=270 Identities=16% Similarity=0.195 Sum_probs=214.4
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEE------eCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeeeccccc
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 691 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 691 (956)
...++|.+.+.||+|+||+||+|. ..+++.||||++.... ..++.+|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 3468999999997643 346777888888886 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc---CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--------
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------- 760 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------- 760 (956)
.+..++||||+++|+|.+++... ....+++..++.|+.||++||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999752 3456999999999999999999999999 999999999999998
Q ss_pred ---CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 761 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 761 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543211 12334556799999999999999999999999999999999999999964322
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002178 838 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSE 916 (956)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~~ll~~~ 916 (956)
. . ..+.......+ ..+.+.+++..|++.+|.+| |++.++.+.|+++..... ....+.+.++
T Consensus 291 ~------------~-~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~---~~~~~~l~~~ 352 (365)
T 3e7e_A 291 G------------E-CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY---TNKIRALRNR 352 (365)
T ss_dssp T------------E-EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT---TTTHHHHHHH
T ss_pred C------------c-eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh---hhchHHHHHH
Confidence 0 0 01111222222 24567788899999999988 678888888888766532 2334555555
Q ss_pred cCC
Q 002178 917 HTS 919 (956)
Q Consensus 917 L~~ 919 (956)
|..
T Consensus 353 l~~ 355 (365)
T 3e7e_A 353 LIV 355 (365)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=350.56 Aligned_cols=269 Identities=26% Similarity=0.435 Sum_probs=215.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC--cE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~ 695 (956)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45788899999999999999984 368999999998766666678999999999999999999999986544 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997653 45899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-------
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS------- 848 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~------- 848 (956)
...... ........++..|+|||.+.+..++.++|||||||++|||++|..|+....... .......
T Consensus 196 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~--~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH--HHHHCTTCCTHHHH
T ss_pred cccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH--HHhhccccchhhhH
Confidence 432210 111223457778999999999889999999999999999999999886421110 0000000
Q ss_pred ccchhh-ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 849 SMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 849 ~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
..+.+. ..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001111 12223345667788999999999999999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=340.38 Aligned_cols=200 Identities=30% Similarity=0.461 Sum_probs=173.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999965 578999999864322 2245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999997653 4889999999999999999999998 999999999999999999999999998654321
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 2234568999999999999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.10 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---------hhhHHHHHHHHHHHHhcC-CCceeeeeccccc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---------LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 691 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 691 (956)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999975 68999999987543 112356789999999996 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999764 35889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccc------cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 845 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~ 845 (956)
+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ ...
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~- 240 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRM- 240 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HHH-
Confidence 98754321 123456899999999985 45688899999999999999999999965432111 000
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCC
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 925 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 925 (956)
+........ .|... .......+++.+||..||++||
T Consensus 241 ---------------------------~~~~~~~~~---~~~~~--------------~~~~~l~~li~~~l~~dp~~Rp 276 (298)
T 1phk_A 241 ---------------------------IMSGNYQFG---SPEWD--------------DYSDTVKDLVSRFLVVQPQKRY 276 (298)
T ss_dssp ---------------------------HHHTCCCCC---TTTGG--------------GSCHHHHHHHHHHCCSSGGGSC
T ss_pred ---------------------------HhcCCcccC---ccccc--------------ccCHHHHHHHHHHccCCcccCC
Confidence 000000000 00000 0111223678888999999999
Q ss_pred CCccCCCCCccccCC
Q 002178 926 SSSSMLKHPYVSSDV 940 (956)
Q Consensus 926 sa~e~L~HP~f~~~~ 940 (956)
|++|+|+||||....
T Consensus 277 s~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 277 TAEEALAHPFFQQYV 291 (298)
T ss_dssp CHHHHTTSGGGCTTC
T ss_pred CHHHHHhChHhhhcc
Confidence 999999999997543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.36 Aligned_cols=268 Identities=18% Similarity=0.168 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCChhh-----------HHHHHHHHHHHHhcCCCceeeeec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-----------EKEFLTEIQFLSRLHHRNLVSLVG 687 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~ 687 (956)
.++|++.+.||+|+||+||+|... ++..||+|+........ ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999975 57889999987643211 124667888999999999999999
Q ss_pred cccc----CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-
Q 002178 688 YCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 762 (956)
Q Consensus 688 ~~~~----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~- 762 (956)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9877 67899999999 999999997654 6899999999999999999999998 99999999999999887
Q ss_pred -cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH-
Q 002178 763 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR- 840 (956)
Q Consensus 763 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~- 840 (956)
.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643221111111222455799999999999999999999999999999999999999954211111
Q ss_pred --HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 841 --EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 841 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
......... ....+.... .+..++..+.+++..||+.+|.+||++.++++.|+...
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDE-LPQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHT-TTHHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhccc-ccHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111000 000000000 01145568999999999999999999999999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.65 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788999999999999999996 47999999998753 2334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 700 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 700 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999865 23456899999999999999999999999 99999999999999999999999999976542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||.............. ...
T Consensus 189 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~ 253 (310)
T 2wqm_A 189 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--------EQC 253 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH--------HTT
T ss_pred CC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh--------hcc
Confidence 21 112334689999999999999999999999999999999999999975432211111111 111
Q ss_pred CCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 858 NMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 858 ~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
..... +..++..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11222 2456678999999999999999999999999999887643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=353.09 Aligned_cols=294 Identities=21% Similarity=0.300 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC-----CcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 695 (956)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 68999999987533 33456788999999999999999999987653 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998763 4889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcc---ccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 776 PVPDIEGIV---PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 776 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-FGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HHHhCC
Confidence 532211100 0011233568999999998765 67899999999999999999999999765432221111 100000
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
.. .+......... ...+.+.. +...+ ++... ...+...+...+++.+||..||++|||++|+|
T Consensus 242 ~~-~~~~~~~~~~~---~~~~~~~~-~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 242 PH-SDNDLRCIESP---RAREYIKS-LPMYP--AAPLE----------KMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CC-STTTTTTCCCH---HHHHHHHT-SCCCC--CCCHH----------HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Cc-hhccccccccc---hhhHHhhc-ccCCC--Ccchh----------hhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 00000000011 11111110 00000 11111 11233344556899999999999999999999
Q ss_pred CCCccccCCC
Q 002178 932 KHPYVSSDVS 941 (956)
Q Consensus 932 ~HP~f~~~~~ 941 (956)
+||||+....
T Consensus 305 ~hp~~~~~~~ 314 (353)
T 2b9h_A 305 EHPYLQTYHD 314 (353)
T ss_dssp TSGGGTTTCC
T ss_pred cCccccccCC
Confidence 9999976543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=349.76 Aligned_cols=261 Identities=27% Similarity=0.447 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
..++|++.+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999984 24779999999754 33445688999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEE
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKV 766 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl 766 (956)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 35889999999999999999999999 999999999999984 456999
Q ss_pred EeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002178 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 845 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~ 845 (956)
+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 185 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~-- 256 (327)
T 2yfx_A 185 GDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE-- 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH--
T ss_pred Cccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHH--
Confidence 99999975432221 112234457889999999999999999999999999999998 99999754432 1111
Q ss_pred hhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 846 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.++.+..
T Consensus 257 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 112222334456677889999999999999999999999999987754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.27 Aligned_cols=269 Identities=25% Similarity=0.397 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHH--HHhcCCCceeeeeccc-----ccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF--LSRLHHRNLVSLVGYC-----DEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~-----~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++++ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46889999999999999999987 68999999987432 2344444444 4558999999999744 333467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc---------CCCCEeccCCCcccEEEcCCCcEEE
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE---------ADPPVFHRDIKASNILLDHKFTAKV 766 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~Dlk~~NILl~~~~~~kl 766 (956)
++||||+++|+|.+++.... .++..++.++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 89999999999999997643 57888999999999999999998 7 999999999999999999999
Q ss_pred EeeccccccCCCCCCCc-cccceecccccCCCccccccccc-------CCCCCcccchhHHHHHHHHHhCCCCCCCCchh
Q 002178 767 ADFGLSRLAPVPDIEGI-VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (956)
Q Consensus 767 ~DfGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~ 838 (956)
+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653321110 01122334569999999999987 45667899999999999999998887543221
Q ss_pred ----------------HHHHHHHhhcccchhhccCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 839 ----------------VREVNIAYQSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 839 ----------------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
............ ..+..+ .....++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 001110000000 001111 113457788999999999999999999999999999988
Q ss_pred hhCCCC
Q 002178 900 NMMPES 905 (956)
Q Consensus 900 ~~~~~~ 905 (956)
..+...
T Consensus 318 ~~~~~~ 323 (336)
T 3g2f_A 318 MIWERN 323 (336)
T ss_dssp HCCCC-
T ss_pred HHHHhc
Confidence 766543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=355.09 Aligned_cols=297 Identities=22% Similarity=0.263 Sum_probs=199.7
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc-
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE- 694 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 694 (956)
.+.....++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999975 689999998865332 22356778888999999999999999855333
Q ss_pred ------EEEEEecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhh--hcCCCCEeccCCCcccEEEcC-CCc
Q 002178 695 ------QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLH--TEADPPVFHRDIKASNILLDH-KFT 763 (956)
Q Consensus 695 ------~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlk~~NILl~~-~~~ 763 (956)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999965 66655543 33456888999999999999999999 888 999999999999997 899
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~ 842 (956)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 9999999998764322 22345689999999999765 48999999999999999999999997654322211
Q ss_pred HHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCC
Q 002178 843 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 922 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~ 922 (956)
... . ..+..+.+....+..-. .........+.....+. ..........+.+|+.+||+.||+
T Consensus 243 ~~~-~----------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 243 EIV-R----------VLGCPSREVLRKLNPSH-TDVDLYNSKGIPWSNVF------SDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHH-H----------HHCCCCHHHHHHHCTTC-CCGGGGCCCCCCHHHHT------TTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHH-H----------HcCCCCHHHHHhcccch-hhccccccccCCccccc------chhhccccHHHHHHHHHHhccCcc
Confidence 110 0 00111222111110000 00000000111111110 001111223346799999999999
Q ss_pred CCCCCccCCCCCccccCCCCCc
Q 002178 923 TPPSSSSMLKHPYVSSDVSGSN 944 (956)
Q Consensus 923 ~R~sa~e~L~HP~f~~~~~~~~ 944 (956)
+|||++|+|+||||........
T Consensus 305 ~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 305 ERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccCCHHHHhcCccccccCCccc
Confidence 9999999999999987655433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.83 Aligned_cols=274 Identities=21% Similarity=0.306 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhh-----------------HHHHHHHHHHHHhcCCCceeee
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-----------------EKEFLTEIQFLSRLHHRNLVSL 685 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l 685 (956)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999987432211 1689999999999999999999
Q ss_pred ecccccCCcEEEEEecCCCCCHHHH------HhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEE
Q 002178 686 VGYCDEEGEQMLVYEFMSNGTLRDQ------LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILL 758 (956)
Q Consensus 686 ~~~~~~~~~~~LV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl 758 (956)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC-CCCC-cccchhHHHHHHHHHhCCCCCCCCc
Q 002178 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 759 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
+.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865321 23445689999999999887 6666 8999999999999999999997654
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 916 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~ 916 (956)
...+....... +. ...+..... .. .+...... ....+.......+++.+|
T Consensus 257 ~~~~~~~~i~~---------~~-~~~~~~~~~--------~~--~~~~~~~~----------~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 257 SLVELFNNIRT---------KN-IEYPLDRNH--------FL--YPLTNKKS----------TCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp CSHHHHHHHTS---------CC-CCCCCSSSS--------ST--TTTCC------------------CCCHHHHHHHHHH
T ss_pred cHHHHHHHHhc---------cC-cCCccchhh--------hh--cccccccc----------ccchhhcCHHHHHHHHHH
Confidence 42222221110 00 011100000 00 00000000 000112233345789999
Q ss_pred cCCCCCCCCCCccCCCCCccccC
Q 002178 917 HTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 917 L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
|..||++|||++|+++||||...
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccCChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=373.46 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=204.5
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999975 78999999986422 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc---CCCcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DfGla~~~ 775 (956)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999887653 4889999999999999999999999 99999999999995 4567999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... ..... .
T Consensus 175 ~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i---------~ 235 (486)
T 3mwu_A 175 QQN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRV---------E 235 (486)
T ss_dssp CCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---------H
T ss_pred CCC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH---------H
Confidence 422 12234569999999999876 58999999999999999999999997543211 11100 0
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
.+... ...|.. +...+.+.+|+.+||..||++|||++|+|+|||
T Consensus 236 ~~~~~----------------------~~~~~~--------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 236 TGKYA----------------------FDLPQW--------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HTCCC----------------------SCSGGG--------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred hCCCC----------------------CCCccc--------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 00000 000100 011222347888899999999999999999999
Q ss_pred cccCCC
Q 002178 936 VSSDVS 941 (956)
Q Consensus 936 f~~~~~ 941 (956)
|.....
T Consensus 280 ~~~~~~ 285 (486)
T 3mwu_A 280 IQKYSS 285 (486)
T ss_dssp HHHTCC
T ss_pred hccCcc
Confidence 976544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=353.80 Aligned_cols=290 Identities=19% Similarity=0.278 Sum_probs=209.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CC-cEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc------eeeeecccccCCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 694 (956)
.++|++.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 78999999753 344567888999999998766 8999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----------------
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---------------- 758 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---------------- 758 (956)
.++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 778888887766567999999999999999999999998 9999999999999
Q ss_pred ---cCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 759 ---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 759 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864321 23356899999999999999999999999999999999999999765
Q ss_pred chhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH----hhCCC---CCCC
Q 002178 836 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMPE---SDTK 908 (956)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~----~~~~~---~~~~ 908 (956)
.......... . ..+..|.........- ..... .....+........+.... ..... ....
T Consensus 243 ~~~~~~~~~~-------~----~~~~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 243 ENREHLVMME-------K----ILGPIPSHMIHRTRKQ-KYFYK-GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SHHHHHHHHH-------H----HHCCCCHHHHHHCSCG-GGEET-TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CHHHHHHHHH-------H----HcCCCcHHHhhhccch-hhhcc-cccccccccchhccccccCCcccccccccchhHHH
Confidence 4322111110 0 0112222221110000 00000 0000000000000011000 00000 0112
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
..+++.+||..||++|||++|+|+||||.+-.
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 34799999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.36 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=199.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcC--CCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.+|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 5699999999999999999998889999999986533 334568899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56899999997653 5788899999999999999999999 99999999999996 5899999999998764321
Q ss_pred CCCccccceecccccCCCccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~ 848 (956)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......
T Consensus 209 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~---- 279 (390)
T 2zmd_A 209 -----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 279 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----
T ss_pred -----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH----
Confidence 1112234569999999999875 36888999999999999999999999764433222221
Q ss_pred ccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 849 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 849 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
++++.. ..++...+..+.+++.+||+.+|.+||++.++++.
T Consensus 280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122211 22344445678899999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.47 Aligned_cols=259 Identities=19% Similarity=0.252 Sum_probs=202.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
-++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 689999999875432 2246788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997643 5889999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. ........|++.|+|||++.+..++.++||||||+++|||++|+.||...... ......... ...
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~------~~~ 253 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA------IPR 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC------CCC
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC------CCC
Confidence 1 11223456899999999999999999999999999999999999999765432 111111100 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHh
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 900 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~ 900 (956)
....+..++..+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1123445667899999999999999999 99999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=348.08 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=209.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcE--EEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTV--VAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.+.||+|+||.||+|... ++.. ||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999964 5664 4999887532 23345788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 699 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
|||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 246899999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 843 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~ 843 (956)
||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 182 kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE 252 (327)
T ss_dssp EECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH
T ss_pred EEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-HHHH
Confidence 9999999974321 111233457889999999998889999999999999999998 99999755432 1111
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+..+.....+..++..+.+++.+|+..+|.+||++.++++.|+.+...
T Consensus 253 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1112222344556678899999999999999999999999999988764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.55 Aligned_cols=266 Identities=20% Similarity=0.292 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccc-ccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||.||+|.. .+++.||||++...... +.+.+|+++++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 57999999998754332 3688999999999988877666665 56677899999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~ 777 (956)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999997533 45899999999999999999999999 9999999999999 4889999999999987654
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch-----hHHHHHHHhhcccch
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSMMF 852 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~-----~~~~~~~~~~~~~~~ 852 (956)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------
Confidence 432211111223456799999999999999999999999999999999999999975321 111111000
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
........+..++..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus 235 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 235 --MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp --HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0000000123345789999999999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=357.35 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCC--cEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV 698 (956)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367889999999999999999976 589999999875432 33567889999999999999999999987654 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE----cCCCcEEEEeecccc
Q 002178 699 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 773 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DfGla~ 773 (956)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997643 234899999999999999999999999 9999999999999 788889999999998
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc--------CCCCCcccchhHHHHHHHHHhCCCCCCCCch---hHHHH
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 842 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~---~~~~~ 842 (956)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+..
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 75422 12234569999999999875 5678899999999999999999999964221 11211
Q ss_pred HHHhhcc---cchhh---------cc---CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 843 NIAYQSS---MMFSV---------ID---GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 843 ~~~~~~~---~~~~~---------~~---~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
....... .+... .. +.....+......+.+++.+|++.||++||++.++++.++++..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111110 00000 00 11123457888999999999999999999999999999988765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=376.42 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=204.6
Q ss_pred CeeeeeCCeEEEEEEeC---CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 468899999976432 335789999999999999999999999964 568999999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 9999999764 35889999999999999999999999 999999999999999999999999999876433211
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..+.....+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~---------~i~~~~~~~~p 594 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTA---------MLEKGERMGCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH---------HHHTTCCCCCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHHcCCCCCCC
Confidence 112233456789999999999999999999999999999998 999997654321 111 11223344556
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..++..+.+++..||+.+|++||++.++++.|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7788899999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.34 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=209.7
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccc----cCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~ 696 (956)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999996 579999999987766666778999999999999999999999986 345789
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 697 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
+||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999762 3456899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCCCc--cccceecccccCCCcccccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcc
Q 002178 775 APVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 849 (956)
Q Consensus 775 ~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 849 (956)
......... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-----
Confidence 431110000 0000112345799999999987654 688999999999999999999999421100000000
Q ss_pred cchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 850 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 259 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 259 ---AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ---HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ---HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00111112223456678999999999999999999999999999875443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.19 Aligned_cols=270 Identities=19% Similarity=0.285 Sum_probs=207.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccc-ccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~ 699 (956)
..++|++.+.||+|+||+||+|.. .+++.||||++...... +.+.+|+++++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 57899999987643322 3578899999999988877766665 6667889999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccccC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~~ 776 (956)
||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997543 35899999999999999999999999 9999999999999 789999999999998765
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh--HHHHHHHhhcccchhh
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSV 854 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~ 854 (956)
........+........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~ 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-----K 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-----H
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-----c
Confidence 44322211222334567999999999999999999999999999999999999999753221 0000000000 0
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
...........++..+.+++..||+.+|++||++.++++.|+++.....
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0000000112345789999999999999999999999999999877543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.91 Aligned_cols=199 Identities=30% Similarity=0.501 Sum_probs=172.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|+..+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999996 4799999999875432 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||++ |+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99996 78988886532 46899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 207 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 207 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp ----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12346899999999985 56789999999999999999999999975543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=349.41 Aligned_cols=200 Identities=28% Similarity=0.446 Sum_probs=168.3
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999975 689999999875321 1124578999999999999999999998765
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc---EEEEee
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADF 769 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Df 769 (956)
+ .++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998653 45889999999999999999999999 999999999999987664 999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 162 g~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 162 GHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp TTCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ccceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999865321 1223456899999999974 467889999999999999999999999643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.62 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=170.8
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
+|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555669999999999999964 689999999987665556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeeccccccCCCCCC
Q 002178 704 NGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 704 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 345678889999999999999999999 999999999999987 8999999999998654221
Q ss_pred CccccceecccccCCCcccccccccCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1123456899999999997653 78899999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=350.43 Aligned_cols=200 Identities=24% Similarity=0.374 Sum_probs=174.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh--------hHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
..++|++.+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999964 6899999998764321 223567899999999999999999999999
Q ss_pred CcEEEEEecCCCC-CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 693 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 693 ~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999997643 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 98764322 1234568999999999998876 7889999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.82 Aligned_cols=207 Identities=27% Similarity=0.436 Sum_probs=173.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccc--ccCCcEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~L 697 (956)
.++|++.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++ ...+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367889999999999999999975 68999999987543 33456789999999999999999999987 44678999
Q ss_pred EEecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcC--CCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 698 VYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 3345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 654221 11233568999999999999999999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=355.76 Aligned_cols=290 Identities=17% Similarity=0.274 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----------CCceeeeecccc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCD 690 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 690 (956)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 47899999999753 334567889999998886 899999999987
Q ss_pred cCC----cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEc------
Q 002178 691 EEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLD------ 759 (956)
Q Consensus 691 ~~~----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~------ 759 (956)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 544 789999999 89999999876666799999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchh-
Q 002178 760 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI- 838 (956)
Q Consensus 760 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~- 838 (956)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865321 23346899999999999999999999999999999999999999753311
Q ss_pred ----HHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCC-------CCCCCHHHHHHHHHHhHhhCCCCCC
Q 002178 839 ----VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDET-------DARPSMSEVMRELESIWNMMPESDT 907 (956)
Q Consensus 839 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p-------~~RPs~~~v~~~L~~~~~~~~~~~~ 907 (956)
...... +.+. .+..|......-. .....+.... .......+++. ......+....
T Consensus 243 ~~~~~~~~~~------~~~~----~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 308 (373)
T 1q8y_A 243 YTKDDDHIAQ------IIEL----LGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLT---EKYKFSKDEAK 308 (373)
T ss_dssp --CHHHHHHH------HHHH----HCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHH---HTTCCCHHHHH
T ss_pred cCChHHHHHH------HHHh----cCCCCHHHHhccc-hhhhhcCCcchhcccccccccchhhhhh---hcccCCcchHH
Confidence 000000 0011 1222332221100 0011111100 00111222221 11000011122
Q ss_pred CCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 908 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 908 ~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...+||.+||..||++|||++|+|+||||.....
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 3457999999999999999999999999987544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.51 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 688999999864321 22467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999997653 4889999999999999999999999 999999999999999999999999998764321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........... +... .
T Consensus 168 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----------~~~~-~ 228 (284)
T 2vgo_A 168 --------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----------IVNV-D 228 (284)
T ss_dssp --------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------HHTT-C
T ss_pred --------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH----------Hhcc-c
Confidence 12345689999999999999999999999999999999999999975433211100 0000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..++...+. ...+++.+||..||++|||++|+++||||...
T Consensus 229 ~~~~~~~~~---------------------------------------~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 229 LKFPPFLSD---------------------------------------GSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CCCCTTSCH---------------------------------------HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCCCcCCH---------------------------------------HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 011111111 12356777788888888888888888888765
Q ss_pred CC
Q 002178 940 VS 941 (956)
Q Consensus 940 ~~ 941 (956)
..
T Consensus 270 ~~ 271 (284)
T 2vgo_A 270 SR 271 (284)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.33 Aligned_cols=201 Identities=26% Similarity=0.415 Sum_probs=174.6
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|... +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999976 6899999998754321 356889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGl 771 (956)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999764 35889999999999999999999999 99999999999998877 899999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 159 AHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 98654221 1233468999999999999999999999999999999999999997544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=367.25 Aligned_cols=342 Identities=20% Similarity=0.237 Sum_probs=228.0
Q ss_pred ceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCC
Q 002178 69 GVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (956)
Q Consensus 69 gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~ 144 (956)
.|.|.+.... +.+.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 4777654322 234677888888888887777778888888888888888877777777778888888888888877
Q ss_pred CCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCC-CCccccCCCcccceecccccccCCCCCcccC
Q 002178 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223 (956)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 223 (956)
..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..+..|.
T Consensus 95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 174 (606)
T 3vq2_A 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174 (606)
T ss_dssp CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh
Confidence 777777777777777777777776666667777777777777777664 4566666666666666666665533222110
Q ss_pred --------------------------------------------------------------------------------
Q 002178 224 -------------------------------------------------------------------------------- 223 (956)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (956)
T Consensus 175 ~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~ 254 (606)
T 3vq2_A 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254 (606)
T ss_dssp HHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGG
T ss_pred hhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHH
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 002178 224 -------------------------------------------------------------------------------- 223 (956)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (956)
T Consensus 255 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~ 334 (606)
T 3vq2_A 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT 334 (606)
T ss_dssp GTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEE
T ss_pred hhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceee
Confidence
Q ss_pred -------------CcchhhhhcccCCcCCCC------------------------CCcccccCCCCCcEEeccCCCCccC
Q 002178 224 -------------ELPKLLILQLDNNNFEGT------------------------TIPASYSNMSKLLKLSLRNCSLQGP 266 (956)
Q Consensus 224 -------------~l~~L~~L~Ls~N~l~~~------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (956)
.+++|++|+|++|.+++. .+|..+.++++|+.|++++|++++.
T Consensus 335 l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~ 414 (606)
T 3vq2_A 335 LTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRV 414 (606)
T ss_dssp EESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEEST
T ss_pred ccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCc
Confidence 112233333333333211 1123344445555555555555444
Q ss_pred CC-------------------------C-CCCCCCccEEEccCCcCCcC-CCCCCCc-cccCEEEccCCcCCCCCchhcC
Q 002178 267 MP-------------------------D-LSRIPNLGYLDLSSNQLNGS-IPPGRLS-LNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 267 ~~-------------------------~-l~~l~~L~~L~Ls~N~l~~~-~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
++ . +..+++|++|++++|.+++. +|..+.. .+|+.|+|++|++++..|..|.
T Consensus 415 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 494 (606)
T 3vq2_A 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494 (606)
T ss_dssp TTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc
Confidence 33 2 44555555555555555542 3433322 3788888888888888888888
Q ss_pred CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCC-CCcEEEecCCcccccCCcccccCC
Q 002178 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIP-PNVTVRLRGNPFCLNTNAEQFCGS 396 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~-~l~~l~l~~Np~~c~c~~~~~~~~ 396 (956)
++++|+.|+|++|++++.+|..+..+. +|+.|+|++|+|+++|..+ .++ .+..+++++|||.|+|++.+|..|
T Consensus 495 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~ 569 (606)
T 3vq2_A 495 TLHRLQLLNMSHNNLLFLDSSHYNQLY-----SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQW 569 (606)
T ss_dssp TCTTCCEEECCSSCCSCEEGGGTTTCT-----TCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred ccccCCEEECCCCcCCCcCHHHccCCC-----cCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHH
Confidence 888888888888888887787776544 4569999999999999886 466 599999999999999999999999
Q ss_pred CCCCCcccCcCCCCCCccccC
Q 002178 397 HSDDDNEIDRSTNSTLDCRAQ 417 (956)
Q Consensus 397 ~~~~~~~~~~~~~~~~~c~~~ 417 (956)
+......+. ....+.|..+
T Consensus 570 l~~~~~~~~--~~~~~~C~~p 588 (606)
T 3vq2_A 570 VKEQKQFLV--NVEQMTCATP 588 (606)
T ss_dssp TTTSSSSBS--SGGGCCCC--
T ss_pred HHcCccccc--CCccceeCCC
Confidence 976543322 2345667653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=355.88 Aligned_cols=198 Identities=12% Similarity=0.035 Sum_probs=152.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhc--CCCceeeeec-------cc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL--HHRNLVSLVG-------YC 689 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~~-------~~ 689 (956)
..+|++.+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+++++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999965 789999999987543 2345677885555444 6999887553 33
Q ss_pred ccC-----------------CcEEEEEecCCCCCHHHHHhhcCCCCchhHHH------HHHHHHHHHHHHHhhhcCCCCE
Q 002178 690 DEE-----------------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR------LSIALGSSRGILYLHTEADPPV 746 (956)
Q Consensus 690 ~~~-----------------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 746 (956)
... ...++||||++ |+|.+++..... .+.+..+ ..++.||++||+|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 222 33799999998 899999976422 2355555 788899999999999999 9
Q ss_pred eccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHH
Q 002178 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLE 824 (956)
Q Consensus 747 vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~e 824 (956)
+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999986531 1124457799999999987 779999999999999999
Q ss_pred HHhCCCCCCCC
Q 002178 825 LLTGMQPISHG 835 (956)
Q Consensus 825 lltg~~pf~~~ 835 (956)
|++|+.||...
T Consensus 286 lltg~~Pf~~~ 296 (371)
T 3q60_A 286 VWCLFLPFGLV 296 (371)
T ss_dssp HHHSSCSTTBC
T ss_pred HHhCCCCCCCc
Confidence 99999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=336.92 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=177.4
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457889999999999999999964 68999999987543 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999964 35899999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 11234568999999999999999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.67 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=200.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC----hhhHHHHHHHHHHHHhcCCCceeeeeccc--ccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~ 695 (956)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68999999987532 22356789999999999999999999998 455688
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||++++ |.+++.......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999765 888887766667999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
..... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... +.....
T Consensus 160 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i-------- 225 (305)
T 2wtk_C 160 HPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENI-------- 225 (305)
T ss_dssp CTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH--------
T ss_pred Ccccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHH--------
Confidence 43221 12233456899999999998644 377999999999999999999999754322 111111
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 894 (956)
.......+..++..+.+++.+|++.+|.+||++.++++.
T Consensus 226 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 --GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --HHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111123344566778888888888888888888888764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.59 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=167.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367899999999999999999976 799999999865321 2245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1233468999999999988765 67999999999999999999999654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.89 Aligned_cols=267 Identities=22% Similarity=0.338 Sum_probs=211.5
Q ss_pred cHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeeecccccC
Q 002178 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEE 692 (956)
Q Consensus 615 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~ 692 (956)
.........++|++.+.||+|+||+||+|.. +++.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3334455678999999999999999999998 5899999998643 34577889998887 7899999999999776
Q ss_pred C----cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhh--------hcCCCCEeccCCCcccEEEcC
Q 002178 693 G----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDH 760 (956)
Q Consensus 693 ~----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NILl~~ 760 (956)
. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 5 889999999999999999753 4899999999999999999999 777 999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccC------CCCCcccchhHHHHHHHHHhC------
Q 002178 761 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG------ 828 (956)
Q Consensus 761 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~G~ll~elltg------ 828 (956)
++.+||+|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999765432210 01122345699999999999875 234689999999999999999
Q ss_pred ----CCCCCCCch---hHHHHHHHhhcccchhhccCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 829 ----MQPISHGKN---IVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 829 ----~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
+.||..... ............ ...+.. ..+++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ-------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS-------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHH-------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 778864321 111111111110 111222 2477889999999999999999999999999999
Q ss_pred HhHhh
Q 002178 897 SIWNM 901 (956)
Q Consensus 897 ~~~~~ 901 (956)
++.+.
T Consensus 333 ~i~~~ 337 (342)
T 1b6c_B 333 QLSQQ 337 (342)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 88654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=343.28 Aligned_cols=266 Identities=24% Similarity=0.377 Sum_probs=195.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeeccc--------cc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYC--------DE 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~--------~~ 691 (956)
...+|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++++. ||||+++++++ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468899999999999999999965 68999999987766666778999999999996 99999999988 33
Q ss_pred CCcEEEEEecCCCCCHHHHHhh-cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
....++||||++ |+|.+++.. .....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 446899999995 799998865 23456999999999999999999999875 459999999999999999999999999
Q ss_pred cccccCCCCCCCccc-----cceecccccCCCccccccc---ccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002178 771 LSRLAPVPDIEGIVP-----AHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (956)
Q Consensus 771 la~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~ 842 (956)
+++............ ........||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765332110000 0111244589999999998 56678899999999999999999999996533211
Q ss_pred HHHhhcccchhhccCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002178 843 NIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 903 (956)
Q Consensus 843 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 903 (956)
...... ...+...+..+.+++.+|++.+|.+||++.++++.|+.+.....
T Consensus 261 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 -----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 011111 11223344568899999999999999999999999998876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.72 Aligned_cols=276 Identities=22% Similarity=0.370 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc-----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 694 (956)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999965 69999999987532 2335678899999999999999999999876653
Q ss_pred -EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 695 -QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 695 -~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 688887742 4889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......
T Consensus 175 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~---- 239 (353)
T 3coi_A 175 HADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKV---- 239 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHH----
T ss_pred CCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH----
Confidence 64321 233468999999999987 6789999999999999999999999976543221 1111100
Q ss_pred hhccCCCCCCChHHHHHHH----HHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCc
Q 002178 853 SVIDGNMGSYPSECVEKFI----KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 928 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~----~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ 928 (956)
.+..+.+....+. ......+...+ |+.+. ...+...+...+++.+||..||++|||++
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 240 ------TGVPGTEFVQKLNDKAAKSYIQSLPQTP--RKDFT----------QLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp ------HCBCCHHHHTTCSCHHHHHHHHTSCBCS--SCCTT----------TTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred ------hCCCCHHHHHHHhhHHHHHHHHhCcCCC--CccHH----------HhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 0011111111000 00000111111 11110 11222334456899999999999999999
Q ss_pred cCCCCCccccC
Q 002178 929 SMLKHPYVSSD 939 (956)
Q Consensus 929 e~L~HP~f~~~ 939 (956)
|+|+||||...
T Consensus 302 e~l~hp~f~~~ 312 (353)
T 3coi_A 302 QALTHPFFEPF 312 (353)
T ss_dssp HHHTSGGGTTT
T ss_pred HHhcCcchhhc
Confidence 99999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.15 Aligned_cols=212 Identities=29% Similarity=0.440 Sum_probs=173.5
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
+.+.++....++|++.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344444556789999999999999999999974 789999999875432 345788999999999 79999999999865
Q ss_pred ------CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEE
Q 002178 692 ------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (956)
Q Consensus 692 ------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 765 (956)
.+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998765556899999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 170 l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999997653211 1123446899999999997 5678899999999999999999999996544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=334.99 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=188.0
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh-hhH-HHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-QGE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||+||+|.. .+|+.||+|++..... ... +.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356899999999999999999996 4799999999876432 222 3344455568888999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
|||++ |+|.+++.. .....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 699888764 2345699999999999999999999998 8 999999999999999999999999999865
Q ss_pred CCCCCCCccccceecccccCCCccccccc----ccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...............
T Consensus 161 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 228 (290)
T 3fme_A 161 VDDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE---- 228 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH----
T ss_pred cccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc----
Confidence 4321 12334689999999996 4567889999999999999999999999753332222211111
Q ss_pred hhhccCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 852 FSVIDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 852 ~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
...... +..++. ...+++.+||..||++|||++|+
T Consensus 229 -----~~~~~~~~~~~~~---------------------------------------~~~~li~~~l~~~p~~Rpt~~e~ 264 (290)
T 3fme_A 229 -----EPSPQLPADKFSA---------------------------------------EFVDFTSQCLKKNSKERPTYPEL 264 (290)
T ss_dssp -----SCCCCCCTTTSCH---------------------------------------HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----cCCCCcccccCCH---------------------------------------HHHHHHHHHhhcChhhCcCHHHH
Confidence 111111 111111 12356777788888888888899
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
++||||+..
T Consensus 265 l~hp~f~~~ 273 (290)
T 3fme_A 265 MQHPFFTLH 273 (290)
T ss_dssp TTSHHHHHH
T ss_pred HhCcccccC
Confidence 999998643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=381.15 Aligned_cols=301 Identities=33% Similarity=0.505 Sum_probs=226.5
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCC-CCCEEEccCCCCcccCCccccc--CcccchhhccCcCCCCCCCCccCCCcccc
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLS-YLTILDFMWNKISGSIPKEIGN--IKSLELLLLNGNELTGSLPEELGYLPKLD 157 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~ip~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 157 (956)
..+++.|++++|.+++.+|..+.+++ +|++|+|++|++++.+|..+.. +++|++|+|++|++++.+|..+.++++|+
T Consensus 342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 421 (768)
T 3rgz_A 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421 (768)
T ss_dssp CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence 34677888888888888888887776 7888888888887777777766 67777888888877777777777777788
Q ss_pred eeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCc
Q 002178 158 RIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237 (956)
Q Consensus 158 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 237 (956)
+|+|++|++++.+|..|.++++|+.|+|++|.+++.+|..+..+++|++|+|++|++++.+|..+..+++|++|+|++|+
T Consensus 422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 501 (768)
T 3rgz_A 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501 (768)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCc
Confidence 88888887777777777777778888888887777777777777777888888887777777777777777778887777
Q ss_pred CCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCCCCc--------------------
Q 002178 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-------------------- 296 (956)
Q Consensus 238 l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-------------------- 296 (956)
+++ .+|.+++++++|+.|+|++|++++..| .+..+++|+.|+|++|+++|.+|...+.
T Consensus 502 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (768)
T 3rgz_A 502 LTG-EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580 (768)
T ss_dssp CCS-CCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEEC
T ss_pred cCC-cCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccc
Confidence 776 577777777777788888777776555 4777777777777777777777653211
Q ss_pred ---------------------------------------------------cccCEEEccCCcCCCCCchhcCCCCcCCe
Q 002178 297 ---------------------------------------------------LNITTIKLSNNKLTGTIPSNFSGLPRLQR 325 (956)
Q Consensus 297 ---------------------------------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 325 (956)
.+|+.|||++|+++|.+|..|+++++|+.
T Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 660 (768)
T 3rgz_A 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI 660 (768)
T ss_dssp CSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCE
T ss_pred ccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCE
Confidence 24677788888888777877888888888
Q ss_pred EecccccCCCcCChhhhhhccCCCCcceEEEccCCCCC-CCCCCC-CCCCCcEEEecCCccccc
Q 002178 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSF-NIPPNVTVRLRGNPFCLN 387 (956)
Q Consensus 326 L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~-~l~~~~-~~~~l~~l~l~~Np~~c~ 387 (956)
|+|++|+++|.+|..+..+..| +.|||++|+|+ .+|..+ .++.+..|++++|++...
T Consensus 661 L~Ls~N~l~g~ip~~l~~L~~L-----~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 661 LNLGHNDISGSIPDEVGDLRGL-----NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTC-----CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred EeCcCCccCCCCChHHhCCCCC-----CEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence 8888888887788777665544 47788888777 455555 467777777777776543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=355.08 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=210.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.++||+|+||.||+|.+ .+++.||||++...... .++.+|+++++.++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 46999999987754332 357889999999987 555566666677888999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEE---cCCCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~ 777 (956)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997543 45899999999999999999999999 9999999999999 6889999999999987654
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcccchhhc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 855 (956)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-~~~---- 233 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-KKV---- 233 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH-HHH----
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh-ccc----
Confidence 332211112223456799999999999999999999999999999999999999975332 1111111110 000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.......+..++.++.+++..||+.+|++||++.++++.|+.+....
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00000111234578899999999999999999999999999886644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.91 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC--CCc--EEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|.+. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467889999999999999999853 333 68999887542 234568899999999999999999999998754 8
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
++||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997642 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... .........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... +.......
T Consensus 172 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~------- 239 (291)
T 1u46_A 172 PQNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------- 239 (291)
T ss_dssp CC-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-------
T ss_pred ccccc----chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHc-------
Confidence 43321 0112233457788999999999889999999999999999999 99999765432 11111110
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.......+..++..+.+++.+|+..+|.+||++.++++.|++...
T Consensus 240 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111223455677889999999999999999999999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.35 Aligned_cols=202 Identities=29% Similarity=0.454 Sum_probs=172.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999975 58999999987543 23578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999643 345899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234468999999999999999999999999999999999999997544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=339.25 Aligned_cols=276 Identities=24% Similarity=0.356 Sum_probs=188.0
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999964 68999999887543 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh------cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 698 VYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999864 12346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
+......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------ 239 (303)
T 2vwi_A 168 SAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------ 239 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------
T ss_pred hheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH------
Confidence 9765432110 01122234568999999999976 56899999999999999999999999754432211110
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
............ .++. ..........+++.+|+..||++|||++|+
T Consensus 240 ----~~~~~~~~~~~~-------------~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 240 ----LQNDPPSLETGV-------------QDKE-----------------MLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp ----HTSSCCCTTC------------------C-----------------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ----hccCCCcccccc-------------ccch-----------------hhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 000110000000 0000 011112223367778889999999999999
Q ss_pred CCCCccccCC
Q 002178 931 LKHPYVSSDV 940 (956)
Q Consensus 931 L~HP~f~~~~ 940 (956)
++||||....
T Consensus 286 l~h~~~~~~~ 295 (303)
T 2vwi_A 286 LRHKFFQKAK 295 (303)
T ss_dssp HTSTTC----
T ss_pred hhChhhhcCC
Confidence 9999997543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=368.15 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=212.8
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccC
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 692 (956)
+.....++|++.+.||+|+||+||+|.+. .+..||+|.++... ....+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 33445678999999999999999999864 25689999987543 333568999999999999999999999985 4
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 5789999999999999999764 345889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccc
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 539 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~~-------- 603 (656)
T 2j0j_A 539 RYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIG-------- 603 (656)
T ss_dssp CSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH--------
T ss_pred eecCCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHH--------
Confidence 8764322 111233456789999999999999999999999999999997 999997544321 111
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+..+.....+..++..+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 604 -~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 604 -RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112233344566778899999999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=352.92 Aligned_cols=202 Identities=26% Similarity=0.322 Sum_probs=157.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998776668999999998653 234678899999886 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC-----chhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC-------------CcE
Q 002178 703 SNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------FTA 764 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 764 (956)
+ |+|.+++....... ..+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 79999997653221 134456789999999999999999 9999999999999754 489
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~G~ll~ellt-g~~pf~~~ 835 (956)
||+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999876532210 0111234579999999999976 678999999999999999999 99999654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=364.25 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=174.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeeccccc------CCcE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQ 695 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~ 695 (956)
++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999964 6899999998764 33445678999999999999999999998755 6778
Q ss_pred EEEEecCCCCCHHHHHhhcC-CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc---EEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DfGl 771 (956)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 336899999999999999999999999 999999999999997664 99999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~ 837 (956)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 171 a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 171 AKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred cccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 98764322 22345689999999999999999999999999999999999999976544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.81 Aligned_cols=211 Identities=24% Similarity=0.340 Sum_probs=171.9
Q ss_pred ccHHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcC--CCceeeeeccc
Q 002178 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH--HRNLVSLVGYC 689 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 689 (956)
+.++.+....++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444445566789999999999999999999888999999998653 2334568899999999997 59999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEee
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 769 (956)
...+..++||| +.+++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+||++++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 55899999997643 5888999999999999999999999 999999999999975 89999999
Q ss_pred ccccccCCCCCCCccccceecccccCCCccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 171 GIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp SSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99986543221 112234568999999999875 467889999999999999999999997543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=363.95 Aligned_cols=359 Identities=18% Similarity=0.231 Sum_probs=271.0
Q ss_pred ceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCC
Q 002178 69 GVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (956)
Q Consensus 69 gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~ 144 (956)
.|.|.+.... +.+..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 4678754322 344689999999999998888899999999999999999998888889999999999999999997
Q ss_pred CCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCC-CCccccCCCcccceecccccccCCCCCcccC
Q 002178 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223 (956)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 223 (956)
..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|+|++..+..|.
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence 777889999999999999999998888889999999999999999975 4678889999999999999988754443322
Q ss_pred Cc------------------------------------------------------------------------------
Q 002178 224 EL------------------------------------------------------------------------------ 225 (956)
Q Consensus 224 ~l------------------------------------------------------------------------------ 225 (956)
.+
T Consensus 195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 274 (635)
T 4g8a_A 195 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 274 (635)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred chhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence 11
Q ss_pred --------------------------------------------------------------------------------
Q 002178 226 -------------------------------------------------------------------------------- 225 (956)
Q Consensus 226 -------------------------------------------------------------------------------- 225 (956)
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l 354 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 354 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEE
T ss_pred cccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhc
Confidence
Q ss_pred ----------------chhhhhcccCCcCCCC------------------------------------------------
Q 002178 226 ----------------PKLLILQLDNNNFEGT------------------------------------------------ 241 (956)
Q Consensus 226 ----------------~~L~~L~Ls~N~l~~~------------------------------------------------ 241 (956)
++|+.|++++|.+...
T Consensus 355 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 434 (635)
T 4g8a_A 355 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 434 (635)
T ss_dssp EEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEES
T ss_pred ccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccc
Confidence 1222223333322100
Q ss_pred -CCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCc-CCCCCCCc-cccCEEEccCCcCCCCCchhc
Q 002178 242 -TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG-SIPPGRLS-LNITTIKLSNNKLTGTIPSNF 317 (956)
Q Consensus 242 -~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~-~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~ 317 (956)
.....|.++++|+.++++.|.+.+..+. +..+++|+.|+|++|++.. .+|..+.. .+|+.|+|++|+|++..|..|
T Consensus 435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 514 (635)
T 4g8a_A 435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 514 (635)
T ss_dssp TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence 0011233344455555556666555443 5667788888888887543 34444433 389999999999999999999
Q ss_pred CCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CC-CCCcEEEecCCcccccCCccccc
Q 002178 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCLNTNAEQFC 394 (956)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~-~~l~~l~l~~Np~~c~c~~~~~~ 394 (956)
.++++|++|+|++|+|++..|..|..+. +|+.|||++|+|++++... .+ +.++.|+|++|||.|||++.+|.
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~-----~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~ 589 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLN-----SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 589 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCT-----TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCC-----CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHH
Confidence 9999999999999999988888887654 4569999999999987653 45 57899999999999999999999
Q ss_pred CCCCCCCcccCcCCCCCCccccCcCCCCCccCCCCCCcceeec
Q 002178 395 GSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAA 437 (956)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~c~~~~c~~~~~~~p~~~~~~~c~~ 437 (956)
.|+......+. +...+.|.+|. ...+.|.......|..
T Consensus 590 ~wl~~~~~~~~--~~~~~~C~~P~---~~~g~~l~~~~~~C~~ 627 (635)
T 4g8a_A 590 QWIKDQRQLLV--EVERMECATPS---DKQGMPVLSLNITCQM 627 (635)
T ss_dssp HHHHHTTTTBS--CGGGCBBCSST---TTTTCBGGGCCCCC--
T ss_pred HHHHhCCCccC--CCCCceeCCch---HHCCCEeeeeccCCCC
Confidence 99865544332 23457888743 3344443333345644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=328.11 Aligned_cols=204 Identities=25% Similarity=0.400 Sum_probs=164.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc----------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE---------- 691 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 691 (956)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999964 799999999864 33345678999999999999999999998754
Q ss_pred ---CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 692 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 692 ---~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999764 345788899999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCCCc-------cccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 002178 769 FGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 769 fGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
||+++.......... ..........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 999986542210000 001222345689999999999864 68999999999999999998 5543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.53 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=171.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHH-HHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468889999999999999999975 689999999976432 33445666666 777789999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeecccccc
Q 002178 700 EFMSNGTLRDQLSA---KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 700 e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
||++ |+|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9996 588887753 2345689999999999999999999998 8 999999999999999999999999999765
Q ss_pred CCCCCCCccccceecccccCCCccccccc----ccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......+. +
T Consensus 177 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~ 239 (327)
T 3aln_A 177 VDSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L 239 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred cccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H
Confidence 4221 12234689999999998 4567899999999999999999999999754321111 1
Q ss_pred hhhccCCCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 852 FSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 852 ~~~~~~~~~~~----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.....+..... ...++..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11222221111 1234455556666666666666665555543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=346.96 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=159.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
...+|++.+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34568888999999999976555568899999998754332 356799999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-----CCcEEEEeecccccc
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 775 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DfGla~~~ 775 (956)
|++ |+|.+++..... ...+..++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+|+..
T Consensus 99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 995 699999976542 3455567789999999999999999 999999999999943 346889999999876
Q ss_pred CCCCCCCccccceecccccCCCcccccccc---cCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~G~ll~ellt-g~~pf~~ 834 (956)
..... .........||+.|+|||++. ...++.++|||||||++|||++ |..||..
T Consensus 174 ~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 174 AVGRH----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp ----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cCCCc----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 43211 112234457999999999997 4567889999999999999999 8888854
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=331.75 Aligned_cols=202 Identities=27% Similarity=0.408 Sum_probs=164.5
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhc----CCCceeeeec
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRL----HHRNLVSLVG 687 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~ 687 (956)
.....++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+++++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999864 6899999999754332 223456799999998 8999999999
Q ss_pred ccccCCcEEEEEec-CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEE
Q 002178 688 YCDEEGEQMLVYEF-MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 765 (956)
Q Consensus 688 ~~~~~~~~~LV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~k 765 (956)
++...+..++|||| +++++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999997643 4899999999999999999999999 99999999999999 889999
Q ss_pred EEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCC-CcccchhHHHHHHHHHhCCCCCCC
Q 002178 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 766 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
|+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999998764321 2344589999999999877664 489999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=339.04 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=205.1
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCC
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 693 (956)
.+++....++|++.+.||+|+||.||+|.+.+ .||+|+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445556889999999999999999999754 499998875322 22346778999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999654 346899999999999999999999999 99999999999998 6799999999987
Q ss_pred ccCCCCCCCccccceecccccCCCccccccccc---------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
........ ..........|++.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 178 ~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 178 ISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred cccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 65322111 01122234458999999999875 35788999999999999999999999765432211111
Q ss_pred HhhcccchhhccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 845 AYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+.... .+..++..+.+++..||..+|.+||++.++++.|+.+.+
T Consensus 256 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 ----------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ----------HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ----------ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 122455678999999999999999999999999987754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=361.53 Aligned_cols=326 Identities=19% Similarity=0.249 Sum_probs=288.4
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
.++.|++++|.+++..+..|+.+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..|..+..+++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 7999999999999988888999999999999999999 789999999999999999999998889999999999999999
Q ss_pred cccccCCCCc-cccccccCCeeecccCcCCCCC--ccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 163 QNYISGSLPK-SFANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 163 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
+|.+.+.++. .+.++++|++|++++|.+++.. +..+..+++|++|+|++|++++..|..|..+++|++|+|++|.++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 9999977765 4999999999999999999766 778999999999999999999999999999999999999999998
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcC-CCC--CCC-ccccCEEEccCCcCCCCCc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS-IPP--GRL-SLNITTIKLSNNKLTGTIP 314 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~-~p~--~~~-~~~L~~L~Ls~N~l~~~~p 314 (956)
+...+..+.++++|+.|++++|.+++.++. +..+++|++|+|++|++++. ++. .+. ..+|+.|+|++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 744455699999999999999999997765 88999999999999999863 222 222 3489999999999999999
Q ss_pred hhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCccc
Q 002178 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQ 392 (956)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~l~l~~Np~~c~c~~~~ 392 (956)
..|.++++|+.|+|++|++++..|..+..+. .| .|+|++|++++++... .++.++.+++++|||.|+|+..+
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-----~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 567 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-----GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCC-----SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccc-----cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence 9999999999999999999999998886544 45 7999999999987763 58899999999999999999999
Q ss_pred ccCCCCCCCcccCcCCCCCCccccC
Q 002178 393 FCGSHSDDDNEIDRSTNSTLDCRAQ 417 (956)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~c~~~ 417 (956)
|..|+......+. ....+.|.+|
T Consensus 568 ~~~w~~~~~~~~~--~~~~~~C~~p 590 (606)
T 3t6q_A 568 FLEWYKENMQKLE--DTEDTLCENP 590 (606)
T ss_dssp HHHHHHHCGGGEE--CGGGCBEEES
T ss_pred HHHHHHhCccccc--CCCCCeeCCc
Confidence 9999875543332 2334667664
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=333.17 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=148.4
Q ss_pred HhcCCCCCC-eeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHH-HHHHHhcCCCceeeeeccccc----CCc
Q 002178 622 ATNNFNSST-QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTE-IQFLSRLHHRNLVSLVGYCDE----EGE 694 (956)
Q Consensus 622 ~~~~y~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E-~~~l~~l~h~nIv~l~~~~~~----~~~ 694 (956)
..++|.+.+ .||+|+||+||+|... +++.||||++.... ...+| ...++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 456888855 6999999999999976 69999999987532 22223 334667799999999999865 445
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeecc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGL 771 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGl 771 (956)
.++||||+++|+|.+++.......+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998876667999999999999999999999999 999999999999976 45699999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 178 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 178 AKETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9865321 123456899999999998888999999999999999999999999643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.46 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=173.6
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
..++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3568999999999999999999975 68999999986432 23456889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC---CcEEEEeecccccc
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLA 775 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DfGla~~~ 775 (956)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999887643 4889999999999999999999999 9999999999999754 47999999999865
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
.... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 175 QQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 4321 1223458899999999875 48999999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=330.75 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=172.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hH-HHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.++|++.+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 6899999998764332 22 33444555788889999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||+ ++.+..+.... ...+++..++.++.|+++||.|||++ + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 56666655432 34689999999999999999999995 8 999999999999999999999999999765422
Q ss_pred CCCCccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...............
T Consensus 179 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------ 244 (318)
T 2dyl_A 179 K--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ------ 244 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH------
T ss_pred c--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc------
Confidence 1 123346899999999994 456888999999999999999999999764433222221111
Q ss_pred hccCCCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 854 VIDGNMGSY--PSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 854 ~~~~~~~~~--~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
...... ...++..+.+++.+||+.+|.+||++.++++
T Consensus 245 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 245 ---EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---SCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111 1123445555666666666665555555553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.74 Aligned_cols=201 Identities=25% Similarity=0.422 Sum_probs=171.8
Q ss_pred HHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcC--CCceeeeecccc
Q 002178 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCD 690 (956)
Q Consensus 620 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~ 690 (956)
....++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334678999999999999999999964 6899999998753221 2245678999999996 599999999999
Q ss_pred cCCcEEEEEecCCC-CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEEEe
Q 002178 691 EEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVAD 768 (956)
Q Consensus 691 ~~~~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~D 768 (956)
..+..++||||+.+ ++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 8999999764 35889999999999999999999999 99999999999999 789999999
Q ss_pred eccccccCCCCCCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCC
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 834 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~ 834 (956)
||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 194 fg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998764221 233458999999999987765 6789999999999999999999964
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=349.60 Aligned_cols=306 Identities=21% Similarity=0.230 Sum_probs=239.7
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
+.+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|||++|+++ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 357889999999998877788999999999999999999888888999999999999999988 66666 788889999
Q ss_pred cccccccCC-CCccccccccCCeeecccCcCCCC-------------------------CccccCCCc------------
Q 002178 161 IDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ-------------------------IPPELSRLP------------ 202 (956)
Q Consensus 161 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-------------------------~p~~l~~l~------------ 202 (956)
|++|++++. +|..|+++++|++|+|++|++++. .|..+..+.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~ 207 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSS
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCcc
Confidence 999888863 467888888888888888877532 222222211
Q ss_pred ---------------------------------------------------------------------ccceecccccc
Q 002178 203 ---------------------------------------------------------------------SLVHMLLDNNN 213 (956)
Q Consensus 203 ---------------------------------------------------------------------~L~~L~L~~N~ 213 (956)
+|++|++++|+
T Consensus 208 ~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 287 (562)
T 3a79_B 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287 (562)
T ss_dssp CCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEE
T ss_pred chhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccE
Confidence 55666666666
Q ss_pred cCCCCCccc-----------------------------------------------------CCcchhhhhcccCCcCCC
Q 002178 214 LTGYLPPEL-----------------------------------------------------SELPKLLILQLDNNNFEG 240 (956)
Q Consensus 214 l~~~~p~~l-----------------------------------------------------~~l~~L~~L~Ls~N~l~~ 240 (956)
++|.+|..+ ..+++|++|+|++|.+++
T Consensus 288 l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~ 367 (562)
T 3a79_B 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367 (562)
T ss_dssp ECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT
T ss_pred eeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcccc
Confidence 666666554 566778888888888876
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCC---CCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccCCcCCCCCch
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPS 315 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~ 315 (956)
..|..+.++++|+.|+|++|++++.++ .+..+++|+.|+|++|++++.+|...+. .+|+.|+|++|++++..|.
T Consensus 368 -~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 446 (562)
T 3a79_B 368 -SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446 (562)
T ss_dssp -TTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGS
T ss_pred -chhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhh
Confidence 567788888888888888888887542 4778888888888888888767765332 4788888888888876666
Q ss_pred hcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCcccc
Q 002178 316 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQF 393 (956)
Q Consensus 316 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~~~~~ 393 (956)
.+. ++|+.|+|++|+|+ .+|..++.+ +.|+.|+|++|+|+++|.. + .++.++.+++++|||.|+|++.+|
T Consensus 447 ~l~--~~L~~L~L~~N~l~-~ip~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 447 CLP--PKVKVLDLHNNRIM-SIPKDVTHL-----QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp SCC--TTCSEEECCSSCCC-CCCTTTTSS-----CCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred hhc--CcCCEEECCCCcCc-ccChhhcCC-----CCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 554 68888999999888 677766543 4567999999999999987 5 589999999999999999999998
Q ss_pred cC-CCC
Q 002178 394 CG-SHS 398 (956)
Q Consensus 394 ~~-~~~ 398 (956)
.. |..
T Consensus 519 ~~~~~~ 524 (562)
T 3a79_B 519 LSEWIN 524 (562)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 65 654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.05 Aligned_cols=333 Identities=18% Similarity=0.160 Sum_probs=258.8
Q ss_pred CCCCCCCCCCCCCCCceeecCCC-------CC-------CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCc
Q 002178 54 LSNWNRGDPCTSNWTGVLCFNTT-------MD-------DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKIS 119 (956)
Q Consensus 54 l~~W~~~~~c~~~w~gv~C~~~~-------~~-------~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 119 (956)
+++|.....|++.|.+..|.... .. -...+++.|++.++.+....+..+..+++|++|+|++|.++
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence 57899888888766665552111 00 12367889999999988765556899999999999999999
Q ss_pred ccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccC
Q 002178 120 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199 (956)
Q Consensus 120 ~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 199 (956)
+..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|.++++|++|+|++|.+++..+..+.
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 87778999999999999999999988888999999999999999999966666689999999999999999988888899
Q ss_pred CCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccc---------------cCCCCCcEEeccCCCCc
Q 002178 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY---------------SNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~---------------~~l~~L~~L~Ls~N~l~ 264 (956)
.+++|++|+|++|++++.. +..+++|+.|++++|.+++...+..+ ...++|+.|+|++|.++
T Consensus 163 ~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 239 (390)
T ss_dssp SCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCc
Confidence 9999999999999999653 33445555555555554432111111 12357888888888888
Q ss_pred cCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
+. +.+..+++|+.|+|++|.+++..|..+.. .+|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..
T Consensus 240 ~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~ 316 (390)
T 3o6n_A 240 DT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316 (390)
T ss_dssp CC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred cc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence 65 56788899999999999999776765543 489999999999985 5667788999999999999998 56777766
Q ss_pred hccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCCC
Q 002178 344 SRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398 (956)
Q Consensus 344 l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~ 398 (956)
+.. |+.|+|++|+++.++ ...++.++.|++++|||.|+|...++..+..
T Consensus 317 l~~-----L~~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~ 365 (390)
T 3o6n_A 317 FDR-----LENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 365 (390)
T ss_dssp HTT-----CSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCCT
T ss_pred cCc-----CCEEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHHHHHHh
Confidence 554 569999999999986 2358899999999999999997777665554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=351.48 Aligned_cols=182 Identities=20% Similarity=0.318 Sum_probs=132.8
Q ss_pred CCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC---CCCCCCCCccEEEccCCcCCcCCCCCCC--cc
Q 002178 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM---PDLSRIPNLGYLDLSSNQLNGSIPPGRL--SL 297 (956)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~ 297 (956)
..+++|++|+|++|.+++ ..|..+.++++|++|+|++|++++.+ ..+..+++|++|+|++|.+++.+|...+ ..
T Consensus 321 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp SSCCCCCEEECCSSCCCT-TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhCCcccEEEeECCccCh-hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 455667777777777765 46667777777777777777777522 2366777777777777777765665422 23
Q ss_pred ccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCc
Q 002178 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNV 375 (956)
Q Consensus 298 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~ 375 (956)
+|+.|+|++|++++..|..+. ++|+.|+|++|+++ .+|..+..+ ++|+.|+|++|+|+.+|.. + .++.++
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKL-----EALQELNVASNQLKSVPDGIFDRLTSLQ 471 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGC-----TTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcC-----CCCCEEECCCCcCCccCHHHhccCCccc
Confidence 778888888887776666554 67888888888887 677766554 4566999999999999987 5 589999
Q ss_pred EEEecCCcccccCCcccc-cCCCCCCCcccCcCCCCCCccccC
Q 002178 376 TVRLRGNPFCLNTNAEQF-CGSHSDDDNEIDRSTNSTLDCRAQ 417 (956)
Q Consensus 376 ~l~l~~Np~~c~c~~~~~-~~~~~~~~~~~~~~~~~~~~c~~~ 417 (956)
.+++++|||.|+|++.+| ..|....... ....+.|.+|
T Consensus 472 ~L~l~~N~~~c~c~~~~~~~~~~~~~~~~----~~~~~~C~~p 510 (520)
T 2z7x_B 472 KIWLHTNPWDCSCPRIDYLSRWLNKNSQK----EQGSAKCSGS 510 (520)
T ss_dssp EEECCSSCBCCCHHHHHHHHHHHHHTTTT----EESCCBBTTT
T ss_pred EEECcCCCCcccCCchHHHHHHHHhcccc----CCCCCCcCCc
Confidence 999999999999999999 7787544322 2345667664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=351.86 Aligned_cols=328 Identities=20% Similarity=0.224 Sum_probs=223.9
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcc---------------------------------cccCc
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKE---------------------------------IGNIK 130 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~---------------------------------~~~l~ 130 (956)
++.|+|++|.+++..+..|+.+++|++|+|++|++++..|.. |..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 666777777776666666677777777777777666555443 34455
Q ss_pred ccchhhccCcCCCCCCCCccCCCcccceeecccc----------------------------cccCCCCccccccccCCe
Q 002178 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN----------------------------YISGSLPKSFANLNKTRH 182 (956)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N----------------------------~l~~~~p~~~~~l~~L~~ 182 (956)
+|++|+|++|++++..+..|.++++|++|+|++| ++++..|..|.++++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 5566666666666665665666555555555443 333344455555666666
Q ss_pred eecccCcCCCCCc-cccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC-CCcccccCCCCCcEEeccC
Q 002178 183 FHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRN 260 (956)
Q Consensus 183 L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~Ls~ 260 (956)
|+|++|.+++.+| ..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++. ..|..|.++++|+.|+|++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 6666666655444 4556666666666666666655666666666666666666666521 4678889999999999999
Q ss_pred CCCccCCCC-CCCCCCccEEEccCCcCCcCCCC---------CCCccccCEEEccCCcCCCCCchhcCCCCcCCeEeccc
Q 002178 261 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP---------GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 330 (956)
Q Consensus 261 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~---------~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 330 (956)
|++++.++. +..+++|++|+|++|++++..+. .....+|+.|+|++|+++...+..|.++++|+.|+|++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 999988775 88999999999999999854221 11224899999999999966667899999999999999
Q ss_pred ccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC---CCCCCcEEEecCCcccccCCc-ccccCCCCCCCcccCc
Q 002178 331 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA-EQFCGSHSDDDNEIDR 406 (956)
Q Consensus 331 N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~---~~~~l~~l~l~~Np~~c~c~~-~~~~~~~~~~~~~~~~ 406 (956)
|+|++..+..|..+ ++|+.|+|++|+|++++... .++.+..+++++|||.|||++ .+|..|+......+..
T Consensus 570 N~l~~l~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~ 644 (680)
T 1ziw_A 570 NNLNTLPASVFNNQ-----VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPE 644 (680)
T ss_dssp SCCCCCCTTTTTTC-----TTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC------
T ss_pred CCCCcCCHhHhCCC-----CCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHHhcCccccc
Confidence 99996666555544 45669999999999988763 478999999999999999996 9999998654333221
Q ss_pred CCCCCCccccC
Q 002178 407 STNSTLDCRAQ 417 (956)
Q Consensus 407 ~~~~~~~c~~~ 417 (956)
. ...+.|..|
T Consensus 645 ~-~~~~~C~~p 654 (680)
T 1ziw_A 645 L-SSHYLCNTP 654 (680)
T ss_dssp -----------
T ss_pred c-cCCcEECCc
Confidence 1 234567654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=364.15 Aligned_cols=203 Identities=19% Similarity=0.221 Sum_probs=109.7
Q ss_pred ccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCC
Q 002178 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRI 273 (956)
Q Consensus 195 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l 273 (956)
+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|.+++ ..+..|.++++|+.|+|++|.+++.++. |..+
T Consensus 283 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 361 (844)
T 3j0a_A 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361 (844)
T ss_dssp SCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSC-CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSC
T ss_pred hhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCc-cCHHHhcCCCCCCEEECCCCCCCccChhhhcCC
Confidence 3444455555555555555555555555566666666666666654 3455555566666666666655554443 4555
Q ss_pred CCccEEEccCCcCCcCC------------------CCC-----------------------CCccccCEEEccCCcCC--
Q 002178 274 PNLGYLDLSSNQLNGSI------------------PPG-----------------------RLSLNITTIKLSNNKLT-- 310 (956)
Q Consensus 274 ~~L~~L~Ls~N~l~~~~------------------p~~-----------------------~~~~~L~~L~Ls~N~l~-- 310 (956)
++|+.|+|++|.+++.. |.. ....+|+.|+|++|+++
T Consensus 362 ~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~ 441 (844)
T 3j0a_A 362 EKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441 (844)
T ss_dssp CCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCC
T ss_pred CCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccc
Confidence 55555555555544210 000 00012333333333332
Q ss_pred ----------------------------CCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCC--------------
Q 002178 311 ----------------------------GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN-------------- 348 (956)
Q Consensus 311 ----------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~-------------- 348 (956)
+..+..|.++++|+.|+|++|+|++..|..|..+..|+
T Consensus 442 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 521 (844)
T 3j0a_A 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521 (844)
T ss_dssp CSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCC
T ss_pred ccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccCh
Confidence 12223355555666666666666655555444332221
Q ss_pred ---CCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCCCC
Q 002178 349 ---ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 399 (956)
Q Consensus 349 ---~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~ 399 (956)
.++|+.|||++|+|++++... +..+..+++++|||.|+|++.+|..|...
T Consensus 522 ~~~~~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~~~f~~~~~~ 574 (844)
T 3j0a_A 522 NDLPANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTFINWLNH 574 (844)
T ss_dssp CCCCSCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSCCSHHHHHHH
T ss_pred hhhhccccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccccccHHHHHHHHh
Confidence 033445555555555544332 55788999999999999999999988743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=349.78 Aligned_cols=333 Identities=18% Similarity=0.168 Sum_probs=264.8
Q ss_pred CCCCCCCCCCCCCC---CCceeecCC----CC-------CCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCC
Q 002178 53 KLSNWNRGDPCTSN---WTGVLCFNT----TM-------DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI 118 (956)
Q Consensus 53 ~l~~W~~~~~c~~~---w~gv~C~~~----~~-------~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l 118 (956)
.+++|..+..|+.. |.++.|... .. .-...+++.|++.++.+....+..+.++++|++|+|++|.|
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 46789988888764 555544311 00 01124678899999998876666789999999999999999
Q ss_pred cccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCcccc
Q 002178 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198 (956)
Q Consensus 119 ~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 198 (956)
++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|.+++..|..|
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 98888899999999999999999999888899999999999999999997777778999999999999999998888899
Q ss_pred CCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccc---------------cCCCCCcEEeccCCCC
Q 002178 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY---------------SNMSKLLKLSLRNCSL 263 (956)
Q Consensus 199 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~---------------~~l~~L~~L~Ls~N~l 263 (956)
..+++|++|+|++|.+++.. +..+++|+.|++++|.+++...|..+ ...++|+.|+|++|.+
T Consensus 168 ~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l 244 (597)
T 3oja_B 168 QATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 244 (597)
T ss_dssp TTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCC
T ss_pred hcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCC
Confidence 99999999999999999754 33445555555555555432221111 1125788888888888
Q ss_pred ccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 264 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
++. +.+..+++|+.|+|++|.+++.+|..+.. .+|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+.
T Consensus 245 ~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~ 321 (597)
T 3oja_B 245 TDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321 (597)
T ss_dssp CCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred CCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccc
Confidence 874 56888999999999999999887776554 489999999999996 5777788999999999999999 6787777
Q ss_pred hhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCC
Q 002178 343 QSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (956)
Q Consensus 343 ~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~ 397 (956)
.+.. |+.|+|++|+|++++ ...++.+..|++++|||.|+|...++..+.
T Consensus 322 ~l~~-----L~~L~L~~N~l~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~ 370 (597)
T 3oja_B 322 QFDR-----LENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVA 370 (597)
T ss_dssp HHTT-----CSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCC
T ss_pred cCCC-----CCEEECCCCCCCCcC-hhhcCCCCEEEeeCCCCCChhHHHHHHHHh
Confidence 6655 559999999999886 235889999999999999999766665444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=345.05 Aligned_cols=339 Identities=19% Similarity=0.266 Sum_probs=222.3
Q ss_pred CCCCceeecCCC------CCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhcc
Q 002178 65 SNWTGVLCFNTT------MDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138 (956)
Q Consensus 65 ~~w~gv~C~~~~------~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls 138 (956)
|.|.|+ |+... ..+...+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 468887 75321 11234578999999999988888889999999999999999988778888889999999999
Q ss_pred CcCCCCCCCCccCCCcccceeecccccccC-CCCccccccccCCeeecccCcCCCCCc-cccCCCcccceecccccccCC
Q 002178 139 GNELTGSLPEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTG 216 (956)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~ 216 (956)
+|++++..|..|+++++|++|+|++|.+++ ..|..+.++++|++|++++|.+.+.+| ..|.++++|++|+|++|++++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 999887777778888888888888888886 356677777788888887777443443 456666666666666666555
Q ss_pred CCCcccCC------------------------cchhhhhcccCCcCCCCC------------------------------
Q 002178 217 YLPPELSE------------------------LPKLLILQLDNNNFEGTT------------------------------ 242 (956)
Q Consensus 217 ~~p~~l~~------------------------l~~L~~L~Ls~N~l~~~~------------------------------ 242 (956)
..|..+.. +++|++|+|++|++++..
T Consensus 163 ~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 242 (549)
T 2z81_A 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242 (549)
T ss_dssp ECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH
T ss_pred cChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH
Confidence 44443332 223333333333333210
Q ss_pred --------------------------------------------------------------------------------
Q 002178 243 -------------------------------------------------------------------------------- 242 (956)
Q Consensus 243 -------------------------------------------------------------------------------- 242 (956)
T Consensus 243 l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l 322 (549)
T 2z81_A 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322 (549)
T ss_dssp HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCC
T ss_pred HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcc
Confidence
Q ss_pred --Ccccc-cCCCCCcEEeccCCCCc---------------------------cCCC---CCCCCCCccEEEccCCcCCcC
Q 002178 243 --IPASY-SNMSKLLKLSLRNCSLQ---------------------------GPMP---DLSRIPNLGYLDLSSNQLNGS 289 (956)
Q Consensus 243 --~p~~~-~~l~~L~~L~Ls~N~l~---------------------------~~~~---~l~~l~~L~~L~Ls~N~l~~~ 289 (956)
+|..+ .++++|+.|+|++|+++ +.++ .+..+++|++|+|++|+++ .
T Consensus 323 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 401 (549)
T 2z81_A 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401 (549)
T ss_dssp CCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-C
T ss_pred ccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-c
Confidence 01111 12334444444444433 2221 1445567777777777776 4
Q ss_pred CCCCCCc-cccCEEEccCCcCCCCCch-----------------hcCCCCcCCeEecccccCCCcCChhhhhhccCCCCc
Q 002178 290 IPPGRLS-LNITTIKLSNNKLTGTIPS-----------------NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351 (956)
Q Consensus 290 ~p~~~~~-~~L~~L~Ls~N~l~~~~p~-----------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~ 351 (956)
+|..... .+|++|+|++|+++..... .+.++++|++|+|++|+|+ .+|.. .. .+.
T Consensus 402 lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~-~~-----l~~ 474 (549)
T 2z81_A 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SL-----FPV 474 (549)
T ss_dssp CCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCG-GG-----CTT
T ss_pred CChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCc-cc-----Ccc
Confidence 5543322 2455555555554421111 1247889999999999998 67753 22 456
Q ss_pred ceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCC-cccccCCCCCCCcccCcCCCCCCcccc
Q 002178 352 TFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNEIDRSTNSTLDCRA 416 (956)
Q Consensus 352 L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~-~~~~~~~~~~~~~~~~~~~~~~~~c~~ 416 (956)
|+.|+|++|+|++++.. + .++.++.|++++|||.|+|+ +.++..|+...... ....+.|..
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~~~~~~----~~~~~~C~~ 538 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK----EQGSAKCSG 538 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHHHCTTT----EESCCBBTT
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHHHhcccc----cCCCCeECC
Confidence 78999999999998876 4 58999999999999999998 45565676543322 233455654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=332.97 Aligned_cols=191 Identities=24% Similarity=0.267 Sum_probs=160.5
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhcC----------------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLH---------------- 678 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------------- 678 (956)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|++++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 56788999999999999999998 789999999875421 22367889999998886
Q ss_pred ----------CCceeeeeccccc-------------CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHH
Q 002178 679 ----------HRNLVSLVGYCDE-------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735 (956)
Q Consensus 679 ----------h~nIv~l~~~~~~-------------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 735 (956)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6666666666654 7899999999999977666643 3578999999999999999
Q ss_pred HHhh-hcCCCCEeccCCCcccEEEcCCC--------------------cEEEEeeccccccCCCCCCCccccceeccccc
Q 002178 736 LYLH-TEADPPVFHRDIKASNILLDHKF--------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794 (956)
Q Consensus 736 ~yLH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~g 794 (956)
+||| +++ |+||||||+|||++.++ .+||+|||+|+.... ....|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 899 99999999999999887 999999999986531 13469
Q ss_pred CCCcccccccccCCCCCcccchhHHHH-HHHHHhCCCCCC
Q 002178 795 TPGYLDPEYFLTHKLTDKSDVYSLGVV-FLELLTGMQPIS 833 (956)
Q Consensus 795 t~~y~aPE~~~~~~~~~~sDVwS~G~l-l~elltg~~pf~ 833 (956)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999999998766 889999998777 777888888873
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=344.48 Aligned_cols=298 Identities=21% Similarity=0.351 Sum_probs=200.8
Q ss_pred CcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCC-Ccc-cCCcccccC------cccchhhccCcCCCCCCCC--c
Q 002178 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK-ISG-SIPKEIGNI------KSLELLLLNGNELTGSLPE--E 149 (956)
Q Consensus 80 ~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~ip~~~~~l------~~L~~L~Ls~N~l~~~~p~--~ 149 (956)
...+++.|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~ 325 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS 325 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence 34678999999999999999999999999999999998 998 889888887 89999999999998 8888 8
Q ss_pred cCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcc-cceecccccccCCCCCcccCCcc--
Q 002178 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS-LVHMLLDNNNLTGYLPPELSELP-- 226 (956)
Q Consensus 150 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~-- 226 (956)
++++++|++|+|++|+++|.+| .|.++++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..+.
T Consensus 326 l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~ 402 (636)
T 4eco_A 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402 (636)
T ss_dssp HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSS
T ss_pred hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccC
Confidence 8899999999999998888888 7777888888888888777 66777777777 777777777777 5666665543
Q ss_pred hhhhhcccCCcCCCCCCccccc-------CCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCc-c
Q 002178 227 KLLILQLDNNNFEGTTIPASYS-------NMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-L 297 (956)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~ 297 (956)
+|++|+|++|.+++ ..|..|. .+++|+.|+|++|+++..++. +..+++|++|+|++|+++ .+|...+. .
T Consensus 403 ~L~~L~Ls~N~l~~-~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 403 VMSAIDFSYNEIGS-VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp CEEEEECCSSCTTT-TTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred ccCEEECcCCcCCC-cchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 66666666666665 4555555 555666666666666544443 333555555555555555 44443322 1
Q ss_pred --------ccCEEEccCCcCCCCCchhcC--CCCcCCeEecccccCCCcCChhhhhhccCC-------------------
Q 002178 298 --------NITTIKLSNNKLTGTIPSNFS--GLPRLQRLFIANNSLSGSIPSSIWQSRTLN------------------- 348 (956)
Q Consensus 298 --------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~------------------- 348 (956)
+|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+..|+
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~ 558 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCC
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccC
Confidence 4555555555555 3444443 45555555555555554 444443322221
Q ss_pred ------CCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccc
Q 002178 349 ------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 349 ------~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c 386 (956)
.++|+.|+|++|+|+.+|..+. +.++.|++++||+.|
T Consensus 559 p~~l~~l~~L~~L~Ls~N~l~~ip~~~~-~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 559 PEGITLCPSLTQLQIGSNDIRKVNEKIT-PNISVLDIKDNPNIS 601 (636)
T ss_dssp CTTGGGCSSCCEEECCSSCCCBCCSCCC-TTCCEEECCSCTTCE
T ss_pred hHHHhcCCCCCEEECCCCcCCccCHhHh-CcCCEEECcCCCCcc
Confidence 1234466666666666665543 566666666666655
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.75 Aligned_cols=175 Identities=23% Similarity=0.375 Sum_probs=152.4
Q ss_pred cCCCCC-CeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHH-HhcCCCceeeeeccccc----CCcEE
Q 002178 624 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDE----EGEQM 696 (956)
Q Consensus 624 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~ 696 (956)
++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 77999999999999964 6899999998642 3567888887 55689999999999876 67789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeecccc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~ 773 (956)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998876667999999999999999999999999 999999999999998 7899999999986
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
... +..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 169 ETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 532 134677899999999999999999999653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.66 Aligned_cols=229 Identities=12% Similarity=0.073 Sum_probs=185.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++.+++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 589999999976432 2346889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++... ....++.+|+.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999542 244467889999999999999999 9999999999999999999998543
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
|++ .++.++|||||||++|||++|+.||........ .......+.+.
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 221 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQ 221 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------SEECCBCTTSC
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------hHHHHHHhccC
Confidence 222 257899999999999999999999975432100 00000111111
Q ss_pred CC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 859 MG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 859 ~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.. ..+..++..+.+++.+||+.||.+| ++.++++.|+++..
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11 1123466789999999999999999 99999999998754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=337.87 Aligned_cols=150 Identities=17% Similarity=0.257 Sum_probs=114.4
Q ss_pred ccCCCCCcEEeccCCCCccCCC--CCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCC-CCCchhcCCCCc
Q 002178 247 YSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLT-GTIPSNFSGLPR 322 (956)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~-~~~p~~~~~l~~ 322 (956)
+..+++|+.|++++|.+++.++ .+..+++|++|++++|.+.+..|..+.. .+|+.|+|++|.++ +.+|..|..+++
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 4455555555555555555444 3667777777777777777666655433 37888888888887 578888888889
Q ss_pred CCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCccccc-CCCCC
Q 002178 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFC-GSHSD 399 (956)
Q Consensus 323 L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~~~~~~-~~~~~ 399 (956)
|+.|+|++|++++..|..+..+. +|+.|+|++|++++++.. + .++.++.+++++|||.|+|+..++. .|...
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~-----~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~ 546 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLS-----SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK 546 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHH
T ss_pred CCEEECCCCccccCChhhhhccc-----CCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHh
Confidence 99999999998888788776544 566999999999998765 3 5899999999999999999988887 88765
Q ss_pred CC
Q 002178 400 DD 401 (956)
Q Consensus 400 ~~ 401 (956)
..
T Consensus 547 ~~ 548 (570)
T 2z63_A 547 NS 548 (570)
T ss_dssp TG
T ss_pred cc
Confidence 43
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=345.53 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=193.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC--CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCc-----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 694 (956)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999986533 3445678999999999999999999999977665
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988743 5899999999999999999999999 9999999999999986 899999999986
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.....
T Consensus 231 ~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------- 281 (681)
T 2pzi_A 231 INSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------- 281 (681)
T ss_dssp TTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------
T ss_pred cccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------------
Confidence 5321 3346999999999987654 8899999999999999999888753110
Q ss_pred ccCCCCC-CChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhH
Q 002178 855 IDGNMGS-YPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIW 899 (956)
Q Consensus 855 ~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs-~~~v~~~L~~~~ 899 (956)
+..... .....+..+.+++.+|++.+|.+||+ ++++.+.+..+.
T Consensus 282 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 -DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000011 11234578899999999999999995 556666666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=322.70 Aligned_cols=240 Identities=15% Similarity=0.115 Sum_probs=180.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCC-Cceeeee------------
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHH-RNLVSLV------------ 686 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~nIv~l~------------ 686 (956)
.+|...+.||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.+++.++| +|.....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45667789999999999999954 6999999998843222 24678999999999987 3221111
Q ss_pred ---------ccccc-----CCcEEEEEecCCCCCHHHHHh-----hcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEe
Q 002178 687 ---------GYCDE-----EGEQMLVYEFMSNGTLRDQLS-----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (956)
Q Consensus 687 ---------~~~~~-----~~~~~LV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 747 (956)
.++.. ....+++|+++ +++|.+++. ......+++..++.++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111 22467788876 789999985 233456889999999999999999999999 99
Q ss_pred ccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccc----------ccCCCCCcccchh
Q 002178 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF----------LTHKLTDKSDVYS 817 (956)
Q Consensus 748 H~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVwS 817 (956)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999876431 1334567 999999999 5556888999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 818 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 818 ~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
|||++|||++|+.||...... .....++. .... +++.+.+++.+||+.+|.+||++.++++
T Consensus 303 lGvil~elltg~~Pf~~~~~~----------~~~~~~~~-~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAAL----------GGSEWIFR-SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGG----------SCSGGGGS-SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCCCCcchh----------hhHHHHHh-hccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999999754321 11111111 1122 3367888889999999999999776653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.42 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=227.9
Q ss_pred CCCCEEEccCCCCcc--cCCcccccCcccchhhccC-cCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 106 SYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
.+++.|+|++|++++ .+|..|.++++|++|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred eecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcc-hhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
|+|++|.+++.+|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++ .+|..+..++ |+.|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec-cCChHHhCCc-ccEEECcCC
Confidence 99999999999999999999999999999999999999999998 99999999999987 6889999987 999999999
Q ss_pred CCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChh
Q 002178 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340 (956)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 340 (956)
.+++..+. +..+++|+.|+|++|.+++.+|......+|++|+|++|++++.+|..|..+++|+.|+|++|+++|.+|..
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 99987664 88999999999999999877776544558888888888888888888888888888888888888887764
Q ss_pred hhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCc
Q 002178 341 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA 390 (956)
Q Consensus 341 ~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~ 390 (956)
.. ++.+..+++.+||+.|+.++
T Consensus 288 -~~---------------------------l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 288 -GN---------------------------LQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp -TT---------------------------GGGSCGGGTCSSSEEESTTS
T ss_pred -cc---------------------------ccccChHHhcCCCCccCCCC
Confidence 32 34455677888998886443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=338.76 Aligned_cols=290 Identities=19% Similarity=0.283 Sum_probs=207.9
Q ss_pred cceeeEEEeCCCCccc-----------------cCCcCcC--CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcC
Q 002178 81 YLHLRELQLLNLNLSG-----------------NLSPEIG--RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~-----------------~~~~~l~--~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~ 141 (956)
..+++.|+|++|.|++ .+|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4578888999998888 3888877 89999999999998888888888888899999999887
Q ss_pred -CCC-CCCCccCCCc-------ccceeecccccccCCCCc--cccccccCCeeecccCcCCCCCccccCCCcccceeccc
Q 002178 142 -LTG-SLPEELGYLP-------KLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (956)
Q Consensus 142 -l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (956)
++| .+|..++.++ +|++|+|++|+++ .+|. .|.++++|+.|+|++|+++ .+| .|+.+++|+.|+|+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 887 7777666555 8888888888888 7777 7888888888888888888 777 78888888888888
Q ss_pred ccccCCCCCcccCCcch-hhhhcccCCcCCCCCCcccccCCCC--CcEEeccCCCCccCCCCC-----------------
Q 002178 211 NNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPASYSNMSK--LLKLSLRNCSLQGPMPDL----------------- 270 (956)
Q Consensus 211 ~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~l----------------- 270 (956)
+|+++ .+|..+..+++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++++.++.+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~L 680 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEEC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEc
Confidence 88888 77777888887 888888888876 45666655543 666666666665543321
Q ss_pred -------------CCCCCccEEEccCCcCCcCCCCCCCcc---------ccCEEEccCCcCCCCCchhcC--CCCcCCeE
Q 002178 271 -------------SRIPNLGYLDLSSNQLNGSIPPGRLSL---------NITTIKLSNNKLTGTIPSNFS--GLPRLQRL 326 (956)
Q Consensus 271 -------------~~l~~L~~L~Ls~N~l~~~~p~~~~~~---------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L 326 (956)
..+++|+.|+|++|+|+ .+|...+.. +|+.|+|++|+|+ .+|..+. .+++|+.|
T Consensus 681 s~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 681 SYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp CSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred cCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 24556666666666666 555543321 6777777777777 5666665 77777777
Q ss_pred ecccccCCCcCChhhhhhccCCCCcceEEEccC------CCCC-CCCCCC-CCCCCcEEEecCCcc
Q 002178 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQN------NNLT-NISGSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 327 ~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~------N~L~-~l~~~~-~~~~l~~l~l~~Np~ 384 (956)
+|++|+|++ +|..+..+.+ |+.|+|++ |++. .+|..+ .++.++.|+|++|.+
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~-----L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQ-----LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTT-----CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred EeCCCCCCc-cchhhhcCCC-----CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 777777776 5666654433 34566654 3333 334444 356666666666665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=326.93 Aligned_cols=319 Identities=19% Similarity=0.184 Sum_probs=265.3
Q ss_pred CCCCCCC--CCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccc
Q 002178 60 GDPCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133 (956)
Q Consensus 60 ~~~c~~~--w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~ 133 (956)
...|.|. +..+.|.+.... +.+.+++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|.++++|+
T Consensus 5 ~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 84 (606)
T 3t6q_A 5 DQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84 (606)
T ss_dssp -CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCC
T ss_pred cCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccC
Confidence 3445543 566888765432 3456899999999999999899999999999999999999998899999999999
Q ss_pred hhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccc
Q 002178 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (956)
Q Consensus 134 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 213 (956)
+|+|++|++++..|..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++.....+..+++|++|+|++|+
T Consensus 85 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp EEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred eeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 99999999999999999999999999999999998778889999999999999999997554555569999999999999
Q ss_pred cCCCCCcccCCcchhh--hhcccCCcCCCCCCcccccCC-----------------------------------------
Q 002178 214 LTGYLPPELSELPKLL--ILQLDNNNFEGTTIPASYSNM----------------------------------------- 250 (956)
Q Consensus 214 l~~~~p~~l~~l~~L~--~L~Ls~N~l~~~~~p~~~~~l----------------------------------------- 250 (956)
+++..+..|..+++|+ .|++++|.+++ ..|..|...
T Consensus 165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~-~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i 243 (606)
T 3t6q_A 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243 (606)
T ss_dssp CCEECHHHHHTTTTCCSEEEECTTCCCCE-ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred ccccChhhhhhhcccceeEEecCCCccCc-cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhcccccccc
Confidence 9988888899999999 88999999886 344433221
Q ss_pred ----------CCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcC
Q 002178 251 ----------SKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 251 ----------~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
.+|+.|++++|.+++.++. |..+++|++|++++|+++ .+|..+.. .+|++|+|++|.+++..|..+.
T Consensus 244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 322 (606)
T 3t6q_A 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322 (606)
T ss_dssp CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGG
T ss_pred ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhh
Confidence 1678888888888887775 888999999999999998 67766544 4899999999999988888899
Q ss_pred CCCcCCeEecccccCCCcCChh-hhhhccCCCCcceEEEccCCCCCCCC---CCC-CCCCCcEEEecCCccc
Q 002178 319 GLPRLQRLFIANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNIS---GSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~-~~~l~~l~~~~L~~L~L~~N~L~~l~---~~~-~~~~l~~l~l~~Np~~ 385 (956)
++++|+.|++++|++.+.+|.. +..+ ++|+.|++++|+++.+. ..+ .++.++.|++++|...
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 389 (606)
T 3t6q_A 323 NFPSLTHLSIKGNTKRLELGTGCLENL-----ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389 (606)
T ss_dssp GCTTCSEEECCSCSSCCBCCSSTTTTC-----TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCE
T ss_pred ccCcCCEEECCCCCcccccchhhhhcc-----CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCC
Confidence 9999999999999988777764 4443 45668888888888764 334 5788888888888753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=304.40 Aligned_cols=286 Identities=21% Similarity=0.243 Sum_probs=148.1
Q ss_pred CCCHHHHHHHHHHHHhcc-CCCCCCCCCC---CCCCCCCCCCceeecCCCC---CCCcceeeEEEeCCCCccccCCcCcC
Q 002178 31 ITDPIEVSALRSIKKSLV-DDYSKLSNWN---RGDPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIG 103 (956)
Q Consensus 31 ~~~~~~~~al~~~k~~~~-~~~~~l~~W~---~~~~c~~~w~gv~C~~~~~---~~~~~~~~~L~L~~~~l~~~~~~~l~ 103 (956)
....+|+.||++||+++. ++.+.+.+|. .....+|.|.|+.|..... .....+++.|+|++++++ .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 344678999999999985 5545567884 2222233699999942100 001124455555555554 4444455
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+...
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------ 173 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------ 173 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------
Confidence 5555555555555554 44444555555555555555554 444445455555555555544444444433220
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
.++..|.++++|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..+.++++|++|+|++|++
T Consensus 174 ---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~--l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 174 ---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp ---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--CCGGGGGCTTCCEEECTTCTT
T ss_pred ---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--CchhhccCCCCCEEECcCCcc
Confidence 01111233556666666666655 455555555555555555555553 344555555555555555555
Q ss_pred ccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 264 QGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 264 ~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
.+..|. +..+++|+.|+|++|++.+ .+|..+.++++|+.|+|++|++.+.+|..+.
T Consensus 242 ~~~~p~~~~~l~~L~~L~L~~n~~~~-----------------------~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 242 LRNYPPIFGGRAPLKRLILKDCSNLL-----------------------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp CCBCCCCTTCCCCCCEEECTTCTTCC-----------------------BCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred hhhhHHHhcCCCCCCEEECCCCCchh-----------------------hcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 544332 4555555555555555444 4444455555555555555555555555554
Q ss_pred hhccCCCCcceEEEccCCCCCCC
Q 002178 343 QSRTLNATETFILDFQNNNLTNI 365 (956)
Q Consensus 343 ~l~~l~~~~L~~L~L~~N~L~~l 365 (956)
.+..+ +.+++..|.+..+
T Consensus 299 ~L~~L-----~~l~l~~~~~~~l 316 (328)
T 4fcg_A 299 QLPAN-----CIILVPPHLQAQL 316 (328)
T ss_dssp GSCTT-----CEEECCGGGSCC-
T ss_pred hccCc-----eEEeCCHHHHHHH
Confidence 43332 3455555544443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=309.32 Aligned_cols=298 Identities=21% Similarity=0.281 Sum_probs=157.3
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
..++..+.+|+ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34556665555 3444333 45666666666666555556666666666666666666555555555566666666655
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCc
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (956)
+|+...+..|.++++|++|+|++|+|+...+..|.++++|++|+|++| +..+...+
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~------------------------~~l~~i~~ 178 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL------------------------KRLSYISE 178 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC------------------------TTCCEECT
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC------------------------CCcceeCc
Confidence 555444445555555555555555555333334444444444444442 22111122
Q ss_pred ccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCC
Q 002178 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (956)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (956)
..|.++++|++|+|++|+++.. +.+..+++|+.|+|++|+|+ +..|..|.++++|+
T Consensus 179 ~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~-----------------------~~~~~~~~~l~~L~ 234 (440)
T 3zyj_A 179 GAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLS-----------------------AIRPGSFQGLMHLQ 234 (440)
T ss_dssp TTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCC-----------------------EECTTTTTTCTTCC
T ss_pred chhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccC-----------------------ccChhhhccCccCC
Confidence 2444555555555555555433 23444444444444444444 33344444445555
Q ss_pred eEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCcccccCCCCCCCc
Q 002178 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDN 402 (956)
Q Consensus 325 ~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~ 402 (956)
.|+|++|+|++..+..|..+. +|+.|+|++|+|+.++... .++.+..|+|++|||.|||++.||..|......
T Consensus 235 ~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~~~~~ 309 (440)
T 3zyj_A 235 KLWMIQSQIQVIERNAFDNLQ-----SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKDMAP 309 (440)
T ss_dssp EEECTTCCCCEECTTSSTTCT-----TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHHHTTSC
T ss_pred EEECCCCceeEEChhhhcCCC-----CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHHHhccc
Confidence 555555555444444443322 2334555555555554432 367788999999999999999999888764321
Q ss_pred ccCcCCCCCCccccCcCCCCCccCCCCCCcceeecceee
Q 002178 403 EIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLV 441 (956)
Q Consensus 403 ~~~~~~~~~~~c~~~~c~~~~~~~p~~~~~~~c~~~~~~ 441 (956)
......+.|..|.-...............|..|.+.
T Consensus 310 ---~~~~~~~~C~~P~~l~g~~l~~l~~~~~~C~~P~i~ 345 (440)
T 3zyj_A 310 ---SNTACCARCNTPPNLKGRYIGELDQNYFTCYAPVIV 345 (440)
T ss_dssp ---SSCSCCCBEEESTTTTTCBCC----CCSCCCCCCEE
T ss_pred ---cCCccccCCCChhHhcCccHhHhhhhhccCCCCccc
Confidence 112234567765444444333344445567665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=316.42 Aligned_cols=305 Identities=19% Similarity=0.190 Sum_probs=265.4
Q ss_pred CcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCccccee
Q 002178 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (956)
Q Consensus 80 ~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (956)
...+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|
T Consensus 54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 45689999999999999999999999999999999999997666678999999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
+|++|.+++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|+|++|.+.
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 99999999888999999999999999999999877788999999999999999999988889999999999999999987
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNF 317 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~ 317 (956)
+ .++..+....+|+.|+|++|+++..++ .+..+++|+.|+|++|.+++..+..+.. .+|+.|+|++|++++..|..|
T Consensus 214 ~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (477)
T 2id5_A 214 D-TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292 (477)
T ss_dssp C-EECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTB
T ss_pred c-ccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHh
Confidence 6 566666667799999999999998775 4889999999999999999655544433 489999999999999999999
Q ss_pred CCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcccccCCc
Q 002178 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNA 390 (956)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~c~c~~ 390 (956)
.++++|+.|+|++|+|++..+..|..+. +|+.|+|++|.++.-.... .+.....+.+.+|.+.|.++.
T Consensus 293 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 293 RGLNYLRVLNVSGNQLTTLEESVFHSVG-----NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTCTTCCEEECCSSCCSCCCGGGBSCGG-----GCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred cCcccCCEEECCCCcCceeCHhHcCCCc-----ccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 9999999999999999976666665554 4569999999998543221 122233355678888887653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=329.88 Aligned_cols=300 Identities=19% Similarity=0.208 Sum_probs=231.0
Q ss_pred CcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CcccccCcccchhhccCcCCCCCCCCccCCCcccce
Q 002178 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (956)
Q Consensus 80 ~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (956)
.+.+++.|+|++|.+++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|+++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4568999999999999999999999999999999999766666 788999999999999999999888999999999999
Q ss_pred eecccccccCCCCcc--ccccccCCeeecccCcCCCCCc-cccCCCcccceecccccccCCCCCcccCCc--chhhhhcc
Q 002178 159 IQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSEL--PKLLILQL 233 (956)
Q Consensus 159 L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L 233 (956)
|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+ ++|+.|+|
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999999876665 9999999999999999987755 578999999999999999999888888877 77888888
Q ss_pred cCCcCCCCCCcccccCCCC------CcEEeccCCCCccCCCC-------------------------------------C
Q 002178 234 DNNNFEGTTIPASYSNMSK------LLKLSLRNCSLQGPMPD-------------------------------------L 270 (956)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~~~-------------------------------------l 270 (956)
++|.+.+ ..|..+..+.+ |+.|+|++|.+++..+. |
T Consensus 182 ~~n~l~~-~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f 260 (844)
T 3j0a_A 182 AANSLYS-RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260 (844)
T ss_dssp CCSBSCC-CCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTT
T ss_pred CCCcccc-ccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhh
Confidence 8888876 45555555544 77777777766543221 1
Q ss_pred CC--CCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccC
Q 002178 271 SR--IPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (956)
Q Consensus 271 ~~--l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 347 (956)
.. .++|+.|+|++|.+.+..+..+.. .+|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+.
T Consensus 261 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-- 338 (844)
T 3j0a_A 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP-- 338 (844)
T ss_dssp TTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT--
T ss_pred hccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC--
Confidence 11 256777777777777555544433 3677777777777777777777777777777777777766666665443
Q ss_pred CCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCccc
Q 002178 348 NATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 348 ~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~ 385 (956)
+|+.|+|++|+++.++.. + .++.++.|+|++|.+.
T Consensus 339 ---~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 375 (844)
T 3j0a_A 339 ---KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375 (844)
T ss_dssp ---TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSC
T ss_pred ---CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCC
Confidence 344677777777666553 2 3666666666666643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=311.69 Aligned_cols=297 Identities=20% Similarity=0.283 Sum_probs=169.6
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
..++..+.+++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 345666666653 444433 46677777777777666666666777777777777766666666666666666666666
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCc
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (956)
+|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+. +. ...+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~-----------------------l~-~i~~ 189 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK-----------------------LE-YISE 189 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTT-----------------------CC-EECT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCC-----------------------cc-ccCh
Confidence 66655555555555666666555555544344455555555555544221 11 1112
Q ss_pred ccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCC
Q 002178 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (956)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (956)
..|.++++|+.|+|++|++++. +.+..+++|+.|+|++|.| ++..|..|.++++|+
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l-----------------------~~~~~~~~~~l~~L~ 245 (452)
T 3zyi_A 190 GAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHF-----------------------PEIRPGSFHGLSSLK 245 (452)
T ss_dssp TTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCC-----------------------SEECGGGGTTCTTCC
T ss_pred hhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcC-----------------------cccCcccccCccCCC
Confidence 2344455555555555555433 2344444444444444444 444455566666666
Q ss_pred eEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCcccccCCCCCCCc
Q 002178 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDN 402 (956)
Q Consensus 325 ~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~ 402 (956)
.|+|++|++++..|..|..+. +|+.|+|++|+|++++... .++.+..|+|++|||.|||++.+|..|......
T Consensus 246 ~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~~~l~~~~~ 320 (452)
T 3zyi_A 246 KLWVMNSQVSLIERNAFDGLA-----SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWWLREYIP 320 (452)
T ss_dssp EEECTTSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHHHHHHHHC-
T ss_pred EEEeCCCcCceECHHHhcCCC-----CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHHHHHHHhCc
Confidence 666666666655555554333 3346666666666665543 477888999999999999999999888753211
Q ss_pred ccCcCCCCCCccccCcCCCCCccCCCCCCcceeeccee
Q 002178 403 EIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLL 440 (956)
Q Consensus 403 ~~~~~~~~~~~c~~~~c~~~~~~~p~~~~~~~c~~~~~ 440 (956)
......+.|.+|.-...............|..|..
T Consensus 321 ---~~~~~~~~C~~P~~l~g~~l~~~~~~~~~C~~P~i 355 (452)
T 3zyi_A 321 ---TNSTCCGRCHAPMHMRGRYLVEVDQASFQCSAPFI 355 (452)
T ss_dssp -----CCSSCBEEESTTTTTCBTTSCCGGGCCCCCCCC
T ss_pred ---cCCccCcEeCCchHhccchhhccchhhhcccCccc
Confidence 11223456776554444444444444556766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=314.75 Aligned_cols=282 Identities=18% Similarity=0.199 Sum_probs=236.1
Q ss_pred CcceeeEEEeCCCCccccC-CcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCc--cCCCccc
Q 002178 80 GYLHLRELQLLNLNLSGNL-SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE--LGYLPKL 156 (956)
Q Consensus 80 ~~~~~~~L~L~~~~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L 156 (956)
...+++.|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.. |..+++|
T Consensus 52 ~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L 131 (455)
T 3v47_A 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131 (455)
T ss_dssp SCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTC
T ss_pred cCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccC
Confidence 3467889999999888665 457889999999999999998888888999999999999999998755554 8889999
Q ss_pred ceeecccccccCCCCcc-ccccccCCeeecccCcCCCCCccccCCC----------------------------------
Q 002178 157 DRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRL---------------------------------- 201 (956)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l---------------------------------- 201 (956)
++|+|++|++++..|.. +.++++|++|+|++|++++..+..+..+
T Consensus 132 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~ 211 (455)
T 3v47_A 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211 (455)
T ss_dssp CEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTT
T ss_pred CEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccccccc
Confidence 99999999998887776 7889999999999999988777666544
Q ss_pred cccceecccccccCCCCCcccCC---------------------------------------cchhhhhcccCCcCCCCC
Q 002178 202 PSLVHMLLDNNNLTGYLPPELSE---------------------------------------LPKLLILQLDNNNFEGTT 242 (956)
Q Consensus 202 ~~L~~L~L~~N~l~~~~p~~l~~---------------------------------------l~~L~~L~Ls~N~l~~~~ 242 (956)
++|++|+|++|++++..|..+.. .++|++|+|++|.+++ .
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~ 290 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-L 290 (455)
T ss_dssp CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE-E
T ss_pred ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccc-c
Confidence 67899999999887654443321 2579999999999987 5
Q ss_pred CcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCC
Q 002178 243 IPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
.|..|.++++|++|+|++|++++.++ .+..+++|++|+|++|.+++..|..+. ..+|++|+|++|++++..|..|.++
T Consensus 291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc
Confidence 78899999999999999999999876 589999999999999999866666544 3489999999999999999999999
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCC
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~ 367 (956)
++|++|+|++|+|++..+..+..+ ++|+.|+|++|.++.-..
T Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 371 PNLKELALDTNQLKSVPDGIFDRL-----TSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTC-----TTCCEEECCSSCBCCCTT
T ss_pred ccccEEECCCCccccCCHhHhccC-----CcccEEEccCCCcccCCC
Confidence 999999999999997666555544 456699999999987543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=321.92 Aligned_cols=187 Identities=22% Similarity=0.289 Sum_probs=159.7
Q ss_pred CCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhcc
Q 002178 63 CTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138 (956)
Q Consensus 63 c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls 138 (956)
|.|.++.+.|...... +.+.+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 6666777888754322 344689999999999998888889999999999999999999889999999999999999
Q ss_pred CcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCC
Q 002178 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (956)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 218 (956)
+|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|++++..
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999666668999999999999999999888889999999999999999999988999999999999999999999877
Q ss_pred CcccC--CcchhhhhcccCCcCCCCCCcccccCC
Q 002178 219 PPELS--ELPKLLILQLDNNNFEGTTIPASYSNM 250 (956)
Q Consensus 219 p~~l~--~l~~L~~L~Ls~N~l~~~~~p~~~~~l 250 (956)
+..+. .+++|++|+|++|.+++ ..|..|..+
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l 194 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKE-FSPGCFHAI 194 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCC-BCTTGGGGS
T ss_pred HHHhhccccccccEEECCCCcccc-cChhhhhhh
Confidence 77654 45789999999998876 455544433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=288.59 Aligned_cols=268 Identities=21% Similarity=0.298 Sum_probs=124.4
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeec
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (956)
++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 34455555555554444444455555555555555554444444555555555555555544 2333222 44555555
Q ss_pred ccCcCCCCCccccCCCcccceecccccccC--CCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
++|++++..+..|.++++|++|++++|.++ +..+..+..+ +|++|++++|.+++ +|..+. ++|++|+|++|.+
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~--l~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG--IPKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS--CCSSSC--SSCSCCBCCSSCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc--cCcccc--CCCCEEECCCCcC
Confidence 555554433344444555555555555543 2344444444 45555555555542 333222 3455555555555
Q ss_pred ccCCC-CCCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhh
Q 002178 264 QGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341 (956)
Q Consensus 264 ~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 341 (956)
++.++ .+..+++|+.|+|++|++++..+..+. ..+|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+..|
T Consensus 206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 54443 244555555555555555533332222 124555555555555 445555555555555555555554444444
Q ss_pred hhhcc-CCCCcceEEEccCCCCC--CCCCC-C-CCCCCcEEEecCC
Q 002178 342 WQSRT-LNATETFILDFQNNNLT--NISGS-F-NIPPNVTVRLRGN 382 (956)
Q Consensus 342 ~~l~~-l~~~~L~~L~L~~N~L~--~l~~~-~-~~~~l~~l~l~~N 382 (956)
..... .....|+.|++++|.++ .++.. + .++.++.+++++|
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 32211 11233455666666555 22222 2 2555566666655
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=304.74 Aligned_cols=307 Identities=15% Similarity=0.199 Sum_probs=205.7
Q ss_pred CCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcC
Q 002178 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (956)
Q Consensus 62 ~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~ 141 (956)
.|.|.|.|+ |. +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 27 ~~~C~~~~~-c~---------------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 27 SLSCDRNGI-CK---------------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp CCEECTTSE-EE---------------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCCCCCeE-ee---------------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 344578887 63 2344555 3455444 478888888888886666678888888888888888
Q ss_pred CCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCc-cccCCCcccceeccccc-ccCCCCC
Q 002178 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNN-NLTGYLP 219 (956)
Q Consensus 142 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p 219 (956)
+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++...+ ..+.++++|++|++++| .+++..+
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 887777788888888888888888886555568888888888888888884333 36778888888888887 4665566
Q ss_pred cccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccc
Q 002178 220 PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLN 298 (956)
Q Consensus 220 ~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 298 (956)
..|..+++|++|+|++|.+++ ..|..+.++++|++|++++|.++..+.. +..+++|+.|++++|.+++..+.....
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~-- 244 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-- 244 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCE-ECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------
T ss_pred HHccCCCCCCEEECCCCCcCc-cCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc--
Confidence 677778888888888888775 4567777777777777777777654443 334667777777777776433322110
Q ss_pred cCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCC----cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCC
Q 002178 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG----SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP 372 (956)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~ 372 (956)
......++.++|++|.+++ .+|..+..+ ++|+.|+|++|+|+.+|... .++
T Consensus 245 ------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l-----~~L~~L~Ls~N~l~~i~~~~~~~l~ 301 (353)
T 2z80_A 245 ------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQI-----SGLLELEFSRNQLKSVPDGIFDRLT 301 (353)
T ss_dssp --------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTC-----TTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ------------------ccccchhhccccccccccCcchhhhHHHHhcc-----cCCCEEECCCCCCCccCHHHHhcCC
Confidence 1123334444444444443 233333332 23346666666666666553 477
Q ss_pred CCcEEEecCCcccccCC-cccccCCCCCCCcccCcCCCCCCccccC
Q 002178 373 PNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNEIDRSTNSTLDCRAQ 417 (956)
Q Consensus 373 ~l~~l~l~~Np~~c~c~-~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 417 (956)
.++.|++++|||.|+|+ +.++-.|.......+ ...+.|.++
T Consensus 302 ~L~~L~L~~N~~~~~~~~l~~l~~~~~~~~~~~----~~~~~C~~p 343 (353)
T 2z80_A 302 SLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE----QGSAKCSGS 343 (353)
T ss_dssp TCCEEECCSSCBCCCHHHHHHHHHHHHHTTTTE----ESCCBBTTT
T ss_pred CCCEEEeeCCCccCcCCCcHHHHHHHHhccccC----CCCcccCCC
Confidence 88999999999999996 777777775544332 235667653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=287.43 Aligned_cols=269 Identities=20% Similarity=0.301 Sum_probs=166.1
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeec
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (956)
+.|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 45666666666666555556666666666666666666666666666666666666666666 3444333 56666666
Q ss_pred ccCcCCCCCccccCCCcccceecccccccC--CCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
++|++++..+..|.++++|++|+|++|.++ +..+..|..+++|++|++++|.++. +|..+. ++|++|+|++|.+
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~--l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT--IPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS--CCSSCC--TTCSEEECTTSCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc--CCcccc--ccCCEEECCCCcC
Confidence 666666555556666666777777766664 2555666666667777777776653 444332 5677777777777
Q ss_pred ccCCC-CCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhh
Q 002178 264 QGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341 (956)
Q Consensus 264 ~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 341 (956)
++..+ .+..+++|+.|+|++|.+++..+..+.. .+|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 66544 3666677777777777776544433322 36777777777776 566667777777777777777775555555
Q ss_pred hhhcc-CCCCcceEEEccCCCCCCC--C-CCC-CCCCCcEEEecCC
Q 002178 342 WQSRT-LNATETFILDFQNNNLTNI--S-GSF-NIPPNVTVRLRGN 382 (956)
Q Consensus 342 ~~l~~-l~~~~L~~L~L~~N~L~~l--~-~~~-~~~~l~~l~l~~N 382 (956)
..... .....+..|++++|.++.. + ..+ .+..+..++|++|
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 33211 1234566777777777642 2 223 2566677777776
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=309.69 Aligned_cols=290 Identities=19% Similarity=0.214 Sum_probs=200.9
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|||++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 68999999999999888889999999999999999999888999999999999999999999 67766 8999999999
Q ss_pred ccccccC-CCCccccccccCCeeecccCcCCCCCccccCCCccc--ceeccccccc--CCCCCcccCCcc----------
Q 002178 162 DQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL--VHMLLDNNNL--TGYLPPELSELP---------- 226 (956)
Q Consensus 162 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~---------- 226 (956)
++|.+++ .+|..|+++++|++|+|++|.+++ ..+..+++| ++|+|++|++ .+..|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9999997 478999999999999999999875 344555555 6666666666 444444444321
Q ss_pred -------------------------------------------------------------------------hhhhhcc
Q 002178 227 -------------------------------------------------------------------------KLLILQL 233 (956)
Q Consensus 227 -------------------------------------------------------------------------~L~~L~L 233 (956)
+|++|+|
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 3444455
Q ss_pred cCCcCCCCCCcccc-----------------------------------------------------cCCCCCcEEeccC
Q 002178 234 DNNNFEGTTIPASY-----------------------------------------------------SNMSKLLKLSLRN 260 (956)
Q Consensus 234 s~N~l~~~~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~ 260 (956)
++|.++| .+|..+ ..+++|++|++++
T Consensus 255 ~~n~l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~ 333 (520)
T 2z7x_B 255 SNVKLQG-QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333 (520)
T ss_dssp EEEEEES-CCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCS
T ss_pred ecccccC-ccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeEC
Confidence 5555544 344433 3445555555555
Q ss_pred CCCccCCC-CCCCCCCccEEEccCCcCCc--CCCCCCC-ccccCEEEccCCcCCCCCch-hcCCCCcCCeEecccccCCC
Q 002178 261 CSLQGPMP-DLSRIPNLGYLDLSSNQLNG--SIPPGRL-SLNITTIKLSNNKLTGTIPS-NFSGLPRLQRLFIANNSLSG 335 (956)
Q Consensus 261 N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~--~~p~~~~-~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~ 335 (956)
|++++..+ .+..+++|++|+|++|++++ .+|..+. ..+|+.|+|++|.+++.+|. .|..+++|+.|+|++|++++
T Consensus 334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 55555322 35555555555555555553 2222211 22555566666655553333 35555566666666666555
Q ss_pred cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 002178 336 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 336 ~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~ 385 (956)
.+|..+. +.|+.|+|++|+|+.+|..+ .++.++.|++++|.+.
T Consensus 414 ~~~~~l~-------~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 414 TIFRCLP-------PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp GGGGSCC-------TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred chhhhhc-------ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC
Confidence 5444331 45677888888888777754 5777888888887754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=306.77 Aligned_cols=147 Identities=17% Similarity=0.212 Sum_probs=123.8
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
+.+++++++|++ +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 679999999996 776664 89999999999999888889999999999999999999988999999999999999999
Q ss_pred cccCCCCccccccccCCeeecccCcCCC-CCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (956)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++.....+..+ +|++|+|++|.+
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l 181 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSY 181 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccc
Confidence 999 56666 89999999999999997 457899999999999999999875322222222 225555555555
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=282.65 Aligned_cols=287 Identities=23% Similarity=0.315 Sum_probs=241.6
Q ss_pred CCCCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhh
Q 002178 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~ 136 (956)
..|.|.|+.+.|...... ....+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 456678999999765432 2345789999999999988888999999999999999999988899999999999999
Q ss_pred ccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCC--CCCccccCCCcccceeccccccc
Q 002178 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNL 214 (956)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 214 (956)
|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 9999999 6776665 89999999999999877788999999999999999996 4678888888 999999999999
Q ss_pred CCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCC
Q 002178 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG 293 (956)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~ 293 (956)
++ +|..+. ++|++|+|++|.+++ ..+..|.++++|+.|+|++|++++.++ .+..+++|+.|+|++|+++ .+|..
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCC-CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 96 555554 789999999999987 466789999999999999999999877 4889999999999999999 77776
Q ss_pred CCc-cccCEEEccCCcCCCCCchhcCCC------CcCCeEecccccCC--CcCChhhhhhccCCCCcceEEEccCCC
Q 002178 294 RLS-LNITTIKLSNNKLTGTIPSNFSGL------PRLQRLFIANNSLS--GSIPSSIWQSRTLNATETFILDFQNNN 361 (956)
Q Consensus 294 ~~~-~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~l~~~~L~~L~L~~N~ 361 (956)
+.. .+|+.|+|++|+|++..+..|..+ ++|+.|++++|.+. +..|..|..+.. |+.|+|++|+
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~-----L~~l~l~~n~ 331 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD-----RLAIQFGNYK 331 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCC-----STTEEC----
T ss_pred hhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccch-----hhhhhccccc
Confidence 543 489999999999998888888764 67999999999998 556666655444 4589998884
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=280.83 Aligned_cols=288 Identities=23% Similarity=0.301 Sum_probs=229.1
Q ss_pred CCCCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhh
Q 002178 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~ 136 (956)
..|.|.|+.+.|...... .....++.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+
T Consensus 27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 346667899999754332 2345788899999999887777899999999999999999987788899999999999
Q ss_pred ccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCC--CCccccCCCcccceeccccccc
Q 002178 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNL 214 (956)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l 214 (956)
|++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.+.. ..+..+.++++|++|++++|++
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999988 6666654 789999999999987777788999999999999999863 6677888899999999999998
Q ss_pred CCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCC
Q 002178 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG 293 (956)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~ 293 (956)
+. +|..+. ++|++|+|++|.+++ ..+..|.++++|+.|+|++|.+++.++ .+..+++|+.|+|++|+++ .+|..
T Consensus 184 ~~-l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 258 (330)
T 1xku_A 184 TT-IPQGLP--PSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258 (330)
T ss_dssp CS-CCSSCC--TTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-CCcccc--ccCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence 84 555443 789999999999986 467788899999999999999988776 4888899999999999998 67765
Q ss_pred CCc-cccCEEEccCCcCCCCCchhcCCC------CcCCeEecccccCCC--cCChhhhhhccCCCCcceEEEccCCC
Q 002178 294 RLS-LNITTIKLSNNKLTGTIPSNFSGL------PRLQRLFIANNSLSG--SIPSSIWQSRTLNATETFILDFQNNN 361 (956)
Q Consensus 294 ~~~-~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~--~~p~~~~~l~~l~~~~L~~L~L~~N~ 361 (956)
+.. .+|++|+|++|+|++..+..|... +.|+.|++++|.+.. ..|..|.. ...++.++|++|+
T Consensus 259 l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~-----~~~l~~l~L~~N~ 330 (330)
T 1xku_A 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC-----VYVRAAVQLGNYK 330 (330)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT-----CCCGGGEEC----
T ss_pred hccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc-----ccceeEEEecccC
Confidence 543 489999999999998877777643 778899999998863 33445443 3445688988885
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=280.17 Aligned_cols=281 Identities=21% Similarity=0.304 Sum_probs=216.9
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|++++|.+++..+ +..+++|++|+|++|.+++ ++ .+.++++|++|+|++|.+++. +. +..+++|++|+
T Consensus 65 ~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~ 138 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLN 138 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred cCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEE
Confidence 3568888888888875433 8888888888888888874 44 588888888888888888844 33 78888888888
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
+++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++
T Consensus 139 l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 213 (347)
T 4fmz_A 139 LGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213 (347)
T ss_dssp CTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCC
Confidence 88886554443 47888888888888888875444 7788888888888888885433 7778888888888888875
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
. +. +..+++|++|++++|.+++.++ +..+++|++|++++|.+++ ++......+|+.|++++|.+++. ..+..+
T Consensus 214 ~--~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l 286 (347)
T 4fmz_A 214 I--TP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI--SVLNNL 286 (347)
T ss_dssp C--GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred C--ch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC--hhhcCC
Confidence 2 22 7888888899999888887666 8888889999999988884 44444445889999999988865 457888
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcc
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~ 384 (956)
++|+.|+|++|++++..|..+..+. +|+.|+|++|++++++.-..++.+..+++++|++
T Consensus 287 ~~L~~L~L~~n~l~~~~~~~l~~l~-----~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 287 SQLNSLFLNNNQLGNEDMEVIGGLT-----NLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp TTCSEEECCSSCCCGGGHHHHHTCT-----TCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred CCCCEEECcCCcCCCcChhHhhccc-----cCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 8899999999998887777776654 4558999999988887644688888888888875
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=282.43 Aligned_cols=275 Identities=18% Similarity=0.224 Sum_probs=140.4
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCC--CCCCccCCCcccceeeccc
Q 002178 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG--SLPEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~ 163 (956)
.++.++++++. +|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++. ..+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 45666655552 333222 456666666666653222335556666666666665552 1234444455555555555
Q ss_pred ccccCCCCccccccccCCeeecccCcCCCCCc-cccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCC
Q 002178 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (956)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (956)
|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 5554 334444455555555555555443322 33444444444444444444444444444444444444444443212
Q ss_pred CcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCC
Q 002178 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLP 321 (956)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (956)
.|.. +..+++|++|+|++|++++..|..+.. .+|+.|+|++|.+++..+..|..++
T Consensus 167 ~~~~-----------------------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 167 LPDI-----------------------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp ECSC-----------------------CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred chhH-----------------------HhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 2333 444444444444444444332322211 2344444444444444445566666
Q ss_pred cCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCC-CCCcEEEecCCcccccCCcccccCCCCCC
Q 002178 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI-PPNVTVRLRGNPFCLNTNAEQFCGSHSDD 400 (956)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~-~~l~~l~l~~Np~~c~c~~~~~~~~~~~~ 400 (956)
+|+.|+|++|++++..|..+. .+ +.+..|++++|||.|+|.+.+|..|+...
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~---------------------------~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~ 276 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQ---------------------------HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 276 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCC---------------------------CCCTTCCEEECTTCCEECSGGGHHHHHHHHHT
T ss_pred cCCEeECCCCCCcccCHHHHH---------------------------hhhccCCEEEccCCCeecccChHHHHHHHHhh
Confidence 666666666666665554432 23 36788999999999999999998888643
Q ss_pred CcccCcCCCCCCcccc
Q 002178 401 DNEIDRSTNSTLDCRA 416 (956)
Q Consensus 401 ~~~~~~~~~~~~~c~~ 416 (956)
... ......+.|..
T Consensus 277 ~~~--~~~~~~~~C~~ 290 (306)
T 2z66_A 277 RQL--LVEVERMECAT 290 (306)
T ss_dssp GGG--BSCGGGCBEEE
T ss_pred hhh--hccccccccCC
Confidence 322 11233456655
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=283.20 Aligned_cols=281 Identities=18% Similarity=0.208 Sum_probs=231.5
Q ss_pred CCCCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcc--cCCcccccCcccch
Q 002178 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLEL 134 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~ 134 (956)
+.|.|.|++|.|.+.... +.+.+++.|+|++|+++...+..|.++++|++|+|++|+++. .++..+..+++|++
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 568889999999875432 334689999999999996555568999999999999999983 34677888999999
Q ss_pred hhccCcCCCCCCCCccCCCcccceeecccccccCCCC-ccccccccCCeeecccCcCCCCCccccCCCcccceecccccc
Q 002178 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (956)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 213 (956)
|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+.+..+..+..+++|++|+|++|.
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 999999998 678889999999999999999997765 689999999999999999999999999999999999999999
Q ss_pred cCC-CCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCC
Q 002178 214 LTG-YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIP 291 (956)
Q Consensus 214 l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p 291 (956)
+++ .+|..+..+++|++|+|++|.+++ ..|..|.++++|+.|+|++|.+++.++ .+..+++|+.|+|++|++++..|
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCC-cCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 997 678899999999999999999986 567889999999999999999998776 47888899999999998887776
Q ss_pred CCCCc--cccCEEEccCCcCCCCCc--hhcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 292 PGRLS--LNITTIKLSNNKLTGTIP--SNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 292 ~~~~~--~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
..+.. .+|+.|+|++|.+++... ....-+..++.+.+..+.+....|..+.+
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred HHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 65543 267788888887765422 11222344455556666666666665543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=301.39 Aligned_cols=153 Identities=20% Similarity=0.229 Sum_probs=141.2
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
..++.++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46889999888 4566554 89999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCC-CCCcccCCcchhhhhcccCCcCCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
.+++..|..|.++++|++|+|++|.+++..+..++++++|++|+|++|++++ .+|..|+++++|++|+|++|.+++
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9999889999999999999999999998887899999999999999999996 579999999999999999998865
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=282.97 Aligned_cols=272 Identities=20% Similarity=0.202 Sum_probs=195.4
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (956)
-..+++|+.|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|+
T Consensus 41 ~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 120 (390)
T 3o6n_A 41 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120 (390)
T ss_dssp SGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence 34578999999999999854445579999999999999999988888999999999999999999998899999999999
Q ss_pred eeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
+|+|++|+++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++. .+..+++|+.|++++|
T Consensus 121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYN 196 (390)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC----CGGGCTTCSEEECCSS
T ss_pred EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc----ccccccccceeecccc
Confidence 999999999955555679999999999999999998888999999999999999999863 2556677777777777
Q ss_pred CCccCCCC--C---------------CCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCC
Q 002178 262 SLQGPMPD--L---------------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (956)
Q Consensus 262 ~l~~~~~~--l---------------~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (956)
.+++.... + ...++|+.|++++|.+++ ++......+|+.|+|++|.+++..|..|.++++|+
T Consensus 197 ~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (390)
T 3o6n_A 197 LLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD-TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275 (390)
T ss_dssp CCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred cccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcc-cHHHcCCCCccEEECCCCcCCCcChhHccccccCC
Confidence 66542110 0 112345555555555553 22222223555566666655555555555556666
Q ss_pred eEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcc
Q 002178 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 325 ~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~ 384 (956)
.|+|++|++++ +|..+. ..++|+.|+|++|+++.++..+ .++.++.|++++|++
T Consensus 276 ~L~L~~n~l~~-~~~~~~-----~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i 330 (390)
T 3o6n_A 276 RLYISNNRLVA-LNLYGQ-----PIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 330 (390)
T ss_dssp EEECCSSCCCE-EECSSS-----CCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCC
T ss_pred EEECCCCcCcc-cCcccC-----CCCCCCEEECCCCcceecCccccccCcCCEEECCCCcc
Confidence 66666665553 222221 2234455666666666555444 355566666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=281.04 Aligned_cols=278 Identities=17% Similarity=0.153 Sum_probs=183.9
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|+|++|++++. + ++.+++|++|+|++|+|++. + ++++++|++|+|++|++++ +| ++.+++|++|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 4566666666666653 2 66666666666666666642 2 6666666666666666664 33 666666666666
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
++|++++. .+.++++|++|++++|+..+.+ .+..+++|++|++++|++++. | +..+++|+.|++++|.+++.
T Consensus 135 ~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~ 206 (457)
T 3bz5_A 135 ARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL 206 (457)
T ss_dssp TTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee
Confidence 66666653 2566666666666666544444 366677777777777777753 3 66677777777777777652
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc--------ccCEEEccCCcCCCCC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--------NITTIKLSNNKLTGTI 313 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~L~Ls~N~l~~~~ 313 (956)
.++.+++|+.|++++|++++.+ +..+++|+.|++++|++++..+...... +|+.|++++|.+.+.+
T Consensus 207 ----~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 207 ----DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280 (457)
T ss_dssp ----CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEE
T ss_pred ----ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcc
Confidence 3667777777777777777743 6677777777777777775432221111 3455555666555555
Q ss_pred chhcCCCCcCCeEecccccCCCcCChhhhhhccCC---CCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 002178 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN---ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 314 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~---~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
| ++++++|+.|+|++|++.+.+|.....+..+. .+.|+.|+|++|+|++++ -..++.++.|++++|.+.
T Consensus 281 ~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 281 Q--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELD-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp E--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCCC-CTTCTTCSEEECCSSCCC
T ss_pred c--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccccc-cccCCcCcEEECCCCCCC
Confidence 5 46678888888888888887776554444442 356889999999999974 225888999999999865
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=298.39 Aligned_cols=270 Identities=20% Similarity=0.217 Sum_probs=191.9
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
.+.+++.|++++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46889999999999996666668999999999999999998888899999999999999999999999999999999999
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
+|++|.|++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++. .+..+++|+.|++++|.+
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC----CGGGCTTCSEEECCSSCC
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc----ChhhhhhhhhhhcccCcc
Confidence 9999999976666789999999999999999999999999999999999999999863 255677777777777777
Q ss_pred ccCCCC--C---------------CCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeE
Q 002178 264 QGPMPD--L---------------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326 (956)
Q Consensus 264 ~~~~~~--l---------------~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 326 (956)
++.... + ...++|+.|+|++|.+++. +......+|+.|+|++|.+++..|..|.++++|+.|
T Consensus 205 ~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 205 STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp SEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred ccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 653210 0 0012444444555544431 111222245555555555555555555555555555
Q ss_pred ecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcc
Q 002178 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 327 ~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~ 384 (956)
+|++|++++ +|..+.. .+.|+.|+|++|.|+.+|..+ .++.+..|+|++|++
T Consensus 284 ~Ls~N~l~~-l~~~~~~-----l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l 336 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQP-----IPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336 (597)
T ss_dssp ECTTSCCCE-EECSSSC-----CTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCC
T ss_pred ECCCCCCCC-CCccccc-----CCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCC
Confidence 555555543 2222211 233445555555555554443 345555555555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=300.38 Aligned_cols=172 Identities=14% Similarity=0.207 Sum_probs=147.8
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccc
Q 002178 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (956)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (956)
.+.++++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 678888887 4666554 7999999999999988899999999999999999999998889999999999999999999
Q ss_pred cCCCCccccccccCCeeecccCcCCC-CCccccCCCcccceecccccccCCCC-CcccCCcchhhhhcccCCcCCCCCCc
Q 002178 167 SGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYL-PPELSELPKLLILQLDNNNFEGTTIP 244 (956)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (956)
++..+..|+++++|++|+|++|.+++ ..|..++++++|++|+|++|++.+.+ +..|.++++|++|+|++|.+++ ..|
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~ 165 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQS 165 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc-cCh
Confidence 98888889999999999999999986 46788999999999999999955445 4689999999999999999987 567
Q ss_pred ccccCCCCCcEEeccCCC
Q 002178 245 ASYSNMSKLLKLSLRNCS 262 (956)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~ 262 (956)
..+.++++|++|++++|.
T Consensus 166 ~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp TTTTTCSEEEEEEEECSB
T ss_pred hhhhccccCceEecccCc
Confidence 776655444444444333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=283.75 Aligned_cols=277 Identities=25% Similarity=0.345 Sum_probs=158.0
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|+|++|.+++..+ +.++++|++|+|++|.+++..+ +.++++|++|+|++|.+++..+ +.++++|++|+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence 4578999999999887543 8999999999999999986544 8899999999999999986533 88899999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|++|.+++. + .+..+++|++|+++ |.+.+..+ +.++++|++|++++|.+++. ..+..+++|++|++++|.+++
T Consensus 141 l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 141 LSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp EEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc
Confidence 999988853 2 35555555555553 33332211 45555555555555555532 234455555555555555543
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
. .+ ++.+++|+.|++++|.+++. +.+..+++|+.|++++|.+++..+ .....+|+.|+|++|.+++..+ +..+
T Consensus 214 ~-~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l 286 (466)
T 1o6v_A 214 I-TP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGL 286 (466)
T ss_dssp C-GG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred c-cc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCC
Confidence 1 11 44455555555555555442 234444555555555555543322 1122245555555555554332 4445
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcc
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~ 384 (956)
++|+.|+|++|++++..| +.. .++|+.|+|++|++++++.-..++.++.|++++|++
T Consensus 287 ~~L~~L~L~~n~l~~~~~--~~~-----l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l 343 (466)
T 1o6v_A 287 TALTNLELNENQLEDISP--ISN-----LKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKV 343 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGG-----CTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCC
T ss_pred CccCeEEcCCCcccCchh--hcC-----CCCCCEEECcCCcCCCchhhccCccCCEeECCCCcc
Confidence 555555555555543322 221 123334555555554443322344445555554443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-28 Score=282.67 Aligned_cols=281 Identities=27% Similarity=0.346 Sum_probs=159.1
Q ss_pred CcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCccccee
Q 002178 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (956)
Q Consensus 80 ~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (956)
...+++.|++++|.+.+..+ ++++++|++|+|++|++++. +. +.++++|++|+|++|.+++. + .+..+++|++|
T Consensus 88 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L 161 (466)
T 1o6v_A 88 NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQL 161 (466)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEE
T ss_pred ccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEe
Confidence 34689999999999987654 99999999999999999964 43 89999999999999998853 3 35555555555
Q ss_pred e---------------------cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCC
Q 002178 160 Q---------------------IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (956)
Q Consensus 160 ~---------------------Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 218 (956)
+ +++|.+++. ..+..+++|++|++++|.+++..| ++.+++|++|++++|++++.
T Consensus 162 ~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~- 236 (466)
T 1o6v_A 162 SFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI- 236 (466)
T ss_dssp EEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred ecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-
Confidence 4 444444422 224444555555555555443333 44445555555555555432
Q ss_pred CcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccc
Q 002178 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLN 298 (956)
Q Consensus 219 p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 298 (956)
..+..+++|+.|+|++|.+++. +. +..+++|+.|++++|.+++.++ +..+++|+.|++++|++++..+ .....+
T Consensus 237 -~~l~~l~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~ 310 (466)
T 1o6v_A 237 -GTLASLTNLTDLDLANNQISNL--AP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP-ISNLKN 310 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCC--GG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTT
T ss_pred -hhhhcCCCCCEEECCCCccccc--hh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh-hcCCCC
Confidence 2344455555555555555431 11 4455555555555555554433 4455555555555555553222 222235
Q ss_pred cCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEE
Q 002178 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378 (956)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~ 378 (956)
|+.|+|++|++++..| +..+++|+.|++++|++++. ..+.. .++|+.|++++|++++++.-..++.+..|+
T Consensus 311 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~-----l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~ 381 (466)
T 1o6v_A 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLAN-----LTNINWLSAGHNQISDLTPLANLTRITQLG 381 (466)
T ss_dssp CSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTT-----CTTCCEEECCSSCCCBCGGGTTCTTCCEEE
T ss_pred CCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhcc-----CCCCCEEeCCCCccCccchhhcCCCCCEEe
Confidence 5555555555554443 44555555555555555543 12222 233445666666665554433455556666
Q ss_pred ecCCcccc
Q 002178 379 LRGNPFCL 386 (956)
Q Consensus 379 l~~Np~~c 386 (956)
+++|+|..
T Consensus 382 l~~n~~~~ 389 (466)
T 1o6v_A 382 LNDQAWTN 389 (466)
T ss_dssp CCCEEEEC
T ss_pred ccCCcccC
Confidence 66665543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-30 Score=284.04 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=158.5
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCC-cccCCcccc-------cCcccchhhccCcCCCCCCCCcc--CC
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI-SGSIPKEIG-------NIKSLELLLLNGNELTGSLPEEL--GY 152 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l-~~~ip~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~--~~ 152 (956)
+++.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+ ..
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 455666666666 555555444 67777777777 345565554 56777777777777777777665 67
Q ss_pred CcccceeecccccccCCCCcccccc-----ccCCeeecccCcCCCCCccccCCCcccceecccccccCCC--CCccc--C
Q 002178 153 LPKLDRIQIDQNYISGSLPKSFANL-----NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--LPPEL--S 223 (956)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~l--~ 223 (956)
+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .+..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 77777777777777765 6666666 6777777777777766667777777777777777776543 22333 6
Q ss_pred CcchhhhhcccCCcCCCC-CCc-ccccCCCCCcEEeccCCCCccCCC--CCCCCCCccEEEccCCcCCcCCCCCCCcccc
Q 002178 224 ELPKLLILQLDNNNFEGT-TIP-ASYSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI 299 (956)
Q Consensus 224 ~l~~L~~L~Ls~N~l~~~-~~p-~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 299 (956)
.+++|++|+|++|++++. .++ ..+.++++|++|+|++|++++.++ .+..+++|++|+|++|+|+ .+|.... .+|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCc
Confidence 667777777777777631 111 234566777777777777766553 3555667777777777776 5666554 567
Q ss_pred CEEEccCCcCCCCCchhcCCCCcCCeEecccccCCC
Q 002178 300 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (956)
Q Consensus 300 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (956)
+.|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 7777777777655 44 6666666666666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=267.79 Aligned_cols=284 Identities=20% Similarity=0.300 Sum_probs=241.2
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|++.++.+... +.+..+++|++|+|++|++++ ++. +.++++|++|+|++|.++. + +.+..+++|++|+
T Consensus 43 l~~L~~L~l~~~~i~~~--~~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 43 LESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRELY 116 (347)
T ss_dssp HTTCSEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred cccccEEEEeCCccccc--hhhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEEE
Confidence 34689999999998754 358999999999999999995 444 9999999999999999985 4 4699999999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|++|.+++..+ +..+++|+.|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|++|++++|.+++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 99999996543 89999999999999977655544 8999999999999999996544 8899999999999999985
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++. +......+|+.|+|++|.+++. ..+..+
T Consensus 192 --~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l 264 (347)
T 4fmz_A 192 --ISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDL-SPLANLSQLTWLEIGTNQISDI--NAVKDL 264 (347)
T ss_dssp --CGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred --ccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCC-cchhcCCCCCEEECCCCccCCC--hhHhcC
Confidence 333 8899999999999999998766 88899999999999999954 4344445999999999999974 579999
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCC
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN 389 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~ 389 (956)
++|+.|++++|++++. ..+.. .++|+.|+|++|+++..+.. + .++.++.|++++|++.....
T Consensus 265 ~~L~~L~l~~n~l~~~--~~~~~-----l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDI--SVLNN-----LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGGG-----CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCcCEEEccCCccCCC--hhhcC-----CCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 9999999999999964 33444 34567999999999987654 3 58999999999999876433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=269.46 Aligned_cols=235 Identities=17% Similarity=0.214 Sum_probs=139.1
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccc-ccCCCCccccccccCCeee
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-ISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 184 (956)
++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|. ++...+..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 456666666666665555556666666666666666665556666666666666666665 5555556666666666666
Q ss_pred cccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCc
Q 002178 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (956)
|++|.+++..+..+.++++|++|+|++|++++..+..|..+++|++|+|++|.+++ ..+..|.++++|+.|+|++|.++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cCHHHhcCccccCEEECCCCccc
Confidence 66666665556666666666666666666665555556666666666666666653 23334666666666666666666
Q ss_pred cCCC-CCCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 265 GPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 265 ~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
+..+ .+..+++|+.|+|++|++++..+..+. ..+|+.|+|++|.+....+.. .-+..|+.+..+.|.+....|..+.
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 6533 366666666666666666643322222 235666666666665433221 1113345555666777766776653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=288.58 Aligned_cols=140 Identities=18% Similarity=0.222 Sum_probs=117.5
Q ss_pred cCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCC-cCCCCCCCc-cc
Q 002178 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN-GSIPPGRLS-LN 298 (956)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~-~~~p~~~~~-~~ 298 (956)
+..+++|++|++++|.+++......+.++++|++|++++|.+++..+. +..+++|+.|+|++|.++ +.+|..+.. .+
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 556667777777777776532335789999999999999999987764 889999999999999998 567766544 48
Q ss_pred cCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCC
Q 002178 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366 (956)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~ 366 (956)
|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+. +|+.|++++|.++.-.
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT-----SLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT-----TCCEEECCSSCBCCCT
T ss_pred CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhccc-----CCcEEEecCCcccCCC
Confidence 99999999999999999999999999999999999988887776554 4569999999998643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=267.85 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=171.5
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
..++++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..+.++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3577888888888888 77878888888888888888888 78888888888888888888887 667777777777777
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
+|++|++.+.+|..+... ..+..|.++++|++|+|++|.++ .+|..+.++++|++|+|++|.+
T Consensus 156 ~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp EEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCC
T ss_pred ECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCC
Confidence 777777766666554321 11223455666777777777665 4566666666666666666666
Q ss_pred ccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 264 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
++.++.+..+++| +.|+|++|++.+.+|..|.++++|+.|+|++|++.+.+|..+..
T Consensus 219 ~~l~~~l~~l~~L-----------------------~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~ 275 (328)
T 4fcg_A 219 SALGPAIHHLPKL-----------------------EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR 275 (328)
T ss_dssp CCCCGGGGGCTTC-----------------------CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGG
T ss_pred CcCchhhccCCCC-----------------------CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhc
Confidence 6555445555544 45555555555667778899999999999999999999999876
Q ss_pred hccCCCCcceEEEccCCCCC-CCCCCC-CCCCCcEEEecCCcc
Q 002178 344 SRTLNATETFILDFQNNNLT-NISGSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 344 l~~l~~~~L~~L~L~~N~L~-~l~~~~-~~~~l~~l~l~~Np~ 384 (956)
+.+ |+.|+|++|++. .+|..+ .++.+..+++..|.+
T Consensus 276 l~~-----L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 276 LTQ-----LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CTT-----CCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred CCC-----CCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 654 569999998765 577776 689999999987754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=276.30 Aligned_cols=247 Identities=22% Similarity=0.276 Sum_probs=191.1
Q ss_pred CCCC--CCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchh
Q 002178 62 PCTS--NWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (956)
Q Consensus 62 ~c~~--~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L 135 (956)
.|.| .|..|.|...... +....++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|
T Consensus 38 ~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 38 VCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp SSEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred CCEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 3555 3678999765432 344678999999999999999999999999999999999998888999999999999
Q ss_pred hccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCc-CCCCCccccCCCcccceeccccccc
Q 002178 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDNNNL 214 (956)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l 214 (956)
+|++|++++..+..|..+++|++|+|++|.|+...+..|.++++|++|+|++|. +....+..|.++++|++|+|++|++
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 999999997777789999999999999999998888899999999999999955 4433445788889999999999988
Q ss_pred CCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCC
Q 002178 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 293 (956)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~ 293 (956)
+. +| .+..+++|++|+|++|.+++ ..|..|.++++|+.|+|++|++++..+. |..+++|+.|+|++|+|+
T Consensus 198 ~~-~~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------ 268 (440)
T 3zyj_A 198 RE-IP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT------ 268 (440)
T ss_dssp SS-CC-CCTTCSSCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC------
T ss_pred cc-cc-ccCCCcccCEEECCCCccCc-cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC------
Confidence 84 33 36666677777777777665 3456666666666666666666655443 555555555555555554
Q ss_pred CCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 294 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 294 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
+..+..|..+++|+.|+|++|.+.
T Consensus 269 -----------------~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 269 -----------------LLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp -----------------CCCTTTTSSCTTCCEEECCSSCEE
T ss_pred -----------------ccChhHhccccCCCEEEcCCCCcc
Confidence 445556667777777777777764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=261.37 Aligned_cols=237 Identities=17% Similarity=0.266 Sum_probs=161.1
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccC
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (956)
++++++++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67888888887 566544 357888888888888766677888888888888888887766777777777777777777
Q ss_pred c-CCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC
Q 002178 189 S-ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (956)
Q Consensus 189 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (956)
. +....|..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++ ..+..|.++++|++|+|++|++++.+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc-cCHhHhccCCCccEEECCCCcccccC
Confidence 6 665556667777777777777777776656666666666666666666653 23334555555555555555555444
Q ss_pred CC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhcc
Q 002178 268 PD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346 (956)
Q Consensus 268 ~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 346 (956)
+. +..+++ |+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..+..
T Consensus 170 ~~~~~~l~~-----------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--- 223 (285)
T 1ozn_A 170 ERAFRGLHS-----------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP--- 223 (285)
T ss_dssp TTTTTTCTT-----------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT---
T ss_pred HHHhcCccc-----------------------cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHccc---
Confidence 32 344444 444444444444555667777777777777777777644444432
Q ss_pred CCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCCCC
Q 002178 347 LNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 399 (956)
Q Consensus 347 l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~ 399 (956)
++.++.|++++|||.|+|.+.++..|+..
T Consensus 224 ------------------------l~~L~~L~l~~N~~~c~~~~~~~~~~l~~ 252 (285)
T 1ozn_A 224 ------------------------LRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (285)
T ss_dssp ------------------------CTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred ------------------------CcccCEEeccCCCccCCCCcHHHHHHHHh
Confidence 45667888999999999999888777643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=276.53 Aligned_cols=248 Identities=22% Similarity=0.251 Sum_probs=200.5
Q ss_pred CCCCCC--CCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccch
Q 002178 61 DPCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (956)
Q Consensus 61 ~~c~~~--w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~ 134 (956)
..|.|. |..|.|.+.... +.+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++
T Consensus 48 ~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 127 (452)
T 3zyi_A 48 SVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNT 127 (452)
T ss_dssp TTSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCE
Confidence 456553 578999765432 34468999999999999999999999999999999999999888899999999999
Q ss_pred hhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccC-cCCCCCccccCCCcccceecccccc
Q 002178 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLDNNN 213 (956)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~ 213 (956)
|+|++|++++..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+
T Consensus 128 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp EECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 999999999888888999999999999999999777889999999999999995 4554444578899999999999999
Q ss_pred cCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCC
Q 002178 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP 292 (956)
Q Consensus 214 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~ 292 (956)
+++. | .+..+++|++|+|++|.+++ ..|..|.++++|+.|+|++|++++..+. |..+++|+.|+|++|+|+
T Consensus 208 l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~----- 279 (452)
T 3zyi_A 208 IKDM-P-NLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS----- 279 (452)
T ss_dssp CSSC-C-CCTTCTTCCEEECTTSCCSE-ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-----
T ss_pred cccc-c-cccccccccEEECcCCcCcc-cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC-----
Confidence 9854 3 57778888888888888876 4677788888888888888887776553 666666666666666665
Q ss_pred CCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 293 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
+..+..|..+++|+.|+|++|.+.
T Consensus 280 ------------------~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 280 ------------------SLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ------------------CCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ------------------ccChHHhccccCCCEEEccCCCcC
Confidence 334445666777777777777665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=286.35 Aligned_cols=285 Identities=26% Similarity=0.319 Sum_probs=230.9
Q ss_pred CCCCCCCCCCCCCCCceeecCCCCC-CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCccc
Q 002178 54 LSNWNRGDPCTSNWTGVLCFNTTMD-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL 132 (956)
Q Consensus 54 l~~W~~~~~c~~~w~gv~C~~~~~~-~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L 132 (956)
+++|....+|| .|+|..|...... .....++.|++++++|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|
T Consensus 12 w~~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L 83 (622)
T 3g06_A 12 WSAWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL 83 (622)
T ss_dssp HHHHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC
T ss_pred HHHHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC
Confidence 45687666665 6876433111000 00124789999999998 6777776 89999999999999 5775 57899
Q ss_pred chhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceeccccc
Q 002178 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (956)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 212 (956)
++|+|++|+|+ .+|. .+++|++|+|++|+|++. |. .+++|+.|+|++|+|++ +|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC
Confidence 99999999999 5666 779999999999999954 44 67899999999999995 5654 489999999999
Q ss_pred ccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCC
Q 002178 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292 (956)
Q Consensus 213 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 292 (956)
++++ +|. .+++|+.|+|++|.+++ +| ..+++|+.|+|++|++++.+.. +++|+.|++++|.++ .+|.
T Consensus 152 ~l~~-l~~---~~~~L~~L~L~~N~l~~--l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~ 218 (622)
T 3g06_A 152 QLAS-LPA---LPSELCKLWAYNNQLTS--LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA 218 (622)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred cCCC-cCC---ccCCCCEEECCCCCCCC--Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC
Confidence 9996 443 34689999999999985 55 5578999999999999986653 479999999999999 5665
Q ss_pred CCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CC
Q 002178 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NI 371 (956)
Q Consensus 293 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~ 371 (956)
. ..+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. ..++|+.|+|++|+|+.+|..+ .+
T Consensus 219 ~--~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~--------~~~~L~~L~Ls~N~L~~lp~~l~~l 283 (622)
T 3g06_A 219 L--PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM--------LPSGLLSLSVYRNQLTRLPESLIHL 283 (622)
T ss_dssp C--CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC--------CCTTCCEEECCSSCCCSCCGGGGGS
T ss_pred C--CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc--------ccccCcEEeCCCCCCCcCCHHHhhc
Confidence 3 3589999999999996 55 56789999999999999 4665 2356789999999999998877 58
Q ss_pred CCCcEEEecCCcccc
Q 002178 372 PPNVTVRLRGNPFCL 386 (956)
Q Consensus 372 ~~l~~l~l~~Np~~c 386 (956)
+.+..|+|++|++..
T Consensus 284 ~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 284 SSETTVNLEGNPLSE 298 (622)
T ss_dssp CTTCEEECCSCCCCH
T ss_pred cccCEEEecCCCCCC
Confidence 999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-27 Score=282.80 Aligned_cols=176 Identities=18% Similarity=0.207 Sum_probs=139.5
Q ss_pred CCCCCCCCCCCCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcc
Q 002178 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131 (956)
Q Consensus 52 ~~l~~W~~~~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~ 131 (956)
..+++|+..-|.+ |..-.|... -...+-++.+|+ .+|..+. +++++|||++|+|++..+.+|.++++
T Consensus 11 ~~~~~~~~~~p~~--~~~c~~~~~--------~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~ 77 (635)
T 4g8a_A 11 DKLAAANSSIPES--WEPCVEVVP--------NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPE 77 (635)
T ss_dssp ----------------CCSEEEET--------TTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred chhhcccCCCCCC--CCCccccCC--------CCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCC
Confidence 3466676655543 655444322 123566666777 4566553 47999999999999877889999999
Q ss_pred cchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccc
Q 002178 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (956)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (956)
|++|||++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++
T Consensus 78 L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 78 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 157 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecccc
Confidence 99999999999988888999999999999999999988888899999999999999999987778899999999999999
Q ss_pred cccCC-CCCcccCCcchhhhhcccCCcCCC
Q 002178 212 NNLTG-YLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 212 N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|++++ ..|..+..+++|++|+|++|++++
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CccccCCCchhhccchhhhhhcccCccccc
Confidence 99986 467888999999999999998864
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-29 Score=274.03 Aligned_cols=248 Identities=20% Similarity=0.269 Sum_probs=134.9
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCC-CCCCCCccC-------CCcccceeecccccccCCCCccc
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL-TGSLPEELG-------YLPKLDRIQIDQNYISGSLPKSF 174 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~ 174 (956)
+..++|+.|++++|.+ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 4455666666666666 456555543 66666666666 334554444 56666666666666666666654
Q ss_pred --cccccCCeeecccCcCCCCCccccCCC-----cccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC-CCccc
Q 002178 175 --ANLNKTRHFHMNNNSISGQIPPELSRL-----PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPAS 246 (956)
Q Consensus 175 --~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~p~~ 246 (956)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|..+++|++|+|++|++.+. ..+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 6666666666666666655 5555554 5666666666666665556666666666666666665431 01222
Q ss_pred c--cCCCCCcEEeccCCCCccCCC---C-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 247 Y--SNMSKLLKLSLRNCSLQGPMP---D-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 247 ~--~~l~~L~~L~Ls~N~l~~~~~---~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
+ .++++|++|+|++|++++.+. . +..+++|++|+|++|++++.+|. ..+..+
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----------------------~~~~~l 252 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA----------------------PSCDWP 252 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC----------------------SCCCCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch----------------------hhhhhc
Confidence 2 555566666666665553211 1 23445555555555555544432 233344
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
++|++|+|++|+|+ .+|..+. ++|+.|||++|+|+++|.-..++.++.|++++|++.
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~-------~~L~~L~Ls~N~l~~~p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP-------AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC-------SEEEEEECCSSCCCSCCCTTTSCEEEEEECTTCTTT
T ss_pred CCCCEEECCCCccC-hhhhhcc-------CCceEEECCCCCCCCChhHhhCCCCCEEeccCCCCC
Confidence 45555555555554 4444331 234455555555555543223555555555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=274.38 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=204.5
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCccc-------------chhhccCcCCCCCCCC
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL-------------ELLLLNGNELTGSLPE 148 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 148 (956)
.+++.|+++++++ |.+|++|++|++|++|+|++|+++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4789999999999 8999999999999999999999999999999998875 999999999995 454
Q ss_pred ccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchh
Q 002178 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228 (956)
Q Consensus 149 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 228 (956)
. .++|++|+|++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|+|++|++++ +| .|+.+++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3789999999999997 6654 4789999999999985 3332 2699999999999997 66 69999999
Q ss_pred hhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCc
Q 002178 229 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308 (956)
Q Consensus 229 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 308 (956)
++|++++|++++ +|..+ .+|++|++++|++++.+ .+..+++|+.|++++|++++ +|... .+|+.|++++|.
T Consensus 156 ~~L~l~~N~l~~--lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~ 226 (454)
T 1jl5_A 156 KIIDVDNNSLKK--LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNI 226 (454)
T ss_dssp CEEECCSSCCSC--CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSC
T ss_pred CEEECCCCcCcc--cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCc
Confidence 999999999985 55543 58999999999999854 79999999999999999985 55433 489999999999
Q ss_pred CCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccc
Q 002178 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c 386 (956)
++ .+| .|..+++|+.|++++|++++ +|.. ..+|+.|++++|+++++|.. .+.++.|++++|.+..
T Consensus 227 l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~--------~~~L~~L~l~~N~l~~l~~~--~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 227 LE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL--------PPSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC--------CTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSE
T ss_pred CC-ccc-ccCCCCCCCEEECCCCcCCc-cccc--------ccccCEEECCCCcccccCcc--cCcCCEEECcCCccCc
Confidence 99 566 48999999999999999985 5542 24677899999999887764 3678888888887653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=270.68 Aligned_cols=256 Identities=18% Similarity=0.157 Sum_probs=210.9
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+
T Consensus 51 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 45899999999999987777999999999999999999988888999999999999999999966556699999999999
Q ss_pred cccccccCCCC-ccccccccCCeeecccC-cCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcC
Q 002178 161 IDQNYISGSLP-KSFANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (956)
Q Consensus 161 Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (956)
|++|++++..+ ..|.++++|++|++++| .+....+..|.++++|++|++++|++++..|..|..+++|++|+|++|.+
T Consensus 131 L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred CCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 99999995544 58999999999999999 47766678899999999999999999999999999999999999999999
Q ss_pred CCCCCcc-cccCCCCCcEEeccCCCCccCCCC----CCCCCCccEEEccCCcCCcC----CCCCCC-ccccCEEEccCCc
Q 002178 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLNGS----IPPGRL-SLNITTIKLSNNK 308 (956)
Q Consensus 239 ~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~----l~~l~~L~~L~Ls~N~l~~~----~p~~~~-~~~L~~L~Ls~N~ 308 (956)
+. +|. .+..+++|+.|+|++|.+++.... ......++.++|++|.+++. +|..+. ..+|+.|+|++|+
T Consensus 211 ~~--~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~ 288 (353)
T 2z80_A 211 IL--LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQ 288 (353)
T ss_dssp TT--HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSC
T ss_pred cc--chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCC
Confidence 74 454 456689999999999999986543 33456788888888877642 333222 2367777777777
Q ss_pred CCCCCchhcCCCCcCCeEecccccCCCcCC
Q 002178 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338 (956)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 338 (956)
++...+..|.++++|++|+|++|++.+..|
T Consensus 289 l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 289 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 774433445777777777777777776554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-26 Score=262.60 Aligned_cols=264 Identities=27% Similarity=0.317 Sum_probs=146.4
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|++++|.+++ +|.. +++|++|+|++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 467777777777776 4432 3566666666666663 2211 1466666666666664 55 4666666666666
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|++|++++|.++
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-- 228 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-- 228 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS--
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC--
Confidence 6666664 34332 366666666666664 44 46666666666666666664 33222 35666666666665
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCC--CCchh---
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTG--TIPSN--- 316 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~--~~p~~--- 316 (956)
.+| .+..+++|++|++++|++++.+.. +++|+.|++++|++++ +|... .+|+.|++++|++++ ..|..
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l~~~~~~L~~ 301 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGLSELPPNLYY 301 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEESCCCTTCCE
T ss_pred ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcccCcCCcCCE
Confidence 244 256666666666666666654331 2455566666665553 33321 345555555555554 11110
Q ss_pred ----------cCCC-CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 002178 317 ----------FSGL-PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 317 ----------~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
+..+ ++|+.|++++|++++ +|.. .+.|+.|+|++|+++++|. .++.++.|++++|++.
T Consensus 302 L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~--------~~~L~~L~L~~N~l~~lp~--~l~~L~~L~L~~N~l~ 370 (454)
T 1jl5_A 302 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL--------PPRLERLIASFNHLAEVPE--LPQNLKQLHVEYNPLR 370 (454)
T ss_dssp EECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC--------CTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCS
T ss_pred EECcCCcCCcccCCcCcCCEEECCCCcccc-cccc--------CCcCCEEECCCCccccccc--hhhhccEEECCCCCCC
Confidence 1122 356666666666654 4432 1345566666666666655 3556666666666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=268.25 Aligned_cols=274 Identities=21% Similarity=0.180 Sum_probs=225.9
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|+++++++++. | .++.+++|++|+|++|++++ +| ++++++|++|+|++|++++. + ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 35789999999999975 4 79999999999999999996 44 89999999999999999974 4 89999999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|++|++++. + +..+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|++|+|++|++++
T Consensus 113 L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 113 CDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 999999974 4 89999999999999999974 3 889999999999999766666 58889999999999999986
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
+| +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| .....+|+.|++++|++++..+..+.+|
T Consensus 185 --l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~~~~~~l~~L 256 (457)
T 3bz5_A 185 --LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELDVSTLSKL 256 (457)
T ss_dssp --CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred --ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence 34 88999999999999999987 48899999999999999996 66 3334589999999999998876666666
Q ss_pred C-------cCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCC-CCCCC--------C-CCCCCcEEEecCCc
Q 002178 321 P-------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGS--------F-NIPPNVTVRLRGNP 383 (956)
Q Consensus 321 ~-------~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~-~l~~~--------~-~~~~l~~l~l~~Np 383 (956)
. +|+.|++++|++.|.+|. . ..++|+.|+|++|.+. .+|.. + ..+.++.|++++|.
T Consensus 257 ~~L~l~~n~L~~L~l~~n~~~~~~~~--~-----~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~ 329 (457)
T 3bz5_A 257 TTLHCIQTDLLEIDLTHNTQLIYFQA--E-----GCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTE 329 (457)
T ss_dssp CEEECTTCCCSCCCCTTCTTCCEEEC--T-----TCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCC
T ss_pred CEEeccCCCCCEEECCCCccCCcccc--c-----ccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCc
Confidence 5 567777777777777663 2 2356778899988642 22221 1 35677778888776
Q ss_pred cc
Q 002178 384 FC 385 (956)
Q Consensus 384 ~~ 385 (956)
+.
T Consensus 330 l~ 331 (457)
T 3bz5_A 330 LT 331 (457)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-28 Score=283.15 Aligned_cols=228 Identities=24% Similarity=0.218 Sum_probs=187.5
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.|++.. ..++|+.
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence 344589999999999998888899999999999999999987665 889999999999999998433 3388999
Q ss_pred eecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCccccc-CCCCCcEEeccCC
Q 002178 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS-NMSKLLKLSLRNC 261 (956)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-~l~~L~~L~Ls~N 261 (956)
|+|++|.|++..+. .+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++ ..|..+. ++++|+.|+|++|
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~~l~~L~~L~Ls~N 179 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSDTLEHLNLQYN 179 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-EEGGGGGGGTTTCCEEECTTS
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-cChHHHhhhCCcccEEecCCC
Confidence 99999999976554 45789999999999998888889999999999999999987 4666665 7899999999999
Q ss_pred CCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC-CcCChh
Q 002178 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS-GSIPSS 340 (956)
Q Consensus 262 ~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~ 340 (956)
.+++.++ +..+++|+.|+|++|.|++..|......+|+.|+|++|.|++ +|..+..+++|+.|+|++|.+. +.+|..
T Consensus 180 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 180 FIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 9988743 446889999999999998655543334488899999998885 6777888888999999988887 556655
Q ss_pred hhh
Q 002178 341 IWQ 343 (956)
Q Consensus 341 ~~~ 343 (956)
+..
T Consensus 258 ~~~ 260 (487)
T 3oja_A 258 FSK 260 (487)
T ss_dssp HTT
T ss_pred HHh
Confidence 544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=254.20 Aligned_cols=232 Identities=18% Similarity=0.220 Sum_probs=120.6
Q ss_pred CCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecc
Q 002178 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (956)
Q Consensus 107 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (956)
+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 56666666666665444455556666666666666554444455555555555555555554444444445555555554
Q ss_pred cCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC
Q 002178 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (956)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (956)
+|.++ +..+..+..+++|++|+|++|.+++..+|..|.++++|++|+|++|++++.
T Consensus 109 ~n~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 109 ETNLA------------------------SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp TSCCC------------------------CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCcc------------------------ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 44444 433334444455555555555554333455555555555555555555554
Q ss_pred CCC-CCCCCCcc----EEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhh
Q 002178 267 MPD-LSRIPNLG----YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341 (956)
Q Consensus 267 ~~~-l~~l~~L~----~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 341 (956)
++. +..+++|+ .|++++|.++ +..+..+.. .+|+.|+|++|++++..+..+
T Consensus 165 ~~~~~~~l~~L~~l~l~L~ls~n~l~-----------------------~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~ 220 (276)
T 2z62_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-----------------------FIQPGAFKE-IRLKELALDTNQLKSVPDGIF 220 (276)
T ss_dssp CGGGGHHHHTCTTCCEEEECCSSCCC-----------------------EECTTSSCS-CCEEEEECCSSCCSCCCTTTT
T ss_pred CHHHhhhhhhccccceeeecCCCccc-----------------------ccCccccCC-CcccEEECCCCceeecCHhHh
Confidence 332 32222332 4555555544 222222222 245555555555553322222
Q ss_pred hhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCC-cccccCCCCCCCcccCcCCCCCCccccC
Q 002178 342 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNEIDRSTNSTLDCRAQ 417 (956)
Q Consensus 342 ~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~-~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 417 (956)
. .++.++.|++++|||.|+|+ +.+++.|....... ......|.++
T Consensus 221 ~---------------------------~l~~L~~L~l~~N~~~c~c~~l~~l~~~~~~~~~~----~~~~~~C~~~ 266 (276)
T 2z62_A 221 D---------------------------RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK----EQGSAKCSGS 266 (276)
T ss_dssp T---------------------------TCCSCCEEECCSSCBCCCTTTTHHHHHHHHHTGGG----BCSCCBBTTT
T ss_pred c---------------------------ccccccEEEccCCcccccCCchHHHHHHHHhcccc----cCCCceeeCC
Confidence 1 14455677788889999995 67777777544322 2223466653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-28 Score=287.25 Aligned_cols=184 Identities=18% Similarity=0.104 Sum_probs=129.2
Q ss_pred eeeeCCeEEEEEE-eCCCcEEEEEEecCCC----------hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEEE
Q 002178 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS----------LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 632 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
.+.|++|.+..++ ..-|+.||||++.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5666666666554 2358899999986532 12235799999999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||++|++|.+++.+.+ +++.. +|+.||+.||+|+|++| ||||||||+|||++++|++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999997654 35443 58999999999999999 9999999999999999999999999998764321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~p 831 (956)
.......||++|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 394 -------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 223456799999999999764 57789999999998887665443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=247.83 Aligned_cols=219 Identities=22% Similarity=0.251 Sum_probs=132.6
Q ss_pred cCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhh
Q 002178 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229 (956)
Q Consensus 150 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 229 (956)
+.++++|+++++++|.++ .+|..+. ++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+ ...+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 455666777777777776 3444332 466666666666665556666666666666666666664322 14555555
Q ss_pred hhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCc
Q 002178 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308 (956)
Q Consensus 230 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 308 (956)
+|+|++|+++ .+|..+.++++|++|+|++|++++.++. |..+++|++|+|++| +
T Consensus 81 ~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N-----------------------~ 135 (290)
T 1p9a_G 81 TLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN-----------------------E 135 (290)
T ss_dssp EEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS-----------------------C
T ss_pred EEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC-----------------------C
Confidence 5555555554 3444555555555555555555554432 444555555555554 4
Q ss_pred CCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccccc
Q 002178 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 387 (956)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~c~ 387 (956)
|++..+..|..+++|+.|+|++|+|++..+..|..+ ++|+.|+|++|+|+.+|..+ ..+.+..++|++|||.|+
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l-----~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL-----ENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC-----TTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCc-----CCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 444445555666666666666666664333333332 23446666666666666654 466788999999999999
Q ss_pred CCcccccCCCCCCCcc
Q 002178 388 TNAEQFCGSHSDDDNE 403 (956)
Q Consensus 388 c~~~~~~~~~~~~~~~ 403 (956)
|++.+|..|+..+...
T Consensus 211 c~~~~l~~wl~~~~~~ 226 (290)
T 1p9a_G 211 CEILYFRRWLQDNAEN 226 (290)
T ss_dssp GGGHHHHHHHHHTGGG
T ss_pred CccHHHHHHHHhCccc
Confidence 9999999888765543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-27 Score=263.56 Aligned_cols=251 Identities=22% Similarity=0.207 Sum_probs=204.4
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
.+..++++++++...+...+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45556677777765555666778899999999999998888899999999999999999986655 8999999999999
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCC
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (956)
+|++++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..+..+..+++|++|+|++|.+++ .
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~ 159 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-V 159 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE-E
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc-c
Confidence 99998432 4489999999999998665443 6789999999999998888889999999999999999986 3
Q ss_pred Ccccc-cCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCC
Q 002178 243 IPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (956)
Q Consensus 243 ~p~~~-~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (956)
.+..+ ..+++|++|+|++|.+++.+ ....+++|++|+|++|++++..+......+|+.|+|++|+|+ .+|..+..++
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred cHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 45555 57899999999999998874 344588999999999999854444333348999999999998 5677888999
Q ss_pred cCCeEecccccCC-CcCChhhhhhcc
Q 002178 322 RLQRLFIANNSLS-GSIPSSIWQSRT 346 (956)
Q Consensus 322 ~L~~L~L~~N~l~-~~~p~~~~~l~~ 346 (956)
+|+.|+|++|++. +.+|..+..+..
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~ 263 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQR 263 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHH
T ss_pred CCCEEEccCCCccCcCHHHHHhcccc
Confidence 9999999999998 666766655443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=238.17 Aligned_cols=213 Identities=21% Similarity=0.266 Sum_probs=165.8
Q ss_pred CCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCC
Q 002178 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145 (956)
Q Consensus 66 ~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ 145 (956)
.|.|+.|... ...+.+++++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++..
T Consensus 6 ~~~~~~C~c~------~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 6 KKDGGVCSCN------NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp GGGTCSBEEE------TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CCCCCCCEeC------CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 5999999543 135678888888884 565554 6788999999988876666888888999999999888866
Q ss_pred CCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCc
Q 002178 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 225 (956)
Q Consensus 146 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 225 (956)
.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 66667888888888888888887777778888888888888888887777778888888888888888887666667778
Q ss_pred chhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCc
Q 002178 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 288 (956)
++|++|+|++|.+++ ..+..|.++++|++|+|++|++++.++. +..+++|+.|+|++|.+..
T Consensus 157 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 157 TSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccceeEecCCcCcE-eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 888888888888875 3445677777788888888877776664 6667777777777777653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-27 Score=260.62 Aligned_cols=245 Identities=21% Similarity=0.216 Sum_probs=213.9
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|+|++|.+++..+..|..+++|++|+|++|++++..+ +..+++|++|+|++|++++.. ..++|++|+
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~ 105 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH 105 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEE
Confidence 3479999999999999888899999999999999999997654 999999999999999998432 348999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccC-CcchhhhhcccCCcCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS-ELPKLLILQLDNNNFE 239 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~ 239 (956)
+++|++++..+.. +++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|.++
T Consensus 106 l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 9999999665543 67899999999999988888999999999999999999988777774 7899999999999998
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCC-CCCchhc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLT-GTIPSNF 317 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~-~~~p~~~ 317 (956)
+ ++ ....+++|++|+|++|++++.++.+..+++|+.|+|++|+|+ .+|..+. ..+|+.|+|++|.++ +.+|..+
T Consensus 183 ~--~~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~ 258 (317)
T 3o53_A 183 D--VK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (317)
T ss_dssp E--EE-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHH
T ss_pred c--cc-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHH
Confidence 5 33 344589999999999999999888999999999999999999 5666544 348999999999999 7889999
Q ss_pred CCCCcCCeEecc-cccCCCcCCh
Q 002178 318 SGLPRLQRLFIA-NNSLSGSIPS 339 (956)
Q Consensus 318 ~~l~~L~~L~L~-~N~l~~~~p~ 339 (956)
..+++|+.|+++ .+.++|..|.
T Consensus 259 ~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 259 SKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HTCHHHHHHHHHHHHHHHSSSSC
T ss_pred hccccceEEECCCchhccCCchh
Confidence 999999999999 4556665554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=240.18 Aligned_cols=227 Identities=19% Similarity=0.221 Sum_probs=181.9
Q ss_pred CCCCCCCC--ceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccch
Q 002178 61 DPCTSNWT--GVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (956)
Q Consensus 61 ~~c~~~w~--gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~ 134 (956)
|+|.+.+. .+.|.+.... ..+.+++.|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++
T Consensus 1 ~~C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (276)
T 2z62_A 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80 (276)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCE
Confidence 46655444 4778764432 23457999999999999888889999999999999999999877788999999999
Q ss_pred hhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCC-CccccCCCcccceecccccc
Q 002178 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ-IPPELSRLPSLVHMLLDNNN 213 (956)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~ 213 (956)
|+|++|++++..+..|.++++|++|++++|++++..+..+.++++|++|+|++|.+++. +|..+..+++|++|+|++|+
T Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCC
Confidence 99999999988889999999999999999999988887899999999999999999864 68899999999999999999
Q ss_pred cCCCCCcccCCcchhh----hhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCc
Q 002178 214 LTGYLPPELSELPKLL----ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 214 l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 288 (956)
+++..+..|..+++|+ .|++++|.+++ ++.......+|+.|+|++|++++.++. +..+++|+.|+|++|++++
T Consensus 161 l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~--~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCEECGGGGHHHHTCTTCCEEEECCSSCCCE--ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CCcCCHHHhhhhhhccccceeeecCCCcccc--cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 9987777777777776 66777777764 333333334677777777777666554 4566666666666666654
Q ss_pred C
Q 002178 289 S 289 (956)
Q Consensus 289 ~ 289 (956)
.
T Consensus 239 ~ 239 (276)
T 2z62_A 239 S 239 (276)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=270.20 Aligned_cols=235 Identities=21% Similarity=0.207 Sum_probs=210.1
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
..+++.|+|++|++++..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|.+++.. ..++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEE
Confidence 4589999999999999888899999999999999999997665 999999999999999998543 238999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccC-CcchhhhhcccCCcCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS-ELPKLLILQLDNNNFE 239 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~ 239 (956)
|++|.|++..+. .+++|+.|+|++|.+++..|..++.+++|++|+|++|.|++..|..+. .+++|++|+|++|.++
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 999999976654 457899999999999999899999999999999999999998888886 7999999999999998
Q ss_pred CCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCC-CCCchhc
Q 002178 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLT-GTIPSNF 317 (956)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~-~~~p~~~ 317 (956)
+. + .+..+++|+.|+|++|.|++.++.+..+++|+.|+|++|.|++ +|..+. ..+|+.|+|++|.+. +.+|..+
T Consensus 183 ~~--~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 183 DV--K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp EE--E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred cc--c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 63 3 3456999999999999999999999999999999999999995 665543 358999999999998 7788999
Q ss_pred CCCCcCCeEecc
Q 002178 318 SGLPRLQRLFIA 329 (956)
Q Consensus 318 ~~l~~L~~L~L~ 329 (956)
..++.|+.|+++
T Consensus 259 ~~l~~L~~l~~~ 270 (487)
T 3oja_A 259 SKNQRVQTVAKQ 270 (487)
T ss_dssp TTCHHHHHHHHH
T ss_pred HhCCCCcEEecc
Confidence 999999999886
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=232.82 Aligned_cols=213 Identities=23% Similarity=0.276 Sum_probs=104.8
Q ss_pred CCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeeccc
Q 002178 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (956)
Q Consensus 108 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (956)
++.+++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.+
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~----------- 83 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE----------- 83 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSS-----------
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcC-----------
Confidence 445555555555 3443332 34555555555555444444444444444444444444333333344
Q ss_pred CcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC
Q 002178 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (956)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (956)
+++|++|+|++|++++..+..|..+++|++|+|++|.+++ ..+..|.++++|++|+|++|.+++.+
T Consensus 84 -------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 84 -------------LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp -------------CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred -------------CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe-eCHHHhCcCcCCCEEECCCCcCCccC
Confidence 4444444444444443333333444444444444444433 22233444444444444444444433
Q ss_pred CC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhcc
Q 002178 268 PD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346 (956)
Q Consensus 268 ~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 346 (956)
+. +..+++|+.|+|++|.+ ++..+..|.++++|+.|+|++|++++..+..+.
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l-----------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---- 202 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQL-----------------------KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD---- 202 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCC-----------------------SCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT----
T ss_pred HhHccCCcccceeEecCCcC-----------------------cEeChhHhccCCCcCEEECCCCcCCcCCHHHhc----
Confidence 32 33344444444444333 333344556666666666666666643333222
Q ss_pred CCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCC-cccccCCCC
Q 002178 347 LNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN-AEQFCGSHS 398 (956)
Q Consensus 347 l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~-~~~~~~~~~ 398 (956)
.++.+..|++++|||.|+|+ +.++..|+.
T Consensus 203 -----------------------~l~~L~~L~l~~N~~~c~c~~~~~~~~~l~ 232 (270)
T 2o6q_A 203 -----------------------SLEKLKMLQLQENPWDCTCNGIIYMAKWLK 232 (270)
T ss_dssp -----------------------TCTTCCEEECCSSCBCCSSSSSHHHHHHHH
T ss_pred -----------------------cccCCCEEEecCCCeeCCCccHHHHHHHHH
Confidence 24566788899999999997 666666664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=238.50 Aligned_cols=224 Identities=18% Similarity=0.200 Sum_probs=182.2
Q ss_pred CCCCEEEccCCCCcccCCc---ccccCcccchhhccCcCCCCCCCCcc--CCCcccceeecccccccCCCC----ccccc
Q 002178 106 SYLTILDFMWNKISGSIPK---EIGNIKSLELLLLNGNELTGSLPEEL--GYLPKLDRIQIDQNYISGSLP----KSFAN 176 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 176 (956)
..++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578899998887632111 12335679999999999999999998 899999999999999997665 44568
Q ss_pred cccCCeeecccCcCCCCCccccCCCcccceecccccccCCC--C--CcccCCcchhhhhcccCCcCCCCCCcc----ccc
Q 002178 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--L--PPELSELPKLLILQLDNNNFEGTTIPA----SYS 248 (956)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~Ls~N~l~~~~~p~----~~~ 248 (956)
+++|++|+|++|++++..+..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--l~~~~~~l~~ 221 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET--PTGVCAALAA 221 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC--HHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc--hHHHHHHHHh
Confidence 99999999999999988889999999999999999998742 2 2334788999999999999973 343 357
Q ss_pred CCCCCcEEeccCCCCccCC-CCCCCC---CCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCC
Q 002178 249 NMSKLLKLSLRNCSLQGPM-PDLSRI---PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (956)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (956)
++++|++|+|++|++++.. +.+..+ ++|++|+|++|+|+ .+|.... .+|+.|+|++|+|++. |. +..+++|+
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8899999999999999974 445555 79999999999999 7777665 6899999999999865 33 67888899
Q ss_pred eEecccccCCC
Q 002178 325 RLFIANNSLSG 335 (956)
Q Consensus 325 ~L~L~~N~l~~ 335 (956)
.|+|++|+|+.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999988874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-25 Score=264.14 Aligned_cols=190 Identities=14% Similarity=0.187 Sum_probs=145.3
Q ss_pred CCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--------hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
...+.||+|+||+||+|.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 5678888876542211 134589999999999999999766666677788999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999965 4579999999999999999 999999999999999 9999999999876432
Q ss_pred CCCCccccceecccccCCCccccccccc--CCCCCcccchhHHHHHHHHHhCCCCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPI 832 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G~ll~elltg~~pf 832 (956)
...............||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1000000001235679999999999987 66888899999999888888777666
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-27 Score=278.16 Aligned_cols=305 Identities=17% Similarity=0.151 Sum_probs=212.5
Q ss_pred ceeeEEEeCCCCccccCCcCc-CCCC----CCCEEEccCCCCcc----cCCcccccCcccchhhccCcCCCCCCCCcc--
Q 002178 82 LHLRELQLLNLNLSGNLSPEI-GRLS----YLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGSLPEEL-- 150 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l-~~l~----~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~-- 150 (956)
.+++.|+|++|.+++..+..+ ..+. +|++|+|++|+++. .++..+.++++|++|+|++|.+++..+..+
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 357788888887766433332 2344 68888888888773 457777888888888888888764433332
Q ss_pred ---CCCcccceeecccccccCCC----CccccccccCCeeecccCcCCCCCccccC-----CCcccceecccccccCCC-
Q 002178 151 ---GYLPKLDRIQIDQNYISGSL----PKSFANLNKTRHFHMNNNSISGQIPPELS-----RLPSLVHMLLDNNNLTGY- 217 (956)
Q Consensus 151 ---~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~- 217 (956)
..+++|++|+|++|++++.. +..+..+++|++|+|++|.++...+..+. ..++|++|+|++|++++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 22457888888888877533 55566678888888888887754443333 255888888888888864
Q ss_pred ---CCcccCCcchhhhhcccCCcCCCCCC----cccccCCCCCcEEeccCCCCccC-----CCCCCCCCCccEEEccCCc
Q 002178 218 ---LPPELSELPKLLILQLDNNNFEGTTI----PASYSNMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQ 285 (956)
Q Consensus 218 ---~p~~l~~l~~L~~L~Ls~N~l~~~~~----p~~~~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~ 285 (956)
++..+..+++|++|+|++|.+++... +..+..+++|++|+|++|.++.. +..+..+++|+.|+|++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 46667777888888888888764111 22334578888888888888763 3336667888899999988
Q ss_pred CCcCCCCCCC------ccccCEEEccCCcCCCC----CchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEE
Q 002178 286 LNGSIPPGRL------SLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355 (956)
Q Consensus 286 l~~~~p~~~~------~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L 355 (956)
+++..+.... ..+|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..+...-.-..+.|+.|
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L 375 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEE
Confidence 8644332211 13789999999988865 5667777899999999999988766665544222124567899
Q ss_pred EccCCCCC-----CCCCCC-CCCCCcEEEecCCcccc
Q 002178 356 DFQNNNLT-----NISGSF-NIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 356 ~L~~N~L~-----~l~~~~-~~~~l~~l~l~~Np~~c 386 (956)
+|++|+++ .++..+ ..+.++.|++++|++..
T Consensus 376 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp ECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 99999988 455544 47888999999998653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-24 Score=232.58 Aligned_cols=211 Identities=19% Similarity=0.231 Sum_probs=128.1
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (956)
+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 445666666666666665 233 466666666666666666642 3566666666666666666655555566666666
Q ss_pred eeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
+|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++ ..+..|.++++|+.|+|++|
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc-cCHHHhcCCccCCEEECCCC
Confidence 66666666665555556666666666666666665555555556666666666666654 23344555555555555555
Q ss_pred CCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChh
Q 002178 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340 (956)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 340 (956)
++++.++. +..+++|+.|+|++|.+. + .+++|+.|++..|+++|.+|.+
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~-----------------------~-------~~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWD-----------------------C-------TCPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBC-----------------------C-------CTTTTHHHHHHHHHTGGGBBCT
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCcc-----------------------c-------cCcHHHHHHHHHHhCCCcccCc
Confidence 55554443 455555555555555444 2 3456777788888888888877
Q ss_pred hhhhccC
Q 002178 341 IWQSRTL 347 (956)
Q Consensus 341 ~~~l~~l 347 (956)
++.+...
T Consensus 242 ~~~~~~~ 248 (272)
T 3rfs_A 242 AGSVAPD 248 (272)
T ss_dssp TSCBCGG
T ss_pred ccccCCC
Confidence 7665443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-23 Score=244.49 Aligned_cols=240 Identities=25% Similarity=0.313 Sum_probs=200.2
Q ss_pred cceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
+.+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|++|+
T Consensus 60 ~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~ 127 (622)
T 3g06_A 60 PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLW 127 (622)
T ss_dssp CTTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred CCCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence 3589999999999984 555 6799999999999999 5775 67999999999999995 555 678999999
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|++|+|++ +|.. +++|++|+|++|++++ +|. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|.+++
T Consensus 128 L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 128 IFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred CCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC
Confidence 99999995 5553 4899999999999995 454 35789999999999996 55 456899999999999985
Q ss_pred CCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCC
Q 002178 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (956)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (956)
+|.. +++|+.|++++|.++..+.. +++|+.|+|++|+|++ +|. ...+|+.|+|++|+|+. +|. .+
T Consensus 196 --l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp~--~l~~L~~L~Ls~N~L~~-lp~---~~ 260 (622)
T 3g06_A 196 --LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPV--LPSELKELMVSGNRLTS-LPM---LP 260 (622)
T ss_dssp --CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC---CC
T ss_pred --CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CCC--CCCcCcEEECCCCCCCc-CCc---cc
Confidence 4543 57899999999999976643 4789999999999995 662 33589999999999995 554 67
Q ss_pred CcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCC
Q 002178 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (956)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l 365 (956)
++|+.|+|++|+|+ .+|..+..+.+ |+.|+|++|.+++.
T Consensus 261 ~~L~~L~Ls~N~L~-~lp~~l~~l~~-----L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 261 SGLLSLSVYRNQLT-RLPESLIHLSS-----ETTVNLEGNPLSER 299 (622)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGSCT-----TCEEECCSCCCCHH
T ss_pred ccCcEEeCCCCCCC-cCCHHHhhccc-----cCEEEecCCCCCCc
Confidence 89999999999999 78888876554 56999999999864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=227.63 Aligned_cols=202 Identities=24% Similarity=0.275 Sum_probs=119.6
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (956)
++++++|++|++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 456666777777777776 4554443 4666777777776666666666666666666666666643222 5566666
Q ss_pred eeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
+|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhcccccCCCEEECCCC
Confidence 6666666665 455556666666666666666665555556666666666666666654 23344555555555555555
Q ss_pred CCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~------------------------~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC------------------------ccChhhcccccCCeEEeCCCCcc
Confidence 55554443 344555555555555554 33444445556666666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=224.03 Aligned_cols=203 Identities=18% Similarity=0.243 Sum_probs=182.4
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|++.++.+... +.+..+++|++|+|++|.+++ + ..+.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 4689999999988753 468999999999999999996 3 47999999999999999999888888999999999999
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~- 195 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS- 195 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc-
Confidence 9999998888889999999999999999998888888999999999999999998888889999999999999999997
Q ss_pred CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCC
Q 002178 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 295 (956)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 295 (956)
..+..+.++++|+.|+|++|.+.+. +++|+.|+++.|.++|.+|....
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N~~~~~------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred cCHHHHhCCcCCCEEEccCCCcccc------CcHHHHHHHHHHhCCCcccCccc
Confidence 5667789999999999999998754 44788888888888887776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-26 Score=269.78 Aligned_cols=303 Identities=17% Similarity=0.171 Sum_probs=216.0
Q ss_pred ceeeEEEeCCCCccccCCcC-cCCCCCCCEEEccCCCCcc----cCCcccccCcccchhhccCcCCCCCCCCcc-CCCc-
Q 002178 82 LHLRELQLLNLNLSGNLSPE-IGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLP- 154 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 154 (956)
.+++.|+|++++++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 47888888888887654333 6778888999999888874 356677788889999999988875433333 2344
Q ss_pred ---ccceeecccccccC----CCCccccccccCCeeecccCcCCCCCcccc-----CCCcccceecccccccCCCC----
Q 002178 155 ---KLDRIQIDQNYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPEL-----SRLPSLVHMLLDNNNLTGYL---- 218 (956)
Q Consensus 155 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~---- 218 (956)
+|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+ ...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 68899999988874 457788888899999999988875433332 23567889999999888643
Q ss_pred CcccCCcchhhhhcccCCcCCCCCCccccc-----CCCCCcEEeccCCCCccC-----CCCCCCCCCccEEEccCCcCCc
Q 002178 219 PPELSELPKLLILQLDNNNFEGTTIPASYS-----NMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 219 p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~ 288 (956)
+..+..+++|++|+|++|.+++ ..+..+. ..++|++|+|++|.++.. +..+..+++|+.|+|++|.+++
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINE-AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHH-HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHhhCCCCCEEECcCCCcch-HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 4556667888889999888864 2223332 356888999999888763 2235677888899999888874
Q ss_pred CCC----CCC--CccccCEEEccCCcCCCC----CchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEcc
Q 002178 289 SIP----PGR--LSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 358 (956)
Q Consensus 289 ~~p----~~~--~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~ 358 (956)
... ... ...+|++|+|++|.++.. ++..+..+++|++|+|++|++.+..+..+...-.-..+.|+.|+|+
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 321 111 134788999999988864 5677777888999999998887666655554433334567888898
Q ss_pred CCCCCCCC-----CCC-CCCCCcEEEecCCccc
Q 002178 359 NNNLTNIS-----GSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 359 ~N~L~~l~-----~~~-~~~~l~~l~l~~Np~~ 385 (956)
+|.++... ..+ ..+.++.|++++|.+.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 88887642 222 3578888888888653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=219.87 Aligned_cols=191 Identities=20% Similarity=0.271 Sum_probs=111.7
Q ss_pred CCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcC
Q 002178 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (956)
Q Consensus 62 ~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~ 141 (956)
.|+ .|.|..|.. ..+.+++++++++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+
T Consensus 3 ~Cp-~~~gC~C~~--------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 70 (251)
T 3m19_A 3 TCE-TVTGCTCNE--------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ 70 (251)
T ss_dssp -CH-HHHSSEEEG--------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cCC-CCCceEcCC--------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCc
Confidence 354 588999943 2345667766666 3444443 466666666666666555566666666666666666
Q ss_pred CCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcc
Q 002178 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221 (956)
Q Consensus 142 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 221 (956)
+++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+
T Consensus 71 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-- 148 (251)
T 3m19_A 71 LQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA-- 148 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT--
T ss_pred CCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH--
Confidence 666555556666666666666666665555555555555555555555554444444444555555555444443333
Q ss_pred cCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcC
Q 002178 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS 289 (956)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 289 (956)
..|.++++|++|+|++|++++.++ .+..+++|+.|+|++|.+.+.
T Consensus 149 -----------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 149 -----------------------GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp -----------------------TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred -----------------------HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 345555566666666666665555 356666677777777777644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=219.54 Aligned_cols=195 Identities=16% Similarity=0.189 Sum_probs=143.2
Q ss_pred CCCEEEccCCCCcccCCcccccCcccchhhccCcC-CCCCCCCccCCCcccceeeccc-ccccCCCCccccccccCCeee
Q 002178 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 107 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 184 (956)
+|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67788888888776666677777888888888886 7655556777778888888887 777766667777788888888
Q ss_pred cccCcCCCCCccccCCCcccc---eeccccc-ccCCCCCcccCCcchhh-hhcccCCcCCCCCCcccccCCCCCcEEecc
Q 002178 185 MNNNSISGQIPPELSRLPSLV---HMLLDNN-NLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (956)
|++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|+|++|.++ .+|......++|+.|+|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~--~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT--SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC--EECTTTTTTCEEEEEECT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc--ccCHhhcCCCCCCEEEcC
Confidence 88888775 555 77777777 8888888 77766666778888888 8888888886 344433333788888888
Q ss_pred CCC-CccCCCC-CCCC-CCccEEEccCCcCCcCCCCCCCccccCEEEccCC
Q 002178 260 NCS-LQGPMPD-LSRI-PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 307 (956)
Q Consensus 260 ~N~-l~~~~~~-l~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N 307 (956)
+|+ +++.++. |..+ ++|+.|++++|+++ .+|.. ...+|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~-~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK-GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT-TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh-HhccCceeeccCc
Confidence 884 8776654 7777 88888888888887 45554 3347888888776
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=229.76 Aligned_cols=224 Identities=20% Similarity=0.188 Sum_probs=184.6
Q ss_pred eeeEEEeCCCCccccCCc---CcCCCCCCCEEEccCCCCcccCCccc--ccCcccchhhccCcCCCCCCC----CccCCC
Q 002178 83 HLRELQLLNLNLSGNLSP---EIGRLSYLTILDFMWNKISGSIPKEI--GNIKSLELLLLNGNELTGSLP----EELGYL 153 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~---~l~~l~~L~~L~Ls~N~l~~~ip~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l 153 (956)
.++.+.+.++.++...-. .+..+++|++|+|++|++++.+|..+ .++++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467778887777643111 12335679999999999999999988 999999999999999998766 445689
Q ss_pred cccceeecccccccCCCCccccccccCCeeecccCcCCCC--C--ccccCCCcccceecccccccCCCCCc----ccCCc
Q 002178 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ--I--PPELSRLPSLVHMLLDNNNLTGYLPP----ELSEL 225 (956)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~----~l~~l 225 (956)
++|++|+|++|++++..+..|.++++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988899999999999999999998753 2 2334789999999999999973 333 25678
Q ss_pred chhhhhcccCCcCCCCCCcccccCC---CCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEE
Q 002178 226 PKLLILQLDNNNFEGTTIPASYSNM---SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTI 302 (956)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 302 (956)
++|++|+|++|++++ ..|..+..+ ++|++|+|++|+|+..+..+. ++|+.|+|++|+|++ +|......+|+.|
T Consensus 224 ~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~-~~~~~~l~~L~~L 299 (310)
T 4glp_A 224 VQPHSLDLSHNSLRA-TVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNR-APQPDELPEVDNL 299 (310)
T ss_dssp CCCSSEECTTSCCCC-CCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCS-CCCTTSCCCCSCE
T ss_pred CCCCEEECCCCCCCc-cchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCC-CchhhhCCCccEE
Confidence 999999999999997 457777776 699999999999997766664 799999999999995 3443344689999
Q ss_pred EccCCcCCC
Q 002178 303 KLSNNKLTG 311 (956)
Q Consensus 303 ~Ls~N~l~~ 311 (956)
+|++|.|+.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999974
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=223.18 Aligned_cols=193 Identities=22% Similarity=0.394 Sum_probs=110.8
Q ss_pred cCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCccccee
Q 002178 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (956)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 207 (956)
.+++|++|++++|.++ .+| .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. + .+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEE
Confidence 3444444444444444 222 34444444444444444443222 44455555555555554432 2 35555555555
Q ss_pred cccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCC
Q 002178 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 208 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+|++|++++. + .+..+++|++|+|++|.+++ ++. +..+++|+.|+|++|.+++.++ +..+++|+.|++++|+++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITN--ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCc--Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccC
Confidence 5555555542 2 25555666666666666653 222 5666666666666666665444 666677777777777776
Q ss_pred cCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCC
Q 002178 288 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (956)
Q Consensus 288 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (956)
+ ++......+|+.|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 187 ~-~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 187 D-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp C-CGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred c-ChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 3 3332233467777777777776553 7889999999999999874
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=239.85 Aligned_cols=224 Identities=26% Similarity=0.330 Sum_probs=129.6
Q ss_pred CCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecc
Q 002178 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (956)
Q Consensus 107 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (956)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~------------------ 114 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST------------------ 114 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC------------------
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC------------------
Confidence 55555555555553 444332 45555555555555 344 234445555555554443
Q ss_pred cCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC
Q 002178 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (956)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (956)
+|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++.
T Consensus 115 -------ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~L~~l 175 (571)
T 3cvr_A 115 -------LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM--LPE---LPTSLEVLSVRNNQLTFL 175 (571)
T ss_dssp -------CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSCC
T ss_pred -------cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc--CCC---cCCCcCEEECCCCCCCCc
Confidence 333 332 55555555555554 333 34556666666666653 333 456677777777777765
Q ss_pred CCCCCCCCCccEEEccCCcCCcCCCCCCCcccc-------CEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCCh
Q 002178 267 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI-------TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (956)
Q Consensus 267 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 339 (956)
+. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus 176 p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 176 PE-LP--ESLEALDVSTNLLE-SLPA-VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CC-CC--TTCCEEECCSSCCS-SCCC-CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred ch-hh--CCCCEEECcCCCCC-chhh-HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 44 44 67777777777777 6666 333 66 89999999998 5788888899999999999999999999
Q ss_pred hhhhhccCCCC--cceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCC
Q 002178 340 SIWQSRTLNAT--ETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (956)
Q Consensus 340 ~~~~l~~l~~~--~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~ 397 (956)
.+..+...... ....+++++|++.. -.|| .|+|...||-.+.
T Consensus 249 ~l~~l~~~~~~~~~~~~~~l~~~~~~~---------------~~~p-~~~~~~~Wl~~~~ 292 (571)
T 3cvr_A 249 SLSQQTAQPDYHGPRIYFSMSDGQQNT---------------LHRP-LADAVTAWFPENK 292 (571)
T ss_dssp HHHHHHHSCC---CEEECCC-------------------------C-CSHHHHTTCC---
T ss_pred HHHHhhcCccccCCeeEEeeccccccc---------------cccc-chhhHHHHhhhhc
Confidence 99887653211 11123444444432 2456 7999988885544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=214.38 Aligned_cols=202 Identities=19% Similarity=0.198 Sum_probs=131.4
Q ss_pred cchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccc
Q 002178 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (956)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (956)
.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 444555555555 4444433 3555566666666555555566666666666666666655555666666777777777
Q ss_pred cccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCC
Q 002178 212 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSI 290 (956)
Q Consensus 212 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 290 (956)
|+|++..+..|..+++|++|+|++|++++ ..+..|.++++|++|+|++|+|++.++. +..+++|+.|+|++|+|++..
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 77776666667777777777777777775 3455678899999999999999998884 899999999999999999655
Q ss_pred CCCCCc-cccCEEEccCCcCCCCCc------hhcCCCCcCCeEecccccCCCcCC
Q 002178 291 PPGRLS-LNITTIKLSNNKLTGTIP------SNFSGLPRLQRLFIANNSLSGSIP 338 (956)
Q Consensus 291 p~~~~~-~~L~~L~Ls~N~l~~~~p------~~~~~l~~L~~L~L~~N~l~~~~p 338 (956)
+..+.. .+|+.|+|++|.+++... .++.. ...+..+..+|.+.+..+
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~ 225 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRE-NSNKVKDGTGQNLHESPD 225 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHH-SGGGBCC-------CCGG
T ss_pred HHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHh-cccceeeccCcccccCCC
Confidence 544433 489999999999987622 22221 122334556666664433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.8e-25 Score=245.88 Aligned_cols=153 Identities=21% Similarity=0.217 Sum_probs=87.0
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC----cccccCc-ccchhhccCcCCCCCCCCccCCC-----ccc
Q 002178 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP----KEIGNIK-SLELLLLNGNELTGSLPEELGYL-----PKL 156 (956)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 156 (956)
.++++++++|.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566666666666655656667777777777665444 5556666 66677777776666555555554 666
Q ss_pred ceeecccccccCCCCcccccc-----ccCCeeecccCcCCCCCcccc----CC-CcccceecccccccCCCCCcc----c
Q 002178 157 DRIQIDQNYISGSLPKSFANL-----NKTRHFHMNNNSISGQIPPEL----SR-LPSLVHMLLDNNNLTGYLPPE----L 222 (956)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l----~~-l~~L~~L~L~~N~l~~~~p~~----l 222 (956)
++|+|++|.+++..+..+... ++|++|+|++|++++..+..+ .. .++|++|+|++|++++..... +
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 666666666665555433332 566666666666664444332 22 246666666666665432222 2
Q ss_pred CCcc-hhhhhcccCCcCC
Q 002178 223 SELP-KLLILQLDNNNFE 239 (956)
Q Consensus 223 ~~l~-~L~~L~Ls~N~l~ 239 (956)
..++ +|++|+|++|+++
T Consensus 163 ~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HTSCTTCCEEECTTSCGG
T ss_pred hcCCccccEeeecCCCCc
Confidence 2232 4555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-22 Score=223.45 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=183.6
Q ss_pred CCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcC
Q 002178 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (956)
Q Consensus 62 ~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~ 141 (956)
.|.|.|+.|.|.+. +|+ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|+
T Consensus 6 ~C~C~~~~v~C~~~-----------------~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 65 (350)
T 4ay9_X 6 ICHCSNRVFLCQES-----------------KVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65 (350)
T ss_dssp SSEEETTEEEEEST-----------------TCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCT
T ss_pred ccEeeCCEEEecCC-----------------CCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCC
Confidence 37777888888643 343 345554 3578899999999985555678899999999999999
Q ss_pred CCCCCC-CccCCCcccce-eecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccc-cccCCCC
Q 002178 142 LTGSLP-EELGYLPKLDR-IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-NNLTGYL 218 (956)
Q Consensus 142 l~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~ 218 (956)
+.+.+| ..|.++++|++ +.++.|+|+...|..|.++++|++|++++|++....+..+....++..|++.+ |++....
T Consensus 66 i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 876665 46788888765 56677888877788889999999999999999877666777777888888865 5677655
Q ss_pred CcccCCcc-hhhhhcccCCcCCCCCCcccccCCCCCcEEeccC-CCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCC
Q 002178 219 PPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL 295 (956)
Q Consensus 219 p~~l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~ 295 (956)
+..|..+. .++.|+|++|+|+ .++.......+|+.|++++ |.++.++++ |..+++|++|||++|+|+ .+|...+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~--~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~ 222 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ--EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC--EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSC
T ss_pred ccchhhcchhhhhhcccccccc--CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhh
Confidence 66677664 5888888888887 4566555667888888874 667766664 788888999999999888 6665443
Q ss_pred ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccC
Q 002178 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333 (956)
Q Consensus 296 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 333 (956)
.+|+.|.+.++.--..+| .+.++++|+.++++++.-
T Consensus 223 -~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 223 -ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp -TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred -ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 367777766664433555 477888888888876553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=212.73 Aligned_cols=218 Identities=16% Similarity=0.170 Sum_probs=134.4
Q ss_pred CCCCCCC-Cc--eeecCC-CCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCC-CcccCCcccccCcccchh
Q 002178 61 DPCTSNW-TG--VLCFNT-TMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK-ISGSIPKEIGNIKSLELL 135 (956)
Q Consensus 61 ~~c~~~w-~g--v~C~~~-~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~ip~~~~~l~~L~~L 135 (956)
+.|.|.+ .+ |.|.+- ..+.....++.|++++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 3455533 44 447541 111233456677777777766655566677777777777775 665445566667777777
Q ss_pred hccC-cCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC---eeecccC-cCCCCCccccCCCcccc-eecc
Q 002178 136 LLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR---HFHMNNN-SISGQIPPELSRLPSLV-HMLL 209 (956)
Q Consensus 136 ~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~L 209 (956)
+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++|+ +|++++| .+++..+..|..+++|+ +|+|
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 7776 66765555666667777777777777664 444 66666666 7777777 66655555566677777 7777
Q ss_pred cccccCCCCCcccCCcchhhhhcccCCc-CCCCCCcccccCC-CCCcEEeccCCCCccCCCCCCCCCCccEEEccCC
Q 002178 210 DNNNLTGYLPPELSELPKLLILQLDNNN-FEGTTIPASYSNM-SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284 (956)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 284 (956)
++|+++...+..|.. ++|+.|+|++|+ +++ ..+..|.++ ++|+.|+|++|++++.++. .+++|+.|+++++
T Consensus 164 ~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~-i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTV-IDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CSCCCCEECTTTTTT-CEEEEEECTTCTTCCE-ECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCCCcccCHhhcCC-CCCCEEEcCCCCCccc-CCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 777766333333443 667777777774 653 234556666 6777777777777665544 4566666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-24 Score=240.19 Aligned_cols=255 Identities=15% Similarity=0.157 Sum_probs=198.2
Q ss_pred EEEccCCCCcccCCcccccCcccchhhccCcCCCCCCC----CccCCCc-ccceeecccccccCCCCcccccc-----cc
Q 002178 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP----EELGYLP-KLDRIQIDQNYISGSLPKSFANL-----NK 179 (956)
Q Consensus 110 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 179 (956)
.++|++|+++|.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999877777889999999999997776 7788888 99999999999998888888776 99
Q ss_pred CCeeecccCcCCCCCccccCC----C-cccceecccccccCCCCCcccC----C-cchhhhhcccCCcCCCC---CCccc
Q 002178 180 TRHFHMNNNSISGQIPPELSR----L-PSLVHMLLDNNNLTGYLPPELS----E-LPKLLILQLDNNNFEGT---TIPAS 246 (956)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~Ls~N~l~~~---~~p~~ 246 (956)
|++|+|++|.+++..+..+.. + ++|++|+|++|++++..+..+. . .++|++|+|++|.+++. .++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999777765444 4 8999999999999977665543 3 25899999999999742 12334
Q ss_pred ccCCC-CCcEEeccCCCCccCCCC-----CCCC-CCccEEEccCCcCCcC----CCCCCC--ccccCEEEccCCcCCCCC
Q 002178 247 YSNMS-KLLKLSLRNCSLQGPMPD-----LSRI-PNLGYLDLSSNQLNGS----IPPGRL--SLNITTIKLSNNKLTGTI 313 (956)
Q Consensus 247 ~~~l~-~L~~L~Ls~N~l~~~~~~-----l~~l-~~L~~L~Ls~N~l~~~----~p~~~~--~~~L~~L~Ls~N~l~~~~ 313 (956)
+..++ +|++|+|++|++++..+. +... ++|+.|+|++|.|++. ++.... ..+|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45565 999999999999876652 4455 5999999999999853 222222 237999999999998765
Q ss_pred c----hhcCCCCcCCeEecccccCCCcCChhhhhhcc--CCCCcceEEEccCCCCCC
Q 002178 314 P----SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT--LNATETFILDFQNNNLTN 364 (956)
Q Consensus 314 p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--l~~~~L~~L~L~~N~L~~ 364 (956)
+ ..+..+++|+.|+|++|.+.+..+..+..+.. -....|+.|||++|++..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 5 44577889999999999977655554443321 134557788888887764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.5e-22 Score=203.06 Aligned_cols=183 Identities=20% Similarity=0.209 Sum_probs=114.3
Q ss_pred CCCCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhh
Q 002178 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~ 136 (956)
+.|.|.|++|.|...... ....+++.|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 568889999999765322 2234566666666666655555566666666666666666654444556666666666
Q ss_pred ccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCC
Q 002178 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216 (956)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 216 (956)
|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|.+.+
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 66666665555556666666666666666665555556666666666666666665555556666666666666665553
Q ss_pred CCCcccCCcchhhhhcccCCcCCCCCCcccccCCC
Q 002178 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251 (956)
Q Consensus 217 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~ 251 (956)
.+++|++|+++.|.++| .+|..++.++
T Consensus 163 -------~~~~l~~L~~~~n~~~g-~ip~~~~~l~ 189 (208)
T 2o6s_A 163 -------TCPGIRYLSEWINKHSG-VVRNSAGSVA 189 (208)
T ss_dssp -------CTTTTHHHHHHHHHCTT-TBBCTTSSBC
T ss_pred -------CCCCHHHHHHHHHhCCc-eeeccCcccc
Confidence 23456666666666665 4565555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-22 Score=222.71 Aligned_cols=244 Identities=16% Similarity=0.156 Sum_probs=151.0
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCC-ccccccccCCe-eecc
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRH-FHMN 186 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~ 186 (956)
++++.++|+++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|.+ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 46777777777 6676552 567777777777775445567777777777777777765444 35666666654 4455
Q ss_pred cCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC
Q 002178 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (956)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (956)
+|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.++ |++...
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~------------------------~~i~~l 144 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN------------------------INIHTI 144 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC------------------------TTCCEE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc------------------------cccccc
Confidence 56666555666666666666666666666544444444444444444332 233333
Q ss_pred CCC-CCCC-CCccEEEccCCcCCcCCCCCC-CccccCEEEccC-CcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 267 MPD-LSRI-PNLGYLDLSSNQLNGSIPPGR-LSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 267 ~~~-l~~l-~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
++. |..+ ..++.|+|++|+|+ .+|... ...+|+.|++++ |.++...+..|.++++|+.|+|++|+|+...+..+.
T Consensus 145 ~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 145 ERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred cccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 332 3333 24566666666666 344333 334677777764 455555556778888888888888888844333333
Q ss_pred hhccCCCCcceEEEcc-CCCCCCCCCCCCCCCCcEEEecCCcccccCC
Q 002178 343 QSRTLNATETFILDFQ-NNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 389 (956)
Q Consensus 343 ~l~~l~~~~L~~L~L~-~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~ 389 (956)
. |+.|.+. .++++.+|.-..++++..+++. |||.|.|-
T Consensus 224 ~--------L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~~~ 262 (350)
T 4ay9_X 224 N--------LKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHCCAF 262 (350)
T ss_dssp T--------CCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHHHH
T ss_pred c--------chHhhhccCCCcCcCCCchhCcChhhCcCC-CCccccch
Confidence 3 2344433 3567888865578899999985 78888663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-22 Score=216.81 Aligned_cols=154 Identities=12% Similarity=0.055 Sum_probs=123.8
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRL 677 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 677 (956)
...+......|++.+.||+|+||.||+|.+.+|+.||+|.++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344455667777899999999999999997799999999864321 1345788999999999
Q ss_pred CCCceeeeecccccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 678 ~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 9 5 666665543 56699999999999988 421 224569999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCccccccccc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 806 (956)
++ ++.+||+|||+|+.. ..|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~~--------------------~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV--------------------GEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEET--------------------TSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC--------------------CCCCHHHHHHH
Confidence 99 999999999998742 35789998753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-24 Score=241.85 Aligned_cols=209 Identities=16% Similarity=0.189 Sum_probs=133.0
Q ss_pred CCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCC--CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCC
Q 002178 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL--SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143 (956)
Q Consensus 66 ~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~ 143 (956)
.|.++.|... .++.|+++++++. +..+..+ ++++.|++++|.+++..+. +.++++|++|+|++|.++
T Consensus 38 ~W~~~~~~~~-------~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 38 RWYRLASDES-------LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp HHHHHHTCST-------TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHhcCch-------hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 5888887432 3567777777665 3445555 6777777777777765553 556777777777777776
Q ss_pred CC-CCCccCCCcccceeecccccccCCCCccccccccCCeeecccC-cCCCC-CccccCCCcccceeccccc-ccCCC-C
Q 002178 144 GS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN-SISGQ-IPPELSRLPSLVHMLLDNN-NLTGY-L 218 (956)
Q Consensus 144 ~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~ 218 (956)
+. +|..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. +
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~ 186 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence 54 6666777777777777777776666666777777777777777 55542 4555666677777777777 66643 3
Q ss_pred CcccCCcc-hhhhhcccCC--cCCCCCCcccccCCCCCcEEeccCCC-Ccc-CCCCCCCCCCccEEEccCCc
Q 002178 219 PPELSELP-KLLILQLDNN--NFEGTTIPASYSNMSKLLKLSLRNCS-LQG-PMPDLSRIPNLGYLDLSSNQ 285 (956)
Q Consensus 219 p~~l~~l~-~L~~L~Ls~N--~l~~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~l~~l~~L~~L~Ls~N~ 285 (956)
+..+..++ +|++|+|++| .+++..++..+.++++|+.|+|++|. +++ .++.+..+++|+.|+|++|.
T Consensus 187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 45556666 6666666666 34322345555666666666666666 443 23345555666666666553
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-24 Score=243.11 Aligned_cols=240 Identities=19% Similarity=0.253 Sum_probs=137.0
Q ss_pred CCcCcCCCCCCCEEEccCCCCcccCC----cccccCcccchhhccCc---CCCCCCCCcc-------CCCcccceeeccc
Q 002178 98 LSPEIGRLSYLTILDFMWNKISGSIP----KEIGNIKSLELLLLNGN---ELTGSLPEEL-------GYLPKLDRIQIDQ 163 (956)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~ip----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~ 163 (956)
++..+..+++|++|+|++|++++..+ ..+.++++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 45566677778888888887776433 34667778888888775 3444555444 5677777777777
Q ss_pred ccccC----CCCccccccccCCeeecccCcCCCCCccccC----CC---------cccceecccccccC-CCCC---ccc
Q 002178 164 NYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPELS----RL---------PSLVHMLLDNNNLT-GYLP---PEL 222 (956)
Q Consensus 164 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~L~~N~l~-~~~p---~~l 222 (956)
|.+++ .++..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 77775 3566667777777777777777533333222 22 66666666666665 2233 244
Q ss_pred CCcchhhhhcccCCcCCCC----CCcccccCCCCCcEEeccCCCCc----c-CCCCCCCCCCccEEEccCCcCCcC----
Q 002178 223 SELPKLLILQLDNNNFEGT----TIPASYSNMSKLLKLSLRNCSLQ----G-PMPDLSRIPNLGYLDLSSNQLNGS---- 289 (956)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~----~~p~~~~~l~~L~~L~Ls~N~l~----~-~~~~l~~l~~L~~L~Ls~N~l~~~---- 289 (956)
..+++|++|+|++|+++.. ..+..+..+++|+.|+|++|.++ . .+..+..+++|+.|+|++|.+++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 4555666666666665411 12224555666666666666653 1 222345555666666666665533
Q ss_pred CCCCC---CccccCEEEccCCcCCC----CCchhc-CCCCcCCeEecccccCCCcC
Q 002178 290 IPPGR---LSLNITTIKLSNNKLTG----TIPSNF-SGLPRLQRLFIANNSLSGSI 337 (956)
Q Consensus 290 ~p~~~---~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~ 337 (956)
++... ...+|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 12211 12345555555555554 244444 34555555555555555444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=7e-24 Score=241.16 Aligned_cols=242 Identities=18% Similarity=0.270 Sum_probs=182.3
Q ss_pred cCCcccccCcccchhhccCcCCCCCC----CCccCCCcccceeecccc---cccCCCCccc-------cccccCCeeecc
Q 002178 121 SIPKEIGNIKSLELLLLNGNELTGSL----PEELGYLPKLDRIQIDQN---YISGSLPKSF-------ANLNKTRHFHMN 186 (956)
Q Consensus 121 ~ip~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~ 186 (956)
.++..+..+++|++|+|++|.+++.. +..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 57778889999999999999998663 345778999999999996 4555566655 688999999999
Q ss_pred cCcCCC----CCccccCCCcccceecccccccCCCCCcccC----Cc---------chhhhhcccCCcCCCCCCc---cc
Q 002178 187 NNSISG----QIPPELSRLPSLVHMLLDNNNLTGYLPPELS----EL---------PKLLILQLDNNNFEGTTIP---AS 246 (956)
Q Consensus 187 ~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~Ls~N~l~~~~~p---~~ 246 (956)
+|.++. .++..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++...++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 999997 4777888999999999999999754444443 33 7899999999998743455 46
Q ss_pred ccCCCCCcEEeccCCCCc--c---CCC-CCCCCCCccEEEccCCcCC----cCCCCCCC-ccccCEEEccCCcCCCC---
Q 002178 247 YSNMSKLLKLSLRNCSLQ--G---PMP-DLSRIPNLGYLDLSSNQLN----GSIPPGRL-SLNITTIKLSNNKLTGT--- 312 (956)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~--~---~~~-~l~~l~~L~~L~Ls~N~l~----~~~p~~~~-~~~L~~L~Ls~N~l~~~--- 312 (956)
+..+++|++|+|++|.++ + ..+ .+..+++|+.|+|++|.++ +.+|..+. ..+|+.|+|++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 778889999999999887 2 333 6778888999999998885 34554333 23788888888888765
Q ss_pred -Cchhc--CCCCcCCeEecccccCCC----cCChhhhhhccCCCCcceEEEccCCCCCCCC
Q 002178 313 -IPSNF--SGLPRLQRLFIANNSLSG----SIPSSIWQSRTLNATETFILDFQNNNLTNIS 366 (956)
Q Consensus 313 -~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~ 366 (956)
++..+ +.+++|+.|+|++|++++ .+|..+.. +.++|+.|+|++|.++...
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~----~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE----KMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH----HCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh----cCCCceEEEccCCcCCcch
Confidence 45666 338888888888888886 36665522 1234557888888877654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=214.53 Aligned_cols=189 Identities=21% Similarity=0.377 Sum_probs=90.2
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
+++.|++.++++.. ++ .+..+++|++|+|++|++++ ++. +.++++|++|+|++|++++. ..+..+++|++|+|+
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC
Confidence 45555555555543 22 35555555555555555553 222 55555555555555555532 235555555555555
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCC
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (956)
+|++++. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|.+++
T Consensus 116 ~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-- 187 (308)
T 1h6u_A 116 STQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-- 187 (308)
T ss_dssp TSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--
T ss_pred CCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc--
Confidence 5555532 2 14555555555555555543322 4445555555555555553222 4444555555555555543
Q ss_pred CcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCC
Q 002178 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
++. +..+++|++|+|++|++++.++ +..+++|+.|+|++|+++
T Consensus 188 ~~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 188 ISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEE
T ss_pred Chh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeee
Confidence 111 4444444555555444444332 444444444444444443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-22 Score=232.87 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=150.3
Q ss_pred CCCCC-CCCCCC---CCCce-eecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccC
Q 002178 55 SNWNR-GDPCTS---NWTGV-LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129 (956)
Q Consensus 55 ~~W~~-~~~c~~---~w~gv-~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l 129 (956)
.+|.. .++|.. .|.|+ .|... +++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+
T Consensus 34 ~~W~~~~~~~~~~~~~~~~l~~C~~~-------~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l 99 (571)
T 3cvr_A 34 DKWEKQALPGENRNEAVSLLKECLIN-------QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELP 99 (571)
T ss_dssp HHHHTTCCTTCCHHHHHHHHHHHHHT-------TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCC
T ss_pred HHHhccCCccccccchhhhccccccC-------CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---ccc
Confidence 34532 455632 48998 68532 68999999999997 777663 89999999999999 688 557
Q ss_pred cccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecc
Q 002178 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209 (956)
Q Consensus 130 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 209 (956)
++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV 167 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence 999999999999997 777 765 99999999999997 565 67899999999999985 565 5678888888
Q ss_pred cccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCC-------cEEeccCCCCccCCCCCCCCCCccEEEcc
Q 002178 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL-------LKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282 (956)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 282 (956)
++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+.++..+..+++|+.|+|+
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~--~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~ 238 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE--SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILE 238 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS--SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECC
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC--chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEee
Confidence 8888886 555 55 77888888888887 3555 443 55 66666666666555445555566666666
Q ss_pred CCcCCcCCCC
Q 002178 283 SNQLNGSIPP 292 (956)
Q Consensus 283 ~N~l~~~~p~ 292 (956)
+|+|++.+|.
T Consensus 239 ~N~l~~~~p~ 248 (571)
T 3cvr_A 239 DNPLSSRIRE 248 (571)
T ss_dssp SSSCCHHHHH
T ss_pred CCcCCCcCHH
Confidence 6555544443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-23 Score=228.25 Aligned_cols=249 Identities=18% Similarity=0.221 Sum_probs=199.3
Q ss_pred CCCEEEccCCCCcccCCcccccC--cccchhhccCcCCCCCCCCccCCCcccceeecccccccCC-CCccccccccCCee
Q 002178 107 YLTILDFMWNKISGSIPKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHF 183 (956)
Q Consensus 107 ~L~~L~Ls~N~l~~~ip~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 183 (956)
.++.|++++|.+. +..+..+ ++|+.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4789999999987 5677777 8999999999999977666 66899999999999999866 78889999999999
Q ss_pred ecccCcCCCCCccccCCCcccceeccccc-ccCCC-CCcccCCcchhhhhcccCC-cCCCCCCcccccCCC-CCcEEecc
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSNMS-KLLKLSLR 259 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~p~~~~~l~-~L~~L~Ls 259 (956)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++..++..+..++ +|++|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999888999999999999999999 67753 6666888999999999999 887533677889999 99999999
Q ss_pred CCC--Cc--cCCCCCCCCCCccEEEccCCc-CCcCCCCCCC-ccccCEEEccCCc-CCCCCchhcCCCCcCCeEeccccc
Q 002178 260 NCS--LQ--GPMPDLSRIPNLGYLDLSSNQ-LNGSIPPGRL-SLNITTIKLSNNK-LTGTIPSNFSGLPRLQRLFIANNS 332 (956)
Q Consensus 260 ~N~--l~--~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~-~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~ 332 (956)
+|. ++ +.+..+..+++|+.|++++|. +++..+..+. ..+|+.|+|++|. +.......+.++++|+.|+|++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 994 54 233346778999999999999 6655555433 3489999999995 43333336888999999999999
Q ss_pred CCCcCChhhhhhccCCCCcceEEEccCCCCCCCCC
Q 002178 333 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367 (956)
Q Consensus 333 l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~ 367 (956)
++.. .+..+.. .+..|++++|++++...
T Consensus 283 i~~~---~~~~l~~----~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 283 VPDG---TLQLLKE----ALPHLQINCSHFTTIAR 310 (336)
T ss_dssp SCTT---CHHHHHH----HSTTSEESCCCSCCTTC
T ss_pred cCHH---HHHHHHh----hCcceEEecccCccccC
Confidence 4422 2333221 23357789999987644
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=193.78 Aligned_cols=109 Identities=18% Similarity=0.225 Sum_probs=47.5
Q ss_pred ccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceeccc
Q 002178 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (956)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (956)
+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333334444444444444444443333334444444444444444443333334444444444444
Q ss_pred ccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 211 NNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
+|+|++..+..|..+++|++|+|++|+++
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 44444333333344444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-20 Score=190.80 Aligned_cols=196 Identities=18% Similarity=0.271 Sum_probs=115.5
Q ss_pred ceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccC
Q 002178 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSS 283 (956)
Q Consensus 205 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~ 283 (956)
+.+++++|+++ .+|..+. ++|+.|+|++|.|++ ..+..|.++++|+.|+|++|++++..+ .|..+++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 56777777777 4455443 567777777777764 344467777777777777777776544 366667777777777
Q ss_pred CcCCcCCCCCCC--ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCC
Q 002178 284 NQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361 (956)
Q Consensus 284 N~l~~~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~ 361 (956)
|+|+ .+|...+ ..+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.
T Consensus 90 N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------- 149 (220)
T 2v9t_B 90 NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS------------------- 149 (220)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT-------------------
T ss_pred CcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh-------------------
Confidence 7666 3333221 22455555555555555555555555555555555555433332221
Q ss_pred CCCCCCCCCCCCCcEEEecCCcccccCCcccccCCCCCCCcccCcCCCCCCccccCcCCCCCccCCCCCCcceeec
Q 002178 362 LTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAA 437 (956)
Q Consensus 362 L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~c~~~~~~~p~~~~~~~c~~ 437 (956)
.++.+..|+|++|||.|||++.|+..|+..... ....+.|..|.--.+....-.+.....|..
T Consensus 150 --------~l~~L~~L~L~~N~~~c~c~l~~l~~~l~~~~~-----~~~~~~C~~P~~l~g~~l~~l~~~~~~c~~ 212 (220)
T 2v9t_B 150 --------PLRAIQTMHLAQNPFICDCHLKWLADYLHTNPI-----ETSGARCTSPRRLANKRIGQIKSKKFRCSA 212 (220)
T ss_dssp --------TCTTCCEEECCSSCEECSGGGHHHHHHHHHCCC-----BCSCCBEEESGGGTTCBGGGSCGGGCCC--
T ss_pred --------CCCCCCEEEeCCCCcCCCCccHHHHHHHHhCCC-----CccCCCcCCchHHcCCchhhCCHHHCcCcc
Confidence 366778899999999999999999888654321 123456766443333333333344444433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=208.80 Aligned_cols=24 Identities=17% Similarity=0.121 Sum_probs=19.3
Q ss_pred cEEEecCCcccccCCcccc-cCCCC
Q 002178 375 VTVRLRGNPFCLNTNAEQF-CGSHS 398 (956)
Q Consensus 375 ~~l~l~~Np~~c~c~~~~~-~~~~~ 398 (956)
..|+|.+|||.|||++.++ ..|..
T Consensus 192 ~~l~l~~N~~~C~C~l~~~~~~~~~ 216 (361)
T 2xot_A 192 NGLYLHNNPLECDCKLYQLFSHWQY 216 (361)
T ss_dssp TTEECCSSCEECCHHHHHHHHHHHH
T ss_pred ceEEecCCCccCCcCcHHHHHHHHH
Confidence 5689999999999998875 45553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.6e-20 Score=191.45 Aligned_cols=163 Identities=19% Similarity=0.234 Sum_probs=96.1
Q ss_pred eecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCC
Q 002178 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSN 284 (956)
Q Consensus 206 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N 284 (956)
.+++++|.++. +|..+. ..+++|+|++|.+++...+..|.++++|+.|+|++|+|++.++ .|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45555555552 343332 2345566666666542222345666666666666666666555 3666666666666666
Q ss_pred cCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCC
Q 002178 285 QLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363 (956)
Q Consensus 285 ~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~ 363 (956)
+|++..+..+. ..+|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------------------- 150 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--------------------- 150 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTT---------------------
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhc---------------------
Confidence 66533332221 12455555555555555555555666666666666666554454443
Q ss_pred CCCCCCCCCCCcEEEecCCcccccCCcccccCCCC
Q 002178 364 NISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398 (956)
Q Consensus 364 ~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~ 398 (956)
.++.+..|+|++|||.|+|++.++..|..
T Consensus 151 ------~l~~L~~L~L~~N~l~c~c~l~~l~~~~~ 179 (220)
T 2v70_A 151 ------TLHSLSTLNLLANPFNCNCYLAWLGEWLR 179 (220)
T ss_dssp ------TCTTCCEEECCSCCEECSGGGHHHHHHHH
T ss_pred ------CCCCCCEEEecCcCCcCCCchHHHHHHHH
Confidence 25667789999999999999999988875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=188.31 Aligned_cols=156 Identities=22% Similarity=0.277 Sum_probs=120.6
Q ss_pred CCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCC
Q 002178 64 TSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143 (956)
Q Consensus 64 ~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~ 143 (956)
.|.|++|.|.+.. +. .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 18 ~Cs~~~v~c~~~~-----------------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 77 (229)
T 3e6j_A 18 SCSGTTVDCRSKR-----------------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG 77 (229)
T ss_dssp EEETTEEECTTSC-----------------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEeCCEeEccCCC-----------------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC
Confidence 3469999996542 22 3444333 78888888888888877888888888888888888888
Q ss_pred CCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccC
Q 002178 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223 (956)
Q Consensus 144 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 223 (956)
...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 156 (229)
T 3e6j_A 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156 (229)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTT
T ss_pred CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHh
Confidence 666667788888888888888888777777788888888888888888 6777777888888888888888866666677
Q ss_pred CcchhhhhcccCCcCCC
Q 002178 224 ELPKLLILQLDNNNFEG 240 (956)
Q Consensus 224 ~l~~L~~L~Ls~N~l~~ 240 (956)
.+++|+.|+|++|.+.+
T Consensus 157 ~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 157 RLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TCTTCCEEECTTSCBCT
T ss_pred CCCCCCEEEeeCCCccC
Confidence 77777777777777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=188.08 Aligned_cols=159 Identities=21% Similarity=0.244 Sum_probs=110.5
Q ss_pred CCCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCc
Q 002178 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N 140 (956)
..|.|.|..|.|.+. +++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 7 ~~C~C~~~~v~c~~~-----------------~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N 66 (220)
T 2v9t_B 7 AACTCSNNIVDCRGK-----------------GLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN 66 (220)
T ss_dssp TTSEEETTEEECTTS-----------------CCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSS
T ss_pred CCCEECCCEEEcCCC-----------------CcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCC
Confidence 457666777777543 333 2344443 57788888888887666667777778888888888
Q ss_pred CCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCc
Q 002178 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (956)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 220 (956)
++++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+.
T Consensus 67 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 67 QISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 87777777777777777777777777765555667777777777777777766666777777777777777777766655
Q ss_pred ccCCcchhhhhcccCCcCC
Q 002178 221 ELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~ 239 (956)
.|..+++|++|+|++|++.
T Consensus 147 ~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTCTTCCEEECCSSCEE
T ss_pred HHhCCCCCCEEEeCCCCcC
Confidence 6666666666666666664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=186.17 Aligned_cols=152 Identities=18% Similarity=0.201 Sum_probs=115.5
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC-cccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
.++++++.++. +|..+. ..+++|+|++|+|++..+ ..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 34445555653 555443 346788888888887654 44788888888888888888777778888888888888888
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 8887777778888888888888888887777778888888888888888887777777777777777777777764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.5e-21 Score=231.67 Aligned_cols=217 Identities=18% Similarity=0.198 Sum_probs=97.0
Q ss_pred HHHHHHHHHHHHhccCC-CCCCCCCCCCCCCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEE
Q 002178 34 PIEVSALRSIKKSLVDD-YSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILD 112 (956)
Q Consensus 34 ~~~~~al~~~k~~~~~~-~~~l~~W~~~~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~ 112 (956)
..++++|.++..++... ......|.....-.+.|.++.++.. +++.|+|.++++... +..+ |+.++
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-------~~~~l~L~~n~~~~~-~~~~-----l~~l~ 197 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTP-------LTPKIELFANGKDEA-NQAL-----LQHKK 197 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCC-------ccceEEeeCCCCCcc-hhhH-----hhcCc
Confidence 45688899888777533 2223456543222235888877553 578888888887753 2222 33344
Q ss_pred ccCCCCcc---------cCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 113 FMWNKISG---------SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 113 Ls~N~l~~---------~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
|+.|.|.+ ..|..|..+++|++|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.++++|++|
T Consensus 198 Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 275 (727)
T 4b8c_D 198 LSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVL 275 (727)
T ss_dssp ------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEE
T ss_pred cCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEE
Confidence 44443332 34556666666777777777766 56666666666777777777666 566666666666666
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCC-CcEEeccCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-LLKLSLRNCS 262 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~-L~~L~Ls~N~ 262 (956)
+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++ .+|..+..+.. +..|+|++|.
T Consensus 276 ~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~~~~~~l~l~~N~ 352 (727)
T 4b8c_D 276 DLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK-QFLKILTEKSVTGLIFYLRDNR 352 (727)
T ss_dssp ECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS-HHHHHHHHHHHHHHHHHHHHCC
T ss_pred eCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC-CChHHHhhcchhhhHHhhccCc
Confidence 66666666 55666666666666666666665 455556666666666666666665 45555443321 1234555555
Q ss_pred CccCCC
Q 002178 263 LQGPMP 268 (956)
Q Consensus 263 l~~~~~ 268 (956)
+++.+|
T Consensus 353 l~~~~p 358 (727)
T 4b8c_D 353 PEIPLP 358 (727)
T ss_dssp CCCCCC
T ss_pred ccCcCc
Confidence 554433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-19 Score=195.20 Aligned_cols=84 Identities=24% Similarity=0.307 Sum_probs=40.0
Q ss_pred cCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEe
Q 002178 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 327 (956)
Q Consensus 248 ~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 327 (956)
..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..+ .....+|+.|+|++|.+++. + .+..+++|+.|+
T Consensus 131 ~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~ 206 (291)
T 1h6t_A 131 VHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLE 206 (291)
T ss_dssp GGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEE
T ss_pred cCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEE
Confidence 3333444444444443333 233334444444444444442222 11122444455555555432 2 367777888888
Q ss_pred cccccCCC
Q 002178 328 IANNSLSG 335 (956)
Q Consensus 328 L~~N~l~~ 335 (956)
+++|+++.
T Consensus 207 l~~n~i~~ 214 (291)
T 1h6t_A 207 LFSQECLN 214 (291)
T ss_dssp EEEEEEEC
T ss_pred CcCCcccC
Confidence 88887764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=214.64 Aligned_cols=148 Identities=26% Similarity=0.470 Sum_probs=61.0
Q ss_pred ccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccce
Q 002178 127 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (956)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 206 (956)
..|++|+.|+|++|.+. .++ .+..+++|+.|+|++|+|++..+ +..+++|+.|+|++|.|++ ++ .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence 34444444444444444 222 24444444444444444443322 4444444444444444442 11 3444444444
Q ss_pred ecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcC
Q 002178 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL 286 (956)
Q Consensus 207 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 286 (956)
|+|++|+|++. +.+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.|++.++ +..+++|+.|+|++|+|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l---~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC---GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc---hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 44444444431 2233444444444444444321 233344444444444444433333 33333333333333333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=194.02 Aligned_cols=171 Identities=29% Similarity=0.406 Sum_probs=97.6
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++ + ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCE
Confidence 345566666666666653 33 35666666666666666664333 6666666666666666653 2 23556666666
Q ss_pred eecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCC
Q 002178 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (956)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (956)
|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++ ++. +..+++|+.|+|++|.
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~--~~~-l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--IVP-LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC--CGG-GTTCTTCCEEECCSSC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc--chh-hcCCCccCEEECCCCc
Confidence 66666666532 3455566666666666666543 345555666666666666654 122 5556666666666666
Q ss_pred CccCCCCCCCCCCccEEEccCCcCC
Q 002178 263 LQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 263 l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+++.+ .+..+++|+.|++++|+++
T Consensus 190 i~~l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 190 ISDLR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CCBCG-GGTTCTTCSEEEEEEEEEE
T ss_pred CCCCh-hhccCCCCCEEECcCCccc
Confidence 55532 3555555555655555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-19 Score=212.78 Aligned_cols=173 Identities=29% Similarity=0.402 Sum_probs=114.5
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (956)
+..|++|+.|+|++|.|.. ++ .|..+++|++|+|++|++++..| +..+++|+.|+|++|.|++. + .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCC
Confidence 4556666777777777663 33 46667777777777777765443 66677777777777776642 2 566677777
Q ss_pred eeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
.|+|++|+|++. ..+..+++|+.|+|++|+|++. ..|..+++|+.|+|++|.+++ ..| +..+++|+.|+|++|
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC-CGG--GTTCTTCCEEECCSS
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC-chh--hccCCCCCEEECcCC
Confidence 777777777642 3466677777777777777754 456677777777777777765 223 667777777777777
Q ss_pred CCccCCCCCCCCCCccEEEccCCcCCc
Q 002178 262 SLQGPMPDLSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 262 ~l~~~~~~l~~l~~L~~L~Ls~N~l~~ 288 (956)
.|++. +.+..+++|+.|+|++|++.+
T Consensus 186 ~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 186 HISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 77664 456677777777777777763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=199.63 Aligned_cols=176 Identities=21% Similarity=0.266 Sum_probs=137.5
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccc-cCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
.+++++++|+. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 34555566654 455443 3578888888888877776676 8888888899888888777788888888999999988
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCccc---CCcchhhhhcccCCcCCCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~ 241 (956)
+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~- 177 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK- 177 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC-
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc-
Confidence 8887777788888889999999998887778888888899999999998886555555 568888899999998885
Q ss_pred CCcccccCCCC--CcEEeccCCCCcc
Q 002178 242 TIPASYSNMSK--LLKLSLRNCSLQG 265 (956)
Q Consensus 242 ~~p~~~~~l~~--L~~L~Ls~N~l~~ 265 (956)
..+..+..+++ |+.|+|++|.+..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 34456777776 4788999988863
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-21 Score=227.35 Aligned_cols=204 Identities=16% Similarity=0.122 Sum_probs=119.1
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
...++|+.|+|++|+|+ .+|..++++++|+.|++++|.....+| . .+..+.+.+.+|..+.++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~----------~-ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII----------L-LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH----------H-HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH----------H-HHHhcccccCCHHHHHHHHhccc
Confidence 55667777777777776 667777777777777776654100000 0 00111233445555566666666
Q ss_pred ee-cccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCC
Q 002178 183 FH-MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (956)
Q Consensus 183 L~-L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (956)
|+ ++.|.+ .+|..+.+++|.++...+ ..|+.|+|++|.|++ +|. |+++++|+.|+|++|
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~--lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV--LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS--CCC-GGGGTTCCEEECCSS
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC--CcC-ccccccCcEeecCcc
Confidence 65 444433 244455555555543211 135556666666653 344 666666666666666
Q ss_pred CCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCC-chhcCCCCcCCeEecccccCCCcCCh
Q 002178 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSGSIPS 339 (956)
Q Consensus 262 ~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~ 339 (956)
.|+..+..+..+++|+.|+|++|+|++ +|......+|+.|+|++|+|++.. |..|.++++|+.|+|++|+|++..|.
T Consensus 474 ~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 474 RLRALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cccccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 666554456666666666666666664 442222336777777777777666 78888888888888888888866553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=178.72 Aligned_cols=153 Identities=19% Similarity=0.254 Sum_probs=94.9
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccC
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (956)
+.+++++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|+...+..|.++++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 35677777776 5665443 56777777777777666666666666666666666665444444555555555555555
Q ss_pred cCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC
Q 002178 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (956)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (956)
+|++. .+..|..+++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++.++
T Consensus 99 ~l~~l------------------------~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 99 QLTVL------------------------PSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp CCCCC------------------------CTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred cCCcc------------------------ChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCH
Confidence 55543 3444444555555555555554 345556666677777777777766655
Q ss_pred C-CCCCCCccEEEccCCcCCcCC
Q 002178 269 D-LSRIPNLGYLDLSSNQLNGSI 290 (956)
Q Consensus 269 ~-l~~l~~L~~L~Ls~N~l~~~~ 290 (956)
. +..+++|+.|+|++|.+.+..
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTB
T ss_pred HHHhCCCCCCEEEeeCCCccCCc
Confidence 4 667777778888888777544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-20 Score=227.72 Aligned_cols=296 Identities=15% Similarity=0.092 Sum_probs=159.1
Q ss_pred eeeEEEeCCCC-ccc-cCCcCcCCCCCCCEEEccCCCCccc----CCcccccCcccchhhccCcCCCC----CCCCccCC
Q 002178 83 HLRELQLLNLN-LSG-NLSPEIGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTG----SLPEELGY 152 (956)
Q Consensus 83 ~~~~L~L~~~~-l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~ 152 (956)
+++.|+|.+|. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888775 221 1222334678888888888887654 34445667888888888888763 23334556
Q ss_pred CcccceeecccccccCCCCccccccccCCeeecccCcCC--------------------------CCCccccCCCcccce
Q 002178 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--------------------------GQIPPELSRLPSLVH 206 (956)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--------------------------~~~p~~l~~l~~L~~ 206 (956)
+++|++|+|++|.+.+ ++..+.++++|++|+++.+... ..+|..+..+++|++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCE
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcE
Confidence 7788888888887774 5566666677777766643221 123344444455555
Q ss_pred ecccccccCCCCC-cccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccC-----------CCCccCC-CC-CCC
Q 002178 207 MLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-----------CSLQGPM-PD-LSR 272 (956)
Q Consensus 207 L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~-----------N~l~~~~-~~-l~~ 272 (956)
|+|++|.+++... ..+..+++|++|+|+ |.+.+..++..+.++++|++|+|++ |.++... .. ...
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~ 376 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence 5555555432221 223444555555554 2232212233334455555555552 3333210 01 223
Q ss_pred CCCccEEEccCCcCCcCCCCCCC--ccccCEEEcc----CCcCCCC-----CchhcCCCCcCCeEecccc--cCCCcCCh
Q 002178 273 IPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS----NNKLTGT-----IPSNFSGLPRLQRLFIANN--SLSGSIPS 339 (956)
Q Consensus 273 l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~ 339 (956)
+++|++|+++.|.+++..+.... ..+|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence 45666666666665543332221 2256666664 5555543 3333555666666666532 24444333
Q ss_pred hhhhhccCCCCcceEEEccCCCCCCC--CCCC-CCCCCcEEEecCCcc
Q 002178 340 SIWQSRTLNATETFILDFQNNNLTNI--SGSF-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 340 ~~~~l~~l~~~~L~~L~L~~N~L~~l--~~~~-~~~~l~~l~l~~Np~ 384 (956)
.+.. ..++|+.|+|++|+++.. +... .+++++.|+|++|++
T Consensus 457 ~~~~----~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 457 YIGQ----YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp HHHH----SCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred HHHH----hCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 3322 124466777777777642 2111 357777777777774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=183.35 Aligned_cols=136 Identities=19% Similarity=0.108 Sum_probs=107.7
Q ss_pred CCCCCeeeeeCCeEEEEEEe-CCCcE--EEEEEecCCChh------------------------hHHHHHHHHHHHHhcC
Q 002178 626 FNSSTQIGQGGYGKVYKGIL-PDGTV--VAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 678 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 678 (956)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 68888 999987543111 1236789999999998
Q ss_pred CCce--eeeecccccCCcEEEEEecCCC-C----CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhh-hcCCCCEeccC
Q 002178 679 HRNL--VSLVGYCDEEGEQMLVYEFMSN-G----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRD 750 (956)
Q Consensus 679 h~nI--v~l~~~~~~~~~~~LV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~D 750 (956)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8764 333332 356899999942 3 77776532 235567889999999999999 888 99999
Q ss_pred CCcccEEEcCCCcEEEEeecccccc
Q 002178 751 IKASNILLDHKFTAKVADFGLSRLA 775 (956)
Q Consensus 751 lk~~NILl~~~~~~kl~DfGla~~~ 775 (956)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=5e-19 Score=189.54 Aligned_cols=169 Identities=21% Similarity=0.342 Sum_probs=107.8
Q ss_pred CCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeee
Q 002178 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 105 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (956)
+.++..++|++|.+++ ++ .+..+++|++|++++|.++ .++ .+..+++|++|+|++|+|++..+ +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 4445556666666663 22 4566666666666666666 344 46666666666666666664433 66666666666
Q ss_pred cccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCc
Q 002178 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (956)
|++|++++ +|... . ++|++|+|++|++++. +.+..+++|++|+|++|++++ ++ .+..+++|+.|+|++|+++
T Consensus 92 L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~--~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 92 VNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS--IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB--CG-GGGGCTTCCEEECTTSCCC
T ss_pred CCCCccCC-cCccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC--Ch-HHccCCCCCEEECCCCcCc
Confidence 66666664 33322 2 6677777777777653 346677777777777777764 22 5677777777777777777
Q ss_pred cCCCCCCCCCCccEEEccCCcCCc
Q 002178 265 GPMPDLSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~ 288 (956)
+. ..+..+++|+.|++++|.+++
T Consensus 164 ~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 164 NT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred ch-HHhccCCCCCEEeCCCCcccC
Confidence 66 556777777777777777763
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-20 Score=223.03 Aligned_cols=200 Identities=21% Similarity=0.237 Sum_probs=154.8
Q ss_pred CCcccceeecccccccCCCCccccccccCCeeecccCc-------------CCCCCccccCCCcccceec-ccccccCCC
Q 002178 152 YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-------------ISGQIPPELSRLPSLVHML-LDNNNLTGY 217 (956)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~~ 217 (956)
.+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3445555555555554 445555555555555554443 5567788888888999988 777654
Q ss_pred CCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCcc
Q 002178 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297 (956)
Q Consensus 218 ~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 297 (956)
.+|..+.+++|.++. ++. ..|+.|+|++|.|++.+. +..+++|+.|+|++|+|+ .+|..+...
T Consensus 423 --------~~L~~l~l~~n~i~~--l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLK--MEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp --------HHHHHHHHHHHHHHH--HHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred --------chhhhhhhhcccccc--cCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 478888888888864 222 258999999999999755 999999999999999999 788765543
Q ss_pred -ccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcC-ChhhhhhccCCCCcceEEEccCCCCCCCCCCC-----C
Q 002178 298 -NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNISGSF-----N 370 (956)
Q Consensus 298 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-----~ 370 (956)
+|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..+..+.+ |+.|+|++|+|++++... .
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~-----L~~L~L~~N~l~~~~~~~~~l~~~ 558 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-----LVLLNLQGNSLCQEEGIQERLAEM 558 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT-----CCEEECTTSGGGGSSSCTTHHHHH
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC-----CCEEEecCCcCCCCccHHHHHHHH
Confidence 89999999999997 56 8999999999999999999887 999887655 559999999999987754 2
Q ss_pred CCCCcEEEe
Q 002178 371 IPPNVTVRL 379 (956)
Q Consensus 371 ~~~l~~l~l 379 (956)
+|.++.|++
T Consensus 559 lp~L~~L~l 567 (567)
T 1dce_A 559 LPSVSSILT 567 (567)
T ss_dssp CTTCSEEEC
T ss_pred CcccCccCC
Confidence 788888754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-20 Score=223.39 Aligned_cols=297 Identities=12% Similarity=0.081 Sum_probs=200.2
Q ss_pred ceeeEEEeCCCCcccc----CCcCcCCCCCCCEEEccCCCCc----ccCCcccccCcccchhhccCcCCCC---------
Q 002178 82 LHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKIS----GSIPKEIGNIKSLELLLLNGNELTG--------- 144 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~l~----~~ip~~~~~l~~L~~L~Ls~N~l~~--------- 144 (956)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.++++|++|+|++|.+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~ 243 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA 243 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCT
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhh
Confidence 4577777777776554 2333455667777777777665 2334444566677777777766543
Q ss_pred -----------------CCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCc-cccCCCcccce
Q 002178 145 -----------------SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVH 206 (956)
Q Consensus 145 -----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~ 206 (956)
..+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|++
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~ 322 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCE
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCE
Confidence 222344555566666665543 33667788899999999999999875443 44688999999
Q ss_pred ecccccccC-CCCCcccCCcchhhhhccc-----------CCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCC-C
Q 002178 207 MLLDNNNLT-GYLPPELSELPKLLILQLD-----------NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS-R 272 (956)
Q Consensus 207 L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls-----------~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~-~ 272 (956)
|+|+ |.+. +.++..+..+++|++|+|+ .|.+++..++..+..+++|++|+++.|.+++... .+. .
T Consensus 323 L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~ 401 (592)
T 3ogk_B 323 LETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401 (592)
T ss_dssp EEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHH
T ss_pred Eecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhh
Confidence 9999 4444 3334444667899999999 3667643344445678999999999999876433 243 3
Q ss_pred CCCccEEEcc----CCcCCcCCCC-----CC-CccccCEEEccCC--cCCCCCchhcC-CCCcCCeEecccccCCCcC-C
Q 002178 273 IPNLGYLDLS----SNQLNGSIPP-----GR-LSLNITTIKLSNN--KLTGTIPSNFS-GLPRLQRLFIANNSLSGSI-P 338 (956)
Q Consensus 273 l~~L~~L~Ls----~N~l~~~~p~-----~~-~~~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~-p 338 (956)
+++|+.|+++ .|.+++.... .. ...+|+.|+|++| .+++..+..+. .+++|++|+|++|++++.. +
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 7899999996 7778743111 11 1348999999854 47766665555 4899999999999988633 3
Q ss_pred hhhhhhccCCCCcceEEEccCCCCCCC--CCCC-CCCCCcEEEecCCccc
Q 002178 339 SSIWQSRTLNATETFILDFQNNNLTNI--SGSF-NIPPNVTVRLRGNPFC 385 (956)
Q Consensus 339 ~~~~~l~~l~~~~L~~L~L~~N~L~~l--~~~~-~~~~l~~l~l~~Np~~ 385 (956)
..+.. .++|+.|+|++|.++.- +... .++.++.|+|++|...
T Consensus 482 ~~~~~-----~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 482 EFSRG-----CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp HHHTC-----CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred HHHhc-----CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 22222 35677999999998642 2212 4789999999999843
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.2e-18 Score=173.32 Aligned_cols=154 Identities=15% Similarity=0.227 Sum_probs=70.6
Q ss_pred CCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
+.+++|++|+|++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34445555555555555 334 3555555555555555433 1224444455555555555544444444444444444
Q ss_pred eecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCC
Q 002178 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (956)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (956)
|+|++|++++..+..+..+++|++|+|++|++ ++. ++ .+.++++|+.|++++|.
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~-----------------------i~~--~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA-----------------------ITD--IM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTB-----------------------CCC--CG-GGGGCSSCCEEECTTBC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCC-----------------------ccc--cH-hhcCCCCCCEEECCCCC
Confidence 44444444443444444444444444444431 321 22 34444555555555555
Q ss_pred CccCCCCCCCCCCccEEEccCCcCC
Q 002178 263 LQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 263 l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+++.. .+..+++|+.|++++|++.
T Consensus 171 i~~~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHDYR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCCT-TGGGCSSCCEEEECBC---
T ss_pred CcChH-HhccCCCCCEEEeeCcccC
Confidence 54432 4444455555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=8.6e-19 Score=214.39 Aligned_cols=185 Identities=17% Similarity=0.179 Sum_probs=88.4
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeec
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (956)
+.++.|+|++|.+.. ++.. .|+.++|+.|.|.+ ++++.|++. ..+..|..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chhh-----HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 557888888888874 3332 35556666665552 234444444 45556666666666666
Q ss_pred ccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCcc
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (956)
++|.+. .+|..+.++++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+.
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--ccChhhcCCCCCCEEECCCCCCCc
Confidence 666666 55555556666777777777766 56666666777777777777776 456667777777777777777766
Q ss_pred CCCCCCCCCCccEEEccCCcCCcCCCCCCCcc--ccCEEEccCCcCCCCCch
Q 002178 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPS 315 (956)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~Ls~N~l~~~~p~ 315 (956)
++..|..+++|+.|+|++|.|++.+|..+... .+..|+|++|.+++.+|.
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 65567777777777777777776665544322 223355666666665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.8e-18 Score=172.99 Aligned_cols=150 Identities=21% Similarity=0.280 Sum_probs=128.1
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++.|++++++++ .++ .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..+..++.+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 46899999999998 455 7999999999999999876 3347999999999999999999888999999999999999
Q ss_pred ccccccCCCCccccccccCCeeecccCc-CCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
++|++++..+..+..+++|++|+|++|. ++ .+| .+..+++|++|++++|++++. + .+..+++|++|++++|++.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccC
Confidence 9999998889999999999999999998 55 555 688889999999999988853 2 5666777777777777764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.3e-18 Score=179.65 Aligned_cols=171 Identities=20% Similarity=0.286 Sum_probs=113.1
Q ss_pred cCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCccccee
Q 002178 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (956)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 207 (956)
++.+|..+++++|.+++. + .+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 567788889999988843 3 57788888888888888873 44 67778888888888888875443 7777788888
Q ss_pred cccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCC
Q 002178 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 208 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+|++|++++. +. +.. ++|++|+|++|++++ + ..+.++++|+.|+|++|++++.+ .+..+++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~--~-~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~------------ 151 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD--T-DSLIHLKNLEILSIRNNKLKSIV-MLGFLSK------------ 151 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB--S-GGGTTCTTCCEEECTTSCCCBCG-GGGGCTT------------
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCC--C-hhhcCcccccEEECCCCcCCCCh-HHccCCC------------
Confidence 8888877753 22 222 566666666666653 1 23555555555555555555432 3444444
Q ss_pred cCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCc
Q 002178 288 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336 (956)
Q Consensus 288 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (956)
|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 152 -----------L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 152 -----------LEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -----------CCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -----------CCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 44555555555444 5677788888888888888754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=165.58 Aligned_cols=155 Identities=17% Similarity=0.252 Sum_probs=105.6
Q ss_pred cEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEeccccc
Q 002178 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332 (956)
Q Consensus 254 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 332 (956)
+.+++++|.++..+..+. ++|+.|+|++|+|+ .+|..+.. .+|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 355666666655554432 46666666666666 55543322 267777777777777777778888888888888888
Q ss_pred CCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCcccccCCCCCCCcccCcCCCC
Q 002178 333 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNS 410 (956)
Q Consensus 333 l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~~~~~~~~~ 410 (956)
|++..|..|..+. +|+.|+|++|+|+.++.. + .++.+..|+|++|||.|||++.+|..|+.... ....
T Consensus 90 l~~i~~~~f~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~-----~~~~ 159 (193)
T 2wfh_A 90 LRCIPPRTFDGLK-----SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEY-----KEPG 159 (193)
T ss_dssp CCBCCTTTTTTCT-----TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSS-----CCCS
T ss_pred cCEeCHHHhCCCC-----CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhcc-----CCCC
Confidence 8876666665543 345788888888887765 3 47889999999999999999999998875421 1123
Q ss_pred CCccccCcCCC
Q 002178 411 TLDCRAQSCPT 421 (956)
Q Consensus 411 ~~~c~~~~c~~ 421 (956)
.+.|.+|.--.
T Consensus 160 ~~~C~~P~~l~ 170 (193)
T 2wfh_A 160 IARCAGPGEMA 170 (193)
T ss_dssp CCBEEESGGGT
T ss_pred CcCcCCchHHC
Confidence 45676654333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=5e-17 Score=165.23 Aligned_cols=129 Identities=22% Similarity=0.273 Sum_probs=109.1
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCc-ccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccc
Q 002178 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK-EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (956)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (956)
|++++++++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 344445563 45665544 899999999999866654 48899999999999999998889999999999999999999
Q ss_pred ccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCC
Q 002178 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (956)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 218 (956)
|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 99888888999999999999999999888889999999999999999998654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.5e-19 Score=213.37 Aligned_cols=295 Identities=16% Similarity=0.149 Sum_probs=160.3
Q ss_pred ceeeEEEeCCCCccccCCcCcC-CCCCCCEEEccCC-CCccc-CCcccccCcccchhhccCcCCCCCCCCccC----CCc
Q 002178 82 LHLRELQLLNLNLSGNLSPEIG-RLSYLTILDFMWN-KISGS-IPKEIGNIKSLELLLLNGNELTGSLPEELG----YLP 154 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~-~l~~L~~L~Ls~N-~l~~~-ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 154 (956)
.+++.|+|+++.+++.....+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3688899999888876666665 6889999999988 55532 444455788999999999988765554443 566
Q ss_pred ccceeecccccccCCCCcc----ccccccCCeeecccC-cCCCCCccccCCCcccceecccccc----------------
Q 002178 155 KLDRIQIDQNYISGSLPKS----FANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLDNNN---------------- 213 (956)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~---------------- 213 (956)
+|++|+|++|. ....... +.++++|+.|+|++| .+. .++..+..+++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 88999998886 2111222 344688888888887 233 244444555555555543331
Q ss_pred ----------cCCC----CCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCcc-CCCC-CCC-----
Q 002178 214 ----------LTGY----LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPD-LSR----- 272 (956)
Q Consensus 214 ----------l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~-l~~----- 272 (956)
+... ++..+..+++|++|+|++|.+++..+...+.++++|++|++++| ++. ..+. ...
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 1111 11122234566666666666543222223445555555555555 221 0000 112
Q ss_pred -----------------------------CCCccEEEccCCcCCcCCCCCCC--ccccCEEEcc--C----CcCCCC---
Q 002178 273 -----------------------------IPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS--N----NKLTGT--- 312 (956)
Q Consensus 273 -----------------------------l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls--~----N~l~~~--- 312 (956)
+++|+.|+++.|.+++....... ..+|+.|+|+ + |.++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 34455555544544432222111 2255666665 2 344421
Q ss_pred --CchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC---CCCCCCcEEEecCCcc
Q 002178 313 --IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS---FNIPPNVTVRLRGNPF 384 (956)
Q Consensus 313 --~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~---~~~~~l~~l~l~~Np~ 384 (956)
++..+.++++|+.|+|++ .+++..+..+.. ..++|+.|+|++|.++..... ..++.++.|+|++|++
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~----~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT----YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH----HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHH----hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 111244455566666644 444333333322 133466777777776542211 1367777777777775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=156.95 Aligned_cols=134 Identities=23% Similarity=0.239 Sum_probs=101.5
Q ss_pred CCCCCCEEEccCCCCc-ccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCe
Q 002178 104 RLSYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (956)
..++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3477888888888887 67787788888888888888888855 77888888888888888888777777777888888
Q ss_pred eecccCcCCCCC-ccccCCCcccceecccccccCCCCC---cccCCcchhhhhcccCCcCC
Q 002178 183 FHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGYLP---PELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 183 L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~ 239 (956)
|+|++|.+++.. +..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 888888887532 2667777777777777777775544 35666666666666666664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=162.11 Aligned_cols=129 Identities=26% Similarity=0.394 Sum_probs=96.8
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCC-ccCCCcccceeecccccccCCCCccccccccCCeeeccc
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE-ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (956)
++|++++|+++ .+|..+.. +|++|+|++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888886 67766644 788888888888766554 377788888888888888877777777788888888888
Q ss_pred CcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 87777666677777777777777777777667667767777777777776664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-16 Score=156.20 Aligned_cols=138 Identities=20% Similarity=0.249 Sum_probs=109.2
Q ss_pred CCCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCc
Q 002178 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N 140 (956)
+.|.|.|+++.|.+. ++. .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~l~~~~~-----------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 62 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK-----------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN 62 (177)
T ss_dssp TTCEEETTEEECCSS-----------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCEeCCCEEEecCC-----------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCC
Confidence 568778999988653 232 233332 368899999999998766667888899999999999
Q ss_pred CCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCC
Q 002178 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (956)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 218 (956)
++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+..
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 63 QIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 998777777888999999999999998777777888888999999988888666666778888888888888887543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.1e-16 Score=155.59 Aligned_cols=131 Identities=21% Similarity=0.308 Sum_probs=67.5
Q ss_pred ccceeeccccccc-CCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcc
Q 002178 155 KLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233 (956)
Q Consensus 155 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 233 (956)
+|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 4444444444444 33444444444444444444444432 44444555555555555555444444444555555555
Q ss_pred cCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC----CCCCCCCccEEEccCCcCC
Q 002178 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP----DLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~l~~l~~L~~L~Ls~N~l~ 287 (956)
++|.+++...+..+..+++|++|++++|.+++.++ .+..+++|++|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 55555432222455556666666666666665555 3555666666666666655
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-16 Score=173.35 Aligned_cols=142 Identities=15% Similarity=0.136 Sum_probs=99.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh--------------hhHHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------------QGEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ........++++.....|+|+.+++...
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998753210 0111222233333333344444433222
Q ss_pred cc------CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-
Q 002178 690 DE------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 762 (956)
Q Consensus 690 ~~------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~- 762 (956)
.. ....+|||||++|++|.++... .....++.|++.+|.|||+.| ||||||||.|||+++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 11 1233799999999888665321 234568899999999999999 99999999999998876
Q ss_pred ---------cEEEEeeccccccC
Q 002178 763 ---------TAKVADFGLSRLAP 776 (956)
Q Consensus 763 ---------~~kl~DfGla~~~~ 776 (956)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-18 Score=205.49 Aligned_cols=292 Identities=13% Similarity=0.112 Sum_probs=173.8
Q ss_pred ceeeEEEeCCC-Ccccc-CCcCcCCCCCCCEEEccCCCCcccCCcccc----cCcccchhhccCcCCCCCCC-Cc----c
Q 002178 82 LHLRELQLLNL-NLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLLLNGNELTGSLP-EE----L 150 (956)
Q Consensus 82 ~~~~~L~L~~~-~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~----~l~~L~~L~Ls~N~l~~~~p-~~----~ 150 (956)
.+++.|+|.+| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|+|++|. . .+. .. +
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~ 207 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-S-EVSFSALERLV 207 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-S-CCCHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-C-cCCHHHHHHHH
Confidence 57888888888 55443 333445788888888888887765444443 55688888888886 2 222 22 2
Q ss_pred CCCcccceeecccc-cccCCCCccccc-----------------------------------------------------
Q 002178 151 GYLPKLDRIQIDQN-YISGSLPKSFAN----------------------------------------------------- 176 (956)
Q Consensus 151 ~~l~~L~~L~Ls~N-~l~~~~p~~~~~----------------------------------------------------- 176 (956)
..+++|++|+|++| .+++ ++..+.+
T Consensus 208 ~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~ 286 (594)
T 2p1m_B 208 TRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286 (594)
T ss_dssp HHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH
T ss_pred HhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH
Confidence 34577888888777 2222 3333333
Q ss_pred -cccCCeeecccCcCCCCC-ccccCCCcccceecccccccCCC-CCcccCCcchhhhhccc---------CCcCCCCCCc
Q 002178 177 -LNKTRHFHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLD---------NNNFEGTTIP 244 (956)
Q Consensus 177 -l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls---------~N~l~~~~~p 244 (956)
+++|++|+|++|.+++.. ...+..+++|++|++++| ++.. ++.....+++|++|+|+ .|.+++..+.
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 444555555555443221 112334455555555544 2211 11111234555555552 2333321111
Q ss_pred ccccCCCCCcEEeccCCCCccCCC-CC-CCCCCccEEEcc--C----CcCCcCCCC--C-----CCccccCEEEccCCcC
Q 002178 245 ASYSNMSKLLKLSLRNCSLQGPMP-DL-SRIPNLGYLDLS--S----NQLNGSIPP--G-----RLSLNITTIKLSNNKL 309 (956)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~-~l-~~l~~L~~L~Ls--~----N~l~~~~p~--~-----~~~~~L~~L~Ls~N~l 309 (956)
....++++|+.|.++.|.+++... .+ ..+++|+.|+|+ + |.++ ..|. + ....+|+.|+|++ .+
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l 443 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LL 443 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cc
Confidence 112336677777776676654322 12 257899999999 4 5565 2221 1 1123899999987 77
Q ss_pred CCCCchhcCC-CCcCCeEecccccCCCcCChhh-hhhccCCCCcceEEEccCCCCCCCCCC--C-CCCCCcEEEecCCcc
Q 002178 310 TGTIPSNFSG-LPRLQRLFIANNSLSGSIPSSI-WQSRTLNATETFILDFQNNNLTNISGS--F-NIPPNVTVRLRGNPF 384 (956)
Q Consensus 310 ~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~l~~~~L~~L~L~~N~L~~l~~~--~-~~~~l~~l~l~~Np~ 384 (956)
++..+..+.. +++|+.|+|++|.+++..+..+ .. .++|+.|+|++|.++..... . .++.++.|++++|+.
T Consensus 444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~-----~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG-----CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH-----CTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc-----CCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 7766666665 8999999999999986655544 22 35577999999999543221 2 478999999999886
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-16 Score=152.60 Aligned_cols=126 Identities=23% Similarity=0.244 Sum_probs=70.4
Q ss_pred CCCCEEEccCCCCc-ccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeee
Q 002178 106 SYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (956)
++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 55565556666666666666666644 5555666666666666666655555555566666666
Q ss_pred cccCcCCCC-CccccCCCcccceecccccccCCCCC---cccCCcchhhhhcc
Q 002178 185 MNNNSISGQ-IPPELSRLPSLVHMLLDNNNLTGYLP---PELSELPKLLILQL 233 (956)
Q Consensus 185 L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~L 233 (956)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 666665532 22455555555555555555554333 23444444444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=154.93 Aligned_cols=127 Identities=24% Similarity=0.305 Sum_probs=92.3
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
+.+++++++|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 35777777776 3454443 57788888888877 66777777788888888888887776777777777777777777
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 215 (956)
+|++..+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777777777777777777777777777555556667777777777777665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.2e-15 Score=148.83 Aligned_cols=130 Identities=22% Similarity=0.247 Sum_probs=99.4
Q ss_pred CCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeeccc
Q 002178 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (956)
Q Consensus 108 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (956)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467888888887 5664443 6888888888888876667778888888888888888876667778888888888888
Q ss_pred CcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
|+|++..+..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 88886666667777888888888888876655556777777777777777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=148.11 Aligned_cols=129 Identities=18% Similarity=0.210 Sum_probs=117.3
Q ss_pred cceeeEEEeCCCCcc-ccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCccccee
Q 002178 81 YLHLRELQLLNLNLS-GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (956)
Q Consensus 81 ~~~~~~L~L~~~~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (956)
..+++.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..++++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 357899999999999 78999999999999999999999965 689999999999999999998889988889999999
Q ss_pred ecccccccCC-CCccccccccCCeeecccCcCCCCCc---cccCCCcccceecccc
Q 002178 160 QIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIP---PELSRLPSLVHMLLDN 211 (956)
Q Consensus 160 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~L~~ 211 (956)
+|++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|++|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999964 35889999999999999999997665 5789999999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=9.1e-16 Score=170.05 Aligned_cols=100 Identities=12% Similarity=0.215 Sum_probs=52.7
Q ss_pred CCCCCEEEccCCCCc--ccCCcccccCcccchhhccCcCCCCCCCCccCC--------CcccceeecccccccCCCCccc
Q 002178 105 LSYLTILDFMWNKIS--GSIPKEIGNIKSLELLLLNGNELTGSLPEELGY--------LPKLDRIQIDQNYISGSLPKSF 174 (956)
Q Consensus 105 l~~L~~L~Ls~N~l~--~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~ 174 (956)
+++|+.|||++|+|. ...+ +.++.++.+++..|.+ .+..|.+ +++|+.|+|.+ +++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~---~~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKA---GTYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESS---SSSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcc---cccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 556666666666665 1111 1112233333444322 2334444 66666666666 5554555566
Q ss_pred cccccCCeeecccCcCCCCCccccCCCcccceecccc
Q 002178 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (956)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (956)
.++++|+.|+|++|.+....+..|..+.++..+.+..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 6666666666666666545555566655555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=7.7e-17 Score=164.72 Aligned_cols=149 Identities=23% Similarity=0.310 Sum_probs=78.8
Q ss_pred ccCcccchhhccCcCCCCCCCC------ccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCC
Q 002178 127 GNIKSLELLLLNGNELTGSLPE------ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200 (956)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 200 (956)
.....++.++++.|.++|.+|. .+..+++|++|+|++|.+++ +| .+.++++|++|+|++|.++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344555555555555555444 45555555555555555553 33 5555555555555555555 44444445
Q ss_pred CcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-----------
Q 002178 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD----------- 269 (956)
Q Consensus 201 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~----------- 269 (956)
+++|++|+|++|++++ +| .+..+++|++|+|++|++++......+..+++|++|++++|.+++..+.
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 5555555555555554 22 4555555666666666655311112455566666666666666554332
Q ss_pred CCCCCCccEEE
Q 002178 270 LSRIPNLGYLD 280 (956)
Q Consensus 270 l~~l~~L~~L~ 280 (956)
+..+++|+.||
T Consensus 170 ~~~l~~L~~Ld 180 (198)
T 1ds9_A 170 VKRLPNLKKLD 180 (198)
T ss_dssp HHHCSSCSEEC
T ss_pred HHhCCCcEEEC
Confidence 44555566554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=142.05 Aligned_cols=134 Identities=22% Similarity=0.246 Sum_probs=97.6
Q ss_pred ccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEE
Q 002178 276 LGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355 (956)
Q Consensus 276 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L 355 (956)
.+.|++++|.|+ .+|.... .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+. +|+.|
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~-~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~-----~L~~L 83 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP-TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT-----QLTQL 83 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT-----TCCEE
T ss_pred CCEEEeCCCCcC-ccCccCC-CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC-----CCCEE
Confidence 456666666666 4555443 5777888888888877788888888888888888888866665555443 45588
Q ss_pred EccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCC-cccccCCCCCCCcccCc---CCCCCCcccc
Q 002178 356 DFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNEIDR---STNSTLDCRA 416 (956)
Q Consensus 356 ~L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~-~~~~~~~~~~~~~~~~~---~~~~~~~c~~ 416 (956)
+|++|+|++++.. + .++.++.|+|++|||.|+|. +.++..|.......+.. .+...+.|..
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l~~~l~~~~~~~~~~~~~~~~~~~C~~ 150 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLSRWISQHPGLVFGYLNLDPDSARCSG 150 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHHHHHHHHCGGGEECSSSBCGGGSBBCC
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHHHHHHHhCcceeeccccCCcccceeCC
Confidence 8888888888775 4 58899999999999999995 88888888765544321 3344566654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.1e-17 Score=165.48 Aligned_cols=154 Identities=19% Similarity=0.273 Sum_probs=99.4
Q ss_pred CCCCCCCEEEccCCCCcccCCc------ccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccc
Q 002178 103 GRLSYLTILDFMWNKISGSIPK------EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN 176 (956)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~ip~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 176 (956)
.....++.++|+.|.++|.+|. .|.++++|++|+|++|++++ +| .+..+++|++|+|++|.++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344555555555555555554 66667777777777777764 55 6666777777777777776 45666666
Q ss_pred cccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCC-cccCCcchhhhhcccCCcCCCCCCcc----------
Q 002178 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA---------- 245 (956)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~---------- 245 (956)
+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++ ..|.
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN-DYKENNATSEYRIE 168 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH-HHHTTTTHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc-ccccccchHHHHHH
Confidence 6777777777777764 34 46667777777777777764322 356677777777777777754 2332
Q ss_pred cccCCCCCcEEeccCCCCc
Q 002178 246 SYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~ 264 (956)
.+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 267788888876 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=7.1e-15 Score=147.03 Aligned_cols=133 Identities=18% Similarity=0.230 Sum_probs=86.0
Q ss_pred cCcCCCCCCCEEEccCCCCcccCCcccccCc-ccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccc
Q 002178 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178 (956)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 178 (956)
+.+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 34566777788888888777 3443 44444 778888888877754 5677777777777777777755445557777
Q ss_pred cCCeeecccCcCCCCCcc--ccCCCcccceecccccccCCCCCc----ccCCcchhhhhcccCCcC
Q 002178 179 KTRHFHMNNNSISGQIPP--ELSRLPSLVHMLLDNNNLTGYLPP----ELSELPKLLILQLDNNNF 238 (956)
Q Consensus 179 ~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l 238 (956)
+|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++. +|. .+..+++|+.|++++|.+
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 7777777777775 4444 56666666666666666663 333 244555555555555544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-14 Score=160.84 Aligned_cols=253 Identities=13% Similarity=0.117 Sum_probs=166.4
Q ss_pred ceeeEEEeCCCCcc--ccCCcCcCCCCCCCEEEccCCCCcccCCccccc--------CcccchhhccCcCCCCCCCCccC
Q 002178 82 LHLRELQLLNLNLS--GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGN--------IKSLELLLLNGNELTGSLPEELG 151 (956)
Q Consensus 82 ~~~~~L~L~~~~l~--~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~ 151 (956)
.+++.|||++|++. ......+ +.++.+.+..|.|. +..|.+ +++|+.|+|.+ .++...+..|.
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~ 121 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFK 121 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTT
T ss_pred ccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHhh
Confidence 46899999999988 3332222 33566666666433 455666 99999999999 88877778899
Q ss_pred CCcccceeecccccccCCCCccccccccCCeeecccCcC----CCCCccccCCCcccc-eecccccccCCCCCccc----
Q 002178 152 YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI----SGQIPPELSRLPSLV-HMLLDNNNLTGYLPPEL---- 222 (956)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~l---- 222 (956)
++++|+.|+|++|.+....+.+|.++.++..+.+..+.. ...-...|.++.+|+ .+.+.... .++..+
T Consensus 122 ~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~ 198 (329)
T 3sb4_A 122 GCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAG 198 (329)
T ss_dssp TCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTT
T ss_pred cCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhcc
Confidence 999999999999999878888899988888887766322 222234455566666 34433221 111111
Q ss_pred CCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCc--ccc
Q 002178 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNI 299 (956)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L 299 (956)
....++..+.+.++-.. .........+++|+.|+|++|+++.+++. |..+.+|+.|+|++| ++ .++...+. .+|
T Consensus 199 ~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L 275 (329)
T 3sb4_A 199 LQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRL 275 (329)
T ss_dssp CCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTC
T ss_pred cCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhc
Confidence 12344445555443211 01111112367888888888888776664 778888888888887 65 55555443 268
Q ss_pred C-EEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCC
Q 002178 300 T-TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 348 (956)
Q Consensus 300 ~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 348 (956)
+ .|+|.+ .++...+.+|.++++|+.|++++|+++...+..|..+.+|+
T Consensus 276 ~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 276 AGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp CEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred cEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence 7 888887 67767778888888888888888888866666776655543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-14 Score=145.55 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=75.9
Q ss_pred ccccCcccchhhccCcCCCCCCCCccCCCc-ccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcc
Q 002178 125 EIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203 (956)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 203 (956)
.+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4566677777777777777 3444 33433 777777777777643 45666666666666666666443334456666
Q ss_pred cceecccccccCCCCCc--ccCCcchhhhhcccCCcCCCCCCccc----ccCCCCCcEEeccCCCC
Q 002178 204 LVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNNFEGTTIPAS----YSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 204 L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~p~~----~~~l~~L~~L~Ls~N~l 263 (956)
|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.|++++|.+
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~--~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT--NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG--GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC--CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 666666666664 2333 4555555555555555554 23332 44455555555554444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=6.9e-14 Score=139.42 Aligned_cols=120 Identities=23% Similarity=0.311 Sum_probs=92.7
Q ss_pred cEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEE
Q 002178 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356 (956)
Q Consensus 277 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~ 356 (956)
+.+++++|.++ .+|.... .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+ ++|+.|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l-----~~L~~L~ 87 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP-TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKL-----TQLTQLD 87 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC-----TTCCEEE
T ss_pred cEEEeCCCCCC-ccCCCcC-CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCc-----chhhEEE
Confidence 56777777775 6666543 578888888888888888888888899999999998886555545444 3456899
Q ss_pred ccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCC-cccccCCCCCCCcc
Q 002178 357 FQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNE 403 (956)
Q Consensus 357 L~~N~L~~l~~~-~-~~~~l~~l~l~~Np~~c~c~-~~~~~~~~~~~~~~ 403 (956)
|++|+|+.++.. + .++.+..|+|++|||.|+|. +.++..|.......
T Consensus 88 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~~~~~~~~~~ 137 (174)
T 2r9u_A 88 LNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLRNWVADHTSI 137 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHHHHHHHCGGG
T ss_pred CCCCccceeCHHHhccccCCCEEEeCCCCcccccccHHHHHHHHHhcccc
Confidence 999999988876 4 58899999999999999996 77787787655443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.44 E-value=6.9e-13 Score=150.30 Aligned_cols=262 Identities=10% Similarity=0.140 Sum_probs=198.6
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccc
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (956)
++.+.+.+ +++..-..+|.+. +|+.+.|..| ++.+-..+|.+. +|+.++|.+ .++..-+..|.++++|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 33444433 4444445677774 7999999876 775666778774 799999986 67766778899999999999999
Q ss_pred ccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCC
Q 002178 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (956)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (956)
|+++.....+|. ..+|+.+.|.+| +...-..+|.++++|+.++|.+| ++..-..+|.+ .+|+.+.|. |.++. .-
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~-I~ 263 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN-IA 263 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE-EC
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE-EC
Confidence 999866666676 589999999855 76566778999999999999875 56566677877 789999994 45653 34
Q ss_pred cccccCCCCCcEEeccCCCCc-----cCCC-CCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccCCcCCCCCch
Q 002178 244 PASYSNMSKLLKLSLRNCSLQ-----GPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPS 315 (956)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~-----~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~ 315 (956)
..+|.++++|+.+++.+|.+. .+.. .|..+++|+.++|. |.++ .++...+. .+|+.|+|..| ++.....
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 668999999999999998876 2333 48999999999999 4576 56655443 48999999655 7777788
Q ss_pred hcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCC
Q 002178 316 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (956)
Q Consensus 316 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~ 364 (956)
+|.++ +|+.|++++|.+....+..|..+. ..++.|++..|.+..
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~----~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFP----DDITVIRVPAESVEK 384 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCSC----TTCCEEEECGGGHHH
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCCC----CCccEEEeCHHHHHH
Confidence 99999 999999999998865555554432 245688888877654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.42 E-value=8.1e-13 Score=149.73 Aligned_cols=261 Identities=11% Similarity=0.104 Sum_probs=204.0
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
....++.+.+.+ .++.+-..+|.+. +|+.++|.+| ++..-..+|.+ .+|+.+.|.. .++...+.+|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence 347888888875 5665667778875 7999999887 77566677877 5799999986 6776777899999999999
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
+|.+|+++......|. ..+|+.+.|.++ ++.....+|.++++|+.++|..| ++. .-..+|.+ .+|+.+.| .|++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~-I~~~aF~~-~~L~~i~l-p~~i 259 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST-IGQEAFRE-SGITTVKL-PNGV 259 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE-ECTTTTTT-CCCSEEEE-ETTC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC-cccccccc-CCccEEEe-CCCc
Confidence 9999999955555565 689999999855 77677788999999999999876 442 34456777 89999999 5667
Q ss_pred ccCCC-CCCCCCCccEEEccCCcCC----cCCCCCCCc--cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCc
Q 002178 264 QGPMP-DLSRIPNLGYLDLSSNQLN----GSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336 (956)
Q Consensus 264 ~~~~~-~l~~l~~L~~L~Ls~N~l~----~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (956)
+.+.. .|..+++|+.+++.+|.+. ..++...+. .+|+.++|. |.++.....+|.++++|+.|.|.+| ++..
T Consensus 260 ~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I 337 (401)
T 4fdw_A 260 TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI 337 (401)
T ss_dssp CEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred cEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence 76655 5999999999999998875 125554443 389999999 5588788899999999999999665 6644
Q ss_pred CChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCC-CCcEEEecCCc
Q 002178 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP-PNVTVRLRGNP 383 (956)
Q Consensus 337 ~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~-~l~~l~l~~Np 383 (956)
-..+|..+ .|+.|++++|.+..++... .++ .+..|++..|.
T Consensus 338 ~~~aF~~~------~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 338 NFSAFNNT------GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp CTTSSSSS------CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred cHHhCCCC------CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 45566543 4669999999999887653 354 56788887765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=3e-13 Score=134.23 Aligned_cols=104 Identities=20% Similarity=0.251 Sum_probs=48.4
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
+.|++++++|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 345555555543 333332 44555555555555444444455555555555555554444444444444444444444
Q ss_pred cccCCCCccccccccCCeeecccCcCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (956)
+|++..+..|.++++|++|+|++|.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 444433334444444444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.4e-13 Score=134.32 Aligned_cols=104 Identities=21% Similarity=0.269 Sum_probs=54.8
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
+.+++++++|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34566666553 3444443 55556666666555555555555555555555555555444444455555555555555
Q ss_pred cccCCCCccccccccCCeeecccCcCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (956)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555443434555555555555555444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=144.46 Aligned_cols=112 Identities=17% Similarity=0.258 Sum_probs=89.2
Q ss_pred CC-CCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccC-CCCcccCCcccccCcccchhhccC
Q 002178 62 PC-TSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLNG 139 (956)
Q Consensus 62 ~c-~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~Ls~ 139 (956)
.| .|.|.+|.|.+. ++|++ +|. |..+++|++|+|++ |+|++..+..|++|++|++|+|++
T Consensus 4 ~c~~C~~~~v~~~~~----------------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~ 65 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRD----------------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65 (347)
T ss_dssp SSCCSSSSCEECCSS----------------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCS
T ss_pred cCccccCCEEEcCCC----------------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCC
Confidence 46 567878877432 14554 667 88899999999986 899877778899999999999999
Q ss_pred cCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCC
Q 002178 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192 (956)
Q Consensus 140 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 192 (956)
|+|++..|..|.+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.|..
T Consensus 66 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999988888888899999999999988876666666665 8888888887763
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-12 Score=143.82 Aligned_cols=113 Identities=19% Similarity=0.230 Sum_probs=77.8
Q ss_pred ccCEEEccC-CcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCc
Q 002178 298 NITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNV 375 (956)
Q Consensus 298 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~ 375 (956)
+|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|..+.+ |+.|+|++|+|+++|... ....|.
T Consensus 32 ~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-----L~~L~l~~N~l~~~~~~~~~~~~L~ 106 (347)
T 2ifg_A 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR-----LSRLNLSFNALESLSWKTVQGLSLQ 106 (347)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC-----CCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcC-----CCEEeCCCCccceeCHHHcccCCce
Confidence 455566654 5666566667777777777777777777766666655443 447777777777776653 333488
Q ss_pred EEEecCCcccccCCcccccCCCCCCCcccCcCCCCCCccccCc
Q 002178 376 TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQS 418 (956)
Q Consensus 376 ~l~l~~Np~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~ 418 (956)
.|+|.+|+|.|+|++.+|..|.......+ ....+.|.++.
T Consensus 107 ~l~l~~N~~~c~c~l~~~~~~~~~~~~~l---~~~~~~C~~~~ 146 (347)
T 2ifg_A 107 ELVLSGNPLHCSCALRWLQRWEEEGLGGV---PEQKLQCHGQG 146 (347)
T ss_dssp EEECCSSCCCCCGGGHHHHHHHHTTCSSC---GGGCCCCSSSS
T ss_pred EEEeeCCCccCCCccHHHHHHHHhCcccc---cccCCCCCCCh
Confidence 99999999999999999998876543322 23456776643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=127.87 Aligned_cols=144 Identities=14% Similarity=0.088 Sum_probs=112.2
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEe
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.-+.|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456877788888888999999854 6889999986422122336888999999885 6778889999988889999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------------------------------------- 741 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 741 (956)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987641 1122346888999999999981
Q ss_pred -----------------CCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 742 -----------------ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 742 -----------------~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
..+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01348999999999999876666799999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-13 Score=154.77 Aligned_cols=94 Identities=17% Similarity=0.150 Sum_probs=48.7
Q ss_pred CCCCcEEeccCCCCccCC-----CCCCCCCCccEEEccCCcCCcCC----CCCC-CccccCEEEccCCcCCCC----Cch
Q 002178 250 MSKLLKLSLRNCSLQGPM-----PDLSRIPNLGYLDLSSNQLNGSI----PPGR-LSLNITTIKLSNNKLTGT----IPS 315 (956)
Q Consensus 250 l~~L~~L~Ls~N~l~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~----p~~~-~~~~L~~L~Ls~N~l~~~----~p~ 315 (956)
.++|+.|+|++|.|+... ..+...++|++|+|++|.|+... .... ...+|+.|+|++|.|+.. ++.
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~ 233 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence 344555555555554311 11234455556666666554211 1111 112566666666666542 334
Q ss_pred hcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 316 NFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 316 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
.+...++|++|+|++|.|++.....+..
T Consensus 234 ~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 234 AAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 4555678888888888887655555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=2e-13 Score=153.20 Aligned_cols=162 Identities=15% Similarity=0.170 Sum_probs=78.9
Q ss_pred CCCCEEEccCCCCcccCCcccccC-----cccchhhccCcCCCCCCCCcc-CCCcccceeecccccccCCCCccc-----
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNI-----KSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSF----- 174 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 174 (956)
++|++|+|++|.|+......+..+ ++|++|+|++|.++......+ ..+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456677777777664333333222 466666666666653222222 123455555555555542222222
Q ss_pred cccccCCeeecccCcCCCC----CccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCC
Q 002178 175 ANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250 (956)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l 250 (956)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++... ..+...+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~---------------------~~L~~~L~~~ 210 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGL---------------------ELLAAQLDRN 210 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHH---------------------HHHHHHGGGC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHH---------------------HHHHHHHhcC
Confidence 1234455555555554321 22222334444444444444432100 0123345555
Q ss_pred CCCcEEeccCCCCccCCC-----CCCCCCCccEEEccCCcCCc
Q 002178 251 SKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNG 288 (956)
Q Consensus 251 ~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~ 288 (956)
++|+.|+|++|.|+.... .+...++|++|+|++|.|+.
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 667777777777654221 13445677888888887763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.02 E-value=5.2e-09 Score=118.59 Aligned_cols=281 Identities=14% Similarity=0.033 Sum_probs=152.2
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
.++++.|.. +++..-..+|.++++|+.++|..+ ++..-..+|.++++|+.+.+..+ +.......|.+...++.....
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~ 148 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPE 148 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCc
Confidence 466666643 355444556667777777777543 44344455666666666655443 221222233333222221111
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCC---
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE--- 239 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--- 239 (956)
.. ......+|.++++|+.+.+.++... .-...|.++.+|+.+.+..| ++.....+|.++..|+.+.+..+...
T Consensus 149 ~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~ 224 (394)
T 4fs7_A 149 GV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGD 224 (394)
T ss_dssp TC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECT
T ss_pred cc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeeh
Confidence 11 1122345666666666666544322 33445566666666666554 33333445555555555555443221
Q ss_pred ---------CC--------CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCC--ccccC
Q 002178 240 ---------GT--------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNIT 300 (956)
Q Consensus 240 ---------~~--------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~ 300 (956)
.+ .-...|.++.+|+.+.+..+...-....|.....|+.+.+..+.+ +...+ ..+|+
T Consensus 225 ~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i----~~~~F~~~~~L~ 300 (394)
T 4fs7_A 225 FALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV----PEKTFYGCSSLT 300 (394)
T ss_dssp TTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE----CTTTTTTCTTCC
T ss_pred hhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee----cccccccccccc
Confidence 00 112344555666666665554433333466666666666655432 23222 33788
Q ss_pred EEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEE
Q 002178 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVR 378 (956)
Q Consensus 301 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~ 378 (956)
.+.+.++ ++.....+|.++.+|+.++|.++ ++..-..+|..+.+ |+.++|..| ++.+... | ...+|+.+.
T Consensus 301 ~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~-----L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 301 EVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTS-----LSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp EEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTT-----CCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred ccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCC-----CCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 8888765 66566788899999999998754 66444456655444 457888766 7777654 3 457788888
Q ss_pred ecCC
Q 002178 379 LRGN 382 (956)
Q Consensus 379 l~~N 382 (956)
+..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 7654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=4.1e-10 Score=119.63 Aligned_cols=129 Identities=21% Similarity=0.151 Sum_probs=97.2
Q ss_pred eeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeeecccccCCcEEEEEecCCCCCHHHH
Q 002178 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710 (956)
Q Consensus 633 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~ 710 (956)
+.|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 3555689999987778889999976542 235778999999886544 456888888778899999999998884
Q ss_pred HhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC------------------------------------------------
Q 002178 711 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------------------ 742 (956)
Q Consensus 711 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 742 (956)
... . ....++.++++.|..||+..
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 1 12356777888888888643
Q ss_pred -------CCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 743 -------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 743 -------~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.1e-09 Score=118.82 Aligned_cols=141 Identities=22% Similarity=0.316 Sum_probs=104.9
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEec--CCC-hhhHHHHHHHHHHHHhcC--CCceeeeecccccC---CcEEEEEe
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQ--EGS-LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEE---GEQMLVYE 700 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~LV~e 700 (956)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4578999999999998754 578888765 322 123457788999999997 45578888888765 45899999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------- 742 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 742 (956)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99987774421 123667788889999999999999731
Q ss_pred -----------------CCCEeccCCCcccEEEcCCCc--EEEEeeccccc
Q 002178 743 -----------------DPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 774 (956)
Q Consensus 743 -----------------~~~ivH~Dlk~~NILl~~~~~--~kl~DfGla~~ 774 (956)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999999864
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.7e-08 Score=112.69 Aligned_cols=180 Identities=10% Similarity=-0.050 Sum_probs=125.6
Q ss_pred ccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCcc
Q 002178 94 LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 173 (956)
Q Consensus 94 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 173 (956)
++..-..+|.++++|+.+.|.. .++.+-..+|.++++|+.++|.++ ++..-...|.++.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 3334456899999999999974 477566778999999999999865 56456678999999999888765 44355667
Q ss_pred ccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCC
Q 002178 174 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253 (956)
Q Consensus 174 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 253 (956)
|.++..+.......... .-..+|.++.+|+.+.+.++..+ ....+|.++.+|+.+.+..| ++. .....|.++..|
T Consensus 136 F~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~-I~~~~F~~~~~L 210 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKI-IRDYCFAECILL 210 (394)
T ss_dssp TTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCE-ECTTTTTTCTTC
T ss_pred eecccccccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceE-eCchhhcccccc
Confidence 77776554444333322 33567899999999999876433 55678999999999999877 432 334578888888
Q ss_pred cEEeccCCCCccCCCCCCCCCCccEEEcc
Q 002178 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282 (956)
Q Consensus 254 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 282 (956)
+.+.+..+.... ........+|+.+.+.
T Consensus 211 ~~i~~~~~~~~i-~~~~~~~~~l~~i~ip 238 (394)
T 4fs7_A 211 ENMEFPNSLYYL-GDFALSKTGVKNIIIP 238 (394)
T ss_dssp CBCCCCTTCCEE-CTTTTTTCCCCEEEEC
T ss_pred ceeecCCCceEe-ehhhcccCCCceEEEC
Confidence 888876654321 1222233455555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=7.8e-09 Score=112.68 Aligned_cols=192 Identities=16% Similarity=0.130 Sum_probs=120.5
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCc--eeeeecccccCC---cEEEEEecC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRN--LVSLVGYCDEEG---EQMLVYEFM 702 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~LV~e~~ 702 (956)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 45888886532 34567889999998884 332 344555443332 358899999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------------------------------------- 741 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 741 (956)
+|.++.+.... .++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888653321 255666777888888888888851
Q ss_pred --------------CCCCEeccCCCcccEEEcC--CCcEEEEeeccccccCCCCCCCcc-------ccceecccccCCCc
Q 002178 742 --------------ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIV-------PAHVSTVVKGTPGY 798 (956)
Q Consensus 742 --------------~~~~ivH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~-------~~~~~~~~~gt~~y 798 (956)
..+.++|+|+++.||++++ ...+.|+||+.+..-.....-... ............++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 556889999998653211000000 00000000001111
Q ss_pred cc-ccccccCCCCCcccchhHHHHHHHHHhCCCCC
Q 002178 799 LD-PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832 (956)
Q Consensus 799 ~a-PE~~~~~~~~~~sDVwS~G~ll~elltg~~pf 832 (956)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12258999999999999998776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.2e-09 Score=121.37 Aligned_cols=134 Identities=19% Similarity=0.252 Sum_probs=65.6
Q ss_pred cCCCcccceecccccc-cCCCCCcccCCcchhhhhcccCCcCCCCCCccccc--CCCCCcEEeccC--CCCccC------
Q 002178 198 LSRLPSLVHMLLDNNN-LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS--NMSKLLKLSLRN--CSLQGP------ 266 (956)
Q Consensus 198 l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~------ 266 (956)
+..+|+|+.|+|++|. +. ++. +. +++|+.|+|..|.+.. .....+. .+++|+.|+|+. |...+.
T Consensus 168 l~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~-~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPD-SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCH-HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCCh-HHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 3444555555555542 11 111 22 4556666665555532 1112222 456666666642 111111
Q ss_pred CCCC--CCCCCccEEEccCCcCCcCCCCCC----CccccCEEEccCCcCCCCC----chhcCCCCcCCeEecccccCCCc
Q 002178 267 MPDL--SRIPNLGYLDLSSNQLNGSIPPGR----LSLNITTIKLSNNKLTGTI----PSNFSGLPRLQRLFIANNSLSGS 336 (956)
Q Consensus 267 ~~~l--~~l~~L~~L~Ls~N~l~~~~p~~~----~~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~ 336 (956)
.+.+ ..+++|+.|+|++|.+.+..+... ...+|++|+|+.|.|++.. +..+..+++|+.|+|++|.|+..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 1111 245677777777777653322111 2236777777777666532 22233456777777777766643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.72 E-value=9.8e-10 Score=122.15 Aligned_cols=183 Identities=12% Similarity=0.200 Sum_probs=91.1
Q ss_pred ceeeEEEeCCCCccc-c-------CCcCcCCCCCCCEEEccCCCCc---------ccCCcccccCcccchhhccCcCCCC
Q 002178 82 LHLRELQLLNLNLSG-N-------LSPEIGRLSYLTILDFMWNKIS---------GSIPKEIGNIKSLELLLLNGNELTG 144 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~-~-------~~~~l~~l~~L~~L~Ls~N~l~---------~~ip~~~~~l~~L~~L~Ls~N~l~~ 144 (956)
.+++.|.+......| . +..++.++++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 357777777665542 1 2334566788888888665331 123333455566666666665211
Q ss_pred CCCCccCCCcccceeecccccccCCCCcccc--ccccCCeeeccc--CcCCCCCccccCCCcccceecccccccCCCCCc
Q 002178 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFA--NLNKTRHFHMNN--NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (956)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 220 (956)
.++. + .+++|++|+|..+.+.......+. .+++|+.|+|+. |...+... +. .+..
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~------------------~~-~l~~ 244 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD------------------MN-VFRP 244 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC------------------GG-GTGG
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh------------------HH-HHHH
Confidence 1222 2 255666666665554422222222 455555555532 11111100 00 0001
Q ss_pred cc--CCcchhhhhcccCCcCCCCCCcccc---cCCCCCcEEeccCCCCccC-----CCCCCCCCCccEEEccCCcCC
Q 002178 221 EL--SELPKLLILQLDNNNFEGTTIPASY---SNMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 221 ~l--~~l~~L~~L~Ls~N~l~~~~~p~~~---~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
.+ ..+++|+.|+|++|.+.+ ..+..+ ..+++|++|+|+.|.++.. ...+..+++|+.|+|++|.|+
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~-~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQN-VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHH-HHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHhcCCCCCcCEEeCCCCCCch-HHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 11 134566666666665542 111112 2456777777777777652 222345677888888888776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.70 E-value=2.9e-07 Score=104.09 Aligned_cols=282 Identities=13% Similarity=0.137 Sum_probs=146.3
Q ss_pred eeEEEeCCCCccccCCcCcCCCCCCCEEEccCCC---CcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceee
Q 002178 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK---ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (956)
Q Consensus 84 ~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~---l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (956)
++++.+.. +++..-..+|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+.++ ++......|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 45555543 2444445566777777777776553 44344456666677776666554 3334455666677777777
Q ss_pred cccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC
Q 002178 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (956)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (956)
+..+. .......|.++.+|+.+.+.++ +...-..+|. ...|+.+.+..+-.. ....+|.++.+|+......+....
T Consensus 144 lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred cccee-eeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 75432 3244556666777777766554 3312223333 345666666544322 333445555555554444333221
Q ss_pred CCCccc--------------ccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCCCC--ccccCEEE
Q 002178 241 TTIPAS--------------YSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIK 303 (956)
Q Consensus 241 ~~~p~~--------------~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~ 303 (956)
.... +.....+..+.+. +.++.... .|..+.+|+.+.+..+..+ +....+ ..+|+.+.
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~ 294 (394)
T 4gt6_A 220 --IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIE 294 (394)
T ss_dssp --SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEE
T ss_pred --ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce--ecCccccccccccccc
Confidence 0000 0011122222221 11222112 3666677777777655432 333322 23677777
Q ss_pred ccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecC
Q 002178 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRG 381 (956)
Q Consensus 304 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~ 381 (956)
+. +.++.....+|.++.+|+.+.|.++ ++..-..+|..+.+ |+.+.|..+ ++.+... | ...+|..+.+.+
T Consensus 295 l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~-----L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 295 FS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ-----LERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT-----CCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred CC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC-----CCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 75 4455555667777777777777654 44333344544333 346777543 6666554 3 356777888877
Q ss_pred Ccc
Q 002178 382 NPF 384 (956)
Q Consensus 382 Np~ 384 (956)
|.-
T Consensus 367 ~~~ 369 (394)
T 4gt6_A 367 SRS 369 (394)
T ss_dssp CHH
T ss_pred cee
Confidence 753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.60 E-value=6.4e-07 Score=101.29 Aligned_cols=267 Identities=11% Similarity=0.097 Sum_probs=181.5
Q ss_pred CcCcCCCC-CCCEEEccCCCCcccCCcccccCcccchhhccCcC---CCCCCCCccCCCcccceeecccccccCCCCccc
Q 002178 99 SPEIGRLS-YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE---LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 174 (956)
Q Consensus 99 ~~~l~~l~-~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 174 (956)
..+|.+.. .|+.+.|.. .++.+-..+|.++++|+.+.++.|. ++..-..+|.++.+|+.+.+..+ ++.....+|
T Consensus 56 ~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 45677774 599999975 4776667889999999999998875 55455677888999999888765 444566788
Q ss_pred cccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCc
Q 002178 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254 (956)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 254 (956)
.++.+|+.+.+..+. ...-...|..+.+|+.+.+.++ ++..-..+|.. .+|+.+.+..+-.. .....|.++.+|+
T Consensus 134 ~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~--i~~~af~~c~~l~ 208 (394)
T 4gt6_A 134 HHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR--IGTNAFSECFALS 208 (394)
T ss_dssp TTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE--ECTTTTTTCTTCC
T ss_pred hhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc--cccchhhhccccc
Confidence 999999999997543 3355667888999999999765 44344455654 56888888765443 3445788888888
Q ss_pred EEeccCCCCccCCCC--------------CCCCCCccEEEccCCcCCcCCCCCCC--ccccCEEEccCCcCCCCCchhcC
Q 002178 255 KLSLRNCSLQGPMPD--------------LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFS 318 (956)
Q Consensus 255 ~L~Ls~N~l~~~~~~--------------l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~ 318 (956)
......+........ +.....+..+.+..+ ++ .+....+ ..+|+.+.+.++..+ ....+|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~-~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~ 285 (394)
T 4gt6_A 209 TITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VA-RIETHAFDSCAYLASVKMPDSVVS-IGTGAFM 285 (394)
T ss_dssp EEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EE-EECTTTTTTCSSCCEEECCTTCCE-ECTTTTT
T ss_pred eecccccccccccceeecccccccccccccccccccceEEcCCc-ce-EcccceeeecccccEEecccccce-ecCcccc
Confidence 887776655432221 112223334433322 22 2222222 237999999876543 6678899
Q ss_pred CCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCC
Q 002178 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGN 382 (956)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~-~-~~~~l~~l~l~~N 382 (956)
++++|+.+.+. +.++......|..+. +|+.++|..| ++.+... | ....|..+.|..+
T Consensus 286 ~c~~L~~i~l~-~~i~~I~~~aF~~c~-----~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 286 NCPALQDIEFS-SRITELPESVFAGCI-----SLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp TCTTCCEEECC-TTCCEECTTTTTTCT-----TCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred cccccccccCC-CcccccCceeecCCC-----CcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 99999999996 556634444555444 4558999764 8887664 4 4678888888655
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.7e-08 Score=94.63 Aligned_cols=85 Identities=20% Similarity=0.282 Sum_probs=58.1
Q ss_pred eEecccccCC-CcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCcccccCCCCCCC
Q 002178 325 RLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD 401 (956)
Q Consensus 325 ~L~L~~N~l~-~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~ 401 (956)
.++.+++.|+ ..+|..+ ..+|+.|+|++|+|+.++... .++.+..|+|.+|||.|||++.+|..|+....
T Consensus 12 ~v~Cs~~~L~~~~vP~~l-------p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~ 84 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF-------PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRP 84 (130)
T ss_dssp EEECCSSCCCTTTSCSCC-------CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSS
T ss_pred EEEeCCCCCccccCCCCC-------CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCc
Confidence 4555555554 2444332 123567778888888777664 47888999999999999999999999987654
Q ss_pred cccCcCCCCCCccccCcC
Q 002178 402 NEIDRSTNSTLDCRAQSC 419 (956)
Q Consensus 402 ~~~~~~~~~~~~c~~~~c 419 (956)
.... ...+.|.+|.-
T Consensus 85 ~~~~---~~~~~C~~P~~ 99 (130)
T 3rfe_A 85 ERAP---YRDLRCVAPPA 99 (130)
T ss_dssp CSGG---GTTCBCCBSTT
T ss_pred cccc---ccCcEeCcChH
Confidence 3222 24577877543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.57 E-value=2.2e-10 Score=120.89 Aligned_cols=40 Identities=10% Similarity=0.287 Sum_probs=19.4
Q ss_pred CCcccceeecccccccC--CCCccccccccCCeeecccCcCC
Q 002178 152 YLPKLDRIQIDQNYISG--SLPKSFANLNKTRHFHMNNNSIS 191 (956)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~ 191 (956)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 34455555555555554 22334444455555555555544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=3e-08 Score=104.53 Aligned_cols=96 Identities=20% Similarity=0.313 Sum_probs=68.9
Q ss_pred EEccCCCCc---ccCCcccccCcccchhhccCcCCCC--CCCCccCCCcccceeecccccccCCCCccccccc--cCCee
Q 002178 111 LDFMWNKIS---GSIPKEIGNIKSLELLLLNGNELTG--SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN--KTRHF 183 (956)
Q Consensus 111 L~Ls~N~l~---~~ip~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L 183 (956)
++++.|... +.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 566667433 2222223568899999999999997 4567778899999999999999865 3344444 88888
Q ss_pred ecccCcCCCCCcc-------ccCCCcccceec
Q 002178 184 HMNNNSISGQIPP-------ELSRLPSLVHML 208 (956)
Q Consensus 184 ~L~~N~l~~~~p~-------~l~~l~~L~~L~ 208 (956)
+|++|.+.+.+|. .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 8888888865552 245566666665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.9e-06 Score=89.75 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=91.8
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC---ceeeeecccc-cCCcEEEEEecCCC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCD-EEGEQMLVYEFMSN 704 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~LV~e~~~~ 704 (956)
.+.++.|....||+. |+.+++|+.. .......+.+|+++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 4668888753 233446788999999999752 3556666663 45678899999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------------------------------------------- 741 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 741 (956)
.++.+..-. .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 887653211 123333444444444444444432
Q ss_pred --------------CCCCEeccCCCcccEEEcC---CCc-EEEEeeccccc
Q 002178 742 --------------ADPPVFHRDIKASNILLDH---KFT-AKVADFGLSRL 774 (956)
Q Consensus 742 --------------~~~~ivH~Dlk~~NILl~~---~~~-~kl~DfGla~~ 774 (956)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 455 58999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=4.2e-08 Score=98.31 Aligned_cols=118 Identities=14% Similarity=0.177 Sum_probs=68.8
Q ss_pred CCcCcCCCCCCCEEEccCC-CCcc----cCCcccccCcccchhhccCcCCCCC----CCCccCCCcccceeecccccccC
Q 002178 98 LSPEIGRLSYLTILDFMWN-KISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISG 168 (956)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N-~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 168 (956)
+...+...+.|++|+|++| .|.. .+...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445666778888888887 7763 2334455567777777777777632 22233344567777777776653
Q ss_pred C----CCccccccccCCeeec--ccCcCCCC----CccccCCCcccceecccccccC
Q 002178 169 S----LPKSFANLNKTRHFHM--NNNSISGQ----IPPELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 169 ~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 215 (956)
. +...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2 2344555556666666 55666532 2233334456666666666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.19 E-value=3e-05 Score=86.85 Aligned_cols=247 Identities=10% Similarity=0.044 Sum_probs=118.3
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
+++++.+.. +++..-..+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++..-...|.. .+|+.+.+.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCC
Confidence 466666653 455555667888888888888644 664555667766 5666666543 44233334443 478888876
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCC------------CCCcccCCcchhhh
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG------------YLPPELSELPKLLI 230 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~------------~~p~~l~~l~~L~~ 230 (956)
.+... .....|.+. +|+.+.+..+ ++..-...|..+.+++.+.+..+.... .....+....++..
T Consensus 122 ~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 122 GATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp TTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred Ccccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 55322 333344443 4555544432 222334455566666665554433220 01111222222222
Q ss_pred hcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC-CCCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccCC
Q 002178 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM-PDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNN 307 (956)
Q Consensus 231 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N 307 (956)
+.+..+.-. .....+....+|+.+.+..+ ++... ..+..+.+|+.+.+..+ ++ .+....+. .+|+.+.+..+
T Consensus 199 ~~~~~~~~~--i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~ 273 (379)
T 4h09_A 199 FTIPSTVKT--VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK 273 (379)
T ss_dssp EECCTTCCE--ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC
T ss_pred cccccceeE--Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc
Confidence 222221111 12233444555555555433 22222 23455555555555544 33 23322221 24555555433
Q ss_pred cCCCCCchhcCCCCcCCeEecccccCCCcCChhhhh
Q 002178 308 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (956)
Q Consensus 308 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 343 (956)
++......|.++++|+.+.+.++.++..-..+|..
T Consensus 274 -i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 274 -VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp -CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred -ceeccccccccccccccccccccccceehhhhhcC
Confidence 33344455556666666666555555333334433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=7.4e-06 Score=87.18 Aligned_cols=135 Identities=16% Similarity=0.147 Sum_probs=98.1
Q ss_pred eeeeeCCe-EEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEecCCCCCH
Q 002178 631 QIGQGGYG-KVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 631 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556665 68988754 5678899986532 3456788999998885 33466888888888899999999999888
Q ss_pred HHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 002178 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--------------------------------------------- 742 (956)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 742 (956)
.+..... ......++.++++.|.-||+..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765331 1223456666777777777421
Q ss_pred ----------CCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 743 ----------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 743 ----------~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11378999999999999887778999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.10 E-value=7.4e-05 Score=83.64 Aligned_cols=252 Identities=11% Similarity=0.057 Sum_probs=153.8
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeec
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (956)
.+++++.|.+ +++..-..+|.+. .|+.+.+..+ ++..-..+|.. .+|+.+.+.++- +......|.+ .+|+.+.+
T Consensus 69 ~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~-~~l~~~~~ 142 (379)
T 4h09_A 69 YNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYN-SSVKRIVI 142 (379)
T ss_dssp TTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTT-CCCCEEEE
T ss_pred CCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcc-cccccccccc-ceeeeeec
Confidence 4688888864 4665556678776 6888888654 55344455655 479999887653 3233344444 46766666
Q ss_pred ccccccCCCCccccccccCCeeecccCcCCC------------CCccccCCCcccceecccccccCCCCCcccCCcchhh
Q 002178 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISG------------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229 (956)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~------------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 229 (956)
..+ ++......|.++.+|+.+.+..+.... .....+.....+..+.+..+.-. .....+....+|+
T Consensus 143 ~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~ 220 (379)
T 4h09_A 143 PKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLK 220 (379)
T ss_dssp CTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCS
T ss_pred cce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccc
Confidence 544 333556677788888887776554321 11223334445555544433222 3344566667777
Q ss_pred hhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCC-CCCCCCCccEEEccCCcCCcCCCCCCCc--cccCEEEccC
Q 002178 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 306 (956)
Q Consensus 230 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~ 306 (956)
.+.+..+- +. .....|.++.+|+.+.+..+ ++.+.. .|..+.+|+.+.+..+ ++ .++...+. .+|+.+.+.+
T Consensus 221 ~i~~~~~~-~~-i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~ 295 (379)
T 4h09_A 221 KITITSGV-TT-LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDN 295 (379)
T ss_dssp EEECCTTC-CE-ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECC
T ss_pred eeeeccce-eE-EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccc
Confidence 77775542 21 23456777888888888765 544433 4777788888888654 44 44444332 3788888888
Q ss_pred CcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccC
Q 002178 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (956)
Q Consensus 307 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 347 (956)
+.++.....+|.++.+|+.+.|.++ ++..-..+|..+.+|
T Consensus 296 ~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 296 SAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred cccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 8887777788888888888888654 553334455444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=2.1e-07 Score=93.11 Aligned_cols=110 Identities=15% Similarity=0.216 Sum_probs=88.4
Q ss_pred ceeeEEEeCCC-Ccccc----CCcCcCCCCCCCEEEccCCCCcc----cCCcccccCcccchhhccCcCCCCC----CCC
Q 002178 82 LHLRELQLLNL-NLSGN----LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGS----LPE 148 (956)
Q Consensus 82 ~~~~~L~L~~~-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~----~p~ 148 (956)
..++.|+|++| .+... +...+...++|++|+|++|+|.. .+...+...++|++|+|++|.|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 36899999999 88753 45667788999999999999975 2445566678999999999999843 455
Q ss_pred ccCCCcccceeec--ccccccCC----CCccccccccCCeeecccCcCC
Q 002178 149 ELGYLPKLDRIQI--DQNYISGS----LPKSFANLNKTRHFHMNNNSIS 191 (956)
Q Consensus 149 ~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 191 (956)
.+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6777889999999 88998743 3345666789999999999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=4.7e-06 Score=92.67 Aligned_cols=79 Identities=4% Similarity=-0.005 Sum_probs=54.2
Q ss_pred Cee-eeeCCeEEEEEEeC-------CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCC---CceeeeecccccC---
Q 002178 630 TQI-GQGGYGKVYKGILP-------DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH---RNLVSLVGYCDEE--- 692 (956)
Q Consensus 630 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~--- 692 (956)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 26778899865422 1012356778888888742 3466778777554
Q ss_pred CcEEEEEecCCCCCHH
Q 002178 693 GEQMLVYEFMSNGTLR 708 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~ 708 (956)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=5.9e-05 Score=83.01 Aligned_cols=140 Identities=18% Similarity=0.159 Sum_probs=79.8
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--Cceeeeecc------cccCCcEEEEEec
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGY------CDEEGEQMLVYEF 701 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~------~~~~~~~~LV~e~ 701 (956)
+.|+.|..+.||+....+| .+++|+.... ...+..|+++++.+.. -.+.+++.. ....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987655 4889988752 2234455565555531 123444431 1245678999999
Q ss_pred CCCCCHH--------------HHHhhc--CC--C--------CchhHH-------------------------------H
Q 002178 702 MSNGTLR--------------DQLSAK--SK--E--------PLGFAM-------------------------------R 724 (956)
Q Consensus 702 ~~~gsL~--------------~~l~~~--~~--~--------~l~~~~-------------------------------~ 724 (956)
++|.++. ..+|.. .. . .-.|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 112211 00 0 011111 0
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 725 LSIALGSSRGILYLHT----------EADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 725 ~~i~~~ia~gL~yLH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
..+...+.+++.+|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666763 1234599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=8.4e-05 Score=83.83 Aligned_cols=75 Identities=16% Similarity=0.061 Sum_probs=48.9
Q ss_pred CCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-------hhHHHHHHHHHHHHhcCC--C-ceeeeecccccCCcEEE
Q 002178 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHH--R-NLVSLVGYCDEEGEQML 697 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~L 697 (956)
.+.||.|.++.||++... +++.|+||....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899997653211 112356778888887742 3 34455544 3345689
Q ss_pred EEecCCCC
Q 002178 698 VYEFMSNG 705 (956)
Q Consensus 698 V~e~~~~g 705 (956)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00011 Score=78.80 Aligned_cols=78 Identities=19% Similarity=0.234 Sum_probs=56.6
Q ss_pred CCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC---ceeeeecccccCCcEEEEEecC
Q 002178 626 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 626 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
....+.+|.|..+.||+....||+.|+||+...........|..|++.|+.+.-. .+.+++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3345678999999999999999999999987654443344678899999888421 234455442 347899999
Q ss_pred CCCCH
Q 002178 703 SNGTL 707 (956)
Q Consensus 703 ~~gsL 707 (956)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00022 Score=77.22 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=90.7
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeeecccccCCcEEEEEecCCCC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~LV~e~~~~g 705 (956)
.+.|+.|....+|+... ++..+++|+.... ....+..|++.|+.+. ...+.+++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999886 4667888987542 2457888999888884 356778888887778899999999987
Q ss_pred CHH--------H---HHhhcCC-CC-------------------chhHHHH---HHHH----------------HHH-HH
Q 002178 706 TLR--------D---QLSAKSK-EP-------------------LGFAMRL---SIAL----------------GSS-RG 734 (956)
Q Consensus 706 sL~--------~---~l~~~~~-~~-------------------l~~~~~~---~i~~----------------~ia-~g 734 (956)
.+. . .||.... .. -+|.... ++.. .+. ..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 642 1 2233221 00 1233221 0110 111 11
Q ss_pred HHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 735 ILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 735 L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2356799999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.33 E-value=2.8e-05 Score=75.92 Aligned_cols=83 Identities=10% Similarity=0.076 Sum_probs=39.2
Q ss_pred ceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCC-CcccCCcccccC----cccchhhccCcC-CCCCCCCccCCCcc
Q 002178 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK-ISGSIPKEIGNI----KSLELLLLNGNE-LTGSLPEELGYLPK 155 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~ip~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 155 (956)
.++++|||+++.++..--..+..+++|++|+|++|. |+..--..+..+ ++|++|+|++|. +|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666555433445566666666666663 443222223332 245555555543 44222222333444
Q ss_pred cceeecccc
Q 002178 156 LDRIQIDQN 164 (956)
Q Consensus 156 L~~L~Ls~N 164 (956)
|++|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 444444443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00071 Score=76.76 Aligned_cols=73 Identities=11% Similarity=0.151 Sum_probs=44.9
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecC------CC---hhhHHHHHHHHHHHH-hcCCCceeeeecccccCCcEEEE
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQE------GS---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
.+.||.|..+.||++.. +++.++||.... .. ......+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999965 567899994321 01 012233444443322 22334566676665 4667999
Q ss_pred EecC-CC
Q 002178 699 YEFM-SN 704 (956)
Q Consensus 699 ~e~~-~~ 704 (956)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.21 E-value=6e-05 Score=73.60 Aligned_cols=84 Identities=10% Similarity=0.049 Sum_probs=67.3
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcC-CCCCCCCccCCC----cccceeeccccc-ccCCCCcccccccc
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPEELGYL----PKLDRIQIDQNY-ISGSLPKSFANLNK 179 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 179 (956)
.+|++|||+++.|+..--..+..+++|++|+|++|. ++..--..++.+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999987655678899999999999995 774444445554 479999999985 77443456788999
Q ss_pred CCeeecccCc
Q 002178 180 TRHFHMNNNS 189 (956)
Q Consensus 180 L~~L~L~~N~ 189 (956)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0028 Score=68.86 Aligned_cols=157 Identities=12% Similarity=0.113 Sum_probs=87.1
Q ss_pred ccHHHHHHHhcCCCC-----CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeee
Q 002178 614 FTYGEMALATNNFNS-----STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLV 686 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~ 686 (956)
++.+++...-.+|.. .+.|+.|....+|+....+| .+++|+..... ....+..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555556655 23456688889999987666 57789876521 1224556777777764222 33444
Q ss_pred ccc------ccCCcEEEEEecCCCCCHHH--------------HHhhc----CCC------CchhHHHHH----------
Q 002178 687 GYC------DEEGEQMLVYEFMSNGTLRD--------------QLSAK----SKE------PLGFAMRLS---------- 726 (956)
Q Consensus 687 ~~~------~~~~~~~LV~e~~~~gsL~~--------------~l~~~----~~~------~l~~~~~~~---------- 726 (956)
... ...+..++||+|++|..+.. .+|.. ... ...|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 221 12356789999998765310 12211 000 012222110
Q ss_pred --HHHHHHHHHHHhhhc----CCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 727 --IALGSSRGILYLHTE----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 727 --i~~~ia~gL~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
+...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011133445555532 12348999999999999987666899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0052 Score=67.08 Aligned_cols=140 Identities=15% Similarity=0.131 Sum_probs=72.3
Q ss_pred CeeeeeCCeE-EEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeeecccccCCcEEEEEecCCCCC
Q 002178 630 TQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 630 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
+.|+.|+... +|+....+++.+++|....... ..+..|+++++.+.. -.+.+++.+....+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465555444 6677654467777886543221 233456676666642 23456666544333 78999997767
Q ss_pred HHHHHhhc---------------------CC---CCchhHHHH-------H-H------------HHHHHHHHHHhh---
Q 002178 707 LRDQLSAK---------------------SK---EPLGFAMRL-------S-I------------ALGSSRGILYLH--- 739 (956)
Q Consensus 707 L~~~l~~~---------------------~~---~~l~~~~~~-------~-i------------~~~ia~gL~yLH--- 739 (956)
+.+++... .. ..++..... . + ...+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65444211 00 011111000 0 0 001111222221
Q ss_pred hcCCCCEeccCCCcccEEEcCC----CcEEEEeeccccc
Q 002178 740 TEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 774 (956)
Q Consensus 740 ~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DfGla~~ 774 (956)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0068 Score=65.95 Aligned_cols=141 Identities=17% Similarity=0.182 Sum_probs=80.5
Q ss_pred CeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeeecc-----cccCCcEEEEEecC
Q 002178 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGY-----CDEEGEQMLVYEFM 702 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~-----~~~~~~~~LV~e~~ 702 (956)
..++ |....||+....+|+.+++|....... ....+..|..+++.+.... +.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 778899998877787899999864321 2346677888887774222 3444443 12245668899999
Q ss_pred CCCCHH-----H------H---Hhhc----C---CCCchhHHH----HHH---------------HHHHHHHHHHhhhc-
Q 002178 703 SNGTLR-----D------Q---LSAK----S---KEPLGFAMR----LSI---------------ALGSSRGILYLHTE- 741 (956)
Q Consensus 703 ~~gsL~-----~------~---l~~~----~---~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~- 741 (956)
+|.++. . . +|.. . ....++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 1210 0 011111110 000 01111122232211
Q ss_pred ---CCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 742 ---ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 742 ---~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234488999999999999 4 899999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00012 Score=72.82 Aligned_cols=114 Identities=16% Similarity=0.181 Sum_probs=59.9
Q ss_pred CcCCCCCCCEEEccCC-CCcc----cCCcccccCcccchhhccCcCCCCCC----CCccCCCcccceeecccccccCC--
Q 002178 101 EIGRLSYLTILDFMWN-KISG----SIPKEIGNIKSLELLLLNGNELTGSL----PEELGYLPKLDRIQIDQNYISGS-- 169 (956)
Q Consensus 101 ~l~~l~~L~~L~Ls~N-~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~-- 169 (956)
.+.+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|+|...- -..+..-+.|++|+|++|.|+..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455567777777774 6642 23344555567777777777776322 22222345666666666666522
Q ss_pred --CCccccccccCCeeecccC---cCCC----CCccccCCCcccceeccccccc
Q 002178 170 --LPKSFANLNKTRHFHMNNN---SISG----QIPPELSRLPSLVHMLLDNNNL 214 (956)
Q Consensus 170 --~p~~~~~l~~L~~L~L~~N---~l~~----~~p~~l~~l~~L~~L~L~~N~l 214 (956)
+-.++..-+.|++|+|++| .+.. .+...+..-++|+.|+|+.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 2223344455666666544 2221 1223334445666666655543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0036 Score=67.33 Aligned_cols=71 Identities=8% Similarity=0.066 Sum_probs=43.9
Q ss_pred CCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeeecccccCCcEEEEEecC-CCCC
Q 002178 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFM-SNGT 706 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~e~~-~~gs 706 (956)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .++++++. +.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 567999999999998 458888876432111 122457777777642222 45555543 3346899999 6544
Q ss_pred H
Q 002178 707 L 707 (956)
Q Consensus 707 L 707 (956)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0038 Score=70.76 Aligned_cols=73 Identities=18% Similarity=0.214 Sum_probs=49.7
Q ss_pred CCeeeeeCCeEEEEEEeCC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeeecccccCCcEEEEE
Q 002178 629 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~ 699 (956)
.+.|+.|....+|+....+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3468888889999998653 5789999885421 11355679988888853333 566766543 3899
Q ss_pred ecCCCCCH
Q 002178 700 EFMSNGTL 707 (956)
Q Consensus 700 e~~~~gsL 707 (956)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99976443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00037 Score=69.36 Aligned_cols=82 Identities=12% Similarity=0.165 Sum_probs=38.9
Q ss_pred CCCCcEEeccCC-CCccC-----CCCCCCCCCccEEEccCCcCCcCCCCCCC-----ccccCEEEccCCcCCCC----Cc
Q 002178 250 MSKLLKLSLRNC-SLQGP-----MPDLSRIPNLGYLDLSSNQLNGSIPPGRL-----SLNITTIKLSNNKLTGT----IP 314 (956)
Q Consensus 250 l~~L~~L~Ls~N-~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-----~~~L~~L~Ls~N~l~~~----~p 314 (956)
-+.|+.|+|++| .|... ...+..-..|+.|+|++|.|....-..+. ...|++|+|++|.|... +.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 345555555553 44321 11234445566666666665422211111 12466666666666542 23
Q ss_pred hhcCCCCcCCeEecccc
Q 002178 315 SNFSGLPRLQRLFIANN 331 (956)
Q Consensus 315 ~~~~~l~~L~~L~L~~N 331 (956)
..+..-+.|++|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 34444555666666654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0073 Score=66.99 Aligned_cols=140 Identities=20% Similarity=0.219 Sum_probs=81.7
Q ss_pred CeeeeeCCeEEEEEEeC--------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEEEEEe
Q 002178 630 TQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+.|..|-...+|+.... +++.+++|+... .......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998864 247899998643 2223446678999888875 2223566766654 29999
Q ss_pred cCCCCCHHH--------------H---Hhhc----CCCCc-hhHHHHHHHHHHHH-------------------HHHHhh
Q 002178 701 FMSNGTLRD--------------Q---LSAK----SKEPL-GFAMRLSIALGSSR-------------------GILYLH 739 (956)
Q Consensus 701 ~~~~gsL~~--------------~---l~~~----~~~~l-~~~~~~~i~~~ia~-------------------gL~yLH 739 (956)
|++|.+|.. . +|.. .+.+. -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765421 1 1211 11111 23444444433321 122332
Q ss_pred ----hc-CCCCEeccCCCcccEEEcCC----CcEEEEeeccccc
Q 002178 740 ----TE-ADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 774 (956)
Q Consensus 740 ----~~-~~~~ivH~Dlk~~NILl~~~----~~~kl~DfGla~~ 774 (956)
.. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 22348899999999999876 7899999998863
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0039 Score=57.76 Aligned_cols=56 Identities=25% Similarity=0.447 Sum_probs=41.3
Q ss_pred EEEccCCcCC-cCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 278 YLDLSSNQLN-GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 278 ~L~Ls~N~l~-~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
.++.+++.|+ ..+|.. ...+|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 244543 2336788888888888777788889999999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0096 Score=67.87 Aligned_cols=74 Identities=14% Similarity=-0.011 Sum_probs=47.6
Q ss_pred CCeeeeeCCeEEEEEEeCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeeecccccCCcEEEEEecCCCCC
Q 002178 629 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFMSNGT 706 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~e~~~~gs 706 (956)
.+.|+.|-...+|+....+ +..+++|+........ -+..+|..+++.+...++ .++++++.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3568888889999998765 5788899875422111 112478888888864444 467776632 25999998754
Q ss_pred H
Q 002178 707 L 707 (956)
Q Consensus 707 L 707 (956)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0088 Score=66.32 Aligned_cols=73 Identities=14% Similarity=0.105 Sum_probs=43.1
Q ss_pred CeeeeeCCeEEEEEEeCC---------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeeecccccCCcEEEEE
Q 002178 630 TQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~LV~ 699 (956)
..|+.|....+|+....+ ++.+++|+....... ..+...|.++++.+...+ +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457778888999988654 268889987543211 112356888887775333 345665442 26899
Q ss_pred ecCCCCCH
Q 002178 700 EFMSNGTL 707 (956)
Q Consensus 700 e~~~~gsL 707 (956)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.048 Score=59.56 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=27.5
Q ss_pred CCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 744 ~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.0026 Score=69.61 Aligned_cols=62 Identities=15% Similarity=0.261 Sum_probs=42.1
Q ss_pred hcccCCCCCCCHHHHHHHHHHhHhhCCC----CCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 877 CCQDETDARPSMSEVMRELESIWNMMPE----SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 877 c~~~~p~~RPs~~~v~~~L~~~~~~~~~----~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
+....|....+..+++..+..- .++. ..+.+.+||.+||+.||++|+|++|+|+||||+...
T Consensus 219 ltG~~PF~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 219 CTLKHAFEAGSMKNLVLKIISG--SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHCCCCCCCcCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 3344555555666655544321 1221 233456899999999999999999999999997543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=95.15 E-value=0.0036 Score=66.29 Aligned_cols=63 Identities=13% Similarity=0.258 Sum_probs=44.2
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCCCC-CCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 879 QDETDARPSMSEVMRELESIWNMMPES-DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 879 ~~~p~~RPs~~~v~~~L~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...|....+..+..+.+......++.. .....+++.+||..||++|||++|+++||||+....
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 444555556666666555543333332 333467999999999999999999999999976554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=94.34 E-value=0.0083 Score=63.60 Aligned_cols=14 Identities=21% Similarity=0.071 Sum_probs=6.1
Q ss_pred ccCCCCCCCHHHHH
Q 002178 879 QDETDARPSMSEVM 892 (956)
Q Consensus 879 ~~~p~~RPs~~~v~ 892 (956)
...|...++..+..
T Consensus 208 g~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 208 GMPPFDSPSHTETH 221 (284)
T ss_dssp SSCTTCCSSHHHHH
T ss_pred CCCCCCCCCHhHHH
Confidence 33444444444443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=94.04 E-value=0.0078 Score=63.43 Aligned_cols=63 Identities=6% Similarity=0.108 Sum_probs=42.6
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCCCC-CCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 879 QDETDARPSMSEVMRELESIWNMMPES-DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 879 ~~~p~~RPs~~~v~~~L~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...|.......++.+.+..-....+.. .....+++.+||..||++|||++|+++||||..+..
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred CCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 344544455555555544322222322 334567999999999999999999999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.98 E-value=0.18 Score=50.35 Aligned_cols=100 Identities=15% Similarity=0.158 Sum_probs=64.8
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
-||.+.|... ..++++.++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4899999765 45899999999999999987766221111 1233457899999999988764 1111
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg 828 (956)
.....+.|||... ...+.+.=|||+|+++|.-+--
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0122466888763 3445677899999999998853
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.47 E-value=0.17 Score=56.71 Aligned_cols=73 Identities=12% Similarity=0.074 Sum_probs=46.5
Q ss_pred CeeeeeCCeEEEEEEeCC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeeecccccCCcEEEEEe
Q 002178 630 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~LV~e 700 (956)
+.+..|-...+|+....+ ++.+++|+...... ..-+..+|.++++.+.-.+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457777788999988653 57899998654321 1112356888887774222 345555443 278999
Q ss_pred cCCCCCH
Q 002178 701 FMSNGTL 707 (956)
Q Consensus 701 ~~~~gsL 707 (956)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.16 E-value=0.047 Score=37.94 Aligned_cols=25 Identities=24% Similarity=0.569 Sum_probs=18.2
Q ss_pred CCCCccceeehhHHHHHHHHHHHHH
Q 002178 555 SGISKAALAGIILGAIAGAVTISAI 579 (956)
Q Consensus 555 ~~~~~~~~~~ii~g~~~~~~~~~~~ 579 (956)
++.+..+++||++|+++++..+.++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l 30 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGI 30 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHHHHHHH
Confidence 4556778889999888777665554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.00 E-value=0.024 Score=60.61 Aligned_cols=63 Identities=5% Similarity=0.026 Sum_probs=41.6
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 879 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 879 ~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...|.......++.+.+......++. ..+...+++.+||..||++|||++|+++||||.....
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 33444444555555544432212221 2333468999999999999999999999999976654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=92.70 E-value=0.013 Score=64.02 Aligned_cols=35 Identities=11% Similarity=0.215 Sum_probs=30.5
Q ss_pred CCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 907 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 907 ~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+...+++.+||..||++|||++|+|+||||+.-..
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 34567999999999999999999999999976543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=92.54 E-value=0.021 Score=60.36 Aligned_cols=32 Identities=13% Similarity=0.255 Sum_probs=28.8
Q ss_pred CCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 907 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 907 ~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
....+++.+||..||++|||++|+++||||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 34568999999999999999999999999965
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=92.08 E-value=0.0098 Score=63.69 Aligned_cols=32 Identities=9% Similarity=0.268 Sum_probs=26.2
Q ss_pred ccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 910 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 910 ~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+++.+||..||++|||++|+|+||||.....
T Consensus 234 ~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 36777888888999999999999999976554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=92.03 E-value=0.021 Score=60.76 Aligned_cols=31 Identities=10% Similarity=0.223 Sum_probs=28.2
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+++.+||..||++|||++|+++||||...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3579999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=91.65 E-value=0.014 Score=61.87 Aligned_cols=22 Identities=23% Similarity=0.646 Sum_probs=20.8
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 002178 872 KLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 872 ~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
+++.+|++.+|.+||++.++++
T Consensus 245 ~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 245 DFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhhcChhhCcCHHHHHh
Confidence 9999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=91.63 E-value=0.016 Score=62.76 Aligned_cols=28 Identities=4% Similarity=0.238 Sum_probs=23.5
Q ss_pred cccccccCCCCCCCCCCccCCCCCcccc
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+++.+||..||++|||++|+|+||||++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 4677788888889999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=91.36 E-value=0.025 Score=59.99 Aligned_cols=32 Identities=16% Similarity=0.291 Sum_probs=28.6
Q ss_pred CCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 908 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 908 ~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
...+++.+||..||++|||++|+|+||||...
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 34679999999999999999999999999653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=91.15 E-value=0.017 Score=61.59 Aligned_cols=33 Identities=24% Similarity=0.481 Sum_probs=29.8
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 893 (956)
.....++..+.+++.+||+.+|.+||++.++++
T Consensus 255 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 356788999999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.94 E-value=0.08 Score=56.73 Aligned_cols=34 Identities=21% Similarity=0.446 Sum_probs=30.0
Q ss_pred CCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 908 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 908 ~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...+++.+||..||++|||++|+++||||.+...
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 3457999999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=90.59 E-value=0.011 Score=64.55 Aligned_cols=32 Identities=9% Similarity=0.297 Sum_probs=25.1
Q ss_pred ccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 910 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 910 ~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
.+++.+||..||++|||++|+|+||||.....
T Consensus 265 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 35777788888888888888888999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.38 E-value=0.04 Score=58.46 Aligned_cols=31 Identities=10% Similarity=0.224 Sum_probs=22.2
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+++.+||..||++|||++|+|+||||.....
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 4666677788888888888888999875543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.18 E-value=0.38 Score=34.46 Aligned_cols=14 Identities=21% Similarity=0.282 Sum_probs=5.5
Q ss_pred ceeehhHHHHHHHH
Q 002178 561 ALAGIILGAIAGAV 574 (956)
Q Consensus 561 ~~~~ii~g~~~~~~ 574 (956)
++++.++|.+++++
T Consensus 12 ~IA~gVVgGv~~~~ 25 (44)
T 2ks1_B 12 SIATGMVGALLLLL 25 (44)
T ss_dssp SSTHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHH
Confidence 34444444333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.08 E-value=0.74 Score=51.26 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=24.9
Q ss_pred EeccCCCcccEEE------cCCCcEEEEeeccccc
Q 002178 746 VFHRDIKASNILL------DHKFTAKVADFGLSRL 774 (956)
Q Consensus 746 ivH~Dlk~~NILl------~~~~~~kl~DfGla~~ 774 (956)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567899999998864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.034 Score=60.62 Aligned_cols=29 Identities=10% Similarity=0.273 Sum_probs=18.8
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
+++.+||..||++|||++|+++||||+..
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 45555666666666777777777777553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.83 E-value=0.034 Score=60.80 Aligned_cols=32 Identities=19% Similarity=0.306 Sum_probs=28.8
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
..+++.+||..||++|||++|+|+||||+...
T Consensus 250 l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 250 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 46799999999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.27 E-value=0.026 Score=60.57 Aligned_cols=35 Identities=17% Similarity=0.289 Sum_probs=28.9
Q ss_pred CCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 907 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 907 ~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
....+++.+||..||++|||++|+++||||.....
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 34467999999999999999999999999986544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=89.18 E-value=0.073 Score=56.74 Aligned_cols=35 Identities=17% Similarity=0.400 Sum_probs=30.4
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccCCCCC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGS 943 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~~ 943 (956)
..+++.+||..||++|||++|+++||||.......
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 281 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence 46799999999999999999999999997665543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=89.08 E-value=0.045 Score=59.10 Aligned_cols=31 Identities=13% Similarity=0.256 Sum_probs=24.0
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+++.+||..||++|||++|+++||||.....
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 4666677788888888888899999876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=88.92 E-value=0.04 Score=59.20 Aligned_cols=31 Identities=19% Similarity=0.329 Sum_probs=20.4
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+++.+||..||++|||++|+|+||||.....
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 4555666777777777777777888765544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.89 E-value=0.35 Score=34.60 Aligned_cols=7 Identities=29% Similarity=0.382 Sum_probs=2.7
Q ss_pred HHHHhhh
Q 002178 582 LLIVRAH 588 (956)
Q Consensus 582 ~~~~~~~ 588 (956)
++++|+|
T Consensus 31 ~~~~RRR 37 (44)
T 2l2t_A 31 AVYVRRK 37 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3344433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=88.56 E-value=0.1 Score=54.74 Aligned_cols=63 Identities=16% Similarity=0.103 Sum_probs=41.3
Q ss_pred ccCCCCCCCHHHHHHHHHHhHh-hCCC-CCCCCccccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 879 QDETDARPSMSEVMRELESIWN-MMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 879 ~~~p~~RPs~~~v~~~L~~~~~-~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
...|..-.+..++.+.+..... .++. ......+++.+||..||++|||++|+++|||+.....
T Consensus 212 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 212 LMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 3444444455555554443211 1111 2234467999999999999999999999999977544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.22 E-value=0.046 Score=58.66 Aligned_cols=31 Identities=16% Similarity=0.401 Sum_probs=28.2
Q ss_pred CCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 908 KTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 908 ~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
...+++.+||..||++|||++|+++||||..
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 3467999999999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=88.14 E-value=0.051 Score=60.63 Aligned_cols=32 Identities=19% Similarity=0.306 Sum_probs=28.8
Q ss_pred CccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
..+++.+||..||++|||++|+|+||||....
T Consensus 297 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 46799999999999999999999999997544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.88 E-value=0.044 Score=59.19 Aligned_cols=30 Identities=23% Similarity=0.563 Sum_probs=23.1
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
+++.+||..||++||+++|+++||||....
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 466667778888888888888888887543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=86.32 E-value=0.045 Score=59.24 Aligned_cols=30 Identities=30% Similarity=0.484 Sum_probs=27.5
Q ss_pred CccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 909 TPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 909 ~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
..+++.+||..||++|||++|+++||||..
T Consensus 262 l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 262 FINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 457999999999999999999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=85.53 E-value=0.081 Score=57.94 Aligned_cols=31 Identities=26% Similarity=0.449 Sum_probs=24.5
Q ss_pred cccccccCCCCCCCCCCccCCCCCccccCCC
Q 002178 911 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 941 (956)
Q Consensus 911 ~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~ 941 (956)
+++.+||..||++|||++|+++||||.....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 5667778888888888888999999876544
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.66 E-value=0.88 Score=32.47 Aligned_cols=8 Identities=13% Similarity=0.592 Sum_probs=4.8
Q ss_pred ceeehhHH
Q 002178 561 ALAGIILG 568 (956)
Q Consensus 561 ~~~~ii~g 568 (956)
+++++++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 45666666
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=82.42 E-value=0.076 Score=59.70 Aligned_cols=33 Identities=6% Similarity=0.009 Sum_probs=28.9
Q ss_pred CCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 906 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 906 ~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
.+...+++.+||..||++||+++|+++||||..
T Consensus 337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 344567999999999999999999999999964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 956 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 6e-73
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 18/277 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+IG G +G VYKG V + + Q + F E+ L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+ +V ++ +L L + + IA +++G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-- 808
+K++NI L T K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 809 -LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+ +SDVY+ G+V EL+TG P S+ N + + + + + ++ S C
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLSKVRSNCP 239
Query: 868 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
+ +L +C + + D RP +++ +E + +P+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 4e-68
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 20/275 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++G G +G+V+ G T VAVK ++GS FL E + +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L + ++ E+M NG+L D L S L L +A + G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD++A+NIL+ + K+ADFGL+RL + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
T KSDV+S G++ E++T + G ++ ++ G P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVRP 232
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 3e-67
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ +IG G +G V+ G + VA+K +EG+ E++F+ E + + +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G C E+ LV+EFM +G L D + L + L G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRD+ A N L+ KV+DFG++R ST K + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEV 173
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
F + + KSDV+S GV+ E+ + + ++ S ++ + G P
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVEDISTGFRLYKP 224
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
++ C ++ + RP+ S ++R+L I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-65
Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 23/293 (7%)
Query: 618 EMALATNNFN-SSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGE-KEFLTEIQ 672
++ L +N + ++G G +G V +G+ VA+K ++G+ + + +E + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
+ +L + +V L+G C + MLV E G L L K +E + + + S
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YL + HRD+ A N+LL ++ AK++DFGLS+ D +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 172
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
K + PE K + +SDV+S GV E L+ Q +M
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMA 223
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905
+ G P EC + L C + + RP V + + + + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 4e-65
Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 20/296 (6%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTE 670
S Y + + + ++G G YG+VY+G+ VAVK +E +++ E EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+ + H NLV L+G C E ++ EFM+ G L D L +++ + + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
S + YL HRD+ A N L+ KVADFGLSRL
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA 174
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850
K + PE +K + KSDV++ GV+ E+ T G ++ + +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------ 228
Query: 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 906
+ P C EK +L C Q RPS +E+ + E+++ SD
Sbjct: 229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 9e-65
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ ++GQG +G+V+ G T VA+K + G+ + FL E Q + +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L E +V E+MS G+L D L ++ + L + +A + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD++A+NIL+ KVADFGL+RL + K + PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 185
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
L + T KSDV+S G++ EL T + G ++ V G P
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP 236
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 905
EC E L +C + E + RP+ + LE +
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (555), Expect = 9e-65
Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKR-AQEGSLQGEKEFLTE 670
+ NN IG+G +G+V++ P T+VAVK +E S + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------------- 711
++ + N+V L+G C L++E+M+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 712 ---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768
S+ PL A +L IA + G+ YL + HRD+ N L+ K+AD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
FGLSR D ++ PE ++ T +SDV++ GVV E+ +
Sbjct: 184 FGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 829 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 888
+G +++ V DGN+ + P C + L C RPS
Sbjct: 239 GLQPYYGMA---------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 889 SEVMRELESI 898
+ R L+ +
Sbjct: 290 CSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 1e-64
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 29/302 (9%)
Query: 611 VRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILP----DGTVVAVKRAQ 657
+ FT+ + A F IG G +G+V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 658 EG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
G + + ++FL+E + + H N++ L G + M++ EFM NG+L D ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ + G + G+ YL D HRD+ A NIL++ KV+DFGLSR
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-- 177
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
+ D + K + PE K T SDV+S G+V E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
++ ++ P +C +L L C Q + + RP +++ L+
Sbjct: 238 T---------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 897 SI 898
+
Sbjct: 289 KM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-64
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
IG+G +G V G G VAVK + + + FL E +++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 684 SLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
L+G +E+G +V E+M+ G+L D L ++ + LG L +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+ A N+L+ AKV+DFGL++ A K + PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPE 170
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
K + KSDV+S G++ E+ + + + ++ V G
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDA 221
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P C ++ C + RPS ++ +LE I
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-64
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 20/275 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ ++G G +G V G VA+K +EGS E EF+ E + + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G C ++ ++ E+M+NG L + L + L + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+ A N L++ + KV+DFGLSR + S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
+ K + KSD+++ GV+ E+ + + S + G P
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEHIAQGLRLYRP 223
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
EK + C ++ D RP+ ++ + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-64
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 22/313 (7%)
Query: 600 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKR 655
H +++ + V++ + + ++ + + IG+G +G VY G L D AVK
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 656 AQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSA 713
+ GE +FLTE + H N++SL+G C EG ++V +M +G LR+
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIR 121
Query: 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773
+ L ++G + A HRD+ A N +LD KFT KVADFGL+R
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
+ + + H T K ++ E T K T KSDV+S GV+ EL+T P
Sbjct: 179 DMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 834 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
N + ++ G P C + ++ LKC + + RPS SE++
Sbjct: 236 PDVNTF---------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 894 ELESIWNMMPESD 906
+ +I++
Sbjct: 287 RISAIFSTFIGEH 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-62
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 24/298 (8%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGILPDGT-----VVAVKRAQEGSLQGEK-EFLTEIQFL 674
+ + IG G +G+VYKG+L + VA+K + G + ++ +FL E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ H N++ L G + M++ E+M NG L + + + G + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAG 122
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YL + HRD+ A NIL++ KV+DFGLSR+ + + ++ K
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKI 175
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854
+ PE K T SDV+S G+V E++T + + +M ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAI 226
Query: 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912
DG P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-62
Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG VAVK + + E L E + +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C+ E MLV E G L L + + + + S G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865
+K + KSDV+S GV+ E + Q G S + + G P+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAG 234
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMMPE 904
C + L C + + RP + V L + + +++ E
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-60
Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 33/326 (10%)
Query: 619 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 676
M L ++F +++G G G V+K P G V+A K + + E+Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+ +V G +GE + E M G+L L K + + +++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL + + HRD+K SNIL++ + K+ DFG+S + ++ GT
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---------QLIDSMANSFVGTR 167
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856
Y+ PE + +SD++S+G+ +E+ G PI + M ++
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-------DAKELELMFGCQVE 220
Query: 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP---ESDTKTPE-- 911
G+ P D+RP M+ + L+ I N P S + E
Sbjct: 221 GDAAETPPRP----RTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 912 -FINSEHTSKEETPPSSSSMLKHPYV 936
F+N ++ H ++
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-59
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
IG+G +G+V++G G VAVK + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 691 EEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 742
++ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 743 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
P + HRD+K+ NIL+ T +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAP 181
Query: 802 EYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSM 850
E + ++D+Y++G+VF E+ ++ + M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 851 MFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
V + + E + K+ +C AR + + + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 5e-59
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRN 681
++ IG G YG+ K DG ++ K GS+ ++ ++E+ L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 682 LVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILY 737
+V + L V E+ G L ++ K ++ L L + + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 738 LH--TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
H ++ V HRD+K +N+ LD K K+ DFGL+R+ + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------SFAKAFVGT 177
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
P Y+ PE +KSD++SLG + EL M P + Q + +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----------QKELAGKIR 227
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+G P ++ ++ + + RPS+ E++
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-59
Identities = 76/338 (22%), Positives = 130/338 (38%), Gaps = 58/338 (17%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDG---TVVAVKR-AQEGSLQGEKEFLTEIQFLSRL-H 678
N+ IG+G +G+V K + A+KR + S ++F E++ L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMR 724
H N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
L A +RG+ YL HRD+ A NIL+ + AK+ADFGLSR
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 178
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844
T+ + ++ E T SDV+S GV+ E+++ G
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---- 234
Query: 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904
+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 235 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM------ 283
Query: 905 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942
+ +T +++ K Y D S
Sbjct: 284 -------------LEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 631 QIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 685
IG+G +G V++GI VA+K + + +E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G E ++ E + G LR K L A + A S + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRDI A N+L+ K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 182
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865
+ T SDV+ GV E+L G + ++ + +G P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPPN 233
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
C L KC + RP +E+ +L +I
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-58
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G + VYKG+ + VA Q+ L + F E + L L H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 688 YCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ + +LV E M++GTL+ L K + + + S +G+ +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 744 PPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
PP+ HRD+K NI + + K+ D GL+ L A + V GTP ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-MGS 861
K + DVY+ G+ LE+ T P S +N + + V G S
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKPAS 233
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + + ++ C + D R S+ +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-57
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 45/303 (14%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEKE-FLTEIQFLSR 676
N +G G +GKV VAVK +E + E+E ++E++ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------------------- 716
L H N+V+L+G C G L++E+ G L + L +K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 717 --EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774
L F L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 212
Query: 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
DI V + ++ PE T KSDV+S G++ E+ +
Sbjct: 213 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 835 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894
G + + +G P E+ + C ++ RPS +
Sbjct: 269 GIPVDAN--------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 895 LES 897
L
Sbjct: 321 LGC 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 4e-57
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 32/275 (11%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 681
F+ +IG G +G VY + + VVA+K+ Q ++ + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ K+PL ++ G+ +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+KA NILL K+ DFG + + + GTP ++ P
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
E F C Q RP+ +++
Sbjct: 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 9e-57
Identities = 74/328 (22%), Positives = 132/328 (40%), Gaps = 33/328 (10%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHH 679
F +G G +G VYKG+ +P+G V + A + S + KE L E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ L+G C L+ + M G L D + K+ +G L+ + ++G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
D + HRD+ A N+L+ K+ DFGL++L + E + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWM 180
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
E L T +SDV+S GV EL+T G S + + G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGER 231
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 919
P C + +KC + D+RP E++ E + + P+
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 283
Query: 920 KEETPPSSSSMLKHPYVSSDVSGSNLVS 947
+ PS + + + + ++V
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 42/293 (14%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + E+E ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRLS 726
V+L+G C G +++ E+ G L + L K + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ ++G+ +L HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846
V + ++ PE T +SDV+S G+ EL + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------- 252
Query: 847 QSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
S + +I P + + C + RP+ ++++ +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-56
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 29/274 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 679
+F +G+G +G VY ++A+K +AQ E + E++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N++ L GY + L+ E+ GT+ +L + + + + Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V HRDIK N+LL K+ADFG S P+ T + GT YL
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYL 171
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE +K D++SLGV+ E L G P + I
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----------ETYKRISRVE 220
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
++P E L + + RP + EV+
Sbjct: 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 6e-56
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + + A K S + ++++ EI L+ H N+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EF + G + + + + PL + + + + YLH D + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+KA NIL K+ADFG+S GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 810 TD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 864
D K+DV+SLG+ +E+ P + + IA + PS
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------AQPS 239
Query: 865 ECVEKFIKLALKCCQDETDARPSMSEVMR 893
F KC + DAR + S++++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-56
Identities = 62/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 631 QIGQGGYGKVYKGILP----DGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++G G +G V +G VAVK + +F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G +V E G+L D K + A+ + G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+ A N+LL + K+ DFGL R P + + K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCAPES 185
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-DGNMGSY 862
T + SD + GV E+ T Q G N + ++ + +G
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGERLPR 236
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
P +C + + ++C + + RP+ + L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 36/308 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSR 676
S ++GQG +G VY+G+ T VA+K + S++ EFL E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRLSIA 728
+ ++V L+G + +++ E M+ G L+ L + P + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
+ G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RK 191
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 848
++ PE T SDV+S GVV E+ T + G +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NE 242
Query: 849 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 908
++ V++G + P C + +L C Q RPS E++ ++ E +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM----EPGFR 298
Query: 909 TPEFINSE 916
F SE
Sbjct: 299 EVSFYYSE 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-54
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 28/294 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ NILL + K+ DFG + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 810 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 869
K D++SLG++ +E++ G P + + IA + P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------QNPEKLSAI 245
Query: 870 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 923
F +C + + R S E+ L+ + + + + I + +KE T
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL---LQHQFLKIAKPLSSLTPLIAA---AKEAT 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 21/273 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 681
+++ +G+G YG+V + VAVK + ++ + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V G+ E Q L E+ S G L D++ + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK N+LLD + K++DFGL+ + + E + + GT Y+ P
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAP 174
Query: 802 EYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
E + + DV+S G+V +L G P + +E +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------KEKKTYL 226
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + + L K + AR ++ ++ +
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-54
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 631 QIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSR-LHHRNL 682
+G+G +G+V + VAVK +EG+ E + ++E++ L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 683 VSLVGYCDEEGEQ-MLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
V+L+G C + G M++ EF G L L +K K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
+ ++G+ +L + HRD+ A NILL K K+ DFGL+R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 191
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
+ ++ PE T +SDV+S GV+ E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246
Query: 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 247 ---CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-52
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKR-AQEGSLQGEKEFLTEIQFL 674
+ +G+G +G+V T VAVK + + + + ++E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 675 SRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPL 719
+ H+N+++L+G C ++G ++ E+ S G LR+ L S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 720 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779
+S A +RG+ YL HRD+ A N+L+ K+ADFGL+R D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 184
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
I I +T + ++ PE T +SDV+S GV+ E+ T G +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243
Query: 840 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
+ + +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 244 --------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 900 NM 901
+
Sbjct: 296 AL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 5e-50
Identities = 65/318 (20%), Positives = 125/318 (39%), Gaps = 30/318 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
++++ ++G G +G V++ G A K ++ EIQ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V+L +++ E +++YEFMS G L ++++ + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 743 DPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H D+K NI+ K K+ DFGL+ + P V GT +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAA 193
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE + +D++S+GV+ LL+G+ P G+N +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMD------D 246
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR-------ELESIWNMMPESD-TKTPEF 912
S S E K + + R ++ + + + +P S TK +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 913 INSEHTSKEETPPSSSSM 930
I +++ + E P +
Sbjct: 307 IKTKYDAWPEPLPPLGRI 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 7e-50
Identities = 50/276 (18%), Positives = 91/276 (32%), Gaps = 25/276 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHR 680
+F +G+G + V L A+K ++ + E E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V L ++ + + NG L + + + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-----VSALEY 123
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+K NILL+ ++ DFG +++ + GT Y+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVS 178
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE SD+++LG + +L+ G+ P G + + +I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------IFQKIIKLEY- 227
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896
+P + K L K + R E+
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 2e-49
Identities = 59/313 (18%), Positives = 125/313 (39%), Gaps = 28/313 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +G V++ + G V K + EI +++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+++ E +L+ EF+S G L D+++A+ + A ++ + G+ ++H + + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 750 DIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
+ +D++++GV+ LL+G+ P + ++ N+ S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------DAFSSVS 256
Query: 868 EKFIKLALKCCQDETDARPSMSEVMR------ELESIWNMMPESDTKTPEFINSEHTSKE 921
+ Q E R ++ + + + ++ + +P S E +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
Query: 922 ETPPSSSSMLKHP 934
P + + +
Sbjct: 317 PAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 3e-46
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 25/287 (8%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLH 678
++ + +G GG +V+ L VAVK + + F E Q + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 679 HRNLVSLVGYCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
H +V++ + E +V E++ TLRD + ++ P+ + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H + HRD+K +NI++ KV DFG++R + + V G
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIG 176
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854
T YL PE + +SDVYSLG V E+LTG P + + + + S
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235
Query: 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 900
+ + LK + R + +E+ +L + N
Sbjct: 236 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 5e-46
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 19/273 (6%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHR 680
+ ++ +G G + +V +VA+K + +L+G E EI L ++ H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V+L + G L+ + +S G L D++ K + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ LD ++DFGLS++ P V + GTPGY+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVA 177
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860
PE + D +S+GV+ LL G P + +N + ++ F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDS------ 230
Query: 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
Y + + + + + R + + ++
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-45
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G +G V++ + K + + EI L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+ E ++++EF+S + ++++ S L +S + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 750 DIKASNILLDHK--FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
DI+ NI+ + T K+ +FG +R D ++ P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHD 178
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 867
++ +D++SLG + LL+G+ P N NI E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------EAFKEIS 231
Query: 868 EKFIKLALKCCQDETDARPSMSEVMR 893
+ + + E +R + SE ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 2e-45
Identities = 67/286 (23%), Positives = 99/286 (34%), Gaps = 37/286 (12%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR---------AQEGSLQGEKEFLTEIQFL 674
N+ +G+G V + I P AVK + E + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 675 SRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 733
++ H N++ L + LV++ M G L D L K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
I LH + HRD+K NILLD K+ DFG S + P V
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVC 170
Query: 794 GTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 847
GTP YL PE + D++S GV+ LL G P H K ++ I
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 848 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ S + + L + + R + E +
Sbjct: 231 NYQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-45
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 15/274 (5%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G +Y G + G VA+K + + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 690 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
EG+ ++V E + L +A I Y+H H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 749 RDIKASNIL---LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 865
+ + + D+ SLG V + G P K + S S +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKG 243
Query: 866 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899
+F C D +P S + + +++
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 3e-44
Identities = 60/332 (18%), Positives = 116/332 (34%), Gaps = 46/332 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 679
+F +G G +G+V+ +G A+K + L+ + E LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ + G + + ++ +++ G L L + P A + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K NILLD K+ DFG ++ P V+ + GTP Y+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYI 168
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE T D +S G++ E+L G P +++ +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----------TMKTYEKILNAEL 218
Query: 860 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMRE--LESI-WNMMPESDTKTP- 910
+P E L + + + + +V + + W + + +TP
Sbjct: 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277
Query: 911 -------EFINSEHTSKEETPPSSSSMLKHPY 935
+ S+ E + + PY
Sbjct: 278 EPPIQQGQGDTSQFDKYPEEDINYGVQGEDPY 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (397), Expect = 2e-43
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 17/275 (6%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 690 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+EG +LV + + G + L A + +H + + +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 749 RDIKASNILLD-----HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863
L + + + D+ +LG VF+ L G P K + S +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---PLRELC 241
Query: 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898
+ E+F K DA P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 5e-43
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 30/275 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTE---IQFLSR 676
N+F+ IG+GG+G+VY D G + A+K + + QGE L E + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+V + + + + M+ G L LS + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H + V +RD+K +NILLD +++D GL+ GT
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTH 169
Query: 797 GYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855
GY+ PE D +D +SLG + +LL G P K + +M
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226
Query: 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 890
P + L Q + + R
Sbjct: 227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 41/274 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH--HRN 681
+G GG+G VY GI + D VA+K + G L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ L+ + + +L+ E + L + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 742 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ V HRDIK NIL+D ++ K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE+ H+ +S V+SLG++ +++ G P H + I+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--------------- 222
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
+ + L C RP+ E+
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 70/338 (20%), Positives = 127/338 (37%), Gaps = 48/338 (14%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSR-LH 678
+F +G+G +GKV+ A+K ++ + + + + E + LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H L + + V E+++ G L + + K L A + + IL L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-----ILGL 116
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDY 169
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858
+ PE L K D +S GV+ E+L G P HG++ +F I +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE----------LFHSIRMD 218
Query: 859 MGSYPSECVEKFIKLALKCCQDETDARPSM-SEVM---------------RELESIWNMM 902
YP ++ L +K E + R + ++ +E++ +
Sbjct: 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278
Query: 903 PESDTKT----PEFINSEHTSKEETPPSSSSMLKHPYV 936
+S EF+N + +SM ++ +
Sbjct: 279 VKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-42
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 40/300 (13%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL 677
A + +IG+G YGKV+K + G VA+K R Q G + E+ L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 678 ---HHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
H N+V L C D E + LV+E + L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------FQMAL 172
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREV- 842
T V T Y PE L D++S+G +F E+ + I+ +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 843 ---------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
++A S + + ++ E L LKC R S +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 54/296 (18%), Positives = 108/296 (36%), Gaps = 34/296 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE------KEFLTEIQFLSRLHHRNLV 683
++G G + V K G A K ++ + ++ E+ L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+L + + + +L+ E ++ G L D L+ K A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 744 PPVFHRDIKASNILLDH----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ H D+K NI+L K K+ DFGL+ I + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFGTPEFV 183
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE L ++D++S+GV+ LL+G P N++ +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESI-WNMMPESDTKTPEF 912
Y S + + R ++ + ++ ++ S P+F
Sbjct: 238 -EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 67/290 (23%), Positives = 107/290 (36%), Gaps = 31/290 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
NF +IG+G YG VYK G VVA+K R + + EI L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V L+ E + LV+EF+ L+ + A + + + S +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V HRD+K N+L++ + K+ADFGL+R VP + V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPE 172
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
+ D++SLG +F E++T I + I V+ + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 862 YP------------------SECVEKFIKLALKCCQDETDARPSMSEVMR 893
P E L + + + R S +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 56/286 (19%), Positives = 97/286 (33%), Gaps = 36/286 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G + VYK +VA+K+ E + L EI+ L L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQHW 120
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+K +N+LLD K+ADFGL++ P+ T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLF 173
Query: 806 THKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSSMMF 852
++ D++++G + ELL + I E S+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 853 SVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMR 893
V + P S + + L AR + ++ ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-40
Identities = 64/315 (20%), Positives = 109/315 (34%), Gaps = 35/315 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G G GKV + A+K LQ + E++ R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 690 D----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ ++V E + G L ++ + + I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 746 VFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L K K+ DFG ++ + T TP Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862
K D++SLGV+ LL G P + + + M S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMPESDTKTPEFINSEHT 918
SE V+ I+ + E R +++E + W +P++ T + +
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 919 SKEETPPSSSSMLKH 933
E+ +S L
Sbjct: 298 RWEDVKEEMTSALAT 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (366), Expect = 3e-39
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG+G YG VYK G A+K R ++ + EI L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ +LV+E + + + L S L GI Y H D V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K N+L++ + K+ADFGL+R +P + + + K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 809 LTDKSDVYSLGVVFLELLTGMQPIS------------------HGKNIVREVNIAYQSSM 850
+ D++S+G +F E++ G + KN +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
S+ E I L K + + + R + + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 27/269 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
N+F+ +G+G +GKV G A+K ++ + + E +TE + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L +L V E+ + G L LS + A + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-----VSALE 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V +RDIK N++LD K+ DFGL + GTP YL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------ATMKTFCGTPEYL 172
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE + D + LGVV E++ G P + ++ R +F +I
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER----------LFELILMEE 221
Query: 860 GSYPSECVEKFIKLALKCCQDETDARPSM 888
+P + L + + R
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-38
Identities = 59/295 (20%), Positives = 103/295 (34%), Gaps = 31/295 (10%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 680
+ + + IG+G YG V + VA+K+ Q + L EI+ L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTL-RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N++ + + + ++ + D + L RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V HRD+K SN+LL+ K+ DFGL+R+A T T Y
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD----PDHDHTGFLTEYVATRWYR 179
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI-----VREVNIAYQSSMMFS 853
PE L K KS D++S+G + E+L+ + + + + +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 854 VIDGNMGSYPSECVEK---------------FIKLALKCCQDETDARPSMSEVMR 893
+I+ +Y K + L K R + + +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 6e-38
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 33/285 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G YG V+K +VA+K R + L EI L L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ + LV+EF + S L + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+L++ K+A+FGL+R +P S V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAK 177
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID----------- 856
+ D++S G +F EL +P+ G ++ ++ ++ +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 857 --------GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 893
++ + + L + R S E ++
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 66/328 (20%), Positives = 119/328 (36%), Gaps = 38/328 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHR 680
+ + +IGQG +G+V+K G VA+K+ + + L EI+ L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 681 NLVSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
N+V+L+ C +G LV++F + + K L R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ L+ + HRD+KA+N+L+ K+ADFGL+R + + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPNRYTNR 181
Query: 793 KGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851
T Y PE L + D++ G + E+ T + + I+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 911
+ N+ +Y + +K + +D A + ++ + + P
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR----- 296
Query: 912 FINSEHTSKEETPPSSSSMLKHPYVSSD 939
S L H + SD
Sbjct: 297 -------------IDSDDALNHDFFWSD 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 70/339 (20%), Positives = 122/339 (35%), Gaps = 47/339 (13%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++ + IG G +G VY+ L D G +VA+K+ LQ ++ E+Q + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 684 SLVGYCDEEGEQM------LVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGIL 736
L + GE+ LV +++ R +++K+ L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 737 YLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H + HRDIK N+LLD K+ DFG ++ + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSR 186
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREVNIAYQSS 849
F T DV+S G V ELL G + I++ + +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 850 MMFSVIDGNMGSYPS------------ECVEKFIKLALKCCQDETDARPSMSEVM----- 892
+ + +P + I L + + AR + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 893 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931
EL +P + TP N PP ++ ++
Sbjct: 307 DELRDPNVKLP-NGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-36
Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
+ F+ +G G +G+V G A+K + + K+ L E + L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
LV L + +V E+++ G + L + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K N+L+D + +V DFG ++ + + GTP L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEAL 205
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859
PE L+ D ++LGV+ E+ G P ++ ++ I
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQ----------IYEKIVSGK 254
Query: 860 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMR 893
+PS L Q + + + ++++
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 63/324 (19%), Positives = 113/324 (34%), Gaps = 49/324 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G YG V + G VA+K S K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 688 YCDEEG------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ + LV FM GT +L E LG + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K N+ ++ K+ DFGL+R + ++ V
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPE 188
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-------------AYQS 848
+ T D++S+G + E++TG ++ + I QS
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 849 SMMFSVIDG-------NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIW 899
+ + G + S + + L K + + R + E + ES+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 900 NMMPESDTKT--PEFINSEHTSKE 921
+ E + F + + T E
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 127 bits (318), Expect = 1e-32
Identities = 83/334 (24%), Positives = 134/334 (40%), Gaps = 34/334 (10%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPE 148
LNL IP + N+ L L + G L G +P
Sbjct: 58 SGLNLPKPYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ L +L + I +SG++P + + + N++SG +PP +S LP+LV +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
D N ++G +P KL + N IP +++N++ RN
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
N + L+ N L + LS N+ + L NN++ GT+P + L L L +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
+ N+L G IP + + + + NN
Sbjct: 276 SFNNLCGEIP-QGGNLQRFD-----VSAYANNKC 303
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 2e-31
Identities = 54/318 (16%), Positives = 119/318 (37%), Gaps = 37/318 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRN 681
+++ ++G+G Y +V++ I + + V VK + +K+ EI+ L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 682 LVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+++L + + LV+E ++N + + L + + Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 740 TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K N+++DH+ ++ D+GL+ P V + +
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYF 195
Query: 799 LDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857
PE + +++ D D++SLG + ++ +P HG + Q + V+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD------QLVRIAKVLGT 249
Query: 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 917
+ K ++ D S E + +F++
Sbjct: 250 ED------LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 918 TSKEETPPSSSSMLKHPY 935
++ ++ ++HPY
Sbjct: 304 RYDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 29/282 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLS 675
NF +G G YGKV+ G + A+K ++ ++ + + TE Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 676 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ LV+L E + L+ ++++ G L LS + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+L L + +RDIK NILLD + DFGLS+ + E G
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 192
Query: 795 TPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852
T Y+ P+ D +SLGV+ ELLTG P + + +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-------GEKNSQAEIS 245
Query: 853 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 894
I + YP E L + + R +
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 6e-30
Identities = 59/319 (18%), Positives = 111/319 (34%), Gaps = 39/319 (12%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G G V VA+K + K E+ + ++H+N++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 688 YC------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+E + LV E M + E + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLH-- 136
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAP 187
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861
E L + D++S+G + E++ + + G++ + ++ + +G+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYID----------QWNKVIEQLGT 236
Query: 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE---FINSEHT 918
E ++K ++ + + K + ++
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 919 SKEETPPSSSSMLKHPYVS 937
S L+HPY++
Sbjct: 297 IDPAKRISVDDALQHPYIN 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 6e-28
Identities = 58/292 (19%), Positives = 96/292 (32%), Gaps = 45/292 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G YG V G VAVK S+ K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 688 YCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E + + + D + + L + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K SN+ ++ K+ DFGL+R T T Y PE
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 803 YFLTHKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSS 849
L + D++S+G + ELLTG I + SS
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 850 MMFSVIDGNMGSYPSECVEK--------FIKLALKCCQDETDARPSMSEVMR 893
++ P + L K ++D R + ++ +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 6e-24
Identities = 44/331 (13%), Positives = 101/331 (30%), Gaps = 26/331 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG-- 687
++G G + V+ + + T VA+K G + EI+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 688 ------------YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
+ G +++ + L + + I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 736 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854
T Y PE L +D++S + EL+TG + + + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 914
+ G + SY + ++ + L + + + +F++
Sbjct: 251 L-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 915 SEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 945
+ ++ HP++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 3e-20
Identities = 31/204 (15%), Positives = 59/204 (28%), Gaps = 29/204 (14%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRLHHR 680
+G+G V+ VK + G G+ F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
L L G + VY + N L + + AK + + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H D+ N+L+ + + DF S I+ V ++
Sbjct: 121 --HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT------- 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLE 824
+ + + D+ S L+
Sbjct: 171 ---YFSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.9 bits (219), Expect = 8e-20
Identities = 61/321 (19%), Positives = 109/321 (33%), Gaps = 57/321 (17%)
Query: 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGS 121
C + V C + L+ + +L + +LD NKI+
Sbjct: 7 RCQCHLRVVQCSD----------LGLEKVPKDLPPDT----------ALLDLQNNKITEI 46
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181
+ N+K+L L+L N+++ P L KL+R+ + +N + LP+ +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL 105
Query: 182 HFHMN------------------------NNSISGQIPPELSRLPSLVHMLLDNNNLTGY 217
H N SG + L ++ + + N+T
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164
Query: 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR-IPNL 276
+P L P L L LD N AS ++ L KL L S+ P+L
Sbjct: 165 IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG------LPRLQRLFIAN 330
L L++N+L I + L NN ++ ++F + + +
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 331 NSLS-GSIPSSIWQSRTLNAT 350
N + I S ++ + A
Sbjct: 282 NPVQYWEIQPSTFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 54/279 (19%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
L ++ + L +P++L P + + N I+ F NL + NN I
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
S P + L L + L N L LP ++ + + L + + ++ + M
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
+ + S + L Y+ ++ + +IP G ++T + L NK+T
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDGNKIT 184
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF----------------- 353
++ GL L +L ++ NS+S S+ + L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
Query: 354 -ILDFQNNNLTNISGSFNIPPNV--------TVRLRGNP 383
++ NNN++ I + PP V L NP
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.7 bits (221), Expect = 1e-19
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162
+L+ L L N+IS P I + +L+ L LNGN+L L L L + +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL 222
N IS P + L K + N IS P L+ L +L ++ L+ N L P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
L L L L NN + S+++KL +L N + L+ + N+ +L
Sbjct: 305 -NLKNLTYLTLYFNNISD---ISPVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAG 359
Query: 283 SNQLNGSIPPGRLSLNITTIKLSNN 307
NQ++ P L+ IT + L++
Sbjct: 360 HNQISDLTPLANLT-RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 42/186 (22%), Positives = 65/186 (34%), Gaps = 31/186 (16%)
Query: 174 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233
A L NN IS P + +L + L+ N L L+ L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS---------------------R 272
NN A S ++KL +L L + P
Sbjct: 249 ANNQISN---LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 273 IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332
+ NL YL L N ++ P L+ + + +NNK++ S+ + L + L +N
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 333 LSGSIP 338
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.0 bits (196), Expect = 2e-16
Identities = 69/360 (19%), Positives = 131/360 (36%), Gaps = 81/360 (22%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ LQ L + ++ + L+ LT ++F N+++ P + N+ L +L+N N++
Sbjct: 45 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 143 TGSLP---------------------------------------EELGYLPKLDRIQIDQ 163
P ++ L L +Q
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
+ K ANL +++N +S ++L +L ++ NN ++ P +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL 218
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
L L L+ N + + ++++ L L L N + P LS + L L L +
Sbjct: 219 --TNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGA 272
Query: 284 NQLNGSIPPGRLSLN---------------------ITTIKLSNNKLTGTIPSNFSGLPR 322
NQ++ P L+ +T + L N ++ P S L +
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQRLF ANN +S SS+ +N L +N +++++ N+ + L
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNIN-----WLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 3e-08
Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 9/138 (6%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
I++ +S L + L +++SN + T+ L N D + + L
Sbjct: 252 QISNLAPLSGLTKLT-ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK-NL 309
Query: 90 LNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 147 PEELGYLPKLDRIQIDQN 164
P L L ++ ++ ++
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 14/74 (18%), Positives = 31/74 (41%), Gaps = 4/74 (5%)
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
+ L + + L N T S +++ ++ L ++ + + + NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFS 74
Query: 283 SNQLNGSIPPGRLS 296
+NQL P L+
Sbjct: 75 NNQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 38/246 (15%), Positives = 80/246 (32%), Gaps = 27/246 (10%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
L + + + + ++ ++ ++ +L++ + I + L +L + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272
LT L L KL+ + ++NN T A+ +N++ L + + + +
Sbjct: 77 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 273 IPNLGYL--------------DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS 318
+ N L+ T +L + + S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
L L+ L NN +S P I + L N L +I ++ +
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLD-------ELSLNGNQLKDIGTLASLTNLTDLD 247
Query: 379 LRGNPF 384
L N
Sbjct: 248 LANNQI 253
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (201), Expect = 1e-17
Identities = 48/254 (18%), Positives = 88/254 (34%), Gaps = 4/254 (1%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ + L +S + LTIL N ++ + LE L L+ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 143 TGSL-PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
S+ P L +L + +D+ + P F L ++ ++ +N++ L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
+L H+ L N ++ L L L L N A + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321
P L+ + L YL L+ N L + + S++++ ++P +G
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 322 RLQRLFIANNSLSG 335
+ +A N L G
Sbjct: 273 LKR---LAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 41/204 (20%), Positives = 59/204 (28%), Gaps = 7/204 (3%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
E+ NL+ L P++ + TIL N + + L L L+ ELT
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ LP L + + N + T N S +P R
Sbjct: 69 KLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLG 124
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
+ L N LPP L L NN + + L L L+ SL
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLN 287
L + L N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 39/210 (18%), Positives = 72/210 (34%), Gaps = 8/210 (3%)
Query: 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160
E+ +++ ++ ++ ++P ++ K +L L+ N L L +L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220
+D+ ++ + T N +P LP+L + + N LT
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQ---SLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
L L +L L L N + N + P L+ + NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 281 LSSNQLNGSIPPGRLSL-NITTIKLSNNKL 309
L N L +IP G + L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
P+ ++S++ + ++ L ++PP L + T + LS N L + RL +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 326 LFIANNS 332
L +
Sbjct: 60 LNLDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 11/213 (5%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ + + + +++ +PP+L + L N L + L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292
LD + + + L + SL L + L L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--LGA 119
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
R + + L N+L P + P+L++L +ANN+L+ + L+
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD---- 175
Query: 353 FILDFQNNNLTNI-SGSFNIPPNVTVRLRGNPF 384
L Q N+L I G F L GNP+
Sbjct: 176 -TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 1e-08
Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289
+L L + + T+ + + L L + L+ P L+ + L L S N +
Sbjct: 2 VLHLAHKDL---TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA-LEN 57
Query: 290 IPPGRLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 335
+ + + L NN+L + PRL L + NSL
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 7/121 (5%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
+L ++ + + + + L L+ N L P L L L+ + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVL--QASDNALE 56
Query: 170 LPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
ANL + + + NN + L P LV + L N+L L ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 229 L 229
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 29/125 (23%)
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL------------ 228
R H+ + ++ + L +L + H+ L +N L PP L+ L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 229 ----------LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG----PMPDLSRIP 274
L L NN + + + +L+ L+L+ SL +P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 275 NLGYL 279
++ +
Sbjct: 118 SVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 33/226 (14%), Positives = 69/226 (30%), Gaps = 17/226 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L+ + + ++ ++ + ++ + L G +T E + YL L +++ N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
I+ P N I S + + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
L L + + G T S + + L+ + L L N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIG----------NAQVSDLTPLANLSKLTTLKADDN 183
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 330
+++ P L N+ + L NN+++ P + L + + N
Sbjct: 184 KISDISPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 32/201 (15%), Positives = 66/201 (32%), Gaps = 21/201 (10%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
L +I ++ ++ ++ + A+L+ ++ + L +L+ + L +N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS----------NMSKLLKLSLRNCS 262
+T P + L L + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-----NITTIKLSNNKLTGTIPSNF 317
L + ++ I L L G+ L+ +TT+K +NK++ P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 318 SGLPRLQRLFIANNSLSGSIP 338
+ LP L + + NN +S P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 290
L L N S ++ + P+ + + ++DLS++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 291 PPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
G LS + + L +L+ I + + L RL
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
++ + L ++ + + L S ++ + L N+ E +T+
Sbjct: 9 GKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGI 66
Query: 247 YSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLD 280
S SKL LSL L P+ + L++ NL L+
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTG----TIPSNFSGLPRLQRLFI 328
++ LD+ +L+ + L L ++L + LT I S P L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+N L + Q + + L QN
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 12/72 (16%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 296 SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
SL+I ++ + +L+ L + Q + + + L+ + I + +N
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE- 59
Query: 355 LDFQNNNLTNIS 366
L+ ++N L ++
Sbjct: 60 LNLRSNELGDVG 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 9/102 (8%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKI 118
GV + LR L L + ++S + L+ + L LD N +
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 119 SGSIPKEIG-----NIKSLELLLLNGNELTGSLPEELGYLPK 155
+ ++ LE L+L + + + L L K
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQLDN 235
+ + +S EL L + LD+ LT + L P L L L +
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 236 NNFEGTTIP----ASYSNMSKLLKLSLRNC 261
N + + K+ KLSL+NC
Sbjct: 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 108 LTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQID 162
+ LD ++S + E+ ++ +++ L+ LT + L P L + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
N + +T + S+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 8/73 (10%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 298 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 353
+ + L++ ++ + + + L+ L ++NN L + + +S
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 354 ILDFQNNNLTNIS 366
L + +
Sbjct: 430 QLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 13/97 (13%), Positives = 26/97 (26%), Gaps = 15/97 (15%)
Query: 128 NIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSLPKSFA-----NLN 178
L +L L +++ SL L L + + N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+ + S ++ L L D +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL------EKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 16/91 (17%), Positives = 25/91 (27%), Gaps = 11/91 (12%)
Query: 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLS 282
+ L + + + + L +C L L P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 283 SNQLNGSIPPG------RLSLNITTIKLSNN 307
SN+L S I + L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 17/102 (16%)
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPPG----- 293
S L L L +C + L +L LDLS+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 294 -RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+ + + L + + + RLQ L SL
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/112 (13%), Positives = 32/112 (28%), Gaps = 5/112 (4%)
Query: 82 LHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLL 136
L ++ L + LS E+ L ++ ++ + K+I +L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L NEL + + +I + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 113
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 10/90 (11%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 156 LDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLD 210
+ + I +S + + L + + +++ ++ I L P+L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+N L + + + ++ + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 12/102 (11%)
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
N+ S +I PSL + + NN L LP + P+L L N+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL--A 317
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
+P L +L + L+ PD+ ++ L ++S
Sbjct: 318 EVPEL---PQNLKQLHVEYNPLRE-FPDI--PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 113 FMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172
+ N S I SLE L ++ N+L LP L +L N+++ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
NL + H+ N + + P + L
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 7e-06
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
N S P+L L++S+N+L +P L + S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHLA-EVPEL--- 322
Query: 320 LPRLQRLFIANNSLSG--SIPSSI 341
L++L + N L IP S+
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 58/353 (16%), Positives = 101/353 (28%), Gaps = 30/353 (8%)
Query: 45 KSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGR 104
KS + Y+ S W R P + + + D EL+L NL LS +L
Sbjct: 1 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 59
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L L N ++ +P+ ++KSL + N L+ P ++++
Sbjct: 60 L---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 115
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELS 223
+ S K N + + I L L
Sbjct: 116 LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
+LP L + L + +L +PDL + +
Sbjct: 176 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNY 235
Query: 284 NQLNGSIPPGRL-----------SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332
+P + N + I S P L+ L ++NN
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 333 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
L +P+ + L N+L + +P N+ + NP
Sbjct: 296 LI-ELPALPPRLERL--------IASFNHLAEVP---ELPQNLKQLHVEYNPL 336
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 4e-06
Identities = 25/139 (17%), Positives = 48/139 (34%), Gaps = 13/139 (9%)
Query: 87 LQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG- 144
L+L G P++ + +L+ + ++ ++ NI L L L+ N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 145 -SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE------ 197
+ + P L + + N + K ++ NS+S +
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
Query: 198 -LSRLPSLVHMLLDNNNLT 215
R P L+ LD + L
Sbjct: 141 IRERFPKLLR--LDGHELP 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 6/125 (4%)
Query: 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 277
L +S+ LD + + L+ R+ IP L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL---RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 278 YLDLSSNQLNGSIPPGRLSLNITTIK---LSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L+LS+N+L + +K LS N+L + +L+ L++ NSLS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 335 GSIPS 339
+
Sbjct: 129 DTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 22/162 (13%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+ + L+ L +L + + + +L N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 181 RHFHMNNNSISGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+++NN + + + + P+L + L N L + + KL L LD N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
T + +S + + R P L LD
Sbjct: 128 S-DTFRDQSTYISAIRE----------------RFPKLLRLD 152
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 32/202 (15%), Positives = 78/202 (38%), Gaps = 15/202 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + ++ ++ + + S++ ++ N +++ + YLP + ++ ++ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
++ K ANL ++ N + + L + +L +++
Sbjct: 79 KLTD--IKPLANLKNLGWLFLDENKVKDLSSLK-------DLKKLKSLSLEHNGISDING 129
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
L L L+ T S ++KL LSL + + + L+ + L L LS N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKN 188
Query: 285 QLNGSIPPGRLSLNITTIKLSN 306
++ L N+ ++L +
Sbjct: 189 HISDLRALAGLK-NLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 42/207 (20%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 139 GNELTGSLPEELGY------LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G+E ++P + + + + + ++ ++ ++ LN NN+ I
Sbjct: 4 GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ LP++ + L+ N LT L+ L L L LD N + + +
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 312
L + G L +P L L L +N++ RL+ + T+ L +N+++
Sbjct: 117 LSLEHNGISDING----LVHLPQLESLYLGNNKITDITVLSRLT-KLDTLSLEDNQISDI 171
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPS 339
+P +GL +LQ L+++ N +S + +
Sbjct: 172 VP--LAGLTKLQNLYLSKNHIS-DLRA 195
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 3e-05
Identities = 25/145 (17%), Positives = 50/145 (34%), Gaps = 10/145 (6%)
Query: 94 LSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL 150
L+ L + + LD KI I + + + + NE+ +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGF 59
Query: 151 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLL 209
L +L + ++ N I L + NNS+ L+ L SL ++ +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 210 DNNN---LTGYLPPELSELPKLLIL 231
N Y + ++P++ +L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
A Y+N + +L LR + + + +D S N++ L + T+ +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLR-RLKTLLV 70
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+NN++ LP L L + NNSL
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 32/311 (10%), Positives = 82/311 (26%), Gaps = 29/311 (9%)
Query: 82 LHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELL 135
+ + L+L + ++ + + + N I + + I + K LE+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 136 LLNGN---ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ + +PE L L + + + S + ++ ++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ + L + + + P L + N E ++
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYL--------------DLSSNQLNGSIPPGRLSLN 298
L G P+ L L + + + N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 299 ITTIKLSNNKLTGTIPS------NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
+ + L++ L+ + + LQ L + N + ++ +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 353 FILDFQNNNLT 363
L+ N +
Sbjct: 305 LFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 13/90 (14%)
Query: 182 HFHMNNNSISGQIPPELSR------LPSLVHMLLDNNNLTGYLPPELSE-----LPKLLI 230
+N+ +S + + L + L N + L +P LL
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L+L+ N F + ++ R
Sbjct: 307 LELNGNRFSE--EDDVVDEIREVFSTRGRG 334
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 30/224 (13%), Positives = 62/224 (27%), Gaps = 10/224 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP---KLDRIQIDQNYISGSLPKSFANL 177
IP ++ ++ L +L K++ Q D + + S
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
NN + + ++ + ++ L K+L+ DN N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
+ + + L L +Q L L+LS N +P
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339
+ +S ++ L +L+ N +P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 35/257 (13%), Positives = 82/257 (31%), Gaps = 26/257 (10%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI 122
C + LC ++ + +L N L F+ K+
Sbjct: 6 CHCSNRVFLCQE----------SKVTEIPSDLPRNA----------IELRFVLTKLRVIQ 45
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL--PKSFANLNKT 180
LE + ++ N++ + ++ + + P++F NL
Sbjct: 46 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 105
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++ ++N I V + + +N + + L N
Sbjct: 106 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSLN 298
I N ++L +L+L + + +P+ LD+S +++ S+P L N
Sbjct: 166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE-N 223
Query: 299 ITTIKLSNNKLTGTIPS 315
+ ++ + +P+
Sbjct: 224 LKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 279 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338
+++ IP L N ++ KL FSG L+++ I+ N + I
Sbjct: 13 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 339 SSIWQ 343
+ ++
Sbjct: 71 ADVFS 75
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 21/147 (14%), Positives = 37/147 (25%), Gaps = 3/147 (2%)
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
P+ + + L L L ++N + +L
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 256 LSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI- 313
L++ L+ P L L+LS N L L++ + LS N L +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSS 340
+ L
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGP 147
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 25/193 (12%), Positives = 59/193 (30%), Gaps = 16/193 (8%)
Query: 105 LSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163
L+ ++ ++ ++ + +L+ L + G + YL L +I
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
N ++ P + N + + + + + L+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
L D + G T + + + P L+ + L LD+SS
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFS---------SNQVTDLKP-LANLTTLERLDISS 181
Query: 284 NQLNGSIPPGRLS 296
N+++ +L+
Sbjct: 182 NKVSDISVLAKLT 194
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 956 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.65 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.22 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.44 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.27 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.38 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 95.02 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=428.19 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=214.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
++|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999964 69999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++.+. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 999999988653 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~------------------ 227 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYL------------------ 227 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH------------------
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHH------------------
Confidence 223455799999999999999999999999999999999999999975432211 110
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 942 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~~~ 942 (956)
+... -...+.. | +..++.+.+|+.+||..||++|+|++|+|+||||+....-
T Consensus 228 ----------~~~~-~~~~~~~-~----------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~ 279 (293)
T d1yhwa1 228 ----------IATN-GTPELQN-P----------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279 (293)
T ss_dssp ----------HHHH-CSCCCSS-G----------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ----------HHhC-CCCCCCC-c----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCC
Confidence 0000 0000000 0 0011223468888999999999999999999999876655
Q ss_pred Ccccc
Q 002178 943 SNLVS 947 (956)
Q Consensus 943 ~~~~~ 947 (956)
+.+.+
T Consensus 280 ~~l~p 284 (293)
T d1yhwa1 280 SSLTP 284 (293)
T ss_dssp GGGHH
T ss_pred CcCCC
Confidence 54433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=446.07 Aligned_cols=291 Identities=22% Similarity=0.366 Sum_probs=213.8
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
..++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|++++++++|||||+++++|.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999965 68999999987543 333568899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-CCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||+++|+|.+++.+.+ .+++..++.++.|+++||.|||++ + |+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999997654 489999999999999999999974 7 99999999999999999999999999986531
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||........+..... ...+.
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-------~~~~~ 222 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC-------QVEGD 222 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-------HhcCC
Confidence 223446799999999999999999999999999999999999999976543222111000 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC------CCCCccccccccCCCCCCCCCCccCCC
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES------DTKTPEFINSEHTSKEETPPSSSSMLK 932 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~------~~~~~~ll~~~L~~dP~~R~sa~e~L~ 932 (956)
+...+.................+|... ..+.++.+....+.. ..++.||+.+||+.||++||||+|+|+
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 223 ----AAETPPRPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------------CCCC-HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----cccCCcccccccccccccccccccchh-HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111111111112222223333344322 122223332222211 233467999999999999999999999
Q ss_pred CCcccc
Q 002178 933 HPYVSS 938 (956)
Q Consensus 933 HP~f~~ 938 (956)
||||+.
T Consensus 298 Hpf~~~ 303 (322)
T d1s9ja_ 298 HAFIKR 303 (322)
T ss_dssp SHHHHH
T ss_pred CHhhCc
Confidence 999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=429.75 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=207.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999975 68999999986432 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999999765422
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... .. ..
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i---------~~-~~ 220 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRI---------SR-VE 220 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHH---------HT-TC
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHHHH---------Hc-CC
Confidence 22345799999999999999999999999999999999999999965332 1111110 00 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+|+. .++.+.+|+.+||..||++|||++|+|+||||+++
T Consensus 221 ~~~p~~---------------------------------------~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 221 FTFPDF---------------------------------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CCCCTT---------------------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCCcc---------------------------------------CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 011111 11223468888999999999999999999999765
Q ss_pred C
Q 002178 940 V 940 (956)
Q Consensus 940 ~ 940 (956)
.
T Consensus 262 s 262 (263)
T d2j4za1 262 S 262 (263)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=429.83 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=207.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 699999999875433 2345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999643 46899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.........||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+.......... .
T Consensus 158 ---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~---------~--- 222 (271)
T d1nvra_ 158 ---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---------K--- 222 (271)
T ss_dssp ---EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---------T---
T ss_pred ---ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------C---
Confidence 1222345679999999999988876 57899999999999999999999754332111111000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
+...+.. +..++.+.+|+.+||..||++|||++|+|+||||+...
T Consensus 223 ---------------------~~~~~~~--------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 223 ---------------------KTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp ---------------------CTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------------------CCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 0000000 01122234788889999999999999999999997654
Q ss_pred C
Q 002178 941 S 941 (956)
Q Consensus 941 ~ 941 (956)
+
T Consensus 268 ~ 268 (271)
T d1nvra_ 268 K 268 (271)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=425.82 Aligned_cols=267 Identities=25% Similarity=0.463 Sum_probs=213.1
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
...++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34578999999999999999999864 35999998753 33445789999999999999999999998764 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.++++... ..+++..+..|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999997543 45899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
. .........||+.|||||++.+ ..++.++|||||||++|||+||+.||............... . ..
T Consensus 158 ~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~-~----~~ 227 (276)
T d1uwha_ 158 S-----GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-G----YL 227 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-T----SC
T ss_pred C-----CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-C----CC
Confidence 2 1223345679999999999964 35788999999999999999999999765443322221111 0 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
.+.....+..+++.+.+++.+||+.+|.+||++.++++.|+.+.+.+|+
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 1122234566778999999999999999999999999999998877663
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=426.81 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=219.9
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
+..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3456888999999999999999999888999999997643 345689999999999999999999998865 56799999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+++|+|.+++.......+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-
Confidence 999999999887655556899999999999999999999998 9999999999999999999999999998765322
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
........||+.|+|||++.+..++.++|||||||++|||+||..|+.......+.... +..+...
T Consensus 164 -----~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~---------i~~~~~~ 229 (272)
T d1qpca_ 164 -----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---------LERGYRM 229 (272)
T ss_dssp -----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCC
T ss_pred -----cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHhcCCC
Confidence 12234456899999999999999999999999999999999977766554443332221 2223344
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
..|+.+++++.+++.+||+.+|++||+++++++.|+++...
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 55677788999999999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=429.24 Aligned_cols=265 Identities=29% Similarity=0.458 Sum_probs=225.8
Q ss_pred HHHHHHHhcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCc
Q 002178 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (956)
Q Consensus 616 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 694 (956)
+++++...++|++.+.||+|+||+||+|.++ +++.||||+++... ...++|.+|++++++++||||++++|+|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445556678999999999999999999976 58999999987643 345689999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+++|+|.+++.......+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999998877778999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
..... ........|++.|+|||++.+..++.++|||||||++|||++|..||....+........
T Consensus 165 ~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i--------- 229 (287)
T d1opja_ 165 MTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------- 229 (287)
T ss_dssp CCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---------
T ss_pred cCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---------
Confidence 64322 223344568999999999999999999999999999999999888876655543322211
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
..+.....|+.+++.+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234566778889999999999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=420.29 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997643 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 99999998754 345889999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+....+..+.... +..+.....|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---------i~~~~~~~~p 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---------ISTGFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---------HHHTCCCCCC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHhcCCCCCc
Confidence 11223456899999999999999999999999999999999965555444433332221 1222334456
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..+++++.+++.+||+.+|++||+++++++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 6778899999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=422.01 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56889999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.+++.+.. .++++..+..++.||++||.|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999986543 45899999999999999999999999 999999999999999999999999999754211
Q ss_pred ccccceecccccCCCcccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
........||+.|+|||++. +..|+.++|||||||++|||+||+.||.......... .+..+
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~----------~i~~~ 230 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----------KIAKS 230 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----------HHHHS
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH----------HHHcC
Confidence 12234567999999999984 4568899999999999999999999997543211100 01111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
..... ..| +...+.+.+|+.+||+.||++|||++|+|+||||+
T Consensus 231 ~~~~~---------------------~~~----------------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 231 EPPTL---------------------AQP----------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp CCCCC---------------------SSG----------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred CCCCC---------------------Ccc----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00000 000 01122234688888999999999999999999998
Q ss_pred cCC
Q 002178 938 SDV 940 (956)
Q Consensus 938 ~~~ 940 (956)
.+.
T Consensus 274 ~~~ 276 (288)
T d2jfla1 274 VDS 276 (288)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-48 Score=420.75 Aligned_cols=261 Identities=27% Similarity=0.459 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.+.||+|+||+||+|.++ ++ ..||||.+.... ....++|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 44556789999999999999975 23 368999887543 34456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
||||++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999988754 345899999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
.... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+..+
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~---------~i~~~ 249 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVIN---------AIEQD 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHHTT
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHH---------HHHcC
Confidence 2111 1112233458899999999999999999999999999999998 89999755432 1111 12223
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
...+.|.+++..+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 3445677788899999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=419.72 Aligned_cols=202 Identities=21% Similarity=0.361 Sum_probs=175.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999974 69999999986432 123467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987653 5899999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 1 12234457999999999999999999999999999999999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=407.87 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=217.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 703 (956)
++|+..++||+|+||+||+|++++++.||||+++.... .+++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998899999999986443 35689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCc
Q 002178 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (956)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 783 (956)
+|+|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+......
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~---- 154 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---- 154 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS----
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC----
Confidence 999999976543 35788999999999999999999998 9999999999999999999999999998664332
Q ss_pred cccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+..+.....
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~---------~i~~~~~~~~ 222 (258)
T d1k2pa_ 155 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAE---------HIAQGLRLYR 222 (258)
T ss_dssp --CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHH---------HHHTTCCCCC
T ss_pred --ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHHH---------HHHhCCCCCC
Confidence 112334568999999999999999999999999999999998 88899755432 1111 2223344456
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELES 897 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 897 (956)
|..+++++.+++.+||+.+|++||+++++++.|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 77778899999999999999999999999998864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=409.76 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=197.1
Q ss_pred CCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeeeccccc----CCcEEEEE
Q 002178 627 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 699 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~LV~ 699 (956)
+..++||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 6889999998653 23345678999999999999999999999854 34679999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc-CCCcEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~ 778 (956)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997653 5889999999999999999999875 5599999999999996 578999999999986432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||....+........ ..+.
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---------~~~~ 229 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGV 229 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTTC
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH---------HcCC
Confidence 12334579999999999865 59999999999999999999999997544332221111 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
. +. .. .....+++.+++.+||..||++|||++|+|+||||+
T Consensus 230 ~---~~----------------------~~-------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 K---PA----------------------SF-------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp C---CG----------------------GG-------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred C---Cc----------------------cc-------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0 00 00 000112234678888999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-48 Score=426.67 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=209.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999964 69999999998777666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC--CCcEEEEeeccccccCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~ 780 (956)
++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999999654 345999999999999999999999999 999999999999964 678999999999876432
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|||||++.+..++.++||||+||++|||++|+.||..... .+.....
T Consensus 180 ------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i--------------- 237 (350)
T d1koaa2 180 ------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNV--------------- 237 (350)
T ss_dssp ------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---------------
T ss_pred ------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHH---------------
Confidence 223456799999999999999999999999999999999999999975432 1111110
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+-..-+.. ..+...+.+.+||.+||..||++|||++|+|+||||+..
T Consensus 238 --------------~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 238 --------------KSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp --------------HHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred --------------HhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0110000000 000111223468888899999999999999999999653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-47 Score=424.57 Aligned_cols=259 Identities=21% Similarity=0.380 Sum_probs=212.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
++|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999998766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc--CCCcEEEEeeccccccCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 780 (956)
++|+|.+++... ..++++.+++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999987543 346999999999999999999999999 99999999999998 6789999999999876432
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~---------------- 239 (352)
T d1koba_ 183 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQN---------------- 239 (352)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH----------------
T ss_pred ------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH----------------
Confidence 223456799999999999999999999999999999999999999975432211 110
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
+..+--.-|.. ..+...+.+.+||.+||+.||++|+|++|+|+||||+.+.
T Consensus 240 -------------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 240 -------------VKRCDWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -------------HHHCCCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------HHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 01100000000 0011122345788999999999999999999999997654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=414.68 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=214.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 346799999999999999999999888899999997543 345689999999999999999999999854 567899999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++.......+++.+++.|+.||++||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-- 167 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 167 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC--
Confidence 99999999997765566999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 861 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (956)
........||+.|+|||++..+.++.++|||||||++|||++|..|+.......+..... ..+...+
T Consensus 168 ----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---------~~~~~~~ 234 (285)
T d1fmka3 168 ----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMP 234 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---------HTTCCCC
T ss_pred ----ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---------HhcCCCC
Confidence 122344568999999999999999999999999999999999877776655444333221 1223345
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 862 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 862 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+..+++++.+++.+||+.+|++||++++|++.|+.+..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 667788899999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=421.66 Aligned_cols=260 Identities=23% Similarity=0.399 Sum_probs=194.0
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
.+.|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 6899999998754432 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc---CCCcEEEEeeccccccCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~ 777 (956)
||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999764 45899999999999999999999999 99999999999994 578999999999986542
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .. +...
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~---------i~~~ 224 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQ---------ILKA 224 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HH---------HHTT
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-HH---------Hhcc
Confidence 2 2233457999999999999999999999999999999999999999754322111 10 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccc
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 937 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~ 937 (956)
... + ..|. .+...+.+.+|+.+||..||++|||++|+|+||||+
T Consensus 225 ~~~-~---------------------~~~~--------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 225 EYE-F---------------------DSPY--------------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp CCC-C---------------------CTTT--------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CCC-C---------------------CCcc--------------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 000 0 0000 011122234788889999999999999999999998
Q ss_pred cCCC
Q 002178 938 SDVS 941 (956)
Q Consensus 938 ~~~~ 941 (956)
++..
T Consensus 269 ~~~~ 272 (307)
T d1a06a_ 269 GDTA 272 (307)
T ss_dssp SSCC
T ss_pred CCCc
Confidence 6554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=411.61 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=214.8
Q ss_pred hcCCCCCC-eeeeeCCeEEEEEEeC---CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 623 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 623 ~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
.++|.+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34566666 4999999999999864 35689999997643 3345789999999999999999999999865 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998653 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+..
T Consensus 162 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~---------~i~~ 227 (285)
T d1u59a_ 162 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA---------FIEQ 227 (285)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHH---------HHHT
T ss_pred cccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHH---------HHHc
Confidence 3211 122234568999999999999999999999999999999998 89999764432 1111 1223
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.....|+.++.++.+++.+||+.+|++||++.++++.|+....
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44556677888999999999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=412.00 Aligned_cols=205 Identities=27% Similarity=0.447 Sum_probs=166.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeeccccc--CCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV 698 (956)
++|++.+.||+|+||+||+|+.+ +|+.||||.+..... ...+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999965 699999999876432 334678999999999999999999999854 4578999
Q ss_pred EecCCCCCHHHHHhhc--CCCCchhHHHHHHHHHHHHHHHHhhhcC--CCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 699 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998652 3456999999999999999999999865 23599999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 64321 2234567999999999999999999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-47 Score=417.38 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=210.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999974 69999999987432 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||++||+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999987654 4678888899999999999999999 999999999999999999999999999875421
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.... +..+ .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~---------i~~~-~ 217 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEK---------ILNA-E 217 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH---------HHHC-C
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHH---------HHcC-C
Confidence 23467999999999999999999999999999999999999999764432 11111 1111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+|...++++.+++.+|+..+|.+|+ |..|+|++|+|+||||++-
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~----------------------------------~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRL----------------------------------GNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhcc----------------------------------ccchhhHHHHHcCcccccC
Confidence 233444556677777777777777775 2356799999999999763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=408.20 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=210.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCC-----cEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDG-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
+.|+..+.||+|+||+||+|.+++. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997532 4799999875433 335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
||||+.+|++.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988654 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+.......+... .+.++
T Consensus 163 ~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---------~i~~~ 229 (283)
T d1mqba_ 163 DPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---------AINDG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------HHHTT
T ss_pred CCc----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---------HHhcc
Confidence 221 11223345689999999999999999999999999999999997777665444333222 12233
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
...+.|.+++..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 4456677788999999999999999999999999999998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=407.35 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=205.2
Q ss_pred CeeeeeCCeEEEEEEeCC---CcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecCCC
Q 002178 630 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 704 (956)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|++++++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 57899999875332 234689999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 002178 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (956)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 784 (956)
|+|.++++.. ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---- 162 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 162 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc----
Confidence 9999999764 35899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCCCCC
Q 002178 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 863 (956)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (956)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+..+.....|
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~---------~i~~~~~~~~p 232 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTA---------MLEKGERMGCP 232 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH---------HHHTTCCCCCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHH---------HHHcCCCCCCC
Confidence 1122334568999999999999999999999999999999998 89999754432 1111 12233445667
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 864 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 864 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
..++.++.+++.+||+.+|++||+++++++.|+.+.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 778899999999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=419.36 Aligned_cols=241 Identities=24% Similarity=0.291 Sum_probs=196.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999964 79999999987532 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|||++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999997754 4788899999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .+..... ....
T Consensus 160 -------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i----------~~~~ 221 (337)
T d1o6la_ 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI----------LMEE 221 (337)
T ss_dssp -------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH----------HHCC
T ss_pred -------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-HHHHHHH----------hcCC
Confidence 223456799999999999999999999999999999999999999976442 1111111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPS 887 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs 887 (956)
..+|...+.++.+++.+|++.||.+|++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcc
Confidence 2334445555556666666666666653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=411.51 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcCCCceeeeecccccCCcE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 695 (956)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 799999999864322 2356899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC----cEEEEeecc
Q 002178 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (956)
Q Consensus 696 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DfGl 771 (956)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997653 5899999999999999999999999 99999999999998776 599999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 851 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 851 (956)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 164 a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~------- 227 (293)
T d1jksa_ 164 AHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------- 227 (293)
T ss_dssp CEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-------
T ss_pred hhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHH-------
Confidence 9876432 223445689999999999999999999999999999999999999975432111 110
Q ss_pred hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCC
Q 002178 852 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 931 (956)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L 931 (956)
+.... ..++... .+...+.+.+||.+||..||++|||++|+|
T Consensus 228 --i~~~~-~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 228 --VSAVN-YEFEDEY-----------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp --HHTTC-CCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred --HHhcC-CCCCchh-----------------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00000 0111100 011223345789999999999999999999
Q ss_pred CCCcccc
Q 002178 932 KHPYVSS 938 (956)
Q Consensus 932 ~HP~f~~ 938 (956)
+||||+.
T Consensus 270 ~hp~~~~ 276 (293)
T d1jksa_ 270 QHPWIKP 276 (293)
T ss_dssp HSTTTCC
T ss_pred cCcccCC
Confidence 9999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-47 Score=412.75 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=201.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999964 789999999875432 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
|||++|+|..++..+ .++++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998776543 45899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccceecccccCCCccccccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........... +..
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----------i~~ 228 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IAQ 228 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------HHH
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----------HHh
Confidence 123469999999999864 4589999999999999999999999975433211111 111
Q ss_pred CCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCc
Q 002178 857 GNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 935 (956)
Q Consensus 857 ~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~ 935 (956)
...+.. +..+ .+.+.+|+.+||..||++|||++|+|+|||
T Consensus 229 ~~~~~~~~~~~---------------------------------------s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 229 NESPALQSGHW---------------------------------------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp SCCCCCSCTTS---------------------------------------CHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCCCCCCCC---------------------------------------CHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 111100 1111 112336777788888888888888888888
Q ss_pred cccCCC
Q 002178 936 VSSDVS 941 (956)
Q Consensus 936 f~~~~~ 941 (956)
|.....
T Consensus 270 ~~~~~~ 275 (309)
T d1u5ra_ 270 VLRERP 275 (309)
T ss_dssp HHSCCC
T ss_pred hcCCCC
Confidence 876544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-47 Score=418.44 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=207.5
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 699 (956)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 79999999986432 123457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 779 (956)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999876421
Q ss_pred CCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ....... .. ..
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i---------~~-~~ 254 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKI---------VS-GK 254 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---------HH-CC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHH---------hc-CC
Confidence 2345799999999999999999999999999999999999999975432 2211111 11 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
..+|..++..+.+++.+|++.||.+|+ +..|+|++|+++||||++.
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~----------------------------------~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRF----------------------------------GNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGTTC
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhcc----------------------------------ccccccHHHHHcCccccCC
Confidence 223444455566666666666666653 2334688888888888653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=412.51 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=210.9
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC-C-----cEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccCC
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD-G-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 693 (956)
..++|++.+.||+|+||+||+|++.. + ..||||.+..... .....+.+|+.+++++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 44688899999999999999998642 2 3699999865432 3346789999999998 8999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCC---------------------CCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCC
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 752 (956)
..++|||||++|+|.++++.+.. ..+++..++.++.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999976432 35889999999999999999999998 9999999
Q ss_pred cccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCC
Q 002178 753 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831 (956)
Q Consensus 753 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~p 831 (956)
|+|||++.++.+||+|||+|+...... .........||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhccccccCCeEEEeeccccccccCCC-----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999998654322 1222345568999999999999999999999999999999998 8999
Q ss_pred CCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002178 832 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 896 (956)
Q Consensus 832 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 896 (956)
|............ . -.+.....|..+++++.+++.+||+.+|++||+++++++.|.
T Consensus 267 f~~~~~~~~~~~~-~--------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANFYKL-I--------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHHHHH-H--------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHH-H--------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9754332211111 1 112234556778889999999999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=409.84 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=219.0
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeeeccc
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~ 689 (956)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344456788999999999999999999863 3578999999764433 356899999999999999999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcC----------------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEe
Q 002178 690 DEEGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (956)
Q Consensus 690 ~~~~~~~LV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 747 (956)
...+..++||||+++|+|.++++... ...+++..++.|+.|++.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999996432 234889999999999999999999999 99
Q ss_pred ccCCCcccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh
Q 002178 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (956)
Q Consensus 748 H~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt 827 (956)
||||||+|||++.++.+||+|||+|+...... .........|++.|+|||.+.+..++.++|||||||++|||++
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCc-----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999998654222 1222344568899999999999999999999999999999999
Q ss_pred CCC-CCCCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002178 828 GMQ-PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 899 (956)
Q Consensus 828 g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 899 (956)
|.. ||... +..+... .+.++.....|+.++.++.+++.+||+.+|++||+|.+|++.|+++.
T Consensus 238 ~~~~p~~~~-~~~e~~~---------~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGM-AHEEVIY---------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCTTTTS-CHHHHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCC-CHHHHHH---------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 965 55443 3222222 23344455567778889999999999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=398.31 Aligned_cols=252 Identities=30% Similarity=0.461 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc-CCcEEEEEec
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEF 701 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e~ 701 (956)
.++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35678889999999999999998 47889999997543 34679999999999999999999999854 4678999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+++|+|.+++..+....+++..+++|+.||+.||.|||+.+ |+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999997765556899999999999999999999998 999999999999999999999999999864321
Q ss_pred CccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+.. ..+..+..+
T Consensus 157 -------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~~~---------~~i~~~~~~ 219 (262)
T d1byga_ 157 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVV---------PRVEKGYKM 219 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHH---------HHHTTTCCC
T ss_pred -------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HHHH---------HHHHcCCCC
Confidence 223457889999999999999999999999999999998 6777654322 1111 122334455
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
..|..++.++.+++.+||+.||.+||++.++++.|+++..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 6677788899999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=410.18 Aligned_cols=278 Identities=22% Similarity=0.337 Sum_probs=202.5
Q ss_pred CCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhh-----HHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 628 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
.+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999965 69999999987543221 24688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
++++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 988777666533 345889999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC-C
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-M 859 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 859 (956)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+.. ....... ..... .
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~------~~~~~~~ 222 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFE------TLGTPTE 222 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------HHCCCCT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHH------hcCCCCh
Confidence 122345699999999998754 57999999999999999999999987554322 2111110 00000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccC
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 939 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~ 939 (956)
...+... ... ....-...|... .....+..++.+.+|+.+||+.||++|+||+|+|+||||++.
T Consensus 223 ~~~~~~~-----~~~---~~~~~~~~~~~~--------~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 223 EQWPDMC-----SLP---DYVTFKSFPGIP--------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSSTT-----SST---TCCCCCCCCCCC--------HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchh-----ccc---hhhhhccCCCCC--------hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000000 000 000000111100 011223345556789999999999999999999999999865
Q ss_pred C
Q 002178 940 V 940 (956)
Q Consensus 940 ~ 940 (956)
.
T Consensus 287 p 287 (299)
T d1ua2a_ 287 P 287 (299)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=399.46 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=205.1
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC----CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
..++|++.+.||+|+||+||+|++.. +..||||.++.... ...+.|.+|++++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999998642 45789999875433 33567999999999999999999999996 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+...
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999988654 346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||....... . ...+.
T Consensus 160 ~~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~---------~~~i~ 223 (273)
T d1mp8a_ 160 DST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-V---------IGRIE 223 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-H---------HHHHH
T ss_pred CCc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-H---------HHHHH
Confidence 322 122344568999999999999999999999999999999998 888887544321 1 11223
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.+...+.|..+++.+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 344455677888999999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=406.30 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC---hhhHHHHHHHHHHHH-hcCCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 69999999987432 122345667777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCC
Q 002178 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 778 (956)
|||+++|+|.++++... .+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 4788899999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 858 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (956)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..... ..+
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i---------~~~- 218 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSI---------RMD- 218 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH---------HHC-
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHH---------HcC-
Confidence 2 2234457999999999999999999999999999999999999999754321 111100 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCc-cCCCCCccc
Q 002178 859 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKHPYVS 937 (956)
Q Consensus 859 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~-e~L~HP~f~ 937 (956)
...+|.. .++.+.+|+++||+.||++|+|++ |+++||||+
T Consensus 219 ~~~~p~~---------------------------------------~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 219 NPFYPRW---------------------------------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp CCCCCTT---------------------------------------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred CCCCCcc---------------------------------------CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 0111111 122334678888888899999885 788999986
Q ss_pred c
Q 002178 938 S 938 (956)
Q Consensus 938 ~ 938 (956)
.
T Consensus 260 ~ 260 (320)
T d1xjda_ 260 E 260 (320)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-45 Score=396.10 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=204.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh---------hHHHHHHHHHHHHhcC-CCceeeeecccccC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 692 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 692 (956)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 47999999998653211 1246889999999997 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccc
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla 772 (956)
+..++|||||++|+|.++++.++ ++++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 5899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecccccCCCccccccccc------CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002178 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 846 (956)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~ 846 (956)
+..... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ....
T Consensus 158 ~~~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i- 227 (277)
T d1phka_ 158 CQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMI- 227 (277)
T ss_dssp EECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-
T ss_pred eEccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHHH-
Confidence 876432 12244569999999999864 3468899999999999999999999975432111 1100
Q ss_pred hcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCC
Q 002178 847 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
..+.. .. + .|. .+...+++.+|+.+||+.||++|+|
T Consensus 228 --------~~~~~-------------------~~-~--~~~--------------~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 228 --------MSGNY-------------------QF-G--SPE--------------WDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp --------HHTCC-------------------CC-C--TTT--------------GGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred --------HhCCC-------------------CC-C--Ccc--------------cccCCHHHHHHHHHHccCChhHCcC
Confidence 00000 00 0 000 0011223346888889999999999
Q ss_pred CccCCCCCcccc
Q 002178 927 SSSMLKHPYVSS 938 (956)
Q Consensus 927 a~e~L~HP~f~~ 938 (956)
++|+|+||||+.
T Consensus 264 ~~eil~h~~~~~ 275 (277)
T d1phka_ 264 AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHTTSGGGCT
T ss_pred HHHHHcCHHHHH
Confidence 999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-46 Score=412.52 Aligned_cols=198 Identities=27% Similarity=0.400 Sum_probs=170.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCCh---hhHHHHHHH---HHHHHhcCCCceeeeecccccCCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTE---IQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+| +++++.++||||+++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999965 699999999864322 122334444 66777778999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997653 4788999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
.. ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 32 1234569999999999975 56899999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=405.85 Aligned_cols=283 Identities=26% Similarity=0.371 Sum_probs=210.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 47999999998654322 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
|+. |++.+++.......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 995 56666666555667999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......||+.|+|||++.... ++.++||||+||++|||++|+.||..................
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~--------- 221 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--------- 221 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC---------
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC---------
Confidence 2234457999999999987765 578999999999999999999999765433221111100000
Q ss_pred CCCChHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 860 GSYPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
..+.......... ...... ...+.... ...+..+..+.+|+.+||..||++|+|++|+|+||||++
T Consensus 222 --~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 222 --PDEVVWPGVTSMP-DYKPSFPKWARQDFS----------KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp --CCTTTSTTGGGST-TCCTTSCCCCCCCHH----------HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred --Cchhhcccccccc-ccccccccccccchh----------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0000000000000 000000 01111111 122334455678999999999999999999999999975
Q ss_pred C
Q 002178 939 D 939 (956)
Q Consensus 939 ~ 939 (956)
-
T Consensus 289 ~ 289 (298)
T d1gz8a_ 289 V 289 (298)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=406.45 Aligned_cols=258 Identities=19% Similarity=0.352 Sum_probs=207.6
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEecC
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 702 (956)
++|++.+.||+|+||+||+|... +|+.||||+++..... ...+.+|+++|++++||||+++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 67999999999999999999975 6899999999865433 456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCC--CcEEEEeeccccccCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DfGla~~~~~~~~ 780 (956)
++|+|.+++.... ..+++.+++.|+.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999996543 35899999999999999999999999 9999999999999854 58999999999875422
Q ss_pred CCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ ... +.... .
T Consensus 158 ------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~---------i~~~~-~ 220 (321)
T d1tkia_ 158 ------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IEN---------IMNAE-Y 220 (321)
T ss_dssp ------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH---------HHHTC-C
T ss_pred ------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHH---------HHhCC-C
Confidence 223445789999999999999999999999999999999999999975432111 110 00000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCccccCC
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
.++... ++...+.+.+|+.+||+.||++|+|++|+|+||||....
T Consensus 221 ~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 221 TFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp CCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CCChhh-----------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 111100 011122345788889999999999999999999996543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=401.25 Aligned_cols=267 Identities=25% Similarity=0.409 Sum_probs=206.7
Q ss_pred HHHHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecc
Q 002178 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGY 688 (956)
Q Consensus 617 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 688 (956)
..+....++|++.++||+|+||+||+|.+. +++.||||+++.... ...+.+.+|.+.+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344455678999999999999999999853 347899999875433 3456788888888777 68999999998
Q ss_pred ccc-CCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCc
Q 002178 689 CDE-EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (956)
Q Consensus 689 ~~~-~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 753 (956)
+.+ +...++|||||++|+|.++++... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 765 457899999999999999997542 235889999999999999999999999 99999999
Q ss_pred ccEEEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCC-CC
Q 002178 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ-PI 832 (956)
Q Consensus 754 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~-pf 832 (956)
+|||+++++++||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||.. ||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeECCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 999999999999999999987543321 122344679999999999999999999999999999999999754 66
Q ss_pred CCCchhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 833 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
............ +..+.....|+.+++++.+++.+||+.+|++||++.++++.|+++.+
T Consensus 238 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 238 PGVKIDEEFCRR---------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TTCCCSHHHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHH---------HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 543322211111 12233445667778899999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=395.69 Aligned_cols=260 Identities=31% Similarity=0.498 Sum_probs=213.1
Q ss_pred CCeeeeeCCeEEEEEEeCC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeeccccc-CCcEEEEEecC
Q 002178 629 STQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEFM 702 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e~~ 702 (956)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999753 236899998753 44455789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCCC
Q 002178 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (956)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 782 (956)
++|+|.++++.. ....++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 999999998754 345778889999999999999999999 999999999999999999999999999876543321
Q ss_pred ccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCCCC
Q 002178 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 862 (956)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (956)
.........||+.|+|||++.+..++.++||||||+++|||+||+.||....+..+.. ..+..+.....
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~---------~~i~~g~~~~~ 255 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---------VYLLQGRRLLQ 255 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH---------HHHHTTCCCCC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH---------HHHHcCCCCCC
Confidence 1222334568999999999999999999999999999999999888887544322211 12334445556
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002178 863 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 904 (956)
Q Consensus 863 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 904 (956)
|+.+++.+.+++.+||+.+|++||++.||++.|+++.+.+..
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 777788999999999999999999999999999999876443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=400.00 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=207.3
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 697 (956)
++|++.++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|++++++++||||++++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 444 6899988653 334467899999999999999999999999764 6788
Q ss_pred EEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCC
Q 002178 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 777 (956)
|+||+.+|+|.+++... ...+++..+++++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988764 446899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhcc
Q 002178 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 856 (956)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 856 (956)
... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +... .+..
T Consensus 164 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~---------~i~~ 228 (317)
T d1xkka_ 164 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISS---------ILEK 228 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHH---------HHHH
T ss_pred ccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHH---------HHHc
Confidence 321 122234568999999999999999999999999999999999 77777643321 1111 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 857 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 857 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+.....|+.++..+.+++.+||+.+|.+||++.++++.++.+..
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 33455677788899999999999999999999999999887643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.3e-46 Score=401.34 Aligned_cols=282 Identities=22% Similarity=0.302 Sum_probs=206.9
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 701 (956)
++|++.++||+|+||+||+|++++|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999989999999999764332 246899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 781 (956)
+.++.+..+... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+|++|||.|.....+.
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 977666666543 346999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCCC
Q 002178 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 860 (956)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (956)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ ....+.. .......
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~-----~~~~~~~ 223 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRI-----LGTPNSK 223 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-----HCCCCTT
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHh-----hCCCChh
Confidence 223344688999999999764 568999999999999999999999975543222 1111100 0000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 861 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 861 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
..+ ................+.. .....+..++.+.||+++||+.||++|+|++|+|+||||+.
T Consensus 224 ~~~-----~~~~~~~~~~~~~~~~~~~----------~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 224 NWP-----NVTELPKYDPNFTVYEPLP----------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TST-----TGGGSTTCCTTCCCCCCCC----------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcc-----chhhhhhcccccccccCcc----------hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000 0000000000000000000 01122233444568999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=405.71 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=170.7
Q ss_pred cCCCCCC-eeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeeeccccc----CCcEE
Q 002178 624 NNFNSST-QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQM 696 (956)
Q Consensus 624 ~~y~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~ 696 (956)
++|++.. .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +||||++++++|.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788775 599999999999996 47999999998642 3567899987655 89999999999864 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC---CCcEEEEeecccc
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DfGla~ 773 (956)
+|||||+||+|.+++..++...+++.+++.|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999998766677999999999999999999999999 999999999999985 5679999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 163 ETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp ECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 764322 223457999999999999999999999999999999999999999643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=397.48 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=212.0
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCc--EEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeeecccccCCcEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 698 (956)
++|++.++||+|+||+||+|+++ +|. .||||+++... ....+.|.+|+++++++ +||||++++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999975 444 57888876433 33456799999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhc--------------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcE
Q 002178 699 YEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (956)
Q Consensus 699 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 764 (956)
|||+++|+|.++++.. ....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 2356899999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002178 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 844 (956)
Q Consensus 765 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~ 844 (956)
||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+....+..+...
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE- 237 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence 99999999864321 122344689999999999999999999999999999999998765444444333222
Q ss_pred HhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 845 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
.+..+.....|..+++++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 238 --------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 --------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2233445566777889999999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=387.19 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC--CC--cEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 696 (956)
++|++.+.||+|+||.||+|++. ++ ..||||+++... ....++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 22 478999887532 2334689999999999999999999999975 4678
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
+||||+++|++.+++..+. ..+++..++.++.||++||.|||+++ |+||||||+||+++.++++||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887643 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... .........|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +.......
T Consensus 163 ~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~-------- 229 (273)
T d1u46a_ 163 QNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK-------- 229 (273)
T ss_dssp C-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT--------
T ss_pred cCCC----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHh--------
Confidence 3321 1222334567889999999999999999999999999999998 89999754332 22221111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 856 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 856 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+...+.++.++..+.+++.+||+.+|++||++.++.+.|++.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223345666778899999999999999999999999888753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=395.52 Aligned_cols=263 Identities=26% Similarity=0.440 Sum_probs=217.7
Q ss_pred HHHHhcCCCCCCeeeeeCCeEEEEEEeC------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeeccccc
Q 002178 619 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (956)
Q Consensus 619 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 691 (956)
+....++|++.+.||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4445578899999999999999999863 35789999997543 3344678999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--------CCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAK--------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 763 (956)
++..++||||+++|+|.+++... ....+++..+.+++.|+|+||.|||+++ |+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999998642 2235788999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002178 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 843 (956)
Q Consensus 764 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~ 843 (956)
+||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||+||..|+..+.+..+...
T Consensus 172 ~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp EEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred EEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999998654322 11223345689999999999999999999999999999999998644433433333222
Q ss_pred HHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002178 844 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 898 (956)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 898 (956)
.+.++.....|..++..+.+++.+||+.+|++||++.++++.|++.
T Consensus 247 ---------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 ---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2234455566777888999999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=391.24 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=217.1
Q ss_pred HHhcCCCCCCeeeeeCCeEEEEEEe------CCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeecccccC
Q 002178 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (956)
Q Consensus 621 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 692 (956)
...++|++.+.||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++++ +||||++++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4457888999999999999999985 2467999999976443 3456789999999999 699999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC----------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccE
Q 002178 693 GEQMLVYEFMSNGTLRDQLSAKS----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (956)
Q Consensus 693 ~~~~LV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 756 (956)
+..++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ ||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999997642 235889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 002178 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (956)
Q Consensus 757 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~ 836 (956)
+++.++.+|++|||.++...... .........||+.|+|||++.+..++.++|||||||++|||+|+..|+....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCT-----TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCcccccccchheeccCCC-----cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998765332 1223345679999999999999999999999999999999999555554433
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
+......... ..+.....+..++..+.+++.+||+.+|.+||++++++++|+++..
T Consensus 252 ~~~~~~~~~i--------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 252 PVDSKFYKMI--------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CSSHHHHHHH--------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHH--------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 3222221111 1122334566677899999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-43 Score=381.53 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeeecccccCC----c
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 694 (956)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999996 4799999999975432 33457899999999999999999999986544 3
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.|+||||+++|+|.+++...+ .+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987653 5899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
...... .........||+.|+|||++.+..++.++||||+||++|||+||+.||........ ..........
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~~--- 232 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPI--- 232 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCC---
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCCC---
Confidence 543221 12233456799999999999999999999999999999999999999976543322 1111111100
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhH
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIW 899 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~ 899 (956)
......+..++.+.+++.+|++.||.+|| +++++.+.|.++.
T Consensus 233 ---~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00112344567899999999999999999 8999999888764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=392.66 Aligned_cols=281 Identities=25% Similarity=0.334 Sum_probs=202.7
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-C-CcEEEEEEecCCCh--hhHHHHHHHHHHHHhc---CCCceeeeecccc-----
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCD----- 690 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~----- 690 (956)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+++++.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999963 4 67899999864321 1223566777777665 7999999999984
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeec
Q 002178 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (956)
Q Consensus 691 ~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfG 770 (956)
.....++||||++++++.... ......+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 235789999999876665444 344556899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||..................
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9876432 22334567999999999999999999999999999999999999999765432221111000000
Q ss_pred c-hhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 851 M-FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 851 ~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
. ....... ...+. . ........| .....+..++.+.+|+.+||+.||++||||+|
T Consensus 234 ~~~~~~~~~-~~~~~-----------~-~~~~~~~~~-----------~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 234 PGEEDWPRD-VALPR-----------Q-AFHSKSAQP-----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp CCGGGSCTT-CSSCG-----------G-GSCCCCCCC-----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred Cchhccccc-ccchh-----------h-hhccccccc-----------hhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 0 0000000 00000 0 000000000 01112233444568999999999999999999
Q ss_pred CCCCCccccC
Q 002178 930 MLKHPYVSSD 939 (956)
Q Consensus 930 ~L~HP~f~~~ 939 (956)
+|+||||+.-
T Consensus 290 ~L~Hpff~~i 299 (305)
T d1blxa_ 290 ALSHPYFQDL 299 (305)
T ss_dssp HHTSGGGTTC
T ss_pred HhcChhhcCc
Confidence 9999999753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=389.12 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=212.4
Q ss_pred HhcCCCCCCeeeeeCCeEEEEEEeCC--------CcEEEEEEecCCCh-hhHHHHHHHHHHHHhc-CCCceeeeeccccc
Q 002178 622 ATNNFNSSTQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (956)
Q Consensus 622 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 691 (956)
..++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35688889999999999999998532 35799999976543 3457889999999888 79999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------CCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEE
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 757 (956)
++..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999997543 245899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 002178 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (956)
Q Consensus 758 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~ellt-g~~pf~~~~ 836 (956)
++.++.+||+|||+++...... .........||+.|+|||.+.++.|+.++|||||||++|||++ |+.||....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCC-----TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCCeEeccchhhccccccc-----cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999998765332 1223345668999999999999999999999999999999998 677775443
Q ss_pred hhHHHHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 837 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
. .+... .+..+.....|..++..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 243 ~-~~~~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 V-EELFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H-HHHHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2 22111 122333445667778899999999999999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=392.94 Aligned_cols=291 Identities=21% Similarity=0.280 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc--------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 691 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 691 (956)
-++|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999964 79999999986432 2234678899999999999999999998744
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecc
Q 002178 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (956)
Q Consensus 692 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGl 771 (956)
+++.++||||++++.+..+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 356899999998766654443 3345888889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
++........ .........||+.|+|||++.+. .++.++||||+||++|||++|+.||....+.............
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9876533221 11222345699999999999865 6899999999999999999999999754432221111100000
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
.. .......... .. ..........++...+.+.... .++.+.|||.+||++||++|+||+|+
T Consensus 241 ~~---~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 241 IT---PEVWPNVDNY---EL----YEKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp CC---TTTSTTCCCC--------------CCSSCCBCHHHHHHHHH--------CCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CC---hhhccccchh---hh----hhhhcccccccccchhhhcccc--------CCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 00 0000000000 00 0111222333444444433221 13345689999999999999999999
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
|+||||+.+
T Consensus 303 L~Hpff~~~ 311 (318)
T d3blha1 303 LNHDFFWSD 311 (318)
T ss_dssp HHSGGGSSS
T ss_pred HcChhhccC
Confidence 999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=390.98 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=198.8
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChh------hHHHHHHHHHHHHhcC--CCceeeeecccccCC
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEG 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 693 (956)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999964 7999999998643211 1234678999999996 899999999999999
Q ss_pred cEEEEEecCCC-CCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-CCcEEEEeecc
Q 002178 694 EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 771 (956)
Q Consensus 694 ~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DfGl 771 (956)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 99999999975 68888886643 5899999999999999999999999 999999999999985 47999999999
Q ss_pred ccccCCCCCCCccccceecccccCCCcccccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhccc
Q 002178 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 850 (956)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 850 (956)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 158 a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------ 216 (273)
T d1xwsa_ 158 GALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------ 216 (273)
T ss_dssp CEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred ceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------
Confidence 9865321 2334579999999999988765 56789999999999999999999642110
Q ss_pred chhhccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 851 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
..+. ..++ +. .++.+.+|+++||..||++|||++|+
T Consensus 217 ----~~~~-~~~~----------------------~~-----------------~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 217 ----IRGQ-VFFR----------------------QR-----------------VSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp ----HHCC-CCCS----------------------SC-----------------CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----hhcc-cCCC----------------------CC-----------------CCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0000 0011 00 11223468888999999999999999
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
|+||||++-
T Consensus 253 l~hp~~~~~ 261 (273)
T d1xwsa_ 253 QNHPWMQDV 261 (273)
T ss_dssp HTSGGGSSC
T ss_pred hcCHhhCCC
Confidence 999999753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=389.11 Aligned_cols=283 Identities=24% Similarity=0.365 Sum_probs=212.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCCcEEEEEe
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 700 (956)
++|++.++||+|+||+||+|++. +++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 78999999986433 2335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccCCCCC
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 780 (956)
++.+++|..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999988887654 45788899999999999999999999 9999999999999999999999999998765332
Q ss_pred CCccccceecccccCCCcccccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccCCC
Q 002178 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 859 (956)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (956)
.......+++.|+|||++.... ++.++||||+||++|||++|+.||..+.+..+......... ...
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~- 222 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL------GTP- 222 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH------CCC-
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc------CCC-
Confidence 1223345778999999988765 68999999999999999999999887766554443321110 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCCcccc
Q 002178 860 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 938 (956)
Q Consensus 860 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f~~ 938 (956)
+........+... ......++.. .......+..++.+.+|+++||+.||++|+||+|+|+||||+.
T Consensus 223 ---~~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 223 ---TEEQWPSMTKLPD---YKPYPMYPAT-------TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp ---CTTTCTTGGGSTT---CCCCCCCCTT-------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ---Chhhhhhhhhccc---cccccccccc-------chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0000000000000 0000000000 0011112223344568999999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=393.85 Aligned_cols=279 Identities=22% Similarity=0.353 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeecccccCC------
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 693 (956)
.++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 69999999997532 233567899999999999999999999986554
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 694 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
+.++||||+ +.+|..+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 67888887543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccch
Q 002178 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 852 (956)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 852 (956)
.... ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||..............
T Consensus 170 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~------ 233 (346)
T d1cm8a_ 170 QADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK------ 233 (346)
T ss_dssp ECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred ccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh------
Confidence 6532 12445699999999999864 568999999999999999999999976654322211110
Q ss_pred hhccCCCCCCChHHHHHHHHHH-HHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccC
Q 002178 853 SVIDGNMGSYPSECVEKFIKLA-LKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 853 ~~~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
..+..+.+......... .......+. .+... ....+..++.+.+||++||++||++||||+|+
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 234 -----VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF----------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp -----HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG----------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -----ccCCCcHHHHhhhcchhhhhhhccCCcccccch----------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 01112222221110000 000000111 11111 11223334556789999999999999999999
Q ss_pred CCCCccccC
Q 002178 931 LKHPYVSSD 939 (956)
Q Consensus 931 L~HP~f~~~ 939 (956)
|+||||++-
T Consensus 299 L~Hp~f~~~ 307 (346)
T d1cm8a_ 299 LAHPYFESL 307 (346)
T ss_dssp HHSGGGTTT
T ss_pred hcChhhCcC
Confidence 999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=391.08 Aligned_cols=288 Identities=22% Similarity=0.305 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeeecccccCC----cEE
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 696 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 696 (956)
+++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999986 479999999997543 334568899999999999999999999986543 234
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccccC
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 776 (956)
++++|+.+|+|.+++..+ .+++..++.++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 455566799999999754 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhc
Q 002178 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 855 (956)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 855 (956)
.... .........||+.|+|||++.. ..++.++||||+||++|||++|+.||............... .
T Consensus 161 ~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~-------~ 229 (345)
T d1pmea_ 161 PDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-------L 229 (345)
T ss_dssp GGGC----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-------H
T ss_pred CCCc----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh-------c
Confidence 3221 1112344569999999999854 56788999999999999999999999765432221111100 0
Q ss_pred cCCCCCCChHHHH-HHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCC
Q 002178 856 DGNMGSYPSECVE-KFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 933 (956)
Q Consensus 856 ~~~~~~~~~~~~~-~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~H 933 (956)
.....+... ....-...+....+... +.... .++..++.+.+|+.+||+.||++|+||+|+|+|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 ----GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----------LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp ----CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH----------HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cCCChhhhhhhhhhhhhcccccCCccCCCCHHH----------hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111100 00001112222233322 23322 234445556789999999999999999999999
Q ss_pred CccccCCC
Q 002178 934 PYVSSDVS 941 (956)
Q Consensus 934 P~f~~~~~ 941 (956)
|||+....
T Consensus 296 pf~~~~~~ 303 (345)
T d1pmea_ 296 PYLEQYYD 303 (345)
T ss_dssp GGGTTTCC
T ss_pred HhhccCCC
Confidence 99985544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=380.98 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=199.1
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeecccccCC----cEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~LV~ 699 (956)
.+|...+.||+|+||+||+|++ +|+.||||+++.... .......|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566778999999999999997 688999999864322 1222334555566789999999999996543 579999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhc-----CCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
|||++|+|.+++++. .++|..+++++.|+|.||+|+|+. ..++||||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999764 489999999999999999999974 123499999999999999999999999999987
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCC------CCCcccchhHHHHHHHHHhCCCCCCCCch-----------
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHGKN----------- 837 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~G~ll~elltg~~pf~~~~~----------- 837 (956)
....... .........||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 158 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 158 HDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 6433211 112234567999999999987642 56789999999999999999887743211
Q ss_pred --hHHHHHHHhhcccchhhccCCCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002178 838 --IVREVNIAYQSSMMFSVIDGNMGSY--PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 901 (956)
Q Consensus 838 --~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 901 (956)
........... ....+..+.. +.+....+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 235 ~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 01111111110 0111111111 235667899999999999999999999999999988653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=391.73 Aligned_cols=280 Identities=22% Similarity=0.284 Sum_probs=201.2
Q ss_pred CCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeeeccccc------CCcEEE
Q 002178 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 697 (956)
Q Consensus 625 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~L 697 (956)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999975 699999999876432 23469999999999999999999843 235789
Q ss_pred EEecCCCCCHHHHHhh-cCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeecccccc
Q 002178 698 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 775 (956)
Q Consensus 698 V~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~ 775 (956)
||||++++.+..+.+. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976544443322 34557999999999999999999999999 99999999999999775 8999999999876
Q ss_pred CCCCCCCccccceecccccCCCccccccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............ ..
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i-~~------- 237 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI-IK------- 237 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH-HH-------
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH-HH-------
Confidence 4322 2234569999999999875 57899999999999999999999999765432221111 00
Q ss_pred ccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCccCCCCC
Q 002178 855 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 934 (956)
Q Consensus 855 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP 934 (956)
..+..+.+.......-............|.. ....+..++.+.+|+.+||++||++|+||+|+|+||
T Consensus 238 ---~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 238 ---VLGTPTREQIREMNPNYTEFKFPQIKAHPWT----------KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp ---HHCCCCHHHHHHHCC---CCCCCCCCCCCGG----------GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---HhCCChHHhhhhhccchhhccccccccCchh----------hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0112222222211110000000000000000 001122344456899999999999999999999999
Q ss_pred ccccCC
Q 002178 935 YVSSDV 940 (956)
Q Consensus 935 ~f~~~~ 940 (956)
||+.-.
T Consensus 305 ~f~~~~ 310 (350)
T d1q5ka_ 305 FFDELR 310 (350)
T ss_dssp GGGGGG
T ss_pred hhcccc
Confidence 997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-43 Score=389.50 Aligned_cols=279 Identities=18% Similarity=0.331 Sum_probs=204.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeeccccc--CCcEEEEE
Q 002178 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 699 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~LV~ 699 (956)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5899999999999999999996 479999999987543 457889999999995 9999999999864 45799999
Q ss_pred ecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCC-cEEEEeeccccccCCC
Q 002178 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 778 (956)
Q Consensus 700 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~ 778 (956)
||+++++|.++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 34889999999999999999999999 99999999999998655 6999999999876432
Q ss_pred CCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (956)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+.......... .+.
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~------~~g- 248 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK------VLG- 248 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH------HHC-
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH------HHC-
Confidence 2 23445689999999998875 4799999999999999999999999876554332221110 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--HHhHhhC-----CCCCCCCccccccccCCCCCCCCCCccC
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL--ESIWNMM-----PESDTKTPEFINSEHTSKEETPPSSSSM 930 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L--~~~~~~~-----~~~~~~~~~ll~~~L~~dP~~R~sa~e~ 930 (956)
...... .... .+....+...+..... ....... ...++++.|||++||++||++|+||+|+
T Consensus 249 ------~~~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~ 316 (328)
T d3bqca1 249 ------TEDLYD---YIDK---YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316 (328)
T ss_dssp ------HHHHHH---HHHH---TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ------Cchhhh---hhhh---cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000000 0000 0000000000000000 0000000 1123345689999999999999999999
Q ss_pred CCCCccccCC
Q 002178 931 LKHPYVSSDV 940 (956)
Q Consensus 931 L~HP~f~~~~ 940 (956)
|+||||++..
T Consensus 317 L~Hp~F~~v~ 326 (328)
T d3bqca1 317 MEHPYFYTVV 326 (328)
T ss_dssp HTSGGGTTSC
T ss_pred hcCcccCCCC
Confidence 9999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=382.11 Aligned_cols=201 Identities=27% Similarity=0.356 Sum_probs=171.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC----CCcEEEEEEecCCCh----hhHHHHHHHHHHHHhcCC-CceeeeecccccCCc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGE 694 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 694 (956)
++|++.+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 488999999864321 223567889999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||||+.+|+|.+++..... +.+...+.++.||+.||+|+|+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999977543 567888899999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~G~ll~elltg~~pf~~~ 835 (956)
..... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 54221 2223456799999999999764 4678999999999999999999999653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=384.84 Aligned_cols=277 Identities=21% Similarity=0.333 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEe-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc-----CCc
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 694 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 694 (956)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999996 479999999997543 3345678899999999999999999998853 334
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.++||+|+.+|+|.+++..+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 56677778899999999543 5899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 853 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 853 (956)
.. .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 171 ~~----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~----- 235 (348)
T d2gfsa1 171 TD----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV----- 235 (348)
T ss_dssp CT----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-----
T ss_pred cC----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-----
Confidence 43 122345689999999997775 46889999999999999999999997654332211111000
Q ss_pred hccCCCCCCChHHHHH----HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccccCCCCCCCCCCcc
Q 002178 854 VIDGNMGSYPSECVEK----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 929 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~----l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 929 (956)
+..+.+.... ...-........ .+..... ..+..++.+.+||++||+.||++|+||+|
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 236 ------GTPGAELLKKISSESARNYIQSLTQM--PKMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp ------CCCCHHHHTTCCCHHHHHHHTTSCCC--CCCCHHH----------HSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ------CCCChHHhhhccchhhhhhhhhcccC--CCcchhh----------hcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 1111111100 000000011111 1122221 12334555678999999999999999999
Q ss_pred CCCCCcccc
Q 002178 930 MLKHPYVSS 938 (956)
Q Consensus 930 ~L~HP~f~~ 938 (956)
+|+||||+.
T Consensus 298 lL~Hp~f~~ 306 (348)
T d2gfsa1 298 ALAHAYFAQ 306 (348)
T ss_dssp HHTSGGGTT
T ss_pred HhcCHhhCC
Confidence 999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=379.20 Aligned_cols=284 Identities=21% Similarity=0.272 Sum_probs=197.2
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeeeccccc------CCc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 694 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 694 (956)
++|++.++||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.++++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 69999999997543 3334678999999999999999999999853 468
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 695 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 8999999965 5555553 24789999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcccchhh
Q 002178 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 854 (956)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 854 (956)
.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||................
T Consensus 169 ~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~------ 234 (355)
T d2b1pa1 169 AGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL------ 234 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH------
T ss_pred cccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc------
Confidence 5422 23345578999999999999999999999999999999999999997654332221111000
Q ss_pred ccCCCCCCChHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC----CCCCCCCccccccccCCCCCCCCC
Q 002178 855 IDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMM----PESDTKTPEFINSEHTSKEETPPS 926 (956)
Q Consensus 855 ~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~----~~~~~~~~~ll~~~L~~dP~~R~s 926 (956)
...+.+.+. ........ ..+....+...+.. +...... ....+.+.+|+++||.+||++|||
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 235 -----GTPCPEFMKKLQPTVRNYVEN---RPKYAGLTFPKLFP--DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHT---SCCCCCCCHHHHSC--GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred -----cCCCHHHHHHhhhhHHHHhhc---Cccccccccccccc--cccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 011111111 11111111 11111111111100 0000000 000122457999999999999999
Q ss_pred CccCCCCCccccC
Q 002178 927 SSSMLKHPYVSSD 939 (956)
Q Consensus 927 a~e~L~HP~f~~~ 939 (956)
|+|+|+||||+..
T Consensus 305 a~elL~Hpw~~~~ 317 (355)
T d2b1pa1 305 VDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSTTTGGG
T ss_pred HHHHhcCcccCCC
Confidence 9999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-41 Score=365.36 Aligned_cols=266 Identities=19% Similarity=0.268 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceee-eecccccCCcEEEEEec
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDEEGEQMLVYEF 701 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~LV~e~ 701 (956)
++|++.+.||+|+||+||+|++. +|+.||||++...... +++..|+++++.++|+|++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 6899999988754322 35788999999998776555 45555777888999999
Q ss_pred CCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEc---CCCcEEEEeeccccccCCC
Q 002178 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVP 778 (956)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~~ 778 (956)
+ ++++.+.+... ...+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 67787776543 345899999999999999999999999 99999999999986 4557999999999987654
Q ss_pred CCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHHHHHHH-hhcccchhhccC
Q 002178 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA-YQSSMMFSVIDG 857 (956)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~ 857 (956)
...............||+.|+|||++.+..++.++|||||||++|||+||+.||............. ..... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----~~~ 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----MST 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH----HHS
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc----CCC
Confidence 3322222333456679999999999999999999999999999999999999997543221111000 00000 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002178 858 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 900 (956)
Q Consensus 858 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 900 (956)
.....+..+++++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0011123456788999999999999999999999998887754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-41 Score=361.99 Aligned_cols=268 Identities=19% Similarity=0.251 Sum_probs=211.9
Q ss_pred hcCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeeecccccCCcEEEEEe
Q 002178 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 623 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~e 700 (956)
.++|++.++||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 689999998865332 2356789999999975 899999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcC-----CCcEEEEeecccccc
Q 002178 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 775 (956)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DfGla~~~ 775 (956)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789999987643 45899999999999999999999999 999999999999974 578999999999887
Q ss_pred CCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcccchh
Q 002178 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 853 (956)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 853 (956)
.........+........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 233 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC---
Confidence 64433222233344556799999999999999999999999999999999999999974322 1111111100000
Q ss_pred hccCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002178 854 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 902 (956)
Q Consensus 854 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 902 (956)
.......+..+++++.+++..|+..+|++||+++.+.+.++++.+..
T Consensus 234 --~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 --STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp --HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000112234567899999999999999999999999888876644
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.1e-41 Score=367.64 Aligned_cols=295 Identities=29% Similarity=0.494 Sum_probs=240.2
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC-CCCCceeecCCCCCCCcceeeEEEeCCCCccc--cCCcCcCCCCC
Q 002178 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (956)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~--~~~~~l~~l~~ 107 (956)
-|+|+|++||++||+++.++ ..+++|..+++|| +.|.||+|++. ....||+.|+|++++++| .+|++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~-~~l~sW~~~~d~C~~~w~gv~C~~~---~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTD---TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC-GGGTTCCTTSCTTTTCSTTEEECCS---SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCC-CcCCCCCCCCCCCCCcCCCeEEeCC---CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 48999999999999999876 4689998666655 46999999754 334689999999999998 58899999999
Q ss_pred CCEEEccC-CCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecc
Q 002178 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (956)
Q Consensus 108 L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (956)
|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+.++++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999987 89999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCccccCCCccc-ceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCcc
Q 002178 187 NNSISGQIPPELSRLPSL-VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (956)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (956)
+|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.+ .+|..+..+++|+.|++++|.+++
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~-~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc-cccccccccccccccccccccccc
Confidence 999999999988888776 788999999998888887766544 57888888876 577777788888888888888877
Q ss_pred CCCCCCCCCCccEEEccCCcCCcCCCCCCCcc-ccCEEEccCCcCCCCCchhcCCCCcCCeEeccccc
Q 002178 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332 (956)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 332 (956)
.++.+..+++|+.|+|++|+|+|.+|..+... +|++|+|++|+|+|.+|. +++|++|+.+++++|+
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 77777777777777777777776666554332 566666666666655552 4555556666665554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-37 Score=349.72 Aligned_cols=292 Identities=17% Similarity=0.232 Sum_probs=199.7
Q ss_pred cCCCCCCeeeeeCCeEEEEEEeC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----------CCceeeeeccccc
Q 002178 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCDE 691 (956)
Q Consensus 624 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 691 (956)
++|++.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999964 799999999986432 3457788999888875 5789999988754
Q ss_pred --CCcEEEEEecCCCC-CHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCC-----
Q 002178 692 --EGEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 762 (956)
Q Consensus 692 --~~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~----- 762 (956)
....++||+++..+ +............+++..++.++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566666665444 34444444555678889999999999999999997 77 99999999999998665
Q ss_pred -cEEEEeeccccccCCCCCCCccccceecccccCCCcccccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCchhHH-
Q 002178 763 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR- 840 (956)
Q Consensus 763 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~G~ll~elltg~~pf~~~~~~~~- 840 (956)
.+|++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||........
T Consensus 169 ~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 499999999976432 12345699999999999999999999999999999999999999964322100
Q ss_pred -HHHHHhhcccchhhccCCCCCCChHHHHHHHHHHHHhc-------ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccc
Q 002178 841 -EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-------QDETDARPSMSEVMRELESIWNMMPESDTKTPEF 912 (956)
Q Consensus 841 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-------~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~l 912 (956)
....... ... .++..+.+....-.. ....+ ......+....+..... ....+...+.+.||
T Consensus 239 ~~~~~~~~---~~~----~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 239 KDDDHIAQ---IIE----LLGELPSYLLRNGKY-TRTFFNSRGLLRNISKLKFWPLEDVLTEK---YKFSKDEAKEISDF 307 (362)
T ss_dssp CHHHHHHH---HHH----HHCSCCHHHHHHCTT-HHHHBCC--CBSSCCCCCBCCHHHHHHHT---TCCCHHHHHHHHHH
T ss_pred chhHHHHH---HHH----HhCCCCHHHhhcccc-cccccccchhhhccccccCCchhhhcccc---cccCcccCHHHHHH
Confidence 0000000 000 012223222211100 01111 11111223333333211 11111123445689
Q ss_pred cccccCCCCCCCCCCccCCCCCccccCC
Q 002178 913 INSEHTSKEETPPSSSSMLKHPYVSSDV 940 (956)
Q Consensus 913 l~~~L~~dP~~R~sa~e~L~HP~f~~~~ 940 (956)
|.+||++||++||||+|+|+||||+...
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999998443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.8e-31 Score=287.05 Aligned_cols=233 Identities=27% Similarity=0.497 Sum_probs=213.8
Q ss_pred CCCCCEEEccCCCCcc--cCCcccccCcccchhhccC-cCCCCCCCCccCCCcccceeecccccccCCCCccccccccCC
Q 002178 105 LSYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (956)
Q Consensus 105 l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (956)
-.+++.|+|++|+++| .+|.++++|++|++|||++ |+++|.+|..|++|++|++|+|++|++.+..+..+..+.+|+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 3579999999999998 5899999999999999997 899999999999999999999999999999999999999999
Q ss_pred eeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchh-hhhcccCCcCCCCCCcccccCCCCCcEEeccC
Q 002178 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL-LILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260 (956)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~ 260 (956)
.+++++|.+.+.+|..+.+++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++ ..|..+.++..+ .+++++
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~-~~~~~~~~l~~~-~l~l~~ 206 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLNLA-FVDLSR 206 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCCCS-EEECCS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccc-cccccccccccc-cccccc
Confidence 99999999999999999999999999999999999999999888886 889999999998 578888887655 799999
Q ss_pred CCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCCh
Q 002178 261 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (956)
Q Consensus 261 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 339 (956)
|.+.+..+. +..+++|+.|++++|.+.+.+|......+|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 999987775 7788999999999999998887665666899999999999999999999999999999999999999885
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.4e-26 Score=241.39 Aligned_cols=212 Identities=22% Similarity=0.242 Sum_probs=134.4
Q ss_pred CCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEecc
Q 002178 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (956)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (956)
+.+++.+++.|+ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+. ++ .++.+++|++|+|+
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~--l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE--EE-CCSCCTTCCEEECC
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc--cc-cccccccccccccc
Confidence 334444444444 3343332 345555555555554444455555555555555555542 22 24456666666666
Q ss_pred CCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCC
Q 002178 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338 (956)
Q Consensus 260 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 338 (956)
+|+++..++.+..+++|+.|++++|.+.+..+..... .+++.|++++|.++...+..+..+++|+.|++++|+|++..+
T Consensus 86 ~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred cccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 6666666555666666666666666666333332222 267777777777776666777777777777777777776666
Q ss_pred hhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcccccCCcccccCCCCCCCc
Q 002178 339 SSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDN 402 (956)
Q Consensus 339 ~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~~~~ 402 (956)
..|..+. +|+.|||++|+|+++|..+ .++.++.|+|+||||.|||++.+|..|+..+..
T Consensus 166 ~~~~~l~-----~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl~~~~~ 225 (266)
T d1p9ag_ 166 GLLNGLE-----NLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAE 225 (266)
T ss_dssp TTTTTCT-----TCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHHHHTGG
T ss_pred ccccccc-----ccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchHHHHHHHHhccc
Confidence 6665433 3457888888888877664 578889999999999999999999999865443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=8.2e-25 Score=237.78 Aligned_cols=264 Identities=21% Similarity=0.340 Sum_probs=150.4
Q ss_pred eEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccc
Q 002178 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (956)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (956)
+.++-++.+|+ .+|..+. +.|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 34555555555 3344442 35556666666555333334555555555555555555444555555555555555555
Q ss_pred cccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCC-CCC
Q 002178 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTI 243 (956)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~ 243 (956)
+|+. +|..+ ...|+.|++.+|.+. +..+..+.....+..++...|.... ...
T Consensus 90 ~l~~-l~~~~--~~~l~~L~~~~n~l~------------------------~l~~~~~~~~~~~~~l~~~~n~~~~~~~~ 142 (305)
T d1xkua_ 90 QLKE-LPEKM--PKTLQELRVHENEIT------------------------KVRKSVFNGLNQMIVVELGTNPLKSSGIE 142 (305)
T ss_dssp CCSB-CCSSC--CTTCCEEECCSSCCC------------------------BBCHHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred ccCc-Cccch--hhhhhhhhccccchh------------------------hhhhhhhhccccccccccccccccccCCC
Confidence 5552 22221 124444444455444 4333334444444444444443321 122
Q ss_pred cccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCc-cccCEEEccCCcCCCCCchhcCCCCc
Q 002178 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPR 322 (956)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~ 322 (956)
+..+..+++|+.+++++|.++..+..+ .++|+.|++++|.+++..+..+.. ..++.|++++|.+++..+..|.++++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred ccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 344556666666666666665544332 456677777777766555544332 26677777777777776777777777
Q ss_pred CCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--------CCCCCcEEEecCCcccc
Q 002178 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 386 (956)
Q Consensus 323 L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~--------~~~~l~~l~l~~Np~~c 386 (956)
|++|+|++|+|+ .+|.++..+. +|+.|+|++|+|+.++... ..+++..++|+||||.+
T Consensus 221 L~~L~L~~N~L~-~lp~~l~~l~-----~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 221 LRELHLNNNKLV-KVPGGLADHK-----YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCEEECCSSCCS-SCCTTTTTCS-----SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ceeeeccccccc-cccccccccc-----CCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 777777777776 5566665443 3457777777777775421 25677889999999865
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=1.2e-24 Score=244.18 Aligned_cols=276 Identities=27% Similarity=0.348 Sum_probs=209.7
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
++++|++++++++.. +.+..|++|++|+|++|+|++ +| .|+++++|++|+|++|++.+.. .++++++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc--cccccccccccccc
Confidence 588899999888753 467888999999999999985 44 3888999999999999988543 37888999999988
Q ss_pred cccccCCC---------------------------------------------------------------Ccccccccc
Q 002178 163 QNYISGSL---------------------------------------------------------------PKSFANLNK 179 (956)
Q Consensus 163 ~N~l~~~~---------------------------------------------------------------p~~~~~l~~ 179 (956)
+|.+++.. ...+..+++
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 198 (384)
T d2omza2 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccc
Confidence 87776421 123455677
Q ss_pred CCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEecc
Q 002178 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (956)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (956)
++.+++++|.+++..| +...++|++|++++|+++.. +.+..+++|+.|++++|.+++. ..+..+++|+.|+++
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~---~~~~~~~~L~~L~l~ 271 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL---APLSGLTKLTELKLG 271 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC---GGGTTCTTCSEEECC
T ss_pred cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCC---CcccccccCCEeecc
Confidence 8888888888876544 45567888888888888753 3577778888888888888752 247778888888888
Q ss_pred CCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCCh
Q 002178 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (956)
Q Consensus 260 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 339 (956)
+|.+++.. .+..++.++.++++.|.+++ ++......+++.|++++|++++.. .+..+++|++|+|++|+|++ ++
T Consensus 272 ~~~l~~~~-~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~- 345 (384)
T d2omza2 272 ANQISNIS-PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS- 345 (384)
T ss_dssp SSCCCCCG-GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-
T ss_pred CcccCCCC-cccccccccccccccccccc-ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-
Confidence 88887654 36777788888888888874 444444458899999999998764 37889999999999999984 33
Q ss_pred hhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCC
Q 002178 340 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382 (956)
Q Consensus 340 ~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~N 382 (956)
.+..+ ++|+.|+|++|+|++++.-..+++++.|+|++|
T Consensus 346 ~l~~l-----~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 346 SLANL-----TNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGC-----TTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred hHcCC-----CCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 45443 456799999999998876446888999999887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.7e-25 Score=237.94 Aligned_cols=236 Identities=19% Similarity=0.250 Sum_probs=142.6
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecc-c
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN-N 187 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~ 187 (956)
..+++++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+..+.+++.++.+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34677777777 6666554 467777777777775555667777777777777777776666666666666665543 4
Q ss_pred CcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC
Q 002178 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (956)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (956)
|.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|.+ ++.+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l-------------------------~~i~ 145 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-------------------------QALP 145 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC-------------------------CCCC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccc-------------------------cccC
Confidence 444444455555555555555555555544444444444444444444444 4433
Q ss_pred CC-CCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhc
Q 002178 268 PD-LSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345 (956)
Q Consensus 268 ~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 345 (956)
+. |..+++|+.|++++|+|++..+..+. ..+|+.|++++|++++..|..|.++++|++|++++|++.+..|..|..
T Consensus 146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~-- 223 (284)
T d1ozna_ 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP-- 223 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT--
T ss_pred hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccc--
Confidence 32 33444444444444444422222221 124555555555555566667777777777777777777655555543
Q ss_pred cCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCcccccCCCCC
Q 002178 346 TLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 399 (956)
Q Consensus 346 ~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~c~c~~~~~~~~~~~ 399 (956)
.+.+..|++++|||.|||++.++..|++.
T Consensus 224 -------------------------~~~L~~L~l~~N~l~C~C~~~~l~~~l~~ 252 (284)
T d1ozna_ 224 -------------------------LRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (284)
T ss_dssp -------------------------CTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred -------------------------ccccCEEEecCCCCCCCccchHHHHHHHh
Confidence 44567889999999999999998888863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-25 Score=241.18 Aligned_cols=235 Identities=17% Similarity=0.204 Sum_probs=142.0
Q ss_pred CCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc-cccccCCCCccccccccCCeee
Q 002178 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID-QNYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 106 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~ 184 (956)
+.+++|+|++|+|++..+..|.++++|++|++++|++.+..+..+..+..++.++.. .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 445666666666664444556666666666666666666666666666666666543 4455555566666666666666
Q ss_pred cccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCc
Q 002178 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (956)
+++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++ ..+..|.++++|+.+++++|+++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhhhccccccchhhhhhcccc
Confidence 66666665555566666666666666666665555666666666666666666664 34556666666666666666666
Q ss_pred cCCCC-CCCCCCccEEEccCCcCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhh
Q 002178 265 GPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (956)
Q Consensus 265 ~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 342 (956)
+..+. |..+++|++|++++|++.+..+..+. ..+|+.|+|++|.+.+.-+. ..-...++.+....+++....|..+.
T Consensus 191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHc
Confidence 65443 66666666666666666644443332 23566666666666543221 01112345555566666666666553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.6e-24 Score=233.73 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=201.6
Q ss_pred CCCCCCCCceeecCCCCC----CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhh
Q 002178 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (956)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~----~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~ 136 (956)
-.|.|.|++|.|.+.... +.+..++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 458888999999875432 2356799999999999976667899999999999999999987888999999999999
Q ss_pred ccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCC--CCCccccCCCcccceeccccccc
Q 002178 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNL 214 (956)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 214 (956)
|++|+++ .+|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|++
T Consensus 86 l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l 162 (305)
T d1xkua_ 86 LSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162 (305)
T ss_dssp CCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred ccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence 9999999 566544 368999999999999777777888889999999888654 33456778888999999999988
Q ss_pred CCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCC
Q 002178 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 293 (956)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~ 293 (956)
+. +|..+ +++|+.|++++|.+++ ..+..|.+++.++.|++++|.+++.++. +..+++|++|+|++|+|+ .+|.+
T Consensus 163 ~~-l~~~~--~~~L~~L~l~~n~~~~-~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 163 TT-IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CS-CCSSC--CTTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-cCccc--CCccCEEECCCCcCCC-CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 84 44433 4678888888888876 5677788888888888888888876554 677777888888777777 44544
Q ss_pred CCc-cccCEEEccCCcCCCCCchhc------CCCCcCCeEecccccCC
Q 002178 294 RLS-LNITTIKLSNNKLTGTIPSNF------SGLPRLQRLFIANNSLS 334 (956)
Q Consensus 294 ~~~-~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~ 334 (956)
+.. .+|++|+|++|+|+......| ..+++|+.|+|++|+++
T Consensus 238 l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 332 356666666666654333332 23445555555555553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.7e-22 Score=226.36 Aligned_cols=274 Identities=26% Similarity=0.319 Sum_probs=218.8
Q ss_pred EeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccccc
Q 002178 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (956)
Q Consensus 88 ~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (956)
.+...++++.+. ...+.+|++|++++|+|+. + ..+..+++|++|||++|+|++. | .++++++|++|+|++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccc
Confidence 344455555443 3467789999999999984 4 3688999999999999999954 4 3999999999999999998
Q ss_pred CCCCccccccccCCeeecccCcCCCCC-----------------------------------------------------
Q 002178 168 GSLPKSFANLNKTRHFHMNNNSISGQI----------------------------------------------------- 194 (956)
Q Consensus 168 ~~~p~~~~~l~~L~~L~L~~N~l~~~~----------------------------------------------------- 194 (956)
+.. .++++++|+.|++++|.+++..
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCE
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccc
Confidence 654 3889999999999998876321
Q ss_pred ----------ccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCc
Q 002178 195 ----------PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 195 ----------p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (956)
...+..+++++.+++++|.+++..| +...++|++|++++|.++. + ..+..+++|+.|++++|.++
T Consensus 180 ~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I-GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp EECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--c-chhhcccccchhccccCccC
Confidence 1234456788899999999987654 4556889999999999974 2 46888999999999999998
Q ss_pred cCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhh
Q 002178 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 344 (956)
+.++ +..+++|+.|++++|++++ ++.......++.+++++|.+++. ..+..+++++.|++++|++++..+ +..+
T Consensus 255 ~~~~-~~~~~~L~~L~l~~~~l~~-~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l 328 (384)
T d2omza2 255 NLAP-LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSL 328 (384)
T ss_dssp CCGG-GTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred CCCc-ccccccCCEeeccCcccCC-CCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccC
Confidence 7654 7888999999999999984 44444455899999999999863 458889999999999999997543 4433
Q ss_pred ccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 002178 345 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 345 ~~l~~~~L~~L~L~~N~L~~l~~~~~~~~l~~l~l~~Np~~ 385 (956)
++|+.|+|++|+|+.++.-..+++++.|++++|.+.
T Consensus 329 -----~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 329 -----TKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp -----TTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred -----CCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCC
Confidence 456799999999999874336899999999999864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.7e-22 Score=213.06 Aligned_cols=195 Identities=26% Similarity=0.232 Sum_probs=121.5
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccc
Q 002178 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (956)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (956)
+++.++++|+. +|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+
T Consensus 14 ~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 14 EVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSC
T ss_pred EEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccc
Confidence 34555666663 555553 46777777777777555566777777777777777776 333 24567777777777777
Q ss_pred ccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcc
Q 002178 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (956)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~ 245 (956)
++ ..+..+.++++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++ ..+.
T Consensus 89 l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~-~~~~ 166 (266)
T d1p9ag_ 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAG 166 (266)
T ss_dssp CS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTT
T ss_pred cc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc-cCcc
Confidence 76 345566666667777777666665556666666666666666666665555555556666666666666654 3344
Q ss_pred cccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCC
Q 002178 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
.|..+++|++|+|++|+|+.+++.+..+++|+.|+|++|.+.
T Consensus 167 ~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 167 LLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 555556666666666665555445555555555555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.2e-22 Score=199.56 Aligned_cols=162 Identities=14% Similarity=0.123 Sum_probs=119.8
Q ss_pred CCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhcCCCceeeeecc
Q 002178 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (956)
Q Consensus 627 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 688 (956)
.+.++||+|+||+||+|...+|+.||||+++.... ........|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988999999998653211 011344578889999999999888765
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcCCCCEeccCCCcccEEEcCCCcEEEEe
Q 002178 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (956)
Q Consensus 689 ~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 768 (956)
.. .++||||+++..+.+ ++......++.|+++|++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998755432 344456789999999999999999 9999999999999965 589999
Q ss_pred eccccccCCCCCCCccccceecccccCCCccc------ccccccCCCCCcccchhHHHH
Q 002178 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD------PEYFLTHKLTDKSDVYSLGVV 821 (956)
Q Consensus 769 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDVwS~G~l 821 (956)
||.|+....+.. ..|.. .|. ....|..++|+||..--
T Consensus 146 FG~a~~~~~~~~---------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGW---------------REILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTH---------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCc---------------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999976543220 01111 111 13567889999997543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.7e-18 Score=177.23 Aligned_cols=202 Identities=19% Similarity=0.335 Sum_probs=100.8
Q ss_pred EEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcC
Q 002178 111 LDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190 (956)
Q Consensus 111 L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 190 (956)
++++.+++++.+ .+..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..| +..+++|+++++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 344444444322 2344445555555555554 222 34455555555555555543322 45555555555555555
Q ss_pred CCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCC
Q 002178 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL 270 (956)
Q Consensus 191 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 270 (956)
+ .++ .+.++++|+.+++++|...+. ..+...+.++.+.++++.+.. ...+.++++|+.|++++|.++... .+
T Consensus 98 ~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~L~~L~l~~n~~~~~~-~l 169 (227)
T d1h6ua2 98 K-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN---ISPLAGLTNLQYLSIGNAQVSDLT-PL 169 (227)
T ss_dssp S-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC---CGGGGGCTTCCEEECCSSCCCCCG-GG
T ss_pred c-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhch---hhhhccccccccccccccccccch-hh
Confidence 4 222 344555555555555555432 224444555555555555532 223455566666666666655332 25
Q ss_pred CCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecc
Q 002178 271 SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329 (956)
Q Consensus 271 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 329 (956)
..+++|+.|+|++|++++ ++......+|++|+|++|+|+... .+.++++|+.|+|+
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 555666666666666652 332222235555666666555432 25666666666665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.6e-18 Score=173.92 Aligned_cols=180 Identities=21% Similarity=0.211 Sum_probs=137.0
Q ss_pred CCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CcccccCcccchhhccCc
Q 002178 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGN 140 (956)
Q Consensus 62 ~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i-p~~~~~l~~L~~L~Ls~N 140 (956)
.|.|.|+.|.|. +++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|
T Consensus 5 ~C~C~~~~v~Cs-----------------~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N 64 (192)
T d1w8aa_ 5 MCHCEGTTVDCT-----------------GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64 (192)
T ss_dssp TSEEETTEEECT-----------------TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSS
T ss_pred CCEEcCCEEEEe-----------------CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccc
Confidence 466666666664 34555 4565553 68899999999998644 566788999999999999
Q ss_pred CCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCc
Q 002178 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (956)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 220 (956)
++.+..+..|..+++|++|+|++|+|+...+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.....
T Consensus 65 ~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~- 143 (192)
T d1w8aa_ 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH- 143 (192)
T ss_dssp CCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-
T ss_pred ccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-
Confidence 9998888999999999999999999998888889999999999999999998888888999999999999998874322
Q ss_pred ccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccC
Q 002178 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (956)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (956)
...-...++.+.+..|.++. ..|.. +..++.++|+.|.+.-.
T Consensus 144 ~~~~~~~l~~~~l~~~~~~c-~~p~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 144 LAWFAEWLRKKSLNGGAARC-GAPSK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp GHHHHHHHHHHCCSGGGCBB-CSSTT---TTTSBGGGSCTTTCCCC
T ss_pred hHHHhhhhhhhcccCCCeEe-CCChh---hcCCEeeecCHhhCcCC
Confidence 11112457777788787765 34443 44455667777776543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.73 E-value=2.1e-16 Score=173.64 Aligned_cols=264 Identities=26% Similarity=0.309 Sum_probs=160.8
Q ss_pred eeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecc
Q 002178 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (956)
Q Consensus 83 ~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (956)
+++.|+|++++|+. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++... +.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence 46788999998874 6643 467889999999998 677654 46788888888887 444321 468899999
Q ss_pred cccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCC-
Q 002178 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT- 241 (956)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~- 241 (956)
+|.++ .+|. ++.+++|+.|++++|.+... +.. ...+..+.+.++.... ...+..++.++.|++++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhccccccc--cccccccccceecccccccccccc
Confidence 99988 4453 57888999999988887633 222 2333344444333321 22344444455555544444321
Q ss_pred ----------------CCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCC----------
Q 002178 242 ----------------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---------- 295 (956)
Q Consensus 242 ----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---------- 295 (956)
.....+..++.|+.+++++|.....+. ...++..+++++|.+... +....
T Consensus 179 ~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l~~~~~~~~ 254 (353)
T d1jl5a_ 179 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTDL-PELPQSLTFLDVSEN 254 (353)
T ss_dssp CCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc-ccccccccccccccc
Confidence 111234556677777777776654332 223455556666555421 11100
Q ss_pred --------ccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCC
Q 002178 296 --------SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367 (956)
Q Consensus 296 --------~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~ 367 (956)
.......++..|.+.+ ....+++|++|+|++|+|+ .+|.. .++|+.|+|++|+|+++|.
T Consensus 255 ~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~--------~~~L~~L~L~~N~L~~l~~ 321 (353)
T d1jl5a_ 255 IFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL--------PPRLERLIASFNHLAEVPE 321 (353)
T ss_dssp CCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCSCCCC
T ss_pred cccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc--------cCCCCEEECCCCcCCcccc
Confidence 0022333444443332 2234578899999999888 56643 2456688899999888875
Q ss_pred CCCCCCCcEEEecCCccc
Q 002178 368 SFNIPPNVTVRLRGNPFC 385 (956)
Q Consensus 368 ~~~~~~l~~l~l~~Np~~ 385 (956)
. +++++.|++++|+..
T Consensus 322 ~--~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 322 L--PQNLKQLHVEYNPLR 337 (353)
T ss_dssp C--CTTCCEEECCSSCCS
T ss_pred c--cCCCCEEECcCCcCC
Confidence 3 457888888888864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=6.5e-18 Score=176.02 Aligned_cols=199 Identities=20% Similarity=0.221 Sum_probs=114.9
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCC-CccccccccCCeeeccc
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNN 187 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~ 187 (956)
+.++.++++++ .+|..+. +++++|||++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 57888888887 6776553 47888888888887555556788888888888888776544 44577777777777653
Q ss_pred -CcCCCCCccccCCCcccceecccccccCCCCCc-ccCCcchhhhhcccCCcCCCCCCcccccCCC-CCcEEeccCCCCc
Q 002178 188 -NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLLILQLDNNNFEGTTIPASYSNMS-KLLKLSLRNCSLQ 264 (956)
Q Consensus 188 -N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~-~L~~L~Ls~N~l~ 264 (956)
|.+....+..|.++++|++|++++|++....+. .+..+..+..+..+++.+.. ..+..|.+++ .++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~-i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT-IERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE-ECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc-ccccccccccccceeeeccccccc
Confidence 566655666667777777777777776633221 12223334334444444432 1122333322 3444444444444
Q ss_pred cCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEE-EccCCcCCCCCchhcCCCCcCCeEecccccCC
Q 002178 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTI-KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (956)
.......... +++.+ ++++|+|+...+..|.++++|++|+|++|+|+
T Consensus 167 ~i~~~~~~~~-----------------------~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 167 EIHNCAFNGT-----------------------QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp EECTTTTTTC-----------------------CEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred ccccccccch-----------------------hhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 4333322222 33333 34455555444455666666666666666666
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=5.9e-18 Score=176.34 Aligned_cols=217 Identities=21% Similarity=0.294 Sum_probs=150.7
Q ss_pred CCCCCCCceeecCCCCCCCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcC
Q 002178 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (956)
Q Consensus 62 ~c~~~w~gv~C~~~~~~~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~ 141 (956)
.|.|..+.|.|... +++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.
T Consensus 5 ~C~C~~~~i~c~~~-----------------~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~ 64 (242)
T d1xwdc1 5 ICHCSNRVFLCQES-----------------KVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64 (242)
T ss_dssp SEEECSSEEEEESC-----------------SCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCT
T ss_pred cCCCcCCEEEEeCC-----------------CCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhcccc
Confidence 46666777777543 344 4555443 468888888888885555568888888888888888
Q ss_pred CCCCC-CCccCCCcccceeeccc-ccccCCCCccccccccCCeeecccCcCCCCCc-cccCCCcccceecccccccCCCC
Q 002178 142 LTGSL-PEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYL 218 (956)
Q Consensus 142 l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~ 218 (956)
+...+ +..|.+++++++|.+.. |++....+..|.++++|+.|++++|.+....+ ..+..+..+..+..+++++....
T Consensus 65 ~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp TCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEEC
T ss_pred ccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 77644 44577888888888764 67776777778888888888888888874322 23445566666677777777666
Q ss_pred CcccCCcc-hhhhhcccCCcCCCCCCcccccCCCCCcEE-eccCCCCccCCCC-CCCCCCccEEEccCCcCCcCCCCCCC
Q 002178 219 PPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKL-SLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL 295 (956)
Q Consensus 219 p~~l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~ 295 (956)
+..|..++ .++.|++++|+++. ++....+..+++.+ ++++|+++..++. |..+++|++|+|++|+|+ .+|...+
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~--i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~ 221 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQE--IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 221 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCE--ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSC
T ss_pred ccccccccccceeeecccccccc--cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHH
Confidence 66676654 68888888888874 44444445555444 5777888877665 788889999999999888 5665433
Q ss_pred ccccCEE
Q 002178 296 SLNITTI 302 (956)
Q Consensus 296 ~~~L~~L 302 (956)
. +|..|
T Consensus 222 ~-~l~~L 227 (242)
T d1xwdc1 222 E-NLKKL 227 (242)
T ss_dssp T-TCCEE
T ss_pred c-CCccc
Confidence 2 34444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.2e-17 Score=172.26 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=125.2
Q ss_pred EeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccccc
Q 002178 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (956)
Q Consensus 88 ~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (956)
++..+.+++.+ .++.|.+|++|++.+|+|+. ++ .+.++++|++|+|++|++++..| +..+++|++|++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 34444444332 33456667777777777763 43 46677777777777777764332 666777777777777665
Q ss_pred CCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccc
Q 002178 168 GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247 (956)
Q Consensus 168 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~ 247 (956)
. + ..+.++++|+.+++++|...+.. .+...+.+..+.++++.+.... .+..+++|+.|++++|.+++ ...+
T Consensus 99 ~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~---~~~l 169 (227)
T d1h6ua2 99 N-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD---LTPL 169 (227)
T ss_dssp C-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC---CGGG
T ss_pred c-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhcccccccccccccccccc---chhh
Confidence 3 2 24666777777777777665432 2455667777777777666432 35566677777777777653 1236
Q ss_pred cCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEcc
Q 002178 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 305 (956)
Q Consensus 248 ~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls 305 (956)
+++++|+.|+|++|++++. +.+..+++|++|+|++|+++ .++......+|+.|+|+
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt-~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCC-BCGGGTTCTTCCEEEEE
T ss_pred cccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCC-CCcccccCCCCCEEEee
Confidence 6777777777777777654 33666777777777777776 34433333467777775
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.4e-18 Score=174.21 Aligned_cols=172 Identities=24% Similarity=0.350 Sum_probs=132.1
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCC-CCccCCCcccceeecccccccCCCCccccccccCCeeeccc
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL-PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (956)
+++++++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 47899999998 6887664 68999999999998644 56678899999999999999988888999999999999999
Q ss_pred CcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCC
Q 002178 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (956)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (956)
|+|+...+..|.++++|++|+|++|+|++..+.+|..+++|++|+|++|.+.......++. ..++.+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhhhhhcccCCCeEeCC
Confidence 9999777888899999999999999999888888888999999999999887521111221 23555566666665433
Q ss_pred CCCCCCCCccEEEccCCcCC
Q 002178 268 PDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 268 ~~l~~l~~L~~L~Ls~N~l~ 287 (956)
| ..+..++.++|+.|.|.
T Consensus 166 p--~~l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 P--SKVRDVQIKDLPHSEFK 183 (192)
T ss_dssp S--TTTTTSBGGGSCTTTCC
T ss_pred C--hhhcCCEeeecCHhhCc
Confidence 3 23344555566666664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.2e-17 Score=167.93 Aligned_cols=165 Identities=25% Similarity=0.370 Sum_probs=79.0
Q ss_pred CcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhc
Q 002178 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232 (956)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 232 (956)
|.+|++|++++|.++... .+..+++|++|+|++|+|++. + .++.+++|++|++++|++++ ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 334444444444444221 234444444444444444432 1 13444445555555554442 22 344445555555
Q ss_pred ccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCCcCCCCCCCccccCEEEccCCcCCCC
Q 002178 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 312 (956)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~ 312 (956)
+++|.+.. ...+..+++|+.+++++|.+++. +.+..+++|+.+++++|++++ ++......+|+.|+|++|+|+.
T Consensus 119 l~~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 119 LEHNGISD---INGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp CTTSCCCC---CGGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCB-
T ss_pred cccccccc---ccccccccccccccccccccccc-ccccccccccccccccccccc-cccccCCCCCCEEECCCCCCCC-
Confidence 55554432 12344455555555555555432 223444555555555555552 2222222356666666666653
Q ss_pred CchhcCCCCcCCeEeccc
Q 002178 313 IPSNFSGLPRLQRLFIAN 330 (956)
Q Consensus 313 ~p~~~~~l~~L~~L~L~~ 330 (956)
++ .|.++++|++|+|++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred Ch-hhcCCCCCCEEEccC
Confidence 33 477788888887764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=3.4e-17 Score=166.51 Aligned_cols=164 Identities=30% Similarity=0.422 Sum_probs=89.6
Q ss_pred CCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeee
Q 002178 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 105 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (956)
|.+|++|++++|.++. ++ .+..+++|++|+|++|++++. + .++.+++|++|++++|+|++ ++ .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 4456666666666653 22 355566666666666666532 2 24556666666666666653 22 355566666666
Q ss_pred cccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCc
Q 002178 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (956)
+++|.+.. + ..+..+++|+.+++++|.+++. ..+..+++|+++++++|++++ ++ .++++++|+.|+|++|+++
T Consensus 119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~--i~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--IV-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC--CG-GGTTCTTCCEEECCSSCCC
T ss_pred cccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccc--cc-cccCCCCCCEEECCCCCCC
Confidence 66665542 2 2355555666666666665532 234455556666666665553 22 2555566666666666555
Q ss_pred cCCCCCCCCCCccEEEcc
Q 002178 265 GPMPDLSRIPNLGYLDLS 282 (956)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls 282 (956)
.. +.+..+++|++|+|+
T Consensus 192 ~l-~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 192 DL-RALAGLKNLDVLELF 208 (210)
T ss_dssp BC-GGGTTCTTCSEEEEE
T ss_pred CC-hhhcCCCCCCEEEcc
Confidence 43 245555566665554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=6.5e-17 Score=162.91 Aligned_cols=147 Identities=25% Similarity=0.361 Sum_probs=79.4
Q ss_pred CcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceec
Q 002178 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208 (956)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 208 (956)
+.++..+.++.+.+++.++ ...+.+|++|++++|.++.. +.+..+++|++|+|++|++++..+ +.++++|++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence 3444455566666654332 23455666666666666532 235556666666666666654322 55666666666
Q ss_pred ccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCCCCccEEEccCCcCC
Q 002178 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 209 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
+++|.+... + .+.++++|+.|++++|.+.. ...+..+++|+.|++++|++... +.+..+++|+.|++++|+++
T Consensus 91 l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~---~~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 91 MNNNQIADI-T-PLANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CCSSCCCCC-G-GGTTCTTCSEEECCSSCCCC---CGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccc-c-cccccccccccccccccccc---ccccchhhhhHHhhhhhhhhccc-cccccccccccccccccccc
Confidence 666665532 2 35555666666666665542 12355555666666666655432 23455555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.1e-16 Score=161.09 Aligned_cols=148 Identities=27% Similarity=0.364 Sum_probs=70.8
Q ss_pred CCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCee
Q 002178 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (956)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (956)
.+.+|++|++++|+++. ++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+... + .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence 34555555555555552 22 34555555555555555553221 45555555555555554422 1 24444445555
Q ss_pred ecccCcCCCCCccccCCCcccceecccccccCCCCCcccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCC
Q 002178 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (956)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (956)
++++|. +... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++
T Consensus 112 ~l~~~~------------------------~~~~--~~~~~l~~L~~L~l~~n~l~~--~-~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 112 TLFNNQ------------------------ITDI--DPLKNLTNLNRLELSSNTISD--I-SALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp ECCSSC------------------------CCCC--GGGTTCTTCSEEECCSSCCCC--C-GGGTTCTTCSEEECCSSCC
T ss_pred cccccc------------------------cccc--cccchhhhhHHhhhhhhhhcc--c-ccccccccccccccccccc
Confidence 554444 4422 224444555555555555432 1 2344555555555555555
Q ss_pred ccCCCCCCCCCCccEEEccCCcCC
Q 002178 264 QGPMPDLSRIPNLGYLDLSSNQLN 287 (956)
Q Consensus 264 ~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (956)
++.. .+..+++|+.|++++|+++
T Consensus 163 ~~l~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 163 TDLK-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCCG-GGTTCTTCCEEECCSSCCC
T ss_pred cCCc-cccCCCCCCEEECCCCCCC
Confidence 4432 2444555555555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.65 E-value=4.2e-15 Score=163.03 Aligned_cols=262 Identities=28% Similarity=0.337 Sum_probs=171.0
Q ss_pred CCcceeeEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccce
Q 002178 79 DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (956)
Q Consensus 79 ~~~~~~~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (956)
+...+++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. +. +.|++|+|++|.+. .+|. ++.+++|+.
T Consensus 55 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~ 124 (353)
T d1jl5a_ 55 ELPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKI 124 (353)
T ss_dssp SCCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-CC--TTCCEEECCSSCCS-SCCC-CTTCTTCCE
T ss_pred CCCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-hc--cccccccccccccc-cccc-hhhhcccee
Confidence 44568999999999998 55654 457899999999988 4442 21 46999999999998 5664 688999999
Q ss_pred eecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceecccccccCCC------------------CCc
Q 002178 159 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY------------------LPP 220 (956)
Q Consensus 159 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~------------------~p~ 220 (956)
|++++|.+..... . ...+..+.+.++... ....+..++.++.|++++|.+... ...
T Consensus 125 L~l~~~~~~~~~~-~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~ 198 (353)
T d1jl5a_ 125 IDVDNNSLKKLPD-L---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198 (353)
T ss_dssp EECCSSCCSCCCC-C---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCC
T ss_pred ecccccccccccc-c---cccccchhhcccccc--ccccccccccceecccccccccccccccccccccccccccccccc
Confidence 9999998874322 2 233444444444332 123344455555555555544321 112
Q ss_pred ccCCcchhhhhcccCCcCCCCCCcccccCCCCCcEEeccCCCCccCCCCCCCC-----------------CCccEEEccC
Q 002178 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI-----------------PNLGYLDLSS 283 (956)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l-----------------~~L~~L~Ls~ 283 (956)
.+..++.|+.+++++|.... .+. ...++..+.+.+|.+.........+ ......++..
T Consensus 199 ~~~~l~~L~~l~l~~n~~~~--~~~---~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~ 273 (353)
T d1jl5a_ 199 ELQNLPFLTTIYADNNLLKT--LPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273 (353)
T ss_dssp CCTTCTTCCEEECCSSCCSS--CCS---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred cccccccccccccccccccc--ccc---ccccccccccccccccccccccccccccccccccccccccccchhccccccc
Confidence 35567788888888887753 333 3456777777777776543221110 1233444444
Q ss_pred CcCCcCCCCCCCccccCEEEccCCcCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCC
Q 002178 284 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363 (956)
Q Consensus 284 N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~ 363 (956)
|.+.+ ++. ...+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+
T Consensus 274 ~~~~~-~~~--~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~--------~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 274 NEIRS-LCD--LPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL--------PQNLKQLHVEYNPLR 337 (353)
T ss_dssp SCCSE-ECC--CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCS
T ss_pred Ccccc-ccc--cCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc--------cCCCCEEECcCCcCC
Confidence 44442 111 1248999999999999 4564 4688999999999998 56643 235779999999999
Q ss_pred CCCCCCCCCCCcEEEe
Q 002178 364 NISGSFNIPPNVTVRL 379 (956)
Q Consensus 364 ~l~~~~~~~~l~~l~l 379 (956)
.+|.. ...+..|++
T Consensus 338 ~lp~~--~~~L~~L~~ 351 (353)
T d1jl5a_ 338 EFPDI--PESVEDLRM 351 (353)
T ss_dssp SCCCC--CTTCCEEEC
T ss_pred CCCcc--ccccCeeEC
Confidence 98753 234566654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.5e-17 Score=187.97 Aligned_cols=184 Identities=20% Similarity=0.105 Sum_probs=118.4
Q ss_pred cccceecccccccCC-----CCCcccCCcchhhhhcccCCcCCCCC---CcccccCCCCCcEEeccCCCCccCCC-----
Q 002178 202 PSLVHMLLDNNNLTG-----YLPPELSELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMP----- 268 (956)
Q Consensus 202 ~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~----- 268 (956)
+.++.+++++|++.. ..........+|+.|++++|.+.... ....+...+.++.+++++|.++....
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 344555555554431 11222344567999999999886421 22345678899999999999864211
Q ss_pred C-CCCCCCccEEEccCCcCCcCCCCCC-----CccccCEEEccCCcCCCC----CchhcC-CCCcCCeEecccccCCCcC
Q 002178 269 D-LSRIPNLGYLDLSSNQLNGSIPPGR-----LSLNITTIKLSNNKLTGT----IPSNFS-GLPRLQRLFIANNSLSGSI 337 (956)
Q Consensus 269 ~-l~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~~ 337 (956)
. ......|+.+++++|.++....... ...+|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|+..-
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 1 2344689999999999874322211 123799999999999753 334443 4678999999999998543
Q ss_pred Chhhhh-hccCCCCcceEEEccCCCCCCCC-----CCC--CCCCCcEEEecCCccccc
Q 002178 338 PSSIWQ-SRTLNATETFILDFQNNNLTNIS-----GSF--NIPPNVTVRLRGNPFCLN 387 (956)
Q Consensus 338 p~~~~~-l~~l~~~~L~~L~L~~N~L~~l~-----~~~--~~~~l~~l~l~~Np~~c~ 387 (956)
...+.. +. ..++|+.|||++|+|+.-. ..+ ....++.+++.+|.|..+
T Consensus 386 ~~~l~~~l~--~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 386 CSSLAATLL--ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHHHHHH--HCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHHHHHh--cCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 233321 11 1346779999999997521 111 233578999999998753
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.4e-14 Score=139.07 Aligned_cols=113 Identities=19% Similarity=0.230 Sum_probs=81.9
Q ss_pred ccCEEEccCC-cCCCCCchhcCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCc
Q 002178 298 NITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNV 375 (956)
Q Consensus 298 ~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~~~~-~~~~l~ 375 (956)
+|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+. +|+.|+|++|+|++++... ...++.
T Consensus 32 ~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~-----~L~~L~Ls~N~l~~l~~~~~~~~~l~ 106 (156)
T d2ifga3 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP-----RLSRLNLSFNALESLSWKTVQGLSLQ 106 (156)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS-----CCCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred ccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccc-----cccceeccCCCCcccChhhhcccccc
Confidence 5555555444 35555567788888888888888888866666666544 4458888888888887764 456789
Q ss_pred EEEecCCcccccCCcccccCCCCCCCcccCcCCCCCCccccCc
Q 002178 376 TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQS 418 (956)
Q Consensus 376 ~l~l~~Np~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~ 418 (956)
.|+|++|||.|||++.||..|.......++ ...+.|.++.
T Consensus 107 ~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~---~~~~~C~~p~ 146 (156)
T d2ifga3 107 ELVLSGNPLHCSCALRWLQRWEEEGLGGVP---EQKLQCHGQG 146 (156)
T ss_dssp EEECCSSCCCCCGGGHHHHHHHHTTCSSCG---GGCCCCSSSS
T ss_pred ccccCCCcccCCchHHHHHHHHHhccCccC---cCCcEECcCh
Confidence 999999999999999999999865544332 2456777644
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=8e-15 Score=141.70 Aligned_cols=113 Identities=19% Similarity=0.165 Sum_probs=74.0
Q ss_pred cCcCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCcccccccc
Q 002178 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (956)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (956)
+.+.+...|++|+|++|+|+ .++..+..+++|++|||++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34566667777777777777 45555566777777777777777 333 4677777777777777777555555566777
Q ss_pred CCeeecccCcCCCCCc-cccCCCcccceecccccccC
Q 002178 180 TRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 180 L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 215 (956)
|+.|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc
Confidence 7777777777663211 24555666666666666655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=6.8e-17 Score=184.27 Aligned_cols=304 Identities=17% Similarity=0.182 Sum_probs=197.4
Q ss_pred ceeeEEEeCCCCcccc-CCcCcCCCCCCCEEEccCCCCcc----cCCcccccCcccchhhccCcCCCCC----CCCccC-
Q 002178 82 LHLRELQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELG- 151 (956)
Q Consensus 82 ~~~~~L~L~~~~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 151 (956)
.++++||++.+++++. +..-+..++++++|+|++|+|+. .+...+..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999974 24456778999999999999873 4456678899999999999998621 222232
Q ss_pred CCcccceeecccccccCC----CCccccccccCCeeecccCcCCCCCccc------------------------------
Q 002178 152 YLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQIPPE------------------------------ 197 (956)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~------------------------------ 197 (956)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235899999999999744 4566788999999999999875210000
Q ss_pred ---cCCCcccceecccccccCCC---------------------------------CCcccCCcchhhhhcccCCcCCCC
Q 002178 198 ---LSRLPSLVHMLLDNNNLTGY---------------------------------LPPELSELPKLLILQLDNNNFEGT 241 (956)
Q Consensus 198 ---l~~l~~L~~L~L~~N~l~~~---------------------------------~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (956)
+.....++.++++++.+... ....+...+.++.+++++|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 01123445555544432210 000112234455566666654210
Q ss_pred ----CCcccccCCCCCcEEeccCCCCccCCC-----CCCCCCCccEEEccCCcCCcCCCCC------CCccccCEEEccC
Q 002178 242 ----TIPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPPG------RLSLNITTIKLSN 306 (956)
Q Consensus 242 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~p~~------~~~~~L~~L~Ls~ 306 (956)
.....+.....|+.|++++|.+..... .+...+.++.+++++|.++...... .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 112233445678888888887764322 1455678888889888886321111 1223799999999
Q ss_pred CcCCCCCchh----cCCCCcCCeEecccccCCCcCChhhhhhccCCCCcceEEEccCCCCCCCC-----CCC-CCCCCcE
Q 002178 307 NKLTGTIPSN----FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNVT 376 (956)
Q Consensus 307 N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~L~~N~L~~l~-----~~~-~~~~l~~ 376 (956)
|.++...... +...++|++|+|++|++++.....+...-.-....|+.|+|++|+|+... ..+ ..+.++.
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 9988654443 34567899999999999754333332211112456889999999997522 222 3688999
Q ss_pred EEecCCccc
Q 002178 377 VRLRGNPFC 385 (956)
Q Consensus 377 l~l~~Np~~ 385 (956)
|+|++|++.
T Consensus 402 L~Ls~N~i~ 410 (460)
T d1z7xw1 402 LDLSNNCLG 410 (460)
T ss_dssp EECCSSSCC
T ss_pred EECCCCcCC
Confidence 999999875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=3.4e-14 Score=130.49 Aligned_cols=102 Identities=24% Similarity=0.332 Sum_probs=58.2
Q ss_pred CEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccC
Q 002178 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (956)
++|+|++|+|+ .++ .+.++++|++|||++|+|+ .+|..++.+++|+.|++++|.|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 35666666666 333 3666666666666666665 4555566666666666666666532 2 3555666666666666
Q ss_pred cCCCCC-ccccCCCcccceecccccccC
Q 002178 189 SISGQI-PPELSRLPSLVHMLLDNNNLT 215 (956)
Q Consensus 189 ~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 215 (956)
+|+... ...+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 655322 134455555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.1e-14 Score=140.63 Aligned_cols=112 Identities=25% Similarity=0.261 Sum_probs=70.1
Q ss_pred ccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCccc
Q 002178 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204 (956)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 204 (956)
.+.+..+|++|||++|+|+ .++..+..+++|+.|+|++|.|+. + +.|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4566777888888888887 456666677777777777777763 2 246666777777777777764444444556666
Q ss_pred ceecccccccCCCCC-cccCCcchhhhhcccCCcCC
Q 002178 205 VHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 205 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 239 (956)
++|+|++|+|+.... ..+..+++|++|++++|+++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 666666666653211 23444555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=7.6e-14 Score=128.10 Aligned_cols=101 Identities=27% Similarity=0.435 Sum_probs=53.4
Q ss_pred chhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCCCccccCCCcccceeccccc
Q 002178 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (956)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 212 (956)
|+|||++|+++ .++ .+..+++|++|+|++|+|+ .+|..|..+++|+.|++++|+|+. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45666666666 333 3566666666666666665 345555566666666666666552 22 2555555555555555
Q ss_pred ccCCCC-CcccCCcchhhhhcccCCcC
Q 002178 213 NLTGYL-PPELSELPKLLILQLDNNNF 238 (956)
Q Consensus 213 ~l~~~~-p~~l~~l~~L~~L~Ls~N~l 238 (956)
+|+... ...+..+++|+.|++++|++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 555321 12334444444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=6.5e-15 Score=156.77 Aligned_cols=219 Identities=18% Similarity=0.232 Sum_probs=122.3
Q ss_pred CEEEccCCCCcccCCcccccC--cccchhhccCcCCCCCCCCccCCCcccceeecccccccCC-CCccccccccCCeeec
Q 002178 109 TILDFMWNKISGSIPKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHM 185 (956)
Q Consensus 109 ~~L~Ls~N~l~~~ip~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 185 (956)
+.|||+++.+.. ..++.+ ..+..+.++.+.+...+ .......+|++|||+++.++.. +...+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCc---hHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 356666666542 222222 12334444444444222 2233445677777777766533 2344666777777777
Q ss_pred ccCcCCCCCccccCCCcccceeccccc-ccCCC-CCcccCCcchhhhhcccCC-cCCCCCCcccccC-CCCCcEEeccCC
Q 002178 186 NNNSISGQIPPELSRLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSN-MSKLLKLSLRNC 261 (956)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~p~~~~~-l~~L~~L~Ls~N 261 (956)
++|.++...+..++.+++|++|+|+++ .++.. +...+..+++|++|+|+++ .++...+...+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 777776666666777777777777774 44421 1112234567777777764 3332112222322 356777777754
Q ss_pred C--CccC-CCC-CCCCCCccEEEccCC-cCCcCCCCCCC-ccccCEEEccCC-cCCCCCchhcCCCCcCCeEecccc
Q 002178 262 S--LQGP-MPD-LSRIPNLGYLDLSSN-QLNGSIPPGRL-SLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANN 331 (956)
Q Consensus 262 ~--l~~~-~~~-l~~l~~L~~L~Ls~N-~l~~~~p~~~~-~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 331 (956)
. ++.. ... +..+++|+.|++++| .+++....... ..+|++|+|+++ .++......++++++|+.|+++++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 2 3221 111 245667777777765 35533333222 236777788774 566666667778888888888877
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.40 E-value=2e-15 Score=165.78 Aligned_cols=94 Identities=16% Similarity=0.164 Sum_probs=51.2
Q ss_pred CCcCcCCCCCCCEEEccCCCCccc----CCcccccCcccchhhccCcCCCCCC----------CCccCCCcccceeeccc
Q 002178 98 LSPEIGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTGSL----------PEELGYLPKLDRIQIDQ 163 (956)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~ 163 (956)
+...+.+...|+.|+|++|.|... +-..+...++|+.|+++++.+.... ...+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 334566677788888888877532 2334556677777777776544211 11233445566666666
Q ss_pred ccccCC----CCccccccccCCeeecccCcCC
Q 002178 164 NYISGS----LPKSFANLNKTRHFHMNNNSIS 191 (956)
Q Consensus 164 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 191 (956)
|.++.. +...+...++|+.|++++|.+.
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred cccccccccchhhhhcccccchheeccccccc
Confidence 655432 1222334455555555555543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=1.2e-15 Score=167.47 Aligned_cols=83 Identities=17% Similarity=0.173 Sum_probs=37.5
Q ss_pred eeEEEeCCCCcccc----CCcCcCCCCCCCEEEccCCCCcc---c-------CCcccccCcccchhhccCcCCCCCC---
Q 002178 84 LRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG---S-------IPKEIGNIKSLELLLLNGNELTGSL--- 146 (956)
Q Consensus 84 ~~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~---~-------ip~~~~~l~~L~~L~Ls~N~l~~~~--- 146 (956)
++.|+|++|.++.. +...+...++|+.|+++++.+.. . +...+...++|++|+|++|.++..-
T Consensus 33 l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 112 (344)
T d2ca6a1 33 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP 112 (344)
T ss_dssp CCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHH
T ss_pred CCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccc
Confidence 45555555554331 22344455555555555543321 1 1122333455555555555554321
Q ss_pred -CCccCCCcccceeecccccc
Q 002178 147 -PEELGYLPKLDRIQIDQNYI 166 (956)
Q Consensus 147 -p~~~~~l~~L~~L~Ls~N~l 166 (956)
...+...++|+.|++++|.+
T Consensus 113 l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 113 LIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp HHHHHHHCTTCCEEECCSSCC
T ss_pred hhhhhcccccchheecccccc
Confidence 12223345555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=8.8e-15 Score=155.71 Aligned_cols=91 Identities=18% Similarity=0.174 Sum_probs=42.1
Q ss_pred cCCCCCcEEeccCCC-CccC-CCCCCCCCCccEEEccCC-cCCcCCCCCCC-ccccCEEEccCCcCCCCCchhcCCCCcC
Q 002178 248 SNMSKLLKLSLRNCS-LQGP-MPDLSRIPNLGYLDLSSN-QLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRL 323 (956)
Q Consensus 248 ~~l~~L~~L~Ls~N~-l~~~-~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 323 (956)
.++++|++|+|++|. +++. +..+..+++|++|+|++| .+++....... ..+|+.|+++++.-.+.+......+|+|
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L 251 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 251 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccc
Confidence 445566666665543 3332 223555566666666653 34432222111 2256666666652111222222334443
Q ss_pred CeEecccccCCCcCChhh
Q 002178 324 QRLFIANNSLSGSIPSSI 341 (956)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~ 341 (956)
.+..+++++..++.+
T Consensus 252 ---~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 252 ---QINCSHFTTIARPTI 266 (284)
T ss_dssp ---EESCCCSCCTTCSSC
T ss_pred ---cccCccCCCCCCCcc
Confidence 356666665544444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=1.8e-14 Score=144.11 Aligned_cols=63 Identities=21% Similarity=0.274 Sum_probs=24.9
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccccc
Q 002178 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (956)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (956)
+..|++|++|+|++|+|+ .++ .|..+++|++|+|++|.++ .+|..+..+++|++|++++|+|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc
Confidence 344444444444444444 222 2444444444444444443 23332223333444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=1.9e-14 Score=144.02 Aligned_cols=126 Identities=19% Similarity=0.281 Sum_probs=68.3
Q ss_pred CCCEEEccCC--CCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeee
Q 002178 107 YLTILDFMWN--KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (956)
Q Consensus 107 ~L~~L~Ls~N--~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (956)
.++.++++++ .+. .++.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .++..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 3455566543 233 44556666777777777777766 333 3666666777777666665 3444444455566666
Q ss_pred cccCcCCCCCccccCCCcccceecccccccCCCCC-cccCCcchhhhhcccCCcC
Q 002178 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNF 238 (956)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 238 (956)
+++|+++. + +.+..+++|++|+|++|+|+.... ..|..+++|+.|+|++|++
T Consensus 100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp CSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred cccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCcc
Confidence 66666652 2 224455555555555555552211 2344444444444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=4e-12 Score=121.54 Aligned_cols=102 Identities=15% Similarity=0.165 Sum_probs=55.0
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCC-CCcccCCcccccCcccchhhccCcCCCCCCCCccCCCcccceeeccccc
Q 002178 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (956)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (956)
++..++++.. .|..+..+++|++|+|++| .|+..-+.+|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 5555555542 3445556666666666544 3554444456666666666666666665555555566666666666666
Q ss_pred ccCCCCccccccccCCeeecccCcC
Q 002178 166 ISGSLPKSFANLNKTRHFHMNNNSI 190 (956)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l 190 (956)
|+...+..|..+ +|+.|+|++|.+
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CcccChhhhccc-cccccccCCCcc
Confidence 553333333332 355555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=1.5e-08 Score=96.85 Aligned_cols=103 Identities=18% Similarity=0.127 Sum_probs=47.5
Q ss_pred cchhhccCcCCCCCCCCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCC--CccccCCCcccceecc
Q 002178 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ--IPPELSRLPSLVHMLL 209 (956)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~L 209 (956)
.+.||+++++.. ..+..+..+..+++..|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 444555544422 12333333444444443332 2333344555666666666666532 1233445556666666
Q ss_pred cccccCCCCCcccCCcchhhhhcccCCcCC
Q 002178 210 DNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (956)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (956)
++|+|+...+-.+....+|+.|+|++|++.
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcC
Confidence 666665322212222334555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=8.3e-09 Score=98.65 Aligned_cols=72 Identities=19% Similarity=0.129 Sum_probs=38.3
Q ss_pred CCcccccCcccchhhccCcCCCCCC--CCccCCCcccceeecccccccCCCCccccccccCCeeecccCcCCCC
Q 002178 122 IPKEIGNIKSLELLLLNGNELTGSL--PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193 (956)
Q Consensus 122 ip~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 193 (956)
++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|.+...
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 3444455666777777777766321 23344556666666666666533332333334455555555555533
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=9.1e-07 Score=91.22 Aligned_cols=149 Identities=14% Similarity=0.106 Sum_probs=99.8
Q ss_pred HHHHHhcCCCCCCeeeeeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeeecccccCCcEE
Q 002178 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 696 (956)
Q Consensus 618 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 696 (956)
++...-..|+..+..+.++.+.||+... +++.+++|+...........+.+|..+++.+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444455666555444444568998875 45566788776443333345677888887774 333567788888888899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCchhHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 002178 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------- 742 (956)
Q Consensus 697 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 742 (956)
+||++++|.++.+..... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999998886654221 112334555666666666421
Q ss_pred ----------------------CCCEeccCCCcccEEEcCCCcEEEEeeccccc
Q 002178 743 ----------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (956)
Q Consensus 743 ----------------------~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~~ 774 (956)
.+.++|+|+.|.||++++++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999877677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=2.3e-05 Score=79.85 Aligned_cols=74 Identities=23% Similarity=0.230 Sum_probs=53.2
Q ss_pred eeeeeCC-eEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeeecccccCCcEEEEEecCCCCCH
Q 002178 631 QIGQGGY-GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (956)
Q Consensus 631 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gsL 707 (956)
.+..|.. +.||+...+++..+++|........ .+..|++.++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 5789998878888999987654322 45678887777643 2356778887888889999999987655
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=1.4e-05 Score=75.98 Aligned_cols=86 Identities=19% Similarity=0.234 Sum_probs=37.5
Q ss_pred CCCCCEEEccCC-CCccc----CCcccccCcccchhhccCcCCCCC----CCCccCCCcccceeecccccccCC----CC
Q 002178 105 LSYLTILDFMWN-KISGS----IPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISGS----LP 171 (956)
Q Consensus 105 l~~L~~L~Ls~N-~l~~~----ip~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 171 (956)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.++.. +...+...+.|++|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355566666543 34321 122334445555555555555421 111222334455555555554421 11
Q ss_pred ccccccccCCeeecccCcC
Q 002178 172 KSFANLNKTRHFHMNNNSI 190 (956)
Q Consensus 172 ~~~~~l~~L~~L~L~~N~l 190 (956)
.++...+.|++|+|++|.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2233444555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.22 E-value=2.1e-05 Score=74.58 Aligned_cols=11 Identities=18% Similarity=0.063 Sum_probs=5.1
Q ss_pred CCccEEEccCC
Q 002178 274 PNLGYLDLSSN 284 (956)
Q Consensus 274 ~~L~~L~Ls~N 284 (956)
++|+.|+++.+
T Consensus 131 ~sL~~l~l~~~ 141 (167)
T d1pgva_ 131 ESLLRVGISFA 141 (167)
T ss_dssp SSCCEEECCCC
T ss_pred CCccEeeCcCC
Confidence 44444554443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00083 Score=72.65 Aligned_cols=76 Identities=18% Similarity=0.080 Sum_probs=47.5
Q ss_pred CCeeeeeCCeEEEEEEeCC-CcEEEEEEecCC------C-hhhHHHHHHHHHHHHhcC-C--CceeeeecccccCCcEEE
Q 002178 629 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEG------S-LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEEGEQML 697 (956)
Q Consensus 629 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~L 697 (956)
.+.||.|....||+....+ ++.|+||..... . .....+...|++.++.+. + ..+.+++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3468999999999998654 678999964321 1 111224556888777663 2 3455666553 445689
Q ss_pred EEecCCCCC
Q 002178 698 VYEFMSNGT 706 (956)
Q Consensus 698 V~e~~~~gs 706 (956)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.44 E-value=0.0063 Score=63.63 Aligned_cols=67 Identities=19% Similarity=0.195 Sum_probs=45.6
Q ss_pred eEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce--eeeec-----ccccCCcEEEEEecCCCC
Q 002178 638 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLVG-----YCDEEGEQMLVYEFMSNG 705 (956)
Q Consensus 638 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~LV~e~~~~g 705 (956)
-.||++..++|+.|++|+..... ...+++..|.+.+..+....+ +..+. .+...+..+.|+++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999999999999999986542 234577889888887753222 11111 123456778999999764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.27 E-value=0.00012 Score=69.13 Aligned_cols=40 Identities=8% Similarity=0.008 Sum_probs=18.4
Q ss_pred CCCCCCEEEccC-CCCccc----CCcccccCcccchhhccCcCCC
Q 002178 104 RLSYLTILDFMW-NKISGS----IPKEIGNIKSLELLLLNGNELT 143 (956)
Q Consensus 104 ~l~~L~~L~Ls~-N~l~~~----ip~~~~~l~~L~~L~Ls~N~l~ 143 (956)
+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 345555555554 234321 1222334455555555555544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.06 E-value=0.00016 Score=68.13 Aligned_cols=12 Identities=42% Similarity=0.326 Sum_probs=5.9
Q ss_pred cCcccchhhccC
Q 002178 128 NIKSLELLLLNG 139 (956)
Q Consensus 128 ~l~~L~~L~Ls~ 139 (956)
+.++|++|+|++
T Consensus 15 ~~~~L~~L~L~~ 26 (166)
T d1io0a_ 15 NDPDLEEVNLNN 26 (166)
T ss_dssp TCTTCCEEECTT
T ss_pred cCCCCcEEEcCC
Confidence 334555555554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.62 E-value=0.017 Score=62.05 Aligned_cols=72 Identities=18% Similarity=0.232 Sum_probs=48.4
Q ss_pred CeeeeeCCeEEEEEEeCC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeeecccccCCcEEEEEe
Q 002178 630 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYE 700 (956)
Q Consensus 630 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~e 700 (956)
+.|+.|-.-.+|+....+ .+.|.+++.... .......+|.++++.+.-.++ .++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467888888999988653 346777776532 223345678888888753344 477777754 58999
Q ss_pred cCCCCCH
Q 002178 701 FMSNGTL 707 (956)
Q Consensus 701 ~~~~gsL 707 (956)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.38 E-value=0.084 Score=54.21 Aligned_cols=157 Identities=10% Similarity=0.030 Sum_probs=83.0
Q ss_pred ccHHHHHHHhcCCCCCCeee-----eeCCeEEEEEEeCCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce--eeee
Q 002178 614 FTYGEMALATNNFNSSTQIG-----QGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLV 686 (956)
Q Consensus 614 ~~~~~~~~~~~~y~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~ 686 (956)
.+.+++.....+|.+.+... .|---+.|+....+|+ +++|+...... .+++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 35567777778887755443 4555678998876665 78898764322 2345556777777643222 1111
Q ss_pred cc------cccCCcEEEEEecCCCCCHHH--------------HHhhc----C-----CCC----------------chh
Q 002178 687 GY------CDEEGEQMLVYEFMSNGTLRD--------------QLSAK----S-----KEP----------------LGF 721 (956)
Q Consensus 687 ~~------~~~~~~~~LV~e~~~~gsL~~--------------~l~~~----~-----~~~----------------l~~ 721 (956)
.. ....+....++.++.+..... .++.. . ... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 122445667777775533310 01100 0 000 001
Q ss_pred HHHHHHHHHHHHHHHHhhh-cCCCCEeccCCCcccEEEcCCCcEEEEeecccc
Q 002178 722 AMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (956)
Q Consensus 722 ~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DfGla~ 773 (956)
......+..+...+.-.+. .-...+||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222222222 112349999999999999998777899999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.02 E-value=0.0025 Score=64.78 Aligned_cols=60 Identities=18% Similarity=0.213 Sum_probs=40.4
Q ss_pred hcccCCCCCCCHHHHHHHHHHhH-hhCCC-CCCCCccccccccCCCCCCCCCCccCCCCCcc
Q 002178 877 CCQDETDARPSMSEVMRELESIW-NMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 936 (956)
Q Consensus 877 c~~~~p~~RPs~~~v~~~L~~~~-~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~e~L~HP~f 936 (956)
|....|-.-.+..++.+.+..-. ..+|. ..+...+++++||+.||++|||++|+|+|||+
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 44445555556666655544321 11221 23445789999999999999999999999995
|